<SEC-DOCUMENT>0001047469-16-009839.txt : 20160125
<SEC-HEADER>0001047469-16-009839.hdr.sgml : 20160125
<ACCEPTANCE-DATETIME>20160125171636
ACCESSION NUMBER:		0001047469-16-009839
CONFORMED SUBMISSION TYPE:	S-1
PUBLIC DOCUMENT COUNT:		30
FILED AS OF DATE:		20160125
DATE AS OF CHANGE:		20160125

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TACTILE SYSTEMS TECHNOLOGY INC
		CENTRAL INDEX KEY:			0001027838
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		S-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-209115
		FILM NUMBER:		161359401

	BUSINESS ADDRESS:	
		STREET 1:		1331 TYLER STREET NE STE 200
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55413
		BUSINESS PHONE:		866-435-3948

	MAIL ADDRESS:	
		STREET 1:		1331 TYLER STREET NE STE 200
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55413
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1
<SEQUENCE>1
<FILENAME>a2227029zs-1.htm
<DESCRIPTION>S-1
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<P><FONT SIZE=3 >
Use these links to rapidly review the document<BR>
<A HREF="#bg12201_table_of_contents">  TABLE OF CONTENTS</A> <BR>
<A HREF="#fa12201_tactile_systems_technology,_inc.">  TACTILE SYSTEMS TECHNOLOGY, INC.</A><BR></font>
</P>

<P style="font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>As filed with the Securities and Exchange Commission on January&nbsp;25, 2016.  </B></FONT></P>

<P ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> Registration No.&nbsp;333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> &nbsp;<BR>  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> <div style="width:100%;border-top:solid #3B5A6F 3.0pt;padding:0in 0in 0in 0in;font-size:3.0pt;"></div>
<div style="width:100%;border-top:solid #3B5A6F 1.0pt;padding:0in 0in 0in 0in;font-size:4.0pt;"></div>  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=5><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>  </B></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Washington, D.C. 20549  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="18%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="18%" ALIGN="CENTER" >


  </I></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>

<!-- COMMAND=ADDING_LINEBREAK -->

<BR>  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=5><B>FORM S-1<BR>  </B></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>REGISTRATION STATEMENT<BR>
UNDER<BR>
THE SECURITIES ACT OF&nbsp;1933  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="18%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="18%" ALIGN="CENTER" >


  </I></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>

<!-- COMMAND=ADDING_LINEBREAK -->

<BR>  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=5><B>TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.<BR>  </B></FONT><FONT COLOR="#3B5A6F" SIZE=2>(Exact name of registrant as specified in its charter) </FONT></P>

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>Delaware</B></FONT><FONT COLOR="#3B5A6F" SIZE=2><BR>
(State or other jurisdiction of<BR>
incorporation or organization)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> 3841</B></FONT><FONT COLOR="#3B5A6F" SIZE=2><BR>
(Primary Standard Industrial<BR>
Classification Code Number)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> 41-1801204</B></FONT><FONT COLOR="#3B5A6F" SIZE=2><BR>
(I.R.S. Employer<BR>
Identification No.)</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>Tactile Systems Technology,&nbsp;Inc.<BR>
1331 Tyler Street NE, Suite&nbsp;200<BR>
Minneapolis, MN 55413<BR>
(612)&nbsp;355-5100</B></FONT><FONT COLOR="#3B5A6F" SIZE=2><BR>
(Address, including zip code, and telephone number, including<BR>
area code, of registrant's principal executive offices) </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>Gerald R. Mattys<BR>
Chief Executive Officer<BR>
Tactile Systems Technology,&nbsp;Inc.<BR>
1331 Tyler Street NE, Suite&nbsp;200<BR>
Minneapolis, MN 55413<BR>
(612)&nbsp;355-5100<BR>  </B></FONT><FONT COLOR="#3B5A6F" SIZE=2>(Name, address, including zip code, and telephone number, including area code, of agent for service) </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="18%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="18%" ALIGN="CENTER" >


  </I></FONT><FONT COLOR="#3B5A6F" SIZE=2>

<!-- COMMAND=ADDING_LINEBREAK -->

<BR></FONT></P>

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="46%" style="font-family:times;"></TD>
<TD WIDTH="33pt" style="font-family:times;"></TD>
<TD WIDTH="46%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD COLSPAN=3 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>Copies to:</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2><B>Jonathan R. Zimmerman<BR>
Faegre Baker Daniels&nbsp;LLP<BR>
2200 Wells Fargo Center<BR>
90 South Seventh Street<BR>
Minneapolis, MN 55402-1425<BR>
(612)&nbsp;766-7000</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2><B> Jonathan B. Abram<BR>
Dorsey&nbsp;&amp; Whitney&nbsp;LLP<BR>
50 South Sixth Street<BR>
Suite&nbsp;1500<BR>
Minneapolis, MN 55402-1498<BR>
(612)&nbsp;340-2868</B></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="18%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="18%" ALIGN="CENTER" >


  </I></FONT><FONT COLOR="#3B5A6F" SIZE=2>

<!-- COMMAND=ADDING_LINEBREAK -->

<BR></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>Approximate date of commencement of proposed sale to the public: </B></FONT><FONT COLOR="#3B5A6F" SIZE=2>As soon as practicable after the effective date of this registration statement. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule&nbsp;415 under the Securities Act of 1933, as amended, check the following
box.&nbsp;&nbsp;&nbsp;&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If this Form is filed to register additional securities for an offering pursuant to Rule&nbsp;462(b) under the Securities Act, check the following box and list the Securities
Act registration number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&nbsp;&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If this Form is a post-effective amendment filed pursuant to Rule&nbsp;462(c) under the Securities Act, check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&nbsp;&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If this Form is a post-effective amendment filed pursuant to Rule&nbsp;462(d) under the Securities Act, check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&nbsp;&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of
"large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule&nbsp;12b-2 of the Exchange Act. (Check one): </FONT></P>
 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="117pt" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="91pt" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="140pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Large&nbsp;accelerated filer&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Accelerated&nbsp;filer&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Non-accelerated filer&nbsp;<FONT FACE="WINGDINGS">&#253;</FONT><BR></FONT> <FONT COLOR="#3B5A6F" SIZE=1>(Do not check if a<BR>
smaller reporting company)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Smaller&nbsp;reporting&nbsp;company&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="18%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="18%" ALIGN="CENTER" >


 </I></FONT><FONT COLOR="#3B5A6F" SIZE=2>

<!-- COMMAND=ADDING_LINEBREAK -->

<BR></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>CALCULATION OF REGISTRATION FEE  </B></FONT></P>

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="65%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="96" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="96" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:4pt;text-indent:-4pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" VALIGN="TOP">
<TD COLSPAN=5 VALIGN="BOTTOM" style="font-family:times;border-bottom:double #3B5A6F 2.25pt;">&nbsp;</TD>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>Title of Each Class of Securities<BR>
to be Registered</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>Proposed Maximum<BR>
Aggregate Offering<BR>
Price(1)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>Amount of<BR>
Registration Fee(2)</B></FONT><BR></TH>
</TR>
<TR style="font-size:1.5pt;" VALIGN="TOP">
<TD COLSPAN=5 VALIGN="BOTTOM" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;">&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:3pt;text-indent:-3pt;"><FONT COLOR="#3B5A6F" SIZE=1><B> </B></FONT><FONT COLOR="#3B5A6F" SIZE=2>Common stock, par value $0.001 per share</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$86,250,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$8,685.38</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" VALIGN="TOP">
<TD COLSPAN=5 VALIGN="BOTTOM" style="font-family:times;border-bottom:double #3B5A6F 2.25pt;"><p style="font-family:times;margin-left:4pt;text-indent:-4pt;"> &nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->

<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Estimated
solely for the purpose of computing the registration fee pursuant to Rule&nbsp;457(o) under the Securities Act of 1933, as amended. Includes
offering price of shares of common stock subject to the underwriters' option to purchase additional shares, solely to cover over-allotments, if any.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Calculated
pursuant to Rule&nbsp;457(o) under the Securities Act of 1933, as amended, based on an estimate of the proposed maximum aggregate offering
price. </FONT></DD></DL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="18%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="18%" ALIGN="CENTER" >


 </I></FONT><FONT COLOR="#3B5A6F" SIZE=2>

<!-- COMMAND=ADDING_LINEBREAK -->

<BR></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file&nbsp;a further
amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section&nbsp;8(a) of the Securities Act of 1933, as amended, or until the
registration statement shall become effective on such date as the Commission, acting pursuant to said Section&nbsp;8(a), may determine</B></FONT><FONT COLOR="#3B5A6F" SIZE=2>. </FONT></P>
 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</font></p>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><div
style="width:100%;border-top:solid #3B5A6F 1.0pt;padding:0in 0in 0in 0in;font-size:3.0pt;"></div>
<div style="width:100%;border-top:solid #3B5A6F 3.0pt;padding:0in 0in 0in 0in;font-size:4.0pt;"></div> </FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=1,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=940557,FOLIO='blank',FILE='DISK131:[15ZBY1.15ZBY12201]BA12201A.;32',USER='JKEENE',CD='25-JAN-2016;09:38' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=ADD_TXTHEX,"PMS193" -->


</B></FONT><FONT COLOR="#D90026" SIZE=2><B>The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration
statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any state
where the offer or sale is not permitted. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>



<!-- COMMAND=ADD_TXTHEX,"PMS193" -->


 </B></FONT><FONT COLOR="#D90026" SIZE=2><B>Subject to Completion, dated January&nbsp;25, 2016</B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=4><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares  </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="406pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=4><B>TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=4>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=4><B><BR>
 <IMG SRC="g202980.jpg" ALT="LOGO" WIDTH="174" HEIGHT="75">
<BR> </B></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=4><B>Common Stock  </B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=4><B>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share  </B></FONT></P>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="100%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="100%" ALIGN="LEFT" >


<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Tactile Systems Technology,&nbsp;Inc. is offering&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares.  </FONT> <FONT
COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> We anticipate that the initial public offering price will be between
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share.
 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> This is our initial public offering and no public market currently exists for our shares.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> We have applied to have our common stock approved for quotation on The NASDAQ Global Market under the symbol "TCMD." </FONT></DD></DL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="19%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="19%" ALIGN="CENTER" >


 </I></FONT><FONT COLOR="#3B5A6F" SIZE=2>

<!-- COMMAND=ADDING_LINEBREAK -->

<BR></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>This investment involves risk. See "Risk Factors" beginning on page&nbsp;15.  </B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We are an "emerging growth company" as defined in the Jumpstart Our Business Startups Act of 2012, and as such, have elected to comply with certain reduced public company
reporting requirements in this prospectus and in future filings. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" VALIGN="TOP">
<TD COLSPAN=7 VALIGN="BOTTOM" style="font-family:times;border-bottom:double #3B5A6F 2.25pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="font-family:times;">&nbsp;</TD>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B><BR>&nbsp;</B></FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B><BR>
Per Share </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B><BR>&nbsp;</B></FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B><BR>
Total </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B><BR>&nbsp;</B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT COLOR="#3B5A6F" SIZE=1><B> </B></FONT><FONT COLOR="#3B5A6F" SIZE=2>Initial public offering price</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Underwriting discounts and commissions<SUP>(1)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Proceeds to Tactile Systems Technology,&nbsp;Inc., before expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" VALIGN="TOP">
<TD COLSPAN=7 VALIGN="BOTTOM" style="font-family:times;border-bottom:double #3B5A6F 2.25pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>See
"Underwriting" for additional information regarding underwriting compensation.  </FONT></DD></DL>
 </DIV>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>The underwriters have the option to purchase up to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional shares from us at the initial public offering price, less the underwriting
discounts and
commissions, for 30&nbsp;days after the date of this prospectus.</I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful
or complete. Any representation to the contrary is a criminal offense.</B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
underwriters expect to deliver the shares of our common stock to investors on or about&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2016. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="34%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="25%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="34%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=5><B>Piper Jaffray</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=5>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=5><B>William Blair</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=5>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=5><B>Canaccord Genuity</B></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="19%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="19%" ALIGN="CENTER" >


 </I></FONT><FONT COLOR="#3B5A6F" SIZE=2>

<!-- COMMAND=ADDING_LINEBREAK -->

<BR></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=4><B>BTIG  </B></FONT></P>
 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT COLOR="#3B5A6F" SIZE=2><B>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</b></font></p><p align=center style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>The date of this prospectus
is&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016.</B></FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=2,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=666059,FOLIO='blank',FILE='DISK131:[15ZBY1.15ZBY12201]BC12201A.;43',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>
<IMG SRC="g981962.jpg" ALT="GRAPHIC" WIDTH="684" HEIGHT="891">
  </B></FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=3,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=307351,FOLIO='blank',FILE='DISK131:[15ZBY1.15ZBY12201]BE12201A.;4',USER='JKEENE',CD='25-JAN-2016;10:00' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_bg12201_1_1"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="BG12201A_main_toc"></A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="bg12201_table_of_contents"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  TABLE OF CONTENTS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<A NAME="BG12201_TOC"></A> </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->
<!-- COMMAND=ADD_START_LINKTABLE -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Page </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#ca12201_prospectus_summary"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Prospectus Summary</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#ca12201_prospectus_summary"><FONT COLOR="#3B5A6F" SIZE=2>1</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#da12201_risk_factors"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Risk Factors</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#da12201_risk_factors"><FONT COLOR="#3B5A6F" SIZE=2>15</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#dk12201_special_note_regarding_forward-looking_statements"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Special Note Regarding Forward-Looking
Statements</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dk12201_special_note_regarding_forward-looking_statements"><FONT COLOR="#3B5A6F" SIZE=2>60</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#dk12201_use_of_proceeds"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Use of Proceeds</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dk12201_use_of_proceeds"><FONT COLOR="#3B5A6F" SIZE=2>62</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#dk12201_dividend_policy"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Dividend Policy</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dk12201_dividend_policy"><FONT COLOR="#3B5A6F" SIZE=2>63</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#dm12201_capitalization"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Capitalization</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dm12201_capitalization"><FONT COLOR="#3B5A6F" SIZE=2>64</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#do12201_dilution"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Dilution</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#do12201_dilution"><FONT COLOR="#3B5A6F" SIZE=2>66</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#dq12201_selected_consolidated_financial_data"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Selected Consolidated Financial Data</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dq12201_selected_consolidated_financial_data"><FONT COLOR="#3B5A6F" SIZE=2>69</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#ds12201_management_s_discussion_and_an__man03466"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Management's Discussion and Analysis of Financial Condition
and Results of Operations</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#ds12201_management_s_discussion_and_an__man03466"><FONT COLOR="#3B5A6F" SIZE=2>72</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#dy12201_business"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Business</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dy12201_business"><FONT COLOR="#3B5A6F" SIZE=2>90</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#ei12201_management"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Management</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#ei12201_management"><FONT COLOR="#3B5A6F" SIZE=2>122</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#ek12201_executive_compensation"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Executive Compensation</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#ek12201_executive_compensation"><FONT COLOR="#3B5A6F" SIZE=2>130</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#eo12201_certain_relationships_and_related_party_transactions"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Certain Relationships and Related Party
Transactions</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#eo12201_certain_relationships_and_related_party_transactions"><FONT COLOR="#3B5A6F" SIZE=2>143</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#eo12201_principal_stockholders"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Principal Stockholders</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#eo12201_principal_stockholders"><FONT COLOR="#3B5A6F" SIZE=2>145</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#eq12201_description_of_capital_stock"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Description of Capital Stock</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#eq12201_description_of_capital_stock"><FONT COLOR="#3B5A6F" SIZE=2>147</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#es12201_shares_eligible_for_future_sale"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Shares Eligible for Future Sale</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#es12201_shares_eligible_for_future_sale"><FONT COLOR="#3B5A6F" SIZE=2>154</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#eu12201_material_u.s._federal_income_t__mat02369"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Material U.S. Federal Income Tax Consequences to Non-U.S.
Holders</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#eu12201_material_u.s._federal_income_t__mat02369"><FONT COLOR="#3B5A6F" SIZE=2>156</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#ew12201_underwriting"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Underwriting</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#ew12201_underwriting"><FONT COLOR="#3B5A6F" SIZE=2>161</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#ey12201_legal_matters"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Legal Matters</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#ey12201_legal_matters"><FONT COLOR="#3B5A6F" SIZE=2>170</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#ey12201_experts"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Experts</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#ey12201_experts"><FONT COLOR="#3B5A6F" SIZE=2>170</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#ey12201_where_you_can_find_additional_information"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Where You Can Find Additional Information</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#ey12201_where_you_can_find_additional_information"><FONT COLOR="#3B5A6F" SIZE=2>170</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#fa12201_index_to_consolidated_financial_statements"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Index to Consolidated Financial Statements</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#fa12201_index_to_consolidated_financial_statements"><FONT COLOR="#3B5A6F" SIZE=2>F-1</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
<!-- COMMAND=ADD_END_LINKTABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="CENTER" >


  </I></FONT><FONT COLOR="#3B5A6F" SIZE=2>

<!-- COMMAND=ADDING_LINEBREAK -->

<BR></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>Until&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016, all dealers that effect transactions in
these securities, whether or not participating in this offering, may be required to deliver a prospectus.
This is in addition to the dealers' obligation to deliver a prospectus when acting as underwriters and with respect to their unsold allotment or subscriptions.  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>You should rely only on the information contained in this prospectus or any related free writing prospectus we may authorize to be delivered to you. We have not, and the
underwriters have not, authorized anyone to provide you with any information other than that contained or incorporated by reference in this prospectus or in any free writing prospectus prepared by or
on behalf of us or to which we have referred you. Neither we nor the underwriters take responsibility for, and can provide no assurance as to the reliability of, any other information that others may
give you. This prospectus is an offer to sell only the shares offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this
prospectus is current only as of its date, regardless of the time of delivery of this prospectus or any sale of shares of our common stock. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>i</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=4,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=670542,FOLIO='i',FILE='DISK131:[15ZBY1.15ZBY12201]BG12201A.;26',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_bg12201_1_2"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="bg12201_investors_outside_of_the_united_states"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  Investors Outside of the United States    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Neither we nor any of the underwriters have done anything that would permit this offering or possession or distribution of this prospectus in any
jurisdiction where action for that purpose is required, other than the United States. You are required to inform yourselves about and to observe any restrictions relating to this offering and the
distribution of this prospectus outside the United States. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="bg12201_trademarks"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  Trademarks    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Tactile Medical, Flexitouch, the Flexitouch and design, ACTitouch, Entr&eacute; and our logo are our trademarks and are used in this
prospectus. Trade names, trademarks and service marks of other companies appearing in this prospectus are the property of their respective owners. Solely for convenience, our trademarks and trade
names referred to in this prospectus appear without the &reg; and <SUP>TM</SUP> symbols, but those references are not intended to indicate, in any way, that we will not assert, to the
fullest extent under applicable law, our rights, or the right of the applicable licensor to these trademarks and trade names. Additionally, we do not intend for our use or display of other companies'
trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us, by these other companies. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="bg12201_industry_and_market_data"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  Industry and Market Data    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Certain market and industry data and forecasts included in this prospectus were obtained from independent market research, industry publications and
surveys, governmental agencies and publicly available information. Industry surveys, publications and forecasts generally state that the information contained therein has been obtained from sources
believed to be reliable, although they do not guarantee the accuracy or completeness of such information. We believe the data from such third-party sources to be reliable. However, we have not
independently verified any of such data and cannot guarantee its accuracy or completeness. Similarly, internal market research and industry forecasts, which we believe to be reliable based upon our
management's knowledge of the market and the industry, have not been verified by any independent sources. While we are not aware of any misstatements regarding the market or industry data presented
herein, our estimates involve risks and uncertainties and are subject to change based on various factors, including those discussed under the heading "Risk Factors," "Special Note Regarding
Forward-Looking Statements" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in this prospectus. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>ii</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=5,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=787775,FOLIO='ii',FILE='DISK131:[15ZBY1.15ZBY12201]BG12201A.;26',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ca12201_1_1"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> </i></font></p>
<DIV style="width:100%;border:#3B5A6F solid 1pt;border-bottom:#3B5A6F solid 1pt;padding-top:12pt;padding-right:12pt;padding-bottom:1pt;padding-left:12pt;">
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ca12201_prospectus_summary"> </A>
<A NAME="toc_ca12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  PROSPECTUS SUMMARY    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>This summary highlights information contained elsewhere in this prospectus and does not contain all of the information you
should consider when making your investment decision. You should read this entire prospectus carefully, including the sections titled "Risk Factors" and "Management's Discussion and Analysis of
Financial Condition and Results of Operations" and our consolidated financial statements and the notes thereto included elsewhere in this prospectus, before making an investment in our common stock.
As used in this prospectus, the terms
"company," "we," "our," and "us" refer to Tactile Systems Technology, Inc., doing business as Tactile Medical, except as otherwise indicated herein or as the context otherwise requires.  </I></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> <A NAME="ca12201_tactile_medical"> </A>
<A NAME="toc_ca12201_2"> </A>
<BR>    </I></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  Tactile Medical    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We are a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases at home. We focus on
advancing the standard of care in treating chronic diseases in the home setting to improve patient outcomes and quality of life and help control rising healthcare expenditures. We possess a unique,
scalable platform to deliver at-home healthcare solutions throughout the United States. This evolving care delivery model is recognized by policy-makers and payers as a key for controlling rising
healthcare expenditures. Our initial area of therapeutic focus is vascular disease, with a goal of advancing the standard of care in treating lymphedema and chronic venous insufficiency. Our
proprietary Flexitouch System is an at-home solution for lymphedema patients. Our proprietary ACTitouch System is a home-based solution for chronic venous insufficiency patients that may be worn
throughout the day. Our products deliver cost-effective, clinically proven, long-term treatment of chronic diseases. We employ a direct-to-patient and -provider model, through which we obtain patient
referrals from clinicians, manage insurance claims on behalf of our patients and their clinicians, deliver our solutions to patients and train them on the proper use of our solutions in their homes.
This model allows us to directly approach patients and clinicians, whereby we disintermediate the traditional durable medical equipment channel and capture both the manufacturer and distributor
margins. For the year ended December&nbsp;31, 2014, we generated revenues of $47.7&nbsp;million and had net income of $2.1&nbsp;million. Our revenues increased 28% during the year ended
December&nbsp;31, 2014 compared to the year ended December&nbsp;31, 2013. For the nine months ended September&nbsp;30, 2015, we generated revenues of $41.7&nbsp;million and had net income of
$0.1&nbsp;million. Our revenues increased 41% during the nine months ended September&nbsp;30, 2015 compared to the nine months ended September&nbsp;30, 2014. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A
traditional treatment for lymphedema is complete decongestive therapy, consisting of manual lymphatic drainage, which is a specialized application of gentle pressure to the skin applied by a
therapist that encourages drainage of lymph fluid, as well as decongestive exercises, skin care and compression with multilayered bandages, compression garments or pumps. Typically, this therapy
begins with clinic visits, but eventually patients transition to self-administered home-based therapy. The standard of care treatment for chronic venous insufficiency is compression therapy. As the
disease progresses, patients may develop a venous leg ulcer, which is commonly treated using multilayered bandages to minimize swelling and enhance blood flow. A clinician applies these non-removable
bandages to patients at a precise pressure and patients wear the bandages between weekly visits to the wound clinic during which the bandages are removed and reapplied. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
advanced at-home Flexitouch System mimics the clinic-based manual lymphatic drainage therapy through an easy-to-use, one-hour daily, self-applied treatment solution. Peer-reviewed, published
studies have shown that our Flexitouch System provides improved quality of life and clinical outcomes and delivers significant cost-savings to payers and patients, compared to traditional treatments.
The predecessor version of our Flexitouch System received 510(k) clearance in July 2002 and our current Flexitouch System received 510(k) clearance from the U.S. Food and Drug Administration, or FDA,
in </FONT></P>
 <p style="font-family:times;"><font style="font-size:1pt;line-height:1pt;">&nbsp;</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=6,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=872643,FOLIO='1',FILE='DISK131:[15ZBY1.15ZBY12201]CA12201A.;63',USER='JKEENE',CD='25-JAN-2016;09:40' -->
<A NAME="page_ca12201_1_2"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> </i></font></p>
<DIV style="width:100%;border:#3B5A6F solid 1pt;border-bottom:#3B5A6F solid 1pt;padding-top:12pt;padding-right:12pt;padding-bottom:1pt;padding-left:12pt;">
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>October
2006. Our Flexitouch System generated $43.7&nbsp;million, or 92%, of our revenues in 2014. Our ACTitouch System addresses chronic venous insufficiency and provides precise, sustained and
wearable compression that a patient may apply, remove and reapply at home. This system was developed to provide maximum convenience for patients by providing them with the freedom to remain active
while simultaneously receiving the benefits of both sustained and intermittent pneumatic compression, which we refer to as dual-compression therapy. In a clinical study, our ACTitouch System was shown
to have comparable efficacy in healing venous leg ulcers and achieved higher patient quality of life scores as compared to multilayered bandages. Our ACTitouch System received 510(k) clearance from
the FDA in June 2013 and generated $2.4&nbsp;million, or 5%, of our revenues in 2014. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>To
support the growth of our business, we invest heavily in our commercial infrastructure, consisting of our direct sales force, reimbursement capabilities and clinical expertise. We are a national,
accredited provider of home medical equipment services approved for coverage by private payers, Medicare, the Veterans Administration and certain Medicaid programs in the United States. We market our
products using a direct-to-patient and -provider model. Our direct sales force is focused on increasing clinician awareness of our solutions, and has grown from three people in March 2005 to over
70&nbsp;people as of September&nbsp;30, 2015. We utilize over 300 licensed, independent healthcare practitioners as at-home trainers who educate patients on the proper use of our solutions. Our
experienced reimbursement operations group of over 50 people focuses on verifying case-by-case benefits, obtaining prior authorization, billing and collecting payments from payers and providing
customer support services. Our payer relationships group of over 20 people is responsible for developing relationships with payer decision-makers to educate them on our product efficacy, develop
overall payer coverage policies and reimbursement criteria, manage Medicare patient claims and contracts with payers and serve as an advocacy liaison between patients, clinicians and payers throughout
the appeals process. Our clinical team, consisting of a scientific advisory board, in-house therapists and nurses and a medical director, serves as a resource to clinicians and patients and guides our
development of clinical evidence in support of our products. We believe these investments are critical to driving patient adoption of our technologies, and together with our commercial infrastructure,
represent a significant competitive advantage. Health insurance coverage for our Flexitouch System and our ACTitouch System is in place with private payers, Medicare, the Veterans Administration and
certain Medicaid programs. Based on our estimates, we have contracts as an in-network provider covering over 230&nbsp;million lives in the United States. Over 44,000&nbsp;patients were treated
with our Flexitouch System since 2002, and over 9,000 Flexitouch Systems were shipped in
2014. More than 1,800&nbsp;patients were treated with our ACTitouch System during its first full year of commercialization in 2014. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Overview of the Lymphedema and Chronic Venous Insufficiency Markets  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Lymphedema  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The lymphatic system performs a fundamental role in maintaining health through balancing fluids and regulating immunity by removing harmful bacteria,
viruses and waste products. Lymphatic structures are situated throughout the body and are comprised of a series of vessels, lymph nodes and lymphoid organs that act as a drainage system by collecting
protein rich lymph fluid and sending it to the venous system. Lymph nodes are located in several areas of the body with superficial and deep lymph nodes under each arm, at the hip, in the groin, above
the collar bones in the neck, in the abdomen, tonsils and spleen and in bone marrow. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Lymphedema
refers to a type of chronic swelling, or edema, which may occur in the arms, legs, neck, trunk or other body parts and causes severe and debilitating symptoms, including decreased mobility,
skin breakdown, pain, increased risk of serious infection and marked psychosocial impairment, resulting in significantly negative implications for a patient's health and quality of life. The disease </FONT></P>
 <p style="font-family:times;"><font style="font-size:1pt;line-height:1pt;">&nbsp;</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=7,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=604418,FOLIO='2',FILE='DISK131:[15ZBY1.15ZBY12201]CA12201A.;63',USER='JKEENE',CD='25-JAN-2016;09:40' -->
<A NAME="page_ca12201_1_3"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> </i></font></p>
<DIV style="width:100%;border:#3B5A6F solid 1pt;border-bottom:#3B5A6F solid 1pt;padding-top:12pt;padding-right:12pt;padding-bottom:1pt;padding-left:12pt;">
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>occurs
when the lymphatic vessels are unable to adequately drain protein-rich lymph fluid from the arms, legs or other regions of the body. Any condition or procedure that damages the lymph nodes or
lymphatic vessels, such as surgery or treatment for breast and other cancers, obesity, infection, scar tissue formation, trauma or chronic venous insufficiency can cause lymphedema. The disease may
also be caused from congenital malformation of the lymphatic system. Lymphedema is progressive in nature, worsens over time, and has no known cure. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Chronic Venous Insufficiency  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Chronic venous insufficiency occurs when the venous wall and/or valves in the veins are not working effectively, making it difficult for blood to
return to the heart. The disease is prevalent among patients who are obese or pregnant and may also be caused by high blood pressure, trauma, lack of exercise, smoking, deep vein thrombosis and
inflammation of the vein walls. As the valves deteriorate, blood leaks or flows backward, leading to increased pressure, stretched and dilated vessels and pooling of blood in the veins. As blood
accumulates, swelling occurs, leading to progressive tissue breakdown and venous leg ulcers. Ulcers develop in areas where blood collects as swelling interferes with the movement of oxygen and
nutrients through tissues, and if left untreated, these ulcers can quickly become infected or even gangrenous. Prolonged or untreated chronic venous insufficiency may damage the lymphatic system. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Market Opportunity  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Lymphedema and chronic venous insufficiency are costly and lifelong conditions with debilitating physical and psychological impacts on patients. We
estimate the addressable market opportunity for our solutions treating lymphedema and chronic venous insufficiency in the United States is approximately $4.1&nbsp;billion. We believe that between
three to five million people in the United States are living with lymphedema. Based on an analysis of claims data commissioned by us, we estimate approximately 700,000 patients were diagnosed with
lymphedema during the 12&nbsp;months ended June&nbsp;30, 2014. We estimate that the addressable market opportunity for our Flexitouch System is approximately $3.5&nbsp;billion in the United
States once clinicians, payers and patients are educated on the benefits of our products. This estimate is based on the number of patients diagnosed with lymphedema and our average selling price per
device. We believe that chronic venous insufficiency afflicts approximately 8% of the U.S. population, and this percentage may rise due to the growing prevalence of obesity and cancer, as well as an
aging population. Based on an analysis of claims data commissioned by us, we estimate there were over 1.5&nbsp;million patients diagnosed with venous leg ulcers in the United States during the
12&nbsp;months ended June&nbsp;30, 2014. We estimate that our immediately addressable patient population consists of the 30% to 40% of these patients, or approximately 525,000 patients, for whom
we believe device reimbursement is available because their venous leg ulcers have not resolved after six months of treatment. We estimate the addressable market
opportunity for our ACTitouch System is approximately $580&nbsp;million in the United States, which is based on the number of patients diagnosed with unresolved venous leg ulcers and our average
selling price per device. These estimates of addressable market opportunities are based on a number of internal and third-party estimates, which in turn are based on projections of current trends in
the diagnosis and treatment of lymphedema and chronic venous insufficiency as well as other estimates of potential patient populations. These projections and estimates involve inherent uncertainties,
and the conditions supporting the projections and estimates may change at any time. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Current Treatment and Limitations  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A traditional treatment for lymphedema is complete decongestive therapy, consisting of manual lymphatic drainage, which is a specialized application
of gentle pressure to the skin applied by a therapist that encourages drainage of lymph fluid, as well as decongestive exercises, skin care and </FONT></P>
 <p style="font-family:times;"><font style="font-size:1pt;line-height:1pt;">&nbsp;</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=8,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=728654,FOLIO='3',FILE='DISK131:[15ZBY1.15ZBY12201]CA12201A.;63',USER='JKEENE',CD='25-JAN-2016;09:40' -->
<A NAME="page_ca12201_1_4"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> </i></font></p>
<DIV style="width:100%;border:#3B5A6F solid 1pt;border-bottom:#3B5A6F solid 1pt;padding-top:12pt;padding-right:12pt;padding-bottom:1pt;padding-left:12pt;">
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>compression
with multilayered bandages, compression garments or pumps. Typically, this therapy begins with clinic visits three to five times per week for four to eight weeks, which is costly and time
consuming. At that point, clinical improvement plateaus or reimbursement for the therapy ends and patients transition to self-administered home-based care. Manual lymphatic drainage is difficult for
patients to self-administer due to limited range of motion and treatment techniques that are difficult to replicate, and traditional pump-based compression is uncomfortable and has not demonstrated
the benefits of our advanced pneumatic pump. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
standard of care treatment for chronic venous insufficiency is compression therapy. As the disease progresses, patients may develop a venous leg ulcer, which is commonly treated using multilayered
bandages to minimize swelling and enhance blood flow. A clinician applies these non-removable bandages to patients at a precise pressure and patients wear the bandages between weekly visits to the
wound clinic during which the bandages are removed and reapplied. Treatment typically occurs for several months and impairs patient quality of life by limiting bathing, range of motion and other
activities. Treatment efficacy is inconsistent because bandages can lose their precise pressure between treatments. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Competitive Strengths  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We focus on advancing the standard of care in treating chronic diseases at home to improve patient outcomes and quality of life and help control
rising healthcare expenditures. Our executive team collectively has over 100&nbsp;years of experience in healthcare, developing and commercializing innovative medical technology products and
services. We believe that our commercialization platform and experience, combined with the following competitive strengths, should allow us to continue to grow our revenues and increase our presence
in the market: </FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Established leadership in providing therapies for at-home treatment of
chronic disease.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;Our strategic focus is developing and providing innovative technologies for the treatment of chronic diseases at home.
Our core competency, which is our direct-to-patient and -provider model, comprises a direct sales force, contract at-home trainers, reimbursement capabilities and medical expertise that we use to
expand awareness, garner referrals and obtain payment for our products.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Proprietary technology with unique advantages over other
treatments.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;Our solutions leverage patented technological advancements that we believe give us a competitive advantage in the
marketplace. The unique ability of our Flexitouch System to mimic manual lymphatic drainage therapy provides improved quality of life and efficacy and delivers significant cost savings to payers and
patients as compared to traditional treatments. Our ACTitouch System has the unique ability to provide both sustained and intermittent pneumatic compression therapy in one wearable product,
demonstrating comparable efficacy in healing venous leg ulcers, while achieving higher patient quality of life scores as compared to the current standard of care.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Substantial clinical evidence and key opinion leader support for our
Flexitouch System.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;We have developed a substantial body of peer-reviewed, published clinical evidence that our Flexitouch System reduces
swelling and improves quality of life for lymphedema patients while reducing healthcare costs. In clinical studies, while using our Flexitouch System, patients reported a significant increase in their
ability to control their lymphedema along with an increase in activities of daily living, improvement in emotional status and reduction in limb volume, skin hardening, and pain. Our clinical evidence
is primarily based on retrospective studies of a limited number of total subjects, which studies do not </FONT></DD></DL>
</UL>
</UL>
 <p style="font-family:times;"><font style="font-size:1pt;line-height:1pt;">&nbsp;</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=9,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=73720,FOLIO='4',FILE='DISK131:[15ZBY1.15ZBY12201]CA12201A.;63',USER='JKEENE',CD='25-JAN-2016;09:40' -->
<A NAME="page_ca12201_1_5"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> </i></font></p>
<DIV style="width:100%;border:#3B5A6F solid 1pt;border-bottom:#3B5A6F solid 1pt;padding-top:12pt;padding-right:12pt;padding-bottom:1pt;padding-left:12pt;">

<UL>
<UL>
<UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>compare
our Flexitouch System with other advanced pneumatic compression devices. In addition, we have established strong relationships with key opinion leaders within vascular and lymphedema
specialties who promote market awareness of our solutions and inform our clinical efforts. We have in-house expertise that designs and manages clinical and economic studies in support of the efficacy
and cost-effectiveness of our products. </FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Significant healthcare system cost
savings.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;Our solutions offer meaningful cost savings for the healthcare system and patients, as compared to traditional treatments. As
demonstrated by a study published by the American Medical Association in </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>JAMA Dermatology</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>, our Flexitouch System reduces hospitalization occurrences and
length of stays, costly cellulitis infections, outpatient visits and physical therapy visits. In addition, we believe that our ACTitouch System eliminates costly multilayered bandage system supplies
and clinic application time, resulting in cost savings for wound clinics.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Distinctive national third-party payer core
competency.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;Our specialized reimbursement team is proficient at obtaining reimbursement from payers across the United States. We work
closely with government and private payers to educate them on lymphedema diagnosis and treatment, expand coverage and negotiate competitive rates for our solutions. We also work directly with
clinicians and patients to help them understand payer requirements for our products. We advocate for coverage and submit claims on behalf of our patients through patient-by-patient support and claim
processing. We also engage in broader payer strategic initiatives to gain general preauthorization for our products. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Strategy  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our goal is to become a leader in the at-home treatment of chronic diseases. We intend to leverage our established platform to be a global provider
of clinically proven, easy-to-use and cost-effective solutions. The key elements of our strategy include: </FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Increase awareness of our solutions and establish them as the
standards of care.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;We believe that many patients with lymphedema and chronic venous insufficiency are undiagnosed or undertreated, and
we intend to further educate physicians, wound nurses and lymphedema therapists, patients and payers to raise awareness of these diseases, the associated health burdens of such diseases on patients
and society and the clinical and economic benefits of using our products.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Expand our direct sales and customer support
teams.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;We plan to expand our direct sales and marketing organization to drive greater product adoption by patients and their clinicians.
We intend to strengthen our distribution network by continuing to recruit, train and retain talented sales representatives and increasing the number of licensed home trainers. With an expanded sales
force, we believe we could target additional clinical call points.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Introduce new features and products to grow our technology
platform.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;We intend to pursue new features for our products, and introduce new solutions to expand the number of patients using our
products and allow us to enter new clinical adjacencies. We pursue internal research, design and development, and work with external collaborators to expand our product offerings. In addition, we
evaluate opportunities to license or acquire additional technologies and products to expand our total addressable market opportunity. </FONT></DD></DL>
</UL>
</UL>
 <p style="font-family:times;"><font style="font-size:1pt;line-height:1pt;">&nbsp;</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=10,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=601777,FOLIO='5',FILE='DISK131:[15ZBY1.15ZBY12201]CA12201A.;63',USER='JKEENE',CD='25-JAN-2016;09:40' -->
<A NAME="page_ca12201_1_6"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> </i></font></p>
<DIV style="width:100%;border:#3B5A6F solid 1pt;border-bottom:#3B5A6F solid 1pt;padding-top:12pt;padding-right:12pt;padding-bottom:1pt;padding-left:12pt;">
 <UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Continue the development of clinical and economic outcome
data.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;A key part of our success is our ability to demonstrate the effectiveness of our products through clinical and economic outcome
data. We intend to invest in additional studies to support peer-reviewed, published studies that evidence the clinical and economic benefits of our solutions as compared to traditional treatments. We
intend to use these data to continue to educate clinicians, payers and patients on the proven advantages of our products compared to other therapies and expand our network of key opinion leader
advocates.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Expand third-party
reimbursement.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;Our products are covered under existing reimbursement codes, and we have secured coverage for our solutions with private
payers, Medicare, the Veterans Administration and certain Medicaid programs. Our team has experienced significant success in obtaining positive coverage policies from payers by developing direct
relationships with payer decision-makers, leveraging our relationships with physician societies and key opinion leaders, providing clinical data, demonstrating the efficacy of our products and
educating payers on the limitations of traditional lymphedema and venous leg ulcer treatments. We believe that reimbursement for our products could be expanded by obtaining preferred contracts with
payers.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Introduce our solutions outside the United
States.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;We currently sell our products only within the United States. While our plan is to continue to focus our direct sales efforts on
penetrating the U.S. market, we plan to pursue future international expansion. We have European CE Mark approval for our Flexitouch System and plan to seek CE Mark approval for our ACTitouch System.
We also have a Medical Device License in Canada for our Flexitouch System. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Related to Our Business  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our ability to successfully operate our business is subject to numerous risks, including those that are generally associated with operating in the
medical device industry. Some of the principal risks relating to our business and our ability to execute our business strategy include:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Our revenues are primarily generated from our Flexitouch System and we are therefore highly dependent on only one product. </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Our long-term growth depends on increasing awareness and adoption of our current products and our ability to develop and commercialize
additional products. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> If we are unable to achieve and maintain adequate levels of coverage or reimbursement for our products, our business and results of
operations will be adversely affected. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Our U.S. patents for our Flexitouch System will expire in 2017, which may subject us to increased competition and reduce our
opportunity to increase or maintain our revenues from our Flexitouch System. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> A recent change to the criteria for Medicare coverage for our products could have an adverse effect on our business and results of
operations. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> If we are unable to expand, manage and maintain our direct sales and marketing organizations, we may not be able to generate
anticipated revenues. </FONT></DD></DL>
</UL>
</UL>
 <p style="font-family:times;"><font style="font-size:1pt;line-height:1pt;">&nbsp;</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=11,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=182946,FOLIO='6',FILE='DISK131:[15ZBY1.15ZBY12201]CA12201A.;63',USER='JKEENE',CD='25-JAN-2016;09:40' -->
<A NAME="page_ca12201_1_7"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> </i></font></p>
<DIV style="width:100%;border:#3B5A6F solid 1pt;border-bottom:#3B5A6F solid 1pt;padding-top:12pt;padding-right:12pt;padding-bottom:1pt;padding-left:12pt;">
 <UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Increases in our operating costs could have an adverse effect on our financial condition and results of operations. </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> We compete and may compete in the future against other companies, some of which have longer operating histories, more established
products or greater resources than we do, which may harm our business. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Physicians and payers may require additional clinical studies prior to prescribing our products or to providing or maintaining
coverage and reimbursement for our products, particularly if the payers and physicians take issue with the design and results of the clinical studies. Any subsequent clinical studies that are
conducted and published may not be positive or consistent with our existing data, which would adversely affect the rate of adoption of our products. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> We are subject to extensive federal and state regulation, and if we fail to comply with applicable regulations, we could suffer severe
criminal or civil sanctions or be required to make significant changes to our operations that could adversely affect our business, financial condition and operating results. </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> If we are unable to protect our intellectual property, or operate our business without infringing on the intellectual property rights
of third parties, our business will be negatively affected. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Implications of Being an Emerging Growth Company  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As a company with less than $1&nbsp;billion in revenues during our last fiscal year, we qualify as an "emerging growth company" as defined in the
Jumpstart Our Business Startups Act of 2012, or the JOBS Act. For so long as we remain an emerging growth company, we are permitted and intend to rely on exemptions from specified disclosure and other
requirements that are applicable to other public companies that are not emerging growth companies. These exemptions include:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> being permitted to provide only two years of audited financial statements, in addition to any required unaudited interim financial
statements, with correspondingly reduced "Management's Discussion and Analysis of Financial Condition and Results of Operations" disclosure; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> not being required to comply with the auditor attestation requirements in the assessment of our internal control over financial
reporting; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> not being required to comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding
mandatory audit firm rotation or a supplement to the auditor's report providing additional information about the audit and the financial statements; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> reduced disclosure obligations regarding executive compensation; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> exemptions from the requirements of holding a non-binding advisory vote on executive compensation and stockholder approval of any
golden parachute payments not previously approved. </FONT></DD></DL>
</UL>
</UL>
 <p style="font-family:times;"><font style="font-size:1pt;line-height:1pt;">&nbsp;</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=12,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=498809,FOLIO='7',FILE='DISK131:[15ZBY1.15ZBY12201]CA12201A.;63',USER='JKEENE',CD='25-JAN-2016;09:40' -->
<A NAME="page_ca12201_1_8"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> </i></font></p>
<DIV style="width:100%;border:#3B5A6F solid 1pt;border-bottom:#3B5A6F solid 1pt;padding-top:12pt;padding-right:12pt;padding-bottom:1pt;padding-left:12pt;">
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
may take advantage of these provisions for up to five years or such earlier time that we are no longer an emerging growth company. We would cease to be an emerging growth company if we have more
than $1&nbsp;billion in annual revenues, have more than $700&nbsp;million in market value of our capital stock held by non-affiliates or issue more than $1&nbsp;billion of non-convertible debt
over a three-year period. We may choose to take advantage of some, but not all, of the available exemptions. We have taken advantage of some reduced reporting burdens in this prospectus. Accordingly,
the information
contained herein may be different than the information you receive from other public companies in which you hold stock. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition, the JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. This provision allows an
emerging growth company to delay the adoption of some accounting standards until those standards would otherwise apply to private companies. We have elected to avail ourselves of this exemption and,
as a result, our financial statements may not be comparable to the financial statements of issuers that are required to comply with the effective dates for new or revised accounting standards that are
applicable to public companies. Section&nbsp;107 of the JOBS Act provides that we can elect to opt out of the extended transition period at any time, which election is irrevocable. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Corporate Information  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We were incorporated in Minnesota in January 1995 and reincorporated in Delaware as Tactile Systems Technology, Inc., through a merger with a
wholly-owned subsidiary in July 2006, but have been doing business as Tactile Medical. Our principal executive offices are located at 1331 Tyler Street NE, Suite&nbsp;200, Minneapolis, Minnesota
55413. Our telephone number is (612)&nbsp;355-5100. Our website address is </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>www.tactilemedical.com</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>. Information contained on, or that can be accessed
through, our website is not incorporated by reference into this prospectus, and should not be considered to be part of this prospectus. </FONT></P>
 <p style="font-family:times;"><font style="font-size:1pt;line-height:1pt;">&nbsp;</font></p>
</DIV>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>8</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=13,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=54844,FOLIO='8',FILE='DISK131:[15ZBY1.15ZBY12201]CA12201A.;63',USER='JKEENE',CD='25-JAN-2016;09:40' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_cc12201_1_9"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;<BR></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> </i></font></p>
<DIV style="width:100%;border:#3B5A6F solid 1pt;border-bottom:#3B5A6F solid 1pt;padding-top:12pt;padding-right:12pt;padding-bottom:1pt;padding-left:12pt;">
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="cc12201_the_offering"> </A>
<A NAME="toc_cc12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  THE OFFERING    <BR>    </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="24%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="73%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Issuer</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Tactile Systems Technology,&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Common stock offered by us</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Common stock to be outstanding immediately after this offering</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares
(or&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares, if the underwriters exercise their option in full to purchase additional shares)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Option to purchase additional shares</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The underwriters have the option to purchase up to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional shares from us. The underwriters can exercise this
option at any time within 30&nbsp;days of this prospectus.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Use of proceeds</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We intend to use the net proceeds from this offering primarily to expand our sales, marketing, reimbursement, clinical, regulatory and product development activities, and the remainder for
working capital, general and administrative expenses and other general corporate purposes. We will also use a portion of the net proceeds to pay the approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million of cumulative accrued dividends to our Series&nbsp;A preferred stockholders as described in "Dividend Policy." We
may also use a portion of our net proceeds to acquire or invest in complementary products, technologies or businesses, although we have no present commitments to complete any such transaction. See "Use of Proceeds" on page&nbsp;62 for a more complete
description of the intended use of proceeds from this offering.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Risk Factors</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Investing in our common stock involves risks. See "Risk Factors" beginning on page 15 and the other information included in this prospectus for a discussion of factors you should carefully
consider before deciding to invest in our common stock.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Dividend Policy</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The terms of our current certificate of incorporation provide that, upon conversion of our preferred stock into our common stock in connection with this offering, the holders of
Series&nbsp;A and Series&nbsp;B preferred stock will receive a cumulative accrued dividend calculated at a rate of 6% per annum. As of September&nbsp;30, 2015, we had $9.1&nbsp;million of cumulative accrued dividends payable to our Series&nbsp;A and
Series&nbsp;B preferred stockholders. Dividends payable to our Series&nbsp;A and Series&nbsp;B preferred stockholders have continued to accrue subsequent to September&nbsp;30, 2015. Based on an assumed closing date
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016, immediately prior to the completion of this offering, we expect to pay approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million of cumulative accrued dividends in cash to our Series&nbsp;A preferred stockholders and
issue&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock for cumulative accrued dividends to our Series&nbsp;B preferred stockholders. The cash dividends will be paid from the net proceeds of this offering and
neither the cash nor the stock dividends will be paid on any shares of our common stock purchased in this offering. We do not pay dividends on our common stock and do not anticipate paying any dividends on our common stock for the
foreseeable</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
<p style="font-family:times;"><font size=1></FONT><FONT COLOR="#3B5A6F" SIZE=2>
</font></p><p style="font-family:times;"><font style="font-size:1pt;line-height:1pt;">&nbsp;</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>9</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=14,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=1024936,FOLIO='9',FILE='DISK131:[15ZBY1.15ZBY12201]CC12201A.;51',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_cc12201_1_10"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> </i></font></p>
<DIV style="width:100%;border:#3B5A6F solid 1pt;border-bottom:#3B5A6F solid 1pt;padding-top:12pt;padding-right:12pt;padding-bottom:1pt;padding-left:12pt;">

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="24%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="73%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>future. Any future determinations relating to our dividend policy will be made at the discretion of our board of directors and will depend on various factors. See "Dividend
Policy."</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Directed Share Program</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>At our request, the underwriters have reserved for sale at the initial public offering price up to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our
common stock, or 5% of the shares offered by this prospectus, for our employees, directors and other persons associated with us. The participants in the directed share program are subject to the 180-day lock-up restriction described in the
"Underwriting" section of this prospectus with respect to the directed shares sold to them. The number of shares of our common stock available for sale to the general public in this offering will be reduced by the number of shares sold pursuant to
the directed share program. Any directed shares not so purchased will be offered by the underwriters to the general public on the same terms as the other shares offered by this prospectus. The directed share program will be arranged through Piper
Jaffray&nbsp;&amp;&nbsp;Co.</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Proposed NASDAQ Global Market symbol</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>"TCMD."</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Shares Outstanding  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The number of shares of common stock to be outstanding after this offering is based on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares
of our common stock outstanding
as of September&nbsp;30, 2015, including preferred stock on an as-converted basis and additional shares that our Series&nbsp;A and Series&nbsp;B preferred stockholders are entitled to receive in
connection with the initial public offering, and excludes the following:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock issuable upon the
exercise of outstanding options, with a weighted-average exercise price
of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock
issuable upon the exercise of outstanding warrants, with a weighted-average exercise price
of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock
reserved under our Employee Stock Purchase Plan, which will become effective prior to the
completion of this offering, as well as shares of our common stock that become available pursuant to provisions in our Employee Stock Purchase Plan that automatically increase the share reserve under
the Employee Stock Purchase Plan on January&nbsp;1 of each calendar year as described in "Executive Compensation&nbsp;&#151; Stock Option and Other Equity Compensation Plans;" </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock
reserved for future issuance under our stock-based compensative plans, consisting
of: </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock reserved for future
issuance under our 2003 Stock Option Plan; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock
reserved for future issuance under our 2007 Omnibus Stock Plan; and </FONT></DD></DL>
</DD></DL>
</UL>
</UL>
 <p style="font-family:times;"><font style="font-size:1pt;line-height:1pt;">&nbsp;</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=15,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=177770,FOLIO='10',FILE='DISK131:[15ZBY1.15ZBY12201]CC12201A.;51',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_cc12201_1_11"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> </i></font></p>
<DIV style="width:100%;border:#3B5A6F solid 1pt;border-bottom:#3B5A6F solid 1pt;padding-top:12pt;padding-right:12pt;padding-bottom:1pt;padding-left:12pt;">
 <UL>
<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock reserved for future
issuance under our 2016 Equity Incentive Plan, which will
become effective prior to the completion of this offering, as well as shares of our common stock that become available pursuant to provisions in our 2016 Equity Incentive Plan that automatically
increase the share reserve under the 2016 Equity Incentive Plan on January&nbsp;1 of each calendar year as described in "Executive Compensation&nbsp;&#151; Stock Option and Other Equity
Compensation Plans." </FONT></DD></DL>
</UL>
</UL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Pro Forma Adjustments  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Except as otherwise noted, the information in this prospectus reflects and assumes the following:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> a 1-for-&nbsp;&nbsp;&nbsp;&nbsp;reverse stock split of our capital stock, which became effective
on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,&nbsp;2016;
</FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the filing and effectiveness of our amended and restated certificate of incorporation and the adoption of our amended and restated
bylaws upon completion of this offering; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the conversion of all shares of our preferred stock outstanding into an aggregate
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock
immediately prior to the completion of this offering; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the issuance of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional
shares of our common stock immediately prior to the completion of this offering that our
Series&nbsp;A and B preferred stockholders are entitled to receive in connection with this initial public offering, assuming an initial offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the
midpoint of the estimated offering price range set forth on the cover page of this prospectus. A $1.00 decrease (increase) in the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share
would increase (decrease) the number of additional shares of our common stock issuable in connection with this initial public offering
by&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the issuance of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of
our common stock immediately prior to the completion of this offering to pay accrued
dividends on our Series&nbsp;B preferred stock, assuming a closing date of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016 and an
initial offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated
offering price range set forth on the cover page of this prospectus. A $1.00 decrease (increase) in the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share would increase (decrease)
the number of additional shares of our common stock issuable in connection with paying the accrued dividends on our Series&nbsp;B preferred stock
by&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the cash payment of a portion of the proceeds from this offering to pay the approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million of
cumulative accrued dividends to our Series&nbsp;A preferred stockholders as described in "Dividend Policy;" </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> no exercise of our outstanding options or warrants subsequent to September&nbsp;30, 2015; and </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> no exercise by the underwriters of their over-allotment option. </FONT></DD></DL>
</UL>
</UL>
 <p style="font-family:times;"><font style="font-size:1pt;line-height:1pt;">&nbsp;</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>11</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=16,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=441053,FOLIO='11',FILE='DISK131:[15ZBY1.15ZBY12201]CC12201A.;51',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<UL>
<UL>
</UL>
</UL>
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ce12201_1_12"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;<BR></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> </i></font></p>
<DIV style="width:100%;border:#3B5A6F solid 1pt;border-bottom:#3B5A6F solid 1pt;padding-top:12pt;padding-right:12pt;padding-bottom:1pt;padding-left:12pt;">
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ce12201_summary_consolidated_financial_data"> </A>
<A NAME="toc_ce12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  SUMMARY CONSOLIDATED FINANCIAL DATA    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The following tables set forth a summary of our historical consolidated financial data as of and for the periods indicated. The summary consolidated
statements of operations data for the years ended December&nbsp;31, 2013 and 2014 have been derived from our audited consolidated financial statements included elsewhere in this prospectus. Our
summary consolidated statements of operations data for the nine months ended September&nbsp;30, 2014 and 2015, and the summary consolidated balance sheet data as of September&nbsp;30, 2015, have
been derived from our
unaudited interim consolidated financial statements included elsewhere in this prospectus. We have prepared the unaudited interim consolidated financial statements on the same basis as the audited
consolidated financial statements and have included, in our opinion, all adjustments, consisting only of normal recurring adjustments that we consider necessary for a fair statement of financial
statements set forth in those statements. Our historical results are not indicative of the results to be expected in the future and our interim results are not necessarily indicative of results to be
expected for the full year ended December&nbsp;31, 2015, or any other period. The following summary financial data should be read in conjunction with, and are qualified in their entirety by
reference to, "Use of Proceeds," "Capitalization," "Selected Consolidated Financial Data," "Management's Discussion and Analysis of Financial Condition and Results of Operations" and our financial
statements and the related notes included elsewhere in this prospectus. </FONT></P>
 <p style="font-family:times;"><font style="font-size:1pt;line-height:1pt;">&nbsp;</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>12</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=17,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=523153,FOLIO='12',FILE='DISK131:[15ZBY1.15ZBY12201]CE12201A.;82',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_ce12201_1_13"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> </i></font></p>
<DIV style="width:100%;border:#3B5A6F solid 1pt;border-bottom:#3B5A6F solid 1pt;padding-top:12pt;padding-right:12pt;padding-bottom:1pt;padding-left:12pt;">

 <DIV style="padding:0pt;position:relative;width:73%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"110%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="110%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="74pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="74pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Nine Months Ended<BR>
September&nbsp;30, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(In thousands, except share and per share data)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Consolidated Statements of Operations Data:</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Revenues, net</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>37,176</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>47,736</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>29,626</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>41,712</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Cost of goods sold</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>9,772</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>12,715</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>8,284</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>11,839 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Gross profit</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>27,404</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>35,021</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>21,342</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>29,873 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Operating expenses:</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Sales and marketing</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>14,298</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>18,154</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>12,457</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>17,297</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Research&nbsp;and&nbsp;development&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,443</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,843</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,931</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,922</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Reimbursement, general and administrative</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>8,283</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10,225</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,419</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>9,448 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:50pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total operating expenses</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>25,024</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>31,222</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>21,807</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>29,667 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Income (loss) from operations</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
2,380</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
3,799</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
(465</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
206</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Other income (expense)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
4</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
(4</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
12</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
18 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Income&nbsp;(loss)
&nbsp;before&nbsp;income&nbsp;taxes&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,384</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,795</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(453</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>224</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Income tax expense (benefit)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
(772</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
1,725</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
(171</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
90 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net income (loss)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
3,156</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
2,070</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
(282</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
134</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Convertible preferred stock dividends</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,668</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,761</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,336</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,396</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Allocation of undistributed earnings to preferred stockholders</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,074</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>216</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net income (loss) attributable to common stockholders</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>414</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>93</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,618</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,262</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net income (loss) per common share attributable to common stockholders<SUP>(1)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.07</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.01</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(0.23</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(0.16</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.06</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.01</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(0.23</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(0.16</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Weighted-average common shares outstanding used to compute net income (loss) per common share attributable
to common stockholders</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6,305,401</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,025,035</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6,903,792</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,992,734</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,276,148</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10,709,649</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6,903,792</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,992,734</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Pro forma net income (loss) per common share attributable to common stockholders (unaudited)<SUP>(2)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Weighted-average common shares used to compute pro forma net income (loss) per common share attributable to common
stockholders (unaudited)<SUP>(2)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>

 <p style="font-family:times;"><font style="font-size:1pt;line-height:1pt;">&nbsp;</font></p>
</DIV>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>13</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=18,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=987996,FOLIO='13',FILE='DISK131:[15ZBY1.15ZBY12201]CE12201A.;82',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_ce12201_1_14"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> </i></font></p>
<DIV style="width:100%;border:#3B5A6F solid 1pt;border-bottom:#3B5A6F solid 1pt;padding-top:12pt;padding-right:12pt;padding-bottom:1pt;padding-left:12pt;">

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="74pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of September&nbsp;30, 2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Actual </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Pro forma<SUP>(3)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Pro forma as<BR>
adjusted<SUP>(4)(5)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(In thousands; unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Consolidated Balance Sheet Data:</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Cash and cash equivalents</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,672</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Working capital</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>18,981</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total assets</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>33,395</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total debt</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Convertible preferred stock</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>32,478</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Accumulated deficit</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(6,738</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total stockholders' equity (deficit)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(6,590</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Net
income (loss) per common share attributable to common stockholders is calculated under the two-class method, as our convertible preferred stock
participates in the undistributed earnings of the company. The two-class method requires earnings for the period to be allocated based upon their respective rights to receive distributed and
undistributed earnings. No adjustment is made during periods with a net loss, as the holders of the convertible preferred stock have no obligation to fund losses.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(2)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Pro
forma net income (loss) per common share attributable to common stockholders and the number of weighted-average common shares used to compute pro forma
net income (loss) per common share attributable to common stockholders reflect the adjustments set forth in "Summary&nbsp;&#151;&nbsp;The Offering &#151; Pro Forma Adjustments,"
except in lieu of the cash payment of a portion of the proceeds to pay cumulative accrued dividends to our Series&nbsp;A preferred stockholders, reflects the
additional&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of
common stock that would have been required to be issued to generate sufficient proceeds to fund the cash payment of the Series&nbsp;A convertible preferred stock dividends that are payable from the
net proceeds of this offering.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(3)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Reflects
the adjustments set forth in "Summary&nbsp;&#151; The Offering&nbsp;&#151; Pro Forma Adjustments," except in lieu of the cash
payment of approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million of cumulative accrued dividends to our Series&nbsp;A preferred stockholders, reflects a pro forma adjustment to accrued dividends
payable for
this amount. Dividends payable to our Series&nbsp;A and Series&nbsp;B preferred stockholders have continued to accrue subsequent to September&nbsp;30, 2015. Assuming a closing date of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016 and an initial offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus,
immediately prior to the completion of this offering, we expect to pay an additional approximately aggregate $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million of cumulative accrued dividends to our
Series&nbsp;A
preferred stockholders and issue an additional&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;aggregate shares of common stock to our Series&nbsp;B preferred stockholders, in payment of approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million of cumulative accrued dividends to our Series&nbsp;B preferred stockholders.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(4)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Reflects
(a)&nbsp;the pro forma adjustments described in footnote (3)&nbsp;above; (b)&nbsp;the cash payment of accrued dividends as of
September&nbsp;30, 2015 to our Series&nbsp;A preferred stockholders described in footnote (3)&nbsp;above; and (c)&nbsp;our sale and issuance
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock in this
offering, at an assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering price range set forth on the cover page of this
prospectus, after
deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(5)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>A
$1.00 increase (decrease) in the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering
price range set forth on the cover page of this prospectus, would increase (decrease) the pro forma as adjusted amount of each of our cash and cash equivalents, working capital, total assets and total
stockholders' equity (deficit), by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, assuming the assumed initial public offering price per share remains the same and after deducting the
estimated
underwriting discounts and commissions and estimated offering expenses payable by us. Similarly, each increase (decrease) of 1,000,000 shares in the number of shares offered by us would increase
(decrease) the pro forma as adjusted amount of each of our cash and cash equivalents, working capital, total assets and total stockholders' equity (deficit) by approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, assuming the assumed initial public offering price remains the same and after deducting the estimated underwriting discounts and commissions and estimated
offering
expenses payable by us. </FONT></DD></DL>
 </DIV>

 <p style="font-family:times;"><font style="font-size:1pt;line-height:1pt;">&nbsp;</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>14</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=19,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=315188,FOLIO='14',FILE='DISK131:[15ZBY1.15ZBY12201]CE12201A.;82',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_da12201_1_15"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="da12201_risk_factors"> </A>
<A NAME="toc_da12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  RISK FACTORS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>An investment in our common stock involves a high degree of risk. You should carefully consider the following risk factors
and all the other information in this prospectus before you decide to buy our common stock. If any of the following risks and uncertainties described below, together with all the other information
related to our business, actually occurs, our business, financial condition, operating results, and prospects would be adversely affected. In that event, the market price of our common stock could
decline and you could lose part or all of your investment.  </I></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Related to Our Business  </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our revenues are primarily generated from our Flexitouch System and we are therefore highly
dependent on only one product.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our Flexitouch System accounted for 92% of our revenues for the year ended December&nbsp;31, 2014 and 87% of our revenues for the nine months ended
September&nbsp;30, 2015. We expect that sales of this product will continue to account for the substantial majority of our revenues going forward. Therefore, our ability to execute our growth
strategy will depend not only upon increasing awareness of lymphedema, but also on the adoption of our Flexitouch System to treat this condition. Many physicians and clinicians may have experience
with, and/or invested substantial resources in, developing expertise in traditional treatments for lymphedema, which may make them less willing to adopt our Flexitouch System. If our Flexitouch System
fails to achieve wide market acceptance for any reason, our business, financial condition and results of operations could be adversely affected. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our long-term growth depends on awareness and adoption of our products.  </I></B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A primary growth strategy is to establish our products as the standard of care for the treatment of lymphedema and chronic venous insufficiency. In
order to achieve this growth strategy, we must:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> increase clinician and consumer awareness of these diseases, which are often undertreated; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> introduce the clinical and economic benefits of our solutions to physicians, therapists and other clinicians across several
specialties and in various clinical settings; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> demonstrate consistent coverage and reimbursement for our solutions by private payers, Medicare, the Veterans Administration and
certain Medicaid programs. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Clinicians
may not adopt our solutions as the standard of care for lymphedema and chronic venous insufficiency or may not prescribe our products for a number of reasons,
including:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our inability to educate a sufficient number of clinicians on these diseases or our products; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the unavailability or inadequacy of insurance coverage or reimbursement for our products; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> failure of evidence supporting clinical benefits or cost-effectiveness of our products over existing alternatives to convince
clinicians to change their treatment methods; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> resistance from clinicians to replace traditional treatments with our solutions. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
believe recommendations and support of our products by key opinion leaders can influence market acceptance and adoption. If these key opinion leaders choose to not support our products, our ability
to achieve broad market acceptance for our products may be impaired. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>15</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=20,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=921527,FOLIO='15',FILE='DISK131:[15ZBY1.15ZBY12201]DA12201A.;64',USER='JKEENE',CD='25-JAN-2016;09:41' -->
<A NAME="page_da12201_1_16"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If we are unable to achieve and maintain adequate levels of coverage or reimbursement for our
products, our business and results of operations will be adversely affected.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Any decline in the amount payers are willing to reimburse patients for our products could cause difficulty for patients to purchase our products and
could create pricing pressure for us. If we are forced to lower the price we charge for our products, our gross margins will decrease, which will adversely affect our business, financial condition and
results of operations. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Third-party
payers, whether foreign or domestic, or governmental or commercial, are developing increasingly sophisticated methods of controlling healthcare costs. In the United States, no uniform
policy of coverage and reimbursement for our products exists among third-party payers. Therefore, reimbursement for our products can differ significantly from payer to payer and our products are not
universally covered by third-party commercial payers. In addition, payers, including Medicare, continually review existing technologies for continued coverage and can, without notice, deny or reverse
coverage for existing products. We believe a reduction or elimination of coverage or reimbursement of our products by Medicare would likely cause commercial third-party payers to implement similar
reductions in their coverage or reimbursement of our products. If we are unable to expand coverage of our products by additional commercial payers, or if third-party payers that currently cover or
reimburse for our products reverse or limit their coverage in the future, our business and results of operations could be adversely affected. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Further,
we believe that future coverage and reimbursement may be subject to increased restrictions, such as additional preauthorization requirements, both in the United States and in international
markets. If we are unable to satisfy any new preauthorization requirements or adjust to any future new restrictions on our products, third-party coverage and reimbursement may be limited in the
future, which could have an adverse impact on our business. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


A recent change to the criteria for Medicare coverage for our products could have an adverse effect
on our business and results of operations.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
Medicare Administrative Contractors, or MACs, responsible for processing Medicare claims for durable medical equipment recently approved a Local Coverage Determination, or LCD, document that may
limit Medicare coverage of our products for certain patients. This LCD, released by the MACs on December&nbsp;17, 2015, is retroactively effective, beginning December&nbsp;1, 2015. The LCD
increases the severity of lymphedema symptoms that a patient must exhibit before such patient is eligible for Medicare reimbursement for a pneumatic compression device. The LCD also inserts more
restrictive criteria that require a patient to potentially endure a longer period of conservative therapy
to prove that it fails to control their lymphedema, instead of requiring completion of just one 4-week round of conservative therapy as stated in the National Coverage Determination, or NCD. The LCD
requires four consecutive weeks of conservative therapy with no significant improvement in symptoms during any of those four weeks. Further, the LCD does not cover use of an advanced pneumatic
compression device, such as our Flexitouch System, unless the patient's lymphedema is present in the chest, trunk or abdomen. Although many patients with lymphedema likely do have some level of chest,
trunk or abdominal involvement, this criteria in the LCD means that patients with lymphedema that is confined to the limb will not have access to advanced pneumatic compression devices until the
lymphedema progresses to impact the trunk, chest or abdomen. There is no similar requirement in the NCD that the lymphedema is present in the chest, trunk or abdomen. We are working through a
coalition of device manufacturers and healthcare providers to have the LCD revised to mirror the NCD. If our efforts and the efforts of other stakeholders to overturn the LCD are unsuccessful, it may
have a negative impact on certain Medicare patients' access to our Flexitouch System and our Entre System, which in turn could have an adverse effect on our business and results of operations. The LCD
pneumatic compression device coverage criteria for chronic venous insufficiency with venous stasis ulcers largely track existing NCD criteria, while defining the elements of a required conservative </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>16</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=21,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=420132,FOLIO='16',FILE='DISK131:[15ZBY1.15ZBY12201]DA12201A.;64',USER='JKEENE',CD='25-JAN-2016;09:41' -->
<A NAME="page_da12201_1_17"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>therapy
trial. Under the new LCD, advanced pneumatic compression devices like our Flexitouch System are no longer covered at all for the treatment of venous stasis ulcers. Private payers often follow
Medicare's lead in setting reimbursement criteria and, if the LCD is not overturned, private payers may adopt the same or similar coverage standards as set forth in the LCD. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


The U.S. patent protection for our Flexitouch System will expire in 2017, which may subject us to
increased competition and reduce or eliminate our opportunity to generate product revenues.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The four U.S. patents for our Flexitouch System will expire in 2017. Upon expiration of such patents, our Flexitouch System could be subject to
increased competition for products attempting to replicate our technology and our opportunity to increase or maintain revenues from our Flexitouch System could be substantially reduced. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If we are unable to expand, manage and maintain our direct sales and marketing organizations, we may
not be able to generate anticipated revenues.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our operating results are directly dependent upon the sales and marketing efforts of our employees. If our direct sales force fails to adequately
promote, market and sell our products, our sales may suffer. Our direct sales force has grown from three people in March 2005 to over 70&nbsp;people as of September&nbsp;30, 2015. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
order to generate future sales growth, we will need to expand the size and geographic scope of our direct sales organization. Accordingly, our future success will depend largely on our ability to
continue to hire, train, retain and motivate skilled sales personnel with significant technical knowledge of lymphedema and chronic venous insufficiency. Because the competition for their services is
high, we cannot assure you we will be able to hire and retain additional personnel on favorable or commercially reasonable terms, if at all. Failure to hire or retain qualified sales personnel would
prevent us from building awareness of our solutions, expanding our business and generating additional sales. If we are unable to expand our sales and marketing capabilities, we may not be able to
effectively commercialize our products, which could have an adverse impact on our business. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Increases in our operating costs could have an adverse effect on our financial condition and results
of operations.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Reimbursement rates are established by fee schedules mandated by private payers, Medicare, the Veterans Administration and certain Medicaid programs
and are likely to remain constant or decrease due, in part, to federal and state government budgetary constraints. As a result, with respect to Medicare and Medicaid related revenues, we may not be
able to offset the effects of general inflation on our operating costs through increases in prices for our products. In particular, labor and related costs account for a significant portion of our
operating costs and we compete with other healthcare providers to attract and retain qualified or skilled personnel and with various industries for administrative and service employees. This
competitive environment could result in increased labor costs. As such, we must control our operating costs, particularly labor and related costs, and failing to do so could adversely affect our
financial conditions and results of operations. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
operating costs may fluctuate significantly in the future as a result of a variety of factors, many of which are outside of our control. These factors
include:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> increased sales and marketing costs to increase awareness of our products; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> costs to develop new and enhanced features for current products and research and development costs for new products; </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>17</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=22,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=414455,FOLIO='17',FILE='DISK131:[15ZBY1.15ZBY12201]DA12201A.;64',USER='JKEENE',CD='25-JAN-2016;09:41' -->
<A NAME="page_da12201_1_18"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the time, resources, and expense required to develop and conduct clinical trials and seek additional regulatory clearances and
approvals for additional treatment indications for our products and for any additional products we develop; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the costs of preparing, filing, prosecuting, defending, and enforcing patent claims and other patent related costs, including
litigation costs and the results of such litigation; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> any product liability or other lawsuits related to our products and the costs associated with defending them or the costs related to
the results of such lawsuits; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the costs to attract and retain personnel with the skills required for effective operations; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the costs associated with being a public company; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> costs associated with entering international markets. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
failure to anticipate and minimize the impact of these costs could adversely affect our business and results of operations. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We compete and may compete in the future against other companies, some of which have longer
operating histories, more established products or greater resources than we do, which may harm our business.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The medical device industry is highly competitive. Our success depends, in part, upon our ability to maintain a competitive position in the
development of technologies and solutions for the at-home treatment of lymphedema and chronic venous insufficiency or for market adjacencies. Any product we develop will have to compete for market
acceptance and market share. We face significant competition in the United States, and we expect the intensity of competition will increase over time. Our primary competitors include Bio Compression
Systems, Inc., Lympha Press USA and Wright Therapy Products (which was recently acquired by BSN Medical GmbH). If we expand internationally, we expect that ArjoHuntleigh, an affiliate of the Getinge
Group, would become a competitor. Many of the companies developing or marketing competing products enjoy several competitive advantages, including:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> significantly greater name recognition; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> established relations with healthcare professionals, customers, and third-party payers; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> established distribution networks; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> additional lines of products, and the ability to offer rebates or bundle products to offer higher discounts or other incentives to
gain a competitive advantage; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> greater history in conducting research and development, manufacturing, marketing, and obtaining regulatory approval for homecare
devices; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> greater financial and human resources for product development, sales and marketing, patent litigation and customer financing. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
competitors may develop and patent processes or products earlier than us, obtain regulatory clearance or approvals for competing devices more rapidly than us or develop more effective or less
expensive products or technologies that render our technology or products obsolete or less competitive. We also face fierce competition in recruiting and retaining qualified sales, scientific,
reimbursement and </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>18</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=23,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=1026340,FOLIO='18',FILE='DISK131:[15ZBY1.15ZBY12201]DA12201A.;64',USER='JKEENE',CD='25-JAN-2016;09:41' -->
<A NAME="page_da12201_1_19"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>management
personnel, particularly those with direct-to-patient and -provider experience. If our competitors are more successful than us in these matters, our business may be harmed. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Physicians and payers may require additional clinical studies prior to prescribing our products or
to providing or maintaining coverage and reimbursement for our products. Any subsequent clinical studies that are conducted and published may not be positive or consistent with our existing data,
which would adversely affect the rate of adoption of our products.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our success depends in large part on the medical and third-party payer community's acceptance of our products as being useful in treating patients
with lymphedema or chronic venous insufficiency. We have sponsored 13 clinical studies in which a total of 682&nbsp;patients were treated with our products to track outcomes of treatment with our
products. While the results of our studies collectively indicate a favorable safety and efficacy profile, the study designs and results may not be viewed as compelling to physicians and insurers. In
particular, payers and physicians may see limitations in the design and results of the studies because certain studies were not specifically based on our products, involved a limited number of total
subjects or subjects outside the control group and made "quality of life" conclusions based upon criteria contained in patient questionnaires that required subjective conclusions. Certain physicians
and insurers may also prefer to see longer-term efficacy data than we have produced. If physicians or insurers do not find our data compelling or wish to wait for additional or independently-performed
studies, they may choose not to prescribe or to provide coverage and reimbursement for our products. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
cannot assure you that any data that we or others generate will be consistent with that observed in the existing studies or that results will be maintained beyond the time points studied. We also
cannot assure you that any data that may be collected will be compelling to the medical community because the data may not be scientifically meaningful or may not demonstrate that our products are
attractive alternatives to traditional treatments. If subsequent studies are not positive or consistent with our existing data, adoption of our products may suffer and, accordingly, our business could
be adversely impacted. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our long-term growth depends on our ability to develop and commercialize additional products.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The medical device industry is highly competitive and subject to rapid change and technological advancements. Therefore, it is important to our
business that we continue to enhance our product offerings and introduce new products. Developing products is expensive and time-consuming and could divert management's attention away from our
business. We may not be successful in developing new products or enhancements to existing products. Our ability to develop and commercialize additional products or enhancements to existing products
will depend on several factors, including our ability to:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> properly identify and anticipate physician and patient needs; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> develop and introduce new products or product enhancements in a timely manner; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> avoid infringing upon the intellectual property rights of third-parties; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> demonstrate the safety and efficacy of new products with data from clinical studies; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> obtain the necessary regulatory clearances or approvals for new products or product enhancements; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> be fully FDA-compliant with the development, manufacturing and marketing of new devices or modified products; </FONT> <FONT COLOR="#3B5A6F"
SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> provide adequate training to potential users of our products; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> secure adequate coverage and reimbursement for our products; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> develop an effective and dedicated sales and marketing team. </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>19</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=24,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=777283,FOLIO='19',FILE='DISK131:[15ZBY1.15ZBY12201]DA12201A.;64',USER='JKEENE',CD='25-JAN-2016;09:41' -->
<A NAME="page_da12201_1_20"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
we are unsuccessful in developing and commercializing new products, our ability to increase our revenues may be impaired. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


It is difficult to forecast future performance and our financial results may vary from forecasts and
may fluctuate from quarter to quarter.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our limited operating history and commercial experience make it difficult for us to predict future performance. A number of factors over which we
have limited control, such as seasonal variations in revenues, may contribute to fluctuations in our financial results. In the first and second quarters, our results of operations have been negatively
impacted by resetting of annual patient healthcare insurance plan deductibles, which may cause patients to delay purchase of elective products. In the third and fourth quarters, our revenues have been
higher because patients often spend the remaining balances in their flexible-spending accounts or because of lower out-of-pocket costs to patients who have met their annual deductibles under their
health insurance plans. To the extent that the prevalence of high deductible insurance plans and higher copay and coinsurance plans continue to grow in the private payer market, the seasonal
variations in our revenues could become even more pronounced. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Other
factors that may cause fluctuation in our quarterly results or variations from our forecasts include:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> physician adoption of our products; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> timing of new product offerings, acquisitions, licenses or other significant events by us or our competitors; </FONT> <FONT COLOR="#3B5A6F"
SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> unanticipated pricing pressure; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the hiring, retention and continued productivity of our sales representatives; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our ability to expand the geographic reach of our sales and marketing efforts; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our ability to obtain regulatory clearance or approval for our products in development or for our current products outside the United
States; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the impact of results from clinical research and trials on our existing products and products in development; </FONT> <FONT COLOR="#3B5A6F"
SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> delays in receipt of anticipated purchase orders; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> delays in, or failure of, component deliveries from our suppliers; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> positive or negative coverage in the media or clinical publications of our products or products of our competitors or our industry.
</FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
the event our actual revenues and operating results do not meet our forecasts or the forecasts or estimates of the research analysts that cover us for a particular period, the market price of our
common stock may decline substantially. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We utilize third-party, single-source suppliers for some components and materials used in our
products, and the loss of any of these suppliers could have an adverse impact on our business.  </I></B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We rely on third-party manufacturers and suppliers to supply all components and materials used in our Flexitouch, ACTitouch and Entr&eacute;
Systems. We rely on a single-source supplier for the controller in our </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>20</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=25,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=554159,FOLIO='20',FILE='DISK131:[15ZBY1.15ZBY12201]DA12201A.;64',USER='JKEENE',CD='25-JAN-2016;09:41' -->
<A NAME="page_da12201_1_21"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>ACTitouch
System. Our ability to supply our products commercially depends, in part, on our ability to obtain components and materials in accordance with our specifications and with regulatory
requirements and in sufficient quantities to meet demand for our products. Our ability to obtain components and materials may be affected by matters outside our control, including that our suppliers
may cancel our arrangements on short notice, we may be relatively less important as a customer to certain suppliers and our suppliers may have disruptions to their operations. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
we are required to establish additional or replacement suppliers for any of our components or materials, it may not be accomplished quickly and our operations could be disrupted. Even if we are
able to find replacement suppliers, the replacement suppliers would need to be qualified and may require additional regulatory authority approval, which could result in further delay. In the event of
a supply disruption, our product inventories may be insufficient to supply our patients. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
our third-party suppliers fail to deliver the required commercial quantities of materials on a timely basis and at commercially reasonable prices, and we are unable to find one or more replacement
suppliers capable of production at a substantially equivalent cost in substantially equivalent volumes and quality on a timely basis, the continued commercialization of our products, the supply of our
products to customers and the development of any future products would be delayed, limited or prevented, which could have an adverse impact on our business. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Consolidation in the healthcare industry could lead to demands for price concessions, which may
impact our ability to sell our products at prices necessary to support our current business strategies.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Healthcare costs have risen significantly over the past decade, which has resulted in or led to numerous cost reform initiatives by legislators,
regulators and third-party payers. Cost reform has triggered a consolidation trend in the healthcare industry to aggregate purchasing power, which may create more requests for pricing concessions in
the future. We expect that market demand, government regulation, third-party coverage and reimbursement policies and societal pressures will continue to change the healthcare industry worldwide,
resulting in further business consolidations and alliances among our payers, which may exert downward pressure on the prices of our products in the future. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may be unable to collect all of our Medicare accounts receivable.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>At September&nbsp;30, 2015, we had approximately $3.6&nbsp;million of accounts receivable for shipments of products to patients covered by
Medicare. A portion of our submitted claims to Medicare are initially denied and enter the appeals process, where many are ultimately reviewed by an Administrative Law Judge. The appeal process can be
lengthy, lasting more than a year in most cases. At September&nbsp;30, 2015, we have classified $2.0&nbsp;million as long-term accounts receivable due to estimated amount of receivables that will
be paid more than one year from September&nbsp;30, 2015. A significant increase in Medicare denial of submitted claims or an increase in the proportion of Medicare denials that are upheld by an
Administrative Law Judge would adversely affect our results of operations or cause us to recognize a write off of Medicare accounts receivables. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As
an alternative to individual appeals, Medicare may seek to settle a number of outstanding appeals at one time through a settlement conference. On September&nbsp;3, 2015, we entered into a
settlement agreement with the Centers for Medicare and Medicaid Services, or CMS, for 247 claims, representing approximately $1.46&nbsp;million of original claims based on the Medicare allowable
rates, in which we had submitted a request for an Administrative Law Judge hearing in 2013. The settlement entitled us to receive a payment of approximately $0.85&nbsp;million no later than
January&nbsp;21, 2016. We received this full amount during the fourth quarter of 2015. The settlement will result in a reduction in the fourth quarter of 2015 of $0.82&nbsp;million in our accounts
receivable for shipment of products to patients covered by Medicare. The settlement was part of a pilot program, facilitated by the Office of Medicare Hearings and Appeals, to address a backlog of
overdue claims awaiting Administrative Law Judge </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>21</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=26,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=979446,FOLIO='21',FILE='DISK131:[15ZBY1.15ZBY12201]DA12201A.;64',USER='JKEENE',CD='25-JAN-2016;09:41' -->
<A NAME="page_da12201_1_22"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>adjudication.
Because the settlement is part of a pilot program, we cannot predict whether we will be able to conclude future settlements with Medicare or achieve settlements on similar terms. Any
future settlement of claims for amounts less than the corresponding amounts receivable would result in a write off. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Changes to the level of Medicare coverage for our products could have an adverse effect on our
business and results of operations.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Determinations of which products or services will be reimbursed under Medicare can be developed at the national level through an NCD, by CMS, or at
the local level through an LCD, by one or all of the four regional Medicare Administrative Contractors, which are private contractors that process and pay claims on behalf of CMS for different
regions. These NCDs and LCDs may be subject to review and revision from time to time, which revisions may not be favorable for coverage of our products, and the NCDs and LCDs may not always be
consistent. We have in the past been required to respond to potential changes in LCDs for our products, which, if enacted, would have had adverse effects on our business. Further, we believe that a
reduction in coverage by Medicare would likely cause some commercial third-party payers to implement similar reductions in their coverage or reimbursement of our products. Given the evolving nature of
the healthcare industry and on-going healthcare cost reforms, we are and will continue to be subject to changes in the level of Medicare coverage for our products, and unfavorable coverage
determinations at the national or local level could adversely affect our business and results of operations. See also "</FONT><FONT COLOR="#3B5A6F" SIZE=2><I>A recent change to the criteria for Medicare coverage for
our products could have an adverse effect on our business and results of operations."</I></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


The size of the market for our products is an estimate, and may be smaller than we believe.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our estimate of the annual total addressable market for our products is based on a number of internal and third-party estimates. In addition, our
internal estimates are based in large part on current trends in diagnosing lymphedema and chronic venous insufficiency. While we believe these factors have historically provided and may continue to
provide us with effective tools in estimating the total market for lymphedema, chronic venous insufficiency and our products, these estimates may not be correct and the conditions supporting our
estimates may change at any time, thereby reducing the predictive accuracy of these underlying factors. As a result, our estimates of the annual total addressable market for our products may prove to
be incorrect. If the actual number of
patients who would benefit from our products and the annual total addressable market for our products is smaller than we have estimated, our future growth could be adversely impacted. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may be unable to manage our growth effectively.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our past growth has provided, and our future growth may create, challenges to our organization. For instance, from March 2005 to September&nbsp;30,
2015, the number of our employees increased from 10 to over 230. We intend to continue to grow and may experience periods of rapid growth and expansion. Future growth will impose significant added
responsibilities on management, including the need to identify, recruit, train, integrate, retain and motivate additional employees. In addition, rapid and significant growth will place a strain on
our administrative personnel, information technology systems and other operational infrastructure. Any failure by us to manage our growth effectively could have an adverse effect on our ability to
achieve our development and commercialization goals. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Successful
growth is also dependent upon our ability to implement appropriate financial and management controls, systems and procedures. In order to manage our operations and growth, we will need to
continue to improve our operational and management controls, reporting and information technology systems and financial internal control procedures. If we are unable to manage our growth effectively,
it may be difficult for us to execute our business strategy and there could be an adverse impact on our business. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>22</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=27,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=737167,FOLIO='22',FILE='DISK131:[15ZBY1.15ZBY12201]DA12201A.;64',USER='JKEENE',CD='25-JAN-2016;09:41' -->
<A NAME="page_da12201_1_23"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our ability to maintain our competitive position depends on our ability to attract, integrate and
retain key executives and highly qualified personnel.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We believe that our continued success depends to a significant extent upon the efforts and abilities of our executive officers and other key
personnel. Our executive officers and other key personnel are critical to the strategic direction and overall management of our company as well as our research and development process. We intend to
enter into new employment agreements with each of our named executive officers prior to the completion of this offering. Our inability to enter into such agreements on commercially reasonable terms or
the loss of any of our named executive officers or other key personnel could adversely affect our business, financial condition and operating results. Our Chief Financial Officer and Chief Operating
Officer intends to transition into a
full-time role as our Chief Operating Officer, and we are actively engaged in a process to identify and hire a new Chief Financial Officer. While he has indicated that he will continue in his current
roles until we have hired his replacement, we cannot assure you that we will be able to identify and hire an appropriate candidate in a timely manner or on terms reasonable to us or at all. Any delay
in hiring a new Chief Financial Officer could significantly disrupt our business and operations. In addition, some key personnel have only joined us in the last year as part of our investment in the
expansion of our business. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
future success also depends on our ability to continue to attract and retain additional executive officers and other key employees. We invest significant time and expense in training our
employees, which increases their value to competitors who may seek to recruit them. Many of our competitors have greater resources than we have that allows them to offer more competitive remuneration,
which could adversely impact our ability to attract and retain experienced executives and other key employees. We carry a "key person" insurance policy on only our Chief Executive Officer. The
replacement of any of our key personnel likely would involve significant time and costs and may significantly delay or prevent the achievement of our business objectives and would harm our business.
Our productivity may be adversely affected if we do not integrate and train our new employees quickly and effectively </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Many
of our employees have become or will soon become vested in a substantial amount of our common stock or a number of common stock options. Our employees may be more likely to leave us if the shares
they own have significantly appreciated in value relative to the original purchase prices of the shares, or if the exercise prices of the options that they hold are significantly below the market
price of our common stock, particularly after the expiration of the lock-up agreements described herein. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We face the risk of product liability claims that could be expensive, divert management's attention
and harm our reputation and business. We may not be able to maintain adequate product liability insurance.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our business exposes us to the risk of product liability claims that are inherent in the testing, manufacturing and marketing of medical devices.
This risk exists even if a device is cleared or approved for commercial sale by the FDA and manufactured in facilities licensed and regulated by the FDA or an applicable foreign regulatory authority.
Our products are designed to affect, and any future products will be designed to affect, important bodily functions and processes. Any side effects, manufacturing defects, misuse or abuse associated
with our products or our products in development could result in patient injury or death. The medical device industry has historically been subject to extensive litigation over product liability
claims, and we cannot offer any assurance that we will not face product liability suits. We may be subject to product liability claims if our products cause, or merely appear to have caused, patient
injury or death. In addition, an injury that is caused by the activities of our suppliers, such as those who provide us with components and materials, may be the basis for a claim against us. Product
liability claims may be brought against us by patients, clinicians or others selling or otherwise coming into contact with our products, among others. If we cannot </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>23</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=28,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=996975,FOLIO='23',FILE='DISK131:[15ZBY1.15ZBY12201]DA12201A.;64',USER='JKEENE',CD='25-JAN-2016;09:41' -->
<A NAME="page_da12201_1_24"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>successfully
defend ourselves against product liability claims, we will incur substantial liabilities and reputational harm. In addition, regardless of merit or eventual outcome, product liability
claims may result in:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> costs of litigation; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> distraction of management's attention from our primary business; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the inability to commercialize our existing or new products; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> decreased demand for our products or, if cleared or approved, products in development; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> damage to our business reputation; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> product recalls or withdrawals from the market; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> withdrawal of clinical trial participants; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> substantial monetary awards to patients or other claimants; or </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> loss of revenues. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>While
we may attempt to manage our product liability exposure by proactively recalling or withdrawing from the market any defective products, any recall or market withdrawal of our products would
delay the supply of those products to our clinicians and patients and may impact our reputation. We can provide no assurance that we will be successful in initiating appropriate market recall or
market withdrawal efforts that may be required in the future or that these efforts will have the intended effect of preventing product malfunctions and the accompanying product liability that may
result. Such recalls and withdrawals may also be used by our competitors to harm our reputation for safety or be perceived by patients as a safety risk when considering the use of our products, either
of which could have an adverse impact on our business. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition, our product liability insurance is subject to deductibles and coverage limitations. Our current product liability insurance may not continue to be available to us on acceptable terms, if
at all, and, if available, coverage may not be adequate to protect us against any future product liability claims. If we are unable to obtain insurance at an acceptable cost or on acceptable terms or
otherwise protect against potential product liability claims, we could be exposed to significant liabilities. A product liability claim, recall or other claim with respect to uninsured liabilities or
for amounts in excess of insured liabilities could have an adverse impact on our business. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Changes in reimbursement coding could impair our ability to receive reimbursement for our products.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The International Statistical Classification of Diseases and Related Health Problems 9th Revision, or ICD-9, is a coding of diseases, signs and
symptoms, abnormal findings, complaints, social circumstances and external causes of injury or diseases, as classified by the World Health Organization that permits the tracking of many diagnoses.
Current health plan systems
and health care providers are required by the Health Insurance Portability and Accountability Act of 1996, or HIPAA, to use a standard code set to indicate diagnoses and procedures on transactions.
For diagnoses, CMS created a derivation of the ICD-9 code for use. For other types of procedures, health plans and providers use Current Procedural Terminology, or CPT, or Healthcare Common Procedure
Coding System, or HCPCS, codes. The International Statistical Classification of Diseases and Related Health Problems 10th Revision, or ICD-10, was recently released and a modified version of ICD-10
was adopted by CMS and use of the updated diagnosis codes is now required. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>24</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=29,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=766179,FOLIO='24',FILE='DISK131:[15ZBY1.15ZBY12201]DA12201A.;64',USER='JKEENE',CD='25-JAN-2016;09:41' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dc12201_1_25"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The ICD-10 codes are markedly different from their predecessors and because ICD-9 codes are used in almost every clinical and administrative process in a healthcare setting,
substantial system and procedural changes will be necessary to implement and correctly use the new codes. The updated code sets will require significant changes in the way health plans reimburse
services, and in the way coverage of services is determined. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
Flexitouch System is reimbursed under HCPCS code E0652, our ACTitouch System is reimbursed under HCPCS code E0651, and our Entr&eacute; System is reimbursed under HCPCS code E0651.
Garments that cover various parts of the body are used with these systems and billed using HCPCS codes E0651, E0652, E0667, E0668 and E0669. These are tied to specific existing ICD-9 diagnoses. Many
private payers have paid for our products using these codes as well. These contracts allow us to be an in-network provider for these payers, and eases our administrative burden in processing at both
prior authorization and billing levels. With the change to ICD-10, it is possible the we or our patients may have difficulty properly submitting claims for reimbursement and, even if the claims are
properly submitted, private payers, Medicare and Medicaid may have problems processing the claims. This could have an adverse impact on our reimbursement rates, results of operations and cash flows. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If the quality of our products does not meet the expectations of physicians or patients, then our
brand and reputation could suffer and our business could be adversely impacted.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In the course of conducting our business, we must adequately address quality issues that may arise with our products, as well as defects in
third-party components included in our products. There can be no assurance that our internal procedures to minimize risks that may arise from quality issues will be able to eliminate or mitigate
occurrences of these issues and associated liabilities. If the quality of our products does not meet the expectations of physicians or patients, then our brand and reputation could suffer with those
physicians or patients and our business could be adversely impacted. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If our facilities are damaged or become inoperable, we will be unable to continue to research,
develop, manufacture and commercialize our products and, as a result, there will be an adverse impact on our business until we are able to secure a new facility.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We do not have redundant facilities. We perform substantially all of our research and development, assembly and back office activity and maintain all
our finished goods inventory in a single location in Minneapolis, Minnesota. Our facility and equipment would be costly to replace and could require substantial lead time to repair or replace. The
facility may be harmed or rendered inoperable by natural or man-made disasters, including, but not limited to, tornadoes, flooding, fire and power outages, which may render it difficult or impossible
for us to perform our research, development, manufacturing and commercialization activities for some period of time. The inability to perform those activities, combined with our limited inventory of
reserve raw materials and finished product, may result in the inability to continue manufacturing our products during such periods and the loss of customers or harm to our reputation. Our insurance
for damage to our property and the disruption of our business may not be sufficient to cover all of our potential losses, and this insurance may not continue to be available to us on acceptable terms,
or at all. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If we choose to acquire new and complementary businesses, products or technologies, we may be unable
to complete these acquisitions or to successfully integrate them in a cost-effective and non-disruptive manner.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our success depends on our ability to continually enhance and broaden our product offerings in response to changing customer demands, competitive
pressures and advances in technologies. Accordingly, although we have no current commitments with respect to any acquisition or investment, we may in the future pursue the acquisition of, or joint
ventures relating to, complementary businesses, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>25</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=30,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=1002752,FOLIO='25',FILE='DISK131:[15ZBY1.15ZBY12201]DC12201A.;43',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_dc12201_1_26"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>products
or technologies instead of developing them ourselves. We do not know if we will be able to successfully complete any future acquisitions or joint ventures, or whether we will be able to
successfully integrate any acquired business, product or technology or retain any key employees related thereto. Integrating any business, product or technology we acquire could be expensive and
time-consuming, disrupt our ongoing business and distract our management. If we are unable to integrate any acquired businesses, products or technologies effectively, our business will suffer. In
addition, any amortization or charges resulting from the costs of acquisitions could increase our expenses. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Failure to protect our information technology infrastructure against cyber-based attacks, network
security breaches, service interruptions or data corruption could significantly disrupt our operations and adversely affect our business and operating results.  </I></B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We rely extensively on information technology systems and telephone networks and systems, including the Internet, to process and transmit sensitive
electronic information and to manage or support a variety of business processes and activities, including sales, billing, customer service, procurement and supply chain, manufacturing, and
distribution. We use enterprise information technology systems to record, process, and summarize financial information and results of operations for internal reporting purposes and to comply with
regulatory financial reporting, legal, and tax requirements. Our information technology systems, some of which are managed by third-parties, may be susceptible to damage, disruptions or shutdowns due
to computer viruses, attacks by computer hackers, failures during the process of upgrading or replacing software, databases or components thereof, power outages, hardware failures, telecommunication
failures, user errors or catastrophic events. Despite the precautionary measures we have taken to prevent breakdowns in our information technology and telephone systems, if our systems suffer severe
damage or disruption or shutdown and we are unable to effectively resolve the issues in a timely manner, our business and operating results may suffer. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition, we accept payments for many of our sales through credit and debit card transactions, which are handled through a third-party payment processor. As a result, we are subject to a number of
risks related to credit and debit card payments, including that we pay interchange and other fees, which may increase over time and could require us to either increase the prices we charge for our
products or experience an increase in our costs and expenses. In addition, as part of the payment processing process, we transmit our patients' and clinicians' credit and debit card information to our
third-party payment processor. We may in the future become subject to lawsuits or other proceedings for purportedly fraudulent transactions arising out of the actual or alleged theft of our patients'
credit or debit card information if the security of our third-party credit card payment processor is breached. We and our third-party credit card payment processor are also subject to payment card
association operating rules, certification requirements and rules governing electronic funds transfers, which could
change or be reinterpreted to make it difficult or impossible for us to comply. If we or our third-party credit card payment processor fail to comply with these rules or requirements, we may be
subject to fines and higher transaction fees and lose our ability to accept credit and debit card payments from our patients, and there may be an adverse impact on our business. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We have no experience selling our products outside of the United States and cannot predict if we
will be successful in achieving adoption of our products and revenue growth outside of the United States in a timely manner or at all. If we commercialize any products outside of the United States, a
variety of risks associated with international operations could impact our strategy and adversely affect our future growth.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We expect that we would be subject to additional risks related to entering into international markets,
including:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> difficulty successfully training patients and physicians on using our products; </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>26</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=31,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=397475,FOLIO='26',FILE='DISK131:[15ZBY1.15ZBY12201]DC12201A.;43',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_dc12201_1_27"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> difficulty hiring a qualified direct-sales force or finding and entering into commercially-acceptable agreements with suitable
third-parties to market our products; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> reduced protection for intellectual property rights; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> unexpected changes in tariffs, trade barriers and regulatory requirements; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> economic weakness, including inflation, or political instability in particular foreign economies and markets; </FONT> <FONT COLOR="#3B5A6F"
SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> compliance with tax, employment, immigration and labor laws for employees living or traveling abroad; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> foreign taxes, including withholding of payroll taxes; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> foreign currency fluctuations, which could result in increased operating expenses and reduced revenues, and other obligations incident
to doing business in another country; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> workforce uncertainty in countries where labor unrest is more common than in the United States; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> international regulators and third-party payers may require additional clinical studies prior to approving or allowing reimbursement
for our products; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> disadvantages of competing against companies from countries that are not subject to U.S. laws and regulations, including the U.S.
Foreign Corrupt Practices Act, regulations of the U.S. Office of Foreign Assets Controls, and U.S. anti-money laundering regulations, as well as exposure of our foreign operations to liability under
these regulatory regimes; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> business interruptions resulting from geopolitical actions, including war and terrorism, or natural disasters including earthquakes,
typhoons, floods and fires. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
we experience any of these risks, our strategy to expand internationally could be impacted and our future growth could be adversely affected. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our employees, independent contractors, consultants, collaborators and suppliers may engage in
misconduct or other improper activities, including noncompliance with regulatory standards and requirements and insider trading.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We are exposed to the risk that our employees and other third parties may engage in fraudulent conduct or other illegal activity. Misconduct by
employees and other third parties could include intentional, reckless and/or negligent conduct or disclosure of unauthorized activities to us that violate FDA regulations, including those laws
requiring the reporting of true, complete and accurate information to the FDA, manufacturing standards, federal and state healthcare fraud and abuse laws and regulations, or laws that require the
reporting of financial information or data accurately. In particular, sales, marketing and business arrangements in the healthcare industry are subject to extensive laws intended to prevent fraud,
kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer
incentive programs and other business arrangements. Activities subject to these laws also involve the improper use of information obtained in the course of clinical trials, which could result in
regulatory sanctions and serious harm to our reputation. It is not always </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>27</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=32,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=581143,FOLIO='27',FILE='DISK131:[15ZBY1.15ZBY12201]DC12201A.;43',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_dc12201_1_28"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>possible
to identify and deter employee and other third-party misconduct, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks
or
losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws. If any such actions are instituted against us, and
we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant civil, criminal and
administrative penalties, damages, monetary fines, disgorgement, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, contractual damages, reputational
harm, diminished profits and future earnings and curtailment or restructuring of our operations, any of which could adversely affect our ability to operate. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


A reclassification of our independent contractor home trainers by tax authorities could require us
to pay retroactive taxes and penalties, which could have a material adverse effect on our business, financial condition and operating results.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We contract with over 300 licensed healthcare practitioners as home trainers, who educate our patients on the proper use of our solutions. Because we
consider these licensed practitioners to be independent contractors, as opposed to employees, we do not withhold federal or state income or other employment related taxes or make federal or state
unemployment tax or Federal Insurance Contributions Act payments. Our contracts with these independent contractors obligate them to pay these taxes. The classification of healthcare practitioners as
independent contractors depends on the facts and circumstances of the relationship. In the event federal or state taxing authorities determine that the healthcare practitioners are employees, our
business may be adversely affected and subject to retroactive taxes and penalties. Under current federal tax law, a safe harbor from reclassification, and consequently retroactive taxes and penalties,
is available if our current treatment is consistent with a long-standing practice of a significant segment of our industry and if we meet certain other requirements. If challenged, we may not prevail
in demonstrating the applicability of the safe harbor to our operations. Further, interested persons have recently proposed to eliminate the safe harbor and may do so again in the future. If such
proposals are reintroduced and passed by Congress, they could impact our classification of healthcare practitioners as independent contractors, which could have a material adverse effect on our
business, financial condition and results of operations. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Relating to Government Regulation  </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We are subject to extensive federal and state regulation, and if we fail to comply with applicable
regulations, we could suffer severe criminal or civil sanctions or be required to make significant changes to our operations that could adversely affect our business, financial condition and operating
results.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The federal government and all states in which we currently operate regulate various aspects of our business. Our operations also are subject to
state laws governing, among other things, distribution of medical equipment and certain types of home health activities, and we are required to obtain and maintain licenses in each state to act as a
durable medical equipment supplier. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As
a healthcare provider participating in governmental healthcare programs, we are subject to laws directed at preventing fraud and abuse, which subject our marketing, billing, documentation and other
practices to government scrutiny. To ensure compliance with Medicare, Medicaid and other regulations, government agencies or their contractors often conduct routine audits and request customer records
and other documents to support our claims submitted for payment of services rendered. Government agencies or their contractors also periodically open investigations and obtain information from
healthcare providers. Violations of federal and state regulations can result in severe criminal, civil and administrative penalties and sanctions, including debarment, suspension or exclusion </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>28</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=33,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=795465,FOLIO='28',FILE='DISK131:[15ZBY1.15ZBY12201]DC12201A.;43',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_dc12201_1_29"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>from
Medicare, Medicaid and other government reimbursement programs, any of which would have a material adverse effect on our business. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Changes
in healthcare laws and regulations and new interpretations of existing laws and regulations may affect permissible activities, the relative costs associated with doing business, and
reimbursement amounts paid by federal, state and other third-party payers. There have been and will continue to be regulatory initiatives affecting our business and we cannot predict the extent to
which future legislation and regulatory changes could have a material adverse effect on our business, financial condition and results of operations. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We are subject to significant regulation by numerous government agencies, including the FDA. We
cannot market or commercially distribute our products without obtaining and maintaining necessary regulatory clearances or approvals.  </I></B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our products are medical devices subject to extensive regulation in the United States. The FDA and other U.S. and foreign governmental agencies
regulate, among other things, with respect to medical devices:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> design, development and manufacturing; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> testing, labeling, content and language of instructions for use and storage; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> clinical trials; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> product safety; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> marketing, sales and distribution; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> unique device identifiers; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> premarket clearance and approval; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> record keeping procedures; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> advertising and promotion; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> recalls and field safety corrective actions; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> post-market surveillance, including reporting of deaths or serious injuries and malfunctions that, if they were to recur, could lead
to death or serious injury; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> post-market approval studies; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> product import and export. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Unless
an exemption applies, each medical device we seek to distribute commercially in the United States requires marketing authorization from the FDA prior to distribution. The two primary types of
FDA marketing authorization applicable to a device are premarket notification, also called 510(k) clearance, and premarket approval. The type of marketing authorization is generally linked to the
classification of the device. When a 510(k) clearance is required, we must submit a premarket notification to the FDA demonstrating that our proposed device is "substantially equivalent" to a </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>29</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=34,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=208450,FOLIO='29',FILE='DISK131:[15ZBY1.15ZBY12201]DC12201A.;43',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_dc12201_1_30"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>previously
cleared and legally marketed 510(k) device or a device that was in commercial distribution before May&nbsp;28, 1976 for which the FDA has not yet called for the submission of a premarket
approval application, which is commonly known as the "predicate device." The FDA may require further information, including clinical data, to make a determination regarding substantial equivalence. A
premarket approval application must be submitted to the FDA if the device cannot be cleared through the 510(k) process. The premarket approval application process is much more demanding than the
510(k) premarket notification process and requires the payment of significant user fees. A premarket approval application must be supported by valid scientific evidence, which typically requires
extensive data to demonstrate the reasonable assurance of safety and effectiveness of the device. The approval process involves FDA review of information, including but not limited to, technical,
preclinical (bench and/or animal), clinical trials, manufacturing and labeling. The FDA clearance and approval process frequently takes longer than anticipated due to increasing FDA demands for
clarification of data or new data requirements. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
there is no predicate device that would permit the device to be cleared through the 510(k) path, then the FDA will automatically classify the device as a Class&nbsp;III high risk premarket
approval device. In the event of this possibility, the sponsor can request a risk-based classification determination for the device in accordance with the de novo process, which is a route to market
for novel medical devices that are low to moderate risk and are not substantially equivalent to a predicate device. A company files a de novo request when it does not have a predicate to which it can
claim substantial equivalence. The FDA reviews the request for a de novo decision and grants or denies the request. If the request is granted, the FDA issues an order indicating that the device may
legally be marketed and the device is classified as a Class&nbsp;I or II device, depending on risk. Once a device is classified through the de novo process, future devices from the company or a
competitor may use that device as a 510(k) predicate. The advantage of the de novo process is that it generally requires less data than a premarket approval. The disadvantage is that it may require
more data than a 510(k) and most often will include human clinical data. The FDA is increasingly moving devices with slightly different proposed indication statements or different technological
features off the 510(k) path and on to the de novo path resulting in more time and expense for the company. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Both
the 510(k) and premarket approval processes can be expensive and lengthy and require the payment of significant fees, unless an exemption applies. The FDA's 510(k) clearance process usually takes
from approximately three to 12&nbsp;months, but may take longer. The process of obtaining a premarket approval is much more costly and uncertain than the 510(k) clearance process and generally takes
from approximately one to five years, or longer, from the time the application is submitted to the FDA until an approval is obtained. The process of obtaining regulatory clearances or approvals to
market a medical device can be costly and time consuming, and we may not be able to obtain these clearances or approvals on a timely basis, if at all. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
the United States, our currently commercialized products are marketed pursuant to premarket clearance under Section&nbsp;510(k) of the Federal Food, Drug and Cosmetic Act, or FDCA. If the FDA
requires us to go through a lengthier, more rigorous examination for future products or modifications to existing products than we had expected, our product introductions or modifications could be
delayed or canceled, which could cause our sales to decline. In addition, the FDA may determine that future products will require the more costly, lengthy and uncertain premarket approval process.
Although we do not currently market any devices under a premarket approval, the FDA may demand that we obtain a premarket approval prior to marketing certain of our future products. In addition, if
the FDA disagrees with our determination that a product we currently market is subject to an exemption from premarket review, the FDA may require us to submit a 510(k) or premarket approval
application in order to continue marketing the product. Further, even with respect to those future </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>30</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=35,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=520046,FOLIO='30',FILE='DISK131:[15ZBY1.15ZBY12201]DC12201A.;43',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_dc12201_1_31"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>products
where a premarket approval is not required, we cannot assure you that we will be able to obtain the 510(k) clearances required with respect to those products. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
FDA can delay, limit or deny clearance or approval of a device for many reasons, including:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> for non-premarket approval devices, failure of the applicant to demonstrate to the FDA's satisfaction that its products meet the
definition of "substantial equivalence" or meet the standard for the FDA to grant a petition for de novo classification; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> failure of the applicant to demonstrate that there is reasonable assurance that the medical device is safe or effective under the
conditions of use prescribed, recommended or suggested in the proposed labeling; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> insufficient data from the preclinical studies and clinical trials; or </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the manufacturing processes, methods, controls or facilities used for the manufacture, processing, packing or installation of the
device do not meet applicable requirements. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Any
delay in, or failure to receive or maintain, clearances or approvals for our products could prevent us from generating revenue from these products or achieving profitability. Additionally, the FDA
and other governmental authorities have broad enforcement powers. Our failure to comply with applicable regulatory requirements could lead governmental authorities or a court to take action against
us, including, but not limited to:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> issuing untitled (notice of violation) letters or public warning letters to us; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> imposing fines and penalties on us; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> obtaining an injunction or administrative detention preventing us from manufacturing or selling our products; </FONT> <FONT COLOR="#3B5A6F"
SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> seizing products to prevent sale or transport or export; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> bringing civil or criminal charges against us; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> recalling our products or mandating a product correction; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> detaining our products at U.S. Customs; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> delaying the introduction of our products into the market; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> delaying pending requests for clearance or approval of new uses or modifications to our existing products; and </FONT> <FONT COLOR="#3B5A6F"
SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> withdrawing or denying approvals or clearances for our products. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
we fail to obtain and maintain regulatory clearances or approvals, our ability to sell our products and generate revenue will be materially harmed. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition, the FDA may change its clearance and approval policies, adopt additional regulations or revise existing regulations, or take other actions which may prevent or delay approval or clearance
of </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>31</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=36,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=632397,FOLIO='31',FILE='DISK131:[15ZBY1.15ZBY12201]DC12201A.;43',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_dc12201_1_32"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>our
products under development or impact our ability to modify our currently approved or cleared products on a timely basis. For example, in response to industry and healthcare provider concerns
regarding the predictability, consistency and rigor of the 510(k) regulatory pathway, the FDA published new guidance on the 510(k) regulatory pathway in 2014, which alters the manner in which the
510(k)
regulatory pathway is administered and interpreted. The FDA intends these reform actions to improve the efficiency and transparency of the clearance process, as well as bolster patient safety. This
new guidance could impose additional regulatory requirements upon us which could delay our ability to obtain new 510(k) clearances, increase the costs of compliance or restrict our ability to maintain
our current clearances. In addition, as part of the Food and Drug Administration Safety and Innovation Act, Congress reauthorized the Medical Device User Fee Amendments with various FDA performance
goal commitments and enacted several "Medical Device Regulatory Improvements" and miscellaneous reforms which are further intended to clarify and improve medical device regulation both pre- and
post-market. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Medical
devices may only be promoted and sold for the indications for which they are approved or cleared. In addition, even if the FDA has approved or cleared a product, it can take action affecting
such product approvals or clearances if serious safety or other problems develop in the marketplace. Delays in obtaining clearances or approvals could adversely affect our ability to introduce new
products or modifications to our existing products in a timely manner, which would delay or prevent commercial sales of our products. Additionally, the FDA and other regulatory authorities have broad
enforcement powers. Regulatory enforcement or inquiries, or other increased scrutiny on us, could affect the perceived safety and efficacy of our products and dissuade patients and clinicians from
using our products. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If we modify our FDA cleared devices, we may need to seek additional clearances or approvals, which,
if not granted, would prevent us from selling our modified products.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The FDA regulations require the submission and clearance of a new 510(k) premarket notification, or possibly, premarket approval, for significant
changes or modifications made in the design, components, method of manufacturer and intended use of a device including changes or modifications to a 510(k)-cleared device that could significantly
affect the device's safety or effectiveness, or would constitute a major change or modification in the device's intended use. The FDA requires each manufacturer to make this determination, but the FDA
may review any manufacturer's decision. The FDA may not agree with our decisions regarding whether new clearances or approvals are necessary. We have modified some of our 510(k) cleared products, and
have determined based on our review of the applicable FDA guidance that in certain instances new 510(k) clearances or premarket approval are not required. If the FDA disagrees with our determination
and requires us to submit new 510(k) notifications or premarket approval for modifications to our previously cleared products for which we have concluded that new clearances or approvals are
unnecessary, we may be required to cease marketing or to recall the modified product until we obtain clearance or approval, and we may be subject to significant regulatory fines or penalties. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Furthermore,
the FDA's ongoing review of the 510(k) program may make it more difficult for us to make modifications to our previously cleared products, either by imposing more strict requirements on
when a manufacturer must submit a new 510(k) for a modification to a previously cleared product, or by applying more onerous review criteria to such submissions. If the FDA requires us to cease
marketing a modified device until we obtain a new 510(k) clearance or premarket approval, our business, financial condition, operating results and future growth prospects could be materially
adversely affected. Further in this situation, our products could be subject to recall. Any recall or FDA requirement that we seek additional approvals or clearances could result in significant
delays, fines, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>32</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=37,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=422004,FOLIO='32',FILE='DISK131:[15ZBY1.15ZBY12201]DC12201A.;43',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_dc12201_1_33"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>increased
costs associated with modification of a product, loss of revenue and potential operating restrictions imposed by the FDA. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


The misuse or off-label use of our products may harm our image in the marketplace, result in
injuries that lead to product liability suits or result in costly investigations, fines or sanctions by regulatory bodies if we are deemed to have engaged in the promotion of these uses, any of which
could be costly to our business.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The products we currently market have been cleared by the FDA for specific treatments. We train our marketing and direct sales force to not promote
our products for uses outside of the FDA-cleared indications for use, known as "off-label uses." We cannot, however, prevent a physician from using our products off-label, when in the physician's
independent professional medical judgment he or she deems it appropriate. The FDA does not restrict or regulate a physician's choice of treatment. There may be increased risk of injury to patients if
physicians use our products off-label. Furthermore, the use of our products for indications other than those cleared by the governing regulatory body may not effectively treat such conditions, which
could harm our reputation in the marketplace among physicians and patients. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
the FDA determines that our promotional materials or training constitute promotion of an off-label use, it could request that we modify our training or promotional materials or subject us to
regulatory or enforcement actions, including the issuance of an untitled letter, a warning letter, injunction, seizure, civil fine or criminal penalties. It is also possible that other federal, state
or foreign enforcement authorities might take action if they consider our business activities to constitute promotion of an off-label use, which could result in significant penalties, including, but
not limited to, criminal, civil and administrative penalties, damages, fines, disgorgement, exclusion from participation in government healthcare programs, and the curtailment of our operations. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition, physicians may misuse our products or use improper techniques, potentially leading to injury and an increased risk of product liability. If our products are misused or used with improper
technique, we may become subject to costly litigation by our clinicians or their patients. As noted above, we can be subject to lawsuits, whether or not our product is proven to be defective and
whether or not our employees have adequately trained the physicians. Similarly, in an effort to decrease costs, physicians may also reuse those of our products that are intended for a single use or
may purchase reprocessed products from third-party reprocessors in lieu of purchasing new products from us, which could result in product failure and liability. As described immediately above, product
liability claims could divert management's attention from our core business, be expensive to defend and result in sizeable damage awards against us that may not be covered by insurance. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our products may cause or contribute to adverse medical events that we are required to report to the
FDA, and if we fail to do so, we would be subject to sanctions that would materially harm our business.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our marketed products are subject to Medical Device Reporting, or MDR, obligations, which require that we report to the FDA any incident in which our
products may have caused or contributed to a death or serious injury, or in which our products malfunctioned and, if the malfunction were to recur, it could likely cause or contribute to a death or
serious injury. The timing of our obligation to report under the MDR regulations is triggered by the date we become aware of the adverse event as well as the nature of the event. We may fail to report
adverse events of which we become aware within the prescribed timeframe. We may also fail to recognize that we have become aware of a reportable adverse event, especially if it is not reported to us
as an adverse event or if it is an adverse event that is unexpected or removed in time from the use of our products. If we fail to comply with our reporting obligations, the FDA could take action
including warning letters, untitled letters, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>33</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=38,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=556535,FOLIO='33',FILE='DISK131:[15ZBY1.15ZBY12201]DC12201A.;43',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_dc12201_1_34"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>administrative
actions, criminal prosecution, imposition of civil monetary penalties, revocation of our device clearances, seizure of our products, or delay in clearance of future products. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our products may in the future be subject to product recalls. A recall of our products, either
voluntarily or at the direction of the FDA or another governmental authority, or the discovery of serious safety issues with our products, could have a significant adverse impact on us.  </I></B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The FDA and similar foreign governmental authorities have the authority to require the recall of commercialized products in the event of material
deficiencies or defects in their design or manufacture. The FDA's authority to require a recall must be based on a finding that there is reasonable probability that the device would cause serious,
adverse health consequences or death. We may also choose to voluntarily recall a product if any material deficiency is found. A government-mandated or voluntary recall could occur as a result of an
unacceptable risk to health,
component failures, malfunctions, manufacturing errors, design or labeling defects or other deficiencies and issues. Recalls of any of our products would divert managerial and financial resources and
have an adverse effect on our reputation and business, which could impair our ability to produce our products in a cost-effective and timely manner in order to meet our patients' demands. We may also
be subject to liability claims, be required to bear other costs, or take other actions that may have a negative impact on our future sales and our ability to generate profits. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Companies
are required to maintain certain records of recalls and corrections, even if they are not reportable to the FDA. We may initiate voluntary recalls or corrections for our products in the
future that we determine do not require notification of the FDA. If the FDA disagrees with our determinations, they could require us to report those actions as recalls and we may be subject to
enforcement action. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If we or our component manufacturers fail to comply with the FDA's Quality System Regulation, our
manufacturing operations could be interrupted, and our product sales and operating results could suffer.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We and many of our component manufacturers are required to comply with the FDA's Quality System Regulation, or QSR, which covers the procedures and
documentation of the design, testing, production, control, quality assurance, labeling, packaging, sterilization, storage and shipping of our devices. The FDA audits compliance with the QSR through
periodic announced and unannounced inspections of manufacturing and other facilities. We and our component manufacturers have been, and anticipate in the future being, subject to such inspections. We
cannot provide assurance that any future inspection will not result in adverse findings with respect to our QSR compliance. If our manufacturing facilities or those of any of our component
manufacturers or suppliers are found to be in violation of applicable laws and regulations, or we or our manufacturers or suppliers fail to take satisfactory corrective action in response to an
adverse inspection, the FDA could take enforcement action, including any of the following sanctions:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> untitled letters, warning letters, fines, injunctions, consent decrees and civil penalties; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> customer notifications or repair, replacement, refunds, recall, detention or seizure of our products; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> operating restrictions or partial suspension or total shutdown of production; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> refusing or delaying our requests for 510(k) clearance or premarket approval of new products or modified products; </FONT> <FONT COLOR="#3B5A6F"
SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> withdrawing 510(k) clearances or premarket approvals that have already been granted; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> refusal to grant export approval for our products; or </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> criminal prosecution. </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>34</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=39,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=24269,FOLIO='34',FILE='DISK131:[15ZBY1.15ZBY12201]DC12201A.;43',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<UL>
<UL>
</UL>
</UL>
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_de12201_1_35"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Any of these sanctions could adversely affect our business, financial condition and results of operations. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
we begin selling our products outside the United States, our products and operations would also be required to comply with standards set by industrial standards bodies, such as the International
Organization for Standardization, or ISO. Foreign regulatory bodies may evaluate our products or the testing that our products undergo against these standards. The specific standards, types of
evaluation and scope of review differ among foreign regulatory bodies. If we fail to adequately comply with any of these standards, a foreign regulatory body may take adverse actions similar to those
within the power of the FDA. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Any
of these actions could prevent us from marketing, distributing or selling our products and would likely harm our business. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If clinical studies of our future products do not produce results necessary to support regulatory
clearance or approval in the United States or, with respect to our current or future products, elsewhere, we will be unable to expand the indications for or commercialize these products.  </I></B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We will likely need to conduct additional clinical studies in the future to support new indications for our products or for clearances of new product
lines, or for the approval of the use of our products in some foreign countries. Clinical testing can take many years, can be expensive and carries uncertain outcomes. The initiation and completion of
any of these studies may be prevented, delayed, or halted for numerous reasons. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Clinical
failure can occur at any stage of testing. Our clinical studies may produce negative or inconclusive results, and we may decide, or regulators may require us, to conduct additional clinical
and non-clinical testing in addition to those we have planned. Our failure to adequately demonstrate the safety and efficacy of any of our devices would prevent receipt of regulatory clearance or
approval and, ultimately, the commercialization of that device or indication for use. Even if our future products are cleared in the United States, commercialization of our products in foreign
countries would require approval by regulatory authorities in those countries. Approval procedures vary among jurisdictions and can involve requirements and administrative review periods different
from, and greater than, those in the United States, including additional preclinical studies or clinical trials. Any of these occurrences could have an adverse impact on our business. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If the third parties on which we rely to conduct our clinical trials and to assist us with
pre-clinical development do not perform as contractually required or expected, we may not be able to obtain regulatory clearance or approval for or commercialize our products.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We often must rely on third parties, such as contract research organizations, medical institutions, clinical investigators and contract laboratories
to conduct our clinical trials. If these third parties do not successfully carry out their contractual duties or regulatory obligations or meet expected deadlines, if these third parties need to be
replaced, or if the quality or accuracy of the data they obtain is compromised due to the failure to adhere to our clinical protocols or regulatory requirements or for other reasons, our pre-clinical
development activities or clinical trials may be extended, delayed, suspended or terminated, and we may not be able to obtain regulatory approval for, or successfully commercialize, our products on a
timely basis, if at all, and our business, operating results and prospects may be adversely affected. Furthermore, our third-party clinical trial investigators may be delayed in conducting our
clinical trials for reasons outside of their control. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>35</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=40,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=35826,FOLIO='35',FILE='DISK131:[15ZBY1.15ZBY12201]DE12201A.;30',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_de12201_1_36"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Future regulatory actions may adversely affect our ability to sell our products profitably.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>From time to time, legislation is drafted and introduced that could significantly change the statutory provisions governing the clearance or
approval, manufacture and marketing of a medical device. In addition, FDA and other regulations and guidance are often revised or reinterpreted in ways that may significantly affect our business and
our products. It is impossible to predict whether legislative changes will be enacted or regulations, guidance or interpretations changed, and what the impact of such changes, if any, may be. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Healthcare regulatory reform may affect our ability to sell our products
profitably</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>.  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In the United States, the legislative landscape, particularly as it relates to healthcare regulation and reimbursement coverage, continues to evolve.
In March 2010, the Patient Protection and Affordable Care Act and Health Care and Education Reconciliation Act, which we refer to as the Patient Protection and Affordable Care Act, was passed, which
has the potential to substantially change healthcare financing by both governmental and private insurers, and significantly impact the U.S. medical device industry. The Patient Protection and
Affordable Care Act, among other things, imposes a new excise tax, which began in 2013, on entities that manufacture, produce or import medical devices in an amount equal to 2.3% of the price for
which such devices are sold in the United States. While we believe that our current products are exempt from this tax under an exemption for retail products, if our belief is determined to be
incorrect, we could be subject to significant tax liabilities and penalties, which could have a material adverse effect on our results of operations and cash position. Moreover, products that we
introduce in the future could be subject to this tax. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition, the Patient Protection and Affordable Care Act also expands the round two of competitive bidding to a total of 91 competitive bidding areas, and by 2016, the process must be nationalized
or prices in non-competitive bidding areas must be adjusted to match competitive bidding prices. Other legislative changes have been proposed and adopted in the United States since the Patient
Protection and Affordable Care Act was enacted. On August&nbsp;2, 2011, the Budget Control Act of 2011 among other things, created measures for spending reductions by Congress. A Joint Select
Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the years 2013 through 2021, was unable to reach required goals, thereby triggering
the legislation's automatic reduction to several government programs. This includes aggregate reductions of Medicare
payments to providers up to 2% per fiscal year, which went into effect on April&nbsp;1, 2013. On January&nbsp;2, 2013, President Obama signed into law the American Taxpayer Relief Act of 2012
which, among other things, further reduced Medicare payments to certain providers, including physicians, hospitals, imaging centers and cancer treatment centers, and increased the statute of
limitations period for the government to recover overpayments to providers from three to five years. We expect that additional state and federal healthcare reform measures will be adopted in the
future, any of which could limit the amounts that federal and state governments will pay for healthcare products and services, which could result in reduced demand for our products or additional
pricing pressures. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


While our products are not currently subject to the competitive bidding process under Medicare, if
our products were to become subject to such process in the future, it could negatively affect our business and financial condition.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 required the Secretary of Health and Human Services to establish and
implement programs under which competitive acquisition areas are established throughout the United States for purposes of awarding contracts for the furnishing of competitively priced items of durable
medical equipment. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>36</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=41,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=631165,FOLIO='36',FILE='DISK131:[15ZBY1.15ZBY12201]DE12201A.;30',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_de12201_1_37"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>CMS,
the agency responsible for administering the Medicare program, conducts a competition for each competitive acquisition area under which providers submit bids to supply certain covered items of
durable medical equipment. Successful bidders must meet certain program quality standards in order to be awarded a contract and only successful bidders can supply the covered items to Medicare
beneficiaries in the acquisition area. There are, however, regulations in place that allow non-contracted providers to continue to provide products and services to their existing customers at the new
competitive bidding payment amounts. The contracts are expected to be re-bid every three years. CMS is required to award contracts to multiple entities submitting bids in each area for an item or
service, but has the authority to limit the number of contractors in a competitive acquisition area to the number it determines to be necessary to meet projected demand. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Although
CMS concluded the bidding process for the first round of Metropolitan Statistical Areas in September 2007, in July 2008, Congress enacted Medicare Improvements for Patients and Providers Act
of 2008, which retroactively delayed the implementation of competitive bidding. Medicare Improvements for Patients and Providers Act of 2008 also reduced Medicare prices nationwide by 9.5% beginning
in 2009 for the product categories that were initially included in competitive bidding. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
Patient Protection and Affordable Care Act legislation requires CMS to expand competitive bidding further to additional geographic markets or to use competitive bid pricing information to adjust
the payment amounts otherwise in effect for areas that are not competitive acquisition areas by January&nbsp;1, 2016. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Although
we continue to monitor developments regarding the implementation of the competitive bidding program, we cannot predict the outcome of the competitive bidding program on our business when
fully implemented, nor the Medicare payment rates that will be in effect in future years for the items subjected to competitive bidding, including our products. We expect that payment rates will
continue to fluctuate, and a large negative payment adjustment could adversely affect our business, financial conditions and results of operations. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We are subject to additional federal, state and foreign laws and regulations relating to our
healthcare business; our failure to comply with those laws could have an adverse impact on our business.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We are subject to healthcare fraud and abuse regulation and enforcement by federal and state governments, which could adversely impact our business.
Healthcare fraud and abuse and health information privacy and security laws potentially applicable to our operations include:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the federal Anti-Kickback Statute, which applies to our marketing practices, educational programs, pricing policies and relationships
with healthcare providers, by prohibiting, among other things, soliciting, receiving, offering or providing remuneration, whether directly or indirectly and overtly or covertly, intended to induce the
referral of an individual for (i)&nbsp;the furnishing or the arranging for the furnishing of items or services reimbursable under a federal healthcare program, such as Medicare or Medicaid; or
(ii)&nbsp;the purchase, lease or order of, or the arrangement or recommendation of the purchasing, leasing or ordering of, of an item or service reimbursable under a federal healthcare program. A
person or entity does not need to have actual knowledge of this statute or specific intent to violate it to have committed a violation; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> federal civil and criminal false claims laws and civil monetary penalty laws, including civil whistleblower or qui tam actions that
prohibit, among other things, knowingly presenting, or causing to be presented, claims for payment or approval to the federal government that are false or fraudulent, knowingly making a false
statement material to an obligation to </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>37</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=42,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=66226,FOLIO='37',FILE='DISK131:[15ZBY1.15ZBY12201]DE12201A.;30',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_de12201_1_38"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>pay
or transmit money or property to the federal government, knowingly concealing or knowingly and improperly avoiding or decreasing an obligation to pay or transmit money or property to the federal
government or knowingly offering remuneration to influence a Medicare or Medicaid beneficiary's selection of health care providers. The government may assert that a claim, including items or services
resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the false claims statutes; </FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> HIPAA and its implementing regulations, which created federal criminal laws that prohibit, among other things, executing a scheme to
defraud any healthcare benefit program or making false statements relating to healthcare matters; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, also imposes certain regulatory and
contractual requirements regarding the privacy, security and transmission of individually identifiable health information; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> federal Open Payments (the Physician Payments Sunshine Act) requirements imposed by the Patient Protection and Affordable Care Act on
device manufacturers regarding certain "transfers of value" made or distributed to physicians and teaching hospitals. Failure to submit required information may result in civil monetary penalties of
up to an aggregate of $150,000 per year (or up to an aggregate of $1.0&nbsp;million per year for "knowing failures"), for all payments, transfers of value or ownership or investment interests that
are not timely, accurately, and completely reported in an annual submission. The period between August&nbsp;1, 2013 and December&nbsp;31, 2013 was the first reporting period, and manufacturers
were required to report aggregate payment data by March&nbsp;31, 2014, and to report detailed payment data and submit legal attestation to the accuracy of such data by June&nbsp;30, 2014.
Thereafter, manufacturers must submit reports by the 90th&nbsp;day of each subsequent calendar year; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> federal consumer protection and unfair competition laws, which broadly regulate marketplace activities and activities that potentially
harm consumers; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> state law equivalents of each of the above federal laws, such as anti-kickback and false claims laws that may apply to items or
services reimbursed by any third-party payer, including commercial insurers; state laws that require device companies to comply with the industry's voluntary compliance guidelines and the relevant
compliance guidance promulgated by the federal government or otherwise restrict payments that may be made to healthcare providers; state laws that require device manufacturers to report information
related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures; and state laws governing the privacy and security of certain health
information, many of which differ from each other in significant ways and often are not preempted by HIPAA. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
risk of our being found in violation of these laws and regulations is increased by the fact that many of them have not been fully interpreted by the regulatory authorities or the courts, and their
provisions are open to a variety of interpretations. We are unable to predict what additional federal or state legislation or regulatory initiatives may be enacted in the future regarding our business
or the healthcare industry in general, or what effect such legislation or regulations may have on us. Federal or state governments may impose additional restrictions or adopt interpretations of
existing laws that could have a material adverse effect on us. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>38</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=43,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=277064,FOLIO='38',FILE='DISK131:[15ZBY1.15ZBY12201]DE12201A.;30',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_de12201_1_39"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Because
of the breadth of these laws and the narrowness of the statutory exceptions and safe harbors available under such laws, it is possible that some of our business activities, including certain
sales and marketing practices and financial arrangements, including the provision of stock options as partial compensation for consulting services, with physicians, some of whom use or purchase our
products, and other customers, could be subject to challenge under one or more of such laws. Any action against us for violation of these laws, even if we successfully defend against it, could cause
us to incur significant legal expenses and divert our management's attention from the operation of our business. If our operations are found to be in violation of any of the laws described above or
any other governmental regulations that apply to us, we may be subject to penalties, including civil and criminal penalties, damages, fines, exclusion from governmental healthcare programs,
disgorgement, contractual damages, reputational harm, diminished profits and future earnings, and the curtailment or restructuring of our operations, any of which could adversely impact our business. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Failure to comply with regulations affecting the transmission, security and privacy of health
information could result in significant penalties.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Numerous federal and state laws and regulations, including HIPAA and the Health Information Technology for Economic and Clinical Health Act, or the
HITECH Act, govern the collection, dissemination, security, use and confidentiality of patient-identifiable health information. HIPAA and the HITECH Act require us to comply with standards for the use
and disclosure of health information within our company and with third parties. The Privacy Standards and Security Standards under HIPAA establish a set of basic national privacy and security
standards for the protection of individually identifiable health information by health plans, healthcare clearinghouses and certain healthcare providers, referred to as covered entities, and the
business associates with whom such covered entities contract for services. Notably, whereas HIPAA previously directly regulated only these covered entities, the HITECH Act, which was signed into law
as part of the stimulus package in February 2009, makes certain of HIPAA's privacy and security standards also directly applicable to covered entities' business associates. As a result, both covered
entities and business associates are now subject to significant civil and criminal penalties for failure to comply with Privacy Standards and Security Standards. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>HIPAA
and the HITECH Act also include standards for common healthcare electronic transactions and code sets, such as claims information, plan eligibility, payment information and the use of electronic
signatures, and privacy and electronic security of individually identifiable health information. Covered entities, such as healthcare providers, are required to conform to such transaction set
standards pursuant to HIPAA. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>HIPAA
requires healthcare providers like us to develop and maintain policies and procedures with respect to protected health information that is used or disclosed, including the adoption of
administrative, physical and technical safeguards to protect such information. The HITECH Act expands the notification requirement for breaches of patient-identifiable health information, restricts
certain disclosures and sales of patient-identifiable health information and provides a tiered system for civil monetary penalties for HIPAA violations. The HITECH Act also increased the civil and
criminal penalties that may be imposed against covered entities, business associates and possibly other persons and gave state attorneys general new authority to file civil actions for damages or
injunctions in federal courts to enforce the federal HIPAA laws and seek attorney fees and costs associated with pursuing federal civil actions. Additionally, certain states have adopted comparable
privacy and security laws and regulations, some of which may be more stringent than HIPAA. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
we do not comply with existing or new laws and regulations related to patient health information, we could be subject to criminal or civil sanctions. New health information standards, whether </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>39</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=44,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=190015,FOLIO='39',FILE='DISK131:[15ZBY1.15ZBY12201]DE12201A.;30',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_de12201_1_40"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>implemented
pursuant to HIPAA, the HITECH Act, congressional action or otherwise, could have a significant effect on the manner in which we handle healthcare related data and communicate with payors,
and the cost of complying with these standards could be significant. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
2013 final HITECH omnibus rule modifies the breach reporting standard in a manner that will likely make more data security incidents qualify as reportable breaches. Any liability from a failure to
comply with the requirements of HIPAA or the HITECH Act could adversely affect our financial condition. The costs of complying with privacy and security related legal and regulatory requirements are
burdensome and could have a material adverse effect on our results of operations. These new provisions, as modified, will be subject to interpretation by various courts and other governmental
authorities, thus creating potentially complex compliance issues for us, as well as our clients and strategic partners. In addition, we are unable to predict what changes to the HIPAA Privacy
Standards and Security Standards might be made in the future or how those changes could affect our business. Any new legislation or regulation in the area of privacy and security of personal
information, including personal health information, could also adversely affect our business operations. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Additionally,
the Federal Trade Commission has issued and several states have issued or are considering new regulations to require holders of certain types of personally identifiable information to
implement formal policies and programs to prevent, detect and mitigate the risk of identity theft and other unauthorized access to or use of such information. Further, the U.S. Congress and a number
of states have considered or are considering prohibitions or limitations on the disclosure of medical or other information to individuals or entities located outside of the United States. If we begin
selling our products outside the United States, we will need to comply with applicable laws in those jurisdictions that regulate the use and disclosure of individually identifiable information. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If we fail to comply with state and federal fraud and abuse laws, including anti-kickback, false
claims and anti-inducement laws, we could face substantial penalties and our business, operations, and financial condition could be adversely affected.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The federal anti-kickback statute prohibits, among other things, knowingly and willfully offering, paying, soliciting or receiving remuneration,
whether directly or indirectly and overtly or covertly, to induce or in return for purchasing, leasing, ordering, or arranging for the purchase, lease or order of any healthcare item or service
reimbursable under Medicare, Medicaid, or other federal financed healthcare programs. The statutory exceptions and regulatory safe harbors protecting certain common activities from prosecution are
drawn narrowly, and any remuneration to or from a prescriber or purchaser of healthcare products or services may be subject to scrutiny if they do not qualify for an exception or safe harbor. Our
practices may not in all cases meet all of the criteria for safe harbor protection from anti-kickback liability. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Federal
false claims laws prohibit, in part, any person from knowingly presenting or causing to be presented a false claim for payment to the federal government, or knowingly making or causing to be
made a false statement to get a false claim paid. The majority of states also have statutes or regulations similar to the federal anti-kickback law and false claims laws, which apply to items or
services reimbursed under Medicaid and other state programs, or, in several states, apply regardless of payer. These false claims statutes allow any person to bring suit in the name of the government
alleging false and fraudulent claims presented to or paid by the government (or other violations of the statutes) and to share in any amounts paid by the entity to the government in fines or
settlement. Such suits, known as </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>qui tam</I></FONT><FONT COLOR="#3B5A6F" SIZE=2> actions, have increased significantly in the healthcare industry in recent years. Sanctions under these federal
and state laws may include civil monetary penalties, exclusion of a manufacturer's products from reimbursement under government programs, criminal fines and imprisonment. In addition, the recently
enacted Patient Protection and Affordable Care Act, among </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>40</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=45,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=240907,FOLIO='40',FILE='DISK131:[15ZBY1.15ZBY12201]DE12201A.;30',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_de12201_1_41"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>other
things, amends the intent requirement of the federal anti-kickback and criminal healthcare fraud statutes. A person or entity no longer needs to have actual knowledge of this statute or specific
intent to violate it. In addition, the Patient Protection and Affordable Care Act provides that the government may assert that a claim, including items or services resulting from a violation of the
federal anti-kickback statute constitutes a false or fraudulent claim for purposes of the false claims statutes. Because of the breadth of these laws and the narrowness of the safe harbors and
exceptions, it is possible that some of our business activities could be subject to challenge under one or more of such laws. Such a challenge, regardless of the outcome, could have a material adverse
effect on our business, business relationships, reputation, financial condition and results of operations. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition, there has been a recent trend of increased federal and state regulation of payments made to physicians. The Patient Protection and Affordable Care Act imposes new reporting and disclosure
requirements on device and drug manufacturers for any "transfer of value" made or distributed to prescribers and other healthcare providers. Device and drug manufacturers will also be required to
report and disclose any investment interests held by physicians and their immediate family members during the preceding calendar year. Failure to submit required information may result in civil
monetary penalties of up to an aggregate of $150,000 per year (and up to an aggregate of $1.0&nbsp;million per year for "knowing failures to report"), for all payments, transfers of value or
ownership or investment interests not reported in an annual submission. As of August&nbsp;1, 2013, manufacturers are required to collect data, and they will be required to submit their first data
reports to CMS by March&nbsp;31, 2014 and by the 90th&nbsp;day of each calendar year thereafter. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Certain
states mandate implementation of compliance programs and/or the tracking and reporting of gifts, compensation and other remuneration to physicians. The shifting compliance environment and the
need to build and maintain robust and expandable systems to comply with different compliance and/or reporting requirements in multiple jurisdictions increase the possibility that a healthcare company
many violate one or more of the requirements. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
Federal Civil Monetary Penalties Law prohibits, in part, the offering or giving of remuneration to a Medicare or Medicaid beneficiary that the person knows or should know is likely to influence
the beneficiary's selection of a particular supplier of items or services reimbursable by a Federal or state governmental program. We sometimes offer customers various discounts and other financial
incentives in connection with the sales of our products. While it is our intent to comply with all applicable laws, the government may find that our marketing activities violate the Civil Monetary
Penalties Law. If we are found to be in noncompliance, we could be subject to civil money penalties of up to $10,000 for each wrongful act, assessment of three times the amount claimed for each item
or service and exclusion from the Federal healthcare programs. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
scope and enforcement of each of these laws is uncertain and subject to rapid change in the current environment of healthcare reform, especially in light of the lack of applicable precedent and
regulations. If our operations are found to be in violation of any of the laws described above or any other government regulations that apply to us, we may be subject to penalties, including civil and
criminal penalties, damages, fines and the curtailment, restructuring, or restricting of our operations. Any penalties, damages, fines, curtailment or restructuring or our operations could harm our
ability to operate our business and our financial results. Any action against us for violation of these laws, even if we successfully defend against it, could cause us to incur significant legal
expenses and divert our management's attention from operation of our business. Moreover, achieving and sustaining compliance with applicable federal and state fraud laws may prove costly. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>41</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=46,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=153535,FOLIO='41',FILE='DISK131:[15ZBY1.15ZBY12201]DE12201A.;30',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dg12201_1_42"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Failure to maintain the licenses and accreditations necessary to operate under our direct-to-patient
and -provider model would adversely affect our business.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>To continue operating our business under our direct-to-patient and -provider model, we must maintain our Durable Medical Equipment license and
certification from the Accreditation Commission for Health Care. In May 2008, we became a Durable, Medical Equipment, Prosthetics, Orthotics, and Supplies accredited Medicare supplier by the
Accreditation Commission for Health Care for our solutions and our Medicare accreditation must be renewed every three years through passage of an on-site inspection. Our current accreditation with
Medicare is due to expire in May 2017. In addition to maintaining our Durable Medical Equipment license and certification from the Accreditation Commission for Health Care, we also must maintain
certain state-required licenses. If we were found to be noncompliant, we could lose our licensure in that state. Losing our licensure could prohibit us from selling our current or future products to
patients in such state and our business, financial condition and results of operations could be adversely affected as a result of any such prohibition. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our products are currently made available to authorized users of the Department of Veterans Affairs
Federal Supply Schedule and if we were no longer eligible to sell our products through such channel, our business may be adversely affected.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>For our products to be eligible for reimbursement by the Veterans Administration, we must participate in the Department of Veterans Affairs Federal
Supply Schedule pricing program, established by Section&nbsp;603 of the Veterans Health Care Act of 1992. To be eligible for this program, we must comply with additional laws and requirements
applicable to our operations and manufacturing processes. If we were to lose eligibility for reimbursement by the Veterans Administration, our business, financial condition and results of operations
could be adversely affected. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may be unable to obtain or maintain international regulatory registrations or approvals for our
current or future products and indications, which could adversely impact our business.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Any future sales of our devices outside the United States are subject to foreign regulatory requirements that vary widely from country to country. In
addition, the FDA regulates exports of medical devices from the United States. Complying with international regulatory requirements can be an expensive and time-consuming process and approval is not
certain. The time required to obtain registration or approvals, if required by other countries, may be longer than that required for FDA clearance, and requirements for such registrations or approvals
may significantly differ from FDA requirements. In certain countries we intend to rely upon third-party distributors to obtain all required regulatory registrations and approvals, and these
distributors may be unable to obtain or maintain such registrations or approvals. Our distributors in these countries may also incur significant costs in attempting to obtain and in maintaining
foreign regulatory approvals or registrations, which could increase the difficulty of attracting and retaining qualified distributors. If these distributors experience delays in receiving necessary
registrations or approvals to market our products outside the United States, or if they fail to receive those registrations or approvals, we may be unable to market our products or enhancements in
certain international markets effectively, or at all. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our operations involve the use of hazardous and toxic materials, and we must comply with
environmental, health and safety laws and regulations, which can be expensive, and could have an adverse impact on our business.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our operations use or generate small volumes of hazardous or toxic materials. We are therefore subject to a variety of federal, state and local
regulations relating to the use, handling, storage, disposal and human exposure to hazardous and toxic materials. Liability under environmental laws can be joint and several and without regard to
comparative fault, and
environmental laws could become more stringent over time, imposing greater compliance costs and increasing risks and penalties </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>42</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=47,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=576498,FOLIO='42',FILE='DISK131:[15ZBY1.15ZBY12201]DG12201A.;25',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_dg12201_1_43"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>associated
with violations, which could have an adverse impact on our business. There can be no assurance that violations of environmental, health and safety laws will not occur in the future as a
result of human error, accident, equipment failure or other causes. The failure to comply with past, present or future laws could result in the imposition of fines, third-party property damage and
personal injury claims, investigation and remediation costs, the suspension of production or a cessation of operations. We also expect that our operations will be affected by other new environmental
and health and safety laws and regulations on an ongoing basis. Although we cannot predict the ultimate impact of any such new laws and regulations, they will likely result in additional costs, and
may require us to change how we manufacture our products, which could have an adverse impact on our business. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Related to Our Financial Condition  </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may need substantial additional funding beyond the proceeds of this offering and may be unable to
raise capital when needed, which could force us to delay or reduce our commercialization efforts or product development programs.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We believe the net proceeds from this offering, together with our existing cash and cash equivalents and revenues, will be sufficient to meet our
capital requirements and fund our operations through&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. However, we have based these estimates on assumptions that may prove to be incorrect, and we could spend our available
financial resources much faster than we currently expect. Any future funding requirements will depend on many factors, including:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> market acceptance of our products; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the scope, rate of progress and cost of our clinical studies; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the cost of our research and development activities; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the cost of filing and prosecuting patent applications and defending and enforcing our patent or other intellectual property rights; </FONT>
<FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the cost of defending, in litigation or otherwise, any claims that we infringe third-party patents or other intellectual property
rights; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the cost and timing of additional regulatory clearances or approvals; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the cost and timing of establishing additional sales, marketing and distribution capabilities; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> costs associated with any product recall that may occur; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the effect of competing technological and market developments; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the extent to which we acquire or invest in products, technologies and businesses, although we currently have no commitments or
agreements relating to any of these types of transactions; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the costs of operating as a public company. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
we raise additional funds by issuing equity securities, our stockholders may experience dilution. Any future debt financing into which we enter may impose upon us covenants that restrict our
operations, including limitations on our ability to incur liens or additional debt, pay dividends, repurchase our </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>43</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=48,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=262122,FOLIO='43',FILE='DISK131:[15ZBY1.15ZBY12201]DG12201A.;25',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_dg12201_1_44"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>common
stock, make certain investments and engage in certain merger, consolidation or asset sale transactions. Any debt financing or additional equity that we raise may contain terms that are not
favorable to us or our stockholders. If we raise additional funds through collaboration and licensing arrangements with third parties, it may be necessary to relinquish some rights to our technologies
or our products, or grant licenses on terms that are not favorable to us. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Furthermore,
we cannot be certain that additional funding will be available on acceptable terms, if at all. If we do not have, or are not able to obtain, sufficient funds, we may have to delay
development or commercialization of our products or license to third parties the rights to commercialize products or technologies that we would otherwise seek to commercialize. We also may have to
reduce marketing, customer support or other resources devoted to our products or cease operations. Any of these factors could harm our operating results. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Related to Our Intellectual Property  </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may not be able to protect our intellectual property rights throughout the world.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Filing, prosecuting and defending patents on products in all countries throughout the world would be prohibitively expensive, and our intellectual
property rights in some countries outside the United States may be less extensive than those in the United States. In addition, the laws of some foreign countries do not protect intellectual property
rights to the same extent as federal and state laws in the United States. For example, many foreign countries have compulsory licensing laws, under which a patent owner must grant licenses to third
parties. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States, or from selling or importing products made using our
inventions in and into the United States or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products, and
further, competitors may export otherwise infringing products to territories where we have patent protection but enforcement rights are not as strong as those in the United States. These products may
compete with our products in jurisdictions where we do not have any issued patents, and our patent claims or other intellectual rights may not be effective or sufficient to prevent them from so
competing. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Many
companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain countries do not favor the
enforcement of patents and other intellectual property protection, which could make it difficult for us to stop the infringement of our patents generally. Proceedings to enforce our patent rights in
foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted
narrowly and our patent applications at risk of not issuing, and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate and the damages or other
remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial
advantage from the intellectual property that we develop or license. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


The patent protection for our products may expire before we are able to maximize their commercial
value, which may subject us to increased competition and reduce or eliminate our opportunity to generate product revenues.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The patents for our products have varying expiration dates and, if these patents expire, we may be subject to increased competition and we may not be
able to recover our development costs or market any of our approved products profitably. For instance, our patents for our Flexitouch System will expire in 2017. Upon expiration of our patents, we may
be subject to increased competition and our </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>44</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=49,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=377828,FOLIO='44',FILE='DISK131:[15ZBY1.15ZBY12201]DG12201A.;25',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_dg12201_1_45"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>opportunity
to establish or maintain product revenues could be substantially reduced or eliminated. Further, we may not have sufficient time to recover our development costs prior to the expiration of
our U.S. and foreign patents. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may not identify relevant patents or may incorrectly interpret the relevance, scope or expiration
of a patent, which may adversely affect our ability to develop and market our products.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We cannot guarantee that any of our patent searches or analyses, including but not limited to the identification of relevant patents, the scope of
patent claims or the expiration of relevant patents, are complete or thorough, nor can we be certain that we have identified each and every patent and pending application in the United States and
abroad that is relevant to or necessary for the commercialization of our products in any jurisdiction. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
scope of a patent claim is determined by an interpretation of the law, the written disclosure in a patent and the patent family's prosecution history. Our interpretation of the relevance or the
scope of a patent or a pending application may be incorrect, which may negatively impact our ability to market our products. We may incorrectly determine that our products are not covered by a
third-party patent. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Many
patents may cover a marketed product, including but not limited to patents covering the product or portions thereof, methods of use or methods relating to the product, and production processes of
or for the product. The identification of all patents and their expiration dates relevant to the production and sale of a therapeutic product is extraordinarily complex and requires sophisticated
legal knowledge
in the relevant jurisdiction. It may be impossible to identify all patents in all jurisdictions relevant to a marketed product. Our determination of the expiration date of any patent in the United
States or abroad that we consider relevant may be incorrect, which may negatively impact our ability to develop and market our products. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Obtaining and maintaining our patent protection depends on compliance with various procedural,
documentary, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.  </I></B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The United States Patent and Trademark Office, or USPTO, and various foreign governmental patent agencies require compliance with a number of
procedural, documentary, fee payment and other similar provisions during the patent prosecution process. Periodic maintenance fees, renewal fees, annuity fees and various other governmental fees on
any issued patent and/or pending patent applications are due to be paid to the USPTO and foreign patent agencies in several stages over the lifetime of a patent or patent application. We have systems
in place to remind us to pay these fees, and we employ an outside firm and rely on our outside counsel to pay these fees. While an inadvertent lapse may sometimes be cured by payment of a late fee or
by other means in accordance with the applicable rules, there are many situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or
complete loss of patent rights in the relevant jurisdiction. If we fail to maintain the patents and patent applications directed to our products, our competitors might be able to enter the market
earlier than should otherwise have been the case, which would have a material adverse effect on our business. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may become involved in lawsuits to protect our patents or other intellectual property rights,
which could be expensive, time-consuming and ultimately unsuccessful.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Competitors may infringe our patents or other intellectual property rights. To counter infringement or unauthorized use, we may be required to file
infringement claims, which can be expensive and time consuming. In addition, in an infringement proceeding, a court may decide that a patent of ours is not valid or is unenforceable, or may refuse to
stop the other party from using the technology at issue on </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>45</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=50,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=33521,FOLIO='45',FILE='DISK131:[15ZBY1.15ZBY12201]DG12201A.;25',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_dg12201_1_46"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>the
grounds that our patents do not cover the technology in question. An adverse result in any litigation or defense proceedings could put one or more of our patents at risk of being invalidated or
interpreted narrowly and could put our patent applications at risk of not issuing. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Various
proceedings brought before the USPTO may be necessary to determine the priority of inventions with respect to our patents and patent applications or those of our current or future
collaborators. An unfavorable outcome could require us to cease using the technology or to attempt to license rights to it from the prevailing party. Our business could be harmed if a prevailing party
does not offer us a license on terms that are acceptable to us. Litigation or other proceedings may fail and, even if successful, may result in substantial costs and distraction of our management and
other employees. We may not be able to prevent misappropriation of our proprietary rights, particularly in countries where the laws may not protect those rights as fully as in the United States. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Furthermore,
because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential and proprietary information
could be compromised by disclosure during this type of litigation. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments. If
securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Third-party claims of intellectual property infringement or misappropriation may adversely affect
our business and could prevent us from developing or commercializing our products.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our commercial success depends in part on us not infringing the patents and proprietary rights of third parties. There is a substantial amount of
litigation, both within and outside the United States, involving patent and other intellectual property rights in the medical device industry, including patent infringement lawsuits, interferences,
oppositions, </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>ex-parte</I></FONT><FONT COLOR="#3B5A6F" SIZE=2> review and </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>inter partes</I></FONT><FONT COLOR="#3B5A6F" SIZE=2> reexamination and post-grant review
proceedings before the
USPTO and corresponding foreign patent offices. Numerous U.S. and foreign issued patents and pending patent applications owned by third parties exist in the fields in which we are developing and may
develop our products. As the medical device industry expands and more patents are issued, the risk increases that our products may be subject to claims of infringement of the patent rights of third
parties. If a third party claims that we infringe on their products or technology, we could face a number of issues, including:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> infringement and other intellectual property claims which, with or without merit, can be expensive and time-consuming to litigate and
can divert management's attention from our core business; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> substantial damages for past infringement, which we may have to pay if a court decides that our product infringes on a competitor's
patent; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> a court prohibiting us from selling or licensing our product, unless the patent holder licenses the patent to us; </FONT> <FONT COLOR="#3B5A6F"
SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> if a license is available from a patent holder, we may have to pay substantial royalties or grant cross licenses to our patents; and </FONT>
<FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> redesigning our processes so they do not infringe, which may not be possible or could require substantial funds and time. </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>46</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=51,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=509826,FOLIO='46',FILE='DISK131:[15ZBY1.15ZBY12201]DG12201A.;25',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_dg12201_1_47"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Third
parties may assert that we are employing their proprietary technology without authorization. There may be third-party patents or patent applications with claims to products, materials,
formulations, methods of manufacture or methods for treatment related to the use or manufacture of our products, that we failed to identify. For example, applications filed before November&nbsp;29,
2000 and certain applications filed after that date that will not be filed outside the United States remain confidential until issued as patents. Except for the preceding exceptions, patent
applications in the United States and elsewhere are generally published only after a waiting period of approximately 18&nbsp;months after the earliest filing. Therefore, patent applications covering
our technology or our products could have been filed by others without our knowledge. Additionally, pending patent applications that have been published can, subject to certain limitations, be later
amended in a manner that could cover our technologies, our products or the use or manufacture of our products. We may
also face a claim of misappropriation, if a third party believes that we inappropriately obtained and used trade secrets of such third parties. If we are found to have misappropriated a third party's
trade secrets, we may be prevented from further using such trade secrets, limiting our ability to develop our products, and we may be required to pay damages. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
any third-party patents were held by a court of competent jurisdiction to cover aspects of our products, materials, formulations, methods of manufacture or methods for treatment, the holders of any
such patents would be able to block our ability to develop and commercialize the applicable product candidate until such patent expired or unless we obtain a license. These licenses may not be
available on acceptable terms, if at all. Even if we were able to obtain a license, the rights may be nonexclusive, which could result in our competitors gaining access to the same intellectual
property. Ultimately, we could be prevented from commercializing a product, or be forced to cease some aspect of our business operations, if, as a result of actual or threatened patent infringement
claims, we are unable to enter into licenses on acceptable terms. In addition, during the course of any patent or other intellectual property litigation, there could be public announcements of the
results of hearings, rulings on motions, and other interim proceedings in the litigation. If securities analysts or investors regard these announcements as negative, the perceived value of our
products, programs, or intellectual property could be diminished. Accordingly, the market price of our common stock may decline. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Parties
making claims against us may obtain injunctive or other equitable relief, which could effectively block our ability to further develop and commercialize one or more of our products. Defending
against claims of patent infringement or misappropriation of trade secrets could be costly and time-consuming, regardless of the outcome. Thus, even if we were to ultimately prevail, or to settle at
an early stage, such litigation could burden us with substantial unanticipated costs. In addition, litigation or threatened litigation could result in significant demands on the time and attention of
our management team, distracting them from the pursuit of other company business. In the event of a successful claim of infringement against us, we may have to pay substantial damages, including
treble damages and attorneys' fees for willful infringement, pay royalties, redesign our infringing products or obtain one or more licenses from third parties, which may be impossible or require
substantial time and monetary expenditure. In addition, the uncertainties associated with litigation could have a material adverse effect on our ability to raise the funds necessary to continue our
clinical trials, continue our research programs, license necessary technology from third parties, or enter into development collaborations that would help us bring our products to market. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Changes in U.S. patent law could diminish the value of patents in general, thereby impairing our
ability to protect our products.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As is the case with other medical device companies, our success is heavily dependent on intellectual property, particularly on obtaining and
enforcing patents. Obtaining and enforcing patents in the medical device industry involves both technological and legal complexity, and therefore is costly, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>47</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=52,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=23168,FOLIO='47',FILE='DISK131:[15ZBY1.15ZBY12201]DG12201A.;25',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_dg12201_1_48"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>time-consuming
and inherently uncertain. In addition, the United States has recently enacted and is currently implementing wide-ranging patent reform legislation. Further, several recent judicial
rulings have either narrowed the scope of patent protection available in certain circumstances or weakened the rights of patent owners in certain situations. In addition to increasing uncertainty with
regard to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of patents, once obtained. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>For
our U.S. patent applications containing a claim not entitled to priority before March&nbsp;16, 2013, there is a greater level of uncertainty in the patent law. In September 2011, the Leahy-Smith
America Invents Act, or the American Invents Act, or AIA, was signed into law. The AIA includes a number of significant changes to U.S. patent law, including provisions that affect the way patent
applications will be prosecuted, reviewed after issuance, and may also affect patent litigation. The USPTO is currently developing regulations and procedures to govern administration of the AIA and
many of the substantive changes to patent law associated with the AIA. It is not clear what other, if any, impact the AIA will have on the operation of our business. Moreover, the AIA and its
implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have a
material adverse effect on our business and financial condition. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>An
important change introduced by the AIA is that, as of March&nbsp;16, 2013, the United States transitioned to a "first-inventor-to-file" system for deciding which party should be granted a patent
when two or more patent applications are filed by different parties claiming the same invention. A third party that files&nbsp;a patent application in the USPTO after that date but before us could
therefore be awarded a patent covering an invention of ours, even if we had made the invention before it was made by the third party. This will require us to be cognizant, going forward, of the time
from invention to filing of a patent application, but early filing of patent applications may not always be possible. Furthermore, our ability to obtain and maintain valid and enforceable patents
depends on whether the differences between our technology and the prior art allow our technology to be patentable over the prior art. Since patent applications in the United States and most other
countries are confidential for a period of time after filing, we cannot be certain that we were the first to either (a)&nbsp;file any patent application related to our products or (b)&nbsp;invent
any of the inventions claimed in our patents or patent applications. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Among
some of the other changes introduced by the AIA are changes that limit where a patentee may file&nbsp;a patent infringement suit and provide opportunities for third parties to challenge any
issued patent in the USPTO. This applies to all of our U.S. patents, even those issued before March&nbsp;16, 2013. Because of a lower evidentiary standard in USPTO proceedings compared to the
evidentiary standard in United States federal court necessary to invalidate a patent claim, a third party could potentially provide evidence in a USPTO proceeding sufficient for the USPTO to hold a
claim invalid as unpatentable, even though the same evidence may be insufficient to invalidate the claim if first presented in a district court action. Accordingly, a third party may attempt to use
the USPTO procedures to invalidate our patent claims that would not have been invalidated if first challenged by the third party as a defendant in a district court action. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Depending
on decisions by the U.S. Congress, the federal courts, and the USPTO, the laws and regulations governing patents could change in unpredictable ways that would weaken our ability to obtain
new patents or to enforce our existing patents and patents that we might obtain in the future. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>48</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=53,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=541459,FOLIO='48',FILE='DISK131:[15ZBY1.15ZBY12201]DG12201A.;25',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_dg12201_1_49"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Because of the expense and uncertainty of litigation, we may not be in a position to enforce our
intellectual property rights against third parties.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We have become aware from time to time that third parties may be infringing on our patents or other intellectual property rights. Because of the
expense and uncertainty of litigation, we have concluded in the past and may conclude in the future that even if a third party is infringing our patents or other intellectual property rights, the
risk-adjusted cost of bringing and enforcing such a claim or action may be too high or not in the best interest of our company or our stockholders. In such cases, we may decide that the more prudent
course of action is to simply monitor the situation or initiate or seek some other non-litigious action or solution. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Intellectual property rights do not address all potential threats to our competitive advantage.  </I></B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The degree of future protection afforded by our intellectual property rights is uncertain, because intellectual property rights have limitations and
may not adequately protect our business or permit us to maintain our competitive advantage. The following examples are illustrative:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Others may be able to make products that are similar to our products but that are not covered by the claims of the patents that we own
or license from others. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Others may independently develop similar or alternative technologies or otherwise circumvent any of our technologies without
infringing our intellectual property rights. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> We might not have been the first to conceive and reduce to practice the inventions covered by the patents or patent applications that
we own, license or will own or license. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> We might not have been the first to file patent applications covering certain subject matter of the patents or patent applications
that we own or for which we have obtained a license, or will own or for which we will obtain a license. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> It is possible that our pending patent applications will not lead to issued patents. </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Issued patents that we own may not provide us with any competitive advantage, or may be held invalid or unenforceable, as a result of
legal challenges by our competitors. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Our competitors might conduct research and development activities in countries where we do not have patent rights, or in countries
where research and development safe harbor laws exist, and then use the information learned from such activities to develop competitive products for sale in our major commercial markets. </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Ownership of our patents or patent applications may be challenged by third parties. </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> The patents of third parties or pending or future applications of third parties, if issued, may have an adverse effect on our
business. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Confidentiality agreements with employees and others may not adequately prevent disclosure of trade
secrets and protect other proprietary information.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We consider proprietary trade secrets and/or confidential know-how and unpatented know-how to be important to our business. We may rely on trade
secrets and/or confidential know-how to protect our technology, especially where patent protection is believed by us to be of limited value. However, trade secrets and/or confidential know-how can be
difficult to maintain as confidential. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>49</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=54,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=197767,FOLIO='49',FILE='DISK131:[15ZBY1.15ZBY12201]DG12201A.;25',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_di12201_1_50"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>To protect this type of information against disclosure or appropriation by competitors, our policy is to require our employees, consultants, contractors and advisors to enter
into confidentiality agreements with us. However, current or former employees, consultants, contractors and advisers may unintentionally or willfully disclose our confidential information to
competitors, and confidentiality agreements may not provide an adequate remedy in the event of unauthorized disclosure of confidential information. Enforcing a claim that a third party obtained
illegally and is using trade secrets and/or confidential know-how is expensive, time consuming and unpredictable. The enforceability of confidentiality agreements may vary from jurisdiction to
jurisdiction. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Failure
to obtain or maintain trade secrets and/or confidential know-how trade protection could adversely affect our competitive position. Moreover, our competitors may independently develop
substantially equivalent proprietary information and may even apply for patent protection in respect of the same. If successful in obtaining such patent protection, our competitors could limit our use
of our trade secrets and/or confidential know-how. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may need to license certain intellectual property from third parties, and such licenses may not
be available or may not be available on commercially reasonable terms.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A third party may hold intellectual property, including patent rights that are important or necessary to the development or commercialization of any
future products. It may be necessary for us to use the patented or proprietary technology of third parties to commercialize our products, in which case we would be required to obtain a license from
these third parties. Such a license may not be available on commercially reasonable terms or at all, which could materially harm our business. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may be subject to claims that our employees, consultants or independent contractors have
wrongfully used or disclosed confidential information of third parties.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We have received confidential and proprietary information from third parties. In addition, we employ individuals who were previously employed at
other medical device companies. We may be subject to claims that we or our employees, consultants or independent contractors have inadvertently or otherwise improperly used or disclosed confidential
information of these third parties or our employees' former employers. Further, we may be subject to ownership disputes in the future, arising, for example, from conflicting obligations of consultants
or others who are involved in developing our products. We may also be subject to claims that former employees, consultants, independent contractors, collaborators or other third parties have an
ownership interest in our patents or other intellectual property. Litigation may be necessary to defend against these and other claims challenging our right to and use of confidential and proprietary
information. If we fail in defending any such claims, in addition to paying monetary damages, we may lose our rights therein. Such an outcome could have a material adverse effect on our business. Even
if we are successful in defending against these claims, litigation could result in substantial cost and be a distraction to our management and employees. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may be subject to claims challenging the inventorship or ownership of our patents and other
intellectual property.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We may also be subject to claims that former employees, collaborators or other third parties have an ownership interest in our patents or other
intellectual property. We may be subject to ownership disputes in the future, arising, for example, from conflicting obligations of consultants or others who are involved in developing our products.
Litigation may be necessary to defend against these and other claims challenging inventorship or ownership. If we fail in defending any such claims, in addition to paying monetary damages, we may lose
valuable intellectual property
rights, such as exclusive ownership of, or right to use, valuable intellectual property. Such an outcome could have a material </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>50</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=55,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=916573,FOLIO='50',FILE='DISK131:[15ZBY1.15ZBY12201]DI12201A.;31',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_di12201_1_51"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>adverse
effect on our business. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our reliance on third parties requires us to share our trade secrets, which increases the
possibility that a competitor will discover them or that our trade secrets will be misappropriated or disclosed.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Because we rely on third parties to assist with research and development and to manufacture our products, we must, at times, share trade secrets with
them. We seek to protect our proprietary technology in part by entering into confidentiality agreements and, if applicable, material transfer agreements, consulting agreements or other similar
agreements with our advisors, employees, third-party contractors and consultants, prior to beginning research or disclosing proprietary information. These agreements typically limit the rights of the
third parties to use or disclose our confidential information, including our trade secrets. Despite the contractual provisions employed when working with third parties, the need to share trade secrets
and other confidential information increases the risk that such trade secrets become known by our competitors, are inadvertently incorporated into the technology of others, or are disclosed or used in
violation of these agreements. Given that our proprietary position is based, in part, on our know-how and trade secrets, a competitor's discovery of our trade secrets or other unauthorized use or
disclosure would impair our competitive position and may have a material adverse effect on our business. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition, these agreements typically restrict the ability of our advisors, employees, third-party contractors and consultants to publish data potentially relating to our trade secrets, although our
agreements may contain certain limited publication rights. For example, any academic institution that we may collaborate with in the future will usually expect to be granted rights to publish data
arising out of such collaboration, provided that we are notified in advance and given the opportunity to delay publication for a limited time period in order for us to secure patent protection of
intellectual property rights arising from the collaboration, in addition to the opportunity to remove confidential or trade secret information from any such publication. In the future, we may also
conduct joint research and development programs that may require us to share trade secrets under the terms of our research and development or similar agreements. Despite our efforts to protect our
trade secrets, our competitors may discover our trade secrets, either through breach of our agreements with third parties, independent development or publication of information by any of our
third-party collaborators. A competitor's discovery of our trade secrets would impair our competitive position and have an adverse impact on our business. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If our trademarks and trade names are not adequately protected, then we may not be able to build
name recognition in our markets of interest and our business may be adversely affected.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest, and our
business may be adversely affected. We currently have registered and unregistered trademarks in the United States. Our trademarks or trade names may be challenged, infringed, circumvented or declared
generic or determined to be infringing on other marks. We may not be able to protect our rights to these trademarks and trade names, which we need to build name recognition among potential
collaborators or customers in our markets of interest. At times, competitors may adopt trade names or trademarks similar to ours, thereby impeding our ability to build brand identity and possibly
leading to market confusion. Further, there could be potential trade name or trademark infringement claims brought by owners of other trademarks or trade names that incorporate variations of our
trademarks or trade names. In addition, we have not registered our trademarks internationally, and the laws of certain foreign countries may not protect proprietary rights to the same extent as do the
laws of the United States. Over the long term, if we are unable to successfully register our trademarks and trade names and/or establish name recognition based on our trademarks and trade names, then
we may not be able to compete effectively and our business may be </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>51</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=56,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=739596,FOLIO='51',FILE='DISK131:[15ZBY1.15ZBY12201]DI12201A.;31',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_di12201_1_52"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>adversely
affected. Our efforts to enforce or protect our proprietary rights related to trademarks, trade secrets, domain names, copyrights or other intellectual property may be ineffective and could
result in substantial costs and diversion of resources and could adversely impact our financial condition or results of operations. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Related to This Offering and Ownership of Our Common Stock  </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


An active trading market for our common stock may not develop.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Prior to this offering, there has been no public market for our common stock. Although we expect our common stock to be approved for listing on The
NASDAQ Global Market, an active trading market for our shares may never develop or be sustained following this offering. If the market does not develop or is not sustained, it may be difficult for you
to sell your shares of our common stock at a price that is attractive to you or at all. In addition, an inactive market may impair our ability to raise capital by selling shares and may impair our
ability to acquire other companies or technologies by using our shares as consideration, which, in turn, could adversely affect our business. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


The trading price of the shares of our common stock could be highly volatile, and purchasers of our
common stock may not be able to resell the shares of our common stock at or above the initial public offering price and could incur substantial losses.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our stock price is likely to be volatile. The stock market in general has experienced extreme volatility that has often been unrelated to the
operating performance of particular companies. As a result of this volatility, investors may not be able to sell their shares of our common stock at or above the initial public offering price. The
market price for our common stock may be influenced by many factors, including:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the passage of legislation or other regulatory developments in the United States and foreign countries; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> actual or anticipated variations in our financial results or those of companies that are perceived to be similar to us; </FONT> <FONT
COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> changes in the structure of healthcare payment systems, especially in light of current reforms to the U.S. healthcare system; </FONT> <FONT
COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our ability to develop and commercialize additional products; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> announcements by us or our competitors of significant acquisitions, strategic collaborations, joint ventures or capital commitments; </FONT>
<FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> market conditions in medical device sectors and issuance of securities analysts' research reports or recommendations; </FONT> <FONT
COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> sales of our stock by us, our insiders and our other stockholders; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the trading volume of our common stock; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> speculation in the press or investment community; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> general economic, industry and market conditions, or other events or factors, many of which are beyond our control; </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>52</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=57,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=938891,FOLIO='52',FILE='DISK131:[15ZBY1.15ZBY12201]DI12201A.;31',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_di12201_1_53"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> additions or departures of key personnel; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> intellectual property, product liability or other litigation against us. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition, the stock market has recently experienced significant volatility with respect to medical device and other life sciences company stocks. The volatility of medical device and other medical
technology company stocks often does not relate to the operating performance of the companies represented by the stock. As we operate in a single industry, we are especially vulnerable to these
factors to the extent that they affect our industry or our products, or to a lesser extent our markets. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We are an "emerging growth company," and the reduced disclosure requirements applicable to emerging
growth companies may make our common stock less attractive to investors.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We are an "emerging growth company," as defined in the JOBS Act and may remain an emerging growth company for up to five years. For so long as we
remain an emerging growth company, we are permitted and intend to rely on exemptions from certain disclosure requirements that are applicable to other public companies that are not emerging growth
companies. These exemptions include:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> being permitted to provide only two years of audited financial statements, in addition to any required unaudited interim financial
statements, with correspondingly reduced "Management's Discussion and Analysis of Financial Condition and Results of Operations" in this prospectus; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> not being required to comply with the auditor attestation requirements in the assessment of our internal control over financial
reporting; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> not being required to comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding
mandatory audit firm rotation or a supplement to the auditor's report providing additional information about the audit and the financial statements; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> reduced disclosure obligations regarding executive compensation; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> exemptions from the requirements of holding a non-binding advisory vote on executive compensation and stockholder approval of any
golden parachute payments not previously approved. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
have taken advantage of reduced reporting burdens in this prospectus. In particular, in this prospectus, we have provided only two years of audited financial statements and have not included all of
the executive compensation related information that would be required if we were not an emerging growth company. We cannot predict whether investors will find our common stock less attractive if we
rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be reduced or more
volatile. In addition, the JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. This allows an
emerging growth company to delay the adoption of these accounting standards until they would otherwise apply to private companies. We have elected to avail ourselves of this exemption and, as a
result, our financial statements may not be comparable to the financial statements of issuers that are required to comply with the effective dates for new or revised accounting standards that are
applicable to public companies. We cannot predict whether investors will find our common stock less attractive if we rely on these exemptions. If some investors find our common stock less attractive
as a </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>53</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=58,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=176414,FOLIO='53',FILE='DISK131:[15ZBY1.15ZBY12201]DI12201A.;31',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_di12201_1_54"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>result,
there may be a less active trading market for our common stock and our stock price may be reduced or more volatile. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Sales of a substantial number of shares of our common stock by our existing stockholders in the
public market could cause our stock price to fall.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Sales of a substantial number of shares of our common stock in the public market, or the perception that these sales might occur, could significantly
reduce the market price of our common stock and impair our ability to raise adequate capital through the sale of additional equity securities. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Assuming
no exercise of the underwriters' option to purchase additional shares and no exercise of outstanding options and warrants and based on the number of shares outstanding as of
September&nbsp;30, 2015 and the adjustments set forth in "Summary&nbsp;&#151; The Offering&nbsp;&#151; Pro Forma Adjustments," upon completion of this offering, we will have
outstanding a total of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Of
these shares, only the shares of common stock sold in this offering by us, plus any shares sold upon exercise of the underwriters' option to purchase additional shares, will be freely tradable
without restriction in the public market immediately following this offering, unless they are purchased by one of our affiliates. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We,
our directors and officers and other holders of substantially all of our outstanding common stock, preferred stock, options and warrants have agreed, subject to certain exceptions, not to engage
in sales or dispositions of, or other transactions relating to, our common stock or securities convertible into or exercisable or exchangeable for our common stock or warrants or other rights to
acquire shares of our common stock. These "lock-up" restrictions end 180&nbsp;days after the date of this prospectus. However, Piper Jaffray&nbsp;&amp;&nbsp;Co. and William Blair&nbsp;&amp; Company,
L.L.C., in their sole discretion, may permit persons who are subject to these lock-up agreements to sell shares prior to the expiration of the lock-up agreements. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>After
the lock-up agreements expire, up to an additional&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock will
be eligible for sale in the public market, of which&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares are
held by directors, executive officers and other affiliates and will be subject to volume limitations under Rule&nbsp;144 under the Securities Act of 1933, as amended, or the Securities Act. In
addition, shares of our common stock that are subject to
outstanding options, outstanding warrants or reserved for future issuance under our employee benefit plans will become eligible for sale in the public market to the extent permitted by the provisions
of various vesting schedules, the lock-up agreements and Rule&nbsp;144 and Rule&nbsp;701 under the Securities Act. If these additional shares of our common stock are sold, or if it is perceived
that they will be sold, in the public market, the trading price of our common stock could decline. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Following
completion of this offering, the holders of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our outstanding common stock,
or approximately&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% of our total outstanding common stock, will be
entitled to rights with respect to the registration of their shares under the Securities Act, subject to the 180-day lock-up agreements described above. See "Description of Capital
Stock&nbsp;&#151; Registration Rights." Registration of these shares under the Securities Act would result in the shares becoming freely tradable without restriction under the Securities Act,
except for shares held by affiliates, as defined in Rule&nbsp;144 under the Securities Act. Any sales of securities by these stockholders could have a material adverse effect on the trading price of
our common stock. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>54</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=59,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=1032547,FOLIO='54',FILE='DISK131:[15ZBY1.15ZBY12201]DI12201A.;31',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_di12201_1_55"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may use the net proceeds from this offering in ways that you and other stockholders may not
approve.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our management will have broad discretion in the application of the net proceeds from this offering, including for any of the purposes described in
the section entitled "Use of Proceeds," and you will not have the opportunity as part of your investment decision to assess whether the net proceeds are being used appropriately. Because of the number
and variability of factors that will determine our use of the net proceeds from this offering, their ultimate use may vary substantially from their currently intended use. Our management might not
apply our net proceeds in ways that ultimately increase the value of your investment. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
intend to use the net proceeds from this offering primarily to expand our sales, marketing, reimbursement, clinical, regulatory and product development activities, and the remainder for working
capital, general and administrative expenses and other general corporate purposes, as well as to pay the approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million of cumulative accrued dividends to our
Series&nbsp;A preferred stockholders as described in "Dividend Policy." We may also use a portion of our net proceeds to acquire or invest in complementary products, technologies or businesses,
although we have no present commitments to complete any such transaction. The amounts and timing of our expenditures will depend on numerous factors, including the rate of adoption of our devices, the
expenses we incur in sales and marketing our devices, the scope of research and development efforts, the timing and success of any clinical trials we may commence in the future, and the timing of
regulatory submissions. Accordingly, our management will have broad discretion over the use of the net proceeds from this offering. The failure by our
management to apply the net proceeds from this offering effectively could harm our business. Pending the uses described above, we intend to invest the net proceeds in short-term, interest-bearing,
investment-grade securities, certificates of deposit or governmental securities. These investments may not yield a favorable return to our stockholders. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


You will suffer immediate and substantial dilution in the net tangible book value of the common
stock you purchase.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The initial public offering price of our common stock is substantially higher than the pro forma as adjusted net tangible book value per share of our
outstanding common stock immediately after the completion of this offering. Purchasers of our common stock in this offering will experience immediate dilution of approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, based on the assumed initial public offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering price range set forth
on the
cover page of this prospectus. In the past, we issued options and warrants to acquire common stock at prices significantly below the assumed initial public offering price. To the extent these
outstanding options and warrants are ultimately exercised, investors purchasing common stock in this offering will sustain further dilution. For a further description of the dilution that you will
experience immediately after this offering, see "Dilution." </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We do not intend to pay dividends on our common stock, and, consequently, your ability to achieve a
return on your investment will depend on appreciation, if any, in the price of our common stock.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We have never declared or paid any cash dividend on our common stock and do not currently intend to do so for the foreseeable future. We currently
anticipate that we will retain future earnings for the development, operation and expansion of our business. In addition, any future debt financing arrangement may contain terms prohibiting or
limiting the amount of dividends that may be declared or paid on our common stock. Any return to stockholders will therefore be limited to any appreciation of their stock. Therefore, the success of an
investment in shares of our common stock will depend upon any future appreciation in their value. There is no guarantee that shares of our common stock will appreciate in value or even maintain the
price at which our stockholders purchased their shares. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>55</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=60,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=540897,FOLIO='55',FILE='DISK131:[15ZBY1.15ZBY12201]DI12201A.;31',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_di12201_1_56"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We will incur significant increased costs as a result of operating as a public company, and our
management will be required to devote substantial time to new compliance initiatives.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As a public company, we will incur significant legal, accounting and other expenses that we did not incur as a private company. We will be subject to
the reporting requirements of the Securities Exchange Act of 1934, or the Exchange Act, which will require, among other things, that we file with the Securities and Exchange Commission, or the SEC,
annual, quarterly and current reports with respect to our business and financial condition. In addition, the Sarbanes-Oxley Act of 2002, as well as rules subsequently adopted by the SEC and the stock
market to implement provisions of the Sarbanes-Oxley Act, imposes significant requirements on public companies, including requiring establishment and maintenance of effective disclosure and financial
controls and changes in corporate governance practices. Further, pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, the SEC has adopted additional rules and regulations
in these areas, such as mandatory "say on pay" voting requirements that will apply to us when we cease to be an emerging growth company. Stockholder activism, the current political environment and the
current high level of government intervention and regulatory reform may lead to substantial new regulations and disclosure obligations, which may lead to additional compliance costs and may impact the
manner in which we operate our business in ways we cannot currently anticipate. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
expect the rules and regulations applicable to public companies to substantially increase our legal and financial compliance costs and to make some activities more time-consuming and costly. If
these requirements divert the attention of our management and personnel from other business concerns, they could have a material adverse effect on our business, financial condition, results of
operations, and prospects. The increased costs will decrease our net income or increase our net loss, and may require us to reduce costs in other areas of our business or increase the prices of our
products or services. For example, we expect these rules and regulations to make it more difficult and more expensive for us to obtain director and officer liability insurance, and we may be required
to incur substantial costs to maintain the same or similar coverage. We are evaluating these rules and regulations, and cannot predict or estimate the amount of additional costs we may incur or the
timing of such costs. These rules and regulations are often subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application in practice may
evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing
revisions to disclosure and governance practices. The impact of these requirements could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors,
our board committees or as executive officers. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If we fail to maintain proper and effective internal control over financial reporting in the future,
our ability to produce accurate and timely financial statements could be impaired, which could harm our operating results, investors' views of us and, as a result, the value of our common stock.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Pursuant to Section&nbsp;404 of the Sarbanes-Oxley Act, our management will be required to report upon the effectiveness of our internal control
over financial reporting beginning with the annual report for our fiscal year ending December&nbsp;31, 2015. When and if we are a "large accelerated filer" or an "accelerated filer" and are no
longer an "emerging growth company," each as defined in the Exchange Act, our independent registered public accounting firm will be required to attest to the effectiveness of our internal control over
financial reporting. However, for so long as we remain an emerging growth company, we intend to take advantage of an exemption available to emerging growth companies from these auditor attestation
requirements. We could be an "emerging growth company" for up to five years. The rules governing the standards that must be met for management to assess our internal control over financial reporting
are complex and require significant documentation, testing, and possible remediation. To comply with the requirements of being a reporting company under the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>56</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=61,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=710989,FOLIO='56',FILE='DISK131:[15ZBY1.15ZBY12201]DI12201A.;31',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_di12201_1_57"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Exchange
Act, we will need to upgrade our systems, including information technology; implement additional financial and management controls, reporting systems, and procedures; and hire additional
accounting and finance staff. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Any
failure to implement required new or improved controls, or difficulties encountered in their implementation, could cause us to fail to meet our reporting obligations. In addition, any testing by
us conducted in connection with Section&nbsp;404 of the Sarbanes-Oxley Act, or any subsequent testing by our independent registered public accounting firm, may reveal deficiencies in our internal
control over financial reporting that are deemed to be material weaknesses or that may require prospective or retroactive changes to our financial statements or identify other areas for further
attention or improvement. Inferior internal controls could also cause investors to lose confidence in our reported financial information, which could have a negative effect on the trading price of our
common stock. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition, we may encounter problems or delays in implementing any changes necessary to make a favorable assessment of our internal control over financial reporting. Further, once we are no longer
an emerging growth company, we may encounter problems or delays in completing the implementation of any requested improvements and receiving a favorable attestation in connection with the attestation
provided by our independent registered public accounting firm. If we cannot favorably assess the effectiveness of our internal control over financial reporting, or if our independent registered public
accounting firm is unable to provide an unqualified attestation report on our internal controls,
investors could lose confidence in our financial information and the trading price of our common stock could decline. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
connection with our future evaluation of our internal control over financial reporting, we may need to upgrade our systems or create new systems, implement additional financial and management
controls, update our reporting systems and procedures, create or outsource an internal audit function or hire additional accounting and finance staff. If we are unable to accomplish these objectives
in a timely and effective fashion, our ability to comply with the financial reporting requirements and other rules that apply to reporting companies could be impaired. Any failure to maintain
effective internal control over financial reporting could have a material adverse effect on our business, financial condition and results of operations and the trading price of our common stock. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Anti-takeover provisions in our charter documents and under Delaware law could make an acquisition
of us, which may be beneficial to our stockholders, more difficult and may prevent attempts by our stockholders to replace or remove our current management.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Provisions in our amended and restated certificate of incorporation and amended and restated bylaws to become effective upon completion of this
offering, as well as provisions of Delaware law, may delay or prevent an acquisition of us or a change in our management. These provisions include:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> authorizing the issuance of "blank check" preferred stock, the terms of which may be established and shares of which may be issued
without stockholder approval; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> limiting the removal of directors by the stockholders; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> creating a staggered board of directors; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> prohibiting cumulative voting in the election of directors, which would otherwise allow for less than a majority of stockholders to
elect director candidates; </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>57</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=62,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=1020308,FOLIO='57',FILE='DISK131:[15ZBY1.15ZBY12201]DI12201A.;31',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_di12201_1_58"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> prohibiting stockholder action by written consent, thereby requiring all stockholder actions to be taken at a meeting of our
stockholders; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> eliminating the ability of stockholders to call a special meeting of stockholders; and </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> establishing advance notice requirements for nominations for election to the board of directors or for proposing matters that can be
acted upon at stockholder meetings. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>These
provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board of
directors, who are responsible for appointing the members of our management. In addition, because we are incorporated in Delaware, we are governed by the provisions of Section&nbsp;203 of the
Delaware General Corporation Law, which limits the ability of stockholders owning in excess of 15% of our outstanding voting stock to merge or combine with us. These provisions would apply even if an
offer rejected by our board were considered beneficial by some stockholders. Any provision of our amended and restated certificate of incorporation or our amended and restated bylaws or Delaware law
that has the effect of delaying or deterring a change of control could limit the opportunity for our stockholders to receive a premium for their shares of our common stock, and could also affect the
price that some investors are willing to pay for our common stock. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


After this offering, our executive officers, directors and principal stockholders will maintain the
ability to control all matters submitted to stockholders for approval and may take actions that may not be in the best interests of our other stockholders.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Assuming the sale of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock in this offering
(or&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares if the underwriters exercise
their option to purchase additional shares in full), our executive officers, directors and stockholders who owned more than 5% of our outstanding common stock before this offering will, in the
aggregate, beneficially own shares representing approximately&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% of our capital stock (or&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% if the underwriters exercise their option to purchase
additional shares in full).
As a result, if these stockholders were to act together, they would be able to control all matters submitted to our stockholders for approval, as well as our management and affairs. For example, these
persons, if they act together, would control the election of directors and decisions on any merger, consolidation or sale of all or substantially all of our assets. This concentration of voting power
could delay or prevent an acquisition of our company on terms that other stockholders may desire or result in management of our company that our public stockholders disagree with. See "Principal
Stockholders" for further information regarding the stock ownership of our directors, executive officers and principal stockholders. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If securities or industry analysts do not publish research, or publish inaccurate or unfavorable
research, about our business, the price of our common stock and our trading volume could decline.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The trading market for our common stock will depend in part on the research and reports that securities or industry analysts publish about us or our
business. Securities and industry analysts do not currently, and may never, publish research on our company. If no or too few securities or industry analysts commence coverage of our company, the
trading price for our common stock would likely be negatively affected. In the event securities or industry analysts initiate coverage, if one or more of the analysts who cover us downgrade our common
stock or publish inaccurate or unfavorable research about our business, the price of our common stock would likely decline. If one or more of these analysts cease coverage of our company or fail to
publish reports on us regularly, demand for our common stock could decrease, which might cause the price of our shares and trading volume to decline. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>58</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=63,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=722933,FOLIO='58',FILE='DISK131:[15ZBY1.15ZBY12201]DI12201A.;31',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_di12201_1_59"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Claims for indemnification by our directors and officers may reduce our available funds to satisfy
successful third-party claims against us and may reduce the amount of money available to us.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our amended and restated certificate of incorporation and amended and restated bylaws that will become effective upon completion of this offering
provide that we will indemnify our directors and officers, in each case to the fullest extent permitted by Delaware law. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition, as permitted by Section&nbsp;145 of the Delaware General Corporation Law, our amended and restated bylaws and our indemnification agreements that we intend to enter into with our
directors and officers provide that:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> We will indemnify our directors and officers for serving us in those capacities or for serving other business enterprises at our
request, to the fullest extent permitted by Delaware law. Delaware law provides that a corporation may indemnify such person if such person acted in good faith and in a manner such person reasonably
believed to be in or not opposed to the best interests of the corporation and, with respect to any criminal proceeding, had no reasonable cause to believe such person's conduct was unlawful. </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> We may, in our discretion, indemnify employees and agents in those circumstances where indemnification is permitted by applicable law. </FONT>
<FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> We are required to advance expenses, as incurred, to our directors and officers in connection with defending a proceeding, except that
such directors or officers shall undertake to repay such advances if it is ultimately determined that such person is not entitled to indemnification. </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> We will not be obligated pursuant to our amended and restated bylaws to indemnify a person with respect to proceedings initiated by
that person against us or our other indemnitees, except with respect to proceedings authorized by our board of directors or brought to enforce a right to indemnification. </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> The rights conferred in our amended and restated bylaws are not exclusive, and we are authorized to enter into indemnification
agreements with our directors, officers, employees and agents and to obtain insurance to indemnify such persons. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> We may not retroactively amend our bylaw provisions to reduce our indemnification obligations to directors, officers, employees and
agents. </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>59</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=64,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=45810,FOLIO='59',FILE='DISK131:[15ZBY1.15ZBY12201]DI12201A.;31',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<UL>
<UL>
</UL>
</UL>
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dk12201_1_60"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="dk12201_special_note_regarding_forward-looking_statements"> </A>
<A NAME="toc_dk12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>This prospectus contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of
historical facts, contained in this prospectus, including statements regarding our business, operations and financial performance and condition, as well as our plans, objectives and expectations for
our business, operations and financial performance and condition, are forward-looking statements. In some cases, you can identify forward-looking statements by the following words: "anticipate,"
"believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "target," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these
terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements involve known and unknown risks, uncertainties and other factors that
may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this prospectus. The
forward-looking statements in this prospectus include, among other things, statements relating to:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our expectations regarding the potential market size and widespread adoption of our products; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our ability to increase awareness of lymphedema and chronic venous insufficiency and to demonstrate the clinical and economic benefits
of our solutions to clinicians and patients; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> developments and projections relating to our competitors or our industry; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the expected growth in our business and our organization, including outside of the United States; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our ability to achieve and maintain adequate levels of coverage or reimbursement for our products and the effect of a recent change to
the level of Medicare coverage; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our financial performance, our estimates of our expenses, future revenues, capital requirements and our needs for, or ability to
obtain, additional financing; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our ability to retain and recruit key personnel, including the continued development and expansion of our sales and marketing
organization; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our ability to obtain an adequate supply of components for our products from our third-party suppliers; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our ability to obtain and maintain intellectual property protection for our products or avoid claims of infringement; </FONT> <FONT
COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our ability to identify and develop new products; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our compliance with extensive government regulation; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our expected uses of the net proceeds from this offering; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the volatility of our stock price; and </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>60</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=65,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=655984,FOLIO='60',FILE='DISK131:[15ZBY1.15ZBY12201]DK12201A.;31',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_dk12201_1_61"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our expectations regarding the time during which we will be an emerging growth company under the JOBS Act. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>You
should read the matters described in "Risk Factors" and the other cautionary statements made in this prospectus as being applicable to all related forward-looking statements wherever they appear
in this prospectus. We cannot assure you that the forward-looking statements in this prospectus will prove to be accurate and therefore prospective investors are encouraged not to place undue reliance
on forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. You should read this
prospectus, the documents that we reference in this prospectus and the documents that we have filed as exhibits to the registration statement, of which this prospectus is a part, completely. Other
than as required by law, we undertake no obligation to update or revise these forward-looking statements, even though our situation may change in the future. Our forward-looking statements do not
reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments that we may make. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>61</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=66,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=1047228,FOLIO='61',FILE='DISK131:[15ZBY1.15ZBY12201]DK12201A.;31',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_dk12201_1_62"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="dk12201_use_of_proceeds"> </A>
<A NAME="toc_dk12201_2"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  USE OF PROCEEDS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We estimate that the net proceeds that we will receive from the sale of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock in this initial public offering
will be approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, or approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million if the underwriters
exercise their option in full to purchase additional shares from us. This
estimate is based upon an assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering price range set forth on the cover page
of this
prospectus, after the underwriting discounts and commissions and estimated offering expenses payable by us. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A
$1.00 increase (decrease) in the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share would increase (decrease) the net proceeds to us from this offering by
approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, assuming the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting underwriting discounts
and
commissions and estimated offering expenses payable by us. We may also increase or decrease the number of shares we are offering. Each increase (decrease) of 1,000,000 in the number of shares we are
offering would increase (decrease) the net proceeds to us from this offering, after the underwriting discounts and commissions and estimated offering expenses payable by us, by approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, assuming the assumed initial public offering price stays the same. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
intend to use the net proceeds from this offering primarily as follows:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> approximately $5.0&nbsp;million to expand our sales and marketing activities; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> approximately $5.0&nbsp;million to expand our product development activities; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> approximately $3.0&nbsp;million to expand our reimbursement and clinical activities; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million to pay the cumulative accrued
dividends to our Series&nbsp;A preferred stockholders
(assuming a closing date of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,&nbsp;2016 and an initial public offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share) as described in "Dividend Policy"; and </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the remainder for working capital, general and administrative expenses and other general corporate purposes. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
may also use a portion of our net proceeds to acquire or invest in complementary products, technologies or businesses, although we have no present commitments to complete any such transaction. The
amounts and timing of our expenditures will depend on numerous factors, including the rate of adoption of our devices, the expenses we incur in sales and marketing our devices, the scope of research
and development efforts, the timing and success of any clinical trials we may commence in the future, and the timing of regulatory submissions. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Accordingly,
our management will have broad discretion over the use of the net proceeds from this offering. Pending the uses described above, we intend to invest the net proceeds in short-term,
interest-bearing, investment-grade securities, certificates of deposit or governmental securities. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>62</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=67,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=684183,FOLIO='62',FILE='DISK131:[15ZBY1.15ZBY12201]DK12201A.;31',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_dk12201_1_63"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="dk12201_dividend_policy"> </A>
<A NAME="toc_dk12201_3"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  DIVIDEND POLICY    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We have never declared or paid any cash dividends on our common stock. Following the completion of this offering, we intend to retain our future
earnings, if any, to finance the operation and expansion of our business. We do not expect to pay cash dividends on our common stock in the foreseeable future. Payment of future cash dividends, if
any, will be at the discretion of our board of directors after taking into account various factors, including our financial condition, operating results, current and anticipated cash needs,
outstanding indebtedness and plans for expansion and restrictions imposed by lenders, if any. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Holders
of our Series&nbsp;A and Series&nbsp;B preferred stock are entitled to dividends upon the conversion of such shares of preferred stock to our common stock in connection with this initial
public offering, which will occur immediately prior to the completion of this offering. Each Series&nbsp;A and Series&nbsp;B preferred stockholder is entitled to a cumulative accrued dividend
calculated at a rate of 6% per annum of the original issue price of such series of preferred stock. Series&nbsp;B preferred stockholders may elect to receive payment of such dividend in additional
shares of Series&nbsp;B preferred stock. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As
of September&nbsp;30, 2015, we had $9.1&nbsp;million of cumulative accrued dividends payable to our Series&nbsp;A and Series&nbsp;B preferred stockholders. These dividends have continued to
accrue subsequent to September&nbsp;30, 2015. As such, we anticipate that the Series&nbsp;B preferred stockholders will elect to receive payment of such cumulative accrued dividends in additional
shares of Series&nbsp;B preferred stock rather than cash. Assuming a closing date of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016, immediately
prior to the completion of this offering, we expect to pay approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million of cumulative accrued dividends in cash to our Series&nbsp;A preferred stockholders and
issue&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock in payment of
approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million of cumulative accrued dividends to our Series&nbsp;B preferred stockholders. The cash dividend will be paid from the net proceeds of this
offering and
neither cash nor stock dividends will be paid on any shares purchased in this offering. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>63</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=68,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=569619,FOLIO='63',FILE='DISK131:[15ZBY1.15ZBY12201]DK12201A.;31',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dm12201_1_64"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="dm12201_capitalization"> </A>
<A NAME="toc_dm12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  CAPITALIZATION    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The following table sets forth our cash and cash equivalents and capitalization as of September&nbsp;30,
2015:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> on an actual basis; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> on a pro forma basis to give effect to: (a)&nbsp;the conversion of all outstanding preferred stock into an aggregate of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock immediately prior to the completion of this offering; (b)&nbsp;the issuance
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional shares of our common stock immediately
prior to the completion of this offering that our Series&nbsp;A and Series&nbsp;B preferred stockholders are entitled to receive in connection with this initial public offering, assuming an
initial offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus; (c)&nbsp;the accrual for
the payment
of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million in cumulative accrued dividends to our Series&nbsp;A preferred stockholders as of September&nbsp;30, 2015; (d)&nbsp;the issuance of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock immediately prior to the completion of this offering to pay accrued dividends on our Series&nbsp;B
preferred stock (assuming a closing date of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016 and an initial offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus); and
(e)&nbsp;the effectiveness of our amended and restated certificate of incorporation and the adoption of our amended and restated bylaws; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> on a pro forma as adjusted basis to give effect to (a)&nbsp;the pro forma adjustments described in the preceding bullet;
(b)&nbsp;the cash payment of accrued dividends as of September&nbsp;30, 2015 to our Series&nbsp;A preferred stockholders described in the preceding bullet; and (c)&nbsp;our issuance and sale
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock in this offering at an assumed initial public offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering price range set
forth on the cover page of this prospectus, after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>You
should read this information in conjunction with "Management's Discussion and Analysis of Financial Condition and Results of Operations" and our financial statements and the related notes included
elsewhere in this prospectus. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>64</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=69,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=735688,FOLIO='64',FILE='DISK131:[15ZBY1.15ZBY12201]DM12201A.;41',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_dm12201_1_65"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="58pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of September&nbsp;30, 2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Actual </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Pro<BR>
Forma </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Pro Forma<BR>
As Adjusted </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(In thousands, except for share and<BR>
per share data; unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Cash and cash equivalents</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,672</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Long-term debt (notes payable)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Convertible preferred stock</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Series&nbsp;B preferred stock, $0.001 par value per share,
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares authorized,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares issued and outstanding, actual; no shares authorized,
issued or outstanding, pro forma and pro forma as adjusted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>12,428</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Series&nbsp;A preferred stock, $0.001 par value per share,
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares authorized,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares issued and outstanding, actual; no shares authorized,
issued or outstanding, pro forma and pro forma as adjusted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>20,050</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Stockholders' equity (deficit):</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Preferred stock $0.001 par value per share, no shares authorized, issued and outstanding,
actual;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares authorized, no shares issued and outstanding, pro forma and pro forma as adjusted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Common stock $0.001 par value per share,
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares authorized,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares issued and outstanding,
actual;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares authorized,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares issued and outstanding, pro
forma;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares authorized,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares issued and outstanding, pro forma as
adjusted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>8</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Additional paid-in capital</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>140</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Accumulated deficit</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(6,738</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total stockholders' equity (deficit)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(6,590</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total capitalization</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>25,894</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Each
$1.00 increase (decrease) in the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering price range set forth on the cover page of
this prospectus, would increase (decrease) our pro forma as adjusted cash and cash equivalents, additional paid-in capital, total stockholders' equity and total capitalization by approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, assuming that the number of shares of our common stock offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting
underwriting discounts and commissions and estimated offering expenses payable by us. Each increase (decrease) of 1,000,000 shares in the number of shares offered by us would increase (decrease) the
amount of our pro forma as adjusted cash and cash equivalents, additional paid-in capital, total stockholders' equity and total capitalization by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, assuming
an initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint
of the estimated offering price range set forth on the cover page of this prospectus, after deducting underwriting discounts and commissions and estimated offering expenses payable by us. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
table and calculations above are based on the adjustments set forth in "Summary&nbsp;&#151; The Offering&nbsp;&#151; Pro Forma Adjustments." </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>65</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=70,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=551112,FOLIO='65',FILE='DISK131:[15ZBY1.15ZBY12201]DM12201A.;41',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_do12201_1_66"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="do12201_dilution"> </A>
<A NAME="toc_do12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  DILUTION    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If you invest in our common stock, your ownership interest will be diluted to the extent of the difference between the initial public offering price
per share of our common stock and the pro forma as adjusted net tangible book value per share of our common stock immediately after completion of this offering. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As
of September&nbsp;30, 2015, our net tangible book value (deficit) was approximately&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, or approximately&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share. Our net
tangible book value
represents total tangible assets less total liabilities. Our net tangible book value (deficit) per share is our net tangible book value divided by the number of shares of common stock outstanding as
of September&nbsp;30, 2015. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As
of September&nbsp;30, 2015, our pro forma net tangible book value (deficit) of our common stock was approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, or approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per
share. Our pro forma net tangible book value (deficit) represents total tangible assets less total liabilities. Our pro forma net tangible book value (deficit) per share is our pro forma net tangible
book value (deficit) divided by the number of shares of common stock outstanding as of September&nbsp;30, 2015, after giving effect to (a)&nbsp;the conversion of all outstanding
preferred stock into an aggregate of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock immediately prior to the completion of this offering;
(b)&nbsp;the issuance of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional shares of common stock immediately prior to the completion of this offering that our Series&nbsp;A and B
preferred stockholders are entitled to receive in
connection with this initial public offering, assuming an initial offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering price range set forth
on the
cover page of this prospectus; (c)&nbsp;the accrual for the payment of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million in cumulative accrued dividends to our Series&nbsp;A preferred stockholders as of
September&nbsp;30, 2015; (d)&nbsp;the issuance of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock immediately prior to the completion of this offering
to pay accrued dividends on our Series&nbsp;B
preferred stock (assuming a closing date of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016 and an initial offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering price range set
forth on the cover page of this prospectus); and (e)&nbsp;the effectiveness of our amended and restated certificate of incorporation and adoption of our amended and restated bylaws. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>After
giving effect to (a)&nbsp;the pro forma adjustments described above; (b)&nbsp;the payment of accrued dividends as of September&nbsp;30, 2015 to our Series&nbsp;A preferred stockholders
described above; and (c)&nbsp;our issuance and sale of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock in this offering at an assumed initial
public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per
share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus, after deducting the estimated underwriting discounts and commissions and estimated
offering expenses, as of September&nbsp;30, 2015, the pro forma as adjusted net tangible book value (deficit) of our common stock would have been approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, or
approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share. This amount represents an immediate increase in pro forma net tangible book value (deficit) to our existing stockholders of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per
share and an immediate dilution to new investors purchasing shares in this offering of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share. We determine dilution by subtracting the pro forma as adjusted net
tangible
book value (deficit) per share </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>66</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=71,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=433843,FOLIO='66',FILE='DISK131:[15ZBY1.15ZBY12201]DO12201A.;30',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_do12201_1_67"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>after
this offering from the amount of cash that a new investor paid for a share of common stock. The following table illustrates this per share dilution: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Assumed initial public offering price per share</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Historical net tangible book value (deficit) per share as of September&nbsp;30, 2015</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Pro forma increase in net tangible book value (deficit) per share</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Pro forma net tangible book value (deficit) per share as of September&nbsp;30, 2015</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Increase in pro forma net tangible book value (deficit) per share attributable to investors purchasing shares in this
offering</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Pro forma as adjusted net tangible book value (deficit) per share, after giving effect to this offering</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Dilution in pro forma as adjusted net tangible book value (deficit) per share to investors purchasing shares in this
offering</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A
$1.00 increase (decrease) in the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering price range set forth on the
cover page
of this prospectus, would increase (decrease) the pro forma as adjusted net tangible book value (deficit) per share after this offering by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, and dilution in
pro forma net
tangible book value (deficit) per share to new investors by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, assuming that the number of shares offered by us, as set forth on the cover page of this
prospectus, remains
the same and after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
the underwriters exercise their option to purchase additional shares in full, there will be an increase in pro forma as adjusted net tangible book value (deficit) to existing stockholders of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share and an immediate dilution in pro forma as adjusted net tangible book value (deficit) to new investors of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, assuming that the number
of shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting the estimated underwriting discounts and commissions and estimated offering expenses
payable by us. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
following table summarizes, on a pro forma as adjusted basis described above, the difference between existing stockholders and new investors with respect to number of shares of common stock
purchased from us, the total consideration paid to us, and the average price per share paid, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus,
remains the same and after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=3 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Shares<BR>
Purchased </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Total Consideration </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Average Price<BR>
Per Share </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Number </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Percent </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Amount </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Percent </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Existing stockholders</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Investors purchasing shares in this offering</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>100</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>100</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>67</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=72,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=501481,FOLIO='67',FILE='DISK131:[15ZBY1.15ZBY12201]DO12201A.;30',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_do12201_1_68"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A
$1.00 increase (decrease) in the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering price range set forth on the
cover page
of this prospectus, would increase (decrease) the total consideration paid by new investors by $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, and increase (decrease) the percentage of total consideration
paid by
investors purchasing shares in this offering by approximately&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;%, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and
before deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. Similarly, each increase (decrease) of 1,000,000 shares in the number of shares offered
by us would increase (decrease) the total consideration paid by investors purchasing shares in this offering by $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, and increase (decrease) the percentage of
total
consideration paid by new investors by approximately&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;%, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and before
deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
the underwriters exercise their option to purchase additional shares in full:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the percentage of shares of common stock held by existing stockholders will decrease
to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, or approximately
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% of the total number of shares of our common stock outstanding after completion of this offering; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the number of shares held by new investors will increase
to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, or approximately&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% of the total
number of
shares of our common stock outstanding after completion of this offering. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
table and calculations above are based on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares outstanding as of September&nbsp;30, 2015 and the adjustments set forth in
"Summary&nbsp;&#151; The
Offering&nbsp;&#151; Pro Forma Adjustments." </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>To
the extent any of the outstanding options to purchase shares of our common stock or warrants to purchase shares of our common stock are exercised or new awards are granted under our equity
compensation plans, there will be further dilution to investors participating in this offering. To the extent all of such outstanding options and warrants had been exercised as of September&nbsp;30,
2015, the pro forma as adjusted net tangible book value (deficit) per share after this offering would be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, and total dilution per share to new investors would
be&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>68</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=73,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=696583,FOLIO='68',FILE='DISK131:[15ZBY1.15ZBY12201]DO12201A.;30',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dq12201_1_69"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="dq12201_selected_consolidated_financial_data"> </A>
<A NAME="toc_dq12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  SELECTED CONSOLIDATED FINANCIAL DATA    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The following tables set forth our selected historical consolidated financial data as of and for the periods indicated. The selected consolidated
statements of operations data for the years ended December&nbsp;31, 2013 and 2014, and the selected consolidated balance sheet data as of December&nbsp;31, 2013 and 2014, have been derived from
our audited consolidated financial statements included elsewhere in this prospectus. Our selected consolidated statements of operations data for the nine months ended September&nbsp;30, 2014 and
2015, and the selected consolidated balance sheet data as of September&nbsp;30, 2015, have been derived from our unaudited interim consolidated financial statements included elsewhere in this
prospectus. We have prepared the unaudited interim consolidated financial statements on the same basis as the audited consolidated financial statements and have included, in our opinion, all
adjustments, consisting only of normal recurring adjustments that we consider necessary for a fair statement of financial statements set forth in those statements. Our historical results are not
indicative of the results to be expected in the future and our interim results are not necessarily indicative of results to be expected for the full year ended December&nbsp;31, 2015 or any other
period. The following financial data should be read in conjunction with, and are qualified in their entirety by reference to, "Use of Proceeds," "Capitalization," "Management's Discussion and Analysis
of Financial Condition and Results of Operations" and our financial statements and the related notes included elsewhere in this prospectus. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>69</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=74,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=518003,FOLIO='69',FILE='DISK131:[15ZBY1.15ZBY12201]DQ12201A.;64',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_dq12201_1_70"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>
 <DIV style="padding:0pt;position:relative;width:73%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"110%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="110%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="74pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Nine Months Ended<BR>
September&nbsp;30, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(In thousands, except share and per share data)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Consolidated Statements of Operations Data:</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Revenues, net</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>37,176</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>47,736</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>29,626</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>41,712</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Cost of goods sold</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>9,772</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>12,715</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>8,284</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>11,839 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Gross profit</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>27,404</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>35,021</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>21,342</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>29,873 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Operating expenses:</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Sales and marketing</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>14,298</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>18,154</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>12,457</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>17,297</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Research and development</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,443</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,843</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,931</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,922</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Reimbursement, general and administrative</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>8,283</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10,225</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,419</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>9,448 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:50pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total operating expenses</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>25,024</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>31,222</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>21,807</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>29,667 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Income (loss) from operations</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
2,380</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
3,799</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
(465</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
206</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Other income (expense)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
4</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
(4</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
12</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
18 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Income (loss) before income
taxes&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,384</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,795</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(453</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>224</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Income tax expense (benefit)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
(772</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
1,725</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
(171</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
90 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net income (loss)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
3,156</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
2,070</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
(282</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
134</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Convertible preferred stock dividends</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,668</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,761</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,336</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,396</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Allocation of undistributed earnings to preferred stockholders</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,074</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>216</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net income (loss) attributable to common stockholders</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>414</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>93</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,618</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,262</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net income (loss) per common share attributable to common stockholders<SUP>(1)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.07</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.01</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(0.23</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(0.16</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.06</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.01</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(0.23</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(0.16</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Weighted-average shares outstanding used to compute net income (loss) per common share attributable to
common stockholders</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6,305,401</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,025,035</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6,903,792</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,992,734</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,276,148</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10,709,649</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6,903,792</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,992,734</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Pro forma net income (loss) per common share attributable to common stockholders (unaudited)<SUP>(2)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Weighted-average shares used to compute pro forma net income (loss) per common share attributable to common stockholders
(unaudited)<SUP>(2)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>70</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=75,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=866065,FOLIO='70',FILE='DISK131:[15ZBY1.15ZBY12201]DQ12201A.;64',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_dq12201_1_71"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR></FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="98pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
September&nbsp;30, 2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(In thousands)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Consolidated Balance Sheet Data</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Cash and cash equivalents</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6,539</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,416</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,672</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Working capital</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>17,164</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>18,927</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>18,981</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total assets</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>29,226</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>31,494</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>33,395</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total debt</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>22</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>13</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Convertible preferred stock</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>29,321</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>31,082</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>32,478</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Accumulated deficit</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(8,942</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(6,872</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(6,738</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total stockholders' equity (deficit)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(7,114</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(6,427</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(6,590</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Net
income (loss) per common share attributable to common stockholders is calculated under the two-class method, as our convertible preferred stock
participates in the undistributed earnings of the company. The two-class method requires earnings for the period to be allocated based upon their respective rights to receive distributed and
undistributed earnings. No adjustment is made during periods with a net loss, as the holders of the convertible preferred stock have no obligation to fund losses.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(2)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Pro
forma net income (loss) per common share attributable to common stockholders and the number of weighted-average common shares used to compute pro forma
net income (loss) per common share attributable to common stockholders reflect the adjustments set forth in "Summary&nbsp;&#151;&nbsp;The Offering &#151; Pro Forma Adjustments,"
except in lieu of the cash payment of a portion of the proceeds to pay cumulative accrued dividends to our Series A preferred stockholders, reflects the additional&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of
common
stock that would have been required to be issued to generate sufficient proceeds to fund the cash payment of the Series&nbsp;A convertible preferred stock dividends that are payable from the net
proceeds of our this offering. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>71</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=76,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=84573,FOLIO='71',FILE='DISK131:[15ZBY1.15ZBY12201]DQ12201A.;64',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ds12201_1_72"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ds12201_management_s_discussion_and_an__man03466"> </A>
<A NAME="toc_ds12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  MANAGEMENT'S DISCUSSION AND ANALYSIS OF<BR>  FINANCIAL CONDITION AND RESULTS OF OPERATIONS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>The following discussion and analysis of our financial condition and results of operations should be read in conjunction with
the Selected Consolidated Financial Data and our consolidated financial statements and the accompanying notes thereto included elsewhere in this prospectus. Our actual results could differ materially
from those anticipated in the forward-looking statements included in this discussion as a result of certain factors, including, but not limited to, those discussed in "Risk Factors" and "Special Note
Regarding Forward-Looking Statements" included elsewhere in this prospectus.  </I></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Overview  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We are a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases at home. We focus on
advancing the
standard of care in treating chronic diseases in the home setting to improve patient outcomes and quality of life and help control rising healthcare expenditures. We possess a unique, scalable
platform to deliver at-home healthcare solutions throughout the United States. This evolving care delivery model is recognized by policy-makers and payers as a key for controlling rising healthcare
expenditures. Our initial area of therapeutic focus is vascular disease, with a goal of advancing the standard of care in treating lymphedema and chronic venous insufficiency. Our solutions deliver
cost-effective, clinically proven, long-term treatment for these chronic diseases. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
two proprietary products are the Flexitouch System and the ACTitouch System. A predecessor to our Flexitouch System received 510(k) clearance from the FDA in July 2002, and we introduced the
system to address the many limitations of self-administered home-based manual lymphatic drainage therapy. We began selling our more-advanced Flexitouch System after receiving 510(k) clearance from the
FDA in October 2006. Historically, we derived substantially all of our revenues from our Flexitouch System. For the years ended December&nbsp;31, 2013 and 2014, and for the nine months ended
September&nbsp;30, 2015, our Flexitouch System represented 97%, 92% and 87% of our revenues, respectively. In September 2012, we acquired our second proprietary product, the ACTitouch System. The
system received 510(k) clearance from the FDA in June 2013, and we began selling the product in September 2013 to address the many limitations of non-removable multilayered bandages that are worn by
patients suffering from venous leg&nbsp;ulcers. For the years ended December&nbsp;31, 2013 and 2014, and for the nine months ended September&nbsp;30, 2015, our ACTitouch System represented 0%,
5% and 6% of our revenues, respectively. We also began selling our Entr&eacute; System, a 510(k) cleared basic pneumatic compression device, in February 2013. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>To
support the growth of our business, we invest heavily in our commercial infrastructure, consisting of our direct sales force, home training resources, reimbursement capabilities and clinical
expertise. We market our products in the United States using a direct-to-patient and -provider model. Our direct sales force has grown from three representatives in March 2005 to a team of
over&nbsp;70&nbsp;people as of September&nbsp;30, 2015. This model allows us to directly approach patients and clinicians, whereby we disintermediate the traditional durable medical equipment
channel, allowing us to capture both the manufacturer and distributor margins. We also utilize over 300 licensed, independent healthcare practitioners as home trainers who educate patients on the
proper use of our solutions. We invest substantial resources in our reimbursement operations group of over 50&nbsp;people that focuses on verifying case-by-case benefits, obtaining prior
authorization, billing and collecting payments from payers and providing customer support services. Our payer relationships group of over 20&nbsp;people is responsible for developing relationships
with payer decision-makers to educate them on our product efficacy, develop overall payer coverage policies and reimbursement criteria, manage Medicare patient claims and contracts with payers and
serve as an advocacy liaison between patients, clinicians and payers throughout the appeals process. We also have a clinical team, consisting of a scientific advisory </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>72</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=77,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=205675,FOLIO='72',FILE='DISK131:[15ZBY1.15ZBY12201]DS12201A.;71',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_ds12201_1_73"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>board,
in-house therapists and nurses, and a medical director, that serves as a resource to clinicians and patients and guides our development of clinical evidence in support of our products. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
patients are reimbursed by government and private payers for the purchase of our products pursuant to established rates with each payer. We rely on third-party contract manufacturers for the
sourcing of parts, the assembly of our controllers and the manufacturing of the garments used with our systems. We conduct final assembly of the garments used with our Flexitouch System at, and
perform quality assurance and ship our products from, our facility in Minneapolis, Minnesota. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>For
the year ended December&nbsp;31, 2014, we generated revenues of $47.7&nbsp;million and had net income of $2.1&nbsp;million, compared to revenues of $37.2&nbsp;million and net income of
$3.2&nbsp;million for the year ended December&nbsp;31, 2013. For the nine months ended September&nbsp;30, 2015, we generated revenues of $41.7&nbsp;million and had net income of
$0.1&nbsp;million, compared to revenues of $29.6&nbsp;million and a net loss of $0.3&nbsp;million for the nine months ended September&nbsp;30, 2014. As of September&nbsp;30, 2015, we had an
accumulated deficit of $6.7&nbsp;million. Our primary sources of capital to date have been from operating income and private placements of our capital stock. We operate in one segment. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Components of our Results of Operations  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Revenues  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We derive our revenues from the sale of our Flexitouch, ACTitouch and Entr&eacute; systems to patients in the United States. Revenue growth
has been driven by increased clinician, patient and payer awareness of lymphedema and the clinical efficacy of our Flexitouch System, and launch of our ACTitouch and Entr&eacute; systems in
2013. We have expanded our direct sales force that helps us drive and support our revenue growth and intend to continue this expansion. However, any reversal in these recent trends could have a
negative impact on our future revenues. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
revenues have fluctuated, and we expect our revenues to continue to fluctuate, from quarter to quarter due to a variety of factors. For instance, our fourth quarter tends to be our strongest
quarter of the year. See "&#151;&nbsp;Seasonality" for a further discussion of factors contributing to seasonality. Further, our revenues are impacted by fluctuations in the mix of products
being sold during each period and changes in the mix of our payers. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
sell our products directly to patients, who are referred to us by physicians, therapists or nurses. We bill payers, such as private insurers, Medicare, the Veterans Administration or Medicaid, on
behalf of
our patients and bill patients directly for their cost-sharing amounts, including any portion of an unsatisfied deductible and any copayments or co-insurance. In 2014, approximately 15% of our sales
came from Medicare patients. A recent change to the level of Medicare coverage for our products could reduce the number of Medicare patients who have access to our products, and we are seeking to have
the coverage determination overturned. Our products currently are not subject to the competitive bidding process for supplying covered items to Medicare recipients. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
expect our revenues to continue to increase in the future as a result of increased awareness of our solutions, expansion of our direct sales force, marketing and customer support efforts, continued
focus on developing clinical and economic outcome data, expanded third-party reimbursement and introduction of our solutions outside the United States. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Cost of Goods Sold and Gross Margin  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Cost of goods sold consists primarily of component costs, direct labor, overhead costs, product warranties, provisions for slow-moving and obsolete
inventory and delivery costs for items sold. A </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>73</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=78,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=784050,FOLIO='73',FILE='DISK131:[15ZBY1.15ZBY12201]DS12201A.;71',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_ds12201_1_74"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>significant
portion of our cost of goods sold consists of manufacturing overhead costs. These overhead costs include the cost of quality assurance, material procurement, inventory control, facilities,
equipment and operations supervision and management. We expect overhead costs as a percentage of revenues to decrease as a result of expected increases in production volume and yields. Cost of goods
sold also includes depreciation expense for product tooling, production equipment and shipping costs. See Note&nbsp;5 to our financial statements included elsewhere in this prospectus for a
description of our royalty payments. We expect cost of goods sold to increase in absolute dollars primarily if, and to the extent, our revenues grow. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
provide a warranty on our devices ranging from one to two years for the controller, and one year for the garment. We establish a reserve for warranty repairs based on historical warranty repair
costs incurred. Provisions for warranty obligations, which are included in cost of goods sold, are recorded at the time of shipment. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
calculate gross margin as gross profit divided by revenues. Our gross margin has been and will continue to be affected by a variety of factors, including product and payer mix, production volumes,
manufacturing costs and cost-reduction strategies. We expect our gross margin to decrease slightly over the near term as we increase the percentage of total revenues from our ACTitouch and
Entr&eacute; systems. However, our gross margin will likely fluctuate from quarter to quarter. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Sales and Marketing Expenses  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our sales and marketing expenses support our direct-to-patient and -provider model. These expenses consist primarily of personnel-related expenses,
including salaries, bonuses, commissions and benefits for employees. They also include expenses for patient home training, social media and advertising, informational kits, public relations and other
promotional and marketing activities, field sales travel and entertainment expenses, trade shows and conferences, stock-based compensation, as well as customer service. We expect sales and marketing
expenses to continue to increase in absolute dollars as we expand our commercial infrastructure to drive and support our planned revenue growth. To the extent our revenues grow, we expect sales and
marketing expenses to decrease as a percentage of revenues over time. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Research and Development Expenses  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Research and development, or R&amp;D, expenses consist primarily of personnel-related expenses, third-party product development costs, laboratory
supplies, consulting fees and related costs, clinical research expenses, expenses related to clinical and regulatory affairs, patent amortization costs, stock-based compensation and patent legal fees,
including defense costs and testing costs for new product launches. Clinical research expenses include clinical trial management and monitoring, payment to clinical investigators, consulting fees,
data management, stock-based compensation, travel expenses and the cost of manufacturing products for clinical trials. We have made substantial investments in R&amp;D since our inception. Our R&amp;D efforts
have focused primarily on activities designed to enhance our technologies and to support development and commercialization of new and existing products. We expect R&amp;D expenses to increase in absolute
dollars for the foreseeable future as we continue to develop, enhance and commercialize new products and expand clinical trial efforts. We expect R&amp;D expenses as a percentage of our revenues to vary
over time depending on the level and timing of initiating new product development efforts, as well as our clinical trial activities. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Reimbursement, General and Administrative Expenses  </I></B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Reimbursement, general and administrative expenses consist primarily of compensation, including salaries, bonuses and benefits for employees in our
patient services and advocacy, billing and </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>74</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=79,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=225727,FOLIO='74',FILE='DISK131:[15ZBY1.15ZBY12201]DS12201A.;71',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_ds12201_1_75"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>collections,
case management, payer relations and governmental affairs and reimbursement authorization departments, as well as finance, human resources and administration, information technology,
business development and general management functions, and facilities costs. Our experienced reimbursement authorization department of over 50 people focuses on verifying case-by-case benefits,
obtaining prior authorization, billing and collecting payments from payers and providing customer support services. Reimbursement authorization department expenses also include consulting, travel to
payer case manager seminars, professional development and training and certification expenses. General and administrative expenses also include professional services, such as legal, consulting and
accounting services, stock-based compensation, travel expenses and insurance costs. We expect to incur additional legal, accounting, insurance and other professional service fees associated with being
a public company, which may increase further when we are no longer able to rely on the "emerging growth company" exemption we are afforded under the JOBS Act. We expect our reimbursement, general and
administrative expenses to increase in absolute dollars, but decrease as a percentage of our revenues, to the extent our revenues grow. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Other Income (Expense), Net  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Other income (expense), net consists primarily of interest expense related to our notes payable and interest income driven by the interest accruing
on cash and past due insurance balances. We do not accrue interest on a majority of past due customer accounts receivable balances. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Income Tax Expense (Benefit)  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our income tax expense (benefit) consists primarily of deferred income taxes resulting from temporary differences between the reporting of amounts
for financial statement purposes and income tax purposes. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Results of Operations  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Comparison of the Nine Months Ended September&nbsp;30, 2014 and 2015  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The following table sets forth our results of operations for the nine months ended September&nbsp;30, 2014 and 2015: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Nine Months Ended<BR>
September&nbsp;30, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>%&nbsp;Change </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(In thousands, except percentages)</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Consolidated Statement of Operations Data:</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Revenues</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>29,626</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>41,712</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>41</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Cost of goods sold</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>8,284</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>11,839</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>43 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Gross profit</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>21,342</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>29,873</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>40 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Operating expenses:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Sales and marketing</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>12,457</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>17,297</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>39</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Research and development</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,931</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,922</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>51</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Reimbursement, general and administrative</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,419</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>9,448</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>27 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total operating expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>21,807</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>29,667</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>36 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Income (loss) from operations</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(465</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>206</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>144</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Other income (expense):</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
12</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
50 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Income (loss) before income taxes</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(453</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>224</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>149</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Income tax expense (benefit)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
(171</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
90</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
153 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net income (loss)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(282</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>134</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>148 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>75</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=80,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=983352,FOLIO='75',FILE='DISK131:[15ZBY1.15ZBY12201]DS12201A.;71',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_ds12201_1_76"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Revenues  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Revenues increased $12.1&nbsp;million, or 41%, to $41.7&nbsp;million during the nine months ended September&nbsp;30, 2015, compared to
$29.6&nbsp;million during the nine months ended September&nbsp;30, 2014. The growth in revenues was primarily attributable to an increase of approximately $9.1&nbsp;million, or 34%, in sales of
our Flexitouch System, an increase of approximately $1.0&nbsp;million, or 66%, in sales of our ACTitouch System, and an increase of approximately $2.0&nbsp;million, or 180%, in sales of our
Entr&eacute; System. The increase in unit sales of our Flexitouch System was driven by expansion of our sales force and increased physician and patient awareness. The increase in unit sales of
our ACTitouch System was due to continued penetration of wound clinics, particularly within Veterans Administration hospitals. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
following table summarizes our revenues by product for the nine months ended September&nbsp;30, 2014 and 2015 both in dollars and percentage of total revenues: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Nine Months Ended<BR>
September&nbsp;30, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>%&nbsp;Change </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(In thousands, except percentages)</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Revenues</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Flexitouch System</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>27,010</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>36,100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>34</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>ACTitouch System</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,504</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>66</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Entr&eacute; System</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,112</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,112</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>180 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>29,626</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>41,712</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>41 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Percentage of total revenues</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Flexitouch System</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>91</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>87</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>ACTitouch System</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Entr&eacute; System</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Cost of Goods Sold and Gross Margin  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Cost of goods sold increased $3.6&nbsp;million, or 43%, to $11.8&nbsp;million during the nine months ended September&nbsp;30, 2015, compared to
$8.3&nbsp;million during the nine months ended September&nbsp;30, 2014. The increase in cost of goods sold was primarily attributable to an increase in the number of systems sold. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Gross
margin for the nine months ended September&nbsp;30, 2015 decreased slightly to 71.6% compared to 72.0% for the nine months ended September&nbsp;30, 2014. The decrease in gross margin was
primarily due to the growth in sales of our ACTitouch and Entr&eacute; Systems, which have a lower gross margin than our Flexitouch System. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Sales and Marketing Expenses  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Sales and marketing expenses increased $4.8&nbsp;million, or 39%, to $17.3&nbsp;million during the nine months ended September&nbsp;30, 2015,
compared to $12.5&nbsp;million during the nine months ended September&nbsp;30, 2014. The increase was primarily attributable to a $3.6&nbsp;million increase in compensation expenses as a result
of increased sales and marketing headcount. In addition,
other sales and marketing expenses increased $1.2&nbsp;million due to increased field sales meeting, travel and entertainment, consulting and field sales training expenses. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>76</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=81,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=40569,FOLIO='76',FILE='DISK131:[15ZBY1.15ZBY12201]DS12201A.;71',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_du12201_1_77"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Research and Development Expenses  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>R&amp;D expenses increased $1.0&nbsp;million, or 51%, to $2.9&nbsp;million during the nine months ended September&nbsp;30, 2015, compared to
$1.9&nbsp;million during the nine months ended September&nbsp;30, 2014. The increase in R&amp;D expenses was primarily attributable to increases in product development and clinical study costs. In
addition, compensation and other personnel-related expenses increased. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Reimbursement, General and Administrative Expenses  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Reimbursement, general and administrative expenses increased $2.0&nbsp;million, or 27%, to $9.4&nbsp;million during the nine months ended
September&nbsp;30, 2015, compared to $7.4&nbsp;million during the nine months ended September&nbsp;30, 2014. The increase in reimbursement, general
and administrative expenses was primarily attributable to an increase in personnel-related expenses as a result of increased headcount on our patient services, contracting, case management, billing
and collections, advocacy, reimbursement and administrative teams, as well as higher facility costs for rent, utilities, property taxes and maintenance. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Other Income (Expense), Net  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Other income (expense), net, was less than $20,000 during the nine months ended September&nbsp;30, 2015 and 2014. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Comparison of the Years Ended December&nbsp;31, 2013 and 2014  </I></B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The following table sets forth our results of operations for the years ended December&nbsp;31, 2013 and 2014: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>% Change </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=7 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(In thousands, except percentages)</B></FONT><BR></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Consolidated Statement of Operations Data:</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Revenues</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>37,176</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>47,736</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>28</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Cost of goods sold</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>9,772</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>12,715</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>30 </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Gross profit</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>27,404</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>35,021</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>28 </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Operating expenses:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Sales and marketing</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>14,298</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>18,154</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>27</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Research and development</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,443</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,843</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>16</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Reimbursement, general and administrative</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>8,283</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10,225</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>23 </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total operating expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>25,024</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>31,222</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>25 </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Income (loss) from operations</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,380</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,799</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>60</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Other income (expense)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(4</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> * </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Income (loss) before income taxes</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,384</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,795</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>59</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Income tax expense (benefit)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(772</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,725</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>* </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net income (loss)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,156</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,070</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (34) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" >


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>*Not
meaningful. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>77</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=82,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=910843,FOLIO='77',FILE='DISK131:[15ZBY1.15ZBY12201]DU12201A.;88',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_du12201_1_78"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Revenues  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Revenues increased $10.6&nbsp;million, or 28%, to $47.7&nbsp;million during the year ended December&nbsp;31, 2014, compared to
$37.2&nbsp;million during the year ended December&nbsp;31, 2013. The growth in revenues was primarily attributable to an increase of approximately $7.7&nbsp;million, or 22%, in sales of our
Flexitouch System, an increase of approximately $2.3&nbsp;million, in sales of our ACTitouch System, and an increase of approximately $0.6&nbsp;million, or 52%, in sales of our
Entr&eacute; System. The increase in unit sales of our Flexitouch System was driven by expansion of our sales force and increased physician and patient awareness. The increase in unit sales of
our ACTitouch System was due to continued penetration of wound clinics, particularly within Veterans Administration hospitals. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
following table summarizes our revenues by product for the years ended December&nbsp;31, 2013 and 2014 both in dollars and percentage of total revenues: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>% Change </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=7 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(In thousands, except percentages)</B></FONT><BR></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Revenues</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Flexitouch System</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>35,996</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>43,738</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>22</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>ACTitouch System</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,357</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>*</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Entr&eacute; System</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,080</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,641</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>52 </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>37,176</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>47,736</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>28 </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Percentage of total revenues</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Flexitouch System</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>97</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>92</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>ACTitouch System</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Entr&eacute; System</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


</FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


</FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" >


<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1>*Not</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>*Not
meaningful.</FONT></DD></DL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Cost of Goods Sold and Gross Margin  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Cost of goods sold increased $2.9&nbsp;million, or 30%, to $12.7&nbsp;million during the year ended December&nbsp;31, 2014, compared to
$9.8&nbsp;million during the year ended December&nbsp;31, 2013. The increase in cost of goods sold was primarily attributable to an increase in the number of systems sold, partially offset by
reduced material and labor costs for our products associated with better sourcing and increased volumes. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Gross
margin for the year ended December&nbsp;31, 2014 decreased slightly to 73.4% compared to 73.7% for the year ended December&nbsp;31, 2013. The decrease in gross margin was primarily due to
increased
cost of goods sold associated with our ACTitouch and Entr&eacute; systems, which carry lower gross margins, partially offset by the increase in sales of our Flexitouch System. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Sales and Marketing Expenses  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Sales and marketing expenses increased $3.9&nbsp;million, or 27%, to $18.2&nbsp;million during the year ended December&nbsp;31, 2014, compared
to $14.3&nbsp;million during the year ended December&nbsp;31, 2013. The increase was primarily attributable to a $2.1&nbsp;million increase in personnel-related compensation expenses as a result
of increased sales and marketing headcount. In addition, other sales and marketing </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>78</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=83,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=3944,FOLIO='78',FILE='DISK131:[15ZBY1.15ZBY12201]DU12201A.;88',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_du12201_1_79"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>expenses
increased $1.6&nbsp;million due to increased field sales travel expenses, trade show and conference expenses and patient training costs. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Research and Development Expenses  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>R&amp;D expenses increased $0.4&nbsp;million, or 16%, to $2.8&nbsp;million during the year ended December&nbsp;31, 2014, compared to
$2.4&nbsp;million during the year ended December&nbsp;31, 2013. The increase in R&amp;D expenses was primarily attributable to increases in product development and consulting costs of
$0.2&nbsp;million and clinical study costs of $0.4&nbsp;million, offset by ACTitouch System launch costs of $0.2&nbsp;million during 2013. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Reimbursement, General and Administrative Expenses  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Reimbursement, general and administrative expenses increased $1.9&nbsp;million, or 23%, to $10.2&nbsp;million during the year ended
December&nbsp;31, 2014, compared to $8.3&nbsp;million during the year ended December&nbsp;31, 2013. The increase in reimbursement, general and administrative expenses was primarily attributable
to a $1.3&nbsp;million increase in personnel-related expenses as a result of increased headcount on our patient services, contracting, case management, billing and collections, advocacy,
reimbursement and administrative teams, an increase of $0.3&nbsp;million in professional, legal, accounting and information technology costs, and higher facility costs of $0.1&nbsp;million for new
office space, utilities, property taxes and maintenance. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Other Income (Expense), Net  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Other income (expense), net was less than $5,000 during the years ended December&nbsp;31, 2014 and 2013. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Quarterly Results of Operations Data </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
following table sets forth our unaudited quarterly statements of consolidated operations data and other data for each of the seven most recent quarters in the period
ended September&nbsp;30, 2015. We have prepared the quarterly results of operations data on a consistent basis with the audited consolidated financial statements included elsewhere in this
prospectus. In the opinion of management, the quarterly results of operations data reflect all necessary adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of
this data. The statements of consolidated operations data should be read in conjunction with the consolidated financial statements and related </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>79</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=84,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=726308,FOLIO='79',FILE='DISK131:[15ZBY1.15ZBY12201]DU12201A.;88',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_du12201_1_80"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>notes
included elsewhere in this prospectus. The results of historical periods are not necessarily indicative of results for a full year or for any future period. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="47pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="65pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="47pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=20 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Three Months Ended </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>March&nbsp;31,<BR>
2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>June&nbsp;30,<BR>
2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>September&nbsp;30,<BR>
2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>December&nbsp;31,<BR>
2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>March&nbsp;31,<BR>
2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>June&nbsp;30,<BR>
2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>September&nbsp;30,<BR>
2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=20 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(In thousands, except percentages; unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Revenues</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6,763</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10,965</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>11,898</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>18,110</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10,121</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>14,771</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>16,820</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Cost of goods sold</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,011</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,963</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,310</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,431</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,972</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,401</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,466 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Gross profit</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,752</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>8,002</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>8,588</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>13,679</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,149</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10,370</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>12,354 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>Gross margin </I></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>70.3</I></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>%</I></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>73.0</I></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>%</I></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>72.2</I></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>%</I></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>75.5</I></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>%</I></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>70.6</I></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>%</I></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>70.2</I></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>%</I></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>73.4</I></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>%</I></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Operating expenses:</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Sales and marketing</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,824</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,134</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,499</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,697</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,169</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,929</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6,199</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Research and development</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>545</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>686</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>700</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>911</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>817</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,011</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,094</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Reimbursement, general and administrative</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,132</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,504</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,783</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,807</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,647</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,202</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,599 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total operating expenses</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6,501</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,324</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,982</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>9,415</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>8,633</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10,142</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10,892 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Income (loss) from operations</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,749</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>678</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>606</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,264</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,484</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>228</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,462</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Other income (expense)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(16</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>12</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Income (loss) before income taxes</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,746</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>683</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>610</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,248</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,472</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>231</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,465</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Income tax expense (benefit)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(663</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>260</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>232</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,932</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(592</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>93</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>589 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net income (loss)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,083</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>423</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>378</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,316</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(880</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>138</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>876 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Seasonality  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our business may be affected by seasonality. In the first quarter of each year, when most patients have started a new insurance year and have not
paid their annual insurance deductibles, we experience substantially reduced demand for our products. We typically experience higher sales in the third and fourth quarters as a result of patients
having paid their annual insurance deductibles in full, thereby reducing their out-of-pocket costs for our products, or because patients often spend the remaining balances in their flexible-spending
accounts. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Liquidity and Capital Resources  </B></FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Overview  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As of September&nbsp;30, 2015, we had cash and cash equivalents of $5.7&nbsp;million and an accumulated deficit of $6.7&nbsp;million, compared
to cash and cash equivalents of $5.4&nbsp;million and an accumulated deficit of $6.9&nbsp;million as of December&nbsp;31, 2014. Our primary sources of capital have been from operating income and
private placements of our capital stock. As of September&nbsp;30, 2015, we had raised net proceeds of $29.5&nbsp;million from private placements of our capital stock. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>80</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=85,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=29831,FOLIO='80',FILE='DISK131:[15ZBY1.15ZBY12201]DU12201A.;88',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_du12201_1_81"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Cash Flows  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The following table summarizes our cash flows for the periods indicated: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Nine Months Ended<BR>
September&nbsp;30, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(In thousands)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net cash (used in) provided by:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Operating activities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(425</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(991</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(2,330</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(166</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Investing activities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(364</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(353</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(208</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(438</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Financing activities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(2,075</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>221</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>215</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>860 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net (decrease) increase in cash and cash equivalents</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(2,864</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,123</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(2,323</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>256 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Net Cash Used in Operating Activities  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Net cash used in operating activities during the nine months ended September&nbsp;30, 2015 was $0.2&nbsp;million, consisting primarily of our net
income of $0.1&nbsp;million, and a
decrease of $0.1&nbsp;million in deferred income taxes asset, a $0.3&nbsp;million provision for doubtful accounts and a non-cash expense of $0.8&nbsp;million. The cash used in operations was
primarily due to the ongoing commercialization of our products. The non-cash expense items primarily consisted of depreciation and amortization of equipment and leasehold improvements and patents and
stock-based compensation. Our net operating assets and liabilities decreased $1.5&nbsp;million. The decrease in our net operating assets and liabilities was primarily due to increased inventory and
decreased accrued compensation and expenses and increased accounts payable, partially offset by increased collections on accounts receivable. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Net
cash used in operating activities during the nine months ended September&nbsp;30, 2014 was $2.3&nbsp;million, consisting primarily of our net loss of $0.3&nbsp;million and an increase of
$0.2&nbsp;million in deferred income taxes asset, offset by a non-cash expense of $0.7&nbsp;million. The cash used in operations was primarily due to the ongoing commercialization of our products.
The non-cash expense items primarily consisted of depreciation and amortization of equipment and leasehold improvements and patents and stock-based compensation. Our net operating assets and
liabilities increased $2.5&nbsp;million. The increase in our net operating assets and liabilities was primarily due to increased inventory and other non-current assets and a decrease in our accrued
compensation and expenses. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Net
cash used in operating activities during the year ended December&nbsp;31, 2014 was $1.0&nbsp;million, consisting primarily of our net income of $2.1&nbsp;million, a decrease of
$1.6&nbsp;million in deferred income taxes asset, a $0.5&nbsp;million provision for doubtful accounts and a non-cash expense of $0.9&nbsp;million. The cash used in operations was primarily due
to the ongoing commercialization of our products, as well as increased accounts receivable and inventory and decreased accrued compensation, offset by increased accounts payable. The non-cash expense
items primarily consisted of depreciation and amortization of equipment and leasehold improvements and patents and stock-based compensation. Our net operating assets and liabilities increased
$6.0&nbsp;million. The increase in our net operating assets and liabilities was primarily due to increased accounts receivable and inventory. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Net
cash used in operating activities during the year ended December&nbsp;31, 2013 was $0.4&nbsp;million, consisting primarily of our net income of $3.2&nbsp;million, an increase of
$0.9&nbsp;million in deferred income taxes asset, a $0.3&nbsp;million provision for doubtful accounts and a non-cash expense of $0.7&nbsp;million. The cash used in operations was primarily due
to the ongoing commercialization of our products, as well as increased accounts receivable and inventory and decreased accrued expenses, offset by increased accounts payable and accrued compensation.
The non-cash expense items primarily consisted of depreciation and amortization of equipment and leasehold improvements and patents and stock-based compensation. Our net operating assets and
liabilities increased $3.7&nbsp;million. The increase in our net operating assets and liabilities was primarily due to increased accounts receivable and inventory. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>81</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=86,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=362236,FOLIO='81',FILE='DISK131:[15ZBY1.15ZBY12201]DU12201A.;88',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dw12201_1_82"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Net Cash Used in Investing Activities  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Net cash used in investing activities during the nine months ended September&nbsp;30, 2015, was $0.4&nbsp;million, consisting of product tooling
and computer and manufacturing equipment. Net cash used in investing activities during the nine months ended September&nbsp;30, 2014 was $0.2&nbsp;million, consisting of product tooling and
computer and manufacturing equipment. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Net
cash used in investing activities during the year ended December&nbsp;31, 2014, was $0.4&nbsp;million, consisting of product tooling and computer and manufacturing equipment. Net cash used in
investing activities during the year ended December&nbsp;31, 2013 was $0.4&nbsp;million, consisting of product tooling and computer and manufacturing equipment. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Net Cash (Used in) Provided by Financing Activities  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Historically, we have funded our operations through the issuance of capital stock. Net cash provided by financing activities during the nine months
ended September&nbsp;30, 2015, was $0.9&nbsp;million, consisting of proceeds from exercise of stock options and warrants, partially offset by minimal repayments of borrowings. Net cash provided by
financing activities during the nine months ended September&nbsp;30, 2014 was $0.2&nbsp;million, consisting of proceeds from exercise of stock options, partially offset by minimal repayments of
borrowings. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Net
cash provided by financing activities during the year ended December&nbsp;31, 2014, was $0.2&nbsp;million, consisting of proceeds from exercise of stock options, partially offset by minimal
repayments of borrowings. Net cash used in financing activities during the year ended December&nbsp;31, 2013 was $2.1&nbsp;million, consisting of a $2.0&nbsp;million milestone payment relating
to our ACTitouch System asset purchase and redemption of common stock of $0.1&nbsp;million. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Credit Line  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As of September&nbsp;30, 2015, we had a credit line with Venture Bank with borrowing availability of $2.0&nbsp;million, which we refer to as our
credit line. As of September&nbsp;30, 2015, we did not have any outstanding borrowings under our credit line. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
credit line bears interest based on the prime rate, which was 3.25% as of September&nbsp;30, 2015, and expires on May&nbsp;11, 2016. Our credit line is secured by substantially all our assets,
including property and equipment, accounts receivable and inventory. Our credit line contains customary conditions to borrowing, events of default and covenants, including covenants that restrict our
ability to dispose of assets, merge with or acquire other entities, incur indebtedness and encumbrances. In addition, we complied with certain financial covenants relating to liquidity and leverage
ratios until the renewal in May 2015 that released us from our covenant obligations. We were in compliance with those covenants as of December&nbsp;31, 2013 and 2014. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Off-Balance Sheet Arrangements  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We did not have during the periods presented, and we do not currently have, any off-balance sheet arrangements, as defined under the applicable
regulations. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>82</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=87,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=566433,FOLIO='82',FILE='DISK131:[15ZBY1.15ZBY12201]DW12201A.;78',USER='JKEENE',CD='25-JAN-2016;10:12' -->
<A NAME="page_dw12201_1_83"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Contractual Obligations  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The following table summarizes our contractual obligations as of December&nbsp;31, 2014. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=14 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Payments Due by Period </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Less Than<BR>
1 Year </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2-3<BR>
Years </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>4-5<BR>
Years </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>More Than<BR>
5 Years </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Total </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=14 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(In thousands)</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Operating lease obligations<SUP>(1)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>491</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>960</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>990</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>830</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,271</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Future product royalties<SUP>(2)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>924</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>446</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,370</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Purchase commitments<SUP>(3)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,788</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,213</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,001 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,203</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,619</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>990</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>830</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>11,642 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>We
currently lease approximately 52,000 square feet of office and assembly space at our corporate headquarters in Minneapolis, Minnesota under a lease that
expires in July 2021.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(2)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>We
are required to make royalty payments to a third-party for our ACTitouch System through 2023. We are required to make quarterly payments through 2023,
with guaranteed payments through the third quarter of 2016, and for the remaining period equal to 6% of our quarterly revenues attributable to our ACTitouch System. In any year that these revenues
exceed $40&nbsp;million, we are required to pay 7% on revenues over $40&nbsp;million and 6% on revenues $40&nbsp;million and under.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(3)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Represents
purchase orders issued in March&nbsp;2015 to vendors for inventory expected to be received in 2015 and 2016. </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Quantitative and Qualitative Disclosures about Market Risk  </B></FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Interest Rate Risk  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We are exposed to market risk from changes in interest rates, primarily related to our investment activities. The principal objectives of our
investment activities are to preserve principal, provide liquidity and maximize income consistent with minimizing risk of material loss. The recorded carrying amounts of cash and cash equivalents
approximate fair value due to their short maturities. Our interest income is sensitive to changes in the general level of interest rates in the United States, particularly since our investments are
generally short-term in nature. Due to the nature of our short-term investments, an immediate 100 basis point change in interest rates would not have a material effect on the fair market value of our
portfolio. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Additionally,
the interest rates for our credit line have both fixed and variable components. If overall interest rates had increased by 100 basis points during the periods presented, our interest
expense would not have been materially affected. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Inflation  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Inflationary factors, such as increases in our cost of goods sold, sales and marketing expenses and reimbursement expenses, may adversely affect our
operating results. Although we do not believe that inflation has had a material impact on our financial condition or results of operations to date, a high rate of inflation in the future may have an
adverse effect on our ability to maintain and increase our gross margin, and on our sales and marketing and reimbursement expenses as a percentage of our revenues if the selling prices of our products
do not increase as much or more than these increased costs. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Credit Risk  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As of December&nbsp;31, 2013 and 2014 and September&nbsp;30, 2015, our cash and cash equivalents were maintained with one financial institution
in the United states and our current deposits are likely in excess of insured limits. We have reviewed the financial statements of this institution and believe it has </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>83</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=88,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=178389,FOLIO='83',FILE='DISK131:[15ZBY1.15ZBY12201]DW12201A.;78',USER='JKEENE',CD='25-JAN-2016;10:12' -->
<A NAME="page_dw12201_1_84"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>sufficient
assets and liquidity to conduct its operations in the ordinary course of business with little or no credit risk to us. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
accounts receivable primarily relate to revenues from the sale of our products to patients in the United States. For the year ended December&nbsp;31, 2014 and for the nine months ended
September&nbsp;30, 2015, our accounts receivable were $15.0&nbsp;million and $14.4&nbsp;million, respectively. We had accounts receivable from three insurance companies representing
approximately 28%, 20% and 5% of accounts receivable as of September&nbsp;30, 2015 and we had accounts receivable from three insurance companies representing approximately 23%, 16% and 4% as of
September&nbsp;30, 2014. We had accounts receivable from three insurance companies representing approximately 25%, 24% and 5% of accounts receivable as of December&nbsp;31, 2014 and we had
accounts receivable from three insurance companies representing approximately 18%, 33% and 7% as of December&nbsp;31, 2013. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Foreign Currency Risk  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our business is conducted in U.S. dollars and foreign transactions have been minimal. As we begin building relationships to commercialize our
products internationally, our results of operations and cash flows may become increasingly subject to changes in foreign exchange rates. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Critical Accounting Policies and Significant Estimates  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our discussion and analysis of our financial condition and results of operations are based upon our financial statements which have been prepared in
accordance with generally accepted accounting principles in the United States, or GAAP. The preparation of these financial statements requires us to make estimates and judgments that affect the
reported amounts of assets and liabilities and related disclosure of contingent assets and liabilities, revenues and expenses at the date of the financial statements. Generally, we base our estimates
on historical experience and on various other assumptions in accordance with GAAP that we believe to be reasonable under the circumstances. Actual results may differ from these estimates and such
differences could be material to our financial position and results of operations. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>While
our significant accounting policies are more fully described in Note&nbsp;1 to our consolidated financial statements included elsewhere in this prospectus, we believe the following discussion
addresses our most critical accounting policies, which are those that are most important to the portrayal of our financial condition and results of operations and require our most difficult,
subjective and complex judgments. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Revenue Recognition  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We recognize revenue when persuasive evidence of a sale arrangement exists, delivery of product has occurred through the transfer of title and risks
of reward of ownership, the selling price is fixed or determinable and collectability is reasonably assessed. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
distribute our products directly to patients. For any of our products sold to patients covered by private payers, such as commercial insurance companies, we recognize revenues from such sales upon
shipment of our products. A product is not shipped until we have received a prescription from a physician for our products and, as applicable, receipt of prior authorization from payers. At shipment,
we invoice the payer for their portion of the total product cost and we recognize revenue as a percentage of the payer's invoice based on the polices and payment history of the applicable payer. The
payment history of the applicable payer is drawn from our actual payment experience over the last three years. Any differences in payments received as compared to our estimates are recognized in the
period for which we actually receive payment for the product. Over time, we adjust the applicable estimates used for each payer to reflect any such differences. We separately invoice the patient for
their </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>84</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=89,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=921016,FOLIO='84',FILE='DISK131:[15ZBY1.15ZBY12201]DW12201A.;78',USER='JKEENE',CD='25-JAN-2016;10:12' -->
<A NAME="page_dw12201_1_85"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>payment
obligation with respect to the shipped product, such as copayments and deductibles, and recognize revenue upon sending such invoice. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>For
any of our products sold to Medicare patients, we recognize revenues from such sales upon shipment of our products, which can occur only after we have received a prescription from a physician and
all applicable Medicare documentation. We estimate the revenue on each shipment to a Medicare patient as a percentage of the total invoice based on the payment history of each regional administrative
contractor. While we have contracted rates with Medicare, to the extent any claims for reimbursement are denied, we will recognize any necessary adjustments in the period for which the adjustment is
made. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Accounts Receivable  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The majority of our accounts receivable and revenues are from commercial insurance payers and government payers, such as Medicare, Veterans
Administration and Medicaid. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Accounts
receivable are carried net of allowances for estimated non-receipt of patient co-payment and deductible obligations and allowances for uncollectible accounts. We believe all accounts
receivable in excess of the allowance are fully collectible. We do not accrue interest on a majority of the past due accounts receivable. We determine when accounts become past due on a customer by
customer basis. If accounts receivables in excess of the provided allowance are determined uncollectible, they are charged to expense in the quarter that determination is made and accounts receivable
are written off after all collection efforts have failed. A portion of our claims to Medicare are initially denied, and enter the appeals process, where many are ultimately reviewed by an
Administrative Law Judge. After final adjudication of all claims, approximately 90% of the claims submitted are approved (this is on a number of claims, not a dollars claimed, basis). Historically, we
successfully appealed 90% of our initial Medicare claims denials. The appeal process can be lengthy, lasting more than a year in most cases. Accordingly, we classify a portion of our Medicare accounts
receivable as non-current based on our experience with Medicare. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As
an alternative to individual appeals, Medicare may seek to settle a number of outstanding appeals at one time through a settlement conference. On September&nbsp;3, 2015, we entered into a
settlement agreement with the Centers for Medicare and Medicaid Services, or CMS, for 247 claims, representing approximately $1.46 million of original claims based on the Medicare allowable rates, in
which we had submitted a request for an Administrative Law Judge hearing in 2013. The settlement entitled us to receive a payment of approximately $0.85&nbsp;million no later than January&nbsp;21,
2016. We received this full amount during the fourth quarter of 2015. The settlement will result in a reduction in the fourth quarter of 2015 of $0.82&nbsp;million in our accounts receivable for
shipment of products to patients covered by Medicare. The settlement was part of a pilot program, facilitated by the Office of Medicare Hearings and Appeals, to address a backlog of overdue claims
awaiting Administrative Law Judge adjudication. Because the settlement is part of a pilot program, we cannot predict whether we will be able to conclude future settlements with Medicare or achieve
settlements on similar terms. Any future settlement of claims for amounts less than the corresponding amounts receivable would result in a write off. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stock-Based Compensation  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We account for stock-based compensation awards at the fair value on the date of grant expensed over the applicable vesting period. The fair value of
options on the grant date is estimated using the Black-Scholes option-pricing model. We recognize the fair value of each award as an expense on a straight-line basis over the requisite service period,
which is generally the vesting period of the equity grant. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>85</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=90,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=121261,FOLIO='85',FILE='DISK131:[15ZBY1.15ZBY12201]DW12201A.;78',USER='JKEENE',CD='25-JAN-2016;10:12' -->
<A NAME="page_dw12201_1_86"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
Black-Scholes option-pricing model requires the input of highly subjective assumptions, including the expected term of the option, the expected volatility of the price of our common stock, the
risk-free interest rate and the expected dividend yield. These estimates involve inherent uncertainties and the significant application of management's judgment. If factors change and different
assumptions are used, our stock-based compensation expense could be materially different in the future. We determined weighted-average valuation assumptions as follows: </FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Expected term.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;We use the "simplified method" to
determine the expected term of the stock option.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Expected volatility.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;Our expected volatility is derived
using the historical volatility of a public company of similar size and industry because we believe the expected volatility will approximate historical volatility, due to the fact that we have no
trading history.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Risk-free interest rate.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;The risk free interest rate is
based on the yields of U.S. Treasury securities with maturities similar to the expected term of the options for each option group.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Expected dividend yield.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;We have never declared or paid
any cash dividends on our common stock and do not presently plan to pay cash dividends on our common stock in the foreseeable future. Consequently, we use an expected dividend yield of zero. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
following table summarizes the assumptions relating to our stock options for the years ended December&nbsp;31, 2013 and 2014 and the nine months ended September&nbsp;30, 2014 and 2015: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Nine Months Ended<BR>
September&nbsp;30, </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Expected term</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6&nbsp;years</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6&nbsp;years</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6&nbsp;years</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6&nbsp;years</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Expected volatility</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>40%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>60%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>60%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>50%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Risk-free interest rate</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Expected dividend yield</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0%</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
in the future we determine that another method is more reasonable, or if another method for calculating these input assumptions is prescribed by authoritative guidance, and, therefore, should be
used to estimate volatility or expected life, the fair value calculated for our stock options could change significantly. Higher volatility and longer expected lives result in an increase to
stock-based compensation expense determined at the date of grant. Stock-based compensation expense affects our reimbursement, general and administrative expenses. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
estimate our forfeiture rate based on an analysis of our actual forfeitures and will continue to evaluate the appropriateness of the forfeiture rate based on actual forfeiture experience, analysis
of employee turnover behavior and other factors. Quarterly changes in the estimated forfeiture rate can have a significant effect on reported stock-based compensation expense, as the cumulative effect
of adjusting the rate for all expense amortization is recognized in the period the forfeiture estimate is changed. If a revised forfeiture rate is higher than the previously estimated forfeiture rate,
an adjustment is made that will result in a decrease to the stock-based compensation expense recognized in the consolidated financial statements. If a revised forfeiture rate is lower than the
previously estimated forfeiture rate, an adjustment is made that will result in an increase to the stock-based compensation expense recognized in the consolidated financial statements. The effect of
forfeiture adjustments was insignificant for the years ended December&nbsp;31, 2013 and 2014 and the nine-month </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>86</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=91,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=346160,FOLIO='86',FILE='DISK131:[15ZBY1.15ZBY12201]DW12201A.;78',USER='JKEENE',CD='25-JAN-2016;10:12' -->
<A NAME="page_dw12201_1_87"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>periods
ended September&nbsp;30, 2014 and 2015. We will continue to use significant judgment in evaluating the expected term, volatility and forfeiture rate related to our stock-based compensation. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
fair value of the common stock underlying our equity compensation awards was historically determined by our board of directors, with input from management and third-party valuations on an annual
basis. We believe that our board of directors has the relevant experience and expertise to determine the fair value of our common stock. However, the fair value of our common stock may vary
significantly in the future and from the estimates previously made. Given the absence of a public trading market for our common stock, our board of directors exercised reasonable judgment and
considered numerous objective and subjective factors to determine the best estimate of the fair value of our common stock using methodologies, approaches and assumptions consistent with the American
Institute of Certified Public Accountants, or AICPA, Audit and Accounting Practice Aid Series: </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>Valuation of Privately Held Company Equity Securities Issued as
Compensation</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>, known as the AICPA Accounting and Valuation Guide. The following factors, among others, were considered:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our results of operations, history of losses and other financial metrics; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our capital resources and financial condition; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the contemporaneous valuations of our common stock by an unrelated third-party valuation firm; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the prices of our convertible redeemable preferred stock sold to outside investors in arms-length transactions; </FONT> <FONT COLOR="#3B5A6F"
SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the rights, preferences and privileges of our preferred stock relative to those of our common stock; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the rights of freestanding warrants and other similar instruments related to our securities that are redeemable; </FONT> <FONT COLOR="#3B5A6F"
SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the hiring of key personnel; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the introduction of new products; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the fact that the common stock underlying the option grants involves illiquid securities in a private company; </FONT> <FONT COLOR="#3B5A6F"
SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the risks inherent in the development and expansion of our products and services; and </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the likelihood of achieving a liquidity event, such as an initial public offering or sale of our company given prevailing market
conditions. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
valuing our common stock, since January&nbsp;1, 2014, our board of directors determined the equity value of our business using the market approach valuation method and the income approach
valuation method to determine the enterprise value. For 2014, our board of directors exclusively used the market approach valuation method. For 2015, these two approaches were initially weighted
equally. During 2015, we received a summary valuation from the lead underwriters for this offering. In the second half of 2015 we reviewed our fair value determinations for 2015, effectively modifying
our valuation approach for 2015 to include this summary valuation as a third factor in determining fair value, along with the other approaches previously considered. Our board of directors then
considered the factors set forth above in reaching its determination of the fair value. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>87</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=92,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=190481,FOLIO='87',FILE='DISK131:[15ZBY1.15ZBY12201]DW12201A.;78',USER='JKEENE',CD='25-JAN-2016;10:12' -->
<A NAME="page_dw12201_1_88"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
market approach consists of both a comparable publicly traded company methodology and an M&amp;A transaction methodology to determine our enterprise value. The comparable publicly traded company
methodology analyzes publicly traded companies similar in industry and/or business model to our company. This methodology uses these guideline companies to develop relevant market multiples and
ratios, using metrics such as revenue, earnings before interest and taxes (EBIT), earnings before interest, taxes, depreciation and amortization (EBITDA), net income and/or tangible book value. These
multiples and values are then applied to our corresponding financial metrics. Since no two companies are perfectly comparable, premiums or discounts may be applied to the subject company's metrics if
its position in its industry is significantly different from the position of the guideline companies, or if its intangible attributes are significantly different. Our peer group of publicly traded
companies used for determination of the market trading multiples consists of six companies for 2015 and five companies for 2014 that focus primarily on providing lymphedema or wound care treatment
solutions or that are comparable based on our business model. There are, however, significant size and risk differences between our selected peer group of guideline public companies and us. The M&amp;A
transaction methodology uses actual prices paid in merger and acquisition transactions for companies similar to our company. Exit multiples of total purchase price paid to revenues, earnings before
interest and taxes (EBIT), earnings before interest, taxes, depreciation and amortization (EBITDA), net income and/or book value may be developed for each comparable transaction, if the data is
available. These multiples are then applied to our corresponding latest 12-month and projected financial metrics. The transactions used for determination of the multiples consisted of seven
transactions for 2015 and seven transactions for 2014. The transactions consisted of acquired companies that were similar to our company in terms of industry, size and/or developmental stage and
further refined that search to transactions in which the target company competed in an industry or supplied a service that was similar to that of our company. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
income approach determines our enterprise value on the basis of the estimated present value of our projected future cash flows and a residual value based on an exit or steady state terminal
multiple, which represents the future cash flows of our company beyond the discrete projection period. The estimates for future cash flows and the residual value are considered highly complex and
subjective. These future cash flows and residual are discounted to their present values using a discount rate derived from an analysis of the cost of capital of comparable publicly traded companies in
our industry or similar lines of business as of each valuation date and this discount rate is adjusted to reflect the risks inherent in our cash flows. The cost of capital is calculated based on
venture capital rates of return for our company's stage of development and risk profile. A venture capital rate of return of 25.0% is consistent with required returns identified in the AICPA
Accounting and Valuation Guide for companies at a similar stage. Once calculated, the results of the income approach were relied upon to determine an estimated enterprise value. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Following
the closing of this offering, our board of directors will determine the fair value of our common stock based on the closing market price on The NASDAQ Global Market on the date of grant. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Recent Accounting Pronouncements  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Section&nbsp;107 of the JOBS Act provides that an "emerging growth company" can take advantage of the extended transition period provided in
Section&nbsp;7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an "emerging growth company" can delay the adoption of certain accounting
standards until those standards would otherwise apply to private companies. We have elected to avail ourselves of this exemption and, as a result, our financial statements may not be comparable to the
financial statements of issuers who are required to comply with the effective dates for new or revised accounting standards that are applicable to public </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>88</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=93,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=173197,FOLIO='88',FILE='DISK131:[15ZBY1.15ZBY12201]DW12201A.;78',USER='JKEENE',CD='25-JAN-2016;10:12' -->
<A NAME="page_dw12201_1_89"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>companies.
Section&nbsp;107 of the JOBS Act provides that we can elect to opt out of the extended transition period at any time, which election is irrevocable. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
May 2014, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, No.&nbsp;2014-09, </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>Revenue from Contracts with
Customers</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>. The new section will replace Section&nbsp;605, </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>Revenue Recognition</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>, and creates modifications to various other
revenue accounting
standards for specialized transactions and industries. The section is intended to conform revenue accounting principles with a concurrently issued International Financial Reporting Standards to
reconcile previously differing treatment between U.S. practices and those of the rest of the world and to enhance disclosures related to disaggregated revenue information. The updated guidance is
effective for annual reporting periods beginning on or after December&nbsp;15, 2017, and interim periods within those annual periods. We will adopt the new provisions of this accounting standard at
the beginning of fiscal year 2018, because early adoption is not allowed. We will further study the implications of this statement to evaluate the expected impact on our consolidated financial
statements. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


JOBS Act  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As an "emerging growth company" under the JOBS Act, we can take advantage of an extended transition period for complying with new or revised
accounting standards. This allows an emerging growth company to delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to
avail ourselves of this exemption and, as a result, our financial statements may not be comparable to the financial statements of issuers who are required to comply with the effective dates for new or
revised accounting standards that are applicable to public companies. Section&nbsp;107 of the JOBS Act provides that we can elect to opt out of the extended transition period at any time, which
election is irrevocable. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
are in the process of evaluating the benefits of relying on other exemptions and reduced reporting requirements under the JOBS Act. Subject to certain conditions, as an emerging growth company, we
intend to rely on certain of these exemptions, including without limitation (i)&nbsp;reduced financial statement reporting periods, (ii)&nbsp;providing an auditor's attestation report on our
system of internal controls over financial reporting pursuant to Section&nbsp;404(b) of the Sarbanes-Oxley Act of 2002 and (iii)&nbsp;complying with any requirement that may be adopted by the
Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor's report providing additional information about the audit and the financial statements,
known as the auditor discussion and analysis. We will remain an emerging growth company until the earliest of: (a)&nbsp;the last day of the fiscal year in which we have total annual gross revenues
of $1&nbsp;billion or more; (b)&nbsp;the last day of the fiscal year following the fifth anniversary of the date of the completion of this offering; (c)&nbsp;the date on which we have issued
more than $1&nbsp;billion in nonconvertible debt during the previous three years; and (d)&nbsp;the date on which we are deemed to be a large accelerated filer under the rules of the SEC. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>89</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=94,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=280373,FOLIO='89',FILE='DISK131:[15ZBY1.15ZBY12201]DW12201A.;78',USER='JKEENE',CD='25-JAN-2016;10:12' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dy12201_1_90"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="dy12201_business"> </A>
<A NAME="toc_dy12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  BUSINESS    <BR>    </B></FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Overview  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We are a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases at home. We focus on
advancing the standard of care in treating chronic diseases in the home setting to improve patient outcomes and quality of life and help control rising healthcare expenditures. We possess a unique,
scalable platform to deliver at-home healthcare solutions throughout the United States. This evolving care delivery model is recognized by policy-makers and payers as a key for controlling rising
healthcare expenditures. Our initial area of therapeutic focus is vascular disease, with a goal of advancing the standard of care in treating lymphedema and chronic venous insufficiency. Our
proprietary Flexitouch System is an at-home solution for lymphedema patients. Our proprietary ACTitouch System is a home-based solution for chronic venous insufficiency patients that may be worn
throughout the day. Our products
deliver cost-effective, clinically proven, long-term treatment of chronic diseases. We employ a direct-to-patient and -provider model, through which we obtain patient referrals from clinicians, manage
insurance claims on behalf of our patients and their clinicians, deliver our solutions to patients and train them on the proper use of our solutions in their homes. This model allows us to directly
approach patients and clinicians, whereby we disintermediate the traditional durable medical equipment channel and capture both the manufacturer and distributor margins. For the year ended
December&nbsp;31, 2014, we generated revenues of $47.7&nbsp;million and had net income of $2.1&nbsp;million. Our revenues increased 28% during the year ended December&nbsp;31, 2014 compared to
the year ended December&nbsp;31, 2013. For the nine months ended September&nbsp;30, 2015, we generated revenues of $41.7&nbsp;million and had net income of $0.1&nbsp;million. Our revenues
increased 41% during the nine months ended September&nbsp;30, 2015 compared to the nine months ended September&nbsp;30, 2014. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Lymphedema
is a type of chronic swelling, or edema, which occurs in the arms, legs, neck, trunk or other body parts when the lymphatic vessels are unable to adequately drain protein-rich lymph fluid
from these regions. Lymphedema is progressive in nature, worsens over time, and has no known cure. Chronic venous insufficiency is a condition that occurs when the venous wall and/or valves in the
veins are not working effectively, making it difficult for blood to return to the heart from the affected region. This pooling or collecting of blood in the veins can result in painful, slow-healing
wounds on the lower leg, called venous leg ulcers. Patients with lymphedema or chronic venous insufficiency are typically treated by vascular surgeons, vascular medicine physicians, wound physicians,
wound nurses and lymphedema therapists. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Lymphedema
and chronic venous insufficiency are costly and lifelong conditions with debilitating physical and psychological impacts on patients. We estimate the addressable market opportunity for our
solutions treating lymphedema and chronic venous insufficiency in the United States is approximately $4.1&nbsp;billion. We believe that between three to five million people in the United States are
living with lymphedema. Based on an analysis of claims data commissioned by us, we estimate approximately 700,000&nbsp;patients were diagnosed with lymphedema during the 12&nbsp;months ended
June&nbsp;30, 2014. We estimate that the addressable market opportunity for our Flexitouch System is approximately $3.5&nbsp;billion in the United States, which is based on the number of patients
diagnosed with lymphedema and our average selling price per device. We believe that chronic venous insufficiency afflicts approximately 8% of the U.S. population, and this percentage may rise due to
the growing prevalence of obesity and cancer, as well as an aging population. Based on an analysis of claims data commissioned by us, we estimate there were over 1.5&nbsp;million patients diagnosed
with venous leg ulcers in the United States during the 12&nbsp;months ended June&nbsp;30, 2014. We estimate that our immediately addressable patient population consists of the 30% to 40% of these
patients, or approximately 525,000 patients, for whom we believe reimbursement is available because their venous leg ulcers have not resolved after six months of treatment. We estimate the addressable
market opportunity for our </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>90</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=95,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=761221,FOLIO='90',FILE='DISK131:[15ZBY1.15ZBY12201]DY12201A.;64',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_dy12201_1_91"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>ACTitouch
System is approximately $580&nbsp;million in the United States, which is based on the number of patients diagnosed with unresolved venous leg&nbsp;ulcers and our average selling price
per device. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A
traditional treatment for lymphedema is complete decongestive therapy, consisting of manual lymphatic drainage, which is a specialized application of gentle pressure to the skin applied by a
therapist that encourages drainage of lymph fluid, as well as decongestive exercises, skin care and compression with multilayered bandages, compression garments or pumps. Typically, this therapy
begins with clinic visits three to five times per week for four to eight weeks, which is costly, inconvenient and time consuming. At that point, clinical improvement plateaus or reimbursement for the
therapy ends and patients transition to self-administered home-based therapy. Manual lymphatic drainage is difficult for patients to self-administer due to limited range of motion and treatment
techniques that are difficult to replicate, and basic pump-based compression is uncomfortable and has not demonstrated the benefits of our advanced pneumatic pump. To address these limitations, our
advanced at-home Flexitouch System mimics the clinic-based manual lymphatic drainage therapy through an easy-to-use, one-hour daily, self-applied system. Peer-reviewed, published studies have shown
that our Flexitouch System provides improved quality of life and clinical outcomes and delivers significant cost-savings to payers and patients. The predecessor version to our Flexitouch System
received 510(k) clearance from the FDA in July 2002 and our current Flexitouch System received 510(k) clearance from the FDA in October 2006. Our Flexitouch System generated $43.7&nbsp;million, or
92%, of our revenues in 2014. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
standard of care treatment for chronic venous insufficiency is compression therapy. As the disease progresses, patients may develop a venous leg&nbsp;ulcer, which is commonly treated using
multilayered bandages to minimize swelling and enhance blood flow. A clinician applies these non-removable bandages to patients at a precise pressure and patients wear the bandages between weekly
visits to the wound clinic during which the bandages are removed and reapplied. Treatment typically occurs for several months and impairs patient quality of life by limiting bathing, range of motion
and other activities. Treatment efficacy is inconsistent because bandages can lose their precise pressure between treatments. Our ACTitouch System provides precise, consistent and wearable compression
that a patient may apply, remove and reapply at home. This system was developed to provide maximum convenience for patients by providing them with the freedom to remain active while simultaneously
receiving the benefits of sustained and intermittent pneumatic compression, which we refer to as dual-compression. In a clinical study, our ACTitouch System was shown to have comparable efficacy in
healing venous leg&nbsp;ulcers and achieved higher patient quality of life scores, as compared to multilayered bandages. Our ACTitouch System received 510(k) clearance from the FDA in June 2013 and
generated $2.4&nbsp;million, or 5%, of our revenues in 2014. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>To
support the growth of our business, we invest heavily in our commercial infrastructure, consisting of our direct sales force, reimbursement capabilities and clinical expertise. We are a national,
accredited provider of home medical equipment services approved for coverage by private payers, Medicare, the Veterans Administration and certain Medicaid programs in the United States. We market our
products using a direct-to-patient and -provider model. Our direct sales force is focused on increasing clinician awareness of our solutions, and has grown from three representatives in March 2005 to
over 70&nbsp;people as of September&nbsp;30, 2015. We also utilize over 300 licensed, independent healthcare practitioners as home trainers who educate patients on the proper use of our solutions.
Our experienced reimbursement operations group of over 50&nbsp;people focuses on verifying case-by-case benefits, obtaining prior authorization, billing and collecting payments from payers and
providing customer support services. Our payer relationships group of over 20&nbsp;people is responsible for developing relationships with payer decision-makers to educate them on our product
efficacy, develop overall payer coverage policies and reimbursement criteria, manage Medicare patient claims and contracts with payers and serve as an advocacy liaison between patients, clinicians and
payers </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>91</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=96,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=884572,FOLIO='91',FILE='DISK131:[15ZBY1.15ZBY12201]DY12201A.;64',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_dy12201_1_92"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>throughout
the appeals process. Our clinical team, consisting of a scientific advisory board, in-house therapists and nurses, and a medical director, serves as a resource to clinicians and patients
and guides our development of clinical evidence in support of our products. We believe these investments are critical to driving patient adoption of our technologies, and together with our commercial
infrastructure represents a significant competitive advantage. Health insurance coverage for our Flexitouch System and our ACTitouch System is in place with private payers, Medicare, the Veterans
Administration and certain Medicaid programs. Based on our estimates, we have contracts as an in-network provider covering over 230&nbsp;million lives in the United States. Over
44,000&nbsp;patients have been treated with our Flexitouch System since its launch in 2002, and over 9,000 Flexitouch Systems were shipped in 2014. More than 1,800&nbsp;patients were treated with
our ACTitouch System during its first full year of commercialization in 2014. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Overview of the Lymphedema and Chronic Venous Insufficiency Markets  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Lymphedema  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The lymphatic system performs a fundamental role in maintaining health through balancing fluids and regulating immunity by removing harmful bacteria,
viruses and waste products. Lymphatic structures are situated throughout the body and are comprised of a series of vessels, lymph nodes and lymphoid organs that act as a drainage system by collecting
protein rich lymph fluid and sending it to the venous system. Lymph nodes are located in several areas of the body with superficial and deep lymph nodes under each arm, at the hip, in the groin, above
the collar bones in the neck, in the abdomen, tonsils and spleen, and in bone marrow. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>
<IMG SRC="g865608.jpg" ALT="GRAPHIC" WIDTH="277" HEIGHT="400">
  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Lymphedema
refers to a type of chronic swelling, or edema, which may occur in the arms, legs, neck, trunk or other body parts and causes severe and debilitating symptoms, including decreased mobility,
skin breakdown, pain, increased risk of serious infection and marked psychosocial impairment, resulting in significantly negative implications for a patient's health and quality of life. The disease
occurs when the lymphatic vessels are unable to adequately drain protein-rich lymph fluid from the arms, legs or other regions of the body. Any condition or procedure that damages the lymph nodes or </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>92</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=97,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=715553,FOLIO='92',FILE='DISK131:[15ZBY1.15ZBY12201]DY12201A.;64',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_dy12201_1_93"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>lymphatic
vessels, such as surgery or treatment for breast and other cancers, obesity, infection, scar tissue formation, trauma or chronic venous insufficiency can cause lymphedema. The disease may
also be caused from congenital malformation of the lymphatic system. Lymphedema is progressive in nature, worsens over time, and has no known cure. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Misdiagnosis
of lymphedema is fairly common, as many conditions that cause swelling are not related to lymphedema. Correct diagnosis of lymphedema may require evaluation by a physician or other
healthcare provider with knowledge of lymphedema who may choose to perform diagnostic testing. Diagnostic tests for lymphedema include history and physical examination, soft tissue and vascular
imaging, lymph node imaging, volume measurements, changes in electrical conductance, changes in biomechanical properties, genetic testing, and blood tests for other conditions that have similar
symptoms to lymphedema. The International Society of Lymphology categorizes the progression of lymphedema from Stage&nbsp;0, the least severe stage, to Stage&nbsp;3, the most severe stage. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Chronic Venous Insufficiency  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Chronic venous insufficiency occurs when the venous wall and/or valves in the veins are not working effectively, making it difficult for blood to
return to the heart. The disease is prevalent among patients who are obese or pregnant and may also be caused by high blood pressure, trauma, lack of exercise, smoking, deep vein thrombosis and
inflammation of the vein walls. As the valves deteriorate, blood leaks or flows backward, leading to increased pressure in veins, stretched and dilated vessels and pooling of blood in the veins. As
blood accumulates, swelling occurs, leading to progressive tissue breakdown and venous&nbsp;leg ulcers.&nbsp;Ulcers develop in areas where blood collects as swelling interferes with the movement
of oxygen and nutrients through tissues, and if left untreated, these&nbsp;ulcers can quickly become infected or even gangrenous. Prolonged or untreated chronic venous insufficiency may damage the
lymphatic system. Physicians diagnose chronic venous insufficiency based on appearance, symptoms and imaging techniques and classify it based upon a scale endorsed by the Society for Vascular Surgery. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Market Opportunity  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Lymphedema and chronic venous insufficiency are costly and lifelong conditions with debilitating physical and psychological impacts on patients. We
estimate the addressable market opportunity for our solutions treating lymphedema and chronic venous insufficiency in the United States is approximately $4.1&nbsp;billion. We believe that between
three to five million people in the United States are living with lymphedema. Based on analysis of claims data commissioned by us, we estimate approximately 700,000&nbsp;patients were diagnosed with
lymphedema during the 12&nbsp;months ended June&nbsp;30, 2014. We estimate that the addressable market opportunity for our Flexitouch System is approximately $3.5&nbsp;billion in the United
States, which is based on the number of patients diagnosed with lymphedema and our average selling price per device. We believe that chronic venous insufficiency afflicts approximately 8% of the U.S.
population, and this percentage may rise due to the growing prevalence of obesity and cancer, as well as an aging population. Based on an analysis of claims data commissioned by us, we estimate there
were over 1.5&nbsp;million patients diagnosed with venous leg&nbsp;ulcers in the United States during the 12&nbsp;months ended June&nbsp;30, 2014. We estimate that our immediately addressable
patient population consists of the 30% to 40% of these patients, or approximately 525,000 patients, for whom we believe device reimbursement is available because their venous leg&nbsp;ulcers have
not resolved after six months of treatment. We estimate the addressable market opportunity for our ACTitouch System is approximately $580&nbsp;million in the United States, which is based on the
number of patients diagnosed with unresolved leg venous ulcers and our average selling price per device. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>93</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=98,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=701902,FOLIO='93',FILE='DISK131:[15ZBY1.15ZBY12201]DY12201A.;64',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_dy12201_1_94"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Current Treatment and Limitations  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A traditional treatment for lymphedema is complete decongestive therapy consisting of manual lymphatic drainage, which is a specialized application
of gentle pressure to the skin applied by a therapist that encourages drainage of lymph fluid, as well as decongestive exercises, skin care and compression with multilayered bandages, compression
garments or pumps. Typically, this therapy begins with clinic visits three to five times per week for four to eight weeks, which is costly and time consuming. At that point, clinical improvement
plateaus or reimbursement for the therapy ends and patients transition to self-administered home-based care. Manual lymphatic drainage is difficult for patients to self-administer due to limited range
of motion and treatment techniques that are difficult to replicate, and basic pump-based compression is uncomfortable and has not
demonstrated the benefits of our advanced pneumatic pump. To address these limitations, our at-home Flexitouch System mimics the clinic-based manual lymphatic drainage therapy through an advanced,
easy-to-use, self-applied system. Peer-reviewed, published studies have shown that our Flexitouch System provides improved quality of life and clinical outcomes and delivers significant cost-savings
to payers and patients. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
standard of care treatment for chronic venous insufficiency is compression therapy. As the disease progresses, patients may develop a venous leg&nbsp;ulcer, which is commonly treated using
multilayered bandages to minimize swelling and enhance blood flow. A clinician applies these non-removable bandages to patients at a precise pressure and patients wear the bandages between weekly
visits to the wound clinic during which they are then removed and reapplied. Treatment typically occurs for several months and impairs patient quality of life by limiting bathing, range of motion and
other activities. Treatment efficacy is inconsistent because bandages can lose their precise pressure between treatments. Patients also use our ACTitouch System to administer intermittent pneumatic
compression therapy to assist with the circulation of blood through affected veins. Our ACTitouch System provides precise, sustained and wearable compression that a patient may apply, remove and
reapply at home, allowing patients to bathe, improve sleep and increase mobility. In a clinical study, our ACTitouch System was shown to have comparable efficacy in healing venous leg&nbsp;ulcers
and achieved higher patient quality of life scores as compared to multilayered bandages. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Competitive Strengths  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We focus on advancing the standard of care in treating chronic diseases at home to improve patient outcomes and quality of life and help control
rising healthcare expenditures. Our executive team collectively has over 100&nbsp;years of experience in healthcare, developing and commercializing innovative medical technology products. We believe
that our commercialization platform and experience, combined with the following competitive strengths, should allow us to continue to grow our revenues and increase our presence in the
market: </FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Established leadership in providing therapies for at-home treatment of
chronic disease.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;Our strategic focus is developing and providing innovative technologies for the treatment of chronic diseases at home.
Our core competency, which is our direct-to-patient and -provider model, comprises a direct sales force, contract at-home trainers, reimbursement capabilities and medical expertise that we
use to expand awareness, garner referrals and obtain payment for our products. We believe this platform is scalable and can be leveraged to expand our business into market adjacencies. </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Proprietary technology with unique advantages over other
treatments.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;Our solutions leverage patented technological advancements that we believe give us a competitive advantage in the
marketplace. The unique ability of our Flexitouch System to mimic manual lymphatic drainage therapy, provides improved quality of life and efficacy and delivers significant cost savings to payers and
patients as compared to traditional treatments. Our ACTitouch System has the unique ability to provide both sustained and </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>94</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=99,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=428483,FOLIO='94',FILE='DISK131:[15ZBY1.15ZBY12201]DY12201A.;64',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<A NAME="page_dy12201_1_95"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>intermittent
pneumatic compression therapy in one wearable product, demonstrating comparable efficacy in healing venous leg&nbsp;ulcers, while achieving higher patient quality of life scores as
compared to the current standard of care.  </FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Substantial clinical evidence and key opinion leader support for our
Flexitouch System.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;We have developed a substantial body of peer-reviewed, published clinical evidence that our Flexitouch System reduces
swelling and improves quality of life for lymphedema patients while reducing healthcare costs. In clinical studies, patients reported a significant increase in their ability to control their
lymphedema along with an increase in activities of daily living, improvement in emotional status and reduction in limb volume, skin hardening and pain, while using our Flexitouch System. In a study of
lymphedema affecting the lower extremities published in the </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>European Journal of Vascular and Endovascular Surgery</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>, 88% of patients experienced reduced
lower extremity limb volume, 86% showed a reduction in skin hardening and 85% demonstrated increased ability to perform daily life activities, while substantially all of the patients who responded
reported being "very satisfied" or "satisfied" with our Flexitouch System. In addition, we have established strong relationships with key opinion leaders within vascular and lymphedema specialties who
promote market awareness of our solutions and inform our clinical efforts. We have in-house expertise that designs and manages clinical and economic studies in support of the efficacy and
cost-effectiveness of our products.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Significant healthcare system cost
savings.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;Our solutions offer meaningful cost savings for the healthcare system and patients, as compared to traditional treatments. As
demonstrated by a study published by the American Medical Association in </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>JAMA Dermatology,</I></FONT><FONT COLOR="#3B5A6F" SIZE=2> our Flexitouch System reduces hospitalization occurrences and
length of stays, costly cellulitis infections, outpatient visits and physical therapy visits. In addition, we believe that our ACTitouch System eliminates costly multilayered bandage system supplies
and clinic application time, resulting in cost savings for wound clinics.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Distinctive national third-party payer core
competency.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;Our specialized reimbursement team is proficient at obtaining reimbursement from payers across the United States. We work
closely with government and private payers to educate them on lymphedema diagnosis and treatment, expand coverage and negotiate competitive rates for our solutions. We also work directly with
clinicians and patients to help them understand payer requirements for our products. Our experienced reimbursement team of over 50 people focuses on coding, coverage, contracting, prior authorization,
in-house billing and payment collection. We advocate for coverage and submit claims on behalf of our patients through patient-by-patient support and claim processing. We also engage in broader payer
strategic initiatives to gain general preauthorization for our products. Based on our estimates, we have contracts in place as an in-network provider covering over 230&nbsp;million lives in the
United States. We have established payer relationships with large private payers and Medicare. In 2014, our reimbursement team obtained insurance reimbursement approvals for over 80% of submitted
claims. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Strategy  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our goal is to become a leader in the at-home treatment of chronic diseases. We intend to leverage our established platform to be a global provider
of clinically proven, easy-to-use and cost-effective solutions. The key elements of our strategy include: </FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Increase awareness of our solutions and establish them as the
standards of care.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;We believe that many patients with lymphedema and chronic venous insufficiency are undiagnosed or undertreated, and
we intend to further educate physicians, wound nurses and lymphedema therapists, patients and payers to raise awareness of these diseases, the associated health burdens of such diseases on patients
and society and the clinical and economic benefits of using our products. We intend to continue promoting this awareness through advertising campaigns, exhibiting at tradeshows and physician
societies, training and educating clinicians and publishing additional clinical and economic outcome data demonstrating the benefits of our solutions. Our ongoing marketing initiatives focus on
increasing referrals to physicians trained in venous and lymphatic diseases. In addition, we plan to launch more extensive direct-to-patient and -provider marketing programs that we believe will
further increase awareness of our solutions. </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>95</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=100,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=290357,FOLIO='95',FILE='DISK131:[15ZBY1.15ZBY12201]DY12201A.;64',USER='CHE107332',CD='20-JAN-2016;21:18' -->
<UL>
<UL>
</UL>
</UL>
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ea12201_1_96"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Expand our direct sales and customer support
teams.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;We plan to expand our direct sales and marketing organization to drive greater product adoption by patients and their clinicians.
We intend to strengthen our distribution network by continuing to recruit, train and retain talented sales representatives and increasing the number of licensed home trainers. With an expanded sales
force, we believe we could target additional clinical call points.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Introduce new features and products to grow our technology
platform.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;We intend to pursue new features for our products, and introduce new solutions to expand the number of patients using our
products and allow us to enter new clinical adjacencies. We pursue internal research, design and development, and work with external collaborators to expand our product offerings. For example, we are
developing new garment offerings for our Flexitouch System that we intend to release in the first half of 2016 and we are developing controller improvements for our Flexitouch System to launch in the
second half of 2016. In addition, we evaluate opportunities to license or acquire additional technologies and products to expand our total addressable market opportunity.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Continue the development of clinical and economic outcome
data.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;A key part of our success is our ability to demonstrate the effectiveness of our products through clinical and economic outcome
data. We intend to invest in additional studies to support peer-reviewed, published studies that evidence the clinical and economic benefits of our solutions as compared to traditional treatments. We
intend to use these data to continue to educate clinicians, payers and patients on the proven advantages of our products compared to other therapies and expand our network of key opinion leader
advocates.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Expand third-party
reimbursement.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;Our products are covered under existing reimbursement codes, and we have secured coverage for our solutions with private
payers, Medicare, the Veterans Administration and certain Medicaid programs. Our team has experienced significant success in obtaining positive coverage policies from payers by developing direct
relationships with payer decision-makers, leveraging our relationships with physician societies and key opinion leaders, providing clinical data, demonstrating the efficacy of our products and
educating payers on the limitations of traditional treatments. We intend to continue this strategic approach to further expand coverage for our solutions, as well as to meet payer-specific
requirements on behalf of patients. We also believe that reimbursement for our products could be expanded by obtaining preferred contracts with payers.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Introduce our solutions outside the United
States.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;We currently sell our products only within the United States. While our plan is to continue to focus our direct sales efforts on
penetrating the U.S. market, we plan to pursue future international expansion. We have European CE Mark approval for our Flexitouch System and plan to seek CE Mark approval for our ACTitouch System.
We also have a Medical Device License in Canada for our Flexitouch System. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Products  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We market our Flexitouch, ACTitouch and Entr&eacute; systems, as at-home therapies for the treatment of lymphedema and chronic venous
insufficiency. These products have received 510(k) clearance from the FDA to be marketed in the United States. We believe our products have unique features and benefits that address the shortcomings
of traditional treatments, are more cost-effective and enable more consistent and effective therapy, leading to improved patient quality of life. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>96</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=101,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=1041406,FOLIO='96',FILE='DISK131:[15ZBY1.15ZBY12201]EA12201A.;51',USER='JKEENE',CD='25-JAN-2016;09:58' -->
<A NAME="page_ea12201_1_97"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Flexitouch System  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We introduced a predecessor to our Flexitouch System in the United States in 2003 and our Flexitouch System in 2006. Our Flexitouch System is a
fully-automated, programmable, advanced pneumatic compression device designed for treatment of lymphedema in the home setting. Our Flexitouch System has received 510(k) clearance for the treatment of
lymphedema, certain types of edema, venous insufficiencies and certain types of leg&nbsp;ulcers. The mechanism of action of our patented Flexitouch System is designed to mimic manual lymphatic
drainage therapy, the current standard of care in patient treatment. By automating this technique, we believe our system offers an effective, cost-efficient, convenient and accessible treatment for
patients. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>
<IMG SRC="g71132.jpg" ALT="GRAPHIC" WIDTH="508" HEIGHT="265">
  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
Flexitouch System consists of an electronic controller unit that offers 15 treatment settings and multiple contoured garment configurations for the trunk and the arm or leg. Our Flexitouch System
offers flexibility for treating upper and lower extremities, as well as the trunk and chest. The electronic controller is a pneumatic compressor with four connector outlets. Each connector has eight
outflow ports into which the garment hoses are connected. Our unique garments contain 32 air chambers, are made of a soft, pliable fabric and are designed with hook-and-loop fasteners to fit snugly
around affected areas for maximum comfort and optimum pressure delivery. The garments come in a variety of sizes that can be easily adjusted to patients of all sizes. When our system is activated, air
passes through the hoses delivering sequential inflation and deflation to the garments, applying gentle pressure to the skin. The inflation sequence is designed to stimulate the lymphatic system
moving lymph fluid from the impaired areas towards healthy regions of the body to be processed. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>
<IMG SRC="g804100.jpg" ALT="GRAPHIC" WIDTH="460" HEIGHT="144">
  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
electronic controller unit adjusts the amount of pressure and the timing of the pressure and release cycles. This unit is lightweight and easily portable, providing maximum convenience for at-home
treatment. A typical therapy session using our Flexitouch System lasts one hour for upper extremity </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>97</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=102,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=492889,FOLIO='97',FILE='DISK131:[15ZBY1.15ZBY12201]EA12201A.;51',USER='JKEENE',CD='25-JAN-2016;09:58' -->
<A NAME="page_ea12201_1_98"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>treatment
and full leg and core treatment and 45 minutes for lower extremity treatment, with additional treatment options available if prescribed by a clinician. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="30%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><BR>
<FONT COLOR="#3B5A6F" SIZE=2><B>
<IMG SRC="g556508.jpg" ALT="GRAPHIC" WIDTH="205" HEIGHT="355">
 </B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR>
<FONT COLOR="#3B5A6F" SIZE=2><B>
<IMG SRC="g801727.jpg" ALT="GRAPHIC" WIDTH="186" HEIGHT="342">
 </B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR>
<FONT COLOR="#3B5A6F" SIZE=2><B>
<IMG SRC="g654163.jpg" ALT="GRAPHIC" WIDTH="193" HEIGHT="342">
 </B></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


ACTitouch System  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We introduced our ACTitouch System in the United States in September 2013. Our wearable ACTitouch System combines intermittent pneumatic compression
with sustained gradient compression to the lower leg, ankle and foot to improve and accelerate healing, as compared to the current standard of care, which involves sustained compression applied with
compression wraps. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>
<IMG SRC="g618561.jpg" ALT="GRAPHIC" WIDTH="637" HEIGHT="303">
  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
ACTitouch System consists of a compression sleeve, a control unit, an undersock and a power adapter/charger. The compression sleeve has four chambers that inflate to apply pressure to the leg, is
designed with hook and loop fasteners to accommodate a wide range of leg shapes and sizes and may </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>98</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=103,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=920054,FOLIO='98',FILE='DISK131:[15ZBY1.15ZBY12201]EA12201A.;51',USER='JKEENE',CD='25-JAN-2016;09:58' -->
<A NAME="page_ea12201_1_99"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>be
worn under clothing and with most shoes. The control unit is concealed within the compression sleeve and monitors and adjusts the air pressure to ensure the correct level of compression is applied
to the leg. It offers a therapy tracker that monitors and displays average daily use to reinforce therapy goals. The undersock is designed to draw perspiration and moisture away from the skin and has
padding in key areas to provide additional comfort. The system comes with a power adapter/charger that is used to power the device directly during intermittent pneumatic compression mode or to charge
the battery for ambulatory use. The battery life allows the patient to wear the system all day without recharging. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
ACTitouch System operates in sustained compression mode or intermittent pneumatic compression mode. In sustained compression mode, the system provides sustained, graduated compression to the leg
at preset pressures, and the compact, lightweight design gives patients the freedom to stay active while experiencing the benefits of a more comfortable compression therapy. The system ensures
consistent compression regardless of variations in sleeve application, and throughout the day monitors and adjusts pressure automatically every 30 minutes in response to changes in leg circumference.
In intermittent pneumatic compression mode, the system performs cyclic inflation/deflation sequences to preset gradient pressures. Standard daily treatment involves two hours of intermittent
compression while seated or reclining and 10&nbsp;hours of sustained compression while active. The system is worn throughout the day and has the advantage of being removable for bathing or showering
and when driving or operating machinery. The patient removes the system for sleep, allowing the battery to be recharged overnight. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Entr&eacute; System  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We introduced our Entr&eacute; System in the United States in February 2013 to offer a lightweight, portable pneumatic compression solution
for patients who need a basic pump or who do not yet qualify for insurance coverage of an advanced compression device such as our Flexitouch System. Our Entr&eacute; System is a basic
pneumatic compression device used for the at-home treatment of venous disorders including lymphedema and chronic venous insufficiency, including venous leg&nbsp;ulcers. Our Entr&eacute;
System is a pump with garments covering the arm or leg with eight chambers that inflate in sequence and remain inflated for a preset time period. All chambers deflate at once. Our Entr&eacute;
System moves fluid from fingers or toes toward areas closer to the trunk. The system can be programmed to a variety of pressures delivering a prescribed treatment customized to meet the patient's
needs. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Clinical Results and Studies  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Overview  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We have developed a significant body of clinical data supporting the safety and effectiveness of our products. We have sponsored 13 clinical studies
in which a total of 682 patients were treated with our products and followed to assess safety, and 286 patients were followed for an extended period of six to 22&nbsp;months to assess long-term
efficacy. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A
key part of our success is our ability to demonstrate the effectiveness of our products through funding studies that generate clinical and economic outcome data supporting our products. We intend to
continue to invest in additional studies to support peer-reviewed, published articles that evidence the clinical and economic benefits of our solutions as compared to traditional treatments. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Impact on Clinical Outcomes and Healthcare Costs with Use of our Flexitouch System  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A retrospective study published by the American Medical Association in </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>JAMA Dermatology</I></FONT><FONT COLOR="#3B5A6F" SIZE=2> demonstrated
significant improvement in key clinical endpoints and immediate cost reductions for individuals with lymphedema following receipt of our Flexitouch System. The study was conducted in </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>99</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=104,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=179145,FOLIO='99',FILE='DISK131:[15ZBY1.15ZBY12201]EA12201A.;51',USER='JKEENE',CD='25-JAN-2016;09:58' -->
<A NAME="page_ea12201_1_100"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>the
United States and included 718 patients with a lymphedema diagnosis who had continuous insurance coverage during the 12&nbsp;months prior to and the 12&nbsp;months after receiving our
Flexitouch System. Patients were excluded from the study if they had a claim for a pneumatic compression device during the prior 12 month period. The patients in the study included 374 patients with
cancer-related lymphedema and 344 patients with non-cancer-related lymphedema. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
study evaluated a broad, clinically relevant set of healthcare use outcomes for each patient for the 12&nbsp;months before and the 12&nbsp;months after receipt of our Flexitouch System,
including cellulitis infections, inpatient hospitalizations, manual therapy and outpatient hospital visits. Receipt of our Flexitouch System was associated with a significant decline in the rate of
cellulitis diagnosis in the cancer-related lymphedema patients of 79% (from 21.1% to 4.5%; p&lt;.001) and in the non-cancer-related lymphedema patients of 75% (from 28.8% to 7.3%;
p&lt;.001). The inpatient hospitalization rate declined 22% in the cancer-related group (from 2.7% to 2.1%; p=.63) and declined 54% in the non-cancer-related group (from 7.0% to 3.2%; p=.02).
The manual therapy rate decreased 30% in the cancer-related lymphedema patients (from 35.6% to 24.9%; p=.001) and decreased 34% in the non-cancer-related lymphedema patients (from 32.3% to 21.2%;
p=.001). In addition, outpatient hospital visits declined 29% in the cancer-related patients (from 58.6% to 41.4%; p&lt;.001) and 40% in the non-cancer-related patients (from 52.6% to 31.4%;
p&lt;.001). </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
study also reviewed lymphedema-related healthcare costs for each patient in the study for the 12&nbsp;months before and the 12&nbsp;months after receipt of our Flexitouch System. Among the
cancer-related lymphedema patients, total costs per patient, excluding durable medical equipment costs, were reduced by 37%, from $2,597 to $1,642 (p=.002) following receipt of our Flexitouch System.
The greatest contributor to this change was a 54% reduction in outpatient hospital costs from $1,517 to $694 (p&lt;.001). Total costs per non-cancer-related lymphedema patients, excluding
durable medical equipment costs, were reduced by 36% from $2,937 to $1,883 (p=.007). Outpatient hospital costs for the non-cancer patients declined by 65% from $1,726 to $606 (p&lt;.001). </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Impact on Health Outcomes and Costs with Use of Pneumatic Compression Devices  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A retrospective study published in the </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>Public Library of Science Journal</I></FONT><FONT COLOR="#3B5A6F" SIZE=2> demonstrated a significant
improvement in health outcomes for patients who were prescribed a pneumatic compression device, as well as a substantial decrease in the patient's and payer's total healthcare costs. The study was the
first to evaluate overall healthcare costs of lymphedema patients and the impact of available therapeutic intervention in a large, representative national population. The study analyzed U.S. claims
data from a large national insurer for 2007 through 2013 to assess the impact of using a pneumatic compression device. The study included 1,065 patients with cancer-related lymphedema. The claims data
used in the study demonstrated that the prevalence of lymphedema diagnoses among cancer survivors increased from 0.95% in 2007 to&nbsp;1.24% in 2013. The study population included lymphedema
patients who had a claim for a simple or advanced pneumatic compression device during the time period of January&nbsp;1, 2008 through November&nbsp;31, 2012. Each patient in the study had at least
12&nbsp;months of continuous medical and pharmacy insurance eligibility prior to and after receiving the pneumatic compression device. The below diagram depicts the selection strategy for patients
included in the analysis: </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>
<IMG SRC="g122410.jpg" ALT="GRAPHIC" WIDTH="619" HEIGHT="106">
  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>100</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=105,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=234806,FOLIO='100',FILE='DISK131:[15ZBY1.15ZBY12201]EA12201A.;51',USER='JKEENE',CD='25-JAN-2016;09:58' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ec12201_1_101"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The objective of the study was to analyze the impact of using a pneumatic compression device on the health and cost outcomes of patients with cancer-related lymphedema. The
study did not differentiate between the health outcomes and costs of patients who received our Flexitouch System and those who received a different pneumatic compression device. An analysis of health
outcomes and costs was conducted by comparing a pre-specified set of health outcomes and costs for the 12&nbsp;months before and after receipt of a pneumatic compression device. The health outcomes
measured before and after receipt of a pneumatic compression device included the number of hospitalizations, the proportion of patients with hospitalizations, the proportion of patients with
outpatient hospital visits, the proportion of patients with cellulitis and the proportion of patients using physical therapy. The cost outcomes measured before and after receipt of a pneumatic
compression device included costs associated with the device, home health, emergency services, inpatient services, outpatient services, outpatient physical therapy, other outpatient services, office,
lab, other service location and pharmacy related. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>With
respect to health outcomes, use of a pneumatic compression device was associated with a significant decline in the rate of hospitalizations (45% to 32%, p&lt;0.0001). Use of a pneumatic
compression device was also associated with a reduction in the rate of outpatient hospital visits (95% to 90%, p&lt;0.0001). The percentage of patients with a lymphedema-related clinic visit
decreased from 47% in the baseline period to 32% in the post-pneumatic compression device period (p&lt;0.0001). The proportion of patients with cellulitis also declined in the post-pneumatic
compression device period (28% to 22%, p&lt;0.0003). Finally, the proportion of patients using physical therapy declined (50% to 41%, p&lt;0.0001), primarily driven by a reduction in
the use of lymphedema-related physical therapy (29% to 21%, &lt;0.0001). </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>With
respect to overall healthcare costs of treatment, use of a pneumatic compression device was associated with a decrease in total costs of $11,833 in the 12&nbsp;months after device prescription.
The largest cost decreases were achieved by a diminution of office visit costs by 36% (p&lt;0.0001), and outpatient hospital costs by 30% (p&lt;0.0001). Reductions were observed in
lymphedema-related costs for outpatient physical therapy ($276 to $135, p&lt;0.0001) and other outpatient services ($879 to $563, p&lt;0.0001). </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A
summary of the findings of the study is presented below: </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>
<IMG SRC="g700946.jpg" ALT="GRAPHIC" WIDTH="585" HEIGHT="138">
  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Flexitouch System Impact on Limb Volume and Patient-Reported Outcomes  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A prospective study published in the </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>European Journal of Vascular and Endovascular Surgery</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>
demonstrated that use of our Flexitouch System is associated with consistent lower extremity limb volume and pain reduction while achieving improvement in patient health outcomes. The study was
conducted in the United States and collected data from a patient registry required by a third-party payer for 196 patients with lower extremity lymphedema who were prescribed our Flexitouch System
from January 2009 to May 2012. The primary objective of the study was to examine the effectiveness of our Flexitouch System in reducing lower extremity limb volume, with a secondary objective of
evaluating clinician-assessed and patient-reported outcomes. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>101</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=106,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=401039,FOLIO='101',FILE='DISK131:[15ZBY1.15ZBY12201]EC12201A.;66',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_ec12201_1_102"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Use
of our Flexitouch System was associated with a reduction in limb volume, with 88% of patients experiencing a reduction in limb volume and with 35% enjoying a reduction in limb volume of greater
than 10%. Twelve percent of patients experienced an increase in limb volume. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Clinician
assessment indicated that the majority of patients experienced improvement in the condition of their skin. In 168, or 86%, of the patients, a reduction in skin hardening or fibrosis was
reported based on manual assessment of the skin. Based on clinical observation of function, all but three of these patients demonstrated an increased ability to perform activities of daily living.
Additionally, 149, or 77%, of the patients demonstrated improved range of motion. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Patients
reported a significant increase in their ability to control lymphedema through treatment with our Flexitouch System, with an increase in function and a reduction in pain. Of the
98&nbsp;patients who responded, 66% reported being "very satisfied" with the treatment by our Flexitouch System and 29, or 30%, of patients reported being "satisfied" with the treatment by our
Flexitouch System. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Comparison of our Flexitouch System with Pneumatic Compression Devices  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A prospective, randomized controlled study published in </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>Supportive Care in Cancer</I></FONT><FONT COLOR="#3B5A6F" SIZE=2> demonstrated that
our Flexitouch System provides better clinical outcomes as compared to those achieved with a basic pneumatic compression device for home-based treatment of breast cancer-related lymphedema. The study
was conducted in the United States and involved 36&nbsp;patients. This number of participants in the study is considered to be a small sample size and a limitation of the study. The patients were
randomized to our Flexitouch System or a basic pneumatic compression device used for home treatment of one-hour per day for 12&nbsp;weeks. The basic pneumatic compression device used in the study
was a Bio Compression 2004 Sequential Circulator pneumatic compression device. The material difference between our Flexitouch System and the Bio Compression 2004 Sequential Circulator is the ability
of our Flexitouch System to apply calibrated gradient pressure. The Bio Compression 2004 Sequential Circulator is considered a segmented device without calibrated gradient pressure, which is billed
under HCPCS Code E0651. Our Flexitouch System is considered a segmented device with calibrated gradient pressure, which is billed under HCPCS Code E0652. A segmented device with calibrated gradient
pressure for purposes of HCPCS Codes is distinguished by a manual control on at least three outflow ports which can deliver an individually determined pressure to each segmental unit. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
primary objective of the study was to determine whether our Flexitouch System provides better outcomes, as measured by arm edema and tissue water reductions, compared to a basic pneumatic
compression device in patients with arm lymphedema. The study does not reflect a comparison of our Flexitouch System to a product that is billed under the same HCPCS Code as our Flexitouch System. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Thirty-six
patients with unilateral upper extremity lymphedema with at least 5% arm edema volume at the time of enrollment completed treatments over the 12-week period, with 26&nbsp;patients being
evaluated for edema volume change and 28&nbsp;patients being evaluated for changes in arm tissue water content. Arm edema volumes were determined from arm girth measurements and suitable model
calculations, and tissue water was determined based on measurements of the arm tissue. The patients were randomized
into two groups of 18&nbsp;patients each, with one group receiving treatment with our Flexitouch System and the other group receiving treatment using a basic pneumatic compression device. The group
using our Flexitouch System experienced an average of 29% reduction in edema compared to a 16% increase in the group using a basic pneumatic compression device. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Study of Patient-Reported Satisfaction with Use of our Flexitouch System  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A retrospective study published in the </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>Oncology Nursing Forum</I></FONT><FONT COLOR="#3B5A6F" SIZE=2> demonstrated that patients using our
Flexitouch System were "satisfied" with the device and perceived it to be beneficial in managing their lymphedema. The study was conducted in the United States and involved 155&nbsp;patients with </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>102</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=107,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=175422,FOLIO='102',FILE='DISK131:[15ZBY1.15ZBY12201]EC12201A.;66',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_ec12201_1_103"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>lymphedema.
The primary objective of the study was to compare treatment protocol adherence, satisfaction and perceived changes in emotional and functional status between patients with cancer-related
lymphedema and non-cancer-related lymphedema using our Flexitouch System. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Ninety
percent of the 155 study patients reported being "satisfied" with our Flexitouch System. Of these patients, more than 65% reported being "extremely satisfied." The study was conducted by having
patients complete a pre- and post-therapy questionnaire. Of the 286 individuals with lymphedema receiving a pre-therapy questionnaire with our Flexitouch System, 155&nbsp;patients completed
information in the pre- and post-therapy questionnaires required for the analyses. Of these 155&nbsp;patients, 93 had cancer-related lymphedema and 62 had non-cancer-related lymphedema. Patients who
acknowledged using the device as prescribed reported statistically higher levels of satisfaction (p=0.008), a pattern repeated in both lymphedema groups. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Further,
95% of patients reported a positive limb volume outcome, which was defined as a patient perceiving that limb volume had been maintained or reduced with device use. Of these patients, 42%
reported limb volume decreases as much as 20%, and an additional 20% reported decreases of less than 20%. In addition, clinically and statistically significant improvements occurred in all areas of
physical and emotional health (p&nbsp;&lt;&nbsp;0.006). </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Comparison of Conventional Treatment for Venous Leg&nbsp;Ulcers with our ACTitouch System  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A prospective, randomized study published in the </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>International Wound Journal</I></FONT><FONT COLOR="#3B5A6F" SIZE=2> demonstrated that our
ACTitouch System provides a comparable degree of effectiveness in venous leg&nbsp;ulcer healing to conventional treatment and an improved quality of life for patients. The study was conducted in the
United States and Europe, involving a total of 90&nbsp;patients over a 12-week period. The primary objective of the study was to evaluate the efficacy, functionality, safety, patient perceptions and
impact on patient quality of life of two compression methods for venous leg&nbsp;ulcers, including our ACTitouch System and a traditional four-layer bandage system. Of the 90&nbsp;patients,
38&nbsp;patients used our ACTitouch System and 52&nbsp;patients used a traditional four-layer bandage system. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
study demonstrated a comparable degree of effectiveness in venous leg&nbsp;ulcer healing, with healing rate differences not reaching statistical significance. The type and frequency of adverse
events reported were similar between the treatment groups and there were no serious adverse events related to treatment in either group. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition to demonstrating a comparable degree of effectiveness in venous leg&nbsp;ulcer healing, this study also demonstrated that using our ACTitouch System yielded greater improvements in
quality of life as compared to those using the bandage system. We believe our ACTitouch System achieved better patient acceptance because it allows greater control over therapy and gives patients the
ability to remove the device as needed for key activities of daily living and personal hygiene, such as bathing and sleeping. The only area that our ACTitouch System did not rate higher than the
bandage system was discreteness under clothing. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Sales and Marketing  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Unlike many of our competitors, we utilize a direct-to-patient and -provider model to market our solutions directly to patients and clinics, whereby
we disintermediate the traditional durable medical </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>103</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=108,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=793228,FOLIO='103',FILE='DISK131:[15ZBY1.15ZBY12201]EC12201A.;66',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_ec12201_1_104"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>equipment
channel and capture both the manufacturer and distributor margins. The below chart shows this disintermediation: </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>
<IMG SRC="g953521.jpg" ALT="GRAPHIC" WIDTH="675" HEIGHT="145">
  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
direct-to-patient and -provider model is comprised of a direct sales force, contract at-home trainers, reimbursement capabilities and medical expertise to expand awareness, garner referrals and
obtain payment for our products. As of September&nbsp;30, 2015, we employed eight sales managers and 76&nbsp;full-time sales representatives who provide coverage throughout the United States. The
below chart describes our U.S. direct-to-patient and -provider model. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>
<IMG SRC="g341538.jpg" ALT="GRAPHIC" WIDTH="652" HEIGHT="264">
  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
marketing team leads our efforts in brand development, tradeshow attendance, educational forums, product messaging, website development, social media and advertising. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Reimbursement, Payer Relations and Customer Support Process  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Private insurance payers represented approximately 74% of our revenues in 2014 and 71% of our revenues for the nine months ended September&nbsp;30,
2015, while Medicare represented approximately 15% of our revenues in each of 2014 and the nine months ended September&nbsp;30, 2015. Other payers, including the Veterans Administration, represented
the remainder of
our revenues. When we sell our solutions directly to patients, we bill third-party payers, such as private insurance or Medicare, on behalf of our patients and bill the patient for their co-payment
obligations and deductibles. A recent change to the level of Medicare coverage for our products could reduce the number of Medicare patients who have access to our products, and we are seeking to have
the coverage determination overturned. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As
a nationwide provider, we have developed a broad expertise in obtaining billing codes, developing coverage policies, overcoming payer barriers, and obtaining authorization and payment from payers </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>104</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=109,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=703503,FOLIO='104',FILE='DISK131:[15ZBY1.15ZBY12201]EC12201A.;66',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_ec12201_1_105"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>across
all regions of the United States. Our model utilizes our strategic and operational reimbursement proficiency to meet the varying requirements of hundreds of payers across the country. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>To
achieve ongoing success in both the strategic and operational reimbursement arenas, we have developed two teams with specialized focus on these respective competencies. Our payer relations group is
comprised of over 20&nbsp;employees and is responsible for developing relationships with payer decision-makers. Specifically, this group educates payers of our product efficacy, develops overall
payer coverage policies and reimbursement criteria, manages our Medicare strategy and patient claims, codes, and contracts with payers. Our payer relations team is also the advocacy liaison between
patients, clinicians and payers through the appeals process. Our reimbursement operations group is comprised of over 50&nbsp;employees and is responsible for verifying case-by-case benefits,
obtaining prior authorization, billing and collecting payments from payers, analyzing payer data to help understand trends, developing processes and patient programs and providing customer support
services. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
have strong and established payer relationships, including some of the largest private payers in the United States. Based on our estimates, we are contracted or enrolled as an in-network provider
with payers covering over 230&nbsp;million lives. These contracts allow us to be an in-network provider for patients, enabling them to access our systems at a competitive rate and copay comparable
to other suppliers, and easing our administrative burden in processing at both authorization and when billing. We have enjoyed a consistent commercial payer approval rate of greater than 80% for the
last eight years, and greater than 90% Medicare claims submitted approval rate (post-arbitration and based on the number of claims, not dollar amount of claims, submitted) since we began doing
business with Medicare in 2007. We have an in-depth understanding of specific payer coverage criteria, and our submission materials are tailored to address individual payer's distinct requirements.
Our dedicated customer service team is available to answer patient questions regarding reimbursement, account status, device operation and troubleshooting during normal business hours. If necessary,
we will dispatch a trainer for a second time to assist patients with their training needs. We receive no additional reimbursement for patient support, but provide high-quality customer service to
enhance patient comfort, satisfaction, compliance and safety with our products. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
Flexitouch System is reimbursed under HCPCS code E0652, and our ACTitouch System and Entr&eacute; System are reimbursed under HCPCS code E0651. Garments that cover various parts of the
body are used with these systems and billed using HCPCS codes E0651, E0652, E0667, E0668 and E0669. As of September&nbsp;30, 2015, over 600&nbsp;payers have paid for our products. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Research and Clinical Operations  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We are committed to ongoing research and development as part of our efforts to be at the forefront of patient preference in the area of chronic
disease, especially lymphedema and chronic venous insufficiency. As of September&nbsp;30, 2015 our research and development and clinical operations staff included more than 10&nbsp;engineers,
scientists and project managers with expertise in pneumatics, electronics, garment design, embedded software, mechanical design, sensors and manufacturing technologies. Our research and development
expenses, including spending on our clinical evidence development efforts, totaled $2.4&nbsp;million and $2.8&nbsp;million for the years ended December&nbsp;31, 2013 and 2014, respectively, and
$1.9&nbsp;million and $2.9&nbsp;million for the nine months ended September&nbsp;30, 2014 and 2015, respectively. Our current research and development efforts are focused primarily on increasing
efficacy, improving design for ease-of-use, enhancing clinical functionality and reducing production costs of our solutions. Our clinical development efforts are focused on further differentiating our
products from our competitors. We coordinate our development efforts with our intellectual property strategies in order to enhance our ability to obtain patent and other intellectual property
protection. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>105</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=110,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=677411,FOLIO='105',FILE='DISK131:[15ZBY1.15ZBY12201]EC12201A.;66',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ee12201_1_106"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Manufacturing and Quality Assurance  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our manufacturing and quality assurance model combines our internal manufacturing resources and expertise, including assembly, quality assurance,
material procurement and inventory control, with approved third-party manufacturers and suppliers of system components. Our internal manufacturing activities, located in Minneapolis, Minnesota,
include quality inspection, assembly, packaging, warehousing and shipping of our products. We outsource the manufacture of components, which are produced to our specifications and shipped to our
facilities for inspection and final assembly. We use third-party manufacturers and suppliers worldwide to source our components, maintaining dual-source vendors of critical components whenever
possible, and leveraging competitive bids among third-party manufacturers and suppliers to control costs. We have elected to source certain key components from single sources of supply, including our
ACTitouch controller. While we believe alternate sources exist for the ACTitouch controller, we have not yet qualified an alternate supplier. Quality control, risk management, efficiency and the
ability to respond quickly to changing requirements are the primary goals of our manufacturing operations. We believe our manufacturing model permits us to operate with low capital expenditure
requirements. We carefully manage our supply chain in an effort to take costs out of the manufacturing process, as demonstrated by a 58% reduction in controller costs for our Flexitouch System since
2008. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
manage our arrangements with our third-party manufacturers and suppliers to adjust delivery schedules and quantities of components to match our changing manufacturing requirements. We forecast our
component needs based on historical trends, current utilization patterns and sales forecasts of future demand. We establish our relationships with our third-party manufacturers and suppliers through
supplier contracts and purchase orders. In most cases, these supplier relationships may be terminated by either party upon short notice. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
order to mitigate against the risks related to a single-source of supply, we qualify alternative suppliers, when possible, and develop contingency plans for responding to disruptions, including
maintaining adequate inventory of any single source components, along with requiring each supplier to maintain specified quantities of inventory. To date, we have not experienced material delays in
obtaining any of our components, nor has the ready supply of finished products to our patients or clinicians been adversely affected by component supply issues. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
have implemented a quality management system designed to comply with FDA regulations and International Standards Organization, or ISO, standards governing medical device products. In the United
States, we and certain of our manufacturers are required to manufacture our products in compliance with the FDA's Quality System Regulation, which covers the methods and documentation of the design,
testing, control, manufacturing, labeling, quality assurance, packaging, storage, and shipping for our products. We maintain a quality management system to control compliance with such requirements
and have procedures in place designed to ensure that all products and materials purchased by us conform to our requirements and FDA regulations. As of September&nbsp;30, 2015, we had
16&nbsp;employees in operations, manufacturing and quality assurance. Our quality management system has been certified to ISO in 2012 and 2014, including ISO&nbsp;13485:2003. Our manufactures'
quality management systems also have been certified to ISO. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Order Fulfillment and Patient Training  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Once we have a complete order and prior authorization from the payer, we package and ship a system, configured to their physician's prescription,
directly to the patient. Our primary logistics partner is United Parcel Service, which we use for delivery and pick up of our devices. After delivery, we coordinate a visit from one of our over 300
licensed, independent contract trainers that go to our patients' homes to provide individualized training to our patients, when requested. These trainers are </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>106</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=111,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=370055,FOLIO='106',FILE='DISK131:[15ZBY1.15ZBY12201]EE12201A.;40',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_ee12201_1_107"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>healthcare
professionals, licensed in their state of residence, who we have identified through our sales and marketing interest and instructed on proper use of our products. Training visits are
coordinated from our offices in Minneapolis and training sessions assigned by our staff. Upon completion of training, the independent contractor submits an invoice to us for payment for the patient's
training and their travel. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Competition  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The pneumatic compression pump market is a competitive industry, and we compete with a number of manufacturers and distributors of pneumatic
compression pumps. Our significant manufacturing competitors are Bio Compression Systems, Inc., Lympha Press USA and Wright Therapy Products (which was recently acquired by BSN Medical GmbH). If we
expand internationally, we expect that ArjoHuntleigh, an affiliate of Getinge Group, would become a competitor. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Given
the growth of the pneumatic compression pump market, we expect that the industry will become increasingly competitive in the future. Manufacturing companies compete for sales to patients
primarily based on product features and service. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
believe we are the only pneumatic compression home-therapy device company with a meaningful U.S. market position supported by a direct sales force. We believe our manufacturing competitors'
complete reliance on home medical equipment distribution intermediaries compresses their margins and limits their ability to invest in product features that address consumer preferences. To pursue a
direct-to-patient and -provider sales model, our manufacturing competitors would need to meet national accreditation and state-by-state licensing requirements and secure Medicare billing privileges,
as well as compete directly with the home medical equipment providers that many rely on across their entire home care businesses. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Some
of our competitors and potential competitors are large, well-capitalized companies with greater resources than we have. As a consequence, they are able to spend more aggressively on product
development, marketing, sales and other product initiatives than we can. Some of these competitors have:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> significantly greater name recognition; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> established relations with healthcare professionals, customers, and third-party payers; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> established distribution networks; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> additional lines of products, and the ability to offer rebates or bundle products to offer higher discounts or other incentives to
gain a competitive advantage; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> greater history in conducting research and development, manufacturing, marketing, and obtaining regulatory approval for homecare
devices; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> greater financial and human resources for product development, sales and marketing, patent litigation and customer financing. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As
a result, our competitors may be able to respond more quickly and effectively than we can to new or changing opportunities, technologies, standards or customer requirements. In light of our
competitors' advantages, even if our technology and direct-to-patient and -provider marketing strategy is more effective than the technology and marketing strategy of our competitors, current or
potential </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>107</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=112,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=154948,FOLIO='107',FILE='DISK131:[15ZBY1.15ZBY12201]EE12201A.;40',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_ee12201_1_108"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>customers
might accept competitor products and services in lieu of purchasing our products. We anticipate that we will face increased competition in the future as existing companies and competitors
develop new or improved products and distribution strategies and as new companies enter the market with new technologies and distribution strategies. We may not be able to compete effectively against
these organizations. Our ability to compete successfully and to increase our market share is dependent upon our reputation for providing responsive, professional and high-quality products and services
and achieving strong customer satisfaction. Increased competition in the future could adversely affect our revenues, revenues growth rate, if any, margins and market share. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Government Regulation  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our systems are medical devices subject to extensive and ongoing regulation by numerous governmental authorities, principally the FDA, and
corresponding state and foreign regulatory agencies. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


FDA Regulation  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In the United States, the FDA regulates medical devices, including the following activities that we perform, or that are performed on our behalf with
respect to our devices: product design and development, pre-clinical and clinical testing, manufacturing, labeling, storage, premarket clearance or approval, record keeping, product marketing,
advertising and promotion, sales and distribution, and post-marketing surveillance. Failure to comply with applicable U.S. requirements may subject us to a variety of administrative or judicial
sanctions, such as warning letters, product recalls, product seizures, total or partial suspension of production or distribution, injunctions, fines, civil penalties, and criminal prosecution. The FDA
can also refuse to approve pending applications. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Unless
an exemption applies, each medical device we seek to distribute commercially in the United States requires marketing authorization from the FDA prior to distribution. The two primary types of
FDA marketing authorization applicable to a device are premarket notification, also called 510(k) clearance, and premarket approval. The type of marketing authorization is generally linked to the
classification of the device. The FDA classifies medical devices into one of three classes&nbsp;&#151; Class&nbsp;I, Class&nbsp;II or Class&nbsp;III&nbsp;&#151; based on the
degree of risk the FDA determines to be associated with a device and the level of regulatory control deemed necessary to ensure the device's
safety and effectiveness. Devices requiring fewer controls because they are deemed to pose lower risk are placed in Class&nbsp;I or II. Class&nbsp;I devices are deemed to pose the least risk and
are subject only to general controls applicable to all devices, such as requirements for device labeling, premarket notification, and adherence to the FDA's Good Manufacturing Practices.
Class&nbsp;II devices are intermediate risk devices that are subject to general controls and may also be subject to special controls such as performance standards, product-specific guidance
documents, special labeling requirements, patient registries, or post-market surveillance. Class&nbsp;III devices are those for which insufficient information exists to assure safety and
effectiveness solely through general controls or if the device is a life-sustaining, life-supporting or a device of substantial importance in preventing impairment of human health, or which presents a
potential, unreasonable risk of illness or injury and special controls are not adequate to assure safety and effectiveness. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Most
Class&nbsp;I devices and some Class&nbsp;II devices are exempted by regulation from the 510(k) clearance requirement and can be marketed without prior authorization from the FDA. Most
Class&nbsp;II devices (and certain Class&nbsp;I devices that are not exempt) are eligible for marketing through the 510(k) clearance pathway. By contrast, devices placed in Class&nbsp;III
generally require premarket approval or 510(k) de novo clearance prior to commercial marketing. The premarket approval process is more stringent, time-consuming, and expensive than the 510(k)
clearance process. However, the 510(k) clearance process has also become increasingly stringent and expensive. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>108</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=113,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=245630,FOLIO='108',FILE='DISK131:[15ZBY1.15ZBY12201]EE12201A.;40',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_ee12201_1_109"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> 510(k) Clearance Pathway.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;When a 510(k) clearance is required, we must submit a premarket notification to the FDA demonstrating that our
proposed device is
"substantially equivalent" to a previously cleared and legally marketed 510(k) device or a device that was in commercial distribution before May&nbsp;28, 1976 for which the FDA has not yet called
for the submission of a premarket approval application, which is commonly known as the "predicate device." A device is substantially equivalent if, with respect to the predicate device, it has the
same intended use and has either (i)&nbsp;the same technological characteristics or (ii)&nbsp;different technological characteristics and the information submitted demonstrates that the device is
as safe and effective as a legally marked device and does not raise different questions of safety or effectiveness. By law, the FDA is required to clear or deny a 510(k) premarket notification within
90&nbsp;days of submission of the application. As a practical matter, clearance often takes significantly longer. The FDA may require further information, including clinical data, to make a
determination regarding substantial equivalence. If the FDA determines that the device, or its intended use, is not substantially equivalent to a previously-cleared device or use, the FDA will issue a
not substantially equivalent decision. This means the device cannot be cleared through the 510k process and will require marketing authorization through the premarket approval pathway. We obtained
510(k) clearance for our Flexitouch System in October 2006 and for a discontinued predecessor system in July 2002. We obtained 510(k) clearance for our ACTitouch System in June 2013 and our
Entr&eacute; System in May 2013. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Premarket Approval Pathway.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;A premarket approval application must be submitted to the FDA if the device cannot be cleared through the 510(k)
process. The premarket
approval application process is much more demanding than the 510(k) premarket notification process and requires the payment of significant user fees. A premarket approval application must be supported
by valid scientific evidence, which typically requires extensive data, including but not limited to technical, preclinical, clinical trials, manufacturing and labeling to demonstrate to the FDA's
satisfaction reasonable evidence of safety and effectiveness of the device. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
FDA has 45&nbsp;days from its receipt of a premarket approval application to determine whether the application will be accepted for filing based on the FDA's threshold determination that it is
sufficiently complete to permit substantive review. After the FDA determines that the application is sufficiently complete to permit a substantive review, the FDA will accept the application and begin
its in-depth review. The FDA has 180&nbsp;days to review an "accepted" premarket approval application, although this process typically takes significantly longer and may require several years to
complete. During this review period, the FDA may request additional information or clarification of the information already provided. Also, an advisory panel of experts from outside the FDA may be
convened to review and evaluate the application and provide recommendations to the FDA as to the approvability of the device. In addition, the FDA will conduct a preapproval inspection of the
manufacturing facility to ensure compliance with quality system regulations. The FDA may delay, limit or deny approval of a premarket approval application for many reasons,
including:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> failure of the applicant to demonstrate that there is reasonable assurance that the medical device is safe or effective under the
conditions of use prescribed, recommended or suggested in the proposed labeling; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> insufficient data from the preclinical studies and clinical trials; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the manufacturing processes, methods, controls or facilities used for the manufacture, processing, packing or installation of the
device do not meet applicable requirements. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
the FDA evaluations of both the premarket approval application and the manufacturing facilities are favorable, the FDA will either issue an approval order or an approvable letter, which usually
contains </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>109</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=114,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=239078,FOLIO='109',FILE='DISK131:[15ZBY1.15ZBY12201]EE12201A.;40',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_ee12201_1_110"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>a
number of conditions that must be met in order to secure final approval of the premarket approval application. If the FDA's evaluation of the premarket approval application or manufacturing
facilities is not favorable, the FDA will deny approval of the premarket approval application or issue a not approvable letter. A not approvable letter will outline the deficiencies in the application
and, where practical, will identify what is necessary to make the premarket approval application. The FDA may also determine that additional clinical trials are necessary, in which case the premarket
approval application may be delayed for several months or years while the trials are conducted and then the data submitted in an amendment to the premarket approval application. Once granted,
premarket approval application may be withdrawn by the FDA if compliance with post approval requirements, conditions of approval or other regulatory standards is not maintained or problems are
identified following initial marketing. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Clinical Trials.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Clinical trials are almost always required to support premarket approval and are sometimes required for 510(k) clearance. In
the United States,
these trials generally require submission of an application for an Investigational Device Exemption, or IDE, to the FDA. The IDE application must be supported by appropriate data, such as animal and
laboratory testing results, showing it is safe to test the device in humans and that the testing protocol is scientifically sound. The FDA must approve the IDE in advance of trials for a specific
number of patients unless the product is deemed a non-significant risk device eligible for more abbreviated IDE requirements or the clinical investigation is exempt from the IDE regulations. Clinical
trials for significant risk devices may not begin until the IDE application is approved by the FDA and the appropriate institutional review boards, or IRBs, at the clinical trial sites. We, the FDA or
the IRB at each site at which a clinical trial is being performed may suspend a clinical trial at any time for various reasons, including a belief that the risks to study subjects outweigh the
benefits. Even if a trial is completed, the results of clinical testing may not demonstrate the safety and efficacy of the device, may be equivocal or may otherwise not be sufficient to obtain
approval or clearance of the product. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> FDA Ongoing Regulation.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Even after a device receives clearance or approval by the FDA and is placed on the market, numerous regulatory
requirements apply. These
include:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> establishment registration and device listing; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> quality system regulation, which requires manufacturers, including third-party manufacturers, to follow stringent design, testing,
control, documentation and other quality assurance procedures during all aspects of the manufacturing process; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> labeling regulations and the FDA prohibitions against the promotion of products for un-cleared, unapproved or "off-label" uses, and
other requirements related to promotional activities; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> medical device reporting regulations, which require that manufacturers report to the FDA if their device may have caused or
contributed to a death or serious injury or malfunctioned in a way that would likely cause or contribute to a death or serious injury if the malfunction were to recur; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> corrections and removals reporting regulations, which require that manufacturers report to the FDA field corrections and product
recalls or removals if undertaken to reduce a risk to health posed by the device or to remedy a violation that may present a risk to health; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> post-market surveillance regulations, which apply when necessary to protect the public health or to provide additional safety and
effectiveness data for the device. </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>110</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=115,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=430502,FOLIO='110',FILE='DISK131:[15ZBY1.15ZBY12201]EE12201A.;40',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_ee12201_1_111"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>After
a device receives 510(k) clearance or a premarket approval, in general any modification that could significantly affect its safety or effectiveness, or that would constitute a major change in
its intended use, will require a new clearance or approval. The FDA requires each manufacturer to make this determination, but the FDA can review any such decision and can disagree with a
manufacturer's
determination. We have modified various aspects of our systems since receiving regulatory clearance, but we believe that new 510(k) clearances are not required for these modifications. If the FDA
disagrees with our determination not to seek a new 510(k) clearance, the FDA may retroactively require us to seek 510(k) clearance or premarket approval. The FDA could also require us to cease
marketing and distribution and/or recall the modified device until 510(k) clearance or premarket approval is obtained. Also, in these circumstances, we may be subject to significant regulatory fines
and penalties. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Failure
to comply with applicable regulatory requirements can result in enforcement action by the FDA, which may include any of the following sanctions: Warning Letters, fines, injunctions, civil or
criminal penalties, recall or seizure of our products, operating restrictions, partial suspension or total shutdown of production, refusing our request for 510(k) clearance or premarket approval of
new products, rescinding previously granted 510(k) clearances or withdrawing previously granted premarket approvals. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
are also subject to announced and unannounced inspections by the FDA, and these inspections may include the manufacturing facilities of our subcontractors. We were audited two times since January
2010 by the FDA and found to be in compliance with the Quality System Regulation. We cannot assure you that we can maintain a comparable level of regulatory compliance in the future at our facility. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


FTC Regulation  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Device advertising and promotional activity in certain circumstances is also subject to scrutiny by the Federal Trade Commission, as well as similar
state consumer protection agencies, which enforce laws related to false and deceptive trade practices. A company that is found to have advertised its product in violation of these laws may be subject
to liability, including monetary penalties. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Centers for Medicare and Medicaid Services  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Centers for Medicare and Medicaid Services, or CMS, requires providers of product or services to attain and maintain accreditation. To attain and
maintain accreditation, companies are required to institute policies and procedures that, among other things, formalize the interaction of the company with patients. Accrediting bodies that are
approved by CMS will perform audits of these policies and procedures every three years. Should a company fall out of compliance
with the requirements of the Accrediting body, expulsion from the Medicare program could follow. In May 2008, we became a Durable, Medical Equipment, Prosthetics, Orthotics, and Supplies accredited
Medicare supplier by the Accreditation Commission for Health Care for our solutions. Our Medicare accreditation must be renewed every three years through passage of an on-site inspection. Our current
accreditation with Medicare is due to expire in May 2017.&nbsp;Maintaining our accreditation and Medicare enrollment requires that we comply with numerous business and customer support standards. If
we are found to be out of compliance with accreditation standards, our enrollment status in the Medicare program could be jeopardized, up to and including termination. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Licensure  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Several states require that durable medical equipment providers be licensed in order to sell products to patients in that state. Certain of these
states require that durable medical equipment providers </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>111</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=116,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=900240,FOLIO='111',FILE='DISK131:[15ZBY1.15ZBY12201]EE12201A.;40',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_ee12201_1_112"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>maintain
an in-state location. Most of our state licenses are renewed on an annual or bi-annual basis. Although we believe we are in compliance with all applicable state regulations regarding
licensure requirements, if we were found to be noncompliant, we could lose our licensure in that state, which could prohibit us from selling our current or future products to patients in that state.
In addition, we are subject to certain state laws regarding professional licensure. We believe that our certified clinicians are in compliance with all such state laws. If our clinicians were to be
found non-compliant in a given state, we would need to modify our approach to providing education, clinical support and customer service in such state. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Fraud and Abuse Regulations  </I></B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Federal Anti-Kickback and Self-Referral Laws.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Federal Anti-Kickback Statute, among other things, prohibits the knowing and willful offer,
payment, solicitation
or receipt of any form of remuneration,
whether directly or indirectly and overtly or covertly, in return for, or to induce the referral of an individual for the:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> furnishing or arranging for the furnishing of items or services reimbursable in whole or in part under Medicare, Medicaid or other
federal healthcare programs; or </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> purchase, lease, or order of, or the arrangement or recommendation of the purchasing, leasing, or ordering of any item or service
reimbursable in whole or in part under Medicare, Medicaid or other federal healthcare programs. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>There
are a number of safe harbors to the Federal Anti-Kickback Statute. Such safe harbors permit certain payments and business practices that, although they would otherwise potentially implicate the
Federal Anti-Kickback Statute, are not treated as an offense under the same if the requirements of the specific applicable safe harbor are met. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
Federal Anti-Kickback Statute applies to certain arrangements with healthcare providers, product end users, and other parties, including marketing arrangements and discounts and other financial
incentives offered to our clinicians in connection with the sales of our products. Although we believe that we have structured such arrangements to be in compliance with the Anti-Kickback Statute and
other applicable laws, regulatory authorities may determine that our marketing, pricing, or other activities violate the Federal Anti-Kickback Statute or other applicable laws. Noncompliance with the
Federal Anti-Kickback Statute can result in civil, administrative, and criminal penalties, restrictions on our ability to operate in certain jurisdictions, and exclusion from participation in
Medicare, Medicaid or other federal healthcare programs. In addition, to the extent we are found to not be in compliance, we may be required to curtail or restructure our operations. Any penalties,
damages, fines, exclusions, curtailment or restructuring of our operations could adversely affect our ability to operate our business, our financial condition, and our results of operations. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
Ethics in Patient Referrals Act, commonly known as the "Stark Law," prohibits a physician from making referrals for certain "designated health services" payable by Medicare to an entity, including
a company that furnishes durable medical equipment, in which the physician or an immediate family member of such physician has an ownership or investment interest or with which the physician has
entered into a compensation arrangement unless an exception applies. Violation of the Stark Law could result in denial of payment, disgorgement of reimbursements received under a noncompliant
arrangement, civil penalties, and exclusion from Medicare or other governmental programs. Although we believe that we have structured our provider arrangements to comply with current Stark Law
requirements, these requirements are highly technical and there can be no guarantee that regulatory
authorities will not determine or assert that our arrangements do not meet applicable Stark Law exceptions. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>112</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=117,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=802890,FOLIO='112',FILE='DISK131:[15ZBY1.15ZBY12201]EE12201A.;40',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_eg12201_1_113"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Additionally, because some of these laws continue to evolve, we lack definitive guidance as to the application of certain key aspects of these laws as they relate to our
arrangements with providers with respect to patient training. We cannot predict the final form that these regulations will take or the effect that the final regulations will have on us. As a result,
our provider arrangements may ultimately be found to be non-compliant with applicable federal law. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> False statements.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The federal false statements statute prohibits knowingly and willfully falsifying, concealing, or omitting a material fact or
making any
materially false statement in connection with the delivery of healthcare benefits, items, or services. In addition to criminal penalties, violation of this statute may result in collateral
administrative sanctions, including exclusion from participation in Medicare, Medicaid, and other federal health care programs. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Federal False Claims Act and Civil Monetary Penalties Law.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Federal False Claims Act provides, in part, that the federal government may bring
a lawsuit against
any person whom it believes has knowingly presented, or caused to be presented, a false or fraudulent request for payment from the federal government, or who has made a false statement or used a false
record to get a claim paid or to avoid, decrease or conceal an obligation to pay money to the federal government or who has
knowingly retained an overpayment. In addition, amendments in 1986 to the Federal False Claims Act have made it easier for private parties to bring "qui tam" whistleblower lawsuits against companies. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
Civil Monetary Penalties Law provides, in part, that the federal government may seek civil monetary penalties against any person that, like under the False Claims Act, presents or causes to be
presented claims to a Federal health care program that the person knows or should know is for an item or services that was not provided as claimed or is false or fraudulent or that has made a false
statement or used a false record to get a claim paid. The federal government may also seek civil monetary penalties for a wide variety of other conduct, including offering remuneration to influence a
Medicare or Medicaid beneficiary's selection of providers and violations of the Federal Anti-Kickback Statute. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Although
we believe that we are in compliance with the Federal False Claims Act as well as the Civil Monetary Penalties laws, if we are found in violation of the same, penalties include fines ranging
from $5,500 to $11,000 for each false claim violation of the Federal False Claims Act and varying amounts based on the type of violation of the Civil Monetary Penalties Law), plus up to three times
the amount of damages that the federal government sustained because of the act of that person. In addition, the federal government may also seek exclusion from participation in all federal health care
programs. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>To
the extent we are found to not be in compliance, we may be required to curtail or restructure our operations. Any penalties, damages, fines, exclusions, curtailment or restructuring of our
operations could adversely affect our ability to operate our business, our financial condition, and our results of operations. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> The U.S. Foreign Corrupt Practices Act and Other Anti-Corruption Laws.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;We may be subject to a variety of domestic and foreign anti-corruption
laws with respect to
our regulatory compliance efforts and operations. The U.S. Foreign Corrupt Practices Act, commonly known as the FCPA, is a criminal statute that prohibits an individual or business from paying,
offering, promising or authorizing the provision of money (such as a bribe or kickback) or anything else of value (such as an improper gift, hospitality, or favor), directly or indirectly, to any
foreign official, political party or candidate for the purpose of influencing any act or decision in order to assist the individual or business in obtaining, retaining, or directing business or other
advantages (such as favorable regulatory rulings). The FCPA also obligates companies with securities listed in the United States to comply with certain accounting provisions. Those provisions require
a company such as ours to (i)&nbsp;maintain books and records that </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>113</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=118,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=640277,FOLIO='113',FILE='DISK131:[15ZBY1.15ZBY12201]EG12201A.;52',USER='JKEENE',CD='25-JAN-2016;09:59' -->
<A NAME="page_eg12201_1_114"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>accurately
and fairly reflect all transactions, expenses, and asset dispositions, and (ii)&nbsp;devise and maintain an adequate system of internal accounting controls sufficient to provide
reasonable assurances that transactions are properly authorized, executed and recorded. The FCPA is subject to broad interpretation by the U.S. government. The past decade has seen a significant
increase in enforcement activity. In addition to the FCPA, there are a number of other federal and state anti-corruption laws to which we may be subject, including, the U.S. domestic bribery statute
contained in 18 USC </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>&sect;</B></FONT><FONT COLOR="#3B5A6F" SIZE=2> 201 (which prohibits bribing U.S. government officials) and the U.S. Travel Act (which in some instances addresses
private-sector or commercial bribery both within and outside the United States). Also, a number of the countries in which we conduct activities have their own domestic and international
anti-corruption laws, such as the UK Bribery Act 2010. There have been cases where companies have faced multi-jurisdictional liability under the FCPA and the anti-corruption laws of other countries
for the same illegal act. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
could be held liable under the FCPA and other anti-corruption laws for the illegal activities of our employees, representatives, contractors, collaborators, agents, subsidiaries, or affiliates,
even if we did not explicitly authorize such activity. Although we will seek to comply with anti-corruption laws, there can be no assurance that all of our employees, representatives, contractors,
collaborators, agents, subsidiaries or affiliates will comply with these laws at all times. Violation of these laws could subject us to whistleblower complaints, investigations, sanctions,
settlements, prosecution, other enforcement actions, disgorgement of profits, significant fines, damages, other civil and criminal penalties or injunctions, suspension and/or debarment from
contracting with certain governments or other persons, the loss of export privileges, reputational harm, adverse media coverage, and other collateral consequences. In addition, our directors,
officers, employees, and other representatives who engage in violations of the FCPA and certain other anti-corruption statutes may face imprisonment, fines, and penalties. If any subpoenas or
investigations are launched, or governmental or other sanctions are imposed, or if we do not prevail in any possible civil or criminal litigation, our business, financial condition, and results of
operations could be materially harmed. In addition, responding to any action will likely result in a materially significant diversion of management's attention and resources and significant defense
costs and other professional fees. Enforcement actions and sanctions could further harm our business, financial condition, and results of operations. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> State fraud and abuse provisions.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Many states have also adopted some form of anti-kickback and anti-referral laws and false claims acts that
apply regardless of
payer, in addition to items and services reimbursed under Medicaid and other state programs. In some states, these laws apply and we believe that we are in compliance with such laws. Nevertheless, a
determination of liability under such laws could result in fines and penalties and restrictions on our ability to operate in these jurisdictions. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> State and federal transparency/reporting requirements.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;As part of the Patient Protection and Affordable Care Act, the Federal government has
created a transparency
program known as Open Payments (the
Physician Payments Sunshine Act) which requires manufacturers of drugs, devices, biologicals and medical supplies to report annually to the Centers for Medicare&nbsp;&amp; Medicaid Services, or CMS, an
agency within the U.S. Department of Health and Human Services, or HHS, information related to payments and other transfers of value provided to physicians and teaching hospitals and certain ownership
and investment interests held by physicians and their immediate family members. Failure to submit timely, accurate and complete information may result in civil monetary penalties of up to an aggregate
of $150,000 per year and up to an aggregate of $1.0&nbsp;million per year for "knowing failures to report." Certain states require implementation of commercial compliance programs and compliance
with the device industry's voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government, impose restrictions on marketing practices, and/or prohibition
and tracking and reporting of gifts, compensation and other remuneration or items of value provided to physicians and other healthcare professionals and entities. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>114</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=119,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=264640,FOLIO='114',FILE='DISK131:[15ZBY1.15ZBY12201]EG12201A.;52',USER='JKEENE',CD='25-JAN-2016;09:59' -->
<A NAME="page_eg12201_1_115"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
laws described above impact the kinds of financial arrangements we may have with hospitals, healthcare professionals or other potential purchasers of our products. If our operations are found to
be in violation of any of the laws or regulations described above or others that apply to us, we may be subject to penalties, including potentially significant criminal, civil and/or administrative
penalties, damages, fines, disgorgement, exclusion from participation in government healthcare programs, contractual damages, reputational harm, administrative burdens, diminished profits and future
earnings, and the curtailment or restructuring of our operations. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> HIPAA.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Health Insurance Portability and Accountability Act of 1996, or HIPAA, established uniform standards governing the conduct of certain
electronic
healthcare transactions and protecting the security and privacy of individually identifiable health information maintained or transmitted by healthcare providers, health plans and healthcare
clearinghouses, which are referred to as covered entities. The following standards have been promulgated under HIPAA's regulations:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the Standards for Privacy of Individually Identifiable Health Information, which restrict the use and disclosure of individually
identifiable health information, or "protected health information"; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the Standards for Electronic Transactions, which establish standards for common healthcare transactions, such as claims information,
plan eligibility, payment information and the use of electronic signatures; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the Security Standards, which require covered entities to implement and maintain certain security measures to safeguard certain
electronic health information, including the adoption of administrative, physical and technical safeguards to protect such information; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the breach notification rules, which require covered entitles to provide notification to affected individuals, the Department of
Health and Human Services, and the media in the event of a breach of unsecured protected health information. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
2009, Congress passed the American Recovery and Reinvestment Act of 2009, or ARRA, which included sweeping changes to HIPAA, including an expansion of HIPAA's privacy and security standards. ARRA
includes the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH, which, among other things, made HIPAA's privacy and security standards directly applicable to
business associates of covered entities. A business associate is a person or entity that performs certain functions or activities on behalf of a covered entity that involve the use or disclosure of
protected health information. As a result, business associates are now subject to significant civil and criminal penalties for failure to comply with applicable standards. Moreover, HITECH creates a
new requirement to report certain breaches of unsecured, individually identifiable health information and imposes penalties on entities that fail to do so. HITECH also increased the civil and criminal
penalties that may be imposed against covered entities, business associates and possibly other persons and gave state attorneys general new authority to file civil actions for damages or injunctions
in federal courts to enforce the federal HIPAA laws and seek attorney fees and costs associated with pursuing federal civil actions. The 2013 final HITECH omnibus rule modifies the breach reporting
standard in a manner that will likely make more data security incidents qualify as reportable breaches. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition to federal regulations issued under HIPAA, some states have enacted privacy and security statutes or regulations that, in certain cases, are more stringent than those issued under HIPAA.
In those cases, it may be necessary to modify our planned operations and procedures to comply with the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>115</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=120,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=354537,FOLIO='115',FILE='DISK131:[15ZBY1.15ZBY12201]EG12201A.;52',USER='JKEENE',CD='25-JAN-2016;09:59' -->
<A NAME="page_eg12201_1_116"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>more
stringent state laws. Most states have also adopted breach notification laws that require notification to affected individuals and certain state agencies if there is a security breach of certain
individually-identifiable information. If we suffer a privacy or security breach, we could be required to expend significant resources to provide notification to the affected individuals and address
the breach, as well as reputational harm associated with the breach. If we fail to comply with applicable state laws and regulations, we could be subject to additional sanctions. Any liability from
failure to comply with the requirements of HIPAA, HITECH or state privacy and security statutes or regulations could adversely affect our financial condition. The costs of complying with privacy and
security related legal and regulatory requirements are burdensome and could have a material adverse effect on our business, financial condition and results of operations. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Environmental Regulation  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our research and development and manufacturing processes and operations involve the controlled use of hazardous materials, including flammables,
toxics, and corrosives and produce hazardous chemical waste products. We are subject to numerous foreign, federal, state, and local environmental, health and safety laws and regulations relating to,
among other matters, safe working conditions, product stewardship and end-of-life handling or disposition of products, and environmental protection, including those governing the generation, storage,
handling, use, transportation and disposal of hazardous or potentially hazardous materials. Some of these laws and regulations require us to obtain licenses or permits to conduct our operations.
Environmental laws and regulations are complex, change frequently and have tended to become more stringent over time. Although the costs to comply with applicable laws and regulations, including
requirements in the European Union relating to the restriction of use of hazardous substances in products, have not been material, we cannot predict the impact on our business of new or amended laws
or regulations or any changes in the way existing and future laws and regulations are interpreted or enforced, nor can we ensure we will be able to obtain or maintain any required licenses or permits.
Also, we cannot eliminate the risk of accidental contamination or discharge and any resultant injury from these materials. We do not currently maintain separate environmental liability coverage and
any such contamination or discharge could result in significant cost to us in penalties, damages, and suspension of our operations. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Foreign Government Regulation  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>International sales of medical devices are subject to foreign governmental regulations, which vary substantially from country to country. The time
required to obtain clearance or approval by a foreign country may be longer or shorter than that required for FDA clearance or approval, and the requirements may be different. Many countries also
impose product standards, packaging requirements, environmental requirements, labeling requirements, and import restrictions on medical devices. Each country has its own tariff regulations, duties,
and tax requirements. Failure to comply with applicable foreign regulatory requirements may subject a company to fines, suspension or withdrawal of regulatory approvals, product recalls, seizure of
products, operating restrictions, criminal prosecution or other consequences. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
European Union is the primary regulator in Europe, which has adopted numerous directives and has promulgated voluntary standards regulating the design, manufacture, clinical trials, labeling and
adverse event reporting for medical devices. Medical devices that comply with the requirements of applicable directives will be entitled to bear the CE conformity marking, indicating that the device
conforms with the essential requirements of the applicable directives and, accordingly, can be commercially distributed throughout the member states of the European Union, and other countries that
comply with or mirror these directives. The method of assessing conformity varies depending on the type and class of the product, but typically involves a combination of self-assessment by the
manufacturer and a third-party assessment by a notified body, an independent and neutral institution </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>116</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=121,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=764948,FOLIO='116',FILE='DISK131:[15ZBY1.15ZBY12201]EG12201A.;52',USER='JKEENE',CD='25-JAN-2016;09:59' -->
<A NAME="page_eg12201_1_117"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>appointed
by a country to conduct the conformity assessment. This third-party assessment may consist of an audit of the manufacturer's quality system, technical or design file and specific testing of
the manufacturer's device. Such an assessment may be required in order for a manufacturer to commercially distribute the product throughout these countries. Compliance establishes the presumption of
conformity with the essential requirements for a CE Marking. We have the authorization to affix the CE Mark to our products and to commercialize our devices in the European Union. The notified body
who inspected us, issued our ISO&nbsp;13485 certification in October 2014 and our EC-Certificate in December 2014. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
March 2012, we received our Medical Device License in Canada for our Flexitouch System. Before we are permitted to sell our devices in Canada, we must submit and obtain clearance of a license
application, implement and comply with ISO Standard 13485, and undergo an audit by a registrar accredited by Health Canada. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


General Regulatory Compliance and Health Care Reform  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The evolving regulatory and compliance environment and the need to build and maintain robust systems to comply with different compliance or reporting
requirements in multiple jurisdictions increase the possibility that a healthcare company may fail to comply fully with one or more of these requirements. If our operations are found to be in
violation of any of the health regulatory laws described above or any other laws that apply to us, we may be subject to penalties, including potentially significant criminal and civil and
administrative penalties, damages, fines, disgorgement, imprisonment, exclusion from participation in government healthcare programs, contractual damages, reputational harm, administrative burdens,
diminished profits and future earnings, and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business, financial condition, and our
results of operations. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
March 2010, the Patient Protection and Affordable Care Act and Health Care and Education Reconciliation Act, which we refer to as the Patient Protection and Affordable Care Act was enacted into law
in the United States. This healthcare reform, which included a number of provisions aimed at improving the quality and decreasing the cost of healthcare, has resulted in significant reimbursement cuts
in Medicare payments to hospitals and other healthcare providers and in the healthcare reimbursement system evolving toward value- and outcomes-based reimbursement methodologies. It is uncertain what
long-term consequences these provisions will have on patient access to new technologies and what impacts these provisions will have on Medicare reimbursement rates. Other elements of the Patient
Protection and Affordable Care Act, including comparative effectiveness research, an independent payment advisory board, and payment systems reform, including shared savings pilots and other reforms,
may result in fundamental changes to federal healthcare reimbursement programs. These and additional legislative or administrative reforms to the U.S. healthcare reimbursement systems may
significantly reduce reimbursement or deny coverage for our medical devices, or adverse decisions relating to our products by administrators of such systems in coverage or reimbursement issues, any of
which could have an adverse impact on our financial condition and results of operations. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Third-Party Reimbursement  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In the United States and elsewhere, sales of medical devices depend in significant part on the availability of coverage and reimbursement to
providers and patients from third-party payers. Third-party payers include private insurance plans and governmental programs. As with other medical devices, reimbursement for our products can differ
significantly from payer to payer and our products are not universally covered by third-party commercial payers. Further, third-party payers continually </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>117</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=122,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=184653,FOLIO='117',FILE='DISK131:[15ZBY1.15ZBY12201]EG12201A.;52',USER='JKEENE',CD='25-JAN-2016;09:59' -->
<A NAME="page_eg12201_1_118"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>review
existing technologies for continued coverage and can, without notice, deny or reverse coverage for existing products. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Two
principal governmental third-party payers in the United States are Medicaid and Medicare. Medicare is a federal program that provides certain hospital and medical insurance benefits to persons
age&nbsp;65 and over, certain disabled persons and others. In contrast, Medicaid is a medical assistance program jointly funded by federal and state governments and administered by each state
pursuant to which benefits are available to certain individuals and families with low incomes and resources and who meet other eligibility requirements. The Medicare and Medicaid statutory framework
is subject to administrative rulings, interpretations and discretion that affect the amount and timing of reimbursement made under Medicare and Medicaid. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>CMS,
which is the agency within the Department of Health and Human Services that administers both Medicare and Medicaid, has the authority to decline to cover particular products or services if it
determines that they are not "reasonable and necessary" for the treatment of Medicare beneficiaries. A coverage determination for a product, which establishes the indications that will be covered, and
any restrictions or limitations, can be developed at the national level by CMS through a National Coverage Determination, or NCD, or at the local level through a Local Coverage Determination, or LCD,
by a regional Medicare administrative contractor, which is a private contractor that processes and pays claims on behalf of CMS for the geographic area where the services were rendered. Obtaining a
coverage determination, whether an NCD or LCD, is a time-consuming, expensive and highly uncertain proposition, especially for a new device. Under an NCD that has been effective since
January&nbsp;14, 2002, pneumatic devices, including our products, are covered for the treatment of lymphedema or for the treatment of chronic venous insufficiency with venous stasis ulcers. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
four Medicare Administrative Contractors responsible for processing Medicare claims for durable medical equipment recently approved an LCD that significantly limits Medicare coverage of our
Flexitouch System and our Entr&eacute; System for certain patients. This LCD, released by the MACs on December&nbsp;17, 2015, is retroactively effective, beginning December&nbsp;1, 2015.
The LCD increases the severity of lymphedema symptoms that a patient must exhibit before such patient is eligible for Medicare reimbursement for a pneumatic compression device. The LCD also inserts
more restrictive criteria that require a patient to potentially endure a longer period of conservative therapy to prove that it fails to control their lymphedema, instead of requiring completion of
just one 4-week round of conservative therapy as stated in the NCD. The LCD requires four consecutive weeks of conservative therapy with no significant improvement in symptoms during any of those four
weeks. Further, the LCD does not cover use of an advanced pneumatic compression device, such as our Flexitouch System, unless the patient's lymphedema is present in the chest, trunk or abdomen.
Although many patients with lymphedema likely do have some level of chest, trunk or abdominal involvement, this criteria in the LCD means that patients with lymphedema that is confined to the limb
will not have access to advanced pneumatic compression devices until the lymphedema progresses to impact the trunk, chest or abdomen. The LCD pneumatic compression device coverage criteria for chronic
venous insufficiency
with venous stasis ulcers largely track existing NCD criteria, while defining the elements of a required conservative therapy trial. Under the new LCD, advanced pneumatic compression devices like our
Flexitouch System are no longer covered at all for the treatment of venous stasis ulcers. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
are attempting to overturn the LCD by raising awareness among stakeholders, including physicians, patients and advocacy groups, of the negative consequences to patients that the LCD will cause. We
believe that future expenses related to our efforts to overturn the LCD will not be material, and that we will use cash on hand to fund such expenses. Our goal is to have the Medicare Administrative
Contractors rescind or revise the LCD in light of physician and patient concerns, as well as what we believe are flaws with the LCD and the process by which it was approved. If the new </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>118</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=123,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=951670,FOLIO='118',FILE='DISK131:[15ZBY1.15ZBY12201]EG12201A.;52',USER='JKEENE',CD='25-JAN-2016;09:59' -->
<A NAME="page_eg12201_1_119"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>LCD
is not overturned, it could have a negative impact on certain Medicare patients' access to our products, which in turn could have an adverse effect on our business and results of operations. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Private
payers that reimburse for our products do so in a variety of ways, depending on the insurance plan's policies, employer and benefit manager input and contracts with their physician network.
Moreover, Medicaid programs and private insurance plans are frequently influenced by Medicare coverage determinations, and we believe a reduction or elimination of coverage or reimbursement of our
products by Medicare, such as the LCD discussed above or other unfavorable NCD or LCD that may go into effect in the future, would likely cause some commercial third-party payers to implement similar
reductions in their coverage or reimbursement of our products. If we are unable to expand coverage of our products by additional commercial payers, or if third-party payers that currently cover or
reimburse for our products reverse or limit their coverage in the future, our business and results of operations could be adversely affected. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Intellectual Property  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our intellectual property consists of patented designs and methods and proprietary know-how. In addition to the patented designs and methods
discussed below, we have made significant investments in proprietary know-how, including the manufacture of fabrics and garments used in our systems and the algorithms used to manage the inflation and
deflation of our systems and other functions of the controllers. To maintain and protect our proprietary technologies and products, we rely on a combination of patent, copyright, trademark, trade
secret and other intellectual property laws, and confidentiality provisions in our contracts. We have a policy to enter into confidentiality agreements with employees, consultants, third parties and
our advisors to protect
our intellectual property and maintain our competitive position. We also require our employees and consultants to sign agreements requiring that they assign to us their interest in intellectual
property such as patents and copyrights arising from their work for us. We also require all employees to sign an agreement not to compete unfairly with us during their employment and upon termination
of their employment through the misuse of confidential information, soliciting employees, and soliciting customers. Despite any measures taken to protect our intellectual property, unauthorized
parties may attempt to copy aspects of our systems or to obtain and use information that we regard as proprietary. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>On
September&nbsp;14, 2012, we completed an acquisition of certain assets, including inventory, equipment and tooling and patents for the ACTitouch System and a technology known as SMM from
ConvaTec,&nbsp;Inc. and ConvaTec Technologies,&nbsp;Inc., or the Sellers. The purchase price of this acquisition included $3.0&nbsp;million at closing and $2.0&nbsp;million at the earliest of
the commercialization date or the first anniversary of the closing date. In addition, we are required to pay quarterly payments to the Sellers following the commercialization date, which was
September&nbsp;1, 2013, through the following sixteen quarterly calculation periods equal to 9% of sales for the ACTitouch System and 7% of sales of SMM with a guaranteed minimum amount of $45,000
for each of the first four quarterly calculation periods (year 1); $148,500 for each of next four quarterly calculation periods (year 2); and $247,750 for each of the next four quarterly calculation
periods (year&nbsp;3)&nbsp;(total of $1,765,000). For each quarterly calculation period beginning with the seventeenth quarterly calculation period and ending on the tenth anniversary of the
commercialization date, we will make quarterly payments to the Sellers equal to 6% of the sale of the ACTitouch System and 5% on the sale of SMM. If ACTitouch System and SMM sales in any calendar year
in years five through ten exceed $40.0&nbsp;million, the sales percentage amount relating to ACTitouch System sales shall equal 6% of the sales of the ACTitouch System up to $40.0&nbsp;million and
7% on the sales of the ACTitouch System over $40.0&nbsp;million. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Patents  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our patent portfolio consists of three sets of patents, including patents relating to our Flexitouch System, our ACTitouch System and other
compression-related technologies, each of which is described </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>119</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=124,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=135397,FOLIO='119',FILE='DISK131:[15ZBY1.15ZBY12201]EG12201A.;52',USER='JKEENE',CD='25-JAN-2016;09:59' -->
<A NAME="page_eg12201_1_120"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>in
further detail below. As of October&nbsp;31, 2015, we owned more than 70 issued patents globally, of which 17 were issued U.S. patents. As of October&nbsp;31, 2015, we owned 17 patent
applications pending globally, of which 12 were patent applications pending in the United States. Our U.S. issued patents have varying patent terms expiring between 2017 and through at least 2029,
subject to payment of required maintenance fees, annuities and other charges. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Flexitouch System Patent Family.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The following is a summary of patents relating to our Flexitouch System:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> On January&nbsp;30, 2001, our first patent, directed to our unique wrap structure, was issued (U.S. Pat. No.&nbsp;6,179,796). This
patent is specifically directed to an arcuate design and other features of a garment for wrapping about a patient. This arcuate design is one of the keys to the success of our Flexitouch System, as it
facilitates the movement of the lymph fluid from the damaged lymph node area to other functioning lymph node areas. Similar patents have been issued in Europe and Canada. </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> On November&nbsp;11, 2003, a patent directed to our preparation and drainage methodology was issued (U.S. Pat.
No.&nbsp;6,645,165). This second patent is directed to body preparation for receipt of lymph fluid via pressurization and depressurization of chambers, and the subsequent lymph drainage from a body
extremity via select pressurization and depressurization of chambers. This preparation and subsequent drainage of the lymph fluid is another key to our Flexitouch System, as it allows stimulation of
the lymphatic system to promote reabsorption of the lymph fluid. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> On March&nbsp;1, 2005, a patent directed to our wrap structure and fabrication was issued (U.S. Pat. No.&nbsp;6,860,862). This
third patent is directed to the unique aspects of the fabrication of our wrap. In particular, a "four way stretch" and "axial stretch" of our garment allow us to stretch the patient's skin in the same
manner as manual lymphatic drainage therapy. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> On November&nbsp;22, 2005, a patent directed to our preparation and drainage methodology was issued (U.S. Pat.
No.&nbsp;6,966,884). This fourth patent is directed to a lymphedema treatment methodology, entailing optimum sequencing of air chamber inflation/deflation. Correct sequencing of the chambers is
important to proper therapy. The subject method of sequencing of treatment, called 2-Phase Lymph Preparation and Drainage, prepares the trunk and extremity regions of the body prior to draining the
extremity of lymph fluid. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> ACTitouch System Patents.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The following is a summary of our patent families relating to our ACTitouch System:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> On October&nbsp;14, 2008, a "Medical Compress" patent directed to the ornamental aspects of the compression sleeve was issued (U.S.
Design Pat. No.&nbsp;D578,652). Similar patents have been issued in Europe, Japan, Canada, Mexico, Australia, China and Taiwan. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> On June&nbsp;22, 2010, a "Proximity Detection Apparatus" patent directed to control unit proximity detection allowing a different
mode of operation was issued (U.S. Pat. No.&nbsp;7,741,966). Similar patents have been issued in Japan, Canada, Mexico, China and Taiwan, and an application is pending in Europe. </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> On March&nbsp;22, 2011, a "Compression Device for the Limb" patent directed to the storage of data related to duration of use was
issued (U.S. Pat. No.&nbsp;7,909,786). Similar patents </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>120</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=125,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=264525,FOLIO='120',FILE='DISK131:[15ZBY1.15ZBY12201]EG12201A.;52',USER='JKEENE',CD='25-JAN-2016;09:59' -->
<A NAME="page_eg12201_1_121"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>have
been issued in Japan, Canada, Mexico, China, the United Kingdom, Germany, France, Ireland, Italy, Sweden and Taiwan. </FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> On May&nbsp;24, 2011, a "Pressurized Medical Device" patent directed to the detection of malfunctioning pressure sensors was issued
(U.S. Pat. No.&nbsp;7,947,003). Similar patents have been issued in Japan, Canada, Mexico, China and Taiwan and an application is pending in Europe. </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> On December&nbsp;13, 2011, a "Relating to Socks" patent directed to a sock and compression device kit was issued (U.S. Pat.
No.&nbsp;8,075,507). Similar patents have been issued in Japan, Canada, Mexico, China, the United Kingdom, Germany, France, Ireland, Italy and Sweden. </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> On July&nbsp;23, 2013, a "Medical Compress" patent directed to the ornamental aspects of the compression sleeve and control unit was
issued (U.S. Design Pat. No.&nbsp;D686,738). Similar patents have been issued in Europe, Canada, Mexico, Australia, China and Taiwan. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> On November&nbsp;5, 2013, a "Compression Device for the Foot" patent directed to a Y-shaped foot wrap was issued (U.S. Pat.
No.&nbsp;8,574,180). Similar patents have been issued in Japan, Canada, China, the United Kingdom, Germany, France, Ireland, Sweden and Taiwan. A continuation application (U.S. Pub.
No.&nbsp;2014/0058302) directed to the subject matter of this patent family is pending in the United States. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> On January&nbsp;28, 2014, a "Compression Device for the Limb" patent directed to the compression sleeve configuration was issued
(U.S. Pat. No.&nbsp;8,636,679). Similar patents have been issued in Japan, Canada, Mexico and Taiwan, an application for similar subject matter is pending in Europe, and a continuation application
(U.S. Pub. No.&nbsp;2014/0128787) is pending in the United States. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Trademarks  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We have registered the trademarks Flexitouch, the Flexitouch and design and ACTitouch with the United States Patent and Trademark Office on the
Principal Register. We rely in the United States on common law rights to the Entr&eacute;, Tactile Medical and Tactile Medical design trademarks. We have not sought to register any of our
trademarks in jurisdictions outside of the United States. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Employees  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As of September&nbsp;30, 2015, we had 238 employees, including 115 in sales and marketing, 80 in reimbursement and payer relations, 16 in
manufacturing and quality assurance, 16 in general administration, finance, information technology and human resources and 11 in research and development. None of our employees are represented by a
collective bargaining agreement. We believe that our employee relations are positive, as evidenced by our being selected as a Top Workplace in Minnesota by our employees for the last six years. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Facilities  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We lease approximately 52,000 square feet of office and assembly space at our corporate headquarters in Minneapolis, Minnesota under a lease that
expires in July 2021. We believe that our existing facilities are adequate to meet our business requirements for the near term and that additional space will be available on commercially reasonable
terms, if required. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Legal Proceedings  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>From time to time, we may be subject to various claims and legal proceedings arising in the ordinary course of business. We are not currently a party
to any legal proceedings that, in the opinion of our management, are likely to have a material adverse effect on our business. Regardless of outcome, litigation can have an adverse impact on us
because of defense and settlement costs, diversion of management resources, and other factors. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>121</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=126,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=389122,FOLIO='121',FILE='DISK131:[15ZBY1.15ZBY12201]EG12201A.;52',USER='JKEENE',CD='25-JAN-2016;09:59' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ei12201_1_122"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ei12201_management"> </A>
<A NAME="toc_ei12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  MANAGEMENT    <BR>    </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Executive Officers and Directors  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
following table sets forth information concerning our directors and executive officers as of the date of this prospectus: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="30%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="21pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="61%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;width:21pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,21pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Age </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Position </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B><I>Executive Officers</I></B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Gerald R. Mattys</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>56</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Chief Executive Officer, Director</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Robert J. Folkes</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>53</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Chief Operating Officer and Chief Financial Officer</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Mary E. Anderson</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>53</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Vice President, Reimbursement</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Bryan F. Rishe</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>60</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Vice President, Sales</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Mary M. Thompson</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>57</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Vice President, Payer Relations and Government Affairs</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B><I>Non-Employee Directors</I></B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Peter H. Soderberg</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>69</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Chairman of the Board</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>William W. Burke</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>56</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Director</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Jordan S. Davis</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>54</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Director</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Richard Nigon</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>67</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Director</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Kevin H. Roche</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>65</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Director</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Stephen I. Shapiro</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>70</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Director</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Zubeen Shroff</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>51</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Director</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
following is a brief description of the education and business experience of our directors and executive officers: </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Executive Officers  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>Gerald R. Mattys</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2> has served as our Chief Executive Officer and as a member of our board of directors
since 2005. From 2002 to 2004, he served as the Chief Executive Officer of Medisyn Technologies,&nbsp;Inc., a development stage biotechnology company. From 2000 to 2002, he was the President and
Chief Executive Officer of Timm Medical Technologies,&nbsp;Inc., a medical device company. During the period from 1998 to 2000, he was Vice President and General Manager of Alternate Care for
Mallinckrodt,&nbsp;Inc., a pharmaceutical and medical device company. Prior to that, he served 18&nbsp;years in various roles in product management, sales, marketing and management at several
medical device companies. He currently serves as an advisor to Augustine Biomedical and Design,&nbsp;LLC. We believe Mr.&nbsp;Mattys is qualified to serve on our board of directors because of his
extensive industry, leadership and product development experience. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>Robert J. Folkes</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2> has served as our Chief Financial Officer since joining our company in 2004 and added Chief Operating Officer responsibilities in
February 2015. Prior to joining our company, Mr.&nbsp;Folkes was the Chief Financial Officer for Advanced Respiratory, a medical device company, from 1997 until its sale in 2003. Prior to joining
Advanced Respiratory, Mr.&nbsp;Folkes was an Audit Senior Manager for Ernst&nbsp;&amp; Young&nbsp;LLP. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>Mary E. Anderson</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2> serves as our Vice President, Reimbursement and started with our company in 2005 as our Director of Reimbursement. Prior to joining our
company, Ms.&nbsp;Anderson served in various roles at Advanced Respiratory, a medical device company, from 1990 until its sale in 2003, including Controller, Chief Financial Officer and Vice
President of Internal Operations. Ms.&nbsp;Anderson began her career as an auditor with Ernst&nbsp;&amp; Young&nbsp;LLP. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>Bryan F. Rishe</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2> has served as our Vice President, Sales since 2008. From 2004 to 2008, he served as the Vice President, Sales for BSN Medical, a medical
soft goods manufacturer. Mr.&nbsp;Rishe also served as </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>122</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=127,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=565790,FOLIO='122',FILE='DISK131:[15ZBY1.15ZBY12201]EI12201A.;63',USER='JKEENE',CD='25-JAN-2016;09:49' -->
<A NAME="page_ei12201_1_123"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>the
Vice President, Sales and Marketing for TFX Medical, a surgical equipment manufacturer. Prior to that, Mr.&nbsp;Rishe was the Western Area Manager with Surgical Laser Technologies, a specialty
laser company. Mr.&nbsp;Rishe has held other sales leadership and business development roles with Becton Dickinson, Baxter Travenol and American Hospital Supply. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>Mary M. "Maggie" Thompson</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2> has served as our Vice President, Payer Relations and Government Affairs since 2009. Prior to joining our company,
Ms.&nbsp;Thompson served as Director of Reimbursement for Uroplasty, Inc., a medical device company, from 2005-2009. From 1998 until 2005, Ms.&nbsp;Thompson served as Director of Payer Relations
at Advanced Respiratory, a medical device company, from 1998 until 2009. A registered nurse, Ms.&nbsp;Thompson first practiced nursing at Gillette Children's Hospital and at a grant-funded community
clinic in St.&nbsp;Paul. She then worked for the Minnesota Attorney General's Office as a nurse consultant until she joined a large health plan as the Government Programs Quality Regulatory Manager
working closely with the Centers for Medicare and Medicaid Services and Minnesota's Medicaid program. Ms.&nbsp;Thompson is active in the Alliance for Wound Care Stakeholders and is a member of
Women's Business Leaders in Healthcare. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Non-Employee Directors  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>Peter H. Soderberg</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2> has served as a member of our board of directors since September 2012.
Mr.&nbsp;Soderberg currently is the Managing Partner of Worthy Venture Resources,&nbsp;LLC., a company that seeks to add intellectual and financial capital to post start-up companies transitioning
to an established national market presence. Beginning in 2006, Mr.&nbsp;Soderberg served as the President and Chief Executive Officer of both Hillenbrand Industries and Hill-Rom. In 2008,
Hillenbrand Industries separated its two subsidiaries creating two, separately traded, public companies. Mr.&nbsp;Soderberg continued his role as President and Chief Executive Officer of the medical
technology company, Hill-Rom Holdings,&nbsp;Inc. until 2010. Mr.&nbsp;Soderberg served on the board of Hillenbrand Industries/Hill-Rom from 2002 until his semi-retirement in 2011. Previously, he
was President and Chief Executive Officer at Welch Allyn, a manufacturer of medical diagnostic equipment, for six years, and served as Group Vice President and Chief Operating Officer from 1993 to
1999. Prior to his role at Welch Allyn Mr.&nbsp;Soderberg's served 23&nbsp;years at Johnson&nbsp;&amp; Johnson, in a variety of operations, marketing and management positions, including President of
Johnson&nbsp;&amp; Johnson Health Management. His career also includes roles as President and Chief Executive Officer of an industrial technology company and the founder and President of a venture
capital business. Mr.&nbsp;Soderberg currently serves on the board of directors of Greatbatch,&nbsp;Inc., a medical technology company. Mr.&nbsp;Soderberg previously served on the boards of
Constellation Brands,&nbsp;Inc. and the Advanced Medical Technology Association. We believe he is qualified to serve on our board of directors because of his extensive industry, leadership and
investment development experience. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>William W. Burke</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2> has served as a member of our board of directors since September 2015. Since December 2013, he has been a consultant to companies in
the medical device industry. He served as Executive Vice President&nbsp;&amp; Chief Financial Officer of IDEV Technologies, a peripheral vascular devices company, from November 2009 until the company
was acquired by Abbott Laboratories in August 2013. He was retained by Abbott through December 2013 to assist with post-acquisition integration. From August 2004 to December 2007, he served as
Executive Vice President&nbsp;&amp; Chief Financial Officer of ReAble Therapeutics, a diversified orthopedic device company which was sold to The Blackstone Group in a going private transaction in 2006
and subsequently merged with DJO Incorporated in late 2007. Mr.&nbsp;Burke remained with ReAble until June 2008. From 2001 to 2004, he served as Chief Financial Officer of Cholestech Corporation, a
publicly traded medical diagnostic products company. Mr.&nbsp;Burke has served on the board of directors of LDR Holdings, a publicly traded developer of innovative spinal implants, since October
2013, and Invuity,&nbsp;Inc., a publicly traded developer of advanced surgical photonics devices, since May 2015. He also served as a member of the board of directors of Medical Action Industries, a
publicly traded manufacturer of disposable medical products, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>123</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=128,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=490775,FOLIO='123',FILE='DISK131:[15ZBY1.15ZBY12201]EI12201A.;63',USER='JKEENE',CD='25-JAN-2016;09:49' -->
<A NAME="page_ei12201_1_124"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>from
August 2004 to October 2014, when the company was acquired by Owens&nbsp;&amp; Minor. Mr.&nbsp;Burke was selected to serve on our board of directors because of his business experience with other
medical technology companies, and his experience as the chief financial officer of other companies, including other publicly traded companies. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>Jordan S. Davis</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2> has served as a member of our board of directors since September 2012. Mr.&nbsp;Davis is a Managing Partner and co-founder of Radius
Ventures, the investment advisor to the Radius Funds, a venture capital firm focused on growth equity and expansion-stage health and life sciences companies. Prior to founding Radius in 1997, from
1992 to 1996, Mr.&nbsp;Davis served as a Managing Director at KBL Healthcare,&nbsp;Inc., a health and life sciences venture capital and investment banking firm, where he also served as Vice
President and Director of KBL Healthcare Acquisition Corp., a publicly traded acquisition company, which he co-founded. Mr.&nbsp;Davis began his career as an Associate in Morgan
Stanley&nbsp;&amp;&nbsp;Co.'s Private Wealth Management and International Sales and Trading operations. Mr.&nbsp;Davis founded Cambridge Heart,&nbsp;Inc., a medical technology company that
developed and commercialized a
device to non-invasively identify patients at risk of sudden cardiac death, and Voxware,&nbsp;Inc., a speech technology company and early entrant in the voice over IP market, both of which completed
initial public offerings in 1996. Mr.&nbsp;Davis served on the public company board of Athersys, Inc. beginning in June 2007 and effectively resigning in June 2010, and currently serves on the board
of directors of Endogastric Solutions,&nbsp;Inc., Healthsense,&nbsp;Inc., MID Surgical and HealthCorps. We believe Mr.&nbsp;Davis is qualified to serve on our board of directors because of his
extensive industry, investment and capital markets experience. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>Richard Nigon</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2> has served as a member of our board of directors since September 2012. Mr.&nbsp;Nigon is currently Senior Vice President of Cedar Point
Capital,&nbsp;Inc., a private company that raises capital for early stage companies, where he has served since 2007. From February 2001 until December 2006, Mr.&nbsp;Nigon was a Director of Equity
Corporate Finance for Miller Johnson Steichen Kinnard, a privately held investment firm, which was acquired in December 2006 by Stifel Nicolaus, a brokerage and investment banking firm. After that
acquisition, Mr.&nbsp;Nigon became a Managing Director of Private Placements until May 2007. From February 2000 to February 2001, Mr.&nbsp;Nigon served as the Chief Financial Officer of
Dantis,&nbsp;Inc., a web hosting company. Prior to joining Dantis, Mr.&nbsp;Nigon was employed by Ernst&nbsp;&amp; Young&nbsp;LLP from 1970 to 2000, where he was a partner from 1981 to 2000. While
at Ernst&nbsp;&amp; Young, Mr.&nbsp;Nigon served as the Director of Ernst&nbsp;&amp; Young's Twin Cities Entrepreneurial Services Group and was the coordinating partner on several publicly-traded
companies in the consumer retailing and manufacturing sectors. Mr.&nbsp;Nigon is a Director of Northern Technologies International Corporation and Vascular Solutions,&nbsp;Inc. Mr.&nbsp;Nigon
also serves as a director of several private companies. We believe Mr.&nbsp;Nigon is qualified to serve on our board of directors because of his extensive public accounting and auditing experience,
including particular experience with emerging growth companies. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>Kevin H. Roche</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2> has served as a member of our board of directors since October 2004. Mr.&nbsp;Roche was General Counsel of UnitedHealth Group, a health
insurance provider, from 1989 to 1996, at which time he founded and operated as the Chief Executive Officer of the Ingenix division of United Health Group where he served until 2001. Following his
retirement from UnitedHealth Group, Mr.&nbsp;Roche has spent several years assisting emerging growth companies as an investor, advisor and board member. He also serves as a Senior Advisor for Triple
Tree,&nbsp;LLC. He currently serves as a Director of Cogentix Medical,&nbsp;Inc. and several private healthcare companies. We believe that Mr.&nbsp;Roche is qualified to serve on our board of
directors because of his extensive industry and leadership experience and his experience as a board member. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>Stephen I. Shapiro</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2> has served as a member of our board of directors since June 2010. From 1983 through 1999, Mr.&nbsp;Shapiro was a Managing Director
of The Wilkerson Group, a leading medical </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>124</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=129,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=351306,FOLIO='124',FILE='DISK131:[15ZBY1.15ZBY12201]EI12201A.;63',USER='JKEENE',CD='25-JAN-2016;09:49' -->
<A NAME="page_ei12201_1_125"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>products
management consulting firm, with a client base including pharmaceutical, diagnostic, device and biotech companies, where he led the medical devices practice. Prior to joining The Wilkerson
Group, he was Director of Advanced Research and Development and New Business Development for Becton, Dickinson and Company, and spent eight years at Union Carbide Clinical Diagnostics, becoming
engineering group leader. Mr.&nbsp;Shapiro also serves on the board of directors of Pacific Diagnostic Laboratories, LLC, PolyRemedy, Inc., and Cambrooke Therapeutics,&nbsp;Inc. Mr.&nbsp;Shapiro
was a Venture Partner with Advanced Technology Ventures (a venture capital firm focused on investments in healthcare companies) from January&nbsp;2000 through January&nbsp;2015. Mr.&nbsp;Shapiro
served as a consultant to Galen Partners (a venture capital firm focused on investments in healthcare companies) as a Venture Partner from January&nbsp;2000 through December&nbsp;2013. We believe
that Mr.&nbsp;Shapiro is qualified to serve on our board of directors because of his deep industry and medical science background. Mr.&nbsp;Shapiro, however, intends to resign from our board of
directors upon the closing of this offering. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>Zubeen Shroff</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2> has served as a member of our board of directors since September 2007. Mr.&nbsp;Shroff is a Managing Director of Galen Partners, a
healthcare growth equity investment firm which he joined in 1996. Prior to joining Galen, Mr. Shroff was a Principal with The Wilkerson Group, where his client base included pharmaceutical,
diagnostics, device and biotech companies, plus a select number of venture capital firms. Prior to joining The Wilkerson Group, Mr. Shroff worked at Schering-Plough France, a manufacturer of
healthcare products and medicines, where he helped launch their biotech product, alpha-Interferon, in several new indications. Currently, Mr. Shroff is Treasurer and on the Executive Committee of the
Board for The Westchester Medical Center Public Benefit Corporation, as well as Chairman of its Foundation. Since 2004, he has served on the Advisory Committees to Boston University Medical School and
School of Public Health. Mr. Shroff is also on the Advisory Board of the Joslin Diabetes Center. In addition to the above positions, Mr. Shroff has served on the board of directors of numerous
privately held Galen portfolio companies. Mr. Shroff currently serves on the board of directors of Quotient Biodiagnostics and served on the board of directors of Pet DRx Corporation until July 2010
and Encore Medical until June 2006. We believe Mr. Shroff is qualified to serve on our board of directors because of his extensive experience in providing strategic guidance to companies in the
healthcare industry, particularly in the areas of medical devices, diagnostics, and capital equipment. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Board Composition  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Director Independence.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors has determined that seven of our eight directors are independent directors, as defined under the
applicable rules of
the NASDAQ stock market. The independent directors are Peter H. Soderberg, William W. Burke, Jordan S. Davis, Richard Nigon, Kevin H. Roche, Stephen&nbsp;I. Shapiro and Zubeen Shroff. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
making such determination, our board of directors considered the independence of its members in light of the beneficial ownership of these individuals and, notwithstanding their beneficial
ownership,
determined that it would not interfere with their exercise of independent judgment in carrying out the responsibilities of a director. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Familial Relationships.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;There is no family relationship between any director, executive officer or person nominated to become a director or
executive officer. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Board Structure.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors currently is authorized to have eight members. In accordance with the terms of our amended and restated
certificate of
incorporation and amended and restated bylaws that will become effective upon completion of this offering, our board of directors will be divided into three classes, class&nbsp;I, class&nbsp;II
and class&nbsp;III, with members of each class serving staggered </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>125</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=130,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=858998,FOLIO='125',FILE='DISK131:[15ZBY1.15ZBY12201]EI12201A.;63',USER='JKEENE',CD='25-JAN-2016;09:49' -->
<A NAME="page_ei12201_1_126"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>three-year
terms. Upon completion of this offering, the members of the classes will be divided as follows:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the class&nbsp;I directors will
be&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, and their term will expire at the annual meeting of
stockholders to be held in 2016; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the class&nbsp;II directors will
be&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, and their term will expire at the annual meeting of
stockholders to be held in 2017; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the class&nbsp;III directors will be&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, and their term will expire at the annual
meeting of stockholders to be held in 2018. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Upon
the expiration of the term of a class of directors, directors in that class will be eligible to be elected for a new three-year term at the annual meeting of stockholders in the year in which
their term expires. In accordance with the terms of our amended and restated certificate of incorporation that will become effective upon completion of this offering, our directors may be removed only
for cause by the affirmative vote of the holders of at least 75% of the votes that all our stockholders would be entitled to cast in an election of directors. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Compensation Committee Interlocks and Insider Participation  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>No member of our compensation and organization committee is or has been our current or former officer or employee. None of our executive officers
served as a director or a member of a compensation committee (or other committee serving an equivalent function) of any other entity, one of whose executive officers served as a director or member of
our compensation and organization committee during 2015. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Board Committees  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our board has established four standing committees&nbsp;&#151; audit, nominating and corporate governance, compensation and organization and
compliance committee&nbsp;&#151; each of which operates under a charter that has been approved by our board. Upon completion of this offering, each committee's charter will be available under
the Corporate Governance section of our website at </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>www.tactilemedical.com</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>. The reference to our website address does not constitute incorporation by
reference of the information contained at or available through our website, and you should not consider it to be a part of this prospectus. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
following sets forth the membership of each of our committees upon completion of this offering. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="130pt" style="font-family:times;"></TD>
<TD WIDTH="2%" style="font-family:times;"></TD>
<TD WIDTH="136pt" style="font-family:times;"></TD>
<TD WIDTH="2%" style="font-family:times;"></TD>
<TD WIDTH="153pt" style="font-family:times;"></TD>
<TD WIDTH="2%" style="font-family:times;"></TD>
<TD WIDTH="136pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Audit Committee </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Nominating and Corporate<BR>
Governance Committee </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Compensation and<BR>
Organization Committee </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Compliance Committee </B></FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Richard Nigon (Chair)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Kevin H. Roche (Chair)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Peter H. Soderberg (Chair)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Kevin H. Roche (Chair)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>William W. Burke</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>William W. Burke</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Jordan S. Davis</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>William W. Burke</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Kevin H. Roche</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Jordan S. Davis</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Zubeen Shroff</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Jordan S. Davis</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Richard Nigon</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Richard Nigon</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Audit Committee.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The audit committee's responsibilities will include:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> appointing, compensating, retaining, replacing and overseeing our independent auditor; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> pre-approving all audit and permitted non-audit services to be provided by our independent auditor; </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>126</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=131,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=797622,FOLIO='126',FILE='DISK131:[15ZBY1.15ZBY12201]EI12201A.;63',USER='JKEENE',CD='25-JAN-2016;09:49' -->
<A NAME="page_ei12201_1_127"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> assisting our board of directors in its oversight of our financial statements and other financial information to be provided by us; </FONT> <FONT COLOR="#3B5A6F"
SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> overseeing our compliance with legal and regulatory matters and aspects of our risk management processes; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> discussing with management and our independent auditors any major issues as to the adequacy of our internal controls, any actions to
be taken in light of significant or material control deficiencies and the adequacy of disclosures about changes in internal control over financial reporting; and </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> establishing procedures for the receipt, retention and treatment of complaints regarding accounting, internal accounting controls or
auditing matters and the confidential, anonymous submission by employees of concerns regarding questionable accounting or auditing matters. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Each
of the members of our audit committee upon completion of this offering meets the requirements for financial literacy and possesses the financial qualifications required under the applicable rules
and regulations of the SEC and the NASDAQ stock market. Our board of directors has determined that Richard Nigon is an audit committee financial expert, as defined under the applicable rules of the
SEC. Each member of our audit committee upon completion of this offering satisfies the NASDAQ stock market independence standards and the independence standards of Rule&nbsp;10A-3(b)(1) of the
Exchange Act. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Nominating and Corporate Governance Committee.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The nominating and corporate governance committee's responsibilities will include assisting our
board
in:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> identifying qualified individuals to become board members; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> determining the composition of the board and its committees; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> assessing and enhancing the effectiveness of the board and individual directors; and </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> developing and implementing our corporate governance guidelines. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Compensation and Organization Committee.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The compensation and organization committee's responsibilities will
include:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> determining the compensation of our chief executive officer and other executive officers; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> providing oversight of our compensation policies, plans and benefit programs; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> administering our equity compensation plans; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> recommending to our board the compensation arrangements for our non-employee directors; and </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> overseeing and reviewing our executive team and management succession. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Compliance Committee.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The compliance committee's responsibilities will include:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> assisting the Board in overseeing our regulatory compliance activities; and </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>127</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=132,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=342961,FOLIO='127',FILE='DISK131:[15ZBY1.15ZBY12201]EI12201A.;63',USER='JKEENE',CD='25-JAN-2016;09:49' -->
<A NAME="page_ei12201_1_128"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> monitoring and evaluating our compliance with regulatory requirements to which we are subject. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Code of Business Conduct and Ethics  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We expect to adopt a code of business conduct and ethics upon completion of this offering relating to the conduct of our business by our employees,
officers and directors, which will be posted on our website. We intend to disclose any amendments to the code, or any waivers of its requirements, as required by stock exchange or SEC rules, on our
website. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Non-Employee Director Compensation  </B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Prior to this offering, we did not have a formal policy for compensating our non-employee directors. However, in 2015, we reimbursed the members of
our board of directors for their reasonable out-of-pocket travel expenses incurred in connection with attending meetings of our board of directors. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
board of directors has approved a new compensation program for our non-employee directors to be effective upon completion of this offering. Under the program, our non-employee directors will
receive cash compensation as follows:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> each non-employee director will receive an annual cash retainer of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per year; </FONT>
<FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the chairman of our board of directors will receive an additional cash retainer of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per year; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the chairman of the audit committee will receive an additional cash retainer of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per year; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> each member of the audit committee (other than the chairman) will receive an additional cash retainer of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per year; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the chairman of the compensation and organization committee will receive an additional cash retainer of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per year; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> each member of the compensation and organization committee (other than the chairman) will receive an additional cash retainer of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per year; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the chairman of the nominating and corporate governance committee will receive an additional cash retainer of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per
year; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> each member of the nominating and corporate governance committee (other than the chairman) will receive an additional cash retainer of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per year; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the chairman of the compliance committee will receive an additional cash retainer of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per year; and </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> each member of the compliance committee (other than the chairman) will receive an additional cash retainer of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per
year. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
also reimburse our directors for their reasonable out-of-pocket expenses incurred in connection with attending our board and committee meetings. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition, upon the effectiveness of this registration statement and in connection with additional directors joining our board in the future, we expect to grant each of our non-employee directors a
non-statutory stock option to purchase up to $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;of shares of our common stock calculated as </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>128</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=133,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=654853,FOLIO='128',FILE='DISK131:[15ZBY1.15ZBY12201]EI12201A.;63',USER='JKEENE',CD='25-JAN-2016;09:49' -->
<A NAME="page_ei12201_1_129"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>the
grant date fair value of the stock-based awards computed in accordance with FASB Topic ASC 718 on the date of grant using, for purposes of awards granted upon effectiveness of this registration
statement, the price per share to the public of our common stock in this offering. Each option will have an exercise price per share equal to the fair market value on the date of grant, which, for
purposes of awards granted upon effectiveness of this registration statement, will be the price per share to the public of our common stock in this offering. Each stock option will vest immediately
prior to the start of our company's first annual meeting of stockholders following the date of such grant, subject to such director's continued service on our board of directors as of such date. Each
stock option will have a term of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;years from the date of grant. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>129</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=134,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=844079,FOLIO='129',FILE='DISK131:[15ZBY1.15ZBY12201]EI12201A.;63',USER='JKEENE',CD='25-JAN-2016;09:49' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ek12201_1_130"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ek12201_executive_compensation"> </A>
<A NAME="toc_ek12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  EXECUTIVE COMPENSATION    <BR>    </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Summary Compensation Table  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The following table provides information regarding the total compensation for services rendered in all capacities that was earned by our principal
executive officer and our two other most highly compensated executive officers during 2015, whom we collectively refer to as our "named executive officers." </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;width:101pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Name and Principal Position

<!-- COMMAND=ADD_SCROPPEDRULE,101pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Salary<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Non-Equity<BR>
Incentive Plan<BR>
Compensation<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>All Other<BR>
Compensation<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Total<BR>
($) </B></FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Gerald R. Mattys</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2015</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>340,000</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><SUP>(1)</SUP></FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><I>Chief Executive Officer</I></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2> Robert J. Folkes</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>2015</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>240,000</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR><SUP>(1)</SUP></FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>Chief Operating Officer and Chief Financial Officer</I></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


  Bryan F. Rishe</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>2015</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>237,500</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>128,668</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>9,000</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR><SUP>(2)</SUP></FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>375,168</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><I>Vice President, Sales</I></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Non-equity
incentive plan compensation for Messrs. Mattys and Folkes has not yet been determined.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(2)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Represents
amounts paid to the named executive officer for a car allowance. </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Employment Agreements  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>While we currently have employment agreements with each of our named executive officers, we intend to enter into new agreements prior to the
effectiveness of the registration statement of which this prospectus is a part. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Equity Awards  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We did not grant any stock option or other equity-based awards to any of our named executive officers during 2015. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Non-Equity Incentive Plan Compensation  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The non-equity incentive plan compensation that may be earned by each of our named executive officers other than Mr.&nbsp;Rishe during 2015
reflects their participation in our 2015 Bonus Plan. Actual payout amounts under the 2015 Bonus Plan are anticipated to be determined in March 2016. As Vice President, Sales, Mr.&nbsp;Rishe's 2015
bonus opportunity was subject to a separate bonus arrangement described below. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
2015 Bonus Plan incorporates both company financial objectives and company and departmental operational objectives. The company's performance against objectives based on 2015 revenue and 2015
operating income excluding specific board approved expenditures will determine the degree to which a bonus pool would be funded, with payouts from the bonus pool dependent upon the degree to which
financial and operational objectives were achieved. The bonus pool will not be funded if operating income excluding specific board approved expenditures for 2015 is less than
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, and threshold, target and maximum funding levels of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million,
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million and $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, respectively,
were prescribed depending on the degree to which the financial objectives were achieved. The bonus pool will be funded at target level if 2015 revenues are&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million and 2015
operating income excluding specific board approved expenditures is&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, with those metrics assigned </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>130</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=135,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=949592,FOLIO='130',FILE='DISK131:[15ZBY1.15ZBY12201]EK12201A.;60',USER='AGAETZ',CD='25-JAN-2016;14:36' -->
<A NAME="page_ek12201_1_131"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>relative
weightings of 80% and 20%, respectively. Operational objectives generally involved measures to increase efficiencies and reimbursements and advance clinical studies and submissions. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Individual
payouts from the bonus pool for more senior bonus plan participants, including the named executive officers, were based 80% on achievement of financial objectives and 20% on achievement of
operational objectives. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Target
level and actual payouts for 2015 for each named executive officer participating in the 2015 Bonus Plan expressed as a percentage of annual base salary are as follows: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="102pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="102pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;width:21pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,21pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Target Bonus as % of<BR>
Base Salary </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Actual Bonus as % of<BR>
Base Salary </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Gerald R. Mattys</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>65%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Robert J. Folkes</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>35%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;%</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Mr.&nbsp;Rishe's
2015 bonus opportunity was a function of the degree to which our company achieved monthly and quarterly sales objectives and quarterly sales department expense management goals.
These bonus amounts were payable to Mr.&nbsp;Rishe following the close of the applicable month or quarter during 2015. Mr.&nbsp;Rishe's maximum bonus opportunity for 2015 was approximately 69% of
his base salary, and his actual payout was approximately 54% of his base salary. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Outstanding Equity Awards at Fiscal Year-End  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The following table sets forth certain information regarding equity awards that have been granted to our named executive officers and that were
outstanding as of December&nbsp;31, 2015: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="58pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="65pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="41pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="53pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="73pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="84pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Option Awards<SUP>(1)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Stock Awards<SUP>(2)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;width:21pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,21pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Number of<BR>
Securities<BR>
Underlying<BR>
Unexercised<BR>
Options (#)<BR>
Exercisable </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Number of<BR>
Securities<BR>
Underlying<BR>
Unexercised<BR>
Options (#)<BR>
Unexercisable </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Option<BR>
Exercise<BR>
Price ($) </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Option<BR>
Expiration<BR>
Date </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Number of<BR>
Shares or Units<BR>
of Stock that<BR>
Have Not<BR>
Vested (#) </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Market Value of<BR>
Shares or Units of<BR>
Stock That Have<BR>
Not Vested ($)<SUP>(3)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Gerald R. Mattys</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2/26/18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><SUP>(5)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6/4/19</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3/8/20</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4/20/21</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><SUP>(4)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10/13/23</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Robert J. Folkes</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
2/26/18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR><SUP>(5)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6/4/19</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3/8/20</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4/20/21</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><SUP>(4)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10/13/23</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Bryan F. Rishe</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
12/17/18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3/8/20</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4/20/21</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><SUP>(4)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10/13/23</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Option
awards provide a recipient the right to acquire shares of our common stock.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(2)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Stock
awards consist of restricted shares of our Series&nbsp;A preferred stock.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(3)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>The
market value of restricted shares of our Series&nbsp;A preferred stock that have not vested is based on a fair market value of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per
share as of December&nbsp;31, 2015, as determined by our board of directors.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(4)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>The
unvested shares of common stock subject to this option will vest in 22 equal installments on the 9<SUP>th</SUP> day of each month from January 2016
through October 2017.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(5)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>The
unvested restricted shares of our Series&nbsp;A preferred stock will vest upon a change in control of our company. </FONT></DD></DL>
 </DIV>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>131</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=136,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=361336,FOLIO='131',FILE='DISK131:[15ZBY1.15ZBY12201]EK12201A.;60',USER='AGAETZ',CD='25-JAN-2016;14:36' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_em12201_1_132"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Option Exercises and Stock Vested in 2015  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>None of our named executive officers exercised any stock options or had any other form of equity-based award vest during 2015. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Pension Benefits for 2015  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We do not offer pension benefits to our named executive officers. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Non-Qualified Deferred Compensation for 2015  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We do not offer non-qualified deferred compensation to our named executive officers. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Potential Payments Upon Termination or Change-in-Control  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our 2003 Stock Option Plan, which we refer to as the 2003 Plan, our 2007 Omnibus Stock Plan, which we refer to as the 2007 Plan, our restricted stock
award agreements, pursuant to which restricted shares of our Series&nbsp;A preferred stock were granted to certain employees, which we refer to as the Series&nbsp;A Restricted Stock, and our 2016
Equity Incentive Plan, which we refer to as the 2016 Plan, address the effect of a grantee's termination of service or a change in control of our company on outstanding awards granted under those
plans and agreements. See "&#151;&nbsp;Stock Option and Other Equity Compensation Plans" below. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
expect that the new employment agreements with each of our named executive officers that we intend to enter prior to the completion of this offering will provide for payments upon termination of
service or a change in control. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stock Option and Other Equity Compensation Plans  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In this section we describe our 2003 Plan, our 2007 Plan, our Series&nbsp;A Restricted Stock agreements, our 2016 Plan and our Employee Stock
Purchase Plan, which we refer to as the ESPP. Prior to this offering, we granted stock option awards to eligible participants under the 2003 Plan and the 2007 Plan and awards of Series&nbsp;A
Restricted Stock. Following the closing of this offering, we expect to grant awards to eligible participants under the 2016 Plan. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> 2003 Stock Option Plan.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our 2003 Plan was originally approved by our board of directors and our stockholders in 2003, amended in 2005 and
amended and restated in
August 2006. As of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016, there
were&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock subject to outstanding stock options under the 2003 Plan.
Since the 2007 Plan became effective, no additional awards have been granted under the 2003
Plan and no additional awards will be granted under the 2003 Plan in the future. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>All
shares subject to awards outstanding under the 2003 Plan as of the effective date of the 2016 Plan that thereafter are forfeited, expire, are cancelled or otherwise do not result in the issuance
of shares will become available for grant under the 2016 Plan in accordance with its terms. All awards outstanding under the 2003 Plan will remain outstanding in accordance with their terms and will
continue to be governed by their existing terms after the completion of this offering. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Eligibility.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The 2003 Plan provides for the grant of stock options to any person that provides services to us, whether as an employee, director,
consultant or
advisor. Incentive and nonqualified stock options could be granted to employees, but only nonqualified stock options to other eligible participants. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>132</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=137,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=800631,FOLIO='132',FILE='DISK131:[15ZBY1.15ZBY12201]EM12201A.;43',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_em12201_1_133"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Administration.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our compensation and organization committee administers the 2003 Plan and the awards granted under it, except for awards to our
non-employee
directors which are administered by our board of directors. The plan administrator (compensation and organization committee or the board, as applicable) has the authority to, among other things, make
decisions and determinations related to the 2003 Plan and awards thereunder, including determining who shall receive awards, the types of awards granted and the terms and conditions of the awards and
to adopt rules for the administration of the 2003 Plan. To the extent permitted by law, the plan administrator may delegate all or part of its authority under the 2003 Plan to our chief executive
officer. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Stock Options.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Stock options granted under the 2003 Plan are evidenced by stock option award agreements, containing such provisions as the plan
administrator deems
advisable. All options still outstanding under the 2003 Plan expire not more than ten years after the date of the grant, have a per share exercise price that is equal to the fair market value of a
share of our common stock as of the date the option was granted, and are fully vested and exercisable. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Upon
the termination of an optionee's employment or other service relationship with us: (i)&nbsp;if the termination is due to death or disability, options shall immediately vest and become
exercisable in full
and shall remain exercisable for one year after such termination; (ii)&nbsp;if the termination is for "cause," outstanding options shall immediately expire upon such termination; and (iii)&nbsp;if
the termination is for any reason other than death, disability or cause, then to the extent any outstanding options are not then vested and exercisable, they shall immediately terminate, but to the
extent they are already vested and exercisable, they shall remain exercisable for three months following such termination. In no event, however, will an option remain exercisable past its originally
scheduled expiration date. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Change in Control.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;In the event of a change in control of our company, the plan administrator may, in its discretion, cause any outstanding option to
immediately
become vested and exercisable in full. The plan administrator may also cause outstanding options to be assumed or replaced by an acquirer in a merger, consolidation or sale of substantially all of the
company's assets, or provide for outstanding options to be cancelled upon a change in control in exchange for a cash payment reflecting the intrinsic value of the options. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>For
purposes of the 2003 Plan, a "change in control" generally refers to a person acquiring beneficial ownership of 30% or more of the combined voting power of the company's voting securities; the
approval by the company's stockholders of a merger, consolidation or statutory share exchange involving the company, of the sale of all or substantially all of the company's assets or of the
liquidation or dissolution of the company; or a majority of the members of the company's board ceasing to be "continuing" directors. Under the 2003 Plan, "cause" is generally defined to include a
material breach of any agreement between the company and the optionee, gross negligence or willful misconduct by the optionee, the optionee's conviction of a felony or crime involving moral turpitude,
the optionee's willful violation of specific and lawful work-related instructions or prolonged or frequent unexcused absences from work, or fraud, theft or proven dishonesty by the optionee against
the company. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Registration.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;We intend to file with the SEC a registration statement on Form&nbsp;S-8 covering the shares of our common stock issuable under the 2003
Plan. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> 2007 Omnibus Stock Plan.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our 2007 Plan was approved by our board of directors and our stockholders in 2007, was amended and restated in 2008 and
was further
amended in 2012 and 2014. As
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016,
there were&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares subject to outstanding awards under the 2007 Plan,
and&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares remaining available for the grant
of awards under the 2007 Plan. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>133</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=138,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=627482,FOLIO='133',FILE='DISK131:[15ZBY1.15ZBY12201]EM12201A.;43',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_em12201_1_134"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>On
and after the effective date of the 2016 Plan, no additional awards will be granted under the 2007 Plan. On the effective date of the 2016 Plan, any shares remaining available for the grant of
awards under the 2007 Plan will be carried over into the 2016 Plan, and all shares subject to awards outstanding under the 2007 Plan on the effective date of the 2016 Plan that thereafter are
forfeited, expire, are cancelled or otherwise do not result in the issuance of shares will become available for grant under the 2016 Plan in accordance with its terms. All awards outstanding under the
2007 Plan will remain outstanding in accordance with their terms and will continue to be governed by their existing terms after the completion of this offering. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Eligibility.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The 2007 Plan provides for the grant of equity-based awards to any person that provides services to us, whether as an employee, director,
consultant
or advisor. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Administration.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our compensation and organization committee administers the 2007 Plan and the awards granted under it, except for awards to our
non-employee
directors which are administered by our board. The plan administrator (compensation and organization committee or the board, as applicable) has the authority to, among other things, make decisions and
determinations related to the 2007 Plan and awards thereunder, including determining who shall receive awards, the types of awards granted and the terms and conditions of the awards, adopt rules for
the administration of the 2007 Plan, interpret the 2007 Plan and amend the terms of awards thereunder. To the extent permitted by law, the plan administrator may delegate all or part of its authority
under the 2007 Plan with respect to awards to persons who are not officers or directors of the company to one or more persons who are not non-employee directors. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Types of Awards.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Awards under the 2007 Plan may be in the form of stock options, stock appreciation rights, or SARs, restricted stock, performance
units or other
stock-based awards. Each award is to be evidenced by an award agreement containing the terms and conditions of the award. Only stock options have been granted under the 2007 Plan. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Any
stock option granted under the 2007 Plan shall have a term as specified by the plan administrator, not to exceed ten years after the date of the grant in the case of an incentive stock option, and
have a per share exercise price, which is determined by the plan administrator and which may not be less than the fair market value of a share of our common stock as of the date the option is granted. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Upon
the termination of an optionee's employment with us: (i)&nbsp;options that are not then vested and exercisable shall immediately terminate; (ii)&nbsp;if the termination is due to death or
disability, options shall remain exercisable for one year after such termination to the extent they were exercisable immediately before such termination; (iii)&nbsp;if the termination is for
"cause," outstanding options shall immediately terminate upon such termination; and (iv)&nbsp;if the termination is for any reason other than death, disability or cause, then they shall remain
exercisable for three months following such termination to the extent they were exercisable immediately before such termination. In no event, however, will an option remain exercisable past its
originally scheduled expiration date. If a non-employee director's service relationship with the company terminates, any stock option will remain exercisable for the remainder of its scheduled term to
the extent it was exercisable immediately before such termination. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Change in Control.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;In the event of a change in control of our company, the plan administrator may, in its discretion, cause any outstanding option to
immediately
become vested and exercisable in full and to remain exercisable during its scheduled term. The plan administrator may also cause outstanding options to be assumed or replaced by an acquirer in a
merger, consolidation or sale of substantially all of the company's assets, or provide for outstanding options to be cancelled upon a change in control in exchange for a cash payment reflecting the
intrinsic value of the options. Unless </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>134</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=139,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=44196,FOLIO='134',FILE='DISK131:[15ZBY1.15ZBY12201]EM12201A.;43',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_em12201_1_135"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>otherwise
provided in an agreement with our company, if the accelerated vesting of an award or payment of cash in exchange for an award that would otherwise occur in connection with a change in
control would, together with any other payments to the same individual that are deemed contingent on a change in control, be characterized as a "parachute payment" under Code Section&nbsp;280G, then
accelerated vesting or payment of cash in exchange for an award shall be reduced to the extent necessary to avoid the imposition of the excise tax on "excess parachute payments" required by Code
Section&nbsp;4999. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>For
purposes of the 2007 Plan, "change in control" is defined in the same manner as in the 2003 Plan, except that a person must acquire beneficial ownership of 50% or more of the company's voting
securities, rather than 30% or more, and a merger, consolidation or statutory share exchange involving the company, a sale of all or substantially all of the company's assets or the liquidation or
dissolution of the company will constitute a change in control only upon consummation of the transaction, rather than upon stockholder approval of the transaction. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Registration.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;We intend to file with the SEC a registration statement on Form&nbsp;S-8 covering the shares of our common stock issuable under the 2007
Plan. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Series&nbsp;A Restricted Stock.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;In March 2009, we issued awards to certain of our employees of restricted shares of our Series&nbsp;A preferred
stock. As of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016, there
were&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of Series&nbsp;A Restricted Stock subject to these outstanding awards. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
award agreements provide that until the shares of Series&nbsp;A Restricted Stock vest, they may not be sold, transferred or encumbered in any manner, and will be subject to forfeiture if the
award recipient's employment with us terminates for any reason. The award agreements provide that shares of the Series&nbsp;A Restricted Stock will vest upon a change in control of our company if
the holder of the Series&nbsp;A Restricted Stock is employed by our company on the date of the change in control. The award agreements generally define a "change in control" as involving
(i)&nbsp;the acquisition by a person of beneficial ownership of 50% or more of the combined voting power of the company's voting securities; (ii)&nbsp;the consummation of a merger, consolidation,
statutory share exchange or reorganization involving the company; (iii)&nbsp;the consummation of the sale of all or substantially all of the company's assets; (iv)&nbsp;a majority of the members
of the company's board ceasing to be "continuing directors"; or (v)&nbsp;the consummation of a complete liquidation or dissolution of the company. Unless otherwise provided in a separate agreement
with the company, if the vesting of Series&nbsp;A Restricted Stock upon a change in control would, together with any other payments to the same individual that are deemed contingent on a change in
control, be characterized as a "parachute payment" under Code Section&nbsp;280G, then such vesting and other payments are to be reduced to the extent necessary to avoid the imposition of the excise
tax on "excess parachute payments" required by Code Section&nbsp;4999. Mr.&nbsp;Mattys' Series&nbsp;A Restricted Stock also vests 45&nbsp;days following his termination of employment so long
as he provides a release of claims in favor of our company. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> 2016 Equity Incentive Plan.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors adopted the 2016 Plan in 2016 and our stockholders approved the 2016 Plan in 2016. The
purposes of the 2016 Plan
are to attract and retain the best available personnel, to provide them with additional incentives and to align their interests with those of our stockholders. The material terms of the 2016 Plan are
summarized below. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Share Reserve.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;As
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016,
there were no stock options or other equity-based awards outstanding under the 2016 Plan. The 2016 Plan reserves
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares for
future issuance under the plan,
plus&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares
that remained available for future grants under the 2007 Plan on the effective date of the 2016 Plan. We intend
to use up to </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>135</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=140,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=769198,FOLIO='135',FILE='DISK131:[15ZBY1.15ZBY12201]EM12201A.;43',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_em12201_1_136"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F"
SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;shares
for grants of stock options to our employees and directors effective upon completion of this offering with an exercise price equal to the offering price. The number of
shares reserved under the 2016 Plan will increase on January&nbsp;1 of each year beginning in 2017 and ending
on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;202
6 in an amount equal to the least of:
(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% of the total number of shares outstanding as of December&nbsp;31 of the immediately preceding calendar year; (ii)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares; or (iii)&nbsp;a number
of shares determined by our board of directors. Shares subject to awards under the 2016 Plan, the 2007 Plan or the 2003 Plan that expire unexercised, are cancelled or forfeited, are settled for cash
or otherwise do not result in the issuance of all or a portion of the shares subject to the award will again become available for grant under the 2016 Plan. If the payment of the exercise price of any
award under the 2016 Plan, the 2007 Plan or the 2003 Plan is made by the tendering or withholding of shares or if any applicable tax withholding obligation arising from an award under the 2016 Plan is
satisfied by the tendering or withholding of shares, the shares tendered or withheld also will again become available for grant under the 2016 Plan. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Administration of Plan.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The compensation and organization committee of our board of directors will administer the 2016 Plan, other than with respect to
awards to
our non-employee directors, which will be administered by the full board of directors. We refer to the compensation and organization committee or the board of directors, as applicable, as the plan
administrator in this section. Subject to the terms of the 2016 Plan, the compensation and organization committee has the authority to, among other things, interpret the plan and determine who is
granted awards under the plan, the types of awards granted and the terms and conditions of the awards, including the number of shares covered by awards, the vesting schedule or other restrictions
applicable to awards. The committee also has the power to make any determinations and take any action necessary or desirable for the administration of the 2016 Plan. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>To
the extent permitted by law and stock exchange rules, the 2016 Plan permits the committee to delegate to one or more of our executive officers or non-employee directors any or all of the
committee's authority under the plan with respect to awards made to individuals who are neither non-employee directors nor executive officers of our company. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Eligibility.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our employees, non-employee directors and certain consultants and advisors who provide services to us are eligible to receive awards under
the 2016
Plan. Incentive stock options may be granted only to our employees. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Equity Awards.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The 2016 Plan allows us to grant stock options, SARs, restricted stock, stock units and other stock-based awards. Each award will be
evidenced by an
agreement with the award recipient setting forth the terms and conditions of the award, including vesting conditions. Awards under the 2016 Plan will have a maximum term of ten years from the date of
grant. The plan administrator may provide that the vesting or payment of any award will be subject to the attainment of certain performance measures established by the plan administrator, and the plan
administrator will determine whether such measures have been achieved. The plan administrator at any time may amend the terms of any award previously granted, except that, in general, no amendment may
be made that materially impairs the rights of any participant with respect to an outstanding award without the participant's consent. In addition, we may amend the 2016 Plan and any award agreements
under the plan in order to ensure compliance with the requirements of Section&nbsp;409A of the Internal Revenue Code.  </FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Stock Options.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;Stock options permit the holder to
purchase a specified number of shares of our common stock at a set price. Options granted under the 2016 Plan may be either incentive or nonqualified stock options. The exercise price of options
granted under the plan generally may not be less than the fair market value of our common stock on the date of grant. Incentive stock options granted to employees who hold more than 10% of </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>136</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=141,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=409014,FOLIO='136',FILE='DISK131:[15ZBY1.15ZBY12201]EM12201A.;43',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_em12201_1_137"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>the
total combined voting power of our stock will have an exercise price not less than 110% of the fair market value of our common stock on the date of grant and will have a maximum term of
five&nbsp;years. The plan administrator will determine the terms and conditions of options granted under the 2016 Plan, including exercise price and vesting and exercisability terms. The maximum
number of shares subject to stock options that may be granted during a calendar year to a participant under the 2016 Plan may not
exceed&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.
The maximum number of shares that may be
issued upon the exercise of incentive stock options under the 2016 Plan
is&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.
</FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> SARs.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;SARs provide for payment to the holder of all or a
portion of the excess of the fair market value of a specified number of shares of our common stock on the date of exercise over a specified exercise price. Payment may be made in cash or shares of our
common stock or a combination of both, as determined by the plan administrator. The administrator will establish the terms and conditions of exercise, including the exercise price, of SARs granted
under the plan. The maximum number of shares subject to SARs that may be granted during a calendar year to a participant under the 2016 Plan may not
exceed&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.
</FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Restricted Stock.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;Restricted stock awards are awards of
shares of our common stock that are subject to vesting and the lapse of applicable restrictions determined by the plan administrator. The plan administrator will determine whether any consideration
other than services to our company must be paid for a restricted stock award. The maximum number of shares of restricted stock that may be granted during a calendar year to a participant under the
2016 Plan may not
exceed&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.
</FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Stock Units.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;Stock units provide the holder with the
right to receive, in cash or shares of our common stock or a combination of both, the fair market value of a share of our common stock and will be subject to such vesting and forfeiture conditions and
other restrictions as the plan administrator determines. The administrator will determine whether any consideration other than services to our company must be paid prior to settlement of a stock unit
award. The maximum number of stock units that may be granted during a calendar year to a participant under the 2016 Plan may not
exceed&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.
</FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Other.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;The plan administrator, in its discretion, may
grant other stock-based awards under the 2016 Plan. The administrator will set the terms and conditions of such awards. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Substitute Awards.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The plan administrator may grant awards under the 2016 Plan in substitution for awards granted by another entity acquired by our
company or with
which our company combines. The terms and conditions of these substitute awards will be comparable to the terms of the awards replaced, and may therefore differ from the terms and conditions otherwise
set forth in the 2016 Plan. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Dividend and Dividend Equivalents.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;No dividends, dividend equivalents or distributions will be paid with respect to stock options or SARs granted under
the 2016
Plan. Other than regular cash dividends, any dividends or distributions paid with respect to the unvested portion of a restricted stock award
will be subject to the same restrictions as the shares to which such dividends or distributions relate. The plan administrator may provide the holder of a stock unit award or any other stock-based
award with the right to receive dividend equivalents with respect to the shares subject to the award. Any shares issued as the result of the reinvestment of dividends or the deemed reinvestment of
dividend equivalents in connection with an award will be counted against, and replenish upon any subsequent forfeiture, the 2016 Plan's share reserve. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>137</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=142,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=746092,FOLIO='137',FILE='DISK131:[15ZBY1.15ZBY12201]EM12201A.;43',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_em12201_1_138"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Transferability.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise determined by the plan administrator, awards granted under the 2016 Plan generally are not transferable except by
will or the
laws of descent and distribution. The plan administrator may permit the transfer of awards other than incentive stock options pursuant to a domestic relations order or by way of gift to a family
member. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Termination of Service.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise provided in an award agreement (and except with respect to terminations following certain corporate
transactions described
below under "&#151;&nbsp;Change-in-Control; Corporate Transaction"), upon termination of an award recipient's service with our company, all unvested and unexercisable portions of the
recipient's outstanding awards will immediately be forfeited. If an award recipient's service with our company terminates other than for cause (as defined in the 2016 Plan), death or disability, the
vested and exercisable portions of the recipient's outstanding options and SARs generally will remain exercisable for three months after termination. If a recipient's service terminates due to death
or disability (or if a recipient dies during the three-month period after termination of service other than for cause), the vested and exercisable portions of the recipient's outstanding options and
SARs generally will remain exercisable for one year after termination. Upon termination for cause, all unexercised stock options and SARs will also be forfeited. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Change-in-Control; Corporate Transaction.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise provided in an award agreement, in the event of a sale of all or substantially all of our
assets or a
merger, consolidation, or share exchange involving our company, the surviving or successor entity may continue, assume or replace some or all of the outstanding awards under the 2016 Plan. Our award
agreements with our executive officers will typically provide that if awards granted to the executive officer under the 2016 Plan are continued, assumed or replaced in connection with such a
transaction and if within one year after the transaction the executive officer experiences an involuntary termination of service other than for cause, the executive officer's outstanding awards will
vest in full, will immediately become fully exercisable and will remain exercisable for one year following termination. If awards granted to any participant are not continued, assumed or replaced, the
plan administrator may provide: (i)&nbsp;that any outstanding stock
option or SAR will become fully exercisable for a period of time prior to the transaction and terminate at the time of the transaction; (ii)&nbsp;that any outstanding restricted stock, stock units
or other stock-based awards will vest immediately prior to the transaction, or (iii)&nbsp;for the cancellation of any outstanding award in exchange for payment to the holder of the amount of the
consideration that would have been received in the transaction for the number of shares subject to the award less the aggregate exercise price (if any) of the award. In the event of a change in
control (as defined in the 2016 Plan) that does not involve a merger, consolidation, share exchange, or sale of all or substantially all of our company's assets, the plan administrator, in its
discretion may take such action as it deems appropriate with respect to outstanding awards, which may include providing for the cancellation of any award in exchange for payment to the holder of the
amount of the consideration that would have been received in the change in control for the number of shares subject to the award less the aggregate exercise price (if any) of the award, or making
adjustments to any award to reflect the change in control, including the acceleration of vesting in full or in part. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Adjustment of Awards.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;In the event of an equity restructuring that affects the per share value of our common stock, including a stock dividend, stock
split,
spinoff, rights offering or recapitalization through an extraordinary dividend, the plan administrator will make appropriate adjustment to: (i)&nbsp;the number and kind of securities reserved for
issuance under the 2016 Plan, (ii)&nbsp;the number and kind of securities subject to outstanding awards under the 2016 Plan, (iii)&nbsp;the exercise price of outstanding options and SARs, and
(iv)&nbsp;any maximum limitations prescribed by the 2016 Plan as to grants of certain types of awards. The administrator may also make similar adjustments in the event of any other change in our
company's capitalization, including a merger, consolidation, reorganization or liquidation. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>138</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=143,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=492833,FOLIO='138',FILE='DISK131:[15ZBY1.15ZBY12201]EM12201A.;43',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_em12201_1_139"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Amendment and Termination.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The 2016 Plan will remain in effect until the tenth anniversary of the date of the 2016 Plan, or until terminated by our
board of
directors, whichever occurs first. Our board of directors may terminate, suspend or amend the plan at any time, but, in general, no termination, suspension or amendment may materially impair the
rights of any participant with respect to outstanding awards without the participant's consent. Awards that are outstanding on the 2016 Plan's termination date will remain in effect in accordance with
the terms of the plan and the applicable award agreements. Stockholder approval of any amendment of the 2016 Plan will be obtained if required by applicable law or the rules of the applicable stock
exchange. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Registration.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;We intend to file with the SEC a registration statement on Form&nbsp;S-8 covering the shares of our common stock issuable under the 2016
Plan. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Employee Stock Purchase Plan.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Prior to the completion of this offering, we expect to adopt and our stockholders to approve our Employee Stock
Purchase Plan, or
ESPP. Assuming such actions occur as expected, the ESPP will terminate on the earlier of (i)&nbsp;the date on which all shares subject to the ESPP are issued or (ii)&nbsp;the date our board of
directors terminates the ESPP. The purpose of the ESPP is to provide our employees with a convenient means of purchasing shares of our common stock at a discount to market prices through the use of
payroll deductions. The material terms of the ESPP are summarized below. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Share Reserve.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;A total
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares
of our common stock will initially be made available for sale under the ESPP. In addition, the ESPP provides for
annual increases in the number of shares available for issuance under the ESPP on January&nbsp;1 of each year beginning in 2017 and ending
on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2026
in an amount equal to the least
of: (i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% of the total number of shares outstanding as of December&nbsp;31 of the immediately preceding calendar year; (ii)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares; or (iii)&nbsp;a
number of shares determined by our board of directors. If there is any change to our outstanding common stock, such as a recapitalization, stock dividend, stock split or similar event, appropriate
adjustments will be made to the number and class of shares available under the ESPP and to the number, class and purchase price of shares subject to purchase under any pending offering. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Administration.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our compensation and organization committee will administer the ESPP. The compensation and organization committee will have full
authority to adopt
rules and procedures to administer the ESPP, to interpret the provisions of the ESPP, to determine the terms and conditions of offerings under the ESPP and to designate any subsidiaries to participate
in the ESPP. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Eligibility and Participation.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;All of our employees (including those of any participating subsidiary) other than those subject to the 5% ownership
limitation
described below are eligible to participate in the ESPP. Eligible employees may enroll in the ESPP and begin participating at the start of any purchase period. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Purchase Periods.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Shares of our common stock will be offered under the ESPP through a series of offerings, each of which consists of a single purchase
period of
six months, or such other duration (up to 27&nbsp;months) as the compensation and organization committee may prescribe. We expect that our shares will be offered under the ESPP through a series of
successive six-month purchase periods that are expected to commence
on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;each year.
Purchases under the ESPP are expected to occur on the last trading day of each
purchase period. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Purchase Price.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The purchase price of our common stock acquired on each purchase date will be no less than 85% of the lower of (i)&nbsp;the closing
market price
per share of our common stock on the first day of the applicable purchase period or (ii)&nbsp;the closing market price per share of our common stock on the purchase date at the end of the applicable
purchase period. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>139</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=144,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=727694,FOLIO='139',FILE='DISK131:[15ZBY1.15ZBY12201]EM12201A.;43',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_em12201_1_140"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Payroll Deductions and Stock Purchases.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Each participant may elect to have a percentage of eligible compensation between 1% and 15% withheld as a
payroll deduction
per pay period. The accumulated deductions will automatically be applied on each purchase date to the purchase of shares of our common stock at the purchase price in effect for that purchase date. No
more
than&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares
of our common stock may be purchased by an ESPP participant on any purchase date. For purposes of the ESPP, eligible compensation means the total cash compensation
paid to a participant, including base salary, bonuses, commissions and overtime pay, but excludes company 401(k) contributions and income with respect to equity-based awards. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Special Limitations.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The ESPP imposes certain limitations upon a participant's right to acquire our common stock, including the
following:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> purchase rights may not be granted to any individual who owns stock (including stock purchasable under any outstanding purchase
rights) possessing 5% or more of the total combined voting power or value of all classes of our stock or the stock of any of our subsidiaries; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> a participant may not be granted rights to purchase more than $25,000 worth of our common stock (valued at the time each purchase
right is granted) for each calendar year in which such purchase rights are outstanding. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Withdrawal or Termination of Purchase Rights.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;A participant may withdraw from the ESPP at any time, and his or her accumulated payroll deductions will
be promptly
refunded. A participant's purchase right will immediately terminate upon his or her cessation of employment for any reason. Any payroll deductions that the participant may have made for the purchase
period in which such cessation of employment occurs will be refunded and will not be applied to the purchase of common stock. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Transferability.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;No purchase rights will be assignable or transferable by the participant, except by will or the laws of descent and distribution.
</FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Corporate Transactions.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;If our company is acquired by merger, consolidation or other reorganization, or sells all or substantially all its assets, each
right to
acquire shares on any purchase date scheduled to occur after the date of the consummation of the acquisition transaction shall be continued or assumed or an equivalent right shall be substituted by
the surviving or successor corporation or its parent or subsidiary. If those rights are not continued, assumed or substituted, then our board of directors may terminate the ESPP or shorten the
purchase period then in progress by setting a new purchase date to occur prior to the transaction. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Share Proration.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Should the total number of shares of common stock to be purchased pursuant to outstanding purchase rights on any particular purchase
date exceed
the number of shares remaining available for issuance under the ESPP at that time, then the compensation and organization committee will make a pro-rata allocation of the available shares on a uniform
and nondiscriminatory basis. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Amendment.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors may at any time amend or suspend the ESPP. However, our board of directors may not, without stockholder approval,
amend the ESPP
to (i)&nbsp;increase the number of shares issuable under the ESPP outside of the automatic share increase feature, or (ii)&nbsp;effect any other change in the ESPP that would require stockholder
approval under applicable law or to maintain compliance with Code Section&nbsp;423. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>140</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=145,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=242796,FOLIO='140',FILE='DISK131:[15ZBY1.15ZBY12201]EM12201A.;43',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_em12201_1_141"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


401(k) Retirement Plan  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We maintain a 401(k) retirement plan that is intended to be a tax-qualified defined contribution plan under Section&nbsp;401(k) of the Internal
Revenue Code. All of our eligible employees can participate, beginning on the first day of the month following commencement of their employment. The 401(k) plan includes a salary deferral arrangement
pursuant to which participants may elect to reduce their current compensation by up to the statutorily prescribed limit, equal to $18,000 in 2016, and have the amount of the reduction contributed to
the 401(k) plan. Participants who are at least 50&nbsp;years old also can make "catch-up" contributions, which in 2016 may be up to an additional $6,000 above the statutory limit. We also make
discretionary matching contributions to our 401(k) plan equal to 3% of the employee contributions up to 3% of the employee's salary, subject to the statutorily prescribed limit, equal to $18,000 in
2016 for all employees who have been employed at least one year, other than our named executive officers, commissioned field sales representatives and certain highly compensated employees. The match
immediately vests in full. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Limitation of Liability and Indemnification  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our amended and restated certificate of incorporation, which will become effective upon completion of this offering, limits the personal liability of
directors for breach of fiduciary duty to the maximum extent permitted by the DGCL and provides that no director will have personal liability to us or to our stockholders for monetary damages for
breach of fiduciary duty or other duty as a director. However, these provisions do not eliminate or limit the liability of any of our directors:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> for any breach of the director's duty of loyalty to us or our stockholders; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law; </FONT> <FONT COLOR="#3B5A6F"
SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> for voting or assenting to unlawful payments of dividends, stock repurchases or other distributions; or </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> for any transaction from which the director derived an improper personal benefit. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Any
amendment to, or repeal of, these provisions will not eliminate or reduce the effect of these provisions in respect of any act, omission or claim that occurred or arose prior to such amendment or
repeal. If the DGCL is amended to provide for further limitations on the personal liability of directors of corporations, then the personal liability of our directors will be further limited to the
greatest extent permitted by the DGCL. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition, our amended and restated certificate of incorporation, which will become effective upon completion of this offering, provides that we must indemnify our directors and officers and we must
advance expenses, including attorneys' fees, to our directors and officers in connection with legal proceedings, subject to very limited exceptions. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
maintain a general liability insurance policy that covers certain liabilities of our directors and executive officers arising out of claims based on acts or omissions in their capacities as
directors or executive officers. In addition, we intend to enter into indemnification agreements with each of our directors and executive officers. These indemnification agreements may require us,
among other things, to indemnify each such director or executive officer for some expenses, including attorneys' fees, judgments, fines and settlement amounts incurred by him or her in any action or
proceeding arising out of his or her service as one of our directors or executive officers. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>141</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=146,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=309429,FOLIO='141',FILE='DISK131:[15ZBY1.15ZBY12201]EM12201A.;43',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_em12201_1_142"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Certain
of our non-employee directors may, through their relationships with their employers, be insured and/or indemnified against certain liabilities incurred in their capacity as members of our
board of directors. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, executive officers or persons controlling us, in the opinion of the SEC, such indemnification
is against public policy as expressed in the Securities Act and is therefore unenforceable. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Rule&nbsp;10b5-1 Sales Plans  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our directors and executive officers may adopt written plans, known as Rule&nbsp;10b5-1 plans, in which they will contract with a broker to buy or
sell shares of our common stock on a periodic basis. Under a Rule&nbsp;10b5-1 plan, a broker executes trades pursuant to parameters established by the director or officer when entering into the
plan, without further direction from the director or officer. It also is possible that the director or officer could amend or terminate the plan when not in possession of material, nonpublic
information. In addition, our directors and executive officers may buy or sell additional shares outside of a Rule&nbsp;10b5-1 plan when they are not in possession of material, nonpublic
information. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>142</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=11,SEQ=147,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=463320,FOLIO='142',FILE='DISK131:[15ZBY1.15ZBY12201]EM12201A.;43',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_eo12201_1_143"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="eo12201_certain_relationships_and_related_party_transactions"> </A>
<A NAME="toc_eo12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In addition to the director and executive compensation arrangements discussed above under "Executive Compensation," we have been a party to the
following transactions since January&nbsp;1, 2013, in which the amount exceeded or will exceed $120,000, and in which any director, executive officer or holder of more than 5% of any class of our
voting stock, or any member of the immediate family of or entities affiliated with any of them, had or will have a material interest. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Series&nbsp;B Preferred Stock Financing  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In September and October 2012, we issued&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our Series&nbsp;B preferred stock at an issuance price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share for aggregate consideration of approximately $10.4&nbsp;million to a total of 18 investors, including Galen Partners and affiliated entities and Radius
Ventures III&nbsp;LP and affiliated entities, each of which holds 5% or more of our capital stock and is represented on our board of directors, as well as certain of our directors or their
affiliates, including Worthy Ventures Resources LLC (an affiliate of Peter Soderberg), Richard Nigon and Kevin Roche. In connection with the closing of the offering contemplated by this prospectus,
such shares of Series&nbsp;B preferred stock will convert to common stock at a ratio of 1-to-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. The following table summarizes purchases of Series&nbsp;B preferred stock by
such
investors: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="83pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="134pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;width:66pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Stockholder Name

<!-- COMMAND=ADD_SCROPPEDRULE,66pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Shares of Series&nbsp;B </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Series&nbsp;B Total Purchase Price </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Galen Partners</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,400,131</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Radius Ventures</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,400,131</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Worthy Ventures Resources LLC</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>300,010</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Richard Nigon (IRA)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>21,761</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Kevin Roche</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>21,761</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Amended and Restated Investors' Rights Agreement  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In September 2012, in connection with the closing of our Series&nbsp;B preferred stock financing, we entered into an amended and restated
investors' rights agreement with certain holders of our preferred stock, including entities with which certain of our directors are affiliated. Pursuant to this agreement, holders of our preferred
stock, including certain holders of 5% of our capital stock and entities affiliated with certain of our directors, were granted certain registration rights, including the right to demand that we
file&nbsp;a registration statement or request that their shares be covered by a registration statement that we are otherwise filing. The investors' rights agreement also provides for a right of
first offer in favor of certain holders of our stock with regard to certain issuances of our capital stock. The rights of first offer will not apply to, and will terminate upon, the completion of this
offering. For a more detailed description of these registration rights, see "Description of Capital Stock&nbsp;&#151; Registration Rights." </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Voting Agreement  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We are party to a voting agreement under which certain holders of our capital stock, including entities with which certain of our directors are
affiliated, have agreed to vote their shares in a certain way on certain matters, including with respect to the election of directors. The voting agreement also provides for drag-along rights
requiring the stockholders party to this agreement to participate in a sale of our company or a deemed liquidation event under this agreement if any such matter is approved by a certain percentage of
the stockholders party to the agreement. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Upon
the completion of this offering, the voting agreement will terminate in its entirety and none of our stockholders will have any special rights regarding the election or designation of members of
our board of directors or the other rights granted under this agreement. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>143</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=148,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=308367,FOLIO='143',FILE='DISK131:[15ZBY1.15ZBY12201]EO12201A.;51',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_eo12201_1_144"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Right of First Refusal and Co-Sale Agreement  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We are party to a right of first refusal and co-sale agreement pursuant to which our preferred stockholders, including certain holders of 5% of our
capital stock and entities affiliated with certain of our directors, are granted a right of first refusal to purchase shares of our capital stock held by the stockholders party to this agreement and
rights of co-sale in the event of a sale of our capital stock held by the stockholders party to this agreement. The right of first offer and co-sale agreement, and the associated rights described
therein, will not apply to, and will terminate upon, the completion of this offering. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Indemnification Agreements  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our amended and restated certificate of incorporation, which will be effective upon the completion of this offering, will contain provisions limiting
the liability of directors, and our amended and restated certificate of incorporation and our amended and restated bylaws will provide that we will indemnify each of our directors to the fullest
extent permitted under Delaware law. Our amended and restated certificate of incorporation and amended and restated bylaws will also provide our board of directors with discretion to indemnify our
employees and agents when determined appropriate by the board. In addition, we intend to enter into agreements to indemnify our directors and executive officers. For more information regarding these
agreements, see "Executive Compensation&nbsp;&#151; Limitation of Liability and Indemnification." </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Change in Control Agreements  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Certain of our executive officers will be entitled to change in control benefits pursuant to the terms of our equity incentive plans and pursuant to
the terms of their employment agreements that we intend to enter into prior to the completion of this offering, as described in greater detail in "Executive Compensation&nbsp;&#151; Potential
Payments Upon Termination or Change-In-Control." </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Executive Compensation Awards  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We have approved equity compensation awards for our officers and directors to be made upon the completion of this offering. These are described in
greater detail in "Executive Compensation&nbsp;&#151; Stock Option and Other Equity Compensation Plans." </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Directed Share Program  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>At our request, the underwriters have reserved for sale at the initial public offering price up to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock, or
5% of the shares offered by this prospectus, for our employees, directors and other persons associated with us. The participants in the directed share program are subject to the 180-day lock-up
restriction described in the "Underwriting" section of this prospectus, with respect to the directed shares sold to them. The number of shares of common stock available for sale to the general public
in the offering will be reduced by the number of shares sold pursuant to the directed share program. Any directed shares not so purchased will be offered by the underwriters to the general public on
the same terms as the other shares offered by this prospectus. The directed share program will be arranged through Piper Jaffray&nbsp;&amp;&nbsp;Co. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Policy for Approval of Related Party Transactions  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Prior to the completion of this offering, our board of directors will adopt a written statement of policy regarding transactions with related
persons, which we refer to as our related person policy. Our related person policy will cover any transaction, arrangement or relationship, or any series of similar transactions, arrangements or
relationships in which we were or are to be a participant, the amount involved exceeds $120,000 and a related person had or will have a direct or indirect material interest, including, without
limitation, purchases of goods or services by or from the related person or entities in which the related person has a material interest, indebtedness, guarantees of indebtedness or employment by us
of a related person. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>144</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=149,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=43210,FOLIO='144',FILE='DISK131:[15ZBY1.15ZBY12201]EO12201A.;51',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_eo12201_1_145"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="eo12201_principal_stockholders"> </A>
<A NAME="toc_eo12201_2"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  PRINCIPAL STOCKHOLDERS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The following table sets forth information with respect to the beneficial ownership of our common stock, as
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016 by each person
known by us to beneficially own more than 5% of our common stock, each of our directors, each of our named executive officers and all of our current directors and executive officers as a group. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
column entitled "Percentage of Shares Beneficially Owned&#151;Before Offering" is based on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock outstanding as
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016,
assuming the conversion of all outstanding shares of our preferred stock into common stock immediately prior to the completion of this offering. The column entitled "Percentage of Shares Beneficially
Owned&#151;After Offering" is based on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock to be outstanding after this offering, assuming (a)&nbsp;the conversion of all outstanding shares of
our preferred stock into an aggregate&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock immediately prior to the completion of this offering; (b)&nbsp;the issuance
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional shares
of common stock to which our Series&nbsp;A and Series&nbsp;B preferred stockholders are entitled immediately prior to the completion of this offering issuable in connection with the initial public
offering, assuming an initial offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus; and
(c)&nbsp;the issuance of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock immediately prior to the completion of this offering to pay accrued dividends on our Series&nbsp;B preferred stock
(assuming
a closing date of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016 and an initial offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering price range set forth on the cover page of this
prospectus). The table below excludes any shares of common stock that may be purchased in this offering pursuant to the directed share program or otherwise. See "Underwriting." </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
number of shares beneficially owned by each stockholder is determined under rules issued by the SEC and includes voting or investment power with respect to securities. Under these rules,
beneficial ownership includes any shares as to which the individual or entity has sole or shared voting power or investment power. In computing the number of shares beneficially owned by an individual
or entity and the percentage ownership of that person, shares of common stock subject to options, warrants or other rights held by such person that are currently exercisable, or will become
exercisable within 60&nbsp;days of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016, are considered outstanding, although these
shares are not considered outstanding for purposes of computing the percentage ownership of any
other person. Except as indicated by the footnotes below, we believe, based on information furnished to us, that the persons and entities named in the table below have sole voting and sole investment
power with respect to all shares of common stock that they beneficially owned, subject to applicable community property laws. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>145</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=150,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=928047,FOLIO='145',FILE='DISK131:[15ZBY1.15ZBY12201]EO12201A.;51',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_eo12201_1_146"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Unless
otherwise indicated, the address of all listed stockholders is c/o Tactile Systems Technology,&nbsp;Inc., 1331 Tyler Street NE, Suite&nbsp;200, Minneapolis, MN 55413. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="91pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="73pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Percentage of Shares<BR>
Beneficially Owned </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;width:21pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,21pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Number of Shares<BR>
Beneficially Owned </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Before Offering </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>After Offering </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B><I>5% Stockholders</I></B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Galen Partners&nbsp;V L.P.<SUP>(1)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Radius Ventures III QP&nbsp;LP<SUP>(2)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B><I>Named Executive Officers and Directors</I></B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Peter H. Soderberg</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Gerald R. Mattys</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>William W. Burke</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Jordan S. Davis</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Richard Nigon</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Kevin H. Roche</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Stephen I. Shapiro</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Zubeen Shroff</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Robert J. Folkes</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Bryan F. Rishe</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>All executive officers and directors as a group (12&nbsp;persons)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Galen
Partners V,&nbsp;L.P. has one general partner, Galen Partners V,&nbsp;LLC, which has sole voting and investment control over the shares of our
common stock held by Galen Partners V,&nbsp;L.P. and is the beneficial owner of the shares held by Galen Partners&nbsp;V, L.P. Galen Partners V,&nbsp;LLC has three voting partners, including
Zubeen Shroff, one of our directors, David W. Jahns and L.&nbsp;John Wilkerson.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(2)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Jordan
Davis, one of our directors, and Dan Lubin are the Managing Members of Radius Ventures III QP&nbsp;LP and hold the shared voting and/or dispositive
power with respect to the shares of our common stock held by Radius Ventures III QP&nbsp;LP. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>146</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=151,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=369534,FOLIO='146',FILE='DISK131:[15ZBY1.15ZBY12201]EO12201A.;51',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_eq12201_1_147"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="eq12201_description_of_capital_stock"> </A>
<A NAME="toc_eq12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  DESCRIPTION OF CAPITAL STOCK    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>The following is a description of the material provisions of our capital stock, as well as other material terms of our
amended and restated certificate of incorporation and amended and restated bylaws as they will be in effect as of the consummation of the offering. We refer you to the form of our amended and restated
certificate of incorporation and to the form of our amended and restated bylaws, copies of which have been filed as exhibits to the registration statement of which this prospectus forms&nbsp;a
part.</I></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Authorized Capital  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Immediately prior to the completion of this offering and the following the filing of the amended and restated certificate of incorporation, our
authorized capital stock will
consist of (i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock, par value $0.001 per share, and (ii)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of undesignated preferred stock, par value $0.001 per
share. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As
of September&nbsp;30, 2015, there were issued and outstanding:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock held of record
by&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;stockholders; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>

<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our Series&nbsp;A preferred
stock held of record by&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;stockholders; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our Series&nbsp;B preferred
stock held of record by&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;stockholders; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> options to purchase&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our
common stock held of record by&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;option holders; and </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> warrants to purchase&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our
common stock held of record by&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;warrant holders. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Immediately
prior to the completion of this offering, all currently outstanding shares of our Series&nbsp;A and Series&nbsp;B preferred stock will be converted into shares of a single class of
common stock. Our Series&nbsp;A preferred stock will convert to common stock at a ratio of 1-for-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and our Series&nbsp;B preferred stock will convert to common stock at a
ratio of
1-for-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. In addition, upon completion of this offering, (a)&nbsp;each Series&nbsp;A preferred stockholder is entitled to receive the number of common shares equal to the
Series&nbsp;A original issue price divided by the initial public offering price per share in this offering; and (b)&nbsp;each Series&nbsp;B preferred stockholder is entitled to receive the
number of common shares equal to the Series&nbsp;B preferred stock original issue price divided by the initial public offering price per share in this offering. Therefore, we expect to issue
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional shares of common stock immediately prior to the
completion of this offering that our Series&nbsp;A and Series&nbsp;B preferred stockholders are entitled to receive in connection with this initial public offering, assuming an initial offering
price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus. Finally, immediately prior to the
completion of this
offering, each Series&nbsp;B preferred stockholder is entitled to receive the number of common shares equal to the accrued dividends on the shares of Series&nbsp;B preferred stock divided by the
original issue price of the Series&nbsp;B preferred stock divided by the initial public offering price per share in this offering. Therefore, we expect to
issue&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additi
onal shares of
common stock to pay accrued dividends on our Series&nbsp;B preferred stock (assuming a closing date
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016 and an initial offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the
midpoint of the estimated offering price range set forth on the cover page of this prospectus). </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>147</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=152,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=353355,FOLIO='147',FILE='DISK131:[15ZBY1.15ZBY12201]EQ12201A.;33',USER='JKEENE',CD='25-JAN-2016;09:51' -->
<A NAME="page_eq12201_1_148"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Assuming
the conversion of all outstanding shares of our preferred stock into shares of common stock, assuming a closing date
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016 and an initial offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus, immediately following the completion of this offering, we expect to have
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock and no shares of preferred stock outstanding (or&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of
common stock and no shares of preferred stock outstanding if the
underwriters exercise in full their option to purchase additional shares). A $1.00 decrease (increase) in the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share would
increase
(decrease) the number of additional shares of common stock issuable in connection with the conversion of our preferred stock by&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares. A $1.00 decrease (increase) in
the
assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share would increase (decrease) the number of additional shares of common stock issuable in connection with paying the accrued
dividends
on our Series&nbsp;B preferred stock by&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Common Stock  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Pursuant to our amended and restated certificate of incorporation, holders of our common stock will be entitled to one vote on all matters submitted
to a vote of stockholders, except as otherwise expressly provided in our amended and restated certificate of incorporation or as required by applicable law. We have not provided for cumulative voting
for the election of directors. As a result, the holders of a majority of the voting shares will be able to elect all of the directors then standing for election, if they should so choose. Subject to
the rights, if any, of the holders of any outstanding series of preferred stock, holders of our common stock shall be entitled to receive dividends out of any of our funds legally available when, as
and if declared by the board of directors. Upon our liquidation, dissolution or winding-up, the holders of common stock would be entitled to share ratably in all assets remaining after payment of all
debts and other liabilities and the satisfaction of any liquidation preferences granted to the holders of outstanding shares of preferred stock. Holders of common stock have no preemptive or
conversion rights or other subscription rights. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Preferred Stock  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Immediately prior to the completion of this offering, all currently outstanding shares of our Series&nbsp;A and Series&nbsp;B preferred stock
will be converted into shares of a single class of common stock. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Following
this offering, our amended and restated certificate of incorporation provides that we may issue up
to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares
of preferred stock in one or more series as may be determined by
our board of directors. Our board of directors has broad discretionary authority with respect to the rights of any new series of preferred stock and may establish the following with respect to the
shares in each series, without any vote or action of the stockholders:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the number of shares; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the designations, preferences and relative rights, including voting rights, dividend rights, conversion rights, redemption privileges
and liquidation preferences; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> any qualifications, limitations or restrictions. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
believe that the ability of our board of directors to issue one or more series of preferred stock will provide us with flexibility in structuring possible future financings and acquisitions, and in
meeting other corporate needs that may arise. The authorized shares of preferred stock, as well as authorized and unissued shares of common stock, will be available for issuance without action by our
stockholders, unless such action is required by applicable law or the rules of any stock exchange or automated quotation system on which our securities may be listed or traded. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>148</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=153,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=168511,FOLIO='148',FILE='DISK131:[15ZBY1.15ZBY12201]EQ12201A.;33',USER='JKEENE',CD='25-JAN-2016;09:51' -->
<A NAME="page_eq12201_1_149"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
board of directors may authorize, without stockholder approval, the issuance of preferred stock with voting and conversion rights that could adversely affect the voting power and other rights of
holders of common stock. Although our board of directors has no current intention of doing so, it could issue a series of preferred stock that could, depending on the terms of such series, impede the
completion of a merger, tender offer or other takeover attempt of our company. Our board of directors could also issue preferred stock having terms that could discourage an acquisition attempt through
which an acquiror may be able to change the composition of our board of directors, including a tender offer or other transaction that some, or a majority, of our stockholders might believe to be in
their best interests or in which stockholders might receive a premium for their stock over the then-current market price. Any issuance of preferred stock therefore could have the effect of decreasing
the market price of our common stock. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
board of directors will make any determination to issue such shares based on its judgment as to the best interests of our company and stockholders. We have no current plan to issue any preferred
stock after this offering. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Registration Rights  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Following the completion of this offering, the holders of our common stock issued upon conversion of our preferred stock or their permitted
transferees are entitled to certain rights with respect to registration of these shares under the Securities Act. These rights are provided under the terms of an investors' rights agreement between us
and the holders of these shares, which was entered into in connection with our preferred stock financings, and include demand registration rights, piggyback registration rights and Form&nbsp;S-3
registration rights, subject to certain exceptions. In any registration made pursuant to such investors' rights agreement, all fees, costs and expenses of underwritten registrations will be borne by
us, and all selling expenses, including underwriting discounts and commissions, will be borne by the holders of the shares being registered, subject to certain exceptions. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
registration rights terminate three years following the completion of this offering or, with respect to any particular stockholder, at such time that the stockholder can sell all of its shares
during any three-month period pursuant to Rule&nbsp;144 of the Securities Act. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Demand Registration Rights.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Following the completion of this offering, the holders of an aggregate
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock, or their permitted
transferees, are entitled to certain demand registration rights. Under the terms of the investors' rights agreement, we will be required, upon the written request at any time more than 180&nbsp;days
after the effective date of the registration statement of which this prospectus forms&nbsp;a part of holders of at least a majority of the shares that are entitled to registration rights under the
investors' rights agreement and so long as the anticipated aggregate offering price of the shares to be offered and sold under such registration statement on Form&nbsp;S-1 is at least
$10&nbsp;million (net of underwriting discounts and commissions, stock transfer taxes and any other expenses of the such stockholders), to register, within 60&nbsp;days after receiving such
request, all of these shares plus any additional shares requested to be included in such registration requested by any other stockholders within 20&nbsp;days after notice of such registration is
mailed by us. We are required to effect only three registrations pursuant to this provision of the investors' rights agreement. We will not be required to effect a demand registration during the
period from 60&nbsp;days prior to the filing to 90&nbsp;days following the effectiveness of a registration statement relating to a public offering of our securities. These registration rights are
subject to specified conditions and limitations, including our ability to defer the filing of a registration statement with respect to an exercise of such Form&nbsp;S-3 registration rights for up to
90&nbsp;days under certain circumstances. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>149</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=154,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=242526,FOLIO='149',FILE='DISK131:[15ZBY1.15ZBY12201]EQ12201A.;33',USER='JKEENE',CD='25-JAN-2016;09:51' -->
<A NAME="page_eq12201_1_150"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Piggyback Registration Rights.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Following the completion of this offering, the holders of an aggregate
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock or their
permitted transferees are entitled to certain piggyback registration rights. If we register any of our securities for our own account after the completion of this offering, the holders of these shares
are entitled to include their shares in the registration upon written request made within 20&nbsp;days after notice of such registration is mailed by us. Both we and the underwriters of any
underwritten offering have the right to limit the number of shares registered by these holders for marketing reasons, subject to limitations set forth in the investors' rights agreement. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Form&nbsp;S-3 Registration Rights.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Following the completion of this offering, the holders of an aggregate
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock,
or their permitted transferees, are entitled to certain Form&nbsp;S-3 registration rights, upon the written request of the holders of at least 20% of the shares that are entitled to registration
rights under the investors' rights agreement and so long as the aggregate amount of shares to be offered and sold under such registration statement on Form&nbsp;S-3 is at least $2.5&nbsp;million
(net of underwriting discounts and commissions, stock transfer taxes and any other expenses of the such stockholders). We are only obligated to file up to two registration statements on
Form&nbsp;S-3 within a 12-month period. We will not be required to effect a demand registration during the period from 60&nbsp;days prior to the filing to 90&nbsp;days following the
effectiveness of a registration statement relating to a public offering of our securities. These registration rights are subject to specified conditions and
limitations, including our ability to defer the filing of a registration statement with respect to an exercise of such Form&nbsp;S-3 registration rights for up to 90&nbsp;days under certain
circumstances. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Anti-Takeover Effects of Delaware Law and Our Certificate of Incorporation and Bylaws  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Delaware Law.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;We are subject to Section&nbsp;203 of the Delaware General Corporation Law. Section&nbsp;203 generally prohibits a public Delaware
corporation
from engaging in a "business combination" with an "interested stockholder" for a period of three years after the date of the transaction in which the person became an interested stockholder,
unless:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> prior to the date of the transaction, the board of directors of the corporation approved either the business combination or the
transaction which resulted in the stockholder becoming an interested stockholder; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction
commenced, excluding for purposes of determining the number of shares outstanding (a)&nbsp;shares owned by persons who are directors and also officers and (b)&nbsp;shares owned by employee stock
plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> on or subsequent to the date of the transaction, the business combination is approved by the board and authorized at an annual or
special meeting of stockholders, and not by written consent, by the affirmative vote of at least two-thirds of the outstanding voting stock which is not owned by the interested stockholder. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Section&nbsp;203
defines a business combination to include:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> any merger or consolidation involving the corporation and the interested stockholder; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> any sale, transfer, pledge or other disposition involving the interested stockholder of 10% or more of the assets of the corporation;
</FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>150</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=155,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=82764,FOLIO='150',FILE='DISK131:[15ZBY1.15ZBY12201]EQ12201A.;33',USER='JKEENE',CD='25-JAN-2016;09:51' -->
<A NAME="page_eq12201_1_151"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> subject to exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to
the interested stockholder; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits
provided by or through the corporation. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
general, Section&nbsp;203 defines an interested stockholder as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation or any entity or person
affiliated with or controlling or controlled by the entity or person. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A
Delaware corporation may opt out of this provision by express provision in its original certificate of incorporation or by amendment to its certificate of incorporation or bylaws approved by its
stockholders. However, we have not opted out of, and do not currently intend to opt out of, this
provision. The statute could prohibit or delay mergers or other takeover or change in control attempts and, accordingly, may discourage attempts to acquire us. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Provisions of our amended and restated certificate of
incorporation and amended
and restated bylaws, each of which will become effective upon completion of this offering, may delay or discourage transactions involving an actual or potential change in control of our company or
change in our management, including transactions in which stockholders might otherwise receive a premium for their shares, or transactions that our stockholders might otherwise deem to be in their
best interests. Therefore, these provisions could adversely affect the price of our common stock. Among other things, our amended and restated certificate of incorporation and amended and restated
bylaws:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> permit our board of directors to issue up to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of preferred stock, with any
rights, preferences and
privileges as they may designate, including the right to approve an acquisition or other change in our control; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> provide that the authorized number of directors may be changed by resolution of the board of directors; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> provide that all vacancies, including newly created directorships, may, except as otherwise required by law, be filled by the
affirmative vote of a majority of directors then in office, even if less than a quorum; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> divide our board of directors into three classes; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> provide that directors may only be removed for cause by the holders of at least three-fourths of the voting power of the shares
eligible to vote for directors; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> provide that a special meeting of stockholders may be called only by our chief executive officer, the chairman of our board of
directors or by a resolution adopted by a majority of our board of directors; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> require that any action to be taken by our stockholders must be effected at a duly called annual or special meeting of stockholders
and not be taken by written consent; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> provide that our by-laws may be amended or repealed by a majority vote of our board of directors or the affirmative vote of the
holders of at least two-thirds of the votes that all our stockholders would be entitled to cast in an election of directors; </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>151</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=156,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=875589,FOLIO='151',FILE='DISK131:[15ZBY1.15ZBY12201]EQ12201A.;33',USER='JKEENE',CD='25-JAN-2016;09:51' -->
<A NAME="page_eq12201_1_152"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> provide that stockholders seeking to present proposals before a meeting of stockholders or to nominate candidates for election as
directors at a meeting of stockholders must provide notice in writing in a timely manner, and also specify requirements as to the form and content of a stockholder's notice; and </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> do not provide for cumulative voting rights (therefore allowing the holders of a majority of the shares of common stock entitled to
vote in any election of directors to elect all of the directors standing for election, if they should so choose). </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
amended and restated certificate of incorporation provides that, unless we consent in writing to the selection of an alternative forum, any or all internal corporate claims, which shall include
claims, including claims in the right of our company, (i)&nbsp;that are based upon a violation of a duty by a current
or former director or officer or stockholder in such capacity, or (ii)&nbsp;as to which Title 8 of the Delaware General Corporation Law confers jurisdiction upon the Delaware Court of Chancery,
shall be brought solely and exclusively in a state court located within the State of Delaware (or, if no state court located in the State of Delaware has jurisdiction, the federal district court for
the District of Delaware). It is possible that a court of law could rule that the choice of forum provision contained in our certificate of incorporation is inapplicable or unenforceable if it is
challenged in a proceeding or otherwise. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
amendment of any of the above provisions, except for the provision making it possible for our board of directors to issue preferred stock and the provision prohibiting cumulative voting, would
require approval by holders of at least two-thirds in voting power of the outstanding shares of stock entitled to vote thereon. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Limitation on Liability of Directors and Indemnification.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our amended and restated certificate of incorporation limits the liability of our
directors to the
fullest extent permitted by Delaware law. Delaware law provides that directors of a corporation will not be personally liable for monetary damages for breach of their fiduciary duties as directors,
except for liability for any:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> breach of their duty of loyalty to us or our stockholders; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> unlawful payment of dividends or unlawful stock repurchases or redemption of shares as provided in Section&nbsp;174 of the Delaware
General Corporation Law; or </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> transaction from which the directors derived an improper personal benefit. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>These
limitations of liability do not apply to liabilities arising under federal securities laws and do not affect the availability of equitable remedies such as injunctive relief or rescission. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
amended and restated bylaws, in the form that will become effective upon the completion of this offering, provide that we will indemnify and advance expenses to our directors and officers to the
fullest extent permitted by law or, if applicable, pursuant to indemnification agreements. They further provide that we may choose to indemnify other employees or agents of the corporation from time
to time. Section&nbsp;145(g) of the Delaware General Corporation Law and our bylaws also permit us to secure insurance on behalf of any officer, director, employee or other agent for any liability
arising out of his or her actions in connection with their services to us, regardless of whether our bylaws permit indemnification. We intend to obtain a directors' and officers' liability insurance
policy prior to the completion of this offering. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>152</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=157,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=4884,FOLIO='152',FILE='DISK131:[15ZBY1.15ZBY12201]EQ12201A.;33',USER='JKEENE',CD='25-JAN-2016;09:51' -->
<A NAME="page_eq12201_1_153"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
will enter into separate indemnification agreements with our directors and officers, in addition to the indemnification provisions set forth in our bylaws. These agreements, among other things,
will require us to indemnify our directors and officers for certain expenses, including attorneys' fees, judgments, fines and settlement amounts incurred by a director or officer in any action or
proceeding arising out of his or her services as one of our directors or officers, including services provided to any subsidiary or any other company or enterprise to which the person provides
services at our request. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>At
present, there is no pending litigation or proceeding involving any of our directors or officers as to which indemnification is required or permitted, and we are not aware of any threatened
litigation or proceeding that may result in a claim for indemnification. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of ours pursuant to the foregoing provisions, or otherwise,
in the opinion of the SEC, this indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Transfer Agent and Registrar  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The transfer agent and registrar for our common stock is Computershare Trust Company, N.A. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stock Exchange Listing  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We have applied to have our common stock listed on The NASDAQ Global Market under the symbol "TCMD." </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>153</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=158,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=454990,FOLIO='153',FILE='DISK131:[15ZBY1.15ZBY12201]EQ12201A.;33',USER='JKEENE',CD='25-JAN-2016;09:51' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_es12201_1_154"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="es12201_shares_eligible_for_future_sale"> </A>
<A NAME="toc_es12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  SHARES ELIGIBLE FOR FUTURE SALE    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Prior to this offering, there was no public market for our common stock. We cannot predict the effect, if any, that market sales of shares of our
common stock or the availability of shares of our common stock for sale will have on the market price of our common stock. Sales of substantial amounts of our common stock in the public market could
adversely affect the market prices of our common stock and could impair our future ability to raise capital through the sale of our equity securities. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Based
on our outstanding shares as
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016,
and assuming (a)&nbsp;the issuance of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock in this offering;
(b)&nbsp;the conversion of all
outstanding shares of our preferred stock into an aggregate&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock
immediately prior to the completion of this offering; (c)&nbsp;the issuance of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
additional shares of common stock immediately prior to the completion of this offering issuable in connection with the conversion of our preferred stock; and (d)&nbsp;the issuance
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
shares of common stock immediately prior to the completion of this offering to pay accrued dividends on our Series&nbsp;B preferred stock (assuming a closing date of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016), upon completion of this offering, we will have
outstanding a total of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock
(or&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares if the
underwriters' option to purchase additional shares is exercised in full). Of these shares, all of the shares sold in this offering (plus any shares sold as a result of the underwriters' exercise of
their option) will be freely tradable without restriction or
further registration under the Securities Act, unless those shares are purchased by our directors and officers in the directed share program or by our affiliates as that term is defined in
Rule&nbsp;144 under the Securities Act. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
remaining&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;sh
ares of common stock to be outstanding after this offering will be "restricted securities" under Rule&nbsp;144. Of these restricted securities,
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares
will be subject to transfer restrictions for 180&nbsp;days from the date of this prospectus pursuant to lock-up agreements. Restricted securities may be sold in the public market only if they have
been registered or if they qualify for an exemption from registration under Rules&nbsp;144 or 701 or otherwise under the Securities Act. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Lock-up Agreements  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our officers and directors and other holders of substantially all of our outstanding common stock, preferred stock, options and warrants are subject
to lock-up agreements pursuant to which they have agreed, subject to limited exceptions, not to offer, sell, or otherwise transfer or dispose of, directly or indirectly, any shares of common stock or
securities convertible into or exchangeable or exercisable for shares of common stock for a period of 180&nbsp;days from the date of this prospectus without the prior written consent of Piper
Jaffray&nbsp;&amp;&nbsp;Co. and William Blair&nbsp;&amp; Company, L.L.C. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Rule&nbsp;144  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Affiliate resales of restricted securities.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;In general, beginning 90&nbsp;days after the effective date of the registration statement of which
this prospectus is
a part, a person who is an affiliate of ours, or who was an affiliate at any time during the three months before a sale, who has beneficially owned shares of our common stock for at least six months
would be entitled to sell in "broker's transactions" or certain "riskless principal transactions" or to market makers, a number of shares within any three-month period that does not exceed the greater
of:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1% of the number of shares of our common stock then outstanding, which will equal
approximately&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;shares immediately
after this offering; or </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>154</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=159,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=913362,FOLIO='154',FILE='DISK131:[15ZBY1.15ZBY12201]ES12201A.;30',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_es12201_1_155"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the average weekly trading volume in our common stock
on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;during the four calendar weeks preceding the filing of a
notice on Form&nbsp;144 with respect to such sale. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Affiliate
resales under Rule&nbsp;144 also are subject to the availability of current public information about us. In addition, if the number of shares being sold under Rule&nbsp;144 by an
affiliate during any three-month period exceeds 5,000 shares or has an aggregate sale price in excess of $50,000, the seller must file&nbsp;a notice on Form&nbsp;144 with the SEC and NASDAQ
concurrently with either the placing of a sale order with the broker or the execution directly with a market maker. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Non-affiliate resales of restricted securities.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;In general, beginning 90&nbsp;days after the effective date of the registration statement of
which this
prospectus is a part, a person who is not an affiliate of ours at the time of sale, and has not been an affiliate at any time during the three months preceding a sale, and who has beneficially owned
shares of our common stock for at least six months but less than a year, is entitled to sell such shares subject only to the availability of current public information about us. If such person has
held our shares for at least one year, such person can resell under Rule&nbsp;144(b)(1) without regard to any Rule&nbsp;144 restrictions, including the 90-day public company requirement and the
current public information requirement. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Non-affiliate
resales are not subject to the manner of sale, volume limitation or notice filing provisions of Rule&nbsp;144. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Rule&nbsp;701  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In general, under Rule&nbsp;701, any of an issuer's employees, directors, officers, consultants or advisors who purchases shares from the issuer in
connection with a compensatory stock or option plan or other written agreement before the effective date of a registration statement under the Securities Act is entitled to sell such shares
90&nbsp;days after such effective date in reliance on Rule&nbsp;144. An affiliate of the issuer can resell shares in reliance on Rule&nbsp;144 without having to comply with the holding period
requirement, and non-affiliates of the issuer can resell shares in reliance on Rule&nbsp;144 without having to comply with the current public information and holding period requirements. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
SEC has indicated that Rule&nbsp;701 will apply to typical stock options granted by an issuer before it becomes subject to the reporting requirements of the Exchange Act, along with the shares
acquired upon exercise of such options, including exercises after an issuer becomes subject to the reporting requirements of the Exchange Act. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Equity Plans  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We intend to file one or more registration statements on Form&nbsp;S-8 under the Securities Act to register all shares of common stock subject to
outstanding stock options and shares of common stock issued or issuable under our stock plans. We expect to file the registration statement covering shares offered pursuant to our stock plans on or
shortly after the date of this prospectus, permitting the resale of such shares by non-affiliates in the public market without restriction under the Securities Act and the sale by affiliates in the
public market, subject to compliance with the resale provisions of Rule&nbsp;144. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Registration Rights  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>After the completion of this offering, holders
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares
of common stock will be entitled to specific rights to register those shares
for sale in the public market. See "Description of Capital Stock&nbsp;&#151; Registration Rights." Registration of these shares under the Securities Act would result in the shares becoming
freely tradable without restriction under the Securities Act, except for shares purchased by affiliates, immediately upon the effectiveness of the registration statement relating to such shares. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>155</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=160,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=533263,FOLIO='155',FILE='DISK131:[15ZBY1.15ZBY12201]ES12201A.;30',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_eu12201_1_156"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="eu12201_material_u.s._federal_income_t__mat02369"> </A>
<A NAME="toc_eu12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The following discussion is a summary of the material U.S. federal income tax consequences to non-U.S. holders (as defined below) of the purchase,
ownership and disposition of our common stock issued pursuant to this offering, but does not purport to be a complete analysis of all potential tax effects. The effects of other U.S. federal tax laws,
such as estate and gift tax laws, and any applicable state, local or foreign tax laws are not discussed. This discussion is based on the U.S. Internal Revenue Code of 1986, as amended, or the Code,
Treasury Regulations promulgated thereunder, judicial decisions, and published rulings and administrative pronouncements of the U.S. Internal Revenue Service, or the IRS, in effect as of the date of
this offering. These authorities may change or be subject to differing interpretations. Any such change or differing interpretation may be applied retroactively in a manner that could adversely affect
a non-U.S. holder of our common stock. We have not sought and will not seek any rulings from the IRS regarding the matters discussed below. There can be no assurance the IRS or a court will not take a
contrary position regarding the tax consequences of the purchase, ownership and disposition of our common stock. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>This
discussion is limited to non-U.S. holders that hold our common stock as a "capital asset" within the meaning of Section&nbsp;1221 of the Code (generally, property held for investment). This
discussion does not address all U.S. federal income tax consequences relevant to a non-U.S. holder's particular circumstances, including the impact of the Medicare contribution tax on net investment
income. In addition, it does not address consequences relevant to non-U.S. holders subject to particular rules, including, without limitation:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> U.S. expatriates and certain former citizens or long-term residents of the United States; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> persons subject to the alternative minimum tax; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> persons holding our common stock as part of a hedge, straddle or other risk reduction strategy or as part of a conversion transaction
or other integrated investment; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> banks, insurance companies, and other financial institutions; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> real estate investment trusts or regulated investment companies; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> brokers, dealers or traders in securities or currencies; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> "controlled foreign corporations," "passive foreign investment companies" and corporations that accumulate earnings to avoid U.S.
federal income tax; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> S corporations, partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax purposes, or
investors in any such entities; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> tax-exempt organizations or governmental organizations; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> persons for whom our common stock constitutes "qualified small business stock" within the meaning of Section&nbsp;1202 of the Code; </FONT> <FONT
COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> persons who hold or receive our common stock pursuant to the exercise of any employee stock option or otherwise as compensation;
</FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>156</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=161,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=697537,FOLIO='156',FILE='DISK131:[15ZBY1.15ZBY12201]EU12201A.;21',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_eu12201_1_157"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> persons deemed to sell our common stock under the constructive sale provisions of the Code; and </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> tax-qualified retirement plans. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
a partnership (or other entity treated as a partnership for U.S. federal income tax purposes) holds our common stock, the tax treatment of a partner in the partnership will depend on the status of
the partner, the activities of the partnership and certain determinations made at the partner level. Accordingly, partnerships holding our common stock and the partners in such partnerships should
consult their tax advisors regarding the U.S. federal income tax consequences to them of the purchase, ownership and disposition of our common stock. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>THIS DISCUSSION IS FOR INFORMATION PURPOSES ONLY AND IS NOT INTENDED AS TAX ADVICE. INVESTORS SHOULD CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF THE U.S.
FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATIONS AS WELL AS ANY TAX CONSEQUENCES OF THE PURCHASE, OWNERSHIP AND DISPOSITION OF OUR COMMON STOCK ARISING UNDER THE U.S. FEDERAL ESTATE OR GIFT TAX
LAWS OR UNDER THE LAWS OF ANY STATE, LOCAL OR NON-U.S. TAXING JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY.</B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Definition of a Non-U.S. Holder  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>For purposes of this discussion, a "non-U.S. holder" is any beneficial owner of our common stock that is not a "U.S. person," a partnership, or an
entity disregarded as separate from its owner, each for United States federal income tax purposes. A U.S. person is any of the following:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> an individual who is a citizen or resident of the United States; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> a corporation (or other entity taxable as a corporation for U.S. federal income tax purposes) created or organized under the laws of
the United States, any state thereof, or the District of Columbia; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> an estate, the income of which is subject to U.S. federal income tax regardless of its source; or </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> a trust that (i)&nbsp;is subject to the primary supervision of a U.S. court and the control of one or more United States persons
(within the meaning of Section&nbsp;7701(a)(30) of the Code), or (ii)&nbsp;has made a valid election under applicable Treasury Regulations to continue to be treated as a United States person. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Distributions  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As described in "Dividend Policy," we do not anticipate declaring or paying dividends to holders of our common stock in the foreseeable future.
However, if we do make distributions on our common stock, such distributions of cash or property on our common stock will constitute dividends for U.S. federal income tax purposes to the extent paid
from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Amounts not treated as dividends for U.S. federal income tax purposes will constitute a
return of capital and first be applied against and reduce a non-U.S. holder's adjusted tax basis in its common stock, but not below zero. Any excess will be treated as capital gain and will be treated
as described below in "&#151;&nbsp;Sale or Other Taxable Disposition." </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>157</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=162,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=720315,FOLIO='157',FILE='DISK131:[15ZBY1.15ZBY12201]EU12201A.;21',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_eu12201_1_158"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Subject
to the discussion below on backup withholding and foreign accounts, dividends paid to a non-U.S. holder of our common stock that are not effectively connected with the non-U.S. holder's
conduct of a trade or business within the United States will be subject to U.S. federal withholding tax at a rate of 30% of the gross amount of the dividends (or such lower rate specified by an
applicable income tax treaty). </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Non-U.S.
holders may be entitled to a reduction in or an exemption from withholding on dividends as a result of either (a)&nbsp;an applicable income tax treaty or (b)&nbsp;the non-U.S. holder
holding our common stock in connection with the conduct of a trade or business within the United States and dividends being paid in connection with that trade or business. To claim such a reduction in
or exemption from withholding, the non-U.S. holder must provide the applicable withholding agent with a properly executed (a)&nbsp;IRS Form&nbsp;W-8BEN or W-8BEN-E claiming an exemption from or
reduction of the
withholding tax under the benefit of an income tax treaty between the United States and the country in which the non-U.S. holder resides or is established, or (b)&nbsp;IRS Form&nbsp;W-8ECI stating
that the dividends are not subject to withholding tax because they are effectively connected with the conduct by the non-U.S. holder of a trade or business within the United States, as may be
applicable. These certifications must be provided to the applicable withholding agent prior to the payment of dividends and must be updated periodically. Non-U.S. holders that do not timely provide
the applicable withholding agent with the required certification, but that qualify for a reduced rate under an applicable income tax treaty, may obtain a refund of any excess amounts withheld by
timely filing an appropriate claim for refund with the IRS. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Subject
to the discussions below on backup withholding and foreign accounts, if dividends paid to a non-U.S. holder are effectively connected with the non-U.S. holder's conduct of a trade or business
within the United States (and, if required by an applicable income tax treaty, the non-U.S. holder maintains a permanent establishment in the United States to which such dividends are attributable),
then, although exempt from U.S. federal withholding tax (provided the non-U.S. holder provides appropriate certification, as described above), the non-U.S. holder will be subject to U.S. federal
income tax on such dividends on a net income basis at the regular graduated U.S. federal income tax rates. In addition, a non-U.S. holder that is a corporation may be subject to a branch profits tax
at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on its effectively connected earnings and profits for the taxable year that are attributable to such dividends, as
adjusted for certain items. Non-U.S. holders should consult their tax advisors regarding their entitlement to benefits under any applicable income tax treaty. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Sale or Other Taxable Disposition  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Subject to the discussions below on backup withholding and foreign accounts, a non-U.S. holder will not be subject to U.S. federal income tax on any
gain realized upon the sale or other disposition of our common stock unless:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the gain is effectively connected with the non-U.S. holder's conduct of a trade or business within the United States (and, if required
by an applicable income tax treaty, the non-U.S. holder maintains a permanent establishment in the United States to which such gain is attributable); </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the non-U.S. holder is a nonresident alien individual present in the United States for 183&nbsp;days or more during the taxable year
of the disposition and certain other requirements are met; or </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>158</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=163,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=505374,FOLIO='158',FILE='DISK131:[15ZBY1.15ZBY12201]EU12201A.;21',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_eu12201_1_159"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our common stock constitutes a United States real property interest, or USRPI, by reason of our status as a United States real
property holding corporation, or a USRPHC, for U.S. federal income tax purposes. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Gain
described in the first bullet point above will generally be subject to U.S. federal income tax on a net income basis at the regular graduated U.S. federal income tax rates. A non-U.S. holder that
is a foreign corporation may also be subject to a branch profits tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) of a portion of its effectively connected
earnings and profits for the taxable year, as adjusted for certain items. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A
non-U.S. holder described in the second bullet point above will be subject to U.S. federal income tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on any gain
derived from the disposition, which may be offset by certain U.S. source capital losses of the non-U.S. holder (even though the individual is not considered a resident of the United States) provided
the non-U.S. holder has timely filed U.S. federal income tax returns with respect to such losses. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>With
respect to the third bullet point above, we believe we are not currently and do not anticipate becoming a USRPHC. Because the determination of whether we are a USRPHC depends on the fair market
value of our USRPIs relative to the fair market value of our other business assets and our non-U.S. real property interests, however, there can be no assurance we are not a USRPHC or will not become
one in the future. Even if we are or were to become a USRPHC, gain arising from the sale or other taxable disposition by a non-U.S. holder of our common stock will not be subject to U.S. federal
income tax if such class of stock is "regularly traded," as defined by applicable Treasury Regulations, on an established securities market, and such non-U.S. holder owned, actually or constructively,
5% or less of such class of our stock throughout the shorter of the five-year period ending on the date of the sale or other disposition or the non-U.S. holder's holding period for such stock. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Non-U.S.
holders should consult their tax advisors regarding potentially applicable income tax treaties that may provide for different rules. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Information Reporting and Backup Withholding  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Subject to the discussion below on foreign accounts, a non-U.S. holder will not be subject to backup withholding with respect to payments of
dividends on our common stock we make to the non-U.S. holder, provided the applicable withholding agent does not have actual knowledge or reason to know such holder is a United States person and the
holder certifies its non-U.S. status, such as by providing a valid IRS Form&nbsp;W-8BEN, W-8BEN-E or W-8ECI, or other applicable certification. However, information returns will be filed with the
IRS in connection with any dividends on our common stock paid to the non-U.S. holder, regardless of whether any tax was actually withheld. Copies of these information returns may also be made
available under the provisions of a specific treaty or agreement to the tax authorities of the country in which the non-U.S. holder resides or is established. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Information
reporting and backup withholding may apply to the proceeds of a sale of our common stock within the United States, and information reporting may (although backup withholding generally will
not) apply to the proceeds of a sale of our common stock outside the United States conducted through certain U.S.-related financial intermediaries, in each case, unless the beneficial owner certifies
under penalty of perjury that it is a non-U.S. holder on IRS Form&nbsp;W-8BEN, W-8BEN-E or other applicable form (and the payer does not have actual knowledge or reason to know that the beneficial
owner is a U.S. person) or such owner otherwise establishes an exemption. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>159</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=164,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=627049,FOLIO='159',FILE='DISK131:[15ZBY1.15ZBY12201]EU12201A.;21',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_eu12201_1_160"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Backup
withholding is not an additional tax. Any amounts withheld under the backup withholding rules may be allowed as a refund or a credit against a non-U.S. holder's U.S. federal income tax
liability, provided the required information is timely furnished to the IRS. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Additional Withholding Tax on Payments Made to Foreign Accounts  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Withholding taxes may be imposed under the Foreign Account Tax Compliance Act, or FATCA, on certain types of payments made to non-U.S. financial
institutions and certain other non-U.S. entities. Specifically, a 30% withholding tax may be imposed on dividends on, or gross proceeds from the sale or other disposition of, our common stock paid to
a "foreign financial
institution" or a "non-financial foreign entity" (each as defined in the Code), unless (i)&nbsp;the foreign financial institution undertakes certain diligence and reporting obligations,
(ii)&nbsp;the non-financial foreign entity either certifies it does not have any "substantial United States owners" (as defined in the Code) or furnishes identifying information regarding each
substantial United States owner, or (iii)&nbsp;the foreign financial institution or non-financial foreign entity otherwise qualifies for an exemption from these rules. If the payee is a foreign
financial institution and is subject to the diligence and reporting requirements in (i)&nbsp;above, it must enter into an agreement with the U.S. Department of the Treasury requiring, among other
things, that it undertake to identify accounts held by certain "specified United States persons" or "United States-owned foreign entities" (each as defined in the Code), annually report certain
information about such accounts, and withhold 30% on certain payments to non-compliant foreign financial institutions and certain other account holders. Foreign financial institutions located in
jurisdictions that have an intergovernmental agreement with the United States governing FATCA may be subject to different rules. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
withholding provisions described above will generally apply to payments of dividends made any time and to payments of gross proceeds from a sale or other disposition of stock on or after
January&nbsp;1, 2019. Because we may not know the extent to which a distribution is a dividend for U.S. federal income tax purposes at the time it is made, for purposes of these withholding rules we
may treat the entire distribution as a dividend. Prospective investors should consult their tax advisors regarding these withholding provisions. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>160</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=165,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=104562,FOLIO='160',FILE='DISK131:[15ZBY1.15ZBY12201]EU12201A.;21',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ew12201_1_161"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ew12201_underwriting"> </A>
<A NAME="toc_ew12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  UNDERWRITING    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Piper Jaffray&nbsp;&amp;&nbsp;Co. and William Blair&nbsp;&amp; Company, L.L.C. are acting as representatives of each of the underwriters named below.
Subject to the terms and conditions set forth in an underwriting agreement among us and the underwriters, we have agreed to sell to the underwriters, and each of the underwriters has agreed, severally
and not jointly, to purchase from us, the number of shares of our common stock set forth opposite its name below. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:65%;margin-left:17%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;width:46pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Underwriters

<!-- COMMAND=ADD_SCROPPEDRULE,46pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Number<BR>
of Shares </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Piper Jaffray&nbsp;&amp;&nbsp;Co.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>William Blair&nbsp;&amp; Company, L.L.C.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Canaccord Genuity Inc.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>BTIG, LLC</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->

 </TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->

 <font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->

 <font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Subject
to the terms and conditions set forth in the underwriting agreement, the underwriters have agreed, severally and not jointly, to purchase all of the shares sold under the underwriting
agreement if any of these shares are purchased. If an underwriter defaults, the underwriting agreement provides that the purchase commitments of the non-defaulting underwriters may be increased or the
underwriting agreement may be terminated. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>At
our request, the underwriters have reserved for sale at the initial public offering price up to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock,
or&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% of the shares offered by this prospectus,
for our employees, directors and other persons associated with us. The participants in the directed share program are subject to the 180-day lock-up restriction described in "&#151;&nbsp;No
Sales of Similar Securities", below, with respect to the directed shares sold to them. The number of shares of common stock available for sale to the general public in the offering will be reduced by
the number of shares sold pursuant to the directed share program. Any directed shares not so purchased will be offered by the underwriters to the general public on the same terms as the other shares
offered by this prospectus. We have agreed to indemnify the underwriters against certain liabilities and expenses, including liabilities under the Securities Act, in connection with sales of the
directed shares. The directed share program will be arranged through Piper Jaffray&nbsp;&amp;&nbsp;Co. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
have agreed to indemnify the several underwriters against certain liabilities, including liabilities under the Securities Act relating to losses or claims resulting from material misstatements in
or omissions from this prospectus, the registration statement of which this prospectus is a part, certain free writing prospectuses that may be used in the offering and in any marketing materials used
in connection with this offering and to contribute to payments the underwriters may be required to make in respect of those liabilities. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
underwriters are offering the shares, subject to prior sale, when, as and if issued to and accepted by them, subject to approval of legal matters by their counsel, including the validity of the
shares, and other conditions contained in the underwriting agreement, such as the receipt by the underwriters of officers' certificates and legal opinions. The underwriters reserve the right to
withdraw, cancel or modify offers to the public and to reject orders in whole or in part. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Commissions and Discounts  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The representatives have advised us that the underwriters propose initially to offer the shares to the public at the public offering price set forth
on the cover page of this prospectus and to dealers at that </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>161</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=166,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=671784,FOLIO='161',FILE='DISK131:[15ZBY1.15ZBY12201]EW12201A.;46',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_ew12201_1_162"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>price
less a concession not in excess of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share. After the initial offering, the public offering price, concession or any other term of this offering may be changed.
</FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
following table shows the public offering price, underwriting discounts and commissions and proceeds before expenses to us. The information assumes either no exercise or full exercise by the
underwriters of their option to purchase additional shares to cover overallotments, if any. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:65%;margin-left:17%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="75pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Per Share </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Without Option </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>With Option </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Public offering price</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Underwriting discounts and commissions</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Proceeds, before expenses, to us</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
estimated offering expenses payable by us, exclusive of the underwriting discounts and commissions, are approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, which includes legal, accounting and
printing
costs and various other fees associated with the registration and listing of our common stock. We have also agreed to reimburse the underwriters for certain expenses, including an amount not to exceed
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in connection with the clearance of this offering with the Financial Industry Regulatory Authority, as set forth in the underwriting agreement. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Option to Purchase Additional Shares  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The underwriters have an option, exercisable for 30&nbsp;days from the date of this prospectus, to purchase up
to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additiona
l shares
of common stock from us at the public offering price listed on the cover page of this prospectus, less the underwriting discounts and commissions. The underwriters may exercise this option solely for
the purpose of covering over-allotments, if any, made in connection with the offering of the shares of common stock offered by
this prospectus. To the extent the option is exercised, each underwriter will become obligated, subject to certain conditions, to purchase about the same percentage of the additional shares of common
stock as the number listed next to the underwriter's name in the preceding table bears to the total number of shares of common stock listed next to the names of all underwriters in the preceding
table. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


No Sales of Similar Securities  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We, our executive officers and directors and substantially all of our other stockholders, optionholders and warrantholders have agreed not to sell or
transfer any shares of our common stock or securities convertible into, exchangeable or exercisable for, or that represent the right to receive shares of our common stock, for 180&nbsp;days after
the date of the prospectus used to sell our common stock without first obtaining the written consent of Piper Jaffray&nbsp;&amp;&nbsp;Co. and William Blair&nbsp;&amp; Company, L.L.C. Specifically, we
and these other persons have agreed, with certain limited exceptions, not to directly or indirectly:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> offer, pledge, announce the intention to sell, sell or contract to sell any shares of our common stock; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> sell any option or contract to purchase any shares of our common stock; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> purchase any option or contract to sell any shares of our common stock; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> grant any option, right or warrant to purchase any shares of our common stock; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> make any short sale or otherwise transfer or dispose of any shares of our common stock; </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>162</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=167,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=976513,FOLIO='162',FILE='DISK131:[15ZBY1.15ZBY12201]EW12201A.;46',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_ew12201_1_163"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> enter into any swap or other agreement that transfers, in whole or in part, the economic consequences of ownership of any shares of
our common stock whether any such swap or transaction is to be settled by delivery of shares or other securities, in cash or otherwise; or </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> demand that we file&nbsp;a registration statement related to our common stock. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
restrictions in the preceding paragraph do not apply to transfers of securities:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> as a bona fide gift or gifts; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> to an immediate family member or any trust for the direct or indirect benefit of the stockholder or an immediate family member of the
stockholder; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> if the stockholder is a corporation, partnership, limited liability company, trust or other business entity (i)&nbsp;transfers to
another corporation, partnership, limited liability company, trust or other business entity that is a direct or indirect affiliate of the stockholder or (ii)&nbsp;distributions of shares of our
common stock to limited partners, limited liability company members or stockholders of the stockholder; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> if the stockholder is a trust, to the beneficiary of such trust; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> by testate succession or intestate succession; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> pursuant to the underwriting agreement; or </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> pursuant to a "change of control" of our company; </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>provided,
in the case of a transfer described in bullets one through five above, that such transfer does not involve a disposition for value, and each transferee agrees to be subject to the
restrictions described in the immediately preceding paragraph and that no filing by any party under Section&nbsp;16(a) of the Exchange Act, shall be required or shall be made voluntarily in
connection with such transfer. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition, the transfer restrictions described above do not apply to:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the exercise of stock options granted pursuant to our equity incentive plans or warrants described in this prospectus, provided that
the exercise does not require a filing under Section&nbsp;16(a) of the Exchange Act; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the establishment of any 10b5-1 plan, provided that no sales of the stockholders' common stock will be made under such plans for
180&nbsp;days after the date of this prospectus; or </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> any transfers to our company in a transaction exemption from Section&nbsp;16(b) of the Exchange Act to satisfy tax withholding
obligations pursuant to our equity incentive plans or arrangements, provided that any such transfer does not require a filing under Section&nbsp;16(a) of the Exchange Act. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Listing  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We have applied to list our common stock on The NASDAQ Global Market under the symbol "TCMD." In order to meet the requirements for listing on that
exchange, the underwriters have </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>163</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=168,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=1006510,FOLIO='163',FILE='DISK131:[15ZBY1.15ZBY12201]EW12201A.;46',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_ew12201_1_164"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>undertaken
to sell a minimum number of shares to a minimum number of beneficial owners as required by that exchange. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Before
this offering, there has been no public market for our common stock. The initial public offering price will be determined through negotiations among us and the representatives. In addition to
prevailing market conditions, the factors to be considered in determining the initial public offering price include:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our financial information; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the history of, and the prospects for, our company and the industry in which we compete; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> an assessment of our management, its past and present operations and the prospects for, and timing of, our future revenues; </FONT> <FONT
COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the present state of our development; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the valuation multiples of publicly traded companies that the representatives believe to be comparable to us; and </FONT> <FONT COLOR="#3B5A6F"
SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the above factors in relation to market values and various valuation measures of other companies engaged in activities similar to
ours. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>An
active trading market for the shares may not develop. It is also possible that after this offering the shares will not trade in the public market at or above the initial public offering price. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
underwriters have informed us that they do not intend sales to discretionary accounts to exceed 5% of the total number of shares of common stock offered by them. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Price Stabilization, Short Positions and Penalty Bids  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Until the distribution of the shares is completed, SEC rules may limit underwriters and selling group members from bidding for and purchasing shares
of our common stock. However, the representatives may engage in transactions that stabilize the price of our common stock, such as bids or purchases to peg, fix or maintain that price. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
connection with this offering, the underwriters may purchase and sell shares of our common stock in the open market. These transactions may include short sales, purchases on the open market to
cover positions created by short sales and stabilizing transactions. Short sales involve the sale by the underwriters of a greater number of shares than they are required to purchase in this offering.
"Covered" short sales are sales made in an amount not greater than the underwriters' overallotment option described above. The underwriters may close out any covered short position by either
exercising their overallotment option or purchasing shares in the open market. In determining the source of shares to close out the covered short position, the underwriters will consider, among other
things, the price of shares available for purchase in the open market as compared to the price at which they may purchase shares through the overallotment option. "Naked" short sales are sales in
excess of the overallotment option. The underwriters must close out any naked short position by purchasing shares in the open market. A naked short position is more likely to be created if the
underwriters are concerned that there may be downward pressure on the price of our common stock in the open market after pricing that could adversely affect investors who purchase in this offering.
Stabilizing </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>164</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=169,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=678815,FOLIO='164',FILE='DISK131:[15ZBY1.15ZBY12201]EW12201A.;46',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_ew12201_1_165"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>transactions
consist of various bids for or purchases of shares of our common stock made by the underwriters in the open market prior to the completion of this offering. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
underwriters may also impose a penalty bid. This occurs when a particular underwriter repays to the underwriters a portion of the underwriting discounts and commissions received by it because the
representatives have repurchased shares sold by or for the account of such underwriter in stabilizing or short covering transactions. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Similar
to other purchase transactions, the underwriters' purchases to cover the syndicate short sales may have the effect of raising or maintaining the market price of our common stock or preventing
or retarding a decline in the market price of our common stock. As a result, the price of our common stock may be higher than the price that might otherwise exist in the open market. The underwriters
may conduct these transactions on The NASDAQ Global Market, in the over-the-counter market or otherwise. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Neither
we nor any of the underwriters make any representation or prediction as to the direction or magnitude of any effect that the transactions described above may have on the price of our common
stock. In addition, neither we nor any of the underwriters make any representation that the representatives will engage in these transactions or that these transactions, once commenced, will not be
discontinued without notice. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Electronic Offer, Sale and Distribution of Shares  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In connection with this offering, certain of the underwriters or securities dealers may distribute prospectuses by electronic means, such as e-mail.
In addition, one or more of the underwriters may facilitate Internet distribution for this offering to certain of their Internet subscription customers. Any such underwriter may allocate a limited
number of shares for sale to its online brokerage customers. An electronic prospectus is available on the Internet websites maintained by any such underwriter. Other than the prospectus in electronic
format, the information on the websites of any such underwriter is not part of this prospectus. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Other Relationships  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The underwriters and their respective affiliates are full service financial institutions engaged in various activities, which may include securities
trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment, hedging, financing and brokerage activities. Certain of the
underwriters and their affiliates have engaged in, and may in the future engage in, investment banking and other commercial dealings in the ordinary course of business with us or our affiliates. They
have received, or may in the future receive, customary fees and commissions for these transactions. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
the ordinary course of their various business activities, the underwriters and their respective affiliates may make or hold a broad array of investments and actively trade debt and equity
securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their customers, and such investment and securities
activities may involve securities and/or instruments of the issuer. The underwriters and their respective affiliates may also make investment recommendations and/or publish or express independent
research views in respect of
such securities or instruments and may at any time hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>165</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=170,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=138833,FOLIO='165',FILE='DISK131:[15ZBY1.15ZBY12201]EW12201A.;46',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_ew12201_1_166"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Selling Restrictions  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> European Economic Area.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;In relation to each Member State of the European Economic Area which has implemented the Prospectus Directive (each, a
"Relevant Member
State") an offer to the public of any shares of our common stock may not be made in that Relevant Member State, except that an offer to the public in that Relevant Member State of any shares of our
common stock may be made at any time under the following exemptions under the Prospectus Directive, if they have been implemented in that Relevant Member
State:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> to any legal entity which is a qualified investor as defined in the Prospectus Directive; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> to fewer than 100 or, if the Relevant Member State has implemented the relevant provision of the 2010 PD Amending Directive, 150,
natural or legal persons (other than qualified investors as defined in the Prospectus Directive), as permitted under the Prospectus Directive, subject to obtaining the prior consent of the
representatives for any such offer; or </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> in any other circumstances falling within Article&nbsp;3(2) of the Prospectus Directive, provided that no such offer of shares of
our common stock shall result in a requirement for the publication by us or any underwriter of a prospectus pursuant to Article&nbsp;3 of the Prospectus Directive. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>For
the purposes of this provision, the expression an "offer to the public" in relation to any shares of our common stock in any Relevant Member State means the communication in any form and by any
means of sufficient information on the terms of the offer and any shares of our common stock to be offered so as to enable an investor to decide to purchase any shares of our common stock, as the same
may be varied in that Member State by any measure implementing the Prospectus Directive in that Member State, the expression "Prospectus Directive" means Directive 2003/71/EC (and amendments thereto,
including the 2010 PD Amending Directive, to the extent implemented in the Relevant Member State), and includes any relevant implementing measure in the Relevant Member State, and the expression "2010
PD Amending Directive" means Directive 2010/73/EU. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> United Kingdom.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Each underwriter has represented and agreed that:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> it has only communicated or caused to be communicated and will only communicate or cause to be communicated an invitation or
inducement to engage in investment activity (within the meaning of Section&nbsp;21 of the Financial Services and Markets Act 2000 (the "FSMA")) received by it in connection with the issue or sale of
the shares of our common stock in circumstances in which Section&nbsp;21(1) of the FSMA does not apply to us; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> it has complied and will comply with all applicable provisions of the FSMA with respect to anything done by it in relation to the
shares of our common stock in, from or otherwise involving the United Kingdom. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Hong Kong.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The common shares may not be offered or sold in Hong Kong by means of any document other than (i)&nbsp;in circumstances which do not
constitute an
offer to the public within the meaning of the Companies Ordinance (Cap. 32, Laws of Hong Kong), or (ii)&nbsp;to "professional investors" within the meaning of the Securities and Futures Ordinance
(Cap. 571, Laws of Hong Kong) and any rules made thereunder, or (iii)&nbsp;in other circumstances which do not result in the document being a "prospectus"
within the meaning of the Companies Ordinance (Cap. 32, Laws of Hong Kong) and no advertisement, invitation or document relating to the shares may be issued or may </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>166</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=171,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=829424,FOLIO='166',FILE='DISK131:[15ZBY1.15ZBY12201]EW12201A.;46',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_ew12201_1_167"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>be
in the possession of any person for the purpose of issue (in each case whether in Hong Kong or elsewhere), which is directed at, or the contents of which are likely to be accessed or read by, the
public in Hong Kong (except if permitted to do so under the laws of Hong Kong) other than with respect to common shares which are or are intended to be disposed of only to persons outside Hong Kong or
only to "professional investors" within the meaning of the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong) and any rules made thereunder. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Singapore.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this prospectus and
any other document or
material in connection with the offer or sale, or invitation for subscription or purchase, of the common shares may not be circulated or distributed, nor may the common shares be offered or sold, or
be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i)&nbsp;to an institutional investor under Section&nbsp;274
of the Securities and Futures Act, Chapter&nbsp;289 of Singapore (the "SFA"), (ii)&nbsp;to a relevant person pursuant to Section&nbsp;275(1), or any person pursuant to Section&nbsp;275(1A),
and in accordance with the conditions specified in Section&nbsp;275 of the SFA or (iii)&nbsp;otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the
SFA, in each case subject to compliance with conditions set forth in the SFA. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Where
the common shares are subscribed or purchased under Section&nbsp;275 of the SFA by a relevant person which is:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> a corporation (which is not an accredited investor (as defined in Section&nbsp;4A of the SFA)) the sole business of which is to hold
investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary of the trust
is an individual who is an accredited investor, </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>shares,
debentures and units of shares and debentures of that corporation or the beneficiaries' rights and interest (howsoever described) in that trust shall not be transferred within six months after
that corporation or that trust has acquired the common shares pursuant to an offer made under Section&nbsp;275 of the SFA except:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> to an institutional investor (for corporations, under Section&nbsp;274 of the SFA) or to a relevant person defined in
Section&nbsp;275(2) of the SFA, or to any person pursuant to an offer that is made on terms that such shares, debentures and units of shares and debentures of that corporation or such rights and
interest in that trust are acquired at a consideration of not less than $200,000 (or its equivalent in a foreign currency) for each transaction, whether such amount is to be paid for in cash or by
exchange of securities or other assets, and further for corporations, in accordance with the conditions specified in Section&nbsp;275 of the SFA; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> where no consideration is or will be given for the transfer; or </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> where the transfer is by operation of law. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Switzerland.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The common shares may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange (the "SIX") or on any
other stock
exchange or regulated trading facility in Switzerland. This document has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss
Code of Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>167</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=172,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=866940,FOLIO='167',FILE='DISK131:[15ZBY1.15ZBY12201]EW12201A.;46',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_ew12201_1_168"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>exchange
or regulated trading facility in Switzerland. Neither this document nor any other offering or marketing material relating to the common shares or the offering may be publicly distributed or
otherwise made publicly available in Switzerland. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Neither
this document nor any other offering or marketing material relating to the offering, or the common shares have been or will be filed with or approved by any Swiss regulatory authority. In
particular, this document will not be filed with, and the offer of common shares will not be supervised by, the Swiss Financial Market Supervisory Authority FINMA, and the offer of common shares has
not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes ("CISA"). Accordingly, no public distribution, offering or advertising, as defined in CISA, its
implementing ordinances and notices, and no distribution to any non-qualified investor, as defined in CISA, its implementing ordinances and notices, shall be undertaken in or from Switzerland, and the
investor protection afforded to acquirers of interests in collective investment schemes under CISA does not extend to acquirers of common shares. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> United Arab Emirates.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;This offering has not been approved or licensed by the Central Bank of the United Arab Emirates (the "UAE"), Securities
and Commodities
Authority of the UAE and/or any other relevant licensing authority in the UAE, including any licensing authority incorporated under the laws and regulations of any of the free zones established and
operating in the territory of the UAE, in particular the Dubai Financial Services Authority ("DFSA"), a regulatory authority of the Dubai International Financial Centre ("DIFC"). The offering does not
constitute a public offer of securities in the UAE, DIFC and/or any other free zone in accordance with the Commercial Companies Law, Federal Law No 8 of 1984 (as amended), DFSA Offered Securities
Rules and Dubai Listing Rules, accordingly, or otherwise. The common shares may not be offered to the public in the UAE and/or any of the free zones. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
common shares may be offered and issued only to a limited number of investors in the UAE or any of its free zones who qualify as sophisticated investors under the relevant laws and regulations of
the UAE or the free zone concerned. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> France.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;This prospectus (including any amendment, supplement or replacement thereto) is not being distributed in the context of a public
offering in France within
the meaning of Article&nbsp;L. 411-1 of the French Monetary and Financial Code (Code mon&eacute;taire et financier). </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>This
prospectus has not been and will not be submitted to the French Autorit&eacute; des march&eacute;s financiers (the "AMF") for approval in France and accordingly may not and will
not be distributed to the public in France. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Pursuant
to Article&nbsp;211-3 of the AMF General Regulation, French residents are hereby informed that:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the transaction does not require a prospectus to be submitted for approval to the AMF; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> persons or entities referred to in Point 2&deg;, Section&nbsp;II of Article&nbsp;L.411-2 of the Monetary and Financial
Code may take part in the transaction solely for their own account, as provided in Articles&nbsp;D. 411-1, D. 734-1, D. 744-1, D. 754-1 and D. 764-1 of the Monetary and Financial Code; and </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the financial instruments thus acquired cannot be distributed directly or indirectly to the public otherwise than in accordance with
Articles&nbsp;L. 411-1, L. 411-2, L. 412-1 and L. 621-8 to L. 621-8-3 of the Monetary and Financial Code. </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>168</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=173,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=1043823,FOLIO='168',FILE='DISK131:[15ZBY1.15ZBY12201]EW12201A.;46',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_ew12201_1_169"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>This
prospectus is not to be further distributed or reproduced (in whole or in part) in France by the recipients of this prospectus. This prospectus has been distributed on the understanding that such
recipients will only participate in the issue or sale of our common stock for their own account and undertake not to transfer, directly or indirectly, our common stock to the public in France, other
than in compliance with all applicable laws and regulations and in particular with Articles&nbsp;L. 411-1 and L. 411-2 of the French Monetary and Financial Code. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>169</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=174,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=241354,FOLIO='169',FILE='DISK131:[15ZBY1.15ZBY12201]EW12201A.;46',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ey12201_1_170"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ey12201_legal_matters"> </A>
<A NAME="toc_ey12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  LEGAL MATTERS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The validity of the shares of common stock offered hereby and certain other legal matters will be passed upon for us by Faegre Baker
Daniels&nbsp;LLP, Minneapolis, Minnesota. Certain legal matters will be passed upon on behalf of the underwriters by Dorsey&nbsp;&amp; Whitney&nbsp;LLP, Minneapolis, Minnesota. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ey12201_experts"> </A>
<A NAME="toc_ey12201_2"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  EXPERTS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The audited financial statements included in this prospectus and elsewhere in the registration statement have been so included in reliance upon the
report of Grant Thornton&nbsp;LLP, independent registered public accountants, upon the authority of said firm as experts in accounting and auditing. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ey12201_where_you_can_find_additional_information"> </A>
<A NAME="toc_ey12201_3"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  WHERE YOU CAN FIND ADDITIONAL INFORMATION    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We have filed with the SEC a registration statement on Form&nbsp;S-1 under the Securities Act with respect to the shares of common stock offered by
this prospectus. This prospectus does not contain all of the information included in the registration statement, as permitted by the rules and regulations of the SEC. For further information
pertaining to us and the common stock to be sold in this offering, you should refer to the registration statement and its exhibits. Whenever we make reference in this prospectus to any of our
contracts, agreements or other documents, the references are not necessarily complete, and you should refer to the exhibits attached to the registration statement for copies of the actual contract,
agreement or other document filed as an exhibit to the registration statement or such other document, each such statement being qualified in all respects by such reference. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Upon
completion of this offering, we will be subject to the information and reporting requirements of the Exchange Act and will file annual, quarterly and current reports, proxy statements and other
information with the SEC. We anticipate making these documents publicly available, free of charge, on our website as soon as reasonably practicable after filing such documents with the SEC. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>You
can read the registration statement and our future filings with the SEC over the Internet at the SEC's website at www.sec.gov. You may also read and copy any document we file with the SEC at its
public reference facility at 100&nbsp;F Street, N.E., Room&nbsp;1580, Washington, D.C. 20549. You may also obtain copies of the documents at prescribed rates by writing to the Public Reference
Section of the SEC at the foregoing address. Please call the SEC at 1-800-SEC-0330 for further information on the operation of the public reference facilities. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>170</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=175,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=865794,FOLIO='170',FILE='DISK131:[15ZBY1.15ZBY12201]EY12201A.;21',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fa12201_1_1"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="fa12201_tactile_systems_technology,_inc."> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="fa12201_index_to_consolidated_financial_statements"> </A></FONT> <FONT COLOR="#3B5A6F" SIZE=2><B>  Index to Consolidated Financial Statements    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="fa12201_as_of_and_for_the_years_ended___as_04796"> </A></FONT> <FONT COLOR="#3B5A6F" SIZE=2><B>  As of and for the years ended December&nbsp;31, 2013 and 2014 (audited) and<BR>  as of September&nbsp;30, 2015 and for the nine month periods ended
September&nbsp;30, 2014 and 2015 (unaudited)    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<A NAME="FA12201_TOC"></A> </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->
<!-- COMMAND=ADD_START_LINKTABLE -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#aa1"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Report of Independent Registered Public Accounting
Firm</B></FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#aa1"><FONT COLOR="#3B5A6F" SIZE=2>F-2</FONT></A></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Consolidated Financial Statements</B></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#aa2"><p style="font-family:times;margin-top:12pt;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Consolidated Balance Sheets</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#aa2"><FONT COLOR="#3B5A6F" SIZE=2><BR>
F-3</FONT></A></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#aa3"><p style="font-family:times;margin-top:12pt;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Consolidated Statements of Operations</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#aa3"><FONT COLOR="#3B5A6F" SIZE=2><BR>
F-4</FONT></A></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#aa4"><p style="font-family:times;margin-top:12pt;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Consolidated Statements of Stockholders' Equity (Deficit)</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#aa4"><FONT COLOR="#3B5A6F" SIZE=2><BR>
F-5</FONT></A></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#aa5"><p style="font-family:times;margin-top:12pt;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Consolidated Statements of Cash Flows</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#aa5"><FONT COLOR="#3B5A6F" SIZE=2><BR>
F-6</FONT></A></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#aa6"><p style="font-family:times;margin-top:12pt;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Notes to the Consolidated Financial Statements</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#aa6"><FONT COLOR="#3B5A6F" SIZE=2><BR>
F-7&nbsp;- F-32</FONT></A></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
<!-- COMMAND=ADD_END_LINKTABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-1</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=176,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=1032937,FOLIO='F-1',FILE='DISK131:[15ZBY1.15ZBY12201]FA12201A.;18',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fc12201_1_2"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="fc12201_report_of_independent___fc102270"> </A>
<A NAME="toc_fc12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  <A NAME="aa1"></A>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Board
of Directors and Stockholders of<BR>
Tactile Systems Technology,&nbsp;Inc. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
have audited the accompanying consolidated balance sheets of Tactile Systems Technology,&nbsp;Inc. and its subsidiary, Swelling Solutions,&nbsp;Inc. (collectively, the "Company") as of
December&nbsp;31, 2014 and 2013, and the related consolidated statements of operations, stockholders' equity (deficit), and cash flows for each of the two years in the period ended
December&nbsp;31, 2014. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement. We were not engaged to perform an audit of the Company's internal control over financial reporting. Our
audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an
opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement
presentation. We believe that our audits provide a reasonable basis for our opinion. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Tactile Systems Technology, Inc. and subsidiary as of
December&nbsp;31, 2014 and 2013, and the results of their operations and their cash flows for each of the two years in the period ended December&nbsp;31, 2014 in conformity with accounting
principles generally accepted in the United States of America. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>/s/
Grant Thornton LLP </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Minneapolis,
Minnesota<BR>
September&nbsp;25, 2015 </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-2</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=177,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=375035,FOLIO='F-2',FILE='DISK131:[15ZBY1.15ZBY12201]FC12201A.;25',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fe12201_1_3"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="aa2"></A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="fe12201_tactile_systems_technology,_in__tac03507"> </A>
<A NAME="toc_fe12201_1"> </A></FONT> <FONT COLOR="#3B5A6F" SIZE=2><B><BR>  TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.    <BR>    <BR>    Consolidated Balance Sheets    <BR>    <BR>    (in thousands, except share data)    <BR>    </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="37pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="37pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="84pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="84pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
September&nbsp;30, 2015 </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Pro Forma as of<BR>
September&nbsp;30, 2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1><B><I>Assets</I></B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1><B>Current assets</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Cash and cash equivalents</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>6,539</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>5,416</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>5,672</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Accounts receivable, net</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>9,571</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>13,742</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>12,400</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Inventories</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>2,913</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>3,521</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>5,370</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Deferred income taxes</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>3,496</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>2,015</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>1,955</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Prepaid expenses</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>298</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>423</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>452</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:21pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Total current assets</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>22,817</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>25,117</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>25,849</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1><B>Property and equipment, net</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>1,378</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>1,303</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>1,310</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1><B>Other assets</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Patent costs, net</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>3,005</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>2,744</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>2,553</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Medicare accounts receivable&nbsp;&#151; long term</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>921</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>1,302</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>2,006</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Deferred income taxes</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>1,082</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>1,005</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>975</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Other non-current assets</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>23</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>23</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>702</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:21pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Total other assets</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>5,031</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>5,074</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>6,236</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:28pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1><B>Total assets</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>29,226</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>31,494</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>33,395</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1><B><I>Liabilities and Stockholders' Equity</I></B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1><B>Current liabilities</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Accounts payable</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>1,960</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>2,507</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>3,560</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Current portion of notes payable</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>8</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>9</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>6</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Accrued payroll and related taxes</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>2,604</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>2,003</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>2,249</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Accrued expenses</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>532</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>647</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>574</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Future product royalties&nbsp;&#151; current</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>378</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>924</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>479</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Income taxes payable</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>171</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>100</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:21pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Total current liabilities</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>5,653</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>6,190</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>6,868</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1><B>Long-term liabilities</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Notes payable, net of current portion</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>14</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>4</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Deferred compensation</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>199</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>199</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>193</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Future product royalties</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>1,153</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>446</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>446</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:21pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Total long-term liabilities, net of current
portion&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>1,366</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>649</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>639</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:21pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Total liabilities</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>7,019</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>6,839</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>7,507</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1><B>Convertible preferred stock</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Series&nbsp;B convertible preferred stock, $.001 par value:<BR>
15,000,000 shares authorized, 7,708,502 shares issued and outstanding as of both December&nbsp;31, 2013 and 2014, and September&nbsp;30, 2015 (unaudited)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>11,221</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>11,894</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>12,428</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Series&nbsp;A convertible preferred stock, $.001 par value:<BR>
8,776,409 shares authorized, 8,766,359 shares issued and 8,633,535 shares outstanding as of December&nbsp;31, 2013 and 2014, and September&nbsp;30, 2015 (unaudited)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>18,100</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>19,188</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>20,050</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1><B>Stockholders' equity (deficit)</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Common stock, $.001 par value:<BR>
40,000,000 shares authorized, 6,279,440 and 7,407,185 shares issued and outstanding as of December&nbsp;31, 2013 and 2014, respectively, and 9,022,406 as of September&nbsp;30, 2015 (unaudited)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>6</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>7</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>8</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Additional paid-in capital</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>1,822</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>438</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>140</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Accumulated deficit</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(8,942</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(6,872</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(6,738</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:21pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Total stockholders' equity (deficit)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(7,114</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(6,427</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(6,590</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1><B>Total liabilities and stockholders' equity (deficit)</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>29,226</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>31,494</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>33,395</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>

 <p style="font-family:times;line-height:1pt;margin-left:18pt;"> <FONT COLOR="#3B5A6F" SIZE=2>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</font></p><p align=center style="font-family:times;"><font> </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
See accompanying notes to the consolidated financial statements. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-3</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=178,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=296761,FOLIO='F-3',FILE='DISK131:[15ZBY1.15ZBY12201]FE12201A.;38',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fg12201_1_4"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="aa3"></A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="fg12201_tactile_systems_technology,_in__tac03991"> </A>
<A NAME="toc_fg12201_1"> </A></FONT> <FONT COLOR="#3B5A6F" SIZE=2><B><BR>  TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.    <BR>    <BR>    Consolidated Statements of Operations    <BR>    <BR>    (in thousands, except share data)    <BR>    </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="70pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Nine Months Ended<BR>
September&nbsp;30, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Revenues, net</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>37,176</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>47,736</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>29,626</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>41,712</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:11pt;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Cost of goods sold</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
9,772</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
12,715</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
8,284</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
11,839 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Gross profit</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>27,404</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>35,021</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>21,342</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>29,873 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Operating expenses</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Sales and marketing</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>14,298</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>18,154</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>12,457</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>17,297</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Research and development</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,443</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,843</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,931</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,922</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Reimbursement, general and administrative</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>8,283</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10,225</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,419</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>9,448 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:28pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total operating expenses</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>25,024</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>31,222</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>21,807</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>29,667 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:37pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Income (loss) from operations&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,380</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,799</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(465</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>206</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Other income (expense)</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
4</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
(4</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
12</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
18 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:37pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Income (loss) before income taxes</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,384</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,795</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(453</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>224</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Income tax expense (benefit)</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
(772</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
1,725</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
(171</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
90 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Net income (loss)</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,156</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,070</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(282</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>134</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Preferred stock dividends</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,668</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,761</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,336</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,396</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Allocation of undistributed earnings to preferred stockholders</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,074</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>216</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Net income (loss) attributable to common stockholders</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>414</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>93</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,618</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,262</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Net income (loss) per share attributable to common stockholders</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.07</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.01</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(0.23</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(0.16</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.06</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.01</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(0.23</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(0.16</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Weighted-average common shares used to compute net income (loss) per share attributable to common
stockholders</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6,305,401</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,025,035</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6,903,792</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,992,734</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,276,148</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10,709,649</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6,903,792</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,992,734</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Pro forma net income (loss) per share attributable to common stockholders (unaudited)</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Weighted-average shares used to compute pro forma net income (loss) per share attributable to common
stockholders (unaudited)</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>

 <p style="font-family:times;line-height:1pt;margin-left:18pt;"> <FONT COLOR="#3B5A6F" SIZE=2>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</font></p><p align=center style="font-family:times;"><font> </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
See accompanying notes to the consolidated financial statements. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-4</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=179,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=380361,FOLIO='F-4',FILE='DISK131:[15ZBY1.15ZBY12201]FG12201A.;60',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fi12201_1_5"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<!-- COMMAND=ROTATED_TABLE WIDTH="150%" -->

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><A NAME="aa4"></A>TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> Consolidated Statements of Stockholders' Equity (Deficit)  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except share data)  </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:73%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"110%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="110%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Common Stock </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Additional<BR>
Paid-In<BR>
Capital </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Accumulated<BR>
Deficit </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Shares </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Par Value </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Total </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Balances, December&nbsp;31, 2012</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6,392,672</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,401</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(12,098</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(8,691</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Stock-based compensation</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>132</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>132</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Exercise of common stock options</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>186,768</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>62</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>62</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Redemption of common shares</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(300,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(105</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(105</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Preferred stock dividends</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,668</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,668</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net income</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,156</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,156 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Balances, December&nbsp;31, 2013</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6,279,440</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,822</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(8,942</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(7,114</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Stock-based compensation</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>148</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>148</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Exercise of common stock options</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,127,745</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>229</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>230</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Preferred stock dividends</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,761</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,761</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net income</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,070</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,070 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Balances, December&nbsp;31, 2014</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,407,185</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>438</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(6,872</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(6,427</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Stock-based compensation (unaudited)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>232</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>232</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Exercise of common stock options and warrants (unaudited)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,615,221</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>866</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>867</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Preferred stock dividends (unaudited)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,396</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,396</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net loss (unaudited)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>134</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>134 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Balances, September&nbsp;30, 2015 (unaudited)</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>9,022,406</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>8</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>140</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(6,738</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(6,590</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
See accompanying notes to the consolidated financial statements. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-5</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=180,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=270786,FOLIO='F-5',FILE='DISK131:[15ZBY1.15ZBY12201]FI12201A.;22',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fk12201_1_6"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="aa5"></A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="fk12201_tactile_systems_technology,_in__tac03280"> </A>
<A NAME="toc_fk12201_1"> </A></FONT> <FONT COLOR="#3B5A6F" SIZE=2><B><BR>  TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.    <BR>    <BR>    Consolidated Statements of Cash Flows    <BR>    <BR>    (in thousands)    <BR>    </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Nine Months Ended<BR>
September&nbsp;30, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Cash flows from operating activities</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net income (loss)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,156</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,070</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(282</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>134</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Adjustments to reconcile net income (loss) to net cash flows used in operating activities</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Depreciation and amortization</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>585</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>706</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>530</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>622</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Deferred income taxes</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(941</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,558</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(171</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>90</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Stock-based compensation expense</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>132</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>148</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>117</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>232</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Deferred compensation</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(15</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(6</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Change in allowance for doubtful accounts</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>340</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>500</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>250</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Changes in assets and liabilities</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Accounts receivable</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(3,408</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(4,671</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(383</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,092</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Inventories</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(884</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(608</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(768</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,849</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Prepaid expenses and other non-current assets</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>16</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(142</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>37</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(708</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Medicare accounts receivable&nbsp;&#151; long term</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(921</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(381</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(704</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Accounts payable</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>476</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>547</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(195</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,053</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Accrued payroll and related taxes</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,116</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(601</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,110</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>246</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Accrued expenses</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(81</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>44</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>30</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(173</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Future product royalties</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(161</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(135</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(445</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:50pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net cash flows used in operating activities</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(425</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(991</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(2,330</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(166</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Cash flows from investing activities</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Purchases of property and equipment</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(364</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(353</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(208</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(420</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Patent costs</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(18</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:50pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net cash flows used in investing activities</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(364</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(353</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(208</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(438</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Cash flows from financing activities</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Payment of patent acquisition commitment</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(2,000</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Payments on notes payable</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(32</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(9</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(7</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(7</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Proceeds from exercise of common stock options and warrants</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>62</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>230</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>222</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>867</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Redemption of common stock</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(105</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net cash flows from (used in) financing
activities&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(2,075</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>221</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>215</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>860 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net change in cash and cash equivalents</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(2,864</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,123</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(2,323</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>256</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Cash and cash equivalents&nbsp;&#151; beginning of year</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>9,403</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6,539</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6,539</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,416 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Cash and cash equivalents</B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&#151; </FONT><FONT COLOR="#3B5A6F"
SIZE=2><B>end of year</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6,539</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,416</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,216</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,672 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Supplemental cash flow disclosure</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Cash paid for interest</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>21</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Cash paid for taxes</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>117</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>238</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>216</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>226 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>

 <p style="font-family:times;line-height:1pt;margin-left:18pt;"> <FONT COLOR="#3B5A6F" SIZE=2>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</font></p><p align=center style="font-family:times;"><font> </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
See accompanying notes to the consolidated financial statements. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-6</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=181,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=551829,FOLIO='F-6',FILE='DISK131:[15ZBY1.15ZBY12201]FK12201A.;28',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fm12201_1_7"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="aa6"></A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="fm12201_tactile_systems_technology,_in__tac08169"> </A>
<A NAME="toc_fm12201_1"> </A></FONT> <FONT COLOR="#3B5A6F" SIZE=2><B><BR>  TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.    <BR>    <BR>    NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS    <BR>    <BR>    (Information as of September&nbsp;30, 2015 and for
the nine months ended September&nbsp;30, 2014<BR>  and 2015 is unaudited)    <BR>    <BR>    (in thousands, except percentages and share data)    <BR>
</B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 1&nbsp;&#151; Summary of Significant Accounting Policies  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Nature of Operations  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Tactile Systems Technology,&nbsp;Inc. (the "Company") (doing business as Tactile Medical) is the sole manufacturer and distributor of the
Flexitouch and Entr&eacute; Systems, medical devices to help control symptoms of lymphedema, a chronic and progressive medical condition that is often an unintended consequence of cancer
treatment, and the ACTitouch System, a medical device to treat venous leg&nbsp;ulcers and chronic venous insufficiency. The Company provides its products for use both in the home and in health care
institutions, including hospitals and vascular, wound and lymphedema clinics throughout the United States. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Basis of Presentation  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The Company was originally incorporated in Minnesota under the name Tactile Systems Technology,&nbsp;Inc. on January&nbsp;30, 1995. During 2006,
the Company set up a merger corporation and subsequently, on July&nbsp;21, 2006, merged with and into this merger corporation. The resulting corporation assumed the name Tactile Systems
Technology,&nbsp;Inc. The purpose of this merger was to reincorporate the Company in Delaware, increase the number of authorized common shares to 25&nbsp;million and assign a par value of $.001 to
its common stock. In September 2013, the Company began doing business as Tactile Medical. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Basis of Consolidation  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Swelling Solutions,&nbsp;Inc., after
elimination of intercompany accounts and transactions. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


JOBS Act Accounting Election  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As an emerging growth company under the Jumpstart Our Business Startups Act, the Company is eligible to take advantage of certain exemptions from
various reporting requirements that are applicable to other public companies that are not emerging growth companies. The Company has elected to take advantage of the extended transition period for
adopting new or revised accounting standards that have different effective dates for public and private companies until such time as those standards apply to private companies. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Unaudited Interim Consolidated Financial Statements  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The accompanying balance sheet as of September&nbsp;30, 2015, the consolidated statements of operations and cash flows for the nine months ended
September&nbsp;30, 2014 and 2015, and the consolidated statements of stockholders' equity as of September&nbsp;30, 2015, are unaudited. The consolidated financial data and other information
disclosed in these notes to the consolidated financial statements related to September&nbsp;30, 2015, and the nine months ended September&nbsp;30, 2014 and 2015, are also unaudited. The unaudited
interim consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and, in the opinion of management, reflect all adjustments, which include
only normal recurring adjustments, necessary to state fairly the Company's financial position as of September&nbsp;30, 2015, and the results of its operations and cash flows for the nine </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-7</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=182,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=948592,FOLIO='F-7',FILE='DISK131:[15ZBY1.15ZBY12201]FM12201A.;69',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_fm12201_1_8"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of September&nbsp;30, 2015 and for the nine months ended September&nbsp;30, 2014<BR>
and 2015 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 1&nbsp;&#151; Summary of Significant Accounting Policies (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>months
ended September&nbsp;30, 2014 and 2015, respectively. The results for the nine months ended September&nbsp;30, 2015 are not necessarily indicative of results to be expected for the year
ending December&nbsp;31, 2015, or for any other interim period or for any future year. Our business may be affected by seasonality. In the first quarter of each year, when most patients have started
a new insurance year and have not paid their annual deductibles, we experience substantially reduced demand for our products. We typically experience higher sales in the third and fourth quarters as a
result of patients having paid their annual insurance deductibles in full, thereby reducing their out-of-pocket costs for our products, or because patients often spend the remaining balances in their
flexible-spending accounts. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Unaudited Pro Forma Consolidated Balance Sheet  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The unaudited pro forma consolidated balance sheet as of September&nbsp;30, 2015 reflects: (i)&nbsp;the automatic conversion of all outstanding
shares of the Company's convertible preferred stock into an aggregate of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock immediately prior to the completion of this offering; (ii)&nbsp;the accrual
for the
payment of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in cumulative accrued dividends to the Company's Series&nbsp;A convertible preferred stockholders; and (iii)&nbsp;the issuance
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock
to pay accrued dividends on the Company's Series&nbsp;B convertible preferred stock. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Unaudited Pro Forma Net Income (Loss) Per Share Attributable to Common Stockholders  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Unaudited pro forma basic and diluted net income (loss) per share has been computed to give effect to: (1)&nbsp;the conversion of all outstanding
convertible preferred stock into an aggregate of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock immediately prior to the completion of this offering; (2)&nbsp;the
issuance of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional
shares of common stock immediately prior to the completion of this offering that the Company's Series&nbsp;A and Series&nbsp;B preferred stockholders are entitled to receive in connection with
this initial public offering, assuming an initial offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering price range set forth on the cover page of this
prospectus; (3)&nbsp;the additional&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock that would have been required to be issued to generate sufficient proceeds to fund the cash payment of Series&nbsp;A
convertible preferred stock dividends; (4)&nbsp;the issuance of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock immediately prior to the completion of this offering to
pay accrued dividends on the Company's
Series&nbsp;B convertible preferred stock (assuming a closing date of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016 and an initial offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated
offering price range set forth on the cover page of this prospectus); and (5)&nbsp;the effectiveness of the Company's amended and restated certificate of incorporation and adoption of the Company's
amended and restated bylaws. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Cash and Cash Equivalents  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The Company considers all highly liquid investments purchased with an initial maturity date of 90&nbsp;days or less to be cash equivalents. As of
December&nbsp;31, 2013 and 2014 and September&nbsp;30, 2015, cash equivalents consisted of money market funds, which are stated at cost and approximate fair value. The Company maintains cash in
bank accounts which, at times, may exceed the Federal </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-8</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=183,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=640527,FOLIO='F-8',FILE='DISK131:[15ZBY1.15ZBY12201]FM12201A.;69',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_fm12201_1_9"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of September&nbsp;30, 2015 and for the nine months ended September&nbsp;30, 2014<BR>
and 2015 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 1&nbsp;&#151; Summary of Significant Accounting Policies (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Depository
Insurance Corporation ("FDIC") limits. The Company has not experienced any losses from maintaining balances in excess of FDIC limits. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Accounts Receivable  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The majority of the Company's accounts receivable and revenues are from commercial insurance payers and government payers, such as Medicare, Veterans
Administration and Medicaid. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Accounts
receivable are carried net of allowances for estimated non-receipt of patient co-payment and deductible obligations and allowances for uncollectible accounts. The Company believes all
accounts receivable in excess of the allowance are fully collectible. The Company does not accrue interest on a majority of the past due accounts receivable. The Company determines when accounts
become past due on a customer by customer basis. If accounts receivables in excess of the provided allowance are determined uncollectible, they are charged to expense in the quarter that determination
is made and accounts receivable are written off after all collection efforts have failed. A portion of the Company's claims to Medicare are initially denied, and enter the appeals process, where many
are ultimately reviewed by an Administrative Law Judge. After final adjudication of all claims, approximately 90% of the claims submitted are approved (this is on a number of claims, not a dollars
claimed, basis). Historically, the Company successfully appealed 90% of its initial Medicare claims denials. However, the appeal process can be lengthy, lasting more than a year in most cases.
Accordingly, the Company
classifies a portion of its Medicare accounts receivable as non-current based on its experience with Medicare. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Accounts
receivable are carried net of allowances for estimated nonreceipt of co-payment reimbursements and allowances for uncollectible accounts. The allowance for estimated nonreceipt of co-payment
reimbursements and for uncollectible accounts was $1,400 and $1,900 as of December&nbsp;31, 2013 and 2014, respectively, and $2,150 as of September&nbsp;30, 2015. The Company believes all
unsecured accounts receivable in excess of the allowance are fully collectible. The Company does not accrue interest on a majority of the past due accounts receivable. The Company determines when
accounts become past due on a customer by customer basis. If accounts receivables in excess of the provided allowance are determined uncollectible, they are charged to expense in the quarter that
determination is made and accounts receivable are written off after all collection efforts have failed. The Company had accounts receivable from three insurance companies representing approximately
18%, 33% and 7% as of December&nbsp;31, 2013. The Company had accounts receivable from three insurance companies representing approximately 25%, 24% and 5% of accounts receivable as of
December&nbsp;31, 2014. Revenues from these insurance companies accounted for 29%, 14%, and 14% of the Company's total revenues for the year ended December&nbsp;31, 2013 and 31%, 15% and 12% for
the year ended December&nbsp;31, 2014. The Company had accounts receivable from three insurance companies representing approximately 28%, 20% and 5% of accounts receivable as of September&nbsp;30,
2015. Revenues from these insurance companies accounted for 18%, 23% and 10% of the Company's total revenues for the nine months ended September&nbsp;30, 2015. The Company had accounts receivable
from three insurance companies representing approximately 23%, 16% and 4% of accounts receivable </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-9</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=184,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=942637,FOLIO='F-9',FILE='DISK131:[15ZBY1.15ZBY12201]FM12201A.;69',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<A NAME="page_fm12201_1_10"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of September&nbsp;30, 2015 and for the nine months ended September&nbsp;30, 2014<BR>
and 2015 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 1&nbsp;&#151; Summary of Significant Accounting Policies (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>as
of September&nbsp;30, 2014. Revenues from these insurance companies accounted for 27%, 20% and 11% of the Company's total revenues for the nine months ended September&nbsp;30, 2014. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Accounts
receivable include amounts due from Medicare totaling $2,672, $4,088 and $3,573 relating to devices shipped to patients as of December&nbsp;31, 2013 and 2014, and September&nbsp;30, 2015,
respectively, that are waiting insurance approval. The Company estimates the devices for which it expects to receive authorization and payment based on its reimbursement history from Medicare. The
Company classified $921, $1,302 and $2,006 of this receivable as of December&nbsp;31, 2013 and 2014, and September&nbsp;30, 2015, respectively, as noncurrent as the Company does not expect these
claims will be paid within one year of shipment of the device from the respective dates due to delays with the Administrative Law Judge appeal process. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>On
September&nbsp;3, 2015, the Company entered into a settlement agreement with the Centers for Medicare and Medicaid Services for 247 claims, representing approximately $1,457 of original claims
based on the Medicare allowable rates, in which the Company had submitted a request for an Administrative Law Judge hearing in 2013. The settlement entitled us to receive a payment of approximately
$851&nbsp;million no later than January&nbsp;21, 2016. We received this full amount during the
fourth quarter of 2015. The settlement will result in a reduction in the fourth quarter of 2015 of $815&nbsp;million in our accounts receivable for shipment of products to patients covered by
Medicare. The settlement was part of a pilot program, facilitated by the Office of Medicare Hearings and Appeals, to address a backlog of overdue claims awaiting Administrative Law Judge adjudication.
Because the settlement is part of a pilot program, the Company cannot predict whether it will be able to conclude future settlements with Medicare or achieve settlements on similar terms. Any future
settlement of claims for amounts less than the corresponding amounts receivable would result in a write off. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
reserve for uncollectible co-payment reimbursements and doubtful accounts were as follows: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="93pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended<BR>
December 31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Nine Months<BR>
Ended<BR>
September 30, 2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Beginning balance</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,060</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,400</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,900</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Provision charged against revenues</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,725</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,285</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,860</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Write-offs</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(3,385</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(2,785</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(3,610</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Ending balance</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,400</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,900</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,150 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Advertising  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Advertising costs are charged to operations when incurred. Advertising expense was $9 and $23 for the years ended December&nbsp;31, 2013 and 2014,
respectively, and $22 and $52 for the nine month periods ended September&nbsp;30, 2014 and 2015, respectively. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Research and Development Costs  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The Company expenses research and development costs as incurred. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-10</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=185,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=969021,FOLIO='F-10',FILE='DISK131:[15ZBY1.15ZBY12201]FM12201A.;69',USER='CHE107332',CD='20-JAN-2016;21:19' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fo12201_1_11"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of September&nbsp;30, 2015 and for the nine months ended September&nbsp;30, 2014<BR>
and 2015 is unaudited)  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data)  </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 1&nbsp;&#151; Summary of Significant Accounting Policies (Continued)  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Shipping and Handling Costs  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The Company does not charge any shipping and handling costs to its customers and the shipping and handling costs incurred are included in cost of
goods sold. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Product Warranty  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The Company provides a warranty for its products against defects in material and workmanship for a period up to one year on garments and one to two
years on controllers. The Company records a liability for future warranty claims at the time of sale for the warranty period offered to a customer. If the assumptions used in calculating the provision
were to materially change, resulting in more defects than anticipated, an additional provision may be required. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
warranty reserve was as follows: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="93pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Nine Months<BR>
Ended<BR>
September&nbsp;30, 2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Beginning balance</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>165</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>200</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>250</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Warranty provision</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>123</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>142</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>128</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Processed warranty claims</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(88</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(92</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(88</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Ending balance</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>200</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>250</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>290 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Inventories  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Inventories are valued at the lower of cost (first-in, first-out method) or market, and consisted of the following: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="93pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
September&nbsp;30, 2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Finished goods</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,478</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,628</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,113</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Component parts and work-in-process</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,435</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,893</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,257 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Ending balance</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,913</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,521</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,370 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-11</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=186,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=497368,FOLIO='F-11',FILE='DISK131:[15ZBY1.15ZBY12201]FO12201A.;95',USER='CHE107332',CD='20-JAN-2016;21:20' -->
<A NAME="page_fo12201_1_12"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of September&nbsp;30, 2015 and for the nine months ended September&nbsp;30, 2014<BR>
and 2015 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 1&nbsp;&#151; Summary of Significant Accounting Policies (Continued) </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Property and Equipment  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Property and equipment are stated at cost and are being depreciated using the straight-line method over their estimated useful lives of three to five
years and leasehold improvements are depreciated over the remaining life of the building lease agreement. Property and equipment consisted of the following: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="93pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
September&nbsp;30, 2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Equipment</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,521</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,645</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,739</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Leasehold improvements</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>306</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>306</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>424</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Tooling</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>540</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>719</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>861</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Furniture and fixtures</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>187</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>237</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>303 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,554</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,907</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,327</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Less: accumulated depreciation</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,176</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,604</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(2,017</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Property and equipment</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,378</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,303</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,310 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Major
expenditures for property and equipment are capitalized. Maintenance, repairs, and minor renewals are expensed as incurred. When assets are retired or otherwise disposed of, their costs and
related accumulated depreciation are removed from the accounts and resulting gains or losses are included in income. Depreciation expense was $308 and $428 for the years ended December&nbsp;31, 2013
and 2014, respectively, and $322 and $413 for the nine month periods ended September&nbsp;30, 2014 and 2015, respectively. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Deferred Offering Costs  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Deferred offering costs, primarily consisting of legal, accounting and other direct fees and costs relating to the initial public offering, are
capitalized. The deferred offering costs will be offset against the Company's planned initial public offering proceeds upon the closing of the offering. In the event the offering is terminated, all of
the deferred offering costs will be expensed within income from operations. There was $679 in deferred offering costs capitalized as of September&nbsp;30, 2015, in other non-current assets on the
balance sheet. There were no deferred offering costs capitalized as of December&nbsp;31, 2013 or 2014. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Impairment of Long-Lived Assets  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The Company reviews long-lived assets, including property and equipment, for impairment whenever events or changes in business circumstances indicate
that the carrying amount of an asset may not be fully recoverable. The Company will record impairment losses on long-lived assets used in operations when indicators of impairment are present and the
undiscounted cash flows estimated to be generated by those assets are less than the assets' carrying amount. To date, the Company has recorded no such losses other than the write-off of various assets
acquired in the ACTitouch transaction (see Note&nbsp;5). </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-12</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=187,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=499361,FOLIO='F-12',FILE='DISK131:[15ZBY1.15ZBY12201]FO12201A.;95',USER='CHE107332',CD='20-JAN-2016;21:20' -->
<A NAME="page_fo12201_1_13"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of September&nbsp;30, 2015 and for the nine months ended September&nbsp;30, 2014<BR>
and 2015 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 1&nbsp;&#151; Summary of Significant Accounting Policies (Continued) </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Revenue Recognition  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The Company recognizes revenue when persuasive evidence of a sales arrangement exists, delivery of product has occured through the transfer of title
and risks of reward of ownership, the selling price is fixed or determinable and collectibility is reasonably assured. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
Company distributes its products directly to patients. For any of its products sold to patients covered by private payers, such as commercial insurance companies, the Company recognizes revenues
from such sales upon shipment of its products. A product is not shipped until the Company has received a prescription from a physician for its products and, as applicable, receipt of prior
authorization from payers. At shipment, the Company invoices the payer for their portion of the total product cost and the Company recognizes revenue as a percentage of the payer's invoice based on
the polices and payment history of the applicable payer. The payment history of the applicable payer is drawn from the Company's actual payment experience over the last three years. Any differences in
payments received as compared to the Company's estimates are recognized in the period for which it actually receives payment for the product. Over time, the Company adjusts the applicable estimates
used for each payer to reflect any such differences. The Company separately invoices the patient for their payment obligation with respect to the shipped product, such as copayments and deductibles,
and recognizes revenue upon sending such invoice. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>For
any of the its products sold to Medicare patients, the Company recognizes revenues from such sales upon shipment of its products, which can occur only after the Company has received a prescription
from a physician and all applicable Medicare documentation. The Company estimates the revenue on each shipment to a Medicare patient as a percentage of the total invoice based on the payment history
of each regional administrative contractor. While the Company has contracted rates with Medicare, to the extent any claims for reimbursement are denied, the Company will recognize any necessary
adjustments in the period for which the adjustment is made. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Net Income (Loss) per Share Attributable to Common Stockholders  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The Company uses the two-class method to compute net income (loss) per common share attributable to common stockholders because the Company has
issued securities, other than common stock, that contractually entitle the holders to participate in dividends and earnings of the Company. The two-class method requires earnings for the period to be
allocated between common stock and participating securities based upon their respective rights to receive distributed and undistributed earnings. All series of the Company's convertible preferred
stock are considered participating securities. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Under
the two-class method, for periods with net income, basic net income per share attributable to common stockholders is computed by dividing the net income attributable to common stockholders by
the weighted-average number of shares of common stock outstanding during the period. Diluted net income per share attributable to common stockholders is computed by dividing the net income
attributable to common stockholders by the weighted-average number of shares of common stock and dilutive potential shares of common stock outstanding during the period. Net income attributable to
common stockholders is computed by subtracting from net income the portion of current year earnings </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-13</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=188,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=693820,FOLIO='F-13',FILE='DISK131:[15ZBY1.15ZBY12201]FO12201A.;95',USER='CHE107332',CD='20-JAN-2016;21:20' -->
<A NAME="page_fo12201_1_14"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of September&nbsp;30, 2015 and for the nine months ended September&nbsp;30, 2014<BR>
and 2015 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 1&nbsp;&#151; Summary of Significant Accounting Policies (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>that
the participating securities would have been entitled to receive pursuant to their dividend rights had all of the year's earnings been distributed. No such adjustment to earnings is made during
periods with a net loss, as the holders of the participating securities have no obligation to fund losses. Because the Company has reported a net loss for the nine months ended September&nbsp;30,
2014 and 2015, respectively, diluted net loss per share attributable to common stockholders is the same as basic net loss per share attributable to common stockholders for those periods as all
potentially dilutive shares consisting of convertible preferred stock, stock options, and warrants were antidilutive in those periods. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Income Taxes  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Income taxes are accounted for under the liability method. Deferred income taxes are provided for temporary differences between the financial
reporting and the tax bases of assets and liabilities. If the Company determines in the future that it is more likely than not that the Company will realize all or a portion of the deferred tax
assets, the Company will adjust the valuation allowance in the period the determination is made (Note&nbsp;9). </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stock-Based Compensation  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The Company accounted for all share-based payments to employees, including grants of employee stock options, based on the fair value on the date of
grant expensed over the applicable vesting period. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
fair value of each option grant is determined as of grant date, utilizing the Black Scholes option pricing model. The Company uses the "simplified method" to determine the expected term of the
stock option. The Company calculates expected volatility for stock options using the historical volatility of a public company of similar size and industry as the Company believes the expected
volatility will approximate historical volatility. The risk-free rate for periods within the expected term of the option is based on the U.S. Treasury rate at the time of grant. The Company estimates
the forfeiture rate to be 10-15% based on management's estimate of future employee turnover. Based on these valuations, the Company recognized compensation expense of $132 and $148 for the years ended
December&nbsp;31, 2013 and 2014, respectively, and $117 and $232 for the nine month periods ended September&nbsp;30, 2014 and 2015, respectively, and the expense is included in reimbursement,
general and administrative expenses. The amortization of each grant will continue over the remainder of the vesting period of
each option grant. Stock-based compensation expense of outstanding options as of December&nbsp;31, 2014 is expected to approximate $104, $74, $47 and $1 in each of the next four years, respectively. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-14</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=189,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=481080,FOLIO='F-14',FILE='DISK131:[15ZBY1.15ZBY12201]FO12201A.;95',USER='CHE107332',CD='20-JAN-2016;21:20' -->
<A NAME="page_fo12201_1_15"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of September&nbsp;30, 2015 and for the nine months ended September&nbsp;30, 2014<BR>
and 2015 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 1&nbsp;&#151; Summary of Significant Accounting Policies (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
estimated fair value of each option grant is estimated on the date of grant using the Black Scholes pricing model with the following weighted-average assumptions used for options granted: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Nine&nbsp;Months&nbsp;Ended<BR>
September&nbsp;30, </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Expected term</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6 years</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6 years</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6 years</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6 years</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Expected volatility</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>40%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>60%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>60%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>50%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Risk-free interest rate</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Expected dividend yield</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0%</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Financial Instruments and Fair Value  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The carrying amounts for all financial instruments approximate fair value. The carrying amounts for cash and cash equivalents, accounts receivable
and accounts payable approximate fair value because of the short maturity of these instruments. The fair value of short- and long-term debt (including future product royalties) approximates carrying
value and has been estimated
based on discounted cash flows using interest rates being offered for similar debt having the same or similar remaining maturities and collateral requirements. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Recent Accounting Pronouncement  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In May 2014, the Financial Accounting Standards Board ("FASB") issued guidance creating Accounting Standards Codification ("ASC") Section&nbsp;606,
"Revenue from Contracts with Customers." The new section will replace Section&nbsp;605, "Revenue Recognition," and creates modifications to various other revenue accounting standards for specialized
transactions and industries. The section is intended to conform revenue accounting principles with a concurrently issued International Financial Reporting Standards to reconcile previously differing
treatment between United States practices and those of the rest of the world and to enhance disclosures related to disaggregated revenue information. The updated guidance, which was amended
July&nbsp;9, 2015, is effective for annual reporting periods beginning on or after December&nbsp;15, 2017, and interim periods within those annual periods. The Company will adopt the new
provisions of this accounting standard at the beginning of fiscal year 2018, because early adoption is not allowed. The Company will further study the implications of this statement to evaluate the
expected impact on its consolidated financial statements. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Estimates  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America
requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated
financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-15</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=190,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=735460,FOLIO='F-15',FILE='DISK131:[15ZBY1.15ZBY12201]FO12201A.;95',USER='CHE107332',CD='20-JAN-2016;21:20' -->
<A NAME="page_fo12201_1_16"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of September&nbsp;30, 2015 and for the nine months ended September&nbsp;30, 2014<BR>
and 2015 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 1&nbsp;&#151; Summary of Significant Accounting Policies (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
Company continues to refine its estimate of the Medicare accounts receivable and related revenue recognition based on information available to it related to historical approval rates. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 2&nbsp;&#151; Patent Costs, Net  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
The Company's patents, all of which are subject to amortization, are summarized as follows: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
September&nbsp;30,<BR>
2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Patents</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,363</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,380</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,398</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Less: accumulated amortization</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(358</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(636</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(845</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net patents</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,005</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,744</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,553 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Amortization
expense was $278 for both the years ended December&nbsp;31, 2013 and 2014, and $208 and&nbsp;$209 for the nine month periods ended September&nbsp;30, 2014, and 2015, respectively.
Future amortization expenses are expected as follows: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>2015 (remaining)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>70</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>2016</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>279</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>2017</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>279</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>2018</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>278</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>2019</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>278</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Thereafter</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,369 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,553 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 3&nbsp;&#151; Notes Payable  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
On August&nbsp;8, 2008, the Company entered into four promissory note agreements with a bank totaling $230 which were used to help fund the Company's relocation to its new corporate headquarters.
The notes have interest rates ranging from 2% to the greater of prime plus 1.5% or 7% (7% as of both December&nbsp;31, 2013 and 2014). </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
minimum principal payments for the notes payable as of December&nbsp;31, 2014 are as follows: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>2015 (remaining)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-16</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=191,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=99828,FOLIO='F-16',FILE='DISK131:[15ZBY1.15ZBY12201]FO12201A.;95',USER='CHE107332',CD='20-JAN-2016;21:20' -->
<A NAME="page_fo12201_1_17"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of September&nbsp;30, 2015 and for the nine months ended September&nbsp;30, 2014<BR>
and 2015 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 4&nbsp;&#151; Accrued Expenses  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
Accrued expenses consisted of the following: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
September&nbsp;30,<BR>
2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Accrued warranty</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>200</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>250</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>290</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Accrued clinical</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>60</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>160</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>60</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Deferred rent</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>75</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>30</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Other</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>197</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>207</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>224 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>532</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>647</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>574 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 5&nbsp;&#151; Asset Purchase Agreement  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
On September&nbsp;14, 2012, the Company completed an acquisition of certain assets, including inventory, equipment and tooling and patents for the ACTitouch System and a technology known as SMM. The
purchase price of this acquisition included $3,000 at closing and $2,000 at the earliest of the commercialization date or the first anniversary of the closing date. In addition, the Company is
required to pay quarterly payments following the commercialization date, which was September&nbsp;1, 2013, through the following sixteen quarterly calculation periods equal to 9% of sales for the
ACTitouch System and 7% of sales of SMM with a guaranteed minimum amount of $45 for each of the first four quarterly calculation periods (year 1); $148 for each of next four quarterly calculation
periods (year 2);&nbsp;and $248 for each of the next four quarterly calculation periods (year 3)&nbsp;(total of $1,765). For each quarterly calculation period beginning with the seventeenth
quarterly calculation period and ending on the tenth anniversary of the commercialization date, the Company will make quarterly payments equal to 6% of the sale of the ACTitouch product and 5% on the
sale of SMM. If ACTitouch System and SMM sales in any calendar year in years five through ten exceed $40,000, the sales percentage amount shall equal 6%
of the sales of product up to $40,000 and 7% on the sales of product over $40,000. The Company determined the transaction did not qualify as a purchase of a business acquisition and as such, recorded
the transaction as an asset purchase which requires the Company to record the transaction at cost, including transaction costs of $285. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
Company allocated the assets acquired as follows: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Inventory (included in prepaid expenses)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>327</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Equipment and tooling</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>997</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Patents</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,363</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>In-process research and development (IPR&amp;D)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,125 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6,812 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
net present value of the guaranteed quarterly minimum payments of $1,765 discounted at 7% (or $1,527) in the first three years from the commercialization date have been included in the acquisition
price as this portion of the contingent consideration is reasonably estimated and probable. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-17</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=192,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=253107,FOLIO='F-17',FILE='DISK131:[15ZBY1.15ZBY12201]FO12201A.;95',USER='CHE107332',CD='20-JAN-2016;21:20' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fq12201_1_18"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of September&nbsp;30, 2015 and for the nine months ended September&nbsp;30, 2014<BR>
and 2015 is unaudited)  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data)  </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 5&nbsp;&#151; Asset Purchase Agreement (Continued)  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
The Company allocated the cost of the technology for the SMM to IPR&amp;D as it does not have an alternative future use and requires considerable research and development in the future to bring any
potential product to market. This was charged to expense. In addition, the Company recorded a loss on impairment of assets acquired of $264 for the year ended December&nbsp;31, 2012. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 6&nbsp;&#151; Line of Credit&nbsp;&#151; Bank  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
The Company had a $2,000 line of credit with a bank that bore interest at prime (3.25% as of December&nbsp;31, 2013), which expired on May&nbsp;11, 2015. In May 2015, the Company renewed its
credit line with Venture Bank. This transaction did not result in any debt extinguishment losses or gains. The Company's credit line bears interest based on the prime rate, which was 3.25% as of
September&nbsp;30, 2015, and expires on May&nbsp;11, 2016. The Company's credit line is secured by substantially all its assets, including property and equipment, accounts receivable and
inventory. The Company's credit line contains customary conditions to borrowing, events of default and covenants, including covenants that restrict the Company's ability to dispose of assets, merge
with or acquire other entities, incur indebtedness and encumbrances. In addition, the Company complied with certain financial covenants relating to liquidity and leverage ratios
until the renewal in May 2015 that released the Company from its covenant obligations. The Company was in compliance with those covenants as of December&nbsp;31, 2013 and 2014. There was no
outstanding balance on the line of credit as of December&nbsp;31, 2013 or 2014, or as of September&nbsp;30, 2015. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 7&nbsp;&#151; Commitments and Contingencies  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Lease Obligation  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In March 2008, the Company entered into a non-cancelable operating lease agreement for building space for its corporate headquarters which provides
for monthly rent, real estate taxes and operating expenses that expired July&nbsp;31, 2015. In December 2012, the Company extended its lease to July&nbsp;31, 2020. In June 2013, the Company
extended the lease to July&nbsp;31, 2021. Rent expense was $618 and $750 for the years ended December&nbsp;31, 2013 and 2014, respectively, and $546 and $623 for the nine month periods ended
September&nbsp;30, 2014 and 2015, respectively. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
Company also has operating lease agreements for certain computer and office equipment that expire in 2016. The leases provide an option to purchase the related equipment at fair market value at
the end of the lease. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-18</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=193,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=520899,FOLIO='F-18',FILE='DISK131:[15ZBY1.15ZBY12201]FQ12201A.;130',USER='CHE107332',CD='20-JAN-2016;21:20' -->
<A NAME="page_fq12201_1_19"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of September&nbsp;30, 2015 and for the nine months ended September&nbsp;30, 2014<BR>
and 2015 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 7&nbsp;&#151; Commitments and Contingencies (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Future
base minimum lease payments for all lease obligations are expected to be as follows for the years ending December&nbsp;31: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="79pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Building </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Computer/Office </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Total </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>2015 (remaining)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>121</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>128</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>2016</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>464</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>20</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>484</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>2017</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>475</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>475</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>2018</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>489</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>489</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>2019</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>504</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>504</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Thereafter</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>827</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>827 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,880</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>27</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,907 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Major Vendors  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>During the year ended December&nbsp;31, 2013, the Company had purchases from one vendor that accounted for 28% of total purchases. The Company had
purchases from one vendor that accounted for 27% of total purchases during the year ended December&nbsp;31, 2014. The Company had purchases from two vendors that accounted for 27% of total purchases
for the nine months ended September&nbsp;30, 2014. The Company had purchases from three vendors that accounted for 45% of total purchases for the nine months ended September 30, 2015. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Purchase Commitments  </I></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The Company issued purchase orders in March 2015 totalling $6,774 for inventory that it expects to receive between October 2015 and August 2016. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Employment Agreements  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The Company has entered into employment agreements with certain officers of the Company. The agreements require severance ranging from six to twelve
months as defined in the agreements for termination without cause. One severance agreement also requires an amount equal to one year of the annual bonus payable for the calendar year preceding the
termination date as defined in the agreement for termination without cause. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Deferred Compensation  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Deferred compensation consists of 132,824 shares of Restricted Series&nbsp;A Preferred Stock as of both December&nbsp;31, 2013 and 2014, and
128,377 as of September&nbsp;30, 2015. The restricted shares were valued at $1.50 per share and vest upon a Change in Control as defined in the Restricted Stock Agreement. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-19</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=194,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=200363,FOLIO='F-19',FILE='DISK131:[15ZBY1.15ZBY12201]FQ12201A.;130',USER='CHE107332',CD='20-JAN-2016;21:20' -->
<A NAME="page_fq12201_1_20"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of September&nbsp;30, 2015 and for the nine months ended September&nbsp;30, 2014<BR>
and 2015 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 7&nbsp;&#151; Commitments and Contingencies (Continued) </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Retirement Plan  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The Company maintains a 401(k) retirement plan for its employees in which eligible employees can contribute a percentage of their compensation. The
Company may also make discretionary contributions. The Company made contributions of $0 and $82 for the years ended December&nbsp;31, 2013 and 2014, respectively, and $49 and $100 for the nine month
periods ended September&nbsp;30, 2014, and 2015, respectively. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 8&nbsp;&#151; Stockholders' Equity  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
In September and October 2012, the Company received gross proceeds of $10,400 for issuance of 7,708,502 shares of its Series&nbsp;B Preferred Stock at $1.35 per share. The Series&nbsp;B Preferred
Stock includes a liquidation preference of the original investment plus an accruing dividend at a rate of 6%, compounded annually, whether or not declared. The accruing dividend is payable upon a
voluntary or involuntary liquidation or dissolution of the Company, upon conversion of the Series&nbsp;B Preferred Stock to common stock, upon redemption of the Series&nbsp;B Preferred Stock or at
such time as the Company pays a dividend on other shares of its capital stock. The accruing dividend may be paid in cash or, at the option of the stockholder, additional shares of Series&nbsp;B
Preferred Stock determined by dividing the amount of the accruing dividend by the Series&nbsp;B Preferred Stock purchase price as adjusted. There were $821 and $1,494 of undeclared cumulative
preferred dividends as of December&nbsp;31, 2013 and 2014, respectively, and $2,028 as of September&nbsp;30, 2015. Holders of shares of Series&nbsp;B Preferred Stock are
entitled to votes equal to the number of shares of common stock into which such Series&nbsp;B Preferred Stock could be converted. Purchasers of the Series&nbsp;B Preferred Stock received
anti-dilution rights whereby if the Company issues or sells additional shares of preferred or common shares at a purchase price below $1.35 per share, the Company will issue additional shares to these
purchasers of Series&nbsp;B Preferred Stock to effectively reduce their purchase price. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Each
share of Series&nbsp;B Preferred Stock can be converted into equal shares of common stock at the option of the Series&nbsp;B Preferred Stock holder at any time. In addition, the
Series&nbsp;B Preferred Stock shares are automatically convertible into common shares upon the sale of shares of common stock to the public at a price per share of at least $4.05 in a firm
commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended, resulting in at least $30,000 of proceeds to the Company, net of
underwriting discounts and commissions and after which the common stock is listed on an United States national securities exchange. Each Series&nbsp;B Preferred stockholder is also entitled to
receive the number of common shares equal to the Series&nbsp;B Preferred Stock original issue price divided by the initial public offering price per share. In addition, each Series&nbsp;B
Preferred stockholder is entitled to receive the number of common shares equal to the accrued dividends on the shares of Series&nbsp;B Preferred Stock divided by the original issue price of the
Series&nbsp;B Preferred Stock divided by the initial public offering price per share. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>From
2007 through 2009, the Company received gross proceeds of $12,950 for the issuance of 8,633,535 shares of its Series&nbsp;A Preferred Stock at $1.50 per share. The Series&nbsp;A Preferred
Stock includes a liquidation preference of the original investment plus an accruing dividend at a rate of 6%, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-20</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=195,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=537518,FOLIO='F-20',FILE='DISK131:[15ZBY1.15ZBY12201]FQ12201A.;130',USER='CHE107332',CD='20-JAN-2016;21:20' -->
<A NAME="page_fq12201_1_21"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of September&nbsp;30, 2015 and for the nine months ended September&nbsp;30, 2014<BR>
and 2015 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 8&nbsp;&#151; Stockholders' Equity (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>compounded
annually, whether or not declared. The accruing dividend is payable upon a voluntary or involuntary liquidation or dissolution of the Company or upon conversion of the Series&nbsp;A
Preferred Stock to common stock, upon redemption of the Series&nbsp;A Preferred Stock or at such time as the Company pays a dividend on other shares of its capital stock. The accruing dividend will
be paid in cash. There were $5,168 and $6,256 of undeclared cumulative preferred dividends as of December&nbsp;31, 2013 and 2014, respectively, and $7,118 as of September&nbsp;30, 2015. Holders of
shares of Series&nbsp;A Preferred Stock are entitled to votes equal to the number of shares of common stock into which such Series&nbsp;A Preferred Stock could be converted. Purchasers of the
Series&nbsp;A Preferred Stock received anti-dilution rights whereby if the Company issues or sells additional shares of preferred or common shares at a purchase price below $1.50 per share, the
Company will issue additional shares to these purchasers of Series&nbsp;A Preferred Stock to effectively reduce their purchase price. The Series&nbsp;B Preferred Stock was sold at a price less
than the Series&nbsp;A Preferred Stock. As a result, the Company will issue 237,197 shares of Common Stock for this anti-dilution provision once a liquidation event or other conversion (including an
initial public offering) has been declared. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Each
share of Series&nbsp;A Preferred Stock can be converted into equal shares of common stock at the option of the Series&nbsp;A Preferred Stock holder at any time. In addition, the
Series&nbsp;A Preferred Stock
shares are automatically convertible into common shares upon the sale of shares of common stock to the public at a minimum price of $4.05 per share in a firm commitment underwritten public offering
pursuant to an effective registration statement under the Securities Act of 1933, as amended, resulting in at least $30,000 of proceeds to the Company, net of underwriting discounts and commissions.
Each Series&nbsp;A Preferred stockholder is also entitled to receive the number of common shares equal to the Series&nbsp;A Preferred Stock original issue price divided by the initial public
offering price per share. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>All
shares of preferred stock shall be redeemed by the Company in either a lump sum or three equal annual installments any time after the Company receives notice from one of its two largest preferred
stockholders after September&nbsp;14, 2017. Each share of preferred stock shall be repurchased at its purchase price, as adjusted, plus all unpaid accruing dividends. The Company recorded its
convertible preferred stock at fair value on the dates of issuance, net of issuance costs. As the redemption event is outside the control of the Company, all shares of convertible preferred stock have
been presented outside of permanent equity. The Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the convertible preferred
stock to equal the redemption value at the end of each reporting period. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>At
the time of its issuance, the Company determined that the Series&nbsp;B and Series&nbsp;A preferred stock contained two embedded features: (1)&nbsp;optional redemption by the holder and
(2)&nbsp;optional conversion by the holder. The Company determined that each of the embedded features met the definition of a derivative and that the Series&nbsp;B and Series&nbsp;A preferred
stock should be considered an equity host for </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-21</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=196,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=363891,FOLIO='F-21',FILE='DISK131:[15ZBY1.15ZBY12201]FQ12201A.;130',USER='CHE107332',CD='20-JAN-2016;21:20' -->
<A NAME="page_fq12201_1_22"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of September&nbsp;30, 2015 and for the nine months ended September&nbsp;30, 2014<BR>
and 2015 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 8&nbsp;&#151; Stockholders' Equity (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>the
purposes of assessing the embedded derivatives for potential bifurcation. The following was noted regarding these embedded features: </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Optional Redemption by the Holder.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Company determined that the redemption feature was not clearly and closely related to the equity host instrument
but does
not meet the definition of a derivative. As such, the redemption feature did not require bifurcation under the guidance for derivatives. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Optional Conversion by the Holder.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The optional conversion feature was determined to be clearly and closely related to the Series&nbsp;B and
Series&nbsp;A
preferred stock host. As such the conversion feature did not require bifurcation under ASC 815. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
Series&nbsp;B and Series&nbsp;A preferred stock was assessed under ASC 470, "Debt," to determine if there was a beneficial conversion feature, or BCF. The Company determined there was no BCF. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
following are the preferred stock per share amounts of undeclared cumulative preferred dividends: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="94pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of September 30,<BR>
2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Series&nbsp;A</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.60</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.72</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.82</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Series&nbsp;B</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.11</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.19</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.26</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stock Option Plans  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>During 2003, the Company adopted the 2003 Plan, pursuant to which stock options to acquire an aggregate of 700,000 shares of the Company's common
stock may be granted to employees, directors and consultants. In 2003, in connection with the adoption of the 2003 Stock Option Plan (the "2003 Plan"), the board of directors decided they would no
longer grant any options under the 2001 Plan. On March&nbsp;31, 2005, the Company increased the number of authorized shares to 1,400,000 shares. In September 2006, the Company increased the number
of authorized shares to 1,800,000 shares. In general, options vest over a four-year period and expire five to ten years from the date of grant. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>During
2007, the Company adopted the 2007 Omnibus Stock Option Plan (the "2007 Plan") pursuant to which stock options to acquire an aggregate of 1,600,000 shares of the Company's common stock may be
granted to employees, directors, and consultants. In October 2008, the Company increased the number of authorized shares to 2,850,000. In March 2011, the Company increased the number of authorized
shares to 4,850,000. In September 2012, the Company increased the number of authorized shares to 6,500,000. In October 2014, the Company increased the number of authorized shares to 6,850,000. In
February 2015, the Company increased the number of authorized shares to 7,200,000. With the adoption of the 2007 Plan, the board of directors decided the Company would no longer grant any options
under the 2003 Plan. In general, options granted under the 2007 Plan vest over a </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-22</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=197,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=207996,FOLIO='F-22',FILE='DISK131:[15ZBY1.15ZBY12201]FQ12201A.;130',USER='CHE107332',CD='20-JAN-2016;21:20' -->
<A NAME="page_fq12201_1_23"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of September&nbsp;30, 2015 and for the nine months ended September&nbsp;30, 2014<BR>
and 2015 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 8&nbsp;&#151; Stockholders' Equity (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>four-year
period and expire ten years from the date of grant. The Company issues new shares upon the exercise of options. As of December&nbsp;31, 2014 and September&nbsp;30, 2015, approximately
514,000 and 174,000&nbsp;shares were available for grant under the 2007 Plan. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Information
regarding the Company's stock options is summarized below: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="82pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="47pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Number<BR>
outstanding </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Weighted-average<BR>
exercise<BR>
price </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Aggregate<BR>
intrinsic<BR>
value </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Options outstanding&nbsp;&#151; December&nbsp;31, 2012</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,801,979</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.28</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Granted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,503,500</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.31</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Exercised</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(186,768</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.32</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>21</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Forfeited</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(159,309</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.44</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Options outstanding&nbsp;&#151; December&nbsp;31, 2013</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6,959,402</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.28</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Granted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>441,500</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.48</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Exercised</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,127,745</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.20</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>161</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Forfeited</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(189,483</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.30</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Options outstanding&nbsp;&#151; December&nbsp;31, 2014</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6,083,674</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.31</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,912</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Granted (unaudited)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>473,000</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.50</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Exercised (unaudited)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,168,808</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.22</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>692</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Forfeited (unaudited)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(137,764</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.81</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Options outstanding&nbsp;&#151; September&nbsp;30, 2015 (unaudited)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,250,102</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.42</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,600 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Options exercisable&nbsp;&#151; September&nbsp;30, 2015 (unaudited)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,763,882</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.32</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,607 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Weighted-average fair value of options granted during the year ended December&nbsp;31, 2013</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.13</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Weighted-average fair value of options granted during the year ended December&nbsp;31, 2014</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.16</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Weighted-average fair value of options granted during the nine month period ended September&nbsp;30, 2015 (unaudited)
</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.58</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-23</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=198,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=555771,FOLIO='F-23',FILE='DISK131:[15ZBY1.15ZBY12201]FQ12201A.;130',USER='CHE107332',CD='20-JAN-2016;21:20' -->
<A NAME="page_fq12201_1_24"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of September&nbsp;30, 2015 and for the nine months ended September&nbsp;30, 2014<BR>
and 2015 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 8&nbsp;&#151; Stockholders' Equity (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
following table summarizes information about stock options outstanding as of December&nbsp;31, 2014: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="81pt" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<TD WIDTH="6%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="97pt" style="font-family:times;"></TD>
<TD WIDTH="6%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="6%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<TD WIDTH="6%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Options outstanding </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Options exercisable </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Exercise prices </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Number<BR>
outstanding </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Weighted-<BR>
average remaining<BR>
contractual life-years </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Weighted-<BR>
average<BR>
exercise price </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Number<BR>
exercisable </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Weighted-<BR>
average<BR>
exercise price </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$0.18</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,026,370</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3.18</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.18</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,026,370</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.18</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$0.24</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,062,304</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>8.07</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.24</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>539,867</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.24</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$0.26</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>537,000</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5.23</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.26</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>537,000</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.26</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$0.34</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,000,000</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>8.79</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.34</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>296,036</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.34</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$0.48</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>425,500</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>9.32</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.48</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.48</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$0.55</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,027,500</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6.48</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.55</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>922,109</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.55</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$1.50</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,000</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.07</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.50</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,000</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.50 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$0.18&nbsp;- $1.50</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6,083,674</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6.12</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.31</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,326,382</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.29 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD ALIGN="CENTER" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
following table summarizes information about stock options outstanding as of September&nbsp;30, 2015 (unaudited): </FONT></P>
 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="81pt" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<TD WIDTH="6%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="97pt" style="font-family:times;"></TD>
<TD WIDTH="6%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="6%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<TD WIDTH="6%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Options outstanding </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Options exercisable </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Exercise prices </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Number<BR>
outstanding </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Weighted-<BR>
average remaining<BR>
contractual life-years </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Weighted-<BR>
average<BR>
exercise price </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Number<BR>
exercisable </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Weighted-<BR>
average<BR>
exercise price </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$0.18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,237,620</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2.72</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,237,620</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$0.24</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>771,501</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7.33</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.24</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>470,273</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.24</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$0.26</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>492,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4.49</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.26</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>492,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.26</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$0.34</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,000,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>8.04</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.34</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>486,948</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.34</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$0.48</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>392,914</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>8.60</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.48</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>146,126</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.48</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$0.55</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>932,067</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5.69</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.55</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>930,915</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.55</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$1.50</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>424,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>9.41</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.50</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.50 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$0.18 - $1.50</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,250,102</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6.08</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.42</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,763,882</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.32 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-24</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=199,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=859926,FOLIO='F-24',FILE='DISK131:[15ZBY1.15ZBY12201]FQ12201A.;130',USER='CHE107332',CD='20-JAN-2016;21:20' -->
<A NAME="page_fq12201_1_25"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of September&nbsp;30, 2015 and for the nine months ended September&nbsp;30, 2014<BR>
and 2015 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 8&nbsp;&#151; Stockholders' Equity (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
following summarizes additional information about the Company's stock options: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
December 31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
September&nbsp;30,<BR>
2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;width:42pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Number of:

<!-- COMMAND=ADD_SCROPPEDRULE,42pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Non-vested options beginning of the year</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,634,735</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,241,331</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,757,992</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Non-vested options end of the year</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,241,331</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,757,992</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,486,220</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Vested options</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>690,639</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>909,339</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>543,717</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
December 31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
September&nbsp;30,<BR>
2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;width:148pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Weighted-average grant date fair value of:

<!-- COMMAND=ADD_SCROPPEDRULE,148pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Non-vested options beginning of the year</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.16</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.21</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.15</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Non-vested options end of the year</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.15</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.16</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.98</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Vested options</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.19</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.16</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Forfeited options</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.16</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.16</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.30</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stock Warrants  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The Company has also issued warrants to purchase shares of common stock which are summarized below: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="82pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Number<BR>
outstanding </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Weighted-average<BR>
exercise<BR>
price </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Warrants outstanding&nbsp;&#151; December&nbsp;31, 2012</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>487,353</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.36</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Exercised</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Expired</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Warrants outstanding&nbsp;&#151; December&nbsp;31, 2013</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>487,353</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.36</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Exercised</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Expired</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Warrants outstanding&nbsp;&#151; December&nbsp;31, 2014</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>487,353</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.36</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Exercised (unaudited)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>446,413</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.36</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Expired (unaudited)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Warrants outstanding&nbsp;&#151; September&nbsp;30, 2015 (unaudited)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>40,940</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.35 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-25</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=200,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=94696,FOLIO='F-25',FILE='DISK131:[15ZBY1.15ZBY12201]FQ12201A.;130',USER='CHE107332',CD='20-JAN-2016;21:20' -->
<A NAME="page_fq12201_1_26"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of September&nbsp;30, 2015 and for the nine months ended September&nbsp;30, 2014<BR>
and 2015 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 8&nbsp;&#151; Stockholders' Equity (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Information
regarding the warrants outstanding is as follows: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="81pt" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="8%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="129pt" style="font-family:times;"></TD>
<TD WIDTH="8%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="8%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="129pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of September&nbsp;30, 2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of December&nbsp;31, 2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Range of<BR>
exercise prices </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Warrants </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Weighted-average remaining<BR>
contractual<BR>
life-years </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Warrants </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Weighted-average remaining<BR>
contractual<BR>
life-years </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$1.25</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>278,640</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.78</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>24,583</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.03</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$1.50</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>208,713</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2.57</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>16,357</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.82 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$1.25 - $1.50</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>487,353</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.55</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>40,940</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.74 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 9&nbsp;&#151; Income Taxes  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
As of December&nbsp;31, 2014, the Company had net operating loss carryforwards of approximately $1,100
for federal income tax purposes that are available to offset future taxable income and begin to expire in the year 2018. The use of the net operating loss in future years may be limited under
Sections&nbsp;382 and 383 of the Internal Revenue Code if significant ownership changes have occurred. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
provision for income tax expense (benefit) consisted of the following: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="26pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Nine Months Ended September&nbsp;30, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Current income taxes (benefit)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>169</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>167</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Deferred income taxes (benefit)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>939</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,558</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(171</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>90</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Change in valuation allowance</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,880</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total provision (benefit) for income taxes</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(772</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,725</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(171</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>90 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Deferred
income taxes result from temporary differences between the reporting of amounts for financial statement purposes and income tax purposes. These differences relate primarily to different
methods used for income tax purposes including depreciation and amortization, vacation accruals, deductions related to allowances for doubtful accounts, and net operating loss carryforwards. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-26</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=201,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=257996,FOLIO='F-26',FILE='DISK131:[15ZBY1.15ZBY12201]FQ12201A.;130',USER='CHE107332',CD='20-JAN-2016;21:20' -->
<A NAME="page_fq12201_1_27"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of September&nbsp;30, 2015 and for the nine months ended September&nbsp;30, 2014<BR>
and 2015 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 9&nbsp;&#151; Income Taxes (Continued) </B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
components of the Company's deferred tax assets are as follows: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
September&nbsp;30, 2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Deferred tax assets:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net operating loss carryforwards</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,013</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>874</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>741</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Accounts receivable and inventory reserves</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>753</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>977</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,031</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Intangible assets</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>891</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>886</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>861</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Accrued liabilities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>810</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>243</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>256</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Other</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>111</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>40</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>41 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Gross deferred tax assets</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,578</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,020</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,930</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Less valuation allowance</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net deferred tax assets</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,578</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,020</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,930 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net deferred tax assets&nbsp;&#151; current</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,496</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,015</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,955</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net deferred tax assets&nbsp;&#151; long term</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,082</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,005</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>975 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net deferred tax assets</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,578</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,020</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,930 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
Company regularly assesses the likelihood that the deferred tax assets will be recovered from future taxable earnings. The Company considers projected future taxable earnings and ongoing tax
planning strategies, then records a valuation allowance to reduce the carrying value of the net deferred taxes to an amount that is more likely than not to be realized. The amount of the valuation
allowance reduction as of December&nbsp;31, 2013 was based on the Company's projected discounted taxable earnings. For the year ended December&nbsp;31, 2013, based upon its current year earnings
and estimates of future profitability, the Company determined it would be able to realize its deferred tax assets in the future and therefore decreased the remaining valuation allowance. The decrease
in the valuation allowance was $1,880 for the year ended December&nbsp;31, 2013. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-27</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=202,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=540880,FOLIO='F-27',FILE='DISK131:[15ZBY1.15ZBY12201]FQ12201A.;130',USER='CHE107332',CD='20-JAN-2016;21:20' -->
<A NAME="page_fq12201_1_28"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of September&nbsp;30, 2015 and for the nine months ended September&nbsp;30, 2014<BR>
and 2015 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 9&nbsp;&#151; Income Taxes (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A
reconciliation of income tax expense (benefit) to the statutory federal tax rate of 34% is as follows: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="28pt" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="40pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Nine Months Ended September&nbsp;30, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Tax benefit at statutory rate</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>34.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>34.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (34.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>34.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>State income taxes, net of federal benefit</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2.1</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(5.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4.8</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Permanent differences</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4.3</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3.9</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>61.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>164.6</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Other and uncertain tax positions</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4.5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(60.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(163.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Valuation allowance</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(68.7</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net effective rate</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (22.3</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>45.4</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (38.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>40.4</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>% </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For
tax positions meeting the more likely than not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50% likelihood of being realized
upon ultimate settlement with the relevant tax authority. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>With
few exceptions, the Company is no longer subject to U.S. federal, state or local income tax examinations by tax authorities for the years before 2011. The Company is not currently under
examination by any taxing jurisdiction. In the event of any future tax assessments, the Company has elected to record the income taxes and any related interest and penalties as income tax expense on
the Company's statement of operations. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-28</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=11,SEQ=203,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=54813,FOLIO='F-28',FILE='DISK131:[15ZBY1.15ZBY12201]FQ12201A.;130',USER='CHE107332',CD='20-JAN-2016;21:20' -->
<A NAME="page_fq12201_1_29"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of September&nbsp;30, 2015 and for the nine months ended September&nbsp;30, 2014<BR>
and 2015 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 10&nbsp;&#151; Net Income (Loss) Per Share Attributable to Common Stockholders  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
The following table sets forth the computation of the Company's basic and diluted net income (loss) per share attributable to common stockholders. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:73%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"110%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="110%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="74pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Nine Months Ended September&nbsp;30, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net income (loss)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,156</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,070</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(282</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>134</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Preferred stock dividends</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,668</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,761</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,336</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,396</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Allocation of undistributed earnings to preferred stockholders</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,074</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(216</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net income (loss) attributable to common stockholders</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>414</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>93</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,618</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,262</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Weighted average shares outstanding</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
6,305,401</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
7,025,035</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
6,903,792</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
7,992,734</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Effect of common stock options</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>970,747</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,684,614</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Weighted average shares used to compute diluted net income (loss) per share</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,276,148</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10,709,649</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6,903,792</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,992,734</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net income (loss) per share&nbsp;&#151; Basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
0.07</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
0.01</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
(0.23</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
(0.16</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net income (loss) per share&nbsp;&#151; Diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.06</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.01</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(0.23</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(0.16</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
following potentially dilutive securities outstanding were excluded from the computation of weighted shares outstanding for the years ended December&nbsp;31, 2013 and 2014, and have been
excluded from the computations of diluted weighted-average shares outstanding for the nine month periods ended September&nbsp;30, 2014 and 2015, because such securities have an antidilutive impact
due to losses reported: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Nine Months Ended<BR>
September&nbsp;30, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Convertible preferred stock outstanding</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>16,342,037</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>16,342,037</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>16,342,037</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>16,342,037</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Common stock options</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,351,535</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,870</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6,111,918</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,250,102</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Common stock warrants</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>487,353</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>487,353</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>487,353</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>40,940 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>20,180,925</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>16,837,260</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>22,941,308</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>21,633,079 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-29</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=12,SEQ=204,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=732173,FOLIO='F-29',FILE='DISK131:[15ZBY1.15ZBY12201]FQ12201A.;130',USER='CHE107332',CD='20-JAN-2016;21:20' -->
<A NAME="page_fq12201_1_30"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of September&nbsp;30, 2015 and for the nine months ended September&nbsp;30, 2014<BR>
and 2015 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 11&nbsp;&#151; Unaudited Pro Forma Net Income Per Share Attributable to Common Stockholders  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
The following table sets forth the computation of the Company's unaudited pro forma basic and diluted net income per share attributable to common stockholders during the year ended December&nbsp;31,
2014, and nine months ended September&nbsp;30, 2015 after giving effect to (a)&nbsp;the conversion of all outstanding preferred stock into an aggregate of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common
stock
immediately prior to the completion of this offering; (b)&nbsp;the issuance of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional shares of common stock immediately prior to the completion of the offering that the
Company's Series&nbsp;A and Series&nbsp;B preferred stockholders are entitled to receive in connection with its initial public offering, assuming an initial public offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus; (c)&nbsp;the
additional&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock
that would have been required to be issued to generate sufficient proceeds to fund the cash payment of Series A convertible preferred stock dividends; (d)&nbsp;the issuance
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares
of common stock immediately prior to the completion of this offering to pay accrued dividends on Series&nbsp;B preferred stock (assuming a closing date
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016 and assuming an
initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus); and (e)&nbsp;the
effectiveness of the Company's amended and restated certificate of incorporation and adoption of the Company's amended and restated bylaws. Unaudited pro forma net income (loss) per share attributable
to common stockholders is computed using the weighted average number of common shares outstanding after giving effect to the items set forth above as if such events had occurred at the beginning of
the period presented. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-30</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=13,SEQ=205,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=270750,FOLIO='F-30',FILE='DISK131:[15ZBY1.15ZBY12201]FQ12201A.;130',USER='CHE107332',CD='20-JAN-2016;21:20' -->
<A NAME="page_fq12201_1_31"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 11&nbsp;&#151; Unaudited Pro Forma Net Income Per Share Attributable to Common Stockholders  </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="94pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended<BR>
December&nbsp;31,<BR>
2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Nine Months Ended<BR>
September&nbsp;30,<BR>
2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Numerator:</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net income</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,070</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>134 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Denominator</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Weighted average shares used in computing net income per share attributable to common stock, basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,025,035</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,992,734</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Pro forma adjustment to reflect conversion of convertible preferred stock into common stock</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Pro forma adjustment to reflect the issuance of additional shares of common stock to the Series&nbsp;A and Series&nbsp;B
preferred stockholders</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Pro forma adjustment to reflect the additional shares of common stock that would have been issued to generate sufficient
proceeds to fund the cash payment of the Series A convertible preferred stock dividends</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Pro forma adjustment to reflect the issuance of additional shares of common stock for the payment of cumulative but
unpaid dividends to the Series&nbsp;B preferred stockholders</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Pro forma weighted average shares used in computing net income per share attributable to common stockholders,
basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Effect of common stock options and warrants</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Pro forma weighted average shares used in computing net income per share attributable to common stockholders,
diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Pro forma net income per common share attributable to common stockholders:</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-31</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=14,SEQ=206,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=17832,FOLIO='F-31',FILE='DISK131:[15ZBY1.15ZBY12201]FQ12201A.;130',USER='CHE107332',CD='20-JAN-2016;21:20' -->
<A NAME="page_fq12201_1_32"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 12&nbsp;&#151; Subsequent Events  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
For the audited consolidated financial statements, management has reviewed and evaluated material subsequent events from the consolidated balance sheet date of December&nbsp;31, 2014, through the
consolidated financial statements' issue date of September&nbsp;25, 2015. No subsequent events have been identified for disclosure except as disclosed. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 13&nbsp;&#151; Subsequent Events (unaudited)  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
For the interim consolidated financial statements as of September&nbsp;30, 2015, and for the nine months then ended, the Company has evaluated events through November&nbsp;11, 2015, which is the
date the interim consolidated financial statements were available to be issued. No subsequent events have been identified for disclosure. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-32</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=15,SEQ=207,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=656094,FOLIO='F-32',FILE='DISK131:[15ZBY1.15ZBY12201]FQ12201A.;130',USER='CHE107332',CD='20-JAN-2016;21:20' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>
<IMG SRC="g1002989.jpg" ALT="GRAPHIC" WIDTH="684" HEIGHT="891">
  </B></FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=208,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=484835,FOLIO='blank',FILE='DISK131:[15ZBY1.15ZBY12201]HE12201A.;4',USER='CHE107332',CD='20-JAN-2016;21:20' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=4><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=5><B>TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=4><B>Common Stock  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=4><B>
<IMG SRC="g820079.jpg" ALT="LOGO" WIDTH="289" HEIGHT="123">
  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=4><B>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="23%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="23%" ALIGN="CENTER" >


  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=4><B> PROSPECTUS  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=4><B>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="23%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="23%" ALIGN="CENTER" >


 </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=5><B>Piper Jaffray  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=5><B> William Blair  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=5><B> Canaccord Genuity  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=5><B> BTIG  </B></FONT></P>
 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</font></p><p align=center style="font-family:times;"><font> </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=209,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=299699,FOLIO='blank',FILE='DISK131:[15ZBY1.15ZBY12201]HO12201A.;8',USER='CHE107332',CD='20-JAN-2016;21:20' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ja12201_1_1"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ja12201_part_ii_information_not_required_in_prospectus"> </A>
<A NAME="toc_ja12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  PART II    <BR>    <BR>    INFORMATION NOT REQUIRED IN PROSPECTUS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ja12201_item_13._other_expense__ja101979"> </A>
<A NAME="toc_ja12201_2"> </A></FONT> <FONT COLOR="#3B5A6F" SIZE=2><B>  Item&nbsp;13.&nbsp;&nbsp;&nbsp;&nbsp;Other Expenses of Issuance and Distribution.    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The following table sets forth the costs and expenses, other than the underwriting discounts and commissions, payable by us in connection with the
sale of common stock being registered. All amounts shown are estimates, except the SEC registration fee, the Financial Industry Regulatory Authority,&nbsp;Inc. filing fee and stock exchange listing
fee. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Amount </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>SEC registration fee</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>8,685.38</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>FINRA fee</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>*</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Stock exchange initial listing fee</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>*</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Blue sky fees and expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>*</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Legal fees and expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>*</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Accounting fees and expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>*</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Printing and engraving expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>*</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Transfer agent and registrar fees and expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>*</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Miscellaneous</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>* </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->

 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>*</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">

<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1>*To</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>*To
be filed by amendment </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ja12201_item_14._indemnification_of_directors_and_officers."> </A>
<A NAME="toc_ja12201_3"> </A></FONT> <FONT COLOR="#3B5A6F" SIZE=2><B>  Item&nbsp;14.&nbsp;&nbsp;&nbsp;&nbsp;Indemnification of Directors and Officers.    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We are a corporation organized under the laws of the State of Delaware. Section&nbsp;145 of the Delaware General Corporation Law provides that a
corporation may indemnify any person who was or is a party or is threatened to be made a party to an action by reason of the fact that he or she was a director, officer, employee or agent of the
corporation or is or was serving at the request of the corporation against expenses (including attorneys' fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by him
or her in connection with such action if he or she acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, the best interests of the corporation and, with
respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful, except that, in the case of an action by or in right of the corporation, no
indemnification may generally be made in respect of any claim as to which such person is adjudged to be liable to the corporation. Our amended and restated bylaws, which will become effective upon
completion of this offering, provide that we will indemnify and advance expenses to our directors and officers (and may choose to indemnify and advance expenses to other employees and other agents) to
the fullest extent permitted by law; provided, however, that if we enter into an indemnification agreement with such directors or officers, such agreement controls. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Section&nbsp;102(b)(7)
of the Delaware General Corporation Law permits a corporation to provide in its certificate of incorporation that a director of the corporation shall not be personally liable
to the corporation or its stockholders for monetary damages for breach of fiduciary duties as a director, except for liability for any:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> breach of a director's duty of loyalty to the corporation or its stockholders; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>II-1</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=210,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=961711,FOLIO='II-1',FILE='DISK131:[15ZBY1.15ZBY12201]JA12201A.;24',USER='JKEENE',CD='25-JAN-2016;09:52' -->
<A NAME="page_ja12201_1_2"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> unlawful payment of dividends, stock repurchases or redemption of shares; or </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> transaction from which the director derives an improper personal benefit. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
amended and restated certificate of incorporation, which will become effective upon completion of this offering, provides that our directors are not personally liable for breaches of fiduciary
duties to the fullest extent permitted by the Delaware General Corporation Law. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>These
limitations of liability do not apply to liabilities arising under federal securities laws and do not affect the availability of equitable remedies such as injunctive relief or rescission. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Section&nbsp;145(g)
of the Delaware General Corporation Law permits a corporation to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee, or agent of
the corporation. Our amended and restated bylaws, which will become effective upon completion of this offering, permit us to secure insurance on behalf of any officer, director, employee or other
agent for any liability arising out of his or her actions in connection with their services to us, regardless of whether our bylaws permit indemnification. We intend to obtain a directors' and
officers' liability insurance policy prior to the completion of this offering. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As
permitted by the Delaware General Corporation Law, we intend to enter into indemnification agreements with each of our directors and officers that require us to indemnify such persons against
various actions including, but not limited to, third-party actions where such director or officer, by reason of his or her corporate status, is a party or is threatened to be made a party to an
action, or by reason of anything done or not done by such director or officer in any such capacity. We intend to indemnify directors and officers against all costs, judgments, penalties, fines,
liabilities, amounts paid in settlement by or on behalf such directors and officers, and for any expenses actually and reasonably incurred by such directors and officers in connection with such
action, if such directors or officers acted in good faith and in a manner they reasonably believed to be in or not opposed to the best interests of the corporation, and with respect to any criminal
proceeding, had no reasonable cause to believe their conduct was unlawful. We also intend to advance to our directors and officers expenses (including attorney's fees) incurred by such directors or
officers in advance of the final disposition of any action after the receipt by us of a statement or statements from directors or officers requesting such payment or payments from time to time,
provided that such statement or statements are accompanied by an undertaking, by or on behalf of such directors or officers, to repay such amount if it shall ultimately be determined that they are not
entitled to be indemnified against such expenses by us. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
indemnification agreements will also set forth certain procedures that will apply in the event of a claim for indemnification or advancement of expenses, including, among others, provisions about
providing notice to us of any action in connection with which a director or officer seeks indemnification or advancement of expenses from us, and provisions concerning the determination of entitlement
to indemnification or advancement of expenses. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Prior
to the completion of this offering we plan to enter into an underwriting agreement, which will provide that the underwriters are obligated, under some circumstances, to indemnify our directors,
officers and controlling persons against specified liabilities.  </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ja12201_item_15._recent_sales_of_unregistered_securities."> </A>
<A NAME="toc_ja12201_4"> </A></FONT> <FONT COLOR="#3B5A6F" SIZE=2><B>  Item&nbsp;15.&nbsp;&nbsp;&nbsp;&nbsp;Recent Sales of Unregistered Securities.    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In the three years preceding the filing of this registration statement, we issued the securities indicated below that were not registered under the
Securities Act. All of the following securities are deemed </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>II-2</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=211,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=70659,FOLIO='II-2',FILE='DISK131:[15ZBY1.15ZBY12201]JA12201A.;24',USER='JKEENE',CD='25-JAN-2016;09:52' -->
<A NAME="page_ja12201_1_3"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>restricted
securities for purposes of the Securities Act. All certificates representing the issued shares of capital stock described in this Item&nbsp;15 included appropriate legends setting forth
that the securities have not been registered and the applicable restrictions on transfer. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Issuance of Preferred Stock  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In September and October 2012, we sold&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our Series&nbsp;B preferred stock at the price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per
share, for aggregate consideration of $10.4&nbsp;million. No underwriters were involved in the foregoing sales of securities. We believe the offers, sales and issuances of these securities were
exempt from registration under the Securities Act by virtue of Section&nbsp;4(a)(2) and Regulation&nbsp;D promulgated thereunder relative to transactions by an issuer not involving any public
offering, to the extent an exemption from such registration was required. The purchasers of the securities in each of these transactions represented their intentions to acquire the securities for
investment only and not with a view to or for sale in connection with any distribution thereof, and appropriate legends were placed upon the stock certificates issued in these transactions. All
purchasers had general access, through their relationships with us, to information about us. The sales of these securities were made without any general solicitation or advertising. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Issuance of Common Stock  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>From January&nbsp;1, 2015 through November 30, 2015, we issued&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock upon the exercise of previously
issued warrants at an exercise price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share for aggregate consideration of $625,823. We believe the offers, sales and issuance of the above securities were exempt
from
registration under the Securities Act in reliance on Section&nbsp;4(a)(2) because the transactions were pursuant to outstanding warrants. The purchasers of the securities in each of these
transactions represented their intentions to acquire the securities for investment only and not with a view to or for sale in connection with any distribution thereof, and appropriate legends were
placed upon the stock certificates issued in these transactions. All purchasers had general access, through their relationships with us, to information about us. The sales of these securities were
made without any general solicitation or advertising. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>From
January&nbsp;1, 2015 through November 30, 2015, we also issued&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock upon the exercise of previously issued options at an exercise price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share for aggregate consideration of $264,593. We believe the offers, sales and issuance of the above securities were exempt from registration under the Securities Act
in reliance
on Rule&nbsp;701 because the transactions were pursuant to compensatory benefit plans or contracts relating to compensation as provided under such rule. The purchasers of the securities in each of
these transactions represented their intentions to acquire the securities for investment only and not with a view to or for sale in connection with any distribution thereof, and appropriate legends
were placed upon the stock certificates issued in these transactions. All purchasers had general access, through their relationships with us, to information about us. The sales of these securities
were made without any general solicitation or advertising. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stock Option Grants  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>From January&nbsp;1, 2012 through&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016, we granted
stock options to purchase an aggregate of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common
stock at a weighted-average exercise price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, to certain of our employees, directors and consultants in connection with services provided to us by these
individuals. We
believe the offers, sales and issuance of the above securities were exempt from registration under the Securities Act in reliance on Rule&nbsp;701 because the transactions were pursuant to
compensatory benefit plans or contracts relating to compensation as provided under such rule or pursuant to Section&nbsp;4(a)(2) under the Securities Act relative to transactions </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>II-3</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=212,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=167246,FOLIO='II-3',FILE='DISK131:[15ZBY1.15ZBY12201]JA12201A.;24',USER='JKEENE',CD='25-JAN-2016;09:52' -->
<A NAME="page_ja12201_1_4"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>by
an issuer not involving any public offering, to the extent an exemption from such registration was required. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ja12201_item_16._exhibits_and_financial_statement_schedules."> </A>
<A NAME="toc_ja12201_5"> </A></FONT> <FONT COLOR="#3B5A6F" SIZE=2><B>  Item&nbsp;16.&nbsp;&nbsp;&nbsp;&nbsp;Exhibits and Financial Statement Schedules.    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>See the Exhibit Index following the signature page.  </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ja12201_item_17._undertakings."> </A>
<A NAME="toc_ja12201_6"> </A></FONT> <FONT COLOR="#3B5A6F" SIZE=2><B>  Item&nbsp;17.&nbsp;&nbsp;&nbsp;&nbsp;Undertakings.    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The undersigned registrant hereby undertakes to provide to the underwriters at the closing specified in the underwriting agreement, certificates in
such denominations and registered in such names as required by the underwriters to permit prompt delivery to each purchaser. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or
otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is,
therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or
controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being
registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
undersigned registrant hereby undertakes that: </FONT></P>

<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>For
purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this registration
statement in reliance upon Rule&nbsp;430A and contained in a form of prospectus filed by the registrant pursuant to Rule&nbsp;424(b)(1) or (4)&nbsp;or 497(h) under the Securities Act shall be
deemed to be part of this registration statement as of the time it was declared effective.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>For
the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to
be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>For
the purpose of determining liability under the Securities Act to any purchaser, each prospectus filed pursuant to Rule&nbsp;424(b) as part of a
registration statement relating to an offering, other than registration statements relying on Rule&nbsp;430B or other than prospectuses filed in reliance on Rule&nbsp;430A, shall be deemed to be
part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part
of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as
to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration
statement or made in any such document immediately prior to such date of first use.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>(4)</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to
sell the securities to the purchaser, if </FONT></DD></DL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>II-4</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=213,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=832895,FOLIO='II-4',FILE='DISK131:[15ZBY1.15ZBY12201]JA12201A.;24',USER='JKEENE',CD='25-JAN-2016;09:52' -->
<A NAME="page_ja12201_1_5"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>the
securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or
sell such securities to such purchaser: </FONT></P>

<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>(i)</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Any
preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule&nbsp;424;
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>(ii)</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Any
free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned
registrant;
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>(iii)</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its
securities provided by or on behalf of the undersigned registrant; and
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>(iv)</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Any
other communication that is an offer in the offering made by the undersigned registrant to the purchaser. </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>II-5</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=214,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=583712,FOLIO='II-5',FILE='DISK131:[15ZBY1.15ZBY12201]JA12201A.;24',USER='JKEENE',CD='25-JAN-2016;09:52' -->
<UL>
<UL>
</UL>
</UL>
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_jc12201_1_6"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="jc12201_signatures"> </A>
<A NAME="toc_jc12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  SIGNATURES    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this registration statement on Form&nbsp;S-1
to be signed on its behalf by the undersigned, thereunto duly authorized, in Minneapolis, Minnesota, on this 25<SUP>th</SUP> day of January, 2016. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="49%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="21pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="46%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>  By:</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>/s/&nbsp;GERALD R. MATTYS&nbsp;&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#3B5A6F">

</FONT> <FONT COLOR="#3B5A6F" SIZE=2> Gerald R. Mattys<BR>
Chief Executive Officer</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="jc12201_powers_of_attorney"> </A>
<A NAME="toc_jc12201_2"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  POWERS OF ATTORNEY    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We, the undersigned officers and directors of Tactile Systems Technology,&nbsp;Inc., hereby severally constitute and appoint Gerald R. Mattys and
Robert J. Folkes, and each of them singly (with full power to each of them to act alone), our true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution in each
of them for him and in his name, place and stead, and in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement (or any other
registration statement for the same offering that is to be effective upon filing pursuant to Rule&nbsp;462(b) under the Securities Act of 1933), and to file the same, with all exhibits thereto and
other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each
and every act and thing requisite or necessary to be done in and about the premises, as full to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that
said attorneys-in-fact and agents or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Pursuant
to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities held on the dates indicated. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="35%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="35%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="138pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="CENTER" style="font-family:times;"><DIV style="border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;width:33pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Signature

<!-- COMMAND=ADD_SCROPPEDRULE,33pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH NOWRAP  ALIGN="CENTER" style="font-family:times;"><DIV style="border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;width:17pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Title

<!-- COMMAND=ADD_SCROPPEDRULE,17pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH NOWRAP  ALIGN="CENTER" style="font-family:times;"><DIV style="border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;width:17pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Date

<!-- COMMAND=ADD_SCROPPEDRULE,17pt -->

 </B></FONT></DIV></TH>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>/s/&nbsp;GERALD R. MATTYS<BR>



<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#3B5A6F">

</FONT> <FONT COLOR="#3B5A6F" SIZE=2> Gerald R. Mattys</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Chief Executive Officer (principal executive officer) and Director</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>January&nbsp;25, 2016</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>/s/&nbsp;ROBERT J. FOLKES<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#3B5A6F">

</FONT> <FONT COLOR="#3B5A6F" SIZE=2> Robert J. Folkes</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>Chief Operating Officer and Chief Financial Officer (principal financial and accounting officer)</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>January&nbsp;25, 2016</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>/s/&nbsp;PETER H. SODERBERG<BR>



<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#3B5A6F">

</FONT> <FONT COLOR="#3B5A6F" SIZE=2> Peter H. Soderberg</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>Chairman of the Board of Directors</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>January&nbsp;25, 2016</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>/s/&nbsp;WILLIAM W. BURKE<BR>



<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#3B5A6F">

</FONT> <FONT COLOR="#3B5A6F" SIZE=2> William W. Burke</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>Director</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>January&nbsp;25, 2016</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>/s/&nbsp;JORDAN S. DAVIS<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#3B5A6F">

</FONT> <FONT COLOR="#3B5A6F" SIZE=2> Jordan S. Davis</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>Director</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>January&nbsp;25, 2016</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>/s/&nbsp;RICHARD NIGON<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#3B5A6F">

</FONT> <FONT COLOR="#3B5A6F" SIZE=2> Richard Nigon</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>Director</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>January&nbsp;25, 2016</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>/s/&nbsp;KEVIN H. ROCHE<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#3B5A6F">

</FONT> <FONT COLOR="#3B5A6F" SIZE=2> Kevin H. Roche</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>Director</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>January&nbsp;25, 2016</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>/s/&nbsp;STEPHEN I. SHAPIRO<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#3B5A6F">

</FONT> <FONT COLOR="#3B5A6F" SIZE=2> Stephen I. Shapiro</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>Director</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>January&nbsp;25, 2016</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>/s/&nbsp;ZUBEEN SHROFF<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#3B5A6F">

</FONT> <FONT COLOR="#3B5A6F" SIZE=2> Zubeen Shroff</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>Director</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>January&nbsp;25, 2016</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>II-6</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=215,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=800817,FOLIO='II-6',FILE='DISK131:[15ZBY1.15ZBY12201]JC12201A.;22',USER='CHE107332',CD='20-JAN-2016;21:20' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ka12201_1_7"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ka12201_exhibit_index"> </A>
<A NAME="toc_ka12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  EXHIBIT INDEX    <BR>    </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="56pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Exhibit No. </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Description </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.1*</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Form of Underwriting Agreement</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2.1</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Asset Sale and Purchase Agreement, dated as of September&nbsp;14, 2012, by and between Tactile Systems Technology, Inc., Swelling Solutions, Inc., ConvaTec Inc. and ConvaTec Technologies, Inc.^</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3.1*</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Amended and Restated Certificate of Incorporation (to be effective upon completion of the offering)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3.2*</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Amended and Restated Bylaws (to be effective upon completion of the offering)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3.3*</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Amended and Restated Certificate of Incorporation (currently in effect)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3.4</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Amended and Restated Bylaws (currently in effect)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4.1*</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Specimen Certificate representing shares of common stock</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4.2*</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Amended and Restated Investors' Rights Agreement dated September&nbsp;14, 2012</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5.1*</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Opinion of Faegre Baker Daniels&nbsp;LLP</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10.1#</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2003 Stock Option Plan</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10.2#</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Form of Incentive Stock Option Agreement under 2003 Stock Option Plan</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10.3#</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Form of Non-Statutory Stock Option Agreement (Employee) under 2003 Stock Option Plan</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10.4#</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Form of Non-Statutory Stock Option Agreement (Director) under 2003 Stock Option Plan</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10.5#</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2007 Omnibus Stock Plan</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10.6#</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Form of Incentive Stock Option Agreement under 2007 Omnibus Stock Plan</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10.7#</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Form of Non-Statutory Stock Option Agreement (Employee) under 2007 Omnibus Stock Plan</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10.8#</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Form of Non-Statutory Stock Option Agreement (Directors) under 2007 Omnibus Stock Plan</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10.9#</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Form of Non-Statutory Stock Option Agreement (Consultants) under 2007 Omnibus Stock Plan</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10.10#</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Form of Restricted Stock Agreement</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10.11*#</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2016 Equity Incentive Plan</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10.12*#</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Form of Option Agreement under 2016 Equity Incentive Plan</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10.13*#</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Form of Restricted Stock Agreement under 2016 Equity Incentive Plan</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10.14*#</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Employee Stock Purchase Plan</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10.15*#</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Non-Employee Director Compensation Policy</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10.16*#</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Form of Director and Officer Indemnification Agreement</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10.17*#</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Form of Employment Agreement between Tactile Systems Technology,&nbsp;Inc. and its named executive officers</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10.18*</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Promissory Note, dated as of May&nbsp;11, 2014, as amended May&nbsp;11, 2015, by and between Tactile Systems Technology,&nbsp;Inc. and Venture Bank</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>21.1</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Subsidiaries</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>23.1</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Consent of Grant Thornton LLP</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>23.2*</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Consent of Faegre Baker Daniels&nbsp;LLP (included in Exhibit&nbsp;5.1)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>24.1</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Power of Attorney (included in signature page)</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1>*</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>To
be filed by amendment.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1>^</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Schedules
to this exhibit have been omitted pursuant to Item&nbsp;601(b)(2) of Regulation S-K. A copy of any omitted schedule will be furnished
supplementally to the Securities and Exchange Commission upon request.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1>#</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Indicates
management contract or compensatory plan or arrangement. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>II-7</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=216,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=298434,FOLIO='II-7',FILE='DISK131:[15ZBY1.15ZBY12201]KA12201A.;26',USER='JKEENE',CD='25-JAN-2016;09:52' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>a2227029zex-2_1.htm
<DESCRIPTION>EX-2.1
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;2.1</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">EXECUTION VERSION</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ASSET SALE AND PURCHASE AGREEMENT</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">by and between</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Tactile Systems Technology,&nbsp;Inc.,</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Swelling Solutions,&nbsp;Inc.,</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ConvaTec Inc.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">and</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ConvaTec Technologies,&nbsp;Inc.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade align="center" style="color:black;"></div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SEPTEMBER 14, 2012</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=371797,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan 25 21:17 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TABLE OF CONTENTS</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="14%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="76%" valign="bottom" style="padding:0in 0in 0in 0in;width:76.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="8%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:8.76%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Page</font></b></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="80%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:80.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE&nbsp;1</font></p>    </td>
<td width="80%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:80.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">DEFINITIONS AND CONSTRUCTION</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="80%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:80.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;1.1</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Definitions</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;1.2</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Additional Defined Terms</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;1.3</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Construction</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE&nbsp;2</font></p>    </td>
<td width="80%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:80.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">THE TRANSACTION</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="80%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:80.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.1</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sale and Purchase of Purchased   Assets</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.2</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Excluded Assets</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.3</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Assumed Liabilities</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.4</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Excluded Liabilities</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.5</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Consideration</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.6</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Commercialization Payment</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.7</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sales Percentage Amount</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.8</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Allocation of Purchase Price</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.9</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Closing</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.10</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Closing Deliveries</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.11</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Default Interest</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.12</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Removal of Purchased Assets</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.13</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Consents</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.14</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Set-off</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE&nbsp;3</font></p>    </td>
<td width="80%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:80.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">REPRESENTATIONS AND WARRANTIES OF   THE SELLERS</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="80%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:80.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.1</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Organization and Good Standing</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.2</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Authority and Enforceability</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">16</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.3</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No Conflict</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">16</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.4</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Purchased Assets</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">16</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.5</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Intellectual Property</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">16</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.6</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Contracts</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.7</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Tax Matters</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.8</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Governmental Authorizations</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.9</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Compliance with Laws</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.10</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Legal Proceedings</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.11</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">FDA and Regulatory Compliance</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.12</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Inventory</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">20</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.13</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Products and Materials</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">21</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.14</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Brokers Fees</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">21</font></p>    </td>   </tr>
<tr height="0">
<td width="80" style="border:none;"></td>
<td width="25" style="border:none;"></td>
<td width="542" style="border:none;"></td>
<td width="62" style="border:none;"></td>   </tr> </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">i<a name="16022-2-KC-01_PB_i_020339_2438"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=848645,FOLIO='i',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan 25 21:17 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.15</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Anti-Bribery Laws</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">21</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.16</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cidron Healthcare Limited</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">22</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.17</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Disclaimer of Other   Representations and Warranties</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">22</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.18</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No Other Provisions</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">22</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE&nbsp;4</font></p>    </td>
<td width="80%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:80.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">REPRESENTATIONS AND WARRANTIES OF   THE PURCHASER</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">22</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="80%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:80.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;4.1</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Organization and Good Standing</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">22</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;4.2</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Authority and Enforceability</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">23</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;4.3</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No Conflict</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">23</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;4.4</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Legal Proceedings</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">23</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;4.5</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Brokers Fees</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">23</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;4.6</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Financial Capacity</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">23</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;4.7</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Independent Investigation</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">23</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE&nbsp;5</font></p>    </td>
<td width="80%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:80.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">COVENANTS</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">24</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="80%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:80.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.1</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Access and Investigation</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">24</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.2</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Operation of the Project</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">24</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.3</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Consents and Filings</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">25</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.4</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sellers&#146; Names, Assets and   Information</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">25</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.5</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Nonsolicitation</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">26</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.6</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Noncompetition</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">26</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.7</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exclusivity</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">28</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.8</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Insurance</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">28</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.9</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Successors in Interest</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">28</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.10</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Books and Records</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">28</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.11</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Confidentiality</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">28</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.12</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Public Announcements</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">29</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.13</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Further Actions</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.14</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Bulk Transfer Laws</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.15</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Transfer Taxes</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.16</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Data Room</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.17</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Employees and Consultants</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE&nbsp;6</font></p>    </td>
<td width="80%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:80.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CONDITIONS PRECEDENT TO   OBLIGATION TO CLOSE</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">31</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="80%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:80.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;6.1</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Conditions to the Obligation of   the Purchaser</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">31</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;6.2</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Conditions to the Obligation of   the Sellers</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">31</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE&nbsp;7</font></p>    </td>
<td width="80%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:80.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TERMINATION</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">32</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="80%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:80.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;7.1</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Termination Events</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">32</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;7.2</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Effect of Termination</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">32</font></p>    </td>   </tr>
<tr height="0">
<td width="80" style="border:none;"></td>
<td width="25" style="border:none;"></td>
<td width="542" style="border:none;"></td>
<td width="62" style="border:none;"></td>   </tr> </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">ii<a name="16022-2-KC-01_PB_ii_020355_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=3,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=268452,FOLIO='ii',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan 25 21:17 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;7.3</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Certain Effects of Termination</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">33</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE&nbsp;8</font></p>    </td>
<td width="80%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:80.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">INDEMNIFICATION</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">33</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="80%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:80.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;8.1</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Indemnification by ConvaTec</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">33</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;8.2</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Indemnification by the Purchaser</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">33</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;8.3</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Claim Procedure</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">33</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;8.4</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Survival</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">34</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;8.5</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Limitations on Liability</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">34</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;8.6</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exclusive Remedy</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">36</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE&nbsp;9</font></p>    </td>
<td width="80%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:80.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">GENERAL PROVISIONS</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">36</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="80%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:80.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.1</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Notices</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">36</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.2</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amendment</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">37</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.3</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Waiver and Remedies</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">37</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.4</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Entire Agreement</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">37</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.5</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Assignment Successors and No   Third Party Rights</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">37</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.6</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Severability</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">38</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.7</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibits and Schedules</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">38</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.8</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Interpretation</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">38</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.9</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Expenses</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">38</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.10</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Governing Law</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">38</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.11</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Specific Performance</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">38</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.12</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Jurisdiction and Service of   Process</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">38</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.13</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Waiver of Jury Trial</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">39</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.14</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No Joint Venture</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">39</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.15</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Counterparts</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">39</font></p>    </td>   </tr>
<tr>
<td width="14%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:14.76%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.16</font></p>    </td>
<td width="76%" valign="top" style="padding:0in 0in 0in 0in;width:76.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Guarantee</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.76%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">39</font></p>    </td>   </tr>
<tr height="0">
<td width="80" style="border:none;"></td>
<td width="25" style="border:none;"></td>
<td width="542" style="border:none;"></td>
<td width="62" style="border:none;"></td>   </tr> </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibits</font></u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit&nbsp;A</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Bill of Sale</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit&nbsp;B</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Assignment and Assumption   Agreement</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit&nbsp;C</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Patent Assignment</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit&nbsp;D</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Software Assignment</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">iii<a name="16022-2-KC-01_PB_iii_020401_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=4,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=902304,FOLIO='iii',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan 25 21:17 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">EXECUTION VERSION</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ASSET SALE AND PURCHASE AGREEMENT</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This Asset Sale and Purchase Agreement (the &#147;<u>Agreement</u>&#148;) is made as of September&nbsp;14, 2012 by and between ConvaTec Inc., a Delaware corporation (&#147;<u>ConvaTec</u>&#148;), ConvaTec Technologies,&nbsp;Inc., a Nevada corporation (&#147;<u>CTI</u>&#148;, and CTI and ConvaTec together being the &#147;<u>Sellers</u>&#148; and each individually a &#147;<u>Seller</u>&#148;), Swelling Solutions,&nbsp;Inc., a Delaware corporation (the &#147;<u>Purchaser</u>&#148;), and, solely with respect to Section&nbsp;9.16, Tactile Systems Technology,&nbsp;Inc., a Delaware corporation (&#147;<u>Parent</u>&#148;).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Recitals</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Sellers are engaged in the design, development and clinical testing of (a)&nbsp;the Amadeus adaptive compression therapy device for the treatment of chronic venous insufficiency and venous leg ulcers (the &#147;<u>Amadeus Device</u>&#148;), (b)&nbsp;the SMM platform technology entailed in the patents set forth in Part&nbsp;B of Schedule 2.1(d), for a materials-based approach to compression therapy (the &#147;<u>SMM Platform</u>&#148;), and (c)&nbsp;the Products (as hereinafter defined, and the Amadeus Device, the SMM Platform and the Products together being the &#147;<u>Project</u>&#148;).</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">B.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Sellers desire to sell, convey, assign, transfer and deliver to the Purchaser, and the Purchaser desires to purchase and acquire from the Sellers, all of the assets of the Sellers primarily relating to the Project, and the Purchaser agrees to assume certain liabilities of the Sellers.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Agreement</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">NOW, THEREFORE, intending to be legally bound and in consideration of the mutual provisions set forth in this Agreement and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;1</font></b><b><br> DEFINITIONS AND CONSTRUCTION</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;1.1</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Definitions</u>.&#160; For the purposes of this Agreement, the Ancillary Agreements and the Project:</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Acquisition</u>&#148; means any of the following transactions or series of related transactions: the sale, lease, exchange, transfer, license, acquisition or disposition of the Project or any material Purchased Assets.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Acquisition Proposal</u>&#148; means any offer, proposal, inquiry or indication of interest from any Person contemplating or otherwise relating to any Acquisition.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Affiliate</u>&#148; means, with respect to a specified Person, a Person that directly, or indirectly through one or more intermediaries, controls, is controlled by or is under common control with, the specified Person.&#160; In addition to the foregoing, if the specified Person is an individual, the term &#147;Affiliate&#148; also includes (a)&nbsp;the individual&#146;s spouse, (b)&nbsp;the members of the immediate family (including parents, siblings and children) of the individual or of the individual&#146;s spouse and (c)&nbsp;any corporation, limited liability company, general or limited partnership, trust, association or other business or investment entity that directly or indirectly, through one or more intermediaries, controls, is controlled by or is under common control with any of the foregoing individuals.&#160; For purposes of this definition, the term &#147;control&#148; (including the terms &#147;controlling,&#148; &#147;controlled by&#148; and &#147;under common control with&#148;) means the</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=5,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=817361,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan 25 21:17 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">possession, direct or indirect, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise.&#160; Furthermore, for purposes of this definition, when applied to the Sellers, the term &#147;Affiliate&#148; shall include only (and for so long only as they control, are controlled by or are under common control with the Sellers) Cidron Healthcare Limited and its direct and indirect subsidiaries and shall not include the shareholders of Cidron Healthcare Limited, or any of the direct and indirect subsidiaries (other than Cidron Healthcare Limited and its direct and indirect subsidiaries) of such shareholders.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Ancillary Agreements</u>&#148; means, collectively, the Bill of Sale, the Assignment and Assumption Agreement, the Patent Assignment, the Software Assignment and any other agreement entered into in connection with the transactions contemplated hereby.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Annual Period</u>&#148; means a period beginning on the Commercialization Payment Date and ending on the last day of the fourth Quarterly Calculation Period after the Commercialization Payment Date, and thereafter each period consisting of four consecutive Quarterly Calculation Periods.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Business Day</u>&#148; means any day other than Saturday, Sunday or any day on which banking institutions in New York City or Minneapolis, Minnesota are closed either under applicable Law or action of any Governmental Authority.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Code</u>&#148; means the Internal Revenue Code of 1986.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Commercialization</u>&#148; means the earlier of the date on which (a)&nbsp;a Product is shipped or (b)&nbsp;an invoice for a Product is sent, in either case with respect to the actual sale of a Product in normal commercial sales or distribution channels.&#160; When used as a verb, &#147;<u>Commercializing</u>&#148; means to engage in Commercialization and &#147;<u>Commercialize</u>&#148; and &#147;<u>Commercialized</u>&#148; shall have a corresponding meaning.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Commercially Reasonable Efforts</u>&#148; means the efforts that a prudent Person desirous of achieving a result would use in similar circumstances to achieve such result as promptly as reasonable under the circumstances, taking into account any associated expenditure of resources (financial or other) and the expected benefit to such Person; provided, however, that a Person required to use Commercially Reasonable Efforts under or in connection with this Agreement will not be thereby required to dispose of any portion of, or make any material change to, its business.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Contract</u>&#148; means any written or oral contract, agreement, lease, license, commitment, understanding, franchise, warranty, guaranty, mortgage, note, bond or other instrument or consensual obligation that is legally binding.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Encumbrance</u>&#148; means any charge, claim, mortgage, encumbrance, pledge, security interest, or other lien.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>First Commercialization Date</u>&#148; means the first date upon which Commercialization occurs.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>GAAP</u>&#148; means United States generally accepted accounting principles.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Governmental Authority</u>&#148; means any (a)&nbsp;nation, region, state, county, city, town, village, district or other jurisdiction, (b)&nbsp;federal, state, local, municipal, foreign or other government, (c)&nbsp;governmental or quasi-governmental authority of any nature (including any governmental agency, branch, department or other entity and any court or other tribunal), (d)&nbsp;multinational organization exercising judicial, legislative or regulatory power or (e)&nbsp;body exercising, or entitled to exercise, any administrative, executive, judicial, arbitral, legislative, police, regulatory or taxing authority or power of any nature of any federal, state,</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-KC-01_PB_2_015142_9014"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=6,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=1042554,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan 25 21:17 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">local, municipal, foreign or other government, including any self-regulatory organization and any arbitrator.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Governmental Authorization</u>&#148; means any approval, consent, ratification, waiver, license, permit, registration or other authorization issued or granted by any Governmental Authority.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Guaranteed Minimum Sales Percentage Amount</u>&#148; means an amount equal to (a)&nbsp;$45,000 for each of the first four Quarterly Calculation Periods; (b)&nbsp;$148,500 for each of the fifth, sixth, seventh and eighth Quarterly Calculation Periods; and (c)&nbsp;$247,750 for each of the ninth, tenth, eleventh and twelfth Quarterly Calculation Periods.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Independent Valuation of Restricted Business</u>&#148; means a valuation of a Restricted Business as contemplated by Section&nbsp;5.6(c)&nbsp;of this Agreement, which valuation will be prepared by a reputable nationally recognized investment bank jointly selected by the Purchaser and ConvaTec, which valuation will set forth the purchase price at which such investment bank believes the Restricted Business could be sold to a third party in an arms&#146; length transaction, taking into account the efforts of the Sellers to sell the Restricted Business within the 12-month period after Sellers acquire the Restricted Business.&#160; Each of Purchaser, on the one hand, and the Sellers, on the other hand, will pay fifty percent (50%) of all fees and costs incurred by the aforesaid investment bank in the preparation of the Independent Valuation of Restricted Business.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Intellectual Property</u>&#148; means all of the following anywhere in the world and all legal rights, title or interest in the following arising under Law: (a)&nbsp;all patents and applications for patents and all related reissues, reexaminations, divisions, renewals, extensions, provisionals, continuations and continuations in part; (b)&nbsp;all copyrights, copyright registrations and copyright applications, copyrightable works and all other corresponding rights; (c)&nbsp;all mask works, mask work registrations and mask work applications and all other corresponding rights; (d)&nbsp;all trade dress and trade names, logos,&nbsp;Internet addresses and domain names, trademarks and service marks and related registrations and applications, including any intent to use applications, supplemental registrations and any renewals or extensions, all other indicia of commercial source or origin and all goodwill associated with any of the foregoing; (e)&nbsp;all inventions (whether patentable or unpatentable and whether or not reduced to practice), know how, technology, technical data, trade secrets, specifications, test results, methods, ideas or concepts, confidential business information, manufacturing and production processes and techniques, research and development information, financial, marketing and business data, pricing and cost information, business and marketing plans, advertising and promotional materials, customer, distributor, reseller and supplier lists and information, correspondence, records, and other documentation, and other proprietary information of every kind; (f)&nbsp;all computer software (including source and object code), firmware, development tools, algorithms, files, records, analysis, technical drawings and related documentation, data and manuals; and (g)&nbsp;all databases and data collections.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>IRS</u>&#148; means the United States Internal Revenue Service and, to the extent relevant, the United States Department of Treasury.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Judgment</u>&#148; means any order, injunction, judgment, decree, ruling, assessment or arbitration award of any Governmental Authority.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Knowledge</u>&#148; means, with respect to the Sellers, the actual knowledge, after reasonable inquiry, of any of the executive officers or senior managerial employees of the Sellers listed in Section&nbsp;1.1(a)&nbsp;of the Seller Disclosure Schedule. For purposes hereof, &#147;reasonable inquiry&#148; shall not include any obligation to make inquiries other than of the executive officers and senior managerial employees of the Sellers and</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="16022-2-KC-01_PB_3_015151_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=7,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=964346,FOLIO='3',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan 25 21:17 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">any other employees of Sellers with primary responsibility for the applicable facts or circumstances referenced in this Agreement.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Law</u>&#148; means any constitution, law, statute, treaty, rule, regulation, ordinance, code, Order, governmental requirement or rule&nbsp;of law (including common law) enacted, promulgated or imposed by any Governmental Authority.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Liability</u>&#148; means any liability or obligation, whether known or unknown, absolute or contingent, accrued or unaccrued, liquidated or unliquidated, due or to become due.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Loss</u>&#148; means any losses, damages, Judgments, fines, penalties, costs or expenses (including reasonable attorney&#146;s or other professional fees and expenses) but excluding (a)&nbsp;any exemplary or punitive damages and (b)&nbsp;any special, indirect, or consequential damages, lost profits, loss of revenue, lost sales, or amounts calculated as a multiple of earnings, profits, revenue, sales or other measure, in each case that are not reasonably foreseeable by the Indemnifying Party.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Material Adverse Effect</u>&#148; means any event, change, circumstance, effect or other matter that has a material adverse effect on (a)&nbsp;the Purchased Assets or the Project, in each case taken as a whole, or (b)&nbsp;the ability of the Sellers to consummate timely the transactions contemplated by this Agreement; provided, however, that none of the following, either alone or in combination, will constitute, or be considered in determining whether there has been, a Material Adverse Effect (except to the extent that any of the following in clauses (i)&nbsp;or (ii)&nbsp;has a disproportionate impact on the Purchased Assets or the Project): any event, change, circumstance, effect or other matter resulting from or related to (i)&nbsp;changes in Laws, GAAP or enforcement or interpretation thereof, (ii)&nbsp;changes in financial markets, general economic conditions (including prevailing interest rates, exchange rates, commodity prices and fuel costs) or political conditions, (iii)&nbsp;any action taken or failed to be taken in accordance with the express terms of this Agreement or at the request of the Purchaser, or (iv)&nbsp;the execution or delivery of this Agreement, the consummation of the transactions contemplated by this Agreement or the public announcement or other publicity with respect to any of the foregoing.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Non-SMM Product</u>&#148; means any Product other than an SMM Product.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Permitted Encumbrance</u>&#148; means any (a)&nbsp;carrier&#146;s, warehousemen&#146;s, mechanic&#146;s, materialmen&#146;s and other similar liens with respect to amounts that are not yet due and payable or that are being contested in good faith, or (b)&nbsp;liens for Taxes that are not yet due and payable or that are being contested in good faith.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Person</u>&#148; means an individual or an entity, including a corporation, limited liability company, general or limited partnership, trust, association or other business or investment entity, or any Governmental Authority.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Prime Rate</u>&#148; means the prime rate reported from time to time in the &#147;Money Rates&#148; (or successor) section of the<i> Wall Street Journal</i>.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Proceeding</u>&#148; means any action, arbitration, audit, examination, investigation, hearing, litigation or suit (whether civil, criminal, administrative, judicial or investigative, whether formal or informal, and whether public or private) commenced, brought, conducted or heard by or before, or otherwise involving, any Governmental Authority.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">4<a name="16022-2-KC-01_PB_4_015200_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=8,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=491961,FOLIO='4',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan 25 21:17 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Product</u>&#148; means the Amadeus Device, the SMM Platform and any other product the design for which, or of the manufacturing of which, is wholly or partly derived (other than in an immaterial respect) from the Purchased Intellectual Property.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Quarterly Calculation Period</u>&#148; means the time period from the Commercialization Payment Date until the last day of the calendar quarter following the calendar quarter in which the Commercialization Payment Date occurs and thereafter, each three-month period ending on the last day of each calendar quarter during the Percentage Payments Period; provided that the last Quarterly Calculation Period will end on the tenth anniversary of the Commercialization Payment Date.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Restricted Business</u>&#148; means the design, development, marketing or sale of any portable compression therapy device for the treatment of chronic swelling, lymphedema (or lymphoedema), venous insufficiency and venous leg ulcers that is either battery operated or electrically operated.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Sales</u>&#148; means, with respect to a Product for any period, revenues recognized by Purchaser in accordance with GAAP, for the sale of Products after deduction of (a)&nbsp;ordinary and customary trade discounts or rebates given or credited with respect to such sales and consistent with industry standard practices, including discounts imposed by applicable Law (including Medicaid); (b)&nbsp;credits, returns, refunds or allowances (including wholesaler and retailer returns or any copayments) actually allowed; (c)&nbsp;freight, postage, insurance and duties paid for and separately identified on the invoice or other documentation maintained in the ordinary course of business actually paid and not paid separately or otherwise reimbursed by the customer; and (d)&nbsp;value added Taxes, sales Taxes, use Taxes, occupation or excise Taxes, other consumption Taxes, customs duties and compulsory payments to Governmental Authorities imposed on the production, importation, exportation, use or sale of any Products the obligation of payment of which is on the Purchaser or any of its Affiliates.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Schedule</u>&#148; means the Seller Disclosure Schedule or the Purchaser Disclosure Schedule, as the context requires.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>SMM Product</u>&#148; means any Product the design for which, or of the manufacturing of which, is either (a)&nbsp;primarily derived from the SMM Platform, or (b)&nbsp;partly derived (other than in an immaterial respect) from the SMM Platform, if a greater proportion of the Purchased Intellectual Property used in such Product is from the SMM Platform rather than from any Purchased Intellectual Property that is not from the SMM Platform.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Subsidiary</u>&#148; means, with respect to a specified Person, any corporation or other Person of which securities or other interests having the power to elect a majority of that corporation&#146;s or other Person&#146;s board of directors or similar governing body, or otherwise having the power to direct the business and policies of that corporation or other Person (other than securities or other interests having such power only upon the happening of a contingency that has not occurred) are held by the specified Person or one or more of its Subsidiaries.&#160; When used in this Agreement without reference to a particular Person, &#147;Subsidiary&#148; means a Subsidiary of a Seller.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Tax</u>&#148; means (a)&nbsp;any federal, state, local, foreign or other tax, charge, fee, duty (including customs duty), levy or assessment, including any income, gross receipts, net proceeds, alternative or add-on minimum, corporation, ad valorem, turnover, real property, personal property (tangible or intangible), sales, use, franchise, excise, value added, stamp, leasing, lease, user, transfer, fuel, excess profits, profits, occupational, premium, interest equalization, windfall profits, severance, license, registration, payroll, environmental (including taxes under Section&nbsp;59A of the Code), capital stock, capital duty, disability, estimated, gains, wealth, welfare, employee&#146;s income withholding, other withholding, unemployment or social security or other tax of whatever kind (including any fee, assessment or other charges in the nature</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">5<a name="16022-2-KC-01_PB_5_015209_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=9,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=131622,FOLIO='5',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan 25 21:17 2016' -->

<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">of or in lieu of any tax) that is imposed by any Governmental Authority, (b)&nbsp;any interest, fines, penalties or additions resulting from, attributable to, or incurred in connection with any items described in this paragraph or any related contest or dispute and (c)&nbsp;any Liability for the Taxes of another Person.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Tax Return</u>&#148; means any report, return, declaration, claim for refund, or information return or statement related to Taxes, including any schedule or attachment thereto, and including any amendment thereof.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;1.2</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Additional Defined Terms</u>.&#160; For purposes of this Agreement and the Ancillary Agreements, the following terms have the meanings specified in the indicated Section&nbsp;of this Agreement:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="93%" style="border-collapse:collapse;margin-left:.5in;">
<tr>
<td width="48%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Defined&nbsp;Terms</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.12%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="48%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:48.22%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Section</font></b></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Adjustment Amount</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.7(g)&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Agreement</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preamble</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amadeus Device</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preamble</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Annual Sales Threshold</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.7(d)&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Anti-Bribery Laws</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.15(a)&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Assignment and Assumption Agreement</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.10(a)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Assumed Liabilities</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.3</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Bill of Sale</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.10(a)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Claim Notice</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.3(a)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Closing</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.9</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Closing Date</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.9</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Closing Payment</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.5</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Commercialization Payment</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.6(a)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Commercialization Payment Date</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.6(a)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Confidentiality Agreement</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.11(a)&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ConvaTec</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preamble</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CTI</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preamble</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Deductible</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.5(a)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Defaulting Party</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.11</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Equipment</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.1(c)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Excluded Assets</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.2</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Excluded Liabilities</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.4</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">FDA</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.11</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">FDCA</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.11(a)&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Financial Buyer</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.6(d)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Included Contracts</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.1(b)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Initial Sales Payment Period</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.7(a)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Initial Sales Percentage Amount</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.7(a)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Indemnified Party</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.3(a)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Indemnifying Party</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.3(a)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Independent Accounting Firm</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.7(f)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Insurance Policy</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.8</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Inventory</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.1(a)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Large Acquisition</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.6(c)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Non-Financial Buyer</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.6(d)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Non-SMM Product Sales</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.7(a)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Parent</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preamble</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Patent Assignment</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.10(a)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Payment Date</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.14(a)</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">6<a name="16022-2-KC-03_PB_6_021016_6781"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=10,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=706095,FOLIO='6',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-03_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:37 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="93%" style="border-collapse:collapse;margin-left:.5in;">
<tr>
<td width="48%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Defined&nbsp;Terms</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.12%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="48%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:48.22%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Section</font></b></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Percentage Payments Determination Report</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.7(e)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Percentage Payments Period</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.7(c)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Permitted Acquisition</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.6(c)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">PPDR</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.7(e)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Project</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preamble</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Project Information</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.11(b)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Purchase of a Restricted Business</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.6(c)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Purchase Price</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.5</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Purchased Assets</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.1</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Purchased Intellectual Property</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.1(d)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Purchaser</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preamble</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Purchaser Disclosure Schedule</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Article&nbsp;4</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Purchaser Indemnified Parties</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.1</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Purchaser Information</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.4(e)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Restricted Period</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.6(a)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Relevant Acquisition</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.6(c)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sales Payment Period</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.7(c)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sales Percentage Amount</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.7(c)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Seller</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preamble</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Seller Disclosure Schedule</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Article&nbsp;3</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Seller Facility</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.12</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Seller Indemnified Parties</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.2</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Seller Information</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.4(d)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Seller Marks</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.4(a)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Seller Sale</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.6(d)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sellers</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preamble</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SMM Platform</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preamble</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SMM Product Sales</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.7(a)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Software Assignment</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.10(a)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Successor</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.9</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Third Party Claim</font></p>    </td>
<td width="3%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.3(b)</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Transfer Taxes</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.15</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;1.3</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Construction</u>.&#160; Any reference in this Agreement to an &#147;Article,&#148; &#147;Section,&#148; &#147;Exhibit&#148; or &#147;Schedule&#148; refers to the corresponding Article, Section, Exhibit&nbsp;or Schedule of or to this Agreement, unless the context indicates otherwise.&#160; The table of contents and the headings of Articles and Sections are provided for convenience only and are not intended to affect the construction or interpretation of this Agreement.&#160; All words used in this Agreement are to be construed to be of such gender or number as the circumstances require.&#160; The words &#147;including,&#148; &#147;includes,&#148; or &#147;include&#148; are to be read as listing non-exclusive examples of the matters referred to, whether or not words such as &#147;without limitation&#148; or &#147;but not limited to&#148; are used in each instance.&#160; Where this Agreement states that a party &#147;shall&#148;, &#147;will&#148; or &#147;must&#148; perform in some manner or otherwise act or omit to act, it means that the party is legally obligated to do so in accordance with this Agreement. &#160;Any reference to a statute is deemed also to refer to any amendments or successor legislation as in effect at the relevant time.&#160; Any reference to a Contract or other document as of a given date means the Contract or other document as amended, supplemented and modified from time to time through such date.&#160; Any reference to &#147;Dollars&#148; or &#147;$&#148; means U.S. dollars.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">7<a name="16022-2-KC-03_PB_7_021045_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=11,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=411690,FOLIO='7',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-03_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:37 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;2</font></b><b><br> THE TRANSACTION</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.1</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Sale and Purchase of Purchased Assets</u>.&#160; In accordance with the provisions of this Agreement and except as set forth in Section&nbsp;2.2, at the Closing, the Sellers will sell, convey, assign, transfer and deliver to the Purchaser, and the Purchaser will purchase and acquire from the Sellers, free and clear of all Encumbrances except Permitted Encumbrances, all of the Sellers&#146; right, title and interest in and to all of the assets of the Sellers primarily relating to the Project, including the following assets (collectively, the &#147;<u>Purchased Assets</u>&#148;):</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>all inventory of the Project as of the Closing Date (collectively, the &#147;<u>Inventory</u>&#148;), including the inventory set forth on Schedule 2.1(a);</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>except as set forth on Schedule 2.2(g), all of the rights of the Sellers under all Contracts primarily relating to the Project (collectively, the &#147;<u>Included Contracts</u>&#148;), including the Contracts set forth on Schedule 2.1(b);</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>all machinery, equipment, tooling and other items of tangible personal property owned by the Sellers primarily relating to the Project (collectively, the &#147;<u>Equipment</u>&#148;), including the machinery and equipment set forth on Schedule 2.1(c);</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the Intellectual Property primarily relating to the Project (collectively, the &#147;Purchased Intellectual Property&#148;), including the Intellectual Property set forth on Schedule 2.1(d)&nbsp;and any rights Sellers might have to the names &#147;ACT&#148; and &#147;Adaptive Compression Therapy&#148;, and including all of Sellers&#146; rights with respect to past, present or future infringements thereof;</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>all marketing, product packaging, designs, photography and similar items primarily relating to the sale or marketing of the Products;</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>books and records primarily relating to the Project, including records relating to regulatory approvals obtained or applications made before the Closing Date; and</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>to the extent transferable under applicable Law, all Governmental Authorizations held by the Sellers to the extent necessary for and primarily relating to the operation of the Project.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.2</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Excluded Assets</u>.&#160; Notwithstanding the terms of Section&nbsp;2.1, the Sellers will not sell, convey, assign, transfer or deliver to the Purchaser, and the Purchaser will not purchase or acquire, and the Purchased Assets do not include, any assets other than the Purchased Assets, including but not limited to any of the following assets (the &#147;<u>Excluded Assets</u>&#148;):</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>all cash, cash equivalents, bank deposits, investment accounts, lockboxes, certificates of deposit, marketable securities, bank accounts, corporate credit cards and other similar cash items of the Sellers;</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>all notes and accounts receivable of the Sellers;</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>all minute books, records, stock ledgers, Tax records and all other materials that the Sellers are required by Law to retain (provided that copies of such records shall, to the extent legally permissible and to the extent that they constitute Purchased Intellectual Property or Purchased Assets, be provided to the Purchaser);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">8<a name="16022-2-KC-03_PB_8_021104_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=12,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=309290,FOLIO='8',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-03_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:37 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>all financial books and records with respect to the Project and the Purchased Assets, including receipts and invoices (provided that the Sellers shall, as soon as reasonably practicable following receipt of an itemized request from Purchaser, provide to Purchaser copies of those itemized financial records so requested by Seller to be provided);</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the shares of the capital stock of the Sellers and their Affiliates and all of the Sellers&#146; or any of their Affiliates&#146; ownership interest in any Subsidiary or other Person;</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>all insurance policies, binders and claims and rights thereunder and proceeds thereof;</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>all rights under all Contracts of the Sellers set forth on Schedule 2.2(g)&nbsp;and all Contracts of the Sellers other than the Included Contracts;</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>all intellectual property rights of the Sellers other than the Purchased Intellectual Property;</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>all inventory of the Sellers other than the Inventory;</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(j)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>all machinery, equipment and other items of tangible personal property of the Sellers other than the Equipment;</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(k)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>all real property and rights in respect of real property;</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(l)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>all rights arising under any Excluded Liability; and</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(m)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>all rights of the Sellers under this Agreement or any of the Ancillary Agreements.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.3</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Assumed Liabilities</u>.&#160; In accordance with the provisions of this Agreement, at the Closing, the Purchaser will assume and pay or perform and discharge when due only the following Liabilities of the Sellers to the extent relating to the Project or the Purchased Assets (the &#147;<u>Assumed Liabilities</u>&#148;):</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>all Liabilities of the Sellers arising on or after the Closing Date under the Included Contracts and the Governmental Authorizations included in the Purchased Assets, but only to the extent that such Liabilities do not arise from or relate to any breach by the Sellers of any obligations under any provision of any of the Included Contracts or Governmental Authorizations that occurred on or before the Closing Date; and</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>all other Liabilities arising out of, relating to or incurred in connection with (i)&nbsp;the ownership or use of the Purchased Assets after the Closing Date or the operation of the Project after the Closing Date, (ii)&nbsp;the use by the Purchaser or its permitted licensees of Purchased Intellectual Property after the Closing Date and (iii)&nbsp;any other condition arising after the Closing Date with respect to the Purchased Assets.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.4</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Excluded Liabilities</u>.&#160; Notwithstanding any other provision of this Agreement or any other writing to the contrary, the Purchaser is assuming only the Assumed Liabilities and is not assuming any other Liability of the Sellers of whatever nature, whether presently in existence or arising hereafter (the &#147;<u>Excluded Liabilities</u>&#148;).</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.5</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Consideration</u>.&#160; The consideration for the Purchased Assets consists of (a)&nbsp;the payment at the Closing of $3,000,000 (the &#147;<u>Closing Payment</u>&#148;), (b)&nbsp;the Commercialization Payment to be</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">9<a name="16022-2-KC-03_PB_9_021114_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=13,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=418786,FOLIO='9',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-03_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:37 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">paid in accordance with Section&nbsp;2.6, (c)&nbsp;the Initial Sales Percentage Amounts and Sales Percentage Amounts, as applicable, to be paid in accordance with Section&nbsp;2.7 (the amounts set forth in clauses (a), (b)&nbsp;and (c), the &#147;<u>Purchase Price</u>&#148;), and (d)&nbsp;the assumption of the Assumed Liabilities.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.6</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Commercialization Payment.</u></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>In addition to the Closing Payment, the Initial Sales Percentage Amounts and the Sales Percentage Amounts, the Purchaser shall pay to Sellers, as part of the Purchase Price, the amount of $2,000,000 (the &#147;<u>Commercialization Payment</u>&#148;), payable within five Business Days after the Commercialization Payment Date.&#160; For purposes hereof, the &#147;<u>Commercialization Payment Date</u>&#148; shall mean the date that is the earlier of (i)&nbsp;the First Commercialization Date and (ii)&nbsp;the first anniversary of the Closing Date.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any payment pursuant to this Section&nbsp;2.6 shall be made by wire transfer of immediately available funds in U.S. dollars to the account(s)&nbsp;specified by the Sellers no later than two Business Days prior to the due date for such payment.&#160; Except as set forth in Section&nbsp;2.14, no payment made pursuant to this Section&nbsp;2.6 will be subject to deduction, withholding or offset for any reason.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Purchaser shall use its reasonable best efforts to manufacture and Commercialize the Amadeus Device as promptly as practicable after the Closing Date and shall use its Commercially Reasonable Efforts to explore the commercial viability of the SMM Platform.&#160; From and after the Closing Date, the Purchaser shall deliver to ConvaTec on or before each six month anniversary of the Closing Date a brief report setting forth the status of the Project and the anticipated date(s)&nbsp;for Commercializing any Product.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.7</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Sales Percentage Amount</u>.&#160; In addition to the Closing Payment and the Commercialization Payment, for the Percentage Payments Period, the Purchaser shall, as part of the Purchase Price, make payments to Sellers as set forth below:</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>For each of the first sixteen (16) Quarterly Calculation Periods (the &#147;<u>Initial Sales Payment Period</u>&#148;), the Purchaser shall pay to Sellers an amount (each, an &#147;<u>Initial Sales Percentage Amount</u>&#148;) equal to nine percent (9%) of Sales of Non-SMM Products (the &#147;<u>Non-SMM Product Sales</u>&#148;) and seven percent (7%) of Sales of SMM Products (the &#147;<u>SMM Product Sales</u>&#148;) during such Quarterly Calculation Period; provided that, subject to Section&nbsp;2.7(b)&nbsp;below, if the Initial Sales Percentage Amount is less than the Guaranteed Minimum Sales Percentage Amount for any of the first twelve (12) Quarterly Calculation Periods, the Purchaser shall pay to Sellers the Guaranteed Minimum Sales Percentage Amount for that Quarterly Calculation Period.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If during any of the first twelve (12) Quarterly Calculation Periods Sellers or their respective Affiliates conduct a Restricted Business in the United States, then thereafter the proviso in Section&nbsp;2.7(a)&nbsp;shall not apply and the Purchaser shall not be required to pay any further Guaranteed Minimum Sales Percentage Amounts to Sellers notwithstanding that the Initial Sales Percentage Amount may be less than the Guaranteed Minimum Sales Percentage Amount for any of the remaining Quarterly Calculation Periods in the first twelve (12) Quarterly Calculation Periods.&#160; If during any of the first twelve (12) Quarterly Calculation Periods Sellers or their respective Affiliates conduct a Restricted Business anywhere outside the United States, then the proviso in Section&nbsp;2.7(a)&nbsp;shall continue to apply and the Purchaser shall be required to pay the applicable Guaranteed Minimum Sales Percentage Amount to Sellers if the Initial Sales Percentage Amount is less than the Guaranteed Minimum Sales Percentage Amount for any of the remaining Quarterly Calculation Periods in the first twelve (12) Quarterly Calculation Periods; provided, however, that for purposes hereof the Guaranteed Minimum Sales Percentage Amount shall be reduced by sixty percent (60%).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">10<a name="16022-2-KC-03_PB_10_021123_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=14,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=675286,FOLIO='10',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-03_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:37 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>For each Quarterly Calculation Period beginning with the seventeenth Quarterly Calculation Period and ending on the tenth anniversary of the Commercialization Payment Date (the &#147;<u>Sales Payment Period</u>&#148; and, together with the Initial Sales Payment Period, the &#147;<u>Percentage Payments Period</u>&#148;), the Purchaser shall pay to Sellers an amount (each, a &#147;<u>Sales Percentage Amount</u>&#148;) equal to six percent (6%) of Non-SMM Product Sales and five percent (5%) of SMM Product Sales during such Quarterly Calculation Period, subject to clause (d)&nbsp;below.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If (i)&nbsp;Non-SMM Product Sales plus (ii)&nbsp;SMM Product Sales in a calendar year during the Sales Payment Period exceed Forty Million Dollars ($40,000,000) (the &#147;<u>Annual Sales Threshold</u>&#148;), then the Sales Percentage Amount relating to Non-SMM Product Sales payable by the Purchaser to ConvaTec in respect of such calendar year shall equal six percent (6%) of Non-SMM Product Sales during such calendar year up to the Annual Sales Threshold and shall equal seven percent (7%) of Non-SMM Product Sales during such calendar year in excess of the Annual Sales Threshold.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Purchaser shall prepare a &#147;<u>Percentage Payments Determination Report</u>&#148; or &#147;<u>PPDR</u>&#148; for the Sellers setting forth the calculation of the Initial Sales Percentage Amount or the Sales Percentage Amount, as applicable, for each Quarterly Calculation Period.&#160; Each PPDR shall conform substantially to the format set forth in <u>Schedule 2.7(e)</u>&nbsp;attached hereto, and be in accordance with the definition of &#147;Sales&#148; set forth in Section&nbsp;1.1, and shall contain the information reasonably necessary to calculate the Initial Sales Percentage Amount or the Sales Percentage Amount, as applicable, for such Quarterly Calculation Period.&#160; To the extent a Quarterly Calculation Period straddles a calendar year end during the Sales Payment Period, the Purchaser shall ensure that the PPDR for such Quarterly Calculation Period contains sufficient detail for purposes of application of the provisions of clause (d)&nbsp;above.&#160; All moneys reported in the PPDR shall be in U.S. dollars, or in both a foreign currency and U.S. dollars.&#160; If the Purchaser or any of its Affiliates receives payment for a Product in a currency other than U.S. dollars, then for purposes of converting the relevant Initial Sales Percentage Amount or the Sales Percentage Amount, as applicable, in respect thereof, such other currency shall be converted into U.S. dollars at the applicable rate of exchange of Citibank N.A., in New York, New York, on the last Business Day of the last month of the Quarterly Calculation Period in which the relevant sale occurred.&#160; Within forty-five (45) calendar days following the end of each Quarterly Calculation Period during the Percentage Payments Period, the Purchaser shall deliver to the Sellers the PPDR, along with payment, by wire transfer of immediately available funds to an account designated by ConvaTec, of an amount equal to the Initial Sales Percentage Amount or the Sales Percentage Amount, as applicable, for such Quarterly Calculation Period, as set forth in the PPDR.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Sellers may object in writing to a PPDR for a Quarterly Calculation Period only within twenty calendar days of delivery of the PPDR for the last Quarterly Calculation Period in each Annual Period.&#160; If ConvaTec objects in writing to any individual PPDR within such period, then the parties will act in good faith to resolve among themselves any objections to the PPDR.&#160; If they are unable to do so within thirty (30) calendar days after ConvaTec&#146;s notice of objection, then either party may submit the dispute to a mutually agreed-upon independent accounting firm of recognized national standing, which firm is not the regular auditing firm of or otherwise providing material services to the Purchaser or the Sellers or any of their respective Affiliates.&#160; If the Purchaser and ConvaTec are unable to jointly select such independent accounting firm within ten (10)&nbsp;days after the dispute is submitted to the accounting firm, the Purchaser, on the one hand, and ConvaTec, on the other hand, will each select an independent accounting firm of recognized national standing and such selected accounting firms will select a third independent accounting firm of recognized national standing, which firm is not the regular auditing firm of or otherwise providing material services to the Purchaser or the Sellers or any of their respective Affiliates; provided, however, that if either the Purchaser, on the one hand, or ConvaTec, on the other hand, fail to select such independent accounting firm during this 10-day period, then the parties agree that the independent accounting firm selected by the other party will be the independent accounting firm selected by the parties for purposes of this Section&nbsp;2.7 (such selected independent accounting firm,</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">11<a name="16022-2-KC-03_PB_11_021131_7748"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=15,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=961474,FOLIO='11',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-03_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:37 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:2.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">whether pursuant to this sentence or the preceding sentence, the &#147;<u>Independent Accounting Firm</u>&#148;).&#160; The Purchaser and ConvaTec will instruct the Independent Accounting Firm to render its determination with respect to the items in dispute in a written report that specifies the conclusions of the Independent Accounting Firm as to each item in dispute and the resulting Initial Sales Percentage Amount or the Sales Percentage Amount, as applicable.&#160; The Purchaser and ConvaTec will each use their Commercially Reasonable Efforts to cause the Independent Accounting Firm to render its determination within thirty (30) days after referral of the items to such firm or as soon thereafter as reasonably practicable.&#160; The Independent Accounting Firm&#146;s determination of the Adjustment Amount as set forth in its report will be final and binding on the parties for purposes of this Section&nbsp;2.7.&#160; The fees and expenses of the Independent Accounting Firm shall be borne entirely by the Purchaser if a PPDR is adjusted by greater than four percent (4%) in the Sellers&#146; favor.&#160; If the relevant PPDR is adjusted by four percent (4%) or less, the fees and expenses of the Independent Accounting Firm shall be borne entirely by ConvaTec.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The &#147;<u>Adjustment Amount</u>,&#148; with respect to any dispute, will be equal to (i)&nbsp;the Initial Sales Percentage Amount or the Sales Percentage Amount, as applicable, as determined in accordance with Section&nbsp;2.7(f)&nbsp;for such Quarterly Calculation Period, minus (ii)&nbsp;the amount previously paid by the Purchaser to ConvaTec with respect to the Purchaser&#146;s original Percentage Payments Determination Report for such Quarterly Calculation Period, plus (iii)&nbsp;interest at the Prime Rate plus 3% per annum, accruing on the basis of the actual number of days elapsed and a 365-day year, beginning on the 30th day of the month following the Quarterly Calculation Period for which the Percentage Payments Determination Report was disputed by ConvaTec and ending on the date payment is required pursuant to Section&nbsp;2.7(h).</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any payment to Sellers of an Adjustment Amount will be effected by wire transfer of immediately available funds to an account designated by ConvaTec.&#160; Such payment will be made within five Business Days following the final determination of the relevant Initial Sales Percentage Amount or Sales Percentage Amount, as applicable, in accordance with Section&nbsp;2.7(f).&#160; Except as set forth in Section&nbsp;2.14, no payment made pursuant to this Section&nbsp;2.7 will be subject to deduction, withholding or offset for any reason.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>During the Percentage Payments Period, the Purchaser shall provide ConvaTec and its respective advisers, and the Independent Accounting Firm (in the event of any dispute pursuant to Section&nbsp;2.7(f)) with reasonable access during normal business hours to books and records and cooperation and assistance as may be reasonably required to enable ConvaTec and the Independent Accounting Firm to calculate each Initial Sales Percentage Amount or Sales Percentage Amount, as applicable, and confirm each Percentage Payments Determination Report.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(j)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>During the Percentage Payments Period, the Purchaser agrees to use Commercially Reasonable Efforts to promote and sell Products, in the United States, Europe and elsewhere, in a manner consistent with such efforts undertaken by Purchaser with respect to its products.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.8</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Allocation of Purchase Price</u>.&#160; The Sellers and the Purchaser agree that the sum of the Purchase Price plus the Assumed Liabilities (and subsequent adjustments, if any) will be allocated among the Purchased Assets as of the Closing Date in accordance with Schedule 2.8.&#160; Each of the Sellers and the Purchaser will (a)&nbsp;timely file all forms (including IRS Form&nbsp;8594) and Tax Returns required to be filed in connection with such allocation, (b)&nbsp;be bound by such allocation for purposes of determining Taxes, (c)&nbsp;prepare and file, or cause to be prepared and filed, its Tax Returns on a basis consistent with such allocation and (d)&nbsp;take no position, or cause no position to be taken, inconsistent with such allocation on any applicable Tax Return, in any Proceeding before any Governmental Authority, in any report made for Tax, financial accounting or any other purposes, in any litigation, or otherwise.&#160; If the allocation set forth on Schedule 2.8 is disputed by any Governmental Authority, the party receiving notice of such</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">12<a name="16022-2-KC-03_PB_12_021140_141"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=16,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=454838,FOLIO='12',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-03_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:37 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">dispute will promptly notify the other party hereto concerning the existence and resolution of such dispute.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.9</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Closing</u>.&#160; The closing of the transactions contemplated by this Agreement (the &#147;<u>Closing</u>&#148;) will take place at the offices of Baker&nbsp;&amp; McKenzie LLP, 300 East Randolph Street, Chicago,&nbsp;Illinois, at 10:00 a.m., local time, as soon as practicable, but in any event not later than the third Business Day immediately following the date on which the last of the conditions set forth in Article&nbsp;6 has been satisfied or waived (other than those conditions that by their nature can only be satisfied at the Closing), or at such other time and place as ConvaTec and the Purchaser may agree in writing.&#160; The date on which the Closing actually occurs is referred to in this Agreement as the &#147;<u>Closing Date</u>.&#148;</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.10</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Closing Deliveries.</u></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>At the Closing, the Sellers will deliver or cause to be delivered to the Purchaser:</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>a bill of sale in the form of <u>Exhibit&nbsp;A</u> (the &#147;<u>Bill of Sale</u>&#148;) duly executed by the Sellers;</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>an assignment and assumption agreement in the form of <u>Exhibit&nbsp;B</u> (the &#147;<u>Assignment and Assumption Agreement</u>&#148;) duly executed by the Sellers;</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>an assignment of all patents and patent applications included in the Purchased Intellectual Property in the form of <u>Exhibit&nbsp;C</u> (the &#147;<u>Patent Assignment</u>&#148;) duly executed by the Sellers;</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>an assignment of all software included in the Purchased Intellectual Property in the form of <u>Exhibit&nbsp;D</u> (the &#147;<u>Software Assignment</u>&#148;) duly executed by the Sellers;</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(v)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>a certificate, dated as of the Closing Date, duly executed by the Sellers confirming the satisfaction of the conditions specified in Sections 6.1(a)&nbsp;and 6.1(b); and</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(vi)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>such other instruments of sale, transfer, conveyance and assignment as the Purchaser reasonably requests for the purpose of consummating the transactions contemplated by this Agreement.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>At the Closing, the Purchaser will deliver or cause to be delivered to the Sellers:</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the Closing Payment by wire transfer of immediately available funds in U.S. dollars to the account(s)&nbsp;specified by ConvaTec no later than two Business Days prior to the Closing Date;</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the Assignment and Assumption Agreement duly executed by the Purchaser;</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the Bill of Sale, the Patent Assignment and the Software Assignment, if any, that call for a signature by the Purchaser, duly executed by the Purchaser;</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>a certificate, dated as of the Closing Date, duly executed by the Purchaser confirming the satisfaction of the conditions specified in Sections 6.2(a)&nbsp;and 6.2(b); and</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(v)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>such other instruments of assumption as ConvaTec reasonably requests for the purpose of consummating the transactions contemplated by this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">13<a name="16022-2-KC-03_PB_13_021200_7608"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=17,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=695026,FOLIO='13',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-03_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:37 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.11</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Default Interest</u>.&#160; If any party that is required to pay any sum under this Agreement fails to pay such sum on the due date for payment (the &#147;<u>Defaulting Party</u>&#148;), it shall pay interest on such sum for the period from and including such due date through the date of actual payment (after as well as before any applicable Judgment), at the rate of 10% per annum.&#160; Interest under this Section&nbsp;2.11 shall accrue on the basis of the actual number of days elapsed and a 365-day year and shall be paid by the Defaulting Party on demand.&#160; Unpaid interest shall not compound.&#160; The accrual or receipt by the non-defaulting party of interest under this Section&nbsp;2.11 shall not constitute a waiver by the non&#173;defaulting party of any right or remedy it may otherwise have under this Agreement.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.12</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Removal of Purchased Assets</u>.&#160; Promptly but in any event no later than sixty (60) calendar days following the Closing Date, the Purchaser will (a)&nbsp;prepare for relocation such Purchased Assets located at any facilities currently occupied by the Sellers or any Affiliate of the Sellers (each such facility, a &#147;<u>Seller Facility</u>&#148;) and relocate such Purchased Assets from the relevant Seller Facility and (b)&nbsp;be responsible for all data transfer, delivery, transmission and reformatting expenses related to the acquisition of the Purchased Assets; provided that if Purchaser does not relocate the Purchased Assets within 60 calendar days after the Closing Date, Purchaser will following that date begin to pay reasonable fees for storing such Purchased Assets and after 120 calendar days after the Closing Date, Sellers may ship such Purchased Assets to Purchaser at Purchaser&#146;s reasonable expense.&#160; Subject to the provisions of this Agreement, the Sellers will, and will cause their Affiliates to, cooperate with the Purchaser and provide the Purchaser all assistance reasonably requested by the Purchaser in connection with the planning and implementation of the transfer of any Purchased Assets or any portion of any of them to such location as the Purchaser will designate.&#160; The Purchased Assets will be transported by or on behalf of the Purchaser, and until all of the Purchased Assets are removed from a Seller Facility, the Sellers will permit, and will cause their Affiliates to permit, the Purchaser and its authorized agents or representatives, upon prior notice, to have reasonable access to such Seller Facility during normal business hours to the extent necessary to disconnect, detach, remove, package and crate the Purchased Assets for transport.&#160; The Purchaser will be responsible for transporting and reinstalling the Purchased Assets at such location(s)&nbsp;as the Purchaser will determine.&#160; All risk of loss as to the Purchased Assets will be borne by, and will pass to, the Purchaser as of the Closing.&#160; After the Closing Date, Purchaser will be able to remove any Purchased Assets that are in the possession, custody or control of any Person other than Sellers from the location at which such Person has possession, custody or control of such Purchased Assets without the payment of any fees or expenses by Purchaser to such Person, other than any such fees and expenses that may arise from new arrangements entered into directly between Purchaser and such Persons.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.13</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Consents</u>.&#160; Notwithstanding any other provision of this Agreement, this Agreement does not effect an assignment of any Included Contract if an attempted assignment thereof, without the consent of a third party thereto, would constitute a breach or other contravention thereof or would be ineffective with respect to any party thereto.&#160; As to any such Included Contract, the Sellers and the Purchaser will use Commercially Reasonable Efforts to obtain as promptly as practicable after the Closing the consent of the other parties to the assignment of such Included Contract or, if required, novation thereof to the Purchaser or, alternatively, written confirmation from such parties reasonably satisfactory to the Sellers and the Purchaser that such consent is not required.&#160; In no event, however, will the Sellers or any of their Affiliates be obligated to pay any money to any Person or to offer or grant other financial or other accommodations to any Person in connection with obtaining any consent, waiver, confirmation, novation or approval with respect to any such Included Contract.&#160; If any consent, waiver, confirmation, novation or approval is not obtained with respect to any such Included Contract, then the Sellers and the Purchaser will cooperate to establish an agency type or other similar arrangement reasonably satisfactory to the Sellers and the Purchaser under which the Purchaser would obtain, to the extent practicable, all rights, and assume the corresponding Liabilities thereunder (including by means of subcontracting, sublicensing or subleasing arrangement) or under which the Sellers would enforce, for the</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">14<a name="16022-2-KC-03_PB_14_021209_8146"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=18,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=993451,FOLIO='14',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-03_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:37 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">benefit of the Purchaser, with the Purchaser assuming and agreeing to pay the Sellers&#146; Liabilities and expenses, any and all rights of the Sellers against a third party to any such Included Contract.&#160; In such event (i)&nbsp;the Sellers will promptly pay to the Purchaser when received all moneys relating to the period on or after the Closing Date received by it under any Included Contract not transferred pursuant to this Section&nbsp;2.13 and (ii)&nbsp;the Purchaser will promptly pay, perform or discharge when due any Liabilities arising thereunder after the Closing Date but not transferred to the Purchaser pursuant to this Section&nbsp;2.13.&#160; The failure by the Purchaser or the Sellers to obtain any required consent, waiver, confirmation, novation or approval with respect to any Included Contract will not relieve any party from its obligation to consummate at the Closing the transactions contemplated by this Agreement.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.14</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Set-off.</u></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If the Purchaser in good faith gives notice to ConvaTec of a claim under Section&nbsp;8.1 prior to the date that any Commercialization Payment or Initial Sales Percentage Amount or the Sales Percentage Amount, as applicable, would otherwise be due (each a &#147;<u>Payment Date</u>&#148;) then, subject to the Indemnity Cap, to the extent that such claim has been settled or otherwise determined but has not been paid by or on behalf of ConvaTec prior to any Payment Date, the Purchaser will be entitled to set off the amount equal to the payment required to be paid to the Purchaser pursuant to such settlement or determination against the relevant Commercialization Payment or Percentage Payment Amount.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>For the purposes of Section&nbsp;2.14(a):</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>a claim shall be regarded as &#147;<u>settled</u>&#148; where it is the subject of an agreement in writing between ConvaTec and the Purchaser (or their respective attorneys);</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>a claim will be regarded as &#147;<u>determined</u>&#148; if a court of competent jurisdiction has awarded judgment to the Purchaser in respect of the claim, even if the Sellers have a right of appeal with respect to such judgment.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If Purchaser sets off a determined claim amount against a Commercialization Payment,&nbsp;Initial Sales Percentage Amount or Sales Percentage Amount, as applicable, and Purchaser&#146;s relevant determined claim is subsequently overturned on appeal by the judgment of a court of competent jurisdiction, then Purchaser shall promptly, and in any event within five (5)&nbsp;Business Days after such appeal judgment, pay to ConvaTec the amount of the relevant Commercialization Payment,&nbsp;Initial Sales Percentage Amount or Sales Percentage Amount, as applicable, that was withheld by Purchaser, even if Purchaser has a right of appeal with respect to such judgment, together with interest on such amount at the rate of 5% per annum, accruing on the basis of the actual number of days elapsed and a 365-day year, beginning on the date of the relevant set-off and ending on the date payment is required pursuant to this Section&nbsp;2.14( c).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;3</font></b><b><br> REPRESENTATIONS AND WARRANTIES OF THE SELLERS</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Sellers jointly and severally represent and warrant to the Purchaser as follows, except as set forth on the disclosure schedule delivered by the Sellers to the Purchaser concurrently with the execution and delivery of this Agreement and dated as of the date of this Agreement (the &#147;<u>Seller Disclosure Schedule</u>&#148;):</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.1</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Organization and Good Standing</u>.&#160; Each Seller is a corporation duly organized, validly existing and in good standing under the Laws of the state of its incorporation, and has all requisite corporate power and authority to conduct its business as presently conducted.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">15<a name="16022-2-KC-03_PB_15_021223_7091"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=19,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=694031,FOLIO='15',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-03_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:37 2015' -->

<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.2</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Authority and Enforceability</u>.&#160; Each Seller has all requisite corporate power and authority to execute and deliver this Agreement and each Ancillary Agreement to which it is a party and to perform its obligations under this Agreement and each such Ancillary Agreement.&#160; The execution, delivery and performance of this Agreement and each Ancillary Agreement to which each Seller is a party and the consummation of the transactions contemplated hereby and thereby by each Seller have been duly authorized by all necessary action on the part of such Seller.&#160; Each Seller has duly and validly executed and delivered this Agreement and, on or prior to the Closing, such Seller will have duly and validly executed and delivered each Ancillary Agreement to which it is a party.&#160; Assuming the due authorization, execution and delivery of this Agreement and the Ancillary Agreements by the Purchaser and the other parties thereto, this Agreement constitutes, and at the Closing each Ancillary Agreement to which each Seller is a party will constitute, the valid and binding obligation of such Seller, enforceable against such Seller in accordance with its terms, subject to (a)&nbsp;Laws of general application relating to bankruptcy, insolvency and the relief of debtors and (b)&nbsp;Laws governing specific performance, injunctive relief and other equitable remedies.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.3</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>No Conflict</u>.&#160; Except for the requirements of any antitrust Laws (if and to the extent any of the foregoing Laws may apply), neither the execution, delivery and performance of this Agreement and any Ancillary Agreement by the Sellers, nor the consummation by the Sellers of the transactions contemplated by this Agreement, will (a)&nbsp;conflict with or violate either Seller&#146;s certificate of incorporation or bylaws, (b)&nbsp;result in a breach or default under, or create in any Person the right to terminate, cancel, accelerate or modify, or require any notice, consent or waiver under, any Included Contract, (c)&nbsp;violate any Law or Judgment applicable to either Seller (to the extent it relates to the Project), the Project or the Purchased Assets or (d)&nbsp;require either Seller to obtain any Governmental Authorization or make any filing with any Governmental Authority.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.4</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Purchased Assets.</u></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Sellers have good and marketable title to, or in the case of leased assets, valid leasehold interests in, all of the tangible personal property included in the Purchased Assets, free and clear of all Encumbrances other than Permitted Encumbrances.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Except as set forth in Section&nbsp;3.4(b)&nbsp;of the Seller Disclosure Schedule, the Purchased Assets comprise all material assets necessary to manufacture the Amadeus Device; provided, however, that no representation is given as to the production capacity of the Purchased Assets.&#160; Except as set forth in Section&nbsp;3.4(b)&nbsp;of the Seller Disclosure Schedule, the Included Contracts constitute all of the contracts and agreements used for the Project as now being conducted by the Sellers.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>All machinery and equipment included in the Purchased Assets is in good condition and repair in all material respects, normal wear and tear excepted, and is suitable for the purpose of manufacturing the Amadeus Device.&#160; Except as set forth in Section&nbsp;3.4(c)&nbsp;of the Seller Disclosure Schedule, none of the Purchased Assets is in the possession, custody or control of any Person other than the Sellers.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.5</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Intellectual Property</u>.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Section&nbsp;3.5(a)&nbsp;of the Seller Disclosure Schedule sets forth an accurate and complete list (by name and, where applicable, registration number and jurisdiction of registration, application, certification and filing) of all registered patents, trademarks, trade names, copyrights and domain names, and applications therefor, and software, included in the Purchased Intellectual Property.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">16<a name="16022-2-KC-05_PB_16_021331_2191"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=20,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=522965,FOLIO='16',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-05_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:38 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Sellers are the sole owners of all right, title and interest in the Purchased Intellectual Property, free and clear of all Encumbrances other than Permitted Encumbrances; provided that no representation or warranty is given in this Section&nbsp;3.5(b)&nbsp;as to infringement of any Intellectual Property rights of any other Person (in respect of which Section&nbsp;3.5(g)&nbsp;is the sole applicable representation and warranty of the Sellers).</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Except as set forth on Section&nbsp;3.5(c)&nbsp;of the Seller Disclosure Schedule, the Purchased Intellectual Property is free of all payment obligations and other Encumbrances.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>All necessary registration, maintenance and renewal fees in connection with each item of Purchased Intellectual Property required to be listed in Section&nbsp;3.5(a)&nbsp;of the Seller Disclosure Schedule have been paid and all necessary documents and certificates have been filed with the relevant patent, copyright, trademark or other authorities for purposes of maintaining such item of Purchased Intellectual Property.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Except as set forth on Section&nbsp;3.5(e)&nbsp;of the Seller Disclosure Schedule, Sellers own, possess or have sufficient rights to all rights in the Purchased Intellectual Property that are required to manufacture the Amadeus Device; provided that no representation or warranty is given in this Section&nbsp;3.5(e)&nbsp;as to infringement of any Intellectual Property rights of any other Person (in respect of which Section&nbsp;3.5(g)&nbsp;is the sole applicable representation and warranty of the Sellers).</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Sellers do not own, possess, or have rights in any Intellectual Property, other than the Purchased Intellectual Property, that the Purchaser would infringe or misappropriate by making, using, selling, or otherwise commercializing any of the Products or the Purchased Intellectual Property relating to the Project.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>To the Sellers&#146; Knowledge, none of the Products infringe any Intellectual Property rights of any other Person, or contain or use any Intellectual Property misappropriated from any Person.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>To the Sellers&#146; Knowledge, no other Person is infringing, violating or misappropriating any of the Purchased Intellectual Property.&#160; The Sellers have not commenced or threatened any Proceeding, or asserted any allegation or claim, against any Person for infringement or misappropriation of the Purchased Intellectual Property or breach of any Contract involving the Purchased Intellectual Property.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Sellers have not received notice of any pending or threatened Proceeding or any allegation or claim in which any Person alleges that the Project has violated any Person&#146;s Intellectual Property.&#160; Further, Sellers have not received a written offer from any other Person proposing to grant a license to Sellers to Intellectual Property of said other Person purported to relate to the Project.&#160; Sellers have not received in writing or otherwise any complaint, claim or notice from any Person (other than patent officials) suggesting that any of the Intellectual Property embodied in the Project is invalid, unpatentable or unenforceable.&#160; There are no pending disputes between the Sellers and any other Person (other than patent officials) relating to the Purchased Intellectual Property.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(j)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Sellers have taken Commercially Reasonable Efforts to maintain the secrecy of all confidential information relating to the Project.&#160; To Sellers&#146; Knowledge, all Persons who have received confidential information relating to the Project have entered into written confidentiality agreements with the Seller to protect the secret or confidential status of such information.&#160; To Sellers&#146; Knowledge, no confidential Project information of Sellers has been subject to any breach, misappropriation, unauthorized disclosure, or unauthorized access or use by any Person.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">17<a name="16022-2-KC-05_PB_17_021341_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=21,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=706509,FOLIO='17',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-05_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:38 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(k)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Purchased Intellectual Property was: (i)&nbsp;developed by Sellers; (ii)&nbsp;developed by employees, consultants, contractors, subcontractors or others who have executed appropriate instruments of assignment in favor of Sellers as assignee that have conveyed to Sellers ownership of all of their Intellectual Property embodied in the Purchased Intellectual Property; or (iii)&nbsp;acquired in connection with acquisitions transferring title to the Intellectual Property embodied in the Purchased Intellectual Property.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(l)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Sellers currently have the sole and exclusive right to: (i)&nbsp;bring actions for past, present and future infringement, dilution, misappropriation or unauthorized use of the Purchased Intellectual Property in any country or other geographic area in the world; and (ii)&nbsp;receive all proceeds from the foregoing, including licenses, royalties income, payments, claims, damages and proceeds of any such suit.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(m)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Except for any Included Contracts, no licenses or other rights under the Purchased Intellectual Property have been granted by Sellers, or retained by any third persons, including but not limited to any prior owners, or inventors.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(n)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Except as set forth on Section&nbsp;3.5(n)&nbsp;of the Seller Disclosure Schedule, and except in respect of the SMM Platform prior to November&nbsp;10, 2008, no government funding, facilities of a university, college, educational institution or research center, or funding from third Persons, was used in the development of any Purchased Intellectual Property.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(o)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Part&nbsp;B of Schedule 2.1(d)&nbsp;sets forth all of the patents included in the Purchased Intellectual Property that relate to the SMM Platform.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(p)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Sellers make no representation or warranty with respect to the names &#147;ACT&#148; and &#147;Adaptive Compression Therapy&#148;.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(q)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>This Section&nbsp;3.5 constitutes the sole and exclusive representations and warranties of the Sellers with respect to any matters relating to Intellectual Property.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.6</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Contracts.</u></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Section&nbsp;3.6(a)&nbsp;of the Seller Disclosure Schedule sets forth an accurate and complete list as of the date hereof of each written Included Contract and a summary of the material terms of each oral Included Contract.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Sellers have made available to the Purchaser an accurate and complete copy of each Included Contract.&#160; With respect to each such Included Contract, neither the Sellers, nor, to the Sellers&#146; Knowledge, any other party to the Included Contract is in material breach or material default under the Included Contract.&#160; Each Included Contract is legal, valid, binding and enforceable as to the Sellers and, to the Knowledge of the Sellers, each other party thereto, in accordance with its terms except to the extent it has previously expired in accordance with its terms and subject to (i)&nbsp;Laws of general application relating to bankruptcy, insolvency and the relief of debtors, and (ii)&nbsp;rules&nbsp;of Law governing specific performance, injunctive relief and other equitable remedies.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.7</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Tax Matters.</u></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>(i)&nbsp;All Tax Returns required to be filed by the Sellers with respect to the Purchased Assets have been timely filed, (ii)&nbsp;all Taxes shown on such Tax Returns with respect to the Purchased Assets have been paid and (iii)&nbsp;no Governmental Authority has proposed to make or has made any material adjustment with respect to Taxes primarily attributable to the Purchased Assets.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">18<a name="16022-2-KC-05_PB_18_021355_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=22,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=929359,FOLIO='18',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-05_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:38 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Sellers have properly and timely withheld, collected or deposited all amounts required to be withheld, collected or deposited in respect of Taxes relating to the Purchased Assets.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>There are no Tax liens on any of the Purchased Assets.&#160; The Sellers have not received any notice or inquiry from any Governmental Authority in any jurisdiction where the Sellers do not currently file Tax Returns to the effect that the Sellers are currently required to file Tax Returns with respect to the Purchased Assets or that the Purchased Assets are otherwise currently subject to taxation by such jurisdiction.&#160; No federal, state, local or foreign Tax audits or other Tax Proceedings are pending or being conducted, nor have the Sellers received any notice from any Governmental Authority that any such Tax audit or other Tax Proceeding is pending or threatened, in any case with respect to Taxes attributable to the Purchased Assets.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>This Section&nbsp;3.7 constitutes the sole and exclusive representations and warranties of the Sellers with respect to any matters relating to Taxes.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.8</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Governmental Authorizations</u>.&#160; Section&nbsp;3.8 of the Seller Disclosure Schedule lists all material Governmental Authorizations that the Sellers have obtained in connection with the Project prior to the date hereof.&#160; The Sellers are in material compliance with all Governmental Authorizations listed on Section&nbsp;3.8 of the Seller Disclosure Schedule, and all such Governmental Authorizations are in full force and effect.&#160; There has been no default on the part of Sellers with respect to, and no event has occurred which, with the giving of notice or the lapse of time, or both, would constitute a breach of, impose any condition to the issuance, maintenance, renewal or continuance of any Governmental Authorization listed on Section&nbsp;3.8 of the Seller Disclosure Schedule.&#160; Except as set forth on Section&nbsp;3.8 of the Seller Disclosure Schedule, the Sellers have not made an assignment of the rights of any such Governmental Authorizations to any third party, and such Governmental Authorizations are free and clear of all Encumbrances.&#160; There has been no decision by the Sellers not to renew any material Governmental Authorization relating to the Project.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.9</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Compliance with Laws</u>.&#160; The conduct of the Project by the Sellers is in material compliance with all Laws applicable to the conduct of the Project or the ownership or use of the Purchased Assets.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.10</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Legal Proceedings</u>.&#160; There is no Proceeding pending or, to the Sellers&#146; Knowledge, threatened against the Sellers with respect to the Project or any Purchased Asset.&#160; The Sellers are not subject to any outstanding Judgment relating to the Project.&#160; Since November&nbsp;10, 2008, no notice has been received by Sellers claiming any violation of any Law or Governmental Authorization relating to the Project.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.11</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>FDA and Regulatory Compliance</u>.&#160; Section&nbsp;3.11 of the Seller Disclosure Schedule sets forth the status of each filing or application filed with the U.S. Food and Drug Administration (the &#147;FDA&#148;) and any other comparable non-U.S. Governmental Authority with respect to the Products.&#160; Except as set forth on Section&nbsp;3.11 of the Seller Disclosure Schedule:</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Project is being conducted in substantial compliance with all medical device Laws, including (i)&nbsp;the federal Food, Drug, and Cosmetic Act, as amended (including the rules&nbsp;and regulations promulgated thereunder, the &#147;FDCA&#148;), (ii)&nbsp;any comparable foreign Laws, and (iii)&nbsp;state licensing, disclosure and reporting requirements.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>All pre-clinical and clinical investigations conducted or sponsored by the Sellers relating to the Project were conducted or are being conducted in compliance in all material respects with all applicable Laws administered or issued by the applicable Governmental Authorities, including, where</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">19<a name="16022-2-KC-05_PB_19_021403_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=23,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=78852,FOLIO='19',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-05_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:38 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">applicable (i)&nbsp;FDA standards for conducting non-clinical laboratory studies contained in Title 21 part 58 of the Code of Federal Regulations and (ii)&nbsp;applicable FDA standards for the design, conduct, performance, monitoring, auditing, recording, analysis and reporting of clinical trials contained in Title 21 parts 50, 54, 56, 812 and 820 of the Code of Federal Regulations.&#160; The Sellers have not received any information from the FDA or any other Governmental Authority with jurisdiction over the marketing, sale, use, handling and control, safety, efficacy, reliability, or manufacturing of the Products which expressly threatened the denial of any application for marketing approval currently pending before the FDA or such other Governmental Authority.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>All material reports, documents, claims, permits and notices required to be filed, maintained or furnished to the FDA or any other Governmental Authority by the Sellers have been so filed, maintained or furnished.&#160; All such reports, documents, claims, permits and notices were complete and accurate in all material respects on the date filed (or were corrected in or supplemented by a subsequent filing) such that no liability exists with respect to such filing.&#160; The Sellers have not, and to the Knowledge of the Sellers, no officer, employee, agent or distributor of the Sellers or any of its Subsidiaries has, made an untrue statement of a material fact or a fraudulent statement to the FDA or any other Governmental Authority, failed to disclose a material fact required to be disclosed to the FDA or any other Governmental Authority, or committed an act, made a statement, or failed to make a statement that, at the time such disclosure was made, would reasonably be expected to provide a basis for the FDA or any other Governmental Authority to invoke its policy respecting &#147;Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities&#148;, set forth in 56 Fed. Reg. 46191 (September&nbsp;10, 1991) or any similar policy.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>As to each Product subject to the FDCA and the regulations of the FDA promulgated thereunder, or similar foreign Laws and regulations of any other foreign jurisdiction that is or has been developed, manufactured, tested, distributed and/or marketed by or on behalf of the Sellers, each such Product is being or has been developed, manufactured, tested, distributed and/or marketed in substantial compliance with all applicable requirements under the FDCA and the regulations of the FDA promulgated thereunder, and similar foreign Laws and regulations, including those relating to investigational use, or marketing approval to market a Product, good manufacturing practices, good clinical practices, good laboratory practices, labeling, advertising, record keeping, filing of reports and security.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Except as set forth in Section&nbsp;3.11 of the Seller Disclosure Schedule, there have been no recalls, field notifications or seizures ordered or adverse regulatory actions taken or threatened in writing by the FDA or any other Governmental Authority with respect to any of the Products, including, to the Knowledge of the Sellers, during the time period of production, processing, packaging or storage for any Product, any facilities where any such Product is produced, processed, packaged or stored.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Sellers have not received any notice or other communication that (i)&nbsp;the FDA or any other Governmental Authority has commenced, or threatened to initiate, any action to withdraw its investigational device exemption, premarket clearance, premarket approval, rights or other approval or request the recall of any Product or (ii)&nbsp;alleges any violation of applicable Law by the Sellers with respect to any Product.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.12</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Inventory</u>.&#160; All of the inventory of the Project as of five Business Days prior to the date of this Agreement is set forth on Schedule 2.1(a)&nbsp;and there has been no material changes to the Inventory since such date.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">20<a name="16022-2-KC-05_PB_20_021412_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=24,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=170757,FOLIO='20',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-05_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:38 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.13</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Products and Materials.</u></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Sellers have disclosed to Purchaser:</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>All locations at which tangible Purchased Assets are located (including locations owned or controlled by third parties); and</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>All locations at which any Product clinical or other trials (including observational studies) are being conducted.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Except as set forth on Section&nbsp;3.13(b)&nbsp;of the Seller Disclosure Schedule, the Sellers have granted access to, or made available to, Purchaser a true, correct and complete copy of all documentation in the Sellers&#146; possession, relating to all present and past Products clinical or other human trials (including observational studies), consistent with the Health Insurance Portability and Accountability Act of 1996, as amended, and other such Laws governing privacy of human subjects.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Schedule 2.1(c)&nbsp;is a true, correct and complete list of the Equipment as of the date of this Agreement.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The specifications and manufacturing documentation for the Amadeus Device (a copy of which has been made available to Purchaser) is complete and accurate in all material respects.&#160; Such documentation includes all data and know-how used or held for use by the Sellers to manufacture the Amadeus Device and is current, accurate in all material respects, and sufficient in detail and content to identify and explain the designs, concepts and processes described therein.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>No material product liability claim has been made against any Seller arising out of, relating to, or resulting from any injury to any individual or property as a result of the ownership, possession, or use of any Product sold or distributed by Seller before the Closing Date.&#160; Sellers have not received notice as to any claim for personal injury or death, any claim for property, economic, punitive, or exemplary damages, any claim for contribution or indemnification, or any claim for injunctive relief, in each case in connection with any product sold by Sellers.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.14</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Brokers Fees</u>.&#160; The Sellers have not incurred any Liability to pay any fees or commissions to any broker, finder or agent in connection with any of the transactions contemplated by this Agreement for which the Purchaser would become liable or obligated.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.15</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Anti-Bribery Laws.</u></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Since April&nbsp;1, 2007, no Seller, nor any officer, director, or employee of the Sellers, nor any agent or representative of the Sellers, acting in such capacity, has, in connection with the Project, directly or indirectly violated or taken any act in furtherance of violating any provision of the Foreign Corrupt Practices Act of 1977 (as amended), the U.K. Bribery Act 2010 or any other anti-bribery or anti&#173;corruption Laws of any jurisdiction applicable to the Project (collectively, the &#147;<u>Anti-Bribery Laws</u>&#148;), such as by making, offering or promising, directly or indirectly, any contribution, gift, bribe, rebate, loan, payoff, influence payment, kickback or other payment, or promise of payment, of anything of value, to any Government Official for the purpose of inducing such Government Official to do any act or make any decision in his or her or its official capacity (including a decision to fail to perform his or her or its official function) or use his or her or its influence with a Governmental Authority in order to affect any act or decision of such Governmental Authority for the purpose of assisting any Person to obtain or retain any business in connection with the Project, or to facilitate the Project or for any other improper purpose in connection with the Project (e.g., to obtain a tax rate lower than allowed by Law).</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">21<a name="16022-2-KC-05_PB_21_021421_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=25,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=530523,FOLIO='21',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-05_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:38 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>For purposes of this Section&nbsp;3.15, the term &#147;<u>Government Official</u>&#148; shall mean any: (i)&nbsp;officer or employee of a Governmental Authority (including any state-owned or state-controlled enterprise) or of a public international organization; (ii)&nbsp;holder of public office, candidate for public office, political party, official of a political party or member of a royal family; or (iii)&nbsp;Person acting for or on behalf of any Governmental Authority.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.16</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Cidron Healthcare Limited</u>.&#160; Cidron Healthcare Limited directly or indirectly owns all of the outstanding equity interests in the Sellers and any other Persons that are related to the Sellers and that conduct business under the trade name &#147;ConvaTec.&#148; Cidron Healthcare Limited is not a wholly owned subsidiary, directly or indirectly, of any other Person.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.17</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Disclaimer of Other Representations and Warranties</u>.&#160; The representations and warranties set forth in this Article&nbsp;3 are the only representations and warranties made by the Sellers with respect to the Project, the Purchased Assets, the Assumed Liabilities or any other matter relating to the transactions contemplated by this Agreement.&#160; Except as specifically set forth in this Article&nbsp;3, (a)&nbsp;the Sellers are selling the Purchased Assets to the Purchaser &#147;as is&#148; and &#147;where is&#148; and with all faults, and make no warranty, express or implied, as to any matter whatsoever relating to the Project, the Purchased Assets, the Assumed Liabilities or any other matter relating to the transactions contemplated by this Agreement including as to (i)&nbsp;merchantability or fitness for any particular use or purpose, (ii)&nbsp;the operation of the Project by the Purchaser after the Closing in any manner or (iii)&nbsp;the probable success or profitability of the Project after the Closing, and (b)&nbsp;other than the indemnification obligations of the Sellers set forth in Article&nbsp;8, neither the Sellers nor any of their Affiliates, or any of their respective officers, directors, employees, agents, representatives or stockholders, will have, or will be subject to, any Liability or indemnification obligation to the Purchaser or any other Person resulting from the distribution to the Purchaser or its Affiliates or representatives of, or the Purchaser&#146;s use of, any information relating to the Project, including any descriptive memoranda, summary business descriptions or any information, documents or material made available to the Purchaser or its Affiliates or representatives, whether orally or in writing, in certain &#147;data rooms,&#148; management presentations, functional &#147;break-out&#148; discussions, responses to questions submitted on behalf of the Purchaser or in any other form in expectation of the transactions contemplated by this Agreement.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.18</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>No Other Provisions</u>.&#160; The Sellers hereby acknowledge and agree that other than the representations and warranties set forth in Article&nbsp;4 or the covenants set forth in this Agreement, neither the Purchaser nor any of its Affiliates, or any of their respective officers, directors, employees, agents, representatives or stockholders, make or have made any representation or warranty, express or implied, at law or in equity, or covenant as to any matter whatsoever relating to the Project, the Purchased Assets, the Assumed Liabilities or any other matter relating to the transactions contemplated by this Agreement, including as to (a)&nbsp;the operation of the Project by the Purchaser after the Closing in any manner or (b)&nbsp;the probable success or profitability of the Project after the Closing.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;4</font></b><b><br> REPRESENTATIONS AND WARRANTIES OF THE PURCHASER</b></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Purchaser represents and warrants to the Sellers as follows, except as set forth on the disclosure schedule delivered by the Purchaser to the Sellers concurrently with the execution and delivery of this Agreement and dated as of the date of this Agreement (the &#147;<u>Purchaser Disclosure Schedule</u>&#148;):</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;4.1</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Organization and Good Standing</u>.&#160; The Purchaser is a corporation duly organized, validly existing and in good standing under the Laws of the State of Delaware, and has all requisite corporate power and authority to conduct its business as it is presently conducted.&#160; The Parent is a corporation duly organized, validly existing and in good standing under the Laws of the State of</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">22<a name="16022-2-KC-05_PB_22_021432_7748"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=26,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=476870,FOLIO='22',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-05_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:38 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Delaware, and has all requisite corporate power and authority to conduct its business as it is presently conducted.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;4.2</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Authority and Enforceability</u>.&#160; Each of the Purchaser and the Parent has all requisite corporate power and authority to execute and deliver this Agreement and each Ancillary Agreement to which it is a party and to perform its obligations under this Agreement and each such Ancillary Agreement.&#160; The execution, delivery and performance of this Agreement and each Ancillary Agreement to which the Purchaser or the Parent is a party and the consummation of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Purchaser and the Parent.&#160; Each of the Purchaser and the Parent has duly and validly executed and delivered this Agreement and, on or prior to the Closing, each of the Purchaser and the Parent will have duly and validly executed and delivered each Ancillary Agreement to which it is a party.&#160; Assuming the due authorization, execution and delivery of this Agreement and the Ancillary Agreements by the Sellers and the other parties thereto, this Agreement constitutes, and at the Closing each Ancillary Agreement to which the Purchaser and the Parent is a party will constitute, the valid and binding obligation of the Purchaser and the Parent, enforceable against the Purchaser and the Parent in accordance with its terms, subject to (a)&nbsp;Laws of general application relating to bankruptcy, insolvency and the relief of debtors and (b)&nbsp;Laws governing specific performance, injunctive relief and other equitable remedies.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;4.3</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>No Conflict</u>.&#160; Except for the requirements of any antitrust Law (if and to the extent any of the foregoing Laws may apply), and except in any case that would not have a material adverse effect on the ability of the Purchaser or the Parent to perform its obligations under this Agreement or on the ability of the Purchaser to consummate the transactions contemplated by this Agreement, neither the Purchaser&#146;s nor the Parent&#146;s execution, delivery and performance of this Agreement and any Ancillary Agreement to which the Purchaser or the Parent is a party, nor the consummation by the Purchaser of the transactions contemplated by this Agreement, will (a)&nbsp;conflict with or violate the Purchaser&#146;s or the Parent&#146;s certificate of incorporation, bylaws or other organizational documents, (b)&nbsp;result in a breach or default under, or create in any Person the right to terminate, cancel, accelerate or modify, or require any notice, consent or waiver under, any Contract to which the Purchaser or the Parent is a party or by which the Purchaser or the Parent is bound and that is material to the Purchaser or the Parent, (c)&nbsp;violate any Law or Judgment applicable to the Purchaser or the Parent or (d)&nbsp;require the Purchaser or the Parent to obtain any Governmental Authorization or make any filing with any Governmental Authority.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;4.4</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Legal Proceedings</u>.&#160; There is no Proceeding pending or, to the Purchaser&#146;s knowledge, threatened against the Purchaser or the Parent that questions or challenges the validity of this Agreement or that may prevent, delay, make illegal or otherwise interfere with the ability of the Purchaser to consummate any of the transactions contemplated by this Agreement.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;4.5</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Brokers Fees</u>.&#160; Neither the Purchaser nor the Parent nor any Person acting on behalf of either the Purchaser or the Parent has incurred any Liability to pay any fees or commissions to any broker, finder or agent in connection with any of the transactions contemplated by this Agreement.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;4.6</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Financial Capacity</u>.&#160; The Purchaser has, and will have on the Closing Date and on the Commercialization Payment Date, immediately available cash in an amount sufficient to pay the Closing Payment at Closing and to pay the Commercialization Payment in accordance with Section&nbsp;2.6.&#160; The Purchaser knows of no circumstance or condition that it expects will prevent the availability at the Closing and at the Commercialization Payment Date of the requisite financing to consummate the transactions contemplated by this Agreement on the terms set forth in this Agreement.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;4.7</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Independent Investigation</u>.&#160; The Purchaser has conducted its own independent investigation, review and analysis of the Project, operations, assets, liabilities, results of operations,</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">23<a name="16022-2-KC-05_PB_23_021440_141"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=27,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=476479,FOLIO='23',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-05_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:38 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">financial condition and prospects of the Project as it has deemed appropriate, which investigation, review and analysis was done by the Purchaser and its Affiliates and representatives.&#160; The Purchaser acknowledges that it and its Affiliates and representatives have been provided adequate access to the personnel, properties, premises and records of the Project for such purpose.&#160; In entering into this Agreement, the Purchaser acknowledges that it has relied solely upon the aforementioned investigation, review and analysis and not on any factual representations or opinions of any Seller or any Affiliates of any Seller or their representatives (except the representations and warranties set forth in Article&nbsp;3).&#160; The Purchaser hereby acknowledges and agrees that (a)&nbsp;other than the representations and warranties set forth in Article&nbsp;3, neither the Sellers nor any of their Affiliates, or any of their respective officers, directors, employees, agents, representatives or stockholders, make or have made any representation or warranty, express or implied, at law or in equity, as to any matter whatsoever relating to the Project, the Purchased Assets, the Assumed Liabilities or any other matter relating to the transactions contemplated by this Agreement including as to (i)&nbsp;merchantability or fitness for any particular use or purpose, (ii)&nbsp;the operation of the Project by the Purchaser after the Closing in any manner or (iii)&nbsp;the probable success or profitability of the Project after the Closing, and (b)&nbsp;other than the indemnification obligations of the Sellers set forth in Article&nbsp;8, neither the Sellers nor any of their Affiliates, or any of their respective officers, directors, employees, agents, representatives or stockholders, will have or will be subject to any Liability or indemnification obligation to the Purchaser or any other Person resulting from the distribution to the Purchaser or its Affiliates or representatives of, or the Purchaser&#146;s use of, any information relating to the Project or any other matter relating to the transactions contemplated by this Agreement, including any descriptive memoranda, summary business descriptions or any information, documents or material made available to the Purchaser or its Affiliates or representatives, whether orally or in writing, in certain &#147;data rooms,&#148; management presentations, functional &#147;break-out&#148; discussions, responses to questions submitted on behalf of the Purchaser or in any other form in expectation of the transactions contemplated by this Agreement.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;5</font></b><b><br> COVENANTS</b></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.1</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Access and Investigation</u>.&#160; Until the Closing and upon reasonable advance notice from the Purchaser, the Sellers will allow the Purchaser and its representatives reasonable access during normal business hours and without unreasonable interference with the operation of the Project to (a)&nbsp;such materials and information about the Project as the Purchaser may reasonably request and (b)&nbsp;specified members of management of the Project as the parties may reasonably agree.&#160; Notwithstanding the foregoing clause (b), the Purchaser will not, and will not permit its Affiliates and representatives to, contact or otherwise communicate with, either orally or in writing, any employee, officer, director or supplier of the Project without the prior consent of ConvaTec, which consent may be provided in writing, by electronic mail or via telephone confirmation by Michael McNally or such other Person as ConvaTec may designate in writing to the Purchaser</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.2</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Operation of the Project</u>.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Until the Closing, except as otherwise set forth in this Agreement or the Seller Disclosure Schedule or as otherwise consented to by the Purchaser (which consent will not be unreasonably withheld, conditioned or delayed), the Sellers will conduct the Project in the ordinary course of business in all material respects consistent with prior practice.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Until the Closing, except as otherwise set forth in this Agreement or the Seller Disclosure Schedule or as otherwise consented to by the Purchaser, the Sellers will not sell, lease or license, or permit any Encumbrance on, any of the Purchased Assets other than in the ordinary course of business.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">24<a name="16022-2-KC-05_PB_24_021449_7608"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=28,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=254465,FOLIO='24',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-05_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:38 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.3</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Consents and Filings</u>.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Subject to the terms and conditions of this Agreement, each of the parties will use their respective Commercially Reasonable Efforts (i)&nbsp;to take promptly, or cause to be taken, all actions, and to do promptly, or cause to be done, all things necessary, proper or advisable to consummate and make effective the transactions contemplated by this Agreement and (ii)&nbsp;as promptly as practicable after the date of this Agreement, to obtain all Governmental Authorizations from, and make all filings with, all Governmental Authorities, and to obtain all other consents, waivers, approvals and other authorizations from, all other third parties, that are necessary or advisable in connection with the authorization, execution and delivery of this Agreement and the consummation of the transactions contemplated by this Agreement.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Sellers and the Purchaser will promptly notify the other of any communication it or any of its Affiliates receives from any Governmental Authority relating to the transactions contemplated by this Agreement, and will permit the other party to review in advance any proposed communication by such party to any Governmental Authority.&#160; None of the parties will agree to participate in any meeting with any Governmental Authority in respect of any filings, investigation or other inquiry unless it consults with the other parties in advance and, to the extent permitted by such Governmental Authority, gives the other parties the opportunity to attend and participate at such meeting.&#160; The Sellers and the Purchaser will coordinate and cooperate fully with each other in exchanging such information and providing such assistance as the other party may reasonably request in connection with the foregoing.&#160; The Sellers and the Purchaser will provide each other with copies of all correspondence, filings or communications between them or any of their representatives, on the one hand, and any Governmental Authority or members of its staff, on the other hand, with respect to this Agreement and the transactions contemplated by this Agreement.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.4</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Sellers&#146; Names, Assets and Information</u>.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>From and after the Closing, the Purchaser will use Commercially Reasonable Efforts to remove or cause to be removed &#147;ConvaTec&#148; or other similar mark and any other trademark, design or logo previously or currently used by the Sellers or any of their Affiliates (the &#147;<u>Seller Marks</u>&#148;) from all assets of the Project; <u>provided</u>, <u>however</u>, that in no event will the Purchaser or any of its Affiliates use the Seller Marks after the six-month anniversary of the Closing Date.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Purchaser acknowledges and agrees that the Sellers are the owners of the Seller Marks and all goodwill attached thereto.&#160; This Agreement does not give the Purchaser or any of its Affiliates the right to use the Seller Marks except in accordance with this Agreement.&#160; The Purchaser will not, and will not cause or permit any of its Affiliates to, attempt to register the Seller Marks nor to register anywhere in the world a mark that is the same as or similar to the Seller Marks.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>In no event will the Purchaser or any of its Affiliates advertise or hold itself out as a Seller or any Affiliate of a Seller after the Closing.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If, at any time after the Closing, the Purchaser or any of its Affiliates possesses any information belonging to or concerning a Seller or any Affiliate of a Seller that is not part of the Purchased Assets and does not relate to the Project (such information, the &#147;<u>Seller Information</u>&#148;), the Purchaser will promptly transfer, or cause to be transferred, such Seller Information to the Sellers (without retaining a copy thereof, except as required by applicable Law).&#160; For the purposes of this Agreement, Seller Information includes written, graphical or machine-readable information that relates to trade secrets, product plans, software, vendor and customer information, business plans and data stored electronically.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">25<a name="16022-2-KC-05_PB_25_021502_8146"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=29,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=166327,FOLIO='25',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-05_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:38 2015' -->

<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If, at any time after the Closing, the Sellers or any of their Affiliates possesses any information that is part of the Purchased Assets (such information, the &#147;<u>Purchaser Information</u>&#148;), the Sellers will promptly transfer, or cause to be transferred, such Purchaser Information to the Purchaser (without retaining a copy thereof, except as required by applicable Law).&#160; For the purposes of this Agreement, Purchaser Information includes written, graphical or machine-readable information that relates to trade secrets, product plans, software, vendor and customer information, business plans and data stored electronically.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.5</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Nonsolicitation</u>.&#160; Unless otherwise agreed to in writing by ConvaTec, during the period commencing on the date of this Agreement and ending on the second anniversary of the Closing Date (or, if this Agreement is terminated prior to the Closing, ending on the second anniversary of the date of termination), the Purchaser will not, directly or indirectly, for itself or on behalf of or in conjunction with any other Person, nor will it permit any of its Subsidiaries, Affiliates, directors, officers, employees, agents, advisors or representatives to, directly or indirectly, call upon any Person who is, at the time the Person is called upon, an employee of a Seller or any Affiliate of a Seller, for the purpose or with the intent of soliciting such employee away from or out of the employ of a Seller or any Affiliate of a Seller to be employed by the Purchaser or any of its Affiliates or Subsidiaries.&#160; Notwithstanding this Section&nbsp;5.5, nothing in this Agreement prohibits or otherwise restricts the Purchaser or any of its Subsidiaries or Affiliates from performing, permitting or otherwise being involved in: (a)&nbsp;general solicitation for employment (including in any newspaper or magazine, over the internet or by any search or employment agency) if not specifically directed towards any employee of the Sellers or (b)&nbsp;hiring of an individual where the initial contact with such individual regarding such hiring primarily arose from (x)&nbsp;any such general solicitation or (y)&nbsp;initial contact by such individual that was unsolicited by the Purchaser or any Subsidiary or Affiliate of the Purchaser.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.6</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Noncompetition</u>.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>During the period commencing on the Closing Date and ending on the five year anniversary of the Closing Date (the &#147;<u>Restricted Period</u>&#148;), subject to Sections 5.6(b)&nbsp;and (c), the Sellers will not, and they will not cause or permit any of their Affiliates to, directly or indirectly, engage in the Restricted Business.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Notwithstanding the foregoing, this Section&nbsp;5.6 will not prohibit (i)&nbsp;the Sellers or any Affiliate of the Sellers, directly or through any Affiliate, from conducting any business activities conducted by them as of the date of this Agreement (other than the Project) and (ii)&nbsp;the Sellers or any Affiliate of the Sellers, directly or through any Affiliates, from investing in or holding less than five percent of the outstanding voting stock or other ownership interests of any Person that engages in the Restricted Business.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>In addition to the foregoing, the Sellers agree that during the Restricted Period, the Sellers will not acquire (whether by acquisition of assets, merger or otherwise), and will not cause or permit any of their Affiliates to acquire, any interest in, or manage or operate any Person for whom revenues from the Restricted Business (i)&nbsp;represented an amount greater than the lesser of (A)&nbsp;25% of such entity&#146;s aggregate revenues during such entity&#146;s last fiscal year or (B)&nbsp;US$25,000,000, or (ii)&nbsp;is reasonably projected to represent an amount greater than the lesser of (A)&nbsp;25% of such entity&#146;s aggregate revenues during such entity&#146;s next fiscal year or (B)&nbsp;US$25,000,000 (a &#147;<u>Relevant Acquisition</u>&#148;); <u>provided</u>, <u>however</u>, that a Seller or any Affiliate of a Seller may make a Relevant Acquisition if (x)&nbsp;its primary purpose in making such Relevant Acquisition is not to exploit for profit such Restricted Business, and (y)&nbsp;the relevant Seller or such Affiliate of such Seller uses its good faith, reasonable best efforts to dispose of the entity or portion thereof whose business constituted the Restricted Business within 12 months after the consummation of such Relevant Acquisition, irrespective of whether such disposition is</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">26<a name="16022-2-KC-07_PB_26_021557_4752"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=30,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=615850,FOLIO='26',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-07_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:40 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ultimately consummated; and <u>provided further</u>, <u>however</u>, that if the consideration payable by the relevant Seller or its applicable Affiliate(s)&nbsp;for the Relevant Acquisition exceeds US$250,000,000 (a &#147;<u>Large Acquisition</u>&#148;), then the relevant Seller or its applicable Affiliate(s)&nbsp;may make that Large Acquisition and thereafter continue with the Restricted Business entailed therein.&#160; If Sellers or their respective Affiliates conduct a Restricted Business, (i)&nbsp;Purchaser will have no obligation to make any payments of an Initial Sales Percentage Amount or Sales Percentage Amount, as applicable, with respect to Sales conducted on any continent where Sellers or their applicable Affiliates are engaging in the Restricted Business during any Quarterly Calculation Period, and (ii)&nbsp;Purchaser&#146;s obligations under Section&nbsp;2.7(j)&nbsp;will be terminated.&#160; If after such 12-month period, the disposition required to be sought in respect of a Relevant Acquisition (other than any Large Acquisition) has not been consummated, ConvaTec will promptly so notify the Purchaser, and the Purchaser may, within 60 days of receipt of such notice, notify ConvaTec that it requires ConvaTec to obtain an Independent Valuation of Restricted Business.&#160; Within 60 days of receipt of a copy of such Independent Valuation of Restricted Business, the Purchaser may notify ConvaTec that the Purchaser will, subject to obtaining customary regulatory approvals, purchase the Restricted Business that is the subject matter of the Independent Valuation of Restricted Business from ConvaTec and ConvaTec&#146;s relevant Affiliates as soon as practicable thereafter for a purchase price payable in immediately available funds equal to ninety-five percent (95%) of the amount of the Independent Valuation of Restricted Business (a &#147;<u>Purchase of a Restricted Business</u>&#148;).&#160; During the Restricted Period, the Sellers may make any acquisition (whether by acquisition of assets, merger or otherwise), and may cause or permit any of their Affiliates to make any acquisition of any Person for which the Restricted Business is below the levels specified in subclauses (i)&nbsp;and (ii)&nbsp;of this subsection (c)&nbsp;(a &#147;<u>Permitted Acquisition</u>&#148;).&#160; If ConvaTec or any of its Affiliates makes a Permitted Acquisition or a Large Acquisition, or in the case of a Relevant Acquisition (other than a Large Acquisition) until such time as a Purchase of a Restricted Business has occurred, ConvaTec, its relevant Affiliate(s)&nbsp;and the Person acquired may continue with the Restricted Business.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If a Seller Sale is consummated by a Non-Financial Buyer, references to &#147;Affiliates&#148; in this Section&nbsp;5.6 will be deemed to mean the Non-Financial Buyer consummating such Seller Sale and its Affiliates (for so long only as such Non-Financial Buyer and its Affiliates (other than Cidron Healthcare Limited and its direct and indirect subsidiaries) control, are controlled by or are under common control with the Sellers), and Purchaser&#146;s remedies if this Section&nbsp;5.6 is breached by such Non-Financial Buyer or its Affiliates will be limited to the provisions set forth in the second sentence of Section&nbsp;5.6(c).&#160; For the avoidance of doubt, references to &#147;Affiliates&#148; in this Section&nbsp;5.6 and Purchaser&#146;s remedies upon a breach of this Section&nbsp;5.6 by Sellers or their Affiliates will not be changed or amended if any Seller Sale is consummated by a buyer that is not a Non-Financial Buyer.&#160; &#147;<u>Seller Sale</u>&#148; means the direct or indirect sale or transfer of the outstanding equity interests of Sellers or all or substantially all of the assets of Sellers to a Person that is not an Affiliate of Seller during any Quarterly Calculation Period.&#160; &#147;<u>Non-Financial Buyer</u>&#148; means any Person, other than any Person that is a private equity or venture capital firm or entity or otherwise a financial buyer that will hold the equity interests or assets acquired in a Seller Sale as a separate portfolio company of such Person, that (i)&nbsp;consummates a Seller Sale and (ii)&nbsp;is not engaged in a Restricted Business at the time such Seller Sale is consummated.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each Seller acknowledges and agrees that the restrictive covenants and other agreements contained in this Section&nbsp;5.6 are an essential part of this Agreement and the transactions contemplated hereby, constitute a material inducement to Purchaser&#146;s entering into and performing its obligations under this Agreement and the Ancillary Agreements, are an essential part of Purchaser&#146;s willingness to pay the Purchase Price and are necessary for Purchaser to realize the value of the Project.&#160; It is the intention of the parties that if any of the restrictions or covenants contained herein is held to cover a geographic area or to be for a length of time that is not permitted by Law, or is in any way construed to be too broad or to any extent invalid, such provision shall not be construed to be null, void and of no effect, but to the extent such provision would then be valid or enforceable under Law, such provision shall be construed and</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">27<a name="16022-2-KC-07_PB_27_021608_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=31,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=206297,FOLIO='27',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-07_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:40 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">interpreted or reformed to provide for a restriction or covenant having the maximum enforceable geographic area, time period and other provisions as shall be valid and enforceable under Law.&#160; In addition to the rights set forth above, each Seller acknowledges that the rights of Purchaser under this Section&nbsp;5.6 are unique and recognizes and affirms that in the event of a breach of this Agreement by any Seller or their Affiliates, money damages may be inadequate and the non-breaching party may have no adequate remedy at Law.&#160; Accordingly, notwithstanding anything in this Agreement to the contrary, each Seller agrees that Purchaser shall have the right, in addition to any other rights and remedies existing in its favor at Law or in equity, to enforce its rights and each Seller&#146;s obligations hereunder not only by an action or actions for damages but also by an action or actions for specific performance, injunctive and/or other equitable relief (without posting of bond or other security).</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.7</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Exclusivity</u>.&#160; Until the Closing, neither the Sellers nor any Affiliate, representative or advisor of the Sellers will take any action to solicit, initiate, encourage or support any proposal or offer from, participate in any negotiations with, or furnish any non-public information to, any Person (other than the Purchaser), regarding any Acquisition.&#160; The Sellers will, and will cause their Affiliates, representatives and advisors to, promptly cease and cause to be terminated any such negotiations in progress as of the date of this Agreement.&#160; Until the Closing, if the Sellers or any of their Affiliates, representatives or advisors hereafter receives any Acquisition Proposal or any request for information reasonably likely to lead to an Acquisition Proposal, the Sellers will promptly (and in any event within two Business Days) notify the Purchaser thereof orally and in writing, including information as to the identity of the offeror or Person making such Acquisition Proposal or request and the material terms of such Acquisition Proposal or request.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.8</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Insurance</u>.&#160; Effective from and after the Closing Date, the Purchaser hereby agrees that it shall carry a product liability insurance policy (the &#147;<u>Insurance Policy</u>&#148;) covering the Project, the Amadeus Device and each other Product in an amount of not less than U.S.$2,000,000 until the tenth anniversary of the Commercialization Payment Date.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.9</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Successors in Interest</u>.&#160; The Purchaser agrees that (i)&nbsp;it shall not merge, consolidate, or otherwise combine with, or sell, convey, transfer or assign all or substantially all of the assets then used in connection with the Amadeus Device, any other Product or the Project to, any Person, or (ii)&nbsp;license or grant to any Person, or otherwise permit any Person to exercise, all or substantially all of the Purchaser&#146;s right to market or sell any Product or the Project, unless in each case such Person (the &#147;<u>Successor</u>&#148;) assumes in writing (which shall be addressed to, and directly enforceable by, ConvaTec) prior to the consummation of any such transaction any and all of the Purchaser&#146;s obligations under this Agreement and the Ancillary Agreements.&#160; Following any such assumption, the Purchaser and such other Person shall be and remain jointly and severally liable to the Sellers for the performance of the Purchaser&#146;s obligations under this Agreement and the Ancillary Agreements.&#160; The obligations of the Purchaser under this Section&nbsp;5.9 shall continue in full force and effect for so long as any liability or obligation of the Purchaser under this Agreement, or any Ancillary Agreement remains outstanding or unperformed in any respect.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.10</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Books and Records</u>.&#160; The Purchaser will, and will cause its Affiliates to, following the Closing make available to the Sellers, the Affiliates of the Sellers and their respective representatives all information reasonably necessary for Sellers and their Affiliates to prepare their respective Tax returns and financial statements and to conduct any audits in connection therewith.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.11</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Confidentiality</u>.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The parties agree to continue to abide by that certain Confidentiality Agreement between ConvaTec and the Purchaser dated June&nbsp;30, 2011, as amended from time to time (the &#147;<u>Confidentiality</u></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">28<a name="16022-2-KC-07_PB_28_021620_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=32,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=418619,FOLIO='28',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-07_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:40 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Agreement</font></u>&#148;), which will survive until the Closing, at which time the Confidentiality Agreement will terminate; provided, however, that if this Agreement is, for any reason, terminated prior to the Closing, the Confidentiality Agreement will continue in full force and effect in accordance with its terms.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>For a period of three years after the Closing, the Sellers will, and will cause their Affiliates to, and will instruct their respective directors, officers, employees, representatives and advisors to, hold in confidence, unless compelled to disclose by judicial or administrative process or by other requirements of Law, and not use all non-public documents and information relating to the Project, including the Purchaser Information (the &#147;Project Information&#148;), except to the extent that such Project Information (i)&nbsp;can be shown to have been in the public domain through no fault of the Sellers or any of their Affiliates or (ii)&nbsp;was later lawfully acquired by the Sellers or any of their Affiliates from sources other than those related to its prior ownership of the Project.&#160; Notwithstanding the foregoing, in no event will this Section&nbsp;5.11(b)&nbsp;limit or otherwise restrict the right of a Seller or any Affiliate of a Seller to disclose such Project Information (w)&nbsp;to its and its Affiliates&#146; respective directors, officers, employees, agents and advisors to the extent reasonably required to facilitate the negotiation, execution, delivery or performance of this Agreement and the Ancillary Agreements, (x)&nbsp;to any Governmental Authority or arbitrator to the extent necessary in connection with any Proceeding relating to the enforcement of this Agreement or any Ancillary Agreement, (y)&nbsp;in connection with its indemnification obligations under this Agreement, including the defense of any Third Party Claim, and (z)&nbsp;as permitted in accordance with Section&nbsp;5.12.&#160; If any Governmental Authority or arbitrator requires disclosure of Project Information in connection with any Proceeding, the Sellers will, to the extent permitted by Law, give Purchaser prompt notice of such request so that the Purchaser may, at its sole expense, seek an appropriate protective order for the Project Information.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>For a period of three years after the Closing, Parent and the Purchaser will, and will cause their Affiliates to, and will instruct their respective directors, officers, employees, representatives and advisors to, hold in confidence, unless compelled to disclose by judicial or administrative process or by other requirements of Law, and not use all non-public documents and Information included in the Seller Information, except to the extent that such Seller Information (i)&nbsp;can be shown to have been in the public domain through no fault of Purchaser, Parent or any of their Affiliates or (ii)&nbsp;was later lawfully acquired by Purchaser, Parent or any of their Affiliates from sources other than those related to its prior ownership of the Seller Information.&#160; Notwithstanding the foregoing, in no event will this Section&nbsp;5.11(c)&nbsp;limit or otherwise restrict the right of Purchaser, Parent, or any of their respective Affiliates to disclose such Seller Information (w)&nbsp;to its and its Affiliates&#146; respective directors, officers, employees, agents and advisors to the extent reasonably required to facilitate the negotiation, execution, delivery or performance of this Agreement and the Ancillary Agreements, (x)&nbsp;to any Governmental Authority or arbitrator to the extent necessary in connection with any Proceeding relating to the enforcement of this Agreement or any Ancillary Agreement, (y)&nbsp;in connection with its indemnification obligations under this Agreement, including the defense of any Third Party Claim, and (z)&nbsp;as permitted in accordance with Section&nbsp;5.12.&#160; If any Governmental Authority or arbitrator requires disclosure of Seller Information in connection with any Proceeding, Parent and the Purchaser will, to the extent permitted by Law, give Sellers prompt notice of such request so that the Sellers may, at their sole expense, seek an appropriate protective order for the Seller Information.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.12</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Public Announcements</u>.&#160; Each party agrees not to issue any press release or make any other public announcement relating to this Agreement without the prior written approval of the other party, except that each of ConvaTec and the Purchaser reserves the right, without the other party&#146;s prior consent, to make any public disclosure it believes in good faith is required by applicable securities Laws or securities listing standards (in which case the disclosing party agrees to use Commercially Reasonable Efforts to advise the other party prior to making the disclosure).</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">29<a name="16022-2-KC-07_PB_29_021628_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=33,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=5116,FOLIO='29',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-07_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:40 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.13</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Further Actions</u>.&#160; Subject to the other express provisions of this Agreement, upon the request of any party to this Agreement, the other parties will execute and deliver such other documents, instruments and agreements as the requesting party may reasonably require for the purpose of carrying out the intent of this Agreement and the transactions contemplated by this Agreement.&#160; For the avoidance of doubt, Sellers will, at their expense, take all actions necessary to cause the patents included in the Purchased Intellectual Property and transferred pursuant to the Patent Assignment to be registered in the name of the applicable Seller promptly after the Closing so that such patents may be further assigned to Purchaser.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.14</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Bulk Transfer Laws</u>.&#160; The Purchaser hereby waives compliance by the Sellers with any applicable bulk sale or bulk transfer Laws of any jurisdiction in connection with the transactions contemplated by this Agreement.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.15</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Transfer Taxes</u>.&#160; Each of Purchaser, on the one hand, and the Sellers, on the other hand, will pay in a timely manner fifty percent of all applicable sales, use, transfer, conveyance, documentary, recording, notarial, value added, excise, registration, stamp, gross receipts and similar Taxes and fees (&#147;<u>Transfer Taxes</u>&#148;), arising out of or in connection with or attributable to the transactions effected pursuant to this Agreement and the Ancillary Agreements, including expenses and fees relating to registering Purchased Intellectual Property in the name of the Purchaser or its designee, regardless of whether such Transfer Taxes, expenses and fees are imposed by Law on the Purchaser, the Purchased Assets or the Sellers or any Affiliate of the Sellers.&#160; Any Tax Returns that must be filed in connection with any Transfer Taxes will be prepared by the Sellers; provided, however, that the Sellers will deliver such Tax Returns for the Purchaser&#146;s review and approval (not to be unreasonably withheld, conditioned or delayed) at least ten Business Days prior to the applicable due date.&#160; Purchaser shall deliver, if applicable, any exemption documentation for any Transfer Taxes to Seller in a timely manner.&#160; The parties will cooperate with each other in the provision of any information or preparation of any documentation that may be necessary or useful for obtaining any available mitigation, reduction or exemption from any such Transfer Taxes.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.16</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Data Room</u>.&nbsp; Within ten (10)&nbsp;Business Days after the Closing Date, the Sellers shall provide to the Purchaser an electronic copy of all information contained in the electronic data room (including using its Commercially Reasonable Efforts to provide, to the extent reasonably practicable, documents readable and usable by the program in which they were initially prepared rather than as a pdf or other format that restricts editing of the documents) maintained by the Sellers relating to the transactions contemplated hereby.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.17</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Employees and Consultants</u>.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Purchaser shall be provided access to, and the services of,&nbsp;Ian Tabron (or, if Ian Tabron is no longer an employee or consultant of ConvaTec or any of its Affiliates, the individual who succeeds to the duties and responsibilities of Ian Tabron) for purposes of providing transition services related to the Project (i)&nbsp;for seven Business Days of his time, at no cost to the Purchaser, during the first month after the Closing Date; (ii)&nbsp;for up to seven Business Days of his time, for a fee of $1,000 per day, during the second month after the Closing Date; and (iii)&nbsp;for up to two Business Days per month of his time, for the next four months thereafter, for a fee of $1,000 per day.&#160; Within 30 days after the end of each month in respect of which fees are payable, ConvaTec will submit an invoice to the Purchaser for such services provided during the previous month.&#160; The Business Days allocable to the Purchaser as referenced in subclauses (i), (ii)&nbsp;and (iii)&nbsp;in the previous sentence shall include time spent travelling by Ian Tabron in connection with the provision of his services to the Purchaser.&#160; The Purchaser will also reimburse ConvaTec for all reasonable expenses incurred by Ian Tabron (or other applicable employee) in providing such services, including for any travel required to be done at the Purchaser&#146;s request, subject to ConvaTec</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">30<a name="16022-2-KC-07_PB_30_021733_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=34,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=335511,FOLIO='30',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-07_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:40 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">providing receipts or other reasonable supporting evidence thereof and provided that such costs may not exceed $5,000 per month without the prior written consent of the Purchaser; provided, further, however, that it shall not constitute a breach of this Section&nbsp;5.17(a)&nbsp;if Ian Tabron&#146;s (or other applicable employee&#146;s) services are not provided to the Purchaser as a result of the Purchaser not approving travel expenses in accordance with the foregoing.&#160; The Purchaser agrees that, for any flight scheduled for a duration of eight hours or more,&nbsp;Ian Tabron (or other applicable employee) shall be entitled to travel business class and that the expenses thereof are reasonable expenses for purposes hereof.&#160; Such expenses will be included in the monthly invoices referred to above.&#160; The Purchaser will pay all amounts due pursuant to this section 5.l7(a)&nbsp;within 30 days after receipt of each such invoice hereunder.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If the Purchaser desires to retain Landy Toth as an employee, independent contractor or consultant in connection with the Project, Sellers will waive confidentiality or other restrictions owed to Sellers and their Affiliates by Mr.&nbsp;Toth to the extent necessary to enable Mr.&nbsp;Toth to be able to perform the relevant services for the Purchaser in connection with the Project.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;6</font></b><b><br> CONDITIONS PRECEDENT TO OBLIGATION TO CLOSE</b></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;6.1</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Conditions to the Obligation of the Purchaser</u>.&#160; The obligation of the Purchaser to consummate the transactions contemplated by this Agreement is subject to the satisfaction, on or before the Closing Date, of each of the following conditions (any of which may be waived by the Purchaser, in whole or in part):</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Accuracy of Representations and Warranties</u>.&#160; The representations and warranties of the Sellers in Article&nbsp;3 must be true and correct in all material respects as of the Closing (except to the extent any such representation or warranty speaks as of the date of this Agreement or any other specific date, in which case such representation or warranty must have been true and correct in all respects as of such date);</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Performance of Covenants</u>.&#160; All of the covenants and obligations that the Sellers are required to perform or comply with under this Agreement on or before the Closing Date must have been duly performed and complied with in all material respects;</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>No Action</u>.&#160; There must not be in effect any Law or Judgment that would prohibit or make illegal the consummation of the transactions contemplated by this Agreement or cause the transactions contemplated by this Agreement to be rescinded following consummation; and</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Transaction Documents</u>.&#160; The Sellers must have delivered or caused to be delivered each document that Section&nbsp;2.10(a)&nbsp;requires them to deliver.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;6.2</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Conditions to the Obligation of the Sellers</u>.&#160; The obligation of the Sellers to consummate the transactions contemplated by this Agreement is subject to the satisfaction, on or before the Closing Date, of each of the following conditions (any of which may be waived by ConvaTec, in whole or in part):</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Accuracy of Representations and Warranties</u>.&#160; The representations and warranties of the Purchaser in Article&nbsp;4 must be true and correct in all material respects as of the Closing (except to the extent any such representation or warranty speaks as of the date of this Agreement or any other specific date, in which case such representation or warranty must have been true and correct in all material respects as of such date);</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">31<a name="16022-2-KC-07_PB_31_021750_7748"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=35,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=290642,FOLIO='31',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-07_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:40 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Performance of Covenants</u>.&#160; All of the covenants and obligations that the Purchaser is required to perform or comply with under this Agreement on or before the Closing Date must have been duly performed and complied with in all material respects;</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>No Action</u>.&#160; There must not be in effect any Law or Judgment that would prohibit or make illegal the consummation of the transactions contemplated by this Agreement or cause the transactions contemplated by this Agreement to be rescinded following consummation; and</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Transaction Documents</u>.&#160; The Purchaser must have delivered or caused to be delivered to the Sellers each document that Section&nbsp;2.10(b)&nbsp;requires it to deliver.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;7</font></b><b><br> TERMINATION</b></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;7.1</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Termination Events</u>.&#160; This Agreement may, by written notice given before or at the Closing, be terminated:</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>by mutual consent of the Purchaser and ConvaTec;</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>by the Purchaser (so long as the Purchaser is not then in material breach of any of its representations, warranties or covenants contained in this Agreement) if there has been a breach of any of the Sellers&#146; representations, warranties or covenants contained in this Agreement, which would result in the failure of a condition set forth in Section&nbsp;6.1(a)&nbsp;or Section&nbsp;6.1(b), and which breach has not been cured within 15 days after written notice of the breach has been delivered to the Sellers from the Purchaser;</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>by ConvaTec (so long as the Sellers are not then in material breach of any of their representations, warranties or covenants contained in this Agreement) if there has been a breach of any of the Purchaser&#146;s representations, warranties or covenants contained in this Agreement, which would result in the failure of a condition set forth in Section&nbsp;6.2(a)&nbsp;or Section&nbsp;6.2(b), and which breach has not been cured within 15 days after written notice of the breach has been delivered to the Purchaser from ConvaTec;</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>by either the Purchaser or ConvaTec if any Governmental Authority has issued a nonappealable final Judgment or taken any other nonappealable final action, in each case having the effect of permanently restraining, enjoining or otherwise prohibiting the transactions contemplated by this Agreement; <u>provided</u>, <u>however</u>, that the right to terminate this Agreement under this Section&nbsp;7.1(d)&nbsp;will not be available to any party whose failure to fulfill any material covenant under this Agreement has been the cause of or resulted in the action or event described in this Section&nbsp;7.1(d)&nbsp;occurring;</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>by the Purchaser if the Closing has not occurred (other than through the failure of the Purchaser to comply fully with its obligations under this Agreement) on or before September&nbsp;30, 2012; or</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>by ConvaTec if the Closing has not occurred (other than through the failure of the Sellers to comply fully with their obligations under this Agreement) on or before September&nbsp;30, 2012.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;7.2</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Effect of Termination</u>.&#160; If this Agreement is terminated pursuant to Section&nbsp;7.1, this Agreement and all rights and obligations of the parties under this Agreement automatically end without Liability against any party or its Affiliates, except that (a)&nbsp;Section&nbsp;5.11(a)&nbsp;(<i>Confidentiality</i>), Section&nbsp;5.12 (<i>Public Announcements</i>), Section&nbsp;7.3 (<i>Certain Effects of Termination</i>), Article&nbsp;9 (<i>General Provisions</i>) (except for Section&nbsp;9.11 (<i>Specific Performance</i>)) and this Section&nbsp;7.2 will remain in full force</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">32<a name="16022-2-KC-07_PB_32_021808_141"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=36,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=500470,FOLIO='32',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-07_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:40 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">and survive any termination of this Agreement and (b)&nbsp;if this Agreement is terminated by a party because of the knowing and intentional breach of this Agreement by the other party or because one or more of the conditions to the terminating party&#146;s obligations under this Agreement is not satisfied as a result of the other party&#146;s knowing and intentional failure to comply with its obligations under this Agreement, the terminating party&#146;s right to pursue all legal remedies will survive such termination unimpaired.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;7.3</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Certain Effects of Termination</u>.&#160; If the Purchaser or ConvaTec terminates this Agreement pursuant to Section&nbsp;7.1, the Purchaser will comply with the Confidentiality Agreement regarding the return and/or destruction of any information furnished to the Purchaser in connection with this Agreement.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;8</font></b><b><br> INDEMNIFICATION</b></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;8.1</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Indemnification by ConvaTec</u>.&#160; If the Closing occurs, and subject to the limitations expressly set forth in Sections 8.4 and 8.5, ConvaTec will indemnify, defend and hold harmless the Purchaser and its directors, officers, employees, agents, representatives, stockholders and Affiliates (collectively, the &#147;<u>Purchaser Indemnified Parties</u>&#148;) from and against any and all Losses incurred by the Purchaser Indemnified Parties arising or resulting from (a)&nbsp;any breach of any representation or warranty set forth in Article&nbsp;3 or any certificate relating thereto, (b)&nbsp;any breach of any covenant of the Sellers set forth in this Agreement, (c)&nbsp;any Excluded Liability and (d)&nbsp;the failure of Sellers to comply with bulk sale or bulk transfer Laws in connection with the transactions contemplated by this Agreement.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;8.2</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Indemnification by the Purchaser</u>.&#160; If the Closing occurs, and subject to the limitations expressly set forth in Sections 8.4 and 8.5, the Purchaser will indemnify, defend and hold harmless the Sellers and their respective directors, officers, employees, agents, representatives, stockholders and Affiliates (collectively, the &#147;<u>Seller Indemnified Parties</u>&#148;) from and against any and all Losses incurred by the Seller Indemnified Parties arising or resulting from (a)&nbsp;any breach of any representation or warranty set forth in Article&nbsp;4 or any certificate related thereto, (b)&nbsp;any breach of any covenant of the Purchaser set forth in this Agreement and (c)&nbsp;any Assumed Liability.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;8.3</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Claim Procedure</u>.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>A party that seeks indemnity under this Article&nbsp;8 (an &#147;<u>Indemnified Party</u>&#148;) will give written notice (a &#147;<u>Claim Notice</u>&#148;) to the party from whom indemnification is sought (an &#147;<u>Indemnifying Party</u>&#148;) whether the Losses sought arise from matters solely between the parties or from Third Party Claims described in Section&nbsp;8.3(b).&#160; The Claim Notice must contain (i)&nbsp;a brief description and, if known, the estimated amount of any Losses incurred or reasonably expected to be incurred by the Indemnified Party, (ii)&nbsp;a reasonable explanation of the basis for the Claim Notice to the extent of the facts then known by the Indemnified Party and (iii)&nbsp;a demand for payment of those Losses.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If the Indemnified Party seeks indemnity under this Article&nbsp;8 in response to a claim or Proceeding by another Person not a party to this Agreement (a &#147;<u>Third Party Claim</u>&#148;), then the Indemnified Party will give a Claim Notice to the Indemnifying Party promptly and in any event within thirty days after the Indemnified Party has received notice or otherwise learns of the assertion of such Third Party Claim and will include in the Claim Notice (i)&nbsp;a brief description of the facts constituting the basis for such Third Party Claim and the amount of the damages claimed by the other Person, in each case to the extent known to the Indemnified Party and (ii)&nbsp;the assertion of the claim or the notice of the commencement of any Proceeding relating to such Third Party Claim; <u>provided</u>, <u>however</u>, that no delay or deficiency on the part of the Indemnified Party in so notifying the Indemnifying Party will relieve the</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">33<a name="16022-2-KC-07_PB_33_021817_7608"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=37,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=741961,FOLIO='33',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-07_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:40 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Indemnifying Party of any Liability under this Agreement except to the extent such delay or deficiency actually prejudices the rights of the Indemnifying Party with respect thereto.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>In the event of a Third Party Claim, the Indemnifying Party will be entitled to participate in the defense thereof and, if it so chooses, assume at any time control of the defense thereof with counsel reasonably satisfactory to the Indemnified party by giving to the Indemnified Party written notice of its intention to assume control of the defense of such Third Party Claim; <u>provided</u>, <u>however</u>, that the Indemnified Party may participate in the defense of such Third Party Claim with its own counsel at its own expense.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Indemnifying Party will not agree to any settlement of, or consent to the entry of any Judgment (other than a Judgment of dismissal on the merits without costs) arising from, any such Third Party Claim without the prior written consent of the Indemnified Party; <u>provided</u>, <u>however</u>, that the consent of the Indemnified Party will not be required if the Indemnifying Party agrees in writing to pay any amounts payable pursuant to such settlement or any Judgment and such settlement or Judgment includes a full, complete and unconditional release of the Indemnified Party from further Liability and does not impose any injunctive relief or criminal penalties on the Indemnified Party.&#160; The Indemnified Party will not agree to any settlement of, or the entry of any Judgment (other than a Judgment of dismissal on the merits without costs) arising from, any such Third Party Claim without the prior written consent of the Indemnifying Party, unless the Indemnifying Party fails to defend the Indemnified Party pursuant to the terms of this Section&nbsp;8.3.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;8.4</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Survival</u>.&#160; All representations and warranties contained in this Agreement will survive the Closing until the date that is thirty (30) months after the Closing Date, except that the representations and warranties set forth in Sections 3.1, 3.2, 3.3, 3.4(a), 3.7, 3.14, 4.1, 4.2, 4.3 and 4.5 will survive the Closing until the date that is 30 days after expiration of the applicable statute of limitations period.&#160; All covenants contained in this Agreement will survive the Closing until the expiration of the applicable statute of limitations or for such shorter period explicitly specified therein, except that for such covenants that survive for such shorter period, breaches thereof will survive until the expiration of the applicable statute of limitations.&#160; All claims for indemnification under this Agreement must be asserted pursuant to a Claim Notice given prior to the expiration of the applicable survival period set forth in this Section&nbsp;8.4; <u>provided</u>, <u>however</u>, that any representation, warranty or covenant that is the subject of a claim for indemnification which is asserted pursuant to a Claim Notice given after the Closing Date within the survival period specified in this Section&nbsp;8.4 will survive until, but only for purposes of, the resolution of such claim.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;8.5</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Limitations on Liability</u>.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Deductibles</u>.&#160; Notwithstanding anything to the contrary contained in this Agreement (except that the following limitations will only apply to Losses arising under Sections 8.1(a)&nbsp;and 8.2(a)&nbsp;(other than Losses arising with respect to breaches of Sections 3.1, 3.2, 3.3, 3.4(a), 3.5(b), 3.7, 3.14, 4.1, 4.2, 4.3, 4.5 and 4.6, with respect to which such limitations will not apply) and will accordingly not apply to Losses arising under Section&nbsp;8.1(b), (c)&nbsp;and (d)&nbsp;and Section&nbsp;8.2(b)&nbsp;and (c)):</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>no indemnification payments will be made by or on behalf of ConvaTec under this Agreement until the aggregate amount of Losses for which ConvaTec would (but for this clause (i) be liable thereunder exceeds $100,000 (such amount being, the &#147;<u>Deductible</u>&#148;), and then only to the extent of such excess over the Deductible; and</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>no indemnification payments will be made by or on behalf of the Purchaser under this Agreement until the aggregate amount of Losses for which the Purchaser would (but for this</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">34<a name="16022-2-KC-07_PB_34_021825_8146"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=38,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=704231,FOLIO='34',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-07_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:40 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">clause (ii)) be liable thereunder exceeds the Deductible, and then only to the extent of such excess over the Deductible.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Caps</u>.&#160; Notwithstanding anything to the contrary contained in this Agreement (except that the following limitations will only apply to Losses arising under Sections 8.1(a)&nbsp;and 8.2(a)&nbsp;(other than Losses arising with respect to breaches of Sections 3.1, 3.2, 3.3, 3.4(a), 3.5(b), 3.5(e), 3.5(f), 3.5(g), 3.5(i), 3.7, 3.14, 4.1, 4.2, 4.3, 4.5 and 4.6, with respect to which such limitations will not apply) and will accordingly not apply to Losses arising under Section&nbsp;8.1(b), (c)&nbsp;and (d)&nbsp;and Section&nbsp;8.2(b)&nbsp;and (c)):</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the aggregate total amount in respect of which ConvaTec will be liable to indemnify and hold harmless the Purchaser Indemnified Parties pursuant to this Agreement will not exceed $3,000,000; and</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the aggregate total amount in respect of which the Purchaser will be liable to indemnify and hold harmless the Seller Indemnified Parties pursuant to this Agreement will not exceed $3,000,000.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Aggregate Caps on ConvaTec&#146;s Liability</u>.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Notwithstanding anything to the contrary contained in this Agreement, the aggregate total amount in respect of which ConvaTec will be liable to indemnify and hold harmless the Purchaser Indemnified Parties pursuant to Section&nbsp;8.1(a)&nbsp;(other than with respect to breaches of Sections 3.1, 3.2, 3.3, 3.4(a), 3.7 and 3.14, with respect to which such limitation will not apply) will not exceed $5,000,000.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Notwithstanding anything to the contrary contained in this Agreement, the aggregate total amount in respect of which ConvaTec will be liable to indemnify and hold harmless the Purchaser Indemnified Parties pursuant to Sections 8.1(a), (b)&nbsp;and (d)&nbsp;of this Agreement, will not exceed an amount equal to the Purchase Price, as such Purchase Price may be increased by the payment of any amounts after the Closing Date.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Tax Refunds,&nbsp;Insurance Proceeds and Other Payments</u>.&#160; The amount of any and all Losses for which indemnification is provided pursuant to this Article&nbsp;8 will be net of any Tax benefit actually received and utilized by an Indemnified Party arising from the deductibility of any such payment of such Liability (taking into account any Tax cost or reduction in such Tax benefits by reason of receipt of the indemnification payment) and any amounts of any insurance proceeds, indemnification payments, contribution payments or reimbursements actually received by the Indemnified Party with respect to such Losses or any of the circumstances giving rise thereto.&#160; In connection therewith, if, at any time following payment in full by the Indemnifying Party of any amounts of Losses due under this Agreement, the Indemnified Party receives any insurance proceeds, indemnification payments, contribution payments or reimbursements relating to the circumstances giving rise to such Losses, the Indemnified Party will promptly remit to the Indemnifying Party such proceeds, payments or reimbursements in an amount not to exceed the amount of the corresponding indemnification payment made by the Indemnifying Party.&#160; The Purchaser will use (and will cause its Affiliates to use) Commercially Reasonable Efforts to collect the proceeds of any available insurance which would have the effect of reducing any Losses (in which case the net proceeds thereof will reduce the Losses).</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Mitigation</u>.&#160; The Indemnified Party will use its Commercially Reasonable Efforts to mitigate any Losses with respect to which it may be entitled to seek indemnification pursuant to this Agreement.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">35<a name="16022-2-KC-07_PB_35_021833_7091"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=39,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=1039749,FOLIO='35',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-07_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:40 2015' -->

<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;8.6</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Exclusive Remedy</u>.&#160; From and after the Closing, other than with respect to fraud (provided any such claim of fraud is not based on a standard of recklessness, willful ignorance, negligence or similar lesser standard of intent) the sole and exclusive remedy of the Purchaser for money damages for any matter arising out of the transactions contemplated by this Agreement will be pursuant to the indemnification obligations set forth in Article&nbsp;8.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;9</font></b><b><br> GENERAL PROVISIONS</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.1</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Notices</u>.&#160; All notices and other communications under this Agreement must be in writing and are deemed duly delivered (a)&nbsp;when delivered if delivered personally or by nationally recognized overnight courier service (costs prepaid), (b)&nbsp;upon electronic confirmation of receipt if sent by facsimile with confirmation of transmission by the transmitting equipment (or, the first Business Day following such transmission if the date of transmission is not a Business Day) or (c)&nbsp;five days after mailing, if sent by United States of America certified or registered mail, return receipt requested; in each case to the following addresses or facsimile numbers and marked to the attention of the individual (by name or title) designated below (or to such other address, facsimile number or individual as a party may designate by notice to the other party):</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If to the Sellers:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ConvaTec Inc.<br> 100 Headquarters Park Drive<br> Skillman, NJ 08558<br> USA<br> Facsimile: 908-904-2373<br> Attention: Company Secretary</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">with copies (which will not constitute notice) to:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Michael S. McNally<br> ConvaTec Inc.<br> Facsimile: 908-904-2373</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">and</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Baker&nbsp;&amp; McKenzie LLP<br> One Prudential Plaza, Suite&nbsp;3500<br> 130 East Randolph Drive<br> Chicago,&nbsp;IL, 60601<br> Attention: Edward J. West Esq.<br> Facsimile: 312-698-2702</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If to the Purchaser:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 67.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Tactile Systems Technology Inc.<br> 1331 Tyler Street NE, Suite&nbsp;200<br> Minneapolis, MN 55413<br> Attention: Gerald Mattys, Chief Executive Officer<br> Facsimile: 612-355-5101</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">36<a name="16022-2-KC-09_PB_36_021829_5586"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=40,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=672712,FOLIO='36',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-09_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:42 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">with a copy (which will not constitute notice) to:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Faegre Baker Daniels LLP<br> 2200 Wells Fargo Center<br> 90 South Seventh Street<br> Minneapolis, MN 55402<br> Attention: Jonathan Zimmerman<br> Facsimile: 612-766-1600</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.2</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Amendment</u>.&#160; This Agreement may not be amended, supplemented or otherwise modified except in a written document signed by each party to be bound by the amendment and that identifies itself as an amendment to this Agreement.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.3</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Waiver and Remedies</u>.&#160; The parties may (a)&nbsp;extend the time for performance of any of the obligations or other acts of the other party to this Agreement, (b)&nbsp;waive any inaccuracies in the representations and warranties of the other party to this Agreement contained in this Agreement or (c)&nbsp;waive compliance with any of the covenants or conditions for the benefit of such party contained in this Agreement.&#160; (i)&nbsp;Any such extension or waiver by a party to this Agreement will be valid only if set forth in a written document signed on behalf of the party against whom the extension or waiver is to be effective; (ii)&nbsp;no extension or waiver will apply to any time for performance, inaccuracy in any representation or warranty, or noncompliance with any covenant or condition, as the case may be, other than that which is specified in the written extension or waiver; and (iii)&nbsp;no failure or delay by a party in exercising any right or remedy under this Agreement or any of the documents delivered pursuant to this Agreement, and no course of dealing between the parties, operates as a waiver of such right or remedy, and no single or partial exercise of any such right or remedy precludes any other or further exercise of such right or remedy or the exercise of any other right or remedy.&#160; Except as provided in Section&nbsp;8.6, any enumeration of a party&#146;s rights and remedies in this Agreement is not intended to be exclusive, and a party&#146;s rights and remedies are intended to be cumulative to the extent permitted by law and include any rights and remedies authorized in law or in equity.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.4</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Entire Agreement</u>.&#160; This Agreement (including the Schedules and Exhibits hereto and the documents and instruments referred to in this Agreement that are to be delivered at the Closing) constitutes the entire agreement between the parties and supersedes any prior understandings, agreements or representations by or between the parties, or either of them, written or oral, with respect to the subject matter of this Agreement.&#160; Notwithstanding the foregoing, the Confidentiality Agreement will remain in effect in accordance with its terms as modified pursuant to Section&nbsp;5.11.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.5</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Assignment Successors and No Third Party Rights</u>.&#160; This Agreement binds and benefits the parties and their respective successors and assigns, except that no party may assign any rights under this Agreement, or delegate any performance of its obligations under this Agreement whether by operation of law or otherwise, without the prior written consent of the other party (except that (i)&nbsp;Purchaser may assign or delegate performance of its obligations without the prior written consent of Sellers if any Person to whom Purchaser assigns or delegates its obligations hereunder complies with Section&nbsp;5.9, in which event Purchaser and such Person shall be and remain jointly and severally liable to the Sellers for the performance of the Purchaser&#146;s obligations under this Agreement and the Ancillary Agreements and (ii)&nbsp;in the event of a Seller Sale, the Sellers may assign to the buyer in such Seller Sale the Sellers&#146; rights to receive performance of any obligations of Purchaser under this Agreement remaining to be performed after the date of consummation of such Seller Sale if the buyer in such Seller Sale assumes in writing (which shall be addressed to, and directly enforceable by, Purchaser) prior to the consummation of any such Seller Sale any and all of the Sellers&#146; obligations under this Agreement and the Ancillary Agreements).&#160; Any purported assignment or delegation in contravention of the foregoing</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">37<a name="16022-2-KC-09_PB_37_021843_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=41,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=58417,FOLIO='37',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-09_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:42 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">shall be void.&#160; Nothing expressed or referred to in this Agreement will be construed to give any Person, other than the parties to this Agreement, any legal or equitable right, remedy or claim under or with respect to this Agreement or any provision of this Agreement except such rights as may inure to a successor or permitted assignee under this Section&nbsp;9.5.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.6</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Severability</u>.&#160; If any provision of this Agreement is held invalid, illegal or unenforceable, the remaining provisions of this Agreement remain in full force and effect, if the essential terms and conditions of this Agreement for each party remain valid, binding and enforceable.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.7</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Exhibits and Schedules</u>.&#160; The Exhibits and Schedules to this Agreement are incorporated herein by reference and made a part of this Agreement.&#160; The Seller Disclosure Schedule and the Purchaser Disclosure Schedule are arranged in sections and paragraphs corresponding to the numbered and lettered sections and paragraphs of Article&nbsp;3 and Article&nbsp;4, respectively.&#160; The disclosure in any section or paragraph of the Seller Disclosure Schedule or the Purchaser Disclosure Schedule, and those in any amendment or supplement thereto, will be deemed to relate to each other provision of Article&nbsp;3 or Article&nbsp;4, respectively, to the extent that the applicability of such disclosure to any other provision of Article&nbsp;3 or Article&nbsp;4, as applicable, is reasonably apparent on the face of such disclosure.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.8</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Interpretation</u>.&#160; In the negotiation of this Agreement, each party has received advice from its own attorney.&#160; The language used in this Agreement is the language chosen by the parties to express their mutual intent, and no provision of this Agreement will be interpreted for or against either party because that party or its attorney drafted the provision.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.9</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Expenses</u>.&#160; Except as set forth in this Agreement, whether or not the transactions contemplated by this Agreement are consummated, each party will pay its own direct and indirect expenses incurred by it in connection with the preparation and negotiation of this Agreement and the consummation of the transactions contemplated by this Agreement, including all fees and expenses of its advisors and representatives.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.10</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Governing Law</u>.&#160; Unless any Exhibit&nbsp;or Schedule specifies a different choice of law, the internal laws of the State of Delaware (without giving effect to any choice or conflict of law provision or rule&nbsp;(whether of the State of Delaware or any other jurisdiction) that would cause the application of laws of any other jurisdiction) govern all matters arising out of or relating to this Agreement and its Exhibits and Schedules and the transactions contemplated by this Agreement, including its validity, interpretation, construction, performance and enforcement and any disputes or controversies arising therefrom or related thereto.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.11</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Specific Performance</u>.&#160; The parties agree that irreparable damage may occur in the event that any of the provisions of this Agreement were not performed by a party in accordance with their specific terms or were otherwise breached by such party.&#160; The parties accordingly agree that, prior to the termination of this Agreement pursuant to Section&nbsp;7.1, in addition to any other remedy to which a party is entitled at law or in equity, each party is entitled to injunctive relief to prevent breaches of this Agreement by the other party and otherwise to enforce specifically the provisions of this Agreement against such other party.&#160; Each party expressly waives any requirement that the other party obtain any bond or provide any indemnity in connection with any action seeking injunctive relief or specific enforcement of the provisions of this Agreement.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.12</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Jurisdiction and Service of Process</u>.&#160; Any action or Proceeding arising out of or relating to this Agreement or the transactions contemplated by this Agreement must be brought in the courts of the State of Illinois or, if it has or can acquire jurisdiction, in the United States Federal Court in the Northern District of Illinois.&#160; Each of the parties knowingly, voluntarily and irrevocably submits to the</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">38<a name="16022-2-KC-09_PB_38_021856_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=42,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=437644,FOLIO='38',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-09_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:42 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">exclusive jurisdiction of each such court in any such action or proceeding and waives any objection it may now or hereafter have to venue or to convenience of forum.&#160; Each party to this Agreement may make service on the other party by sending or delivering a copy of the process to the party to be served at the address and in the manner provided for the giving of notices in Section&nbsp;9.1.&#160; Nothing in this Section&nbsp;9.12, however, affects the right of a party to serve legal process in any other manner permitted by law.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.13</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Waiver of Jury Trial</u>.&#160; Each of the parties knowingly, voluntarily and irrevocably waives, to the fullest extent permitted by law, all right to trial by jury in any action, proceeding or counterclaim (whether based on contract, tort or otherwise) arising out of or relating to this Agreement or the transactions contemplated by this Agreement or the actions of either party to this Agreement in negotiation, execution and delivery, performance or enforcement of this Agreement.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.14</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>No Joint Venture</u>.&#160; Nothing in this Agreement creates a joint venture or partnership between the parties.&#160; This Agreement does not authorize either party (a)&nbsp;to bind or commit, or to act as an agent, employee or legal representative of, the other party, except as may be specifically set forth in other provisions of this Agreement, or (b)&nbsp;to have the power to control the activities and operations of the other party.&#160; The parties are independent contractors with respect to each other under this Agreement.&#160; Each party agrees not to hold itself out as having any authority or relationship contrary to this Section&nbsp;9.14.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.15</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Counterparts</u>.&#160; The parties may execute this Agreement in multiple counterparts, each of which constitutes an original as against the party that signed it, and all of which together constitute one agreement.&#160; This Agreement is effective upon delivery of one executed counterpart from each party to the other party.&#160; The signatures of all parties need not appear on the same counterpart.&#160; The delivery of signed counterparts by facsimile or email transmission that includes a copy of the sending party&#146;s signature(s)&nbsp;is as effective as signing and delivering the counterpart in person.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.16</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Guarantee</u>.&#160; Parent irrevocably, unconditionally and absolutely guaranties to the Sellers the prompt payment and performance by Purchaser of all of its obligations under this Agreement.&#160; Parent waives any and all defenses, claims, setoffs and discharges with respect to such obligations, except the defense of discharge by payment and performance in full and any defense available to Purchaser that is provided for in this Agreement.&#160; Parent will not exercise or enforce any right of contribution, reimbursement, recourse, or subrogation as to any such obligations against Purchaser until all such obligations have been fully paid and performed.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">[Signature page&nbsp;follows.]</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">39<a name="16022-2-KC-09_PB_39_021914_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=43,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=835681,FOLIO='39',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-09_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:42 2015' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The parties have executed and delivered this Agreement as of the date indicated in the first sentence of this Agreement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CONVATEC INC.</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.42%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.58%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/   Bradford Barton</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.42%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.58%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Bradford   Barton</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.42%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.58%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">President,   Americas</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CONVATEC TECHNOLOGIES,&nbsp;INC.</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.42%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.58%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/   Timothy Winston</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.42%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.58%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Timothy   Winston</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.42%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.58%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Treasurer</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SWELLING SOLUTIONS,&nbsp;INC.</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.42%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.58%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/   Gerald R. Mattys</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.42%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.58%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Gerald R.   Mattys</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.42%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.58%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CEO</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Solely with respect to Section&nbsp;9.16:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.5%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="40%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:40.76%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/   Gerald R. Mattys</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.76%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.5%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>
<td width="43%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:43.5%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Gerald R.   Mattys</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.5%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>
<td width="43%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:43.5%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CEO</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr height="0">
<td width="46" style="border:none;"></td>
<td width="289" style="border:none;"></td>
<td width="20" style="border:none;"></td>
<td width="354" style="border:none;"></td>   </tr> </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">[Signature Page&nbsp;to the Asset and Sale Purchase Agreement]</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=44,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=1028489,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-09_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:42 2015' -->

<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit&nbsp;A</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BILL OF SALE</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This Bill of Sale, dated as of September&nbsp;14, 2012 (the &#147;<u>Bill of Sale</u>&#148;), is delivered pursuant to the Closing under the Asset Sale and Purchase Agreement (the &#147;<u>Purchase Agreement</u>&#148;), dated as of September&nbsp;14, 2012, by and among ConvaTec Inc., a Delaware corporation (&#147;<u>ConvaTec</u>&#148;), ConvaTec Technologies,&nbsp;Inc., a Nevada corporation (&#147;<u>CTI</u>&#148;, and CTI and ConvaTec together being the &#147;Sellers&#148; and each individually a &#147;<u>Sellers</u>&#148;), Swelling Solutions,&nbsp;Inc., a Delaware corporation (the &#147;<u>Purchaser</u>&#148;), and Tactile Systems Technology,&nbsp;Inc., a Delaware corporation. Capitalized terms used in this Bill of Sale without definition have the respective meanings given to them in the Purchase Agreement.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the Purchase Agreement, the Sellers have agreed to sell, convey, assign, transfer and deliver to the Purchaser, and the Purchaser has agreed to purchase and acquire from the Sellers, the Purchased Assets. The Purchaser and the Sellers now seek to consummate the assignment, conveyance and transfer of such Purchased Assets.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">NOW, THEREFORE, intending to be legally bound and in consideration of the mutual provisions set forth in this Bill of Sale and in the Purchase Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;1</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Sale and Transfer of Purchased Assets</u>.&#160; The Sellers hereby sell, convey, assign, transfer and deliver to the Purchaser all of the Purchased Assets.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Power of Attorney</u>.&#160; The Sellers hereby constitute and appoint the Purchaser as the Sellers&#146; true and lawful agent and attorney-in-fact, with full power of substitution and resubstitution, in whole or in part, in the name and stead of Sellers but on behalf and for the benefit of the Purchaser and its successors and assigns, to demand, receive and collect any and all of the Purchased Assets and to give receipts and releases for and in respect of the same, and from time to time to institute and prosecute in the Sellers&#146; name, or otherwise for the benefit of the Purchaser and its successors and assigns, any and all proceedings at law, in equity or otherwise, which the Purchaser or its successors or assigns may deem proper for the collection or recovery of any of the Purchased Assets or for the collection and enforcement of any claim or right of any kind hereby sold, assigned, conveyed and transferred, or intended so to be, and to take any other actions and make, sign, execute, acknowledge and deliver any documents and instruments as may from time to time be necessary or appropriate to assign to the Purchaser and its successors and assigns the Purchased Assets and all rights granted to the Purchaser under the Purchase Agreement. The Sellers declare that the foregoing powers are coupled with an interest and are and will be irrevocable by the Sellers or by its dissolution or in any manner or for any reason whatsoever. Nothing in the Section&nbsp;2 will be deemed a waiver of any remedies otherwise available.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>General</u>.&#160; This Bill of Sale (a)&nbsp;is irrevocable and effective upon the Sellers&#146; signatures to and delivery of a manually signed copy of this Bill of Sale or facsimile or email transmission of the signatures to this Bill of Sale in connection with the Closing, if and only if the Closing is completed, (b)&nbsp;benefits and binds the parties to the Purchase Agreement and their respective successors and assigns, (c)&nbsp;does not modify or affect, and is subject to, the provisions of the Purchase Agreement and (d)&nbsp;may be signed in counterparts as provided in Article&nbsp;9.15 of the Purchase Agreement. In the event of any conflict or inconsistency between the provisions of the Purchase Agreement and the provisions of this Bill of Sale, the provisions of the Purchase Agreement will control.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">[Signature page&nbsp;follows.]</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=45,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=974691,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-11_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:45 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The undersigned has signed this Bill of Sale on the date first set forth above.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CONVATEC INC.</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.84%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CONVATEC TECHNOLOGIES,&nbsp;INC.</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.84%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="font-size:10.0pt;margin:0in 0in .0001pt;punctuation-wrap:simple;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SWELLING SOLUTIONS,&nbsp;</font></b><b>INC.</b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.84%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">[Signature Page&nbsp;to the Bill of Sale]</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=46,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=844831,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-11_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:45 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit&nbsp;B</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ASSIGNMENT AND ASSUMPTION AGREEMENT</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This Assignment and Assumption Agreement, dated as of September&nbsp;14, 2012 (the &#147;<u>Agreement</u>&#148;), is delivered pursuant to the Closing under the Asset Sale and Purchase Agreement (the &#147;<u>Purchase Agreement</u>&#148;), dated as of September&nbsp;14, 2012, by and among ConvaTec Inc., a Delaware corporation (&#147;<u>ConvaTec</u>&#148;), ConvaTec Technologies,&nbsp;Inc., a Nevada corporation (&#147;<u>CTI</u>&#148;, and CTI and ConvaTec together being the &#147;<u>Sellers</u>&#148; and each individually a &#147;<u>Seller</u>&#148;), Swelling Solutions,&nbsp;Inc., a Delaware corporation (the &#147;<u>Purchaser</u>&#148;), and Tactile Systems Technology,&nbsp;Inc., a Delaware corporation. Capitalized terms used in this Agreement without definition have the respective meanings given to them in the Purchase Agreement.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the Purchase Agreement, the Sellers have agreed to assign and the Purchaser has agreed to assume and pay or perform and discharge when due the Assumed Liabilities. The Purchaser and the Sellers now seek to consummate the assignment and assumption of such Assumed Liabilities.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">NOW, THEREFORE, intending to be legally bound and in consideration of the mutual provisions set forth in this Agreement and in the Purchase Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;1</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Assignment and Assumption of Assumed Liabilities</u>.&#160; The Sellers hereby assign, sell, transfer and set over (collectively, the &#147;<u>Assignment</u>&#148;) to the Purchaser the Assumed Liabilities. The Purchaser hereby accepts the Assignment and assumes and agrees to pay or perform and discharge when due only the Assumed Liabilities. Notwithstanding the foregoing, the Purchaser does not assume, or agree to pay or perform and discharge when due, any Liabilities of the Sellers (including, without limitation, the Excluded Liabilities) other than the Assumed Liabilities, and the parties hereto agree that all such Liabilities, other than the Assumed Liabilities, will remain the sole responsibility of the Sellers.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2</font></u><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>General</u>.&#160; This Agreement (a)&nbsp;is irrevocable and effective upon the Purchaser&#146;s signature to and delivery of a manually signed copy of this Agreement or facsimile or email transmission of the signature to this Agreement in connection with the Closing, if and only if the Closing is completed, (b)&nbsp;benefits and binds the parties to the Purchase Agreement and their respective successors and assigns, (c)&nbsp;does not modify or affect, and is subject to, the provisions of the Purchase Agreement and (d)&nbsp;may be signed in counterparts as provided in Article&nbsp;9.15 of the Purchase Agreement. In the event of any conflict or inconsistency between the provisions of the Purchase Agreement and the provisions of this Agreement, the provisions of the Purchase Agreement will control.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">[Signature page&nbsp;follows]</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=47,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=773548,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-11_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:45 2015' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The undersigned has signed this Agreement on the date first set forth above.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CONVATEC INC.</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.84%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CONVATEC TECHNOLOGIES,&nbsp;INC.</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.84%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="font-size:10.0pt;margin:0in 0in .0001pt;punctuation-wrap:simple;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SWELLING SOLUTIONS,&nbsp;</font></b><b>INC.</b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.84%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">[Signature Page&nbsp;to the Assignment and Assumption Agreement]</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=48,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=850155,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-11_ZBY12202.CHC",USER="CPELLEY",CD='Dec  9 15:45 2015' -->

<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit&nbsp;C</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">PATENT ASSIGNMENT</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This Patent Assignment, dated as of September&nbsp;14, 2012, is delivered pursuant to the Closing under that certain Asset Sale and Purchase Agreement (the &#147;<u>Purchase Agreement</u>&#148;) dated as of September&nbsp;14, 2012, between ConvaTec Inc., a Delaware corporation (&#147;<u>ConvaTec</u>&#148;), ConvaTec Technologies,&nbsp;Inc., a Nevada corporation (&#147;<u>CTI</u>&#148;), Swelling Solutions,&nbsp;Inc., a Delaware corporation (the &#147;<u>Purchaser</u>&#148;), and Tactile Systems Technology,&nbsp;Inc., a Delaware corporation. Capitalized terms used in this Patent Assignment without definition have the respective meanings given to them in the Purchase Agreement.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CTI has delivered this instrument signed by CTI to enable the Purchaser to file it with any appropriate Governmental Authority to indicate ownership of Intellectual Property described below and for the other purposes set forth in this instrument. This instrument supplements and is in addition to all other rights of the Purchaser under the Purchase Agreement and other instruments of transfer delivered in connection with the Purchase Agreement.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">NOW, THEREFORE, for good and valuable consideration, receipt of which CTI acknowledges, and by signing and delivering this instrument, CTI sells, assigns, transfers, conveys, and delivers to the Purchaser all of CTI&#146;s right, title, and interest in and to:</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the patents, patent applications and invention disclosures specifically listed in Annex A to this Patent Assignment; and</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the following properties and rights with respect to all patents and patent applications so listed in Annex A:</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the inventions claimed or described in the patents or patent applications;</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any patents in the United States and anywhere else in the world and patent applications in the United States and anywhere else in the world that have been or may be granted or filed, respectively, with respect to those inventions, including without limitation all foreign patents and patent applications that may claim priority based on and correspond to the patents or patent applications listed in Annex A;</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>all divisions, renewals, reissues, continuations, extensions, continuations-in-part of the foregoing patents or patent applications, or other or further applications based in whole or in part upon the inventions, patents, or patent applications;</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>all income, royalties, damages and payments due or payable to CTI with respect to the patents, including without limitation unpaid damages and payments for past, present and future infringements of any patent; and</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(v)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>all rights to sue and recover damages and payments for past (to the extent CTI has such rights), present and future infringements of any of the patents, including the right to fully and entirely replace CTI in all related matters.</p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CTI represents and warrants to Purchaser that ConvaTec does not own any right, title or interest in the Purchased Intellectual Property described in this Patent Assignment.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The foregoing rights in and under the patents and patent applications shall apply to the full end of their terms as fully as CTI would have held the same in the absence of this Patent Assignment. As of the date set forth below, the Purchaser has succeeded to all right, title and standing of CTI to (a)&nbsp;receive all</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=49,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=777032,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-13_ZBY12202.CHC",USER="CPELLEY",CD='Jan  5 10:42 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">rights and benefits pertaining to the patents and patent applications described above and (b)&nbsp;commence, prosecute, defend and settle all claims and take all actions that the Purchaser, in its sole discretion, may elect in relation to the patents, patent applications and rights described above.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.45in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CTI, its successors, and legal representatives will make, execute, and deliver without any further consideration any and all other instruments in writing, including any and all further application papers, affidavits, assignments, and other documents relating to the assets listed in Annex A, and generally do all things deemed reasonably necessary to assign assets listed in Annex A to Purchaser, the entire right, title and interest in and to, and/or ownership interest in and to, the assets listed in Annex A, including all benefits, privileges, and advantages, that were sold, assigned and conveyed to Purchaser, or intended so to be, to the extent CTI has such rights. Purchaser shall be responsible for the recordation of this Patent Assignment from CTI to Purchaser for assets listed in Annex A in all jurisdictions.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This Patent Assignment (a)&nbsp;is irrevocable and effective upon CTI&#146;s signature to and delivery of a manually signed copy of this instrument or facsimile or email transmission of the signature to this instrument in connection with the Closing, if and only if the Closing is completed, (b)&nbsp;benefits and binds the parties to the Purchase Agreement and their respective successors and assigns, and (c)&nbsp;does not modify or affect, and is subject to, the provisions of the Purchase Agreement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">[Signature page&nbsp;follows]</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-KC-13_PB_2_070451_2983"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=50,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=1041392,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-13_ZBY12202.CHC",USER="CPELLEY",CD='Jan  5 10:42 2016' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The undersigned has signed this Patent Assignment on&nbsp;<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>, 2012.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CONVATEC TECHNOLOGIES,&nbsp;INC.</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="46%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:46.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">STATE OF:</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">COUNTY OF:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On&nbsp;<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>&nbsp;before me,&nbsp;<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>&nbsp;(the undersigned notary), personally appeared <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> personally known to me (or proved to me on the basis of satisfactory evidence) to be the person whose name is subscribed to the within instrument and acknowledged to me that he/she executed the same in his/her authorized capacity, and that by his/her signature on the instrument the person, or the entity upon behalf of which the person acted, executed the instrument.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Witness my hand and official seal.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="3" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Notary Public</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="21%" valign="top" style="padding:0in 0in 0in 0in;width:21.26%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">My commission expires:</font></p>    </td>
<td width="28%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:28.76%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="25%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:25.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="25%" valign="top" style="padding:0in 0in 0in 0in;width:25.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Notary Seal)</font></p>    </td>   </tr>
<tr height="0">
<td width="354" style="border:none;"></td>
<td width="151" style="border:none;"></td>
<td width="26" style="border:none;"></td>
<td width="177" style="border:none;"></td>   </tr> </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">[Signature Page&nbsp;to the Patent Assignment Agreement]</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=51,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=939105,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-13_ZBY12202.CHC",USER="CPELLEY",CD='Jan  5 10:42 2016' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit&nbsp;D</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SOFTWARE ASSIGNMENT</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This Software Assignment, dated September&nbsp;14, 2012, is delivered pursuant to the Closing under that certain Asset Sale and Purchase Agreement (the &#147;<u>Purchase Agreement</u>&#148;) dated as of September&nbsp;14, 2012, between ConvaTec Inc., a Delaware corporation (&#147;<u>ConvaTec</u>&#148;), ConvaTec Technologies,&nbsp;Inc., a Nevada corporation (&#147;CTI&#148;), Swelling Solutions,&nbsp;Inc., a Delaware corporation (the &#147;<u>Purchaser</u>&#148;), and Tactile Systems Technology,&nbsp;Inc., a Delaware corporation. Capitalized terms used in this Software Assignment without definition have the respective meanings given to them in the Purchase Agreement.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CTI has delivered this instrument signed by ConvaTec and CTI to enable the Purchaser to file it with any appropriate Governmental Authority to indicate ownership of Intellectual Property described below and for the other purposes set forth in this instrument. This instrument supplements and is in addition to all other rights of the Purchaser under the Purchase Agreement and other instruments of transfer delivered in connection with the Purchase Agreement.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">NOW, THEREFORE, for good and valuable consideration, receipt of which CTI acknowledge, and by signing and delivering this instrument, ConvaTec and CTI sell, assign, transfer, convey, and deliver to the Purchaser all of ConvaTec&#146;s and CTI&#146;s right, title, and interest in and to: the software items specifically listed in Annex A to this Software Assignment together with all related documentation, developer&#146;s notes and similar materials and all Intellectual Property in and to all of the foregoing, to the extent that such documentation, notes and materials exist and are sold, assigned, transferred, conveyed and delivered pursuant to the Purchase Agreement.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The foregoing rights in and under the software items shall apply to the full end of their terms as fully as ConvaTec and/or CTI would have held the same in the absence of this assignment. As of the date set forth below, the Purchaser has succeeded to all right, title and standing of ConvaTec and/or CTI to (a)&nbsp;receive all rights and benefits pertaining to the software items described above and (b)&nbsp;commence, prosecute, defend and settle all claims and take all actions that the Purchaser, in its sole discretion, may elect in relation to the software items and rights described above. Except as expressly set forth in .the Purchase Agreement, the software items, together with all related documentation, developer&#146;s notes and similar materials are assigned &#147;as-is&#148; and without warranty of any kind.</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This Software Assignment (a)&nbsp;is irrevocable and effective upon ConvaTec&#146;s and CTI&#146;s signature to and delivery of a manually signed copy of this instrument or facsimile or email transmission of the signature to this instrument in connection with the Closing, if and only if the Closing is completed, (b)&nbsp;benefits and binds the parties to the Purchase Agreement and their respective successors and assigns, (c)&nbsp;does not modify or affect, and is subject to, the provisions of the Purchase Agreement and (d)&nbsp;may be signed in counterparts as provided in Article&nbsp;9.15 of the Purchase Agreement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">[Signature page&nbsp;follows.]</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=52,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=235661,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-13_ZBY12202.CHC",USER="CPELLEY",CD='Jan  5 10:42 2016' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The undersigned has signed this Software Assignment on <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u>, 2012.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CONVETEC INC.</font></b></p>    </td>
<td width="1%" valign="top" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CONVATEC TECHNOLOGIES,&nbsp;INC.</font></b></p>    </td>   </tr>
<tr>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="top" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="top" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.26%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="42%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:42.76%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="top" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.42%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.58%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.26%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>
<td width="42%" valign="top" style="padding:0in 0in 0in 0in;width:42.76%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="top" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.42%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.58%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.26%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>
<td width="42%" valign="top" style="padding:0in 0in 0in 0in;width:42.76%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="top" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.42%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.58%;">
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">STATE OF:</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">COUNTY OF:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On&nbsp;<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>&nbsp;before me,&nbsp;<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>&nbsp;(the undersigned notary), personally appeared <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> personally known to me (or proved to me on the basis of satisfactory evidence) to be the person whose name is subscribed to the within instrument and acknowledged to me that he/she executed the same in his/her authorized capacity, and that by his/her signature on the instrument the person, or the entity upon behalf of which the person acted, executed the instrument.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Witness my hand and official seal.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="3" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Notary Public</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="20%" valign="top" style="padding:0in 0in 0in 0in;width:20.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">My commission expires:</font></p>    </td>
<td width="29%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:29.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="25%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:25.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="25%" valign="top" style="padding:0in 0in 0in 0in;width:25.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Notary Seal)</font></p>    </td>   </tr>
<tr height="0">
<td width="354" style="border:none;"></td>
<td width="146" style="border:none;"></td>
<td width="31" style="border:none;"></td>
<td width="177" style="border:none;"></td>   </tr> </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">[Signature Page&nbsp;to the Software Assignment]</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=53,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=607343,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-13_ZBY12202.CHC",USER="CPELLEY",CD='Jan  5 10:42 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ANNEX A TO SOFTWARE ASSIGNMENT</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amadeus Device Software (all versions)</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amadeus PC Client Software (all versions)</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amadeus device two pressure profile version software (all versions)</font></p>
<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;punctuation-wrap:simple;text-align:justify;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">NOTE:</font></b>&#160; With respect to the first two items, only Amadeus Device Software Version 2.10 and Amadeus PC Client Software Version 1.8 are compatible and functional with the Product. With respect to the third item, a version that is compatible and functional with the Product remains under development. All previous versions of the first two software items and all versions of the third software item were part of the development and initial testing of the Product and have never been validated or incorporated in the Product as they require additional modifications.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="16022-2-KC-13_PB_3_071018_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=54,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=404503,FOLIO='3',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KC-13_ZBY12202.CHC",USER="CPELLEY",CD='Jan  5 10:42 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.4
<SEQUENCE>3
<FILENAME>a2227029zex-3_4.htm
<DESCRIPTION>EX-3.4
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 3.4</font></b></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.<br> AMENDED AND RESTATED BY-LAWS</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Adopted January&nbsp;21, 2011</font><br><br></p>
<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade align="center" style="color:black;"></div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;I<br>  </font></u>Stockholders</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;1.1.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Annual Meetings.&#160; </b>An annual meeting of stockholders will be held for the election of directors at such date, time and place, either within or without the State of Delaware, as may be designated by resolution of the Board of Directors from time to time.&#160; Any proper business may be transacted at the annual meeting.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;1.2.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Special Meetings.</b>&#160; Special meetings of stockholders for any purpose or purposes may be called at any time only by the Chairman, the Chief Executive Officer, the President, or the Secretary and will be called by any such officer at the request in writing of a majority of the Board of Directors.&#160; Such request must state the purpose or purposes of the meeting.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;1.3.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Notice of Meetings.</b>&#160; Whenever stockholders are required or permitted to take any action at a meeting, a written notice of the meeting must be given that will state the place, date and hour of the meeting and, in the case of a special meeting, the purpose or purposes for which the meeting is called.&#160; Unless otherwise provided by applicable law or regulation, the certificate of incorporation or these bylaws, the written notice of any meeting must be given not less than ten nor more than 60 days before the date of the meeting to each stockholder entitled to vote at such meeting.&#160; If mailed, such notice will be deemed to be given when deposited in the United States mail, postage prepaid, directed to the stockholder at the stockholder&#146;s address as it appears on records of the corporation.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;1.4.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Adjournments.</b>&#160; Any meeting of stockholders, annual or special, may adjourn from time to time to reconvene at the same or some other place, and notice need not be given of any such adjourned meeting if the time and place thereof are announced at the meeting at which the adjournment is taken.&#160; At the adjourned meeting the corporation may transact any business that might have been transacted at the original meeting.&#160; If the adjournment is for more than 30 days, or if after the adjournment a new record date is fixed for the adjourned meeting, notice of the adjourned meeting must be given to each stockholder of record entitled to vote at the meeting.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;1.5.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Quorum.</b>&#160; Except as otherwise provided by law or regulation, the certificate of incorporation or these bylaws, at each meeting of stockholders the presence in person or by proxy of the holders of shares of stock having at least a majority of the votes that could be cast by the holders of all outstanding shares of stock entitled to vote at the meeting will constitute a quorum.&#160; In the absence of a quorum, the stockholders so present may, by majority vote, adjourn the meeting from time to time in the manner provided in Section&nbsp;1.4 of these bylaws until a quorum attends.&#160; The corporation will not vote shares of its own stock belonging to the corporation or to another corporation, if a majority of the shares entitled to vote in the election of directors of such other corporation is held, directly or indirectly, by the corporation, nor will any such shares be counted for quorum purposes.&#160; However, the previous sentence will not limit the right of the corporation to vote stock, including but not limited to its own stock, held by it in a fiduciary capacity.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;1.6.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Organization.</b>&#160; Meetings of stockholders will be presided over by the Chairman of the Board, if any, or in such person&#146;s absence by the Vice Chairman of the Board, if any, or in such person&#146;s absence by the Chief Executive Officer, or in such person&#146;s absence by the President (if not the Chief Executive Officer), or in such person&#146;s absence by a Vice President, or in the absence of the foregoing persons by a chairman designated by the Board of Directors, or in the absence of such designation by a chairman chosen at the meeting.&#160; The Secretary will act as secretary of the meeting, but in such person&#146;s absence the chairman of the meeting may appoint any person to act as secretary of the meeting.&#160; The chairman of the meeting will announce at the meeting of stockholders the date and time of the opening and the closing of the polls for each matter upon which the stockholders will vote.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;1.7.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Voting. </b>&#160;Except as otherwise provided by the certificate of incorporation, each stockholder entitled to vote at any meeting of stockholders is entitled to one vote for each share of stock held by such person that has voting power upon the matter in question. Voting at meetings of stockholders need not be by written ballot and, unless otherwise required by law, need not be conducted by inspectors of election unless so determined by the holders of shares of stock having a majority of the votes that could be cast by the holders of all</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">B-</font>1<a name="16022-2-KI_PB_1_075314_4645"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=922355,FOLIO='B-1',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KI_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 08:22 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">outstanding shares of stock entitled to vote thereon that are present in person or by proxy at such meeting.&#160; At all meetings of stockholders for the election of directors, a plurality of the votes cast will be sufficient to elect.&#160; All other elections and questions will, unless otherwise provided by applicable law or regulation, the certificate of incorporation or these bylaws, be decided by the vote of the holders of shares of stock having a majority of the votes that are present in person or represented by proxy at the meeting and entitled to vote on the election or question.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;1.8.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Proxies.</b>&#160; Each stockholder entitled to vote at a meeting of stockholders may authorize another person or persons to act for him or her by proxy in any manner, including without limitation via telephone,&nbsp;Internet or such other manner as permitted by Section&nbsp;212 of the Delaware General Corporation Law, as amended from time to time, provided that such authorization sets forth or contains information from which the Corporation can determine that the authorization was granted by the stockholder.&#160; If the authorization is granted in a manner other than in a written form, the proxy holder will provide such reasonable verification as required by the corporation. A proxy will be irrevocable only if it states that it is irrevocable and if, and only as long as, it is coupled with an interest sufficient in law to support an irrevocable power.&#160; A stockholder may revoke any proxy that is not irrevocable by attending the meeting and voting in person or by filing an instrument in writing revoking the proxy or by delivering a proxy in accordance with applicable law bearing a later date to the Secretary of the corporation.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;1.9.&#160; Fixing Date for Determination of Stockholders of Record</font></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Board of Directors may fix a record date to determine the stockholders entitled to:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(1)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>notice of or to vote at any meeting of stockholders or any adjournment thereof;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(2)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>express consent to corporate action in writing without a meeting;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(3)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>receive payment of any dividend or other distribution or allotment of any rights; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(4)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>exercise any rights in respect of any change, conversion or exchange of stock or for the purpose of any other lawful action.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(b)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>A record date will not precede the date upon which the resolution fixing the record date is adopted by the Board of Directors.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(c)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The record date:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(1)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>in the case of determination of stockholders entitled to vote at any meeting of stockholders or adjournment thereof, will, unless otherwise required by law, not be more than 60 nor less than ten days before the date of such meeting;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(2)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>in the case of determination of stockholders entitled to express consent to corporate action in writing without a meeting, will not be more than ten days from the date upon which the resolution fixing the record date is adopted by the Board of Directors; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(3)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>in the case of any other action, will not be more than 60 days prior to such other action.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(d)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If no record date is fixed:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(1)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the record date for determining stockholders entitled to notice of or to vote at a meeting of stockholders will be at the close of business on the day next preceding the day on which notice is given, or, if notice is waived, at the close of business on the day next preceding the day on which the meeting is held;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(2)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the record date for determining stockholders entitled to express consent to corporate action in writing without a meeting when no prior action of the Board of Directors is required by law will be the first date on which a signed written consent setting forth the action taken or proposed to be taken is delivered to the corporation in accordance with applicable law, or, if prior action by the Board of Directors is required by law, will be at the close of business on the day on which the Board of Directors adopts the resolution taking such prior action; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(3)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the record date for determining stockholders for any other purpose will be at the close of business on the day on which the Board of Directors adopts the resolution relating thereto.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">B-</font>2<a name="16022-2-KI_PB_2_075345_7748"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=385161,FOLIO='B-2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KI_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 08:22 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(e)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders will apply to any adjournment of the meeting although the Board of Directors may fix a new record date for the adjourned meeting.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;1.10.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>List of Stockholders Entitled to Vote.</b>&#160; The Secretary will prepare and make, at least ten days before every meeting of stockholders, a complete list of the stockholders entitled to vote at the meeting, arranged in alphabetical order, and showing the address of each stockholder and the number of shares registered in the name of each stockholder.&#160; Such list will be open to the examination of any stockholder, for any purpose germane to the meeting, during ordinary business hours, for a period of at least ten days prior to the meeting, either at a place within the city where the meeting is to be held, which place will be specified in the notice of the meeting, or if not so specified, at the place where the meeting is to be held.&#160; The list will also be produced and kept at the time and place of the meeting during the whole time thereof and may be inspected by any stockholder who is present.&#160; Upon the willful neglect or refusal of the directors to produce such a list at any meeting for the election of directors, they will be ineligible for election to any office at such meeting.&#160; The stock ledger will be the only evidence as to who are the stockholders entitled to examine the stock ledger, the list of stockholders or the books of the corporation, or to vote in person or by proxy at any meeting of stockholders.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;1.11.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Action By Consent of Stockholders.</b>&#160; Unless otherwise restricted by the certificate of incorporation, any action required or permitted to be taken at any annual or special meeting of the stockholders may be taken without a meeting, without prior notice and without a vote, if a consent or consents in writing, setting forth the action so taken, is signed by the holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted.&#160; Any such executed consents must be delivered (by hand or by certified or registered mail, return receipt requested) to the corporation by delivery to its registered office in the State of Delaware, its principal place of business, or an officer or agent of the corporation having custody of the book in which proceedings of minutes of stockholders are recorded.&#160; Prompt notice of the taking of the corporate action without a meeting by less than unanimous written consent will be given to those stockholders who have not consented in writing.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;1.12.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Conduct of Meetings.</b>&#160; The Board of Directors of the corporation may adopt by resolution such rules&nbsp;and regulations for the conduct of the meeting of stockholders as it deems appropriate.&#160; The chairman of any meeting of stockholders may prescribe such rules, regulations and procedures and do all such acts as, in the judgment of such chairman, are appropriate for the proper conduct of the meeting, except to the extent inconsistent with such rules&nbsp;and regulations as adopted by the Board of Directors.&#160; Such rules, regulations or procedures, whether adopted by the Board of Directors or prescribed by the chairman of the meeting, may include, without limitation, the following: (1)&nbsp;the establishment of an agenda or order of business for the meeting; (2)&nbsp;rules&nbsp;and procedures for maintaining order at the meeting and the safety of those present; (3)&nbsp;limitations on attendance at or participation in the meeting to stockholders of record of the corporation, their duly authorized and constituted proxies or such other persons as the chairman of the meeting shall determine; (4)&nbsp;restrictions on entry to the meeting after the time fixed for the commencement thereof; and (5)&nbsp;limitations on the time allotted to questions or comments by participants.&#160; Unless and to the extent determined by the Board of Directors or the chairman of the meeting, meetings of stockholders are not required to be held in accordance with the rules&nbsp;of parliamentary procedure.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;1.13</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Advance Notice of Stockholder Business.</b>&#160; As provided in Section&nbsp;1.2, the business conducted at any special meeting of stockholders will be limited to the purposes stated in the notice of the special meeting.&#160; At any annual meeting of stockholders, only such business (other than the nomination and election of directors, which will be subject to Section&nbsp;1.14) may be conducted that is appropriate for consideration at the meeting and that has been brought before the meeting (1)&nbsp;by or at the direction of the Board of Directors, or (2)&nbsp;by any stockholder of the corporation entitled to vote at the meeting who complies with the notice procedures in this Section&nbsp;1.13.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Timing of Notice</u>.</b>&#160; For business to be properly brought before any annual meeting by a stockholder, the stockholder must have given timely notice thereof in writing to the Secretary of the corporation.&#160; To be timely, a stockholder&#146;s notice must be delivered to the Secretary, or mailed and received at the principal executive office of the corporation, not less than 90&nbsp;days before the first anniversary of the date of the preceding year&#146;s annual meeting of stockholders.&#160; If, however, the date of the annual meeting of stockholders is more than 30 days before or after such anniversary date, notice by a stockholder will be considered timely only if delivered or mailed and received not less than 90 days before such annual meeting or, if later, within ten days after the first public announcement of the date of such</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">B-</font>3<a name="16022-2-KI_PB_3_075412_141"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=3,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=168836,FOLIO='B-3',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KI_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 08:22 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">annual meeting.&#160; Except to the extent otherwise required by law, the adjournment of an annual meeting of stockholders will not commence a new time period for the giving of a stockholder&#146;s notice as required above.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(b)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Content of Notice</u>.</b>&#160; For each matter a stockholder proposes to bring before a meeting of stockholders, the stockholder&#146;s notice must state: (1)&nbsp;a brief description of the business desired to be brought before the meeting and the reasons for conducting such business at the meeting, (2)&nbsp;the name and address, as they appear on the corporation&#146;s books, of the stockholder proposing such business, (3)&nbsp;the class or series (if any) and number of shares of the corporation that are beneficially owned by the stockholder, (4)&nbsp;any material interest of the stockholder in such business, and (5)&nbsp;a representation that the stockholder is a holder of record of shares entitled to vote at the meeting and intends to appear in person or by proxy at the meeting to make the proposal.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(c)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Consequences of Failure to Give Timely Notice</u>.</b>&#160; Notwithstanding anything in these bylaws to the contrary, no business (other than the nomination and election of directors) will be conducted at any annual meeting of stockholders except in accordance with the procedures set forth in this Section&nbsp;1.13.&#160; If the officer of the corporation chairing the meeting determines that any business proposed to be conducted at the meeting was not properly brought before the meeting in accordance with the procedures described in this Section&nbsp;1.13, then such officer must declare as such to the meeting and such business will not be transacted.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(d)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Public Announcement</u>.</b>&#160; For purposes of this Section&nbsp;1.13 and Section&nbsp;1.14, &#147;public announcement&#148; means disclosure (1)&nbsp;when made in a press release reported by the Dow Jones News Service, Associated Press, or comparable national news service, (2)&nbsp;when filed in a document publicly filed by the corporation with the Securities and Exchange Commission pursuant to Section&nbsp;13, 14, or 15(d)&nbsp;of the Securities Exchange Act of 1934, or (3)&nbsp;when mailed or otherwise delivered as the notice of the meeting pursuant to Section&nbsp;1.3.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(e)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Compliance with Law</u>.</b>&#160; Notwithstanding the foregoing provisions of this Section&nbsp;1.13, a stockholder must also comply with all applicable requirements of Delaware law and the Securities Exchange Act of 1934 and the rules&nbsp;and regulations thereunder with respect to the matters set forth in this Section&nbsp;1.13.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;1.14</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Advance Notice of Stockholder Nominees.</b>&#160; Only persons who are nominated in accordance with the procedures set forth in this Section&nbsp;1.14 will be eligible for election as directors.&#160; Nominations of persons for election to the Board of Directors of the corporation may be made at a meeting of stockholders by or at the direction of the Board of Directors or&nbsp;by any stockholder of the corporation entitled to vote for the election of directors at the meeting who complies with the notice procedures in this Section&nbsp;1.14.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Timing of Notice</u>.</b>&#160; Nominations by stockholders must be made pursuant to timely notice in writing to the Secretary of the corporation.&#160; To be timely, a stockholder&#146;s notice of nominations must be delivered to the Secretary of the corporation, or mailed and received at the principal executive office of the corporation, not less than 90 days before the first anniversary of the date of the preceding year&#146;s annual meeting of stockholders.&#160; If, however, the date of the annual meeting of stockholders is more than 30 days before or after such anniversary date, notice by a stockholder will be timely only if so delivered or so mailed and received not less than 90 days before such annual meeting or, if later, within ten days after the first public announcement of the date of such annual meeting. &#160;If a special meeting of stockholders of the corporation is called in accordance with Section&nbsp;1.2 for the purpose of electing one or more directors to the Board of Directors, then a stockholder&#146;s notice of nomination must be delivered to the Secretary of the corporation, or mailed and received at the principal executive office of the corporation, not less than 90 days before such special meeting or, if later, within ten days after the first public announcement of the date of such special meeting.&#160; Except to the extent otherwise required by law, the adjournment of a regular or special meeting of stockholders will not commence a new time period for the giving of a stockholder&#146;s notice as described above.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(b)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Content of Notice</u>.</b>&#160; A stockholder&#146;s notice to the corporation of nominations for a regular or special meeting of stockholders must set forth (1)&nbsp;as to each person whom the stockholder proposes to nominate for election or re-election as a director:&#160; (a)&nbsp;such person&#146;s name, age, business address and residence address and principal occupation or employment, (b)&nbsp;all other information relating to such</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">B-</font>4<a name="16022-2-KI_PB_4_075439_7608"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=4,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=713150,FOLIO='B-4',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KI_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 08:22 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">person that is required to be disclosed in solicitations of proxies for election of directors, or that is otherwise required, pursuant to Regulation&nbsp;14A under the Securities Exchange Act of 1934, and (c)&nbsp;such person&#146;s written consent to being named in the proxy statement as a nominee and to serving as a director if elected; and (2)&nbsp;as to the stockholder giving the notice:&#160; (a)&nbsp;the name and address, as they appear on the corporation&#146;s books, of such stockholder, (b)&nbsp;the class or series (if any) and number of shares of the corporation that are beneficially owned by such stockholder, and (c)&nbsp;a representation that the stockholder is a holder of record of shares of the corporation entitled to vote for the election of directors and intends to appear in person or by proxy at the meeting to nominate the person or persons specified in the notice.&#160; At the request of the Board of Directors, any person nominated by the Board of Directors for election as a director must furnish to the Secretary of the corporation the information required to be set forth in a stockholder&#146;s notice of nomination that pertains to a nominee.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(c)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Consequences of Failure to Give Timely Notice</u>.</b>&#160; Notwithstanding anything in these bylaws to the contrary, no person will be eligible for election as a director of the corporation unless nominated in accordance with the procedures set forth in this Section&nbsp;1.14.&#160; If a nomination was not made in accordance with the procedures prescribed in this Section&nbsp;1.14, the officer of the corporation chairing the meeting will determine and declare as such to the meeting and the defective nomination will be disregarded.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;II<br>  </font></u>Board of Directors</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;2.1.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Number; Qualification.&#160; </b>The Board of Directors will fix from time to time the number of Directors constituting the Board of Directors.&#160; Directors need not be stockholders.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;2.2.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Initial Directors; Resignation; Vacancies.</b>&#160; The Board of Directors will initially consist of the persons named as directors by the incorporator.&#160; Any director may resign at any time upon written notice to the corporation.&#160; Any newly created directorship or any vacancy occurring in the Board of Directors for any cause may be filled by a majority of the remaining members of the Board of Directors, even if such majority is less than a quorum, or by a plurality of the votes cast at a meeting of stockholders.&#160; Each director so elected will hold office until the expiration of the term of office of the director whom such person has replaced or until such person&#146;s successor is elected and qualified.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;2.3.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Regular Meetings.</b>&#160; Regular meetings of the Board of Directors may be held at such places within or without the State of Delaware and at such times as the Board of Directors may from time to time determine, and if so determined notices thereof need not be given.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;2.4.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Special Meetings.</b>&#160; Special meetings of the Board of Directors may be held at any time or place within or without the State of Delaware whenever called by the Chairman, the Chief Executive Officer, the President, any Vice President, the Secretary, or by any two members of the Board of Directors.&#160; Notice of a special meeting of the Board of Directors must be given by the person or persons calling the meeting at least 48 hours before the special meeting.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;2.5.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Telephonic Meetings Permitted. </b>&#160;Members of the Board of Directors, or any committee designated by the Board of Directors, may participate in a meeting thereof by means of conference telephone or similar communications equipment by means of which all persons participating in the meeting can hear each other, and participation in a meeting pursuant to this bylaw shall constitute presence in person at such meeting.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;2.6.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Quorum: Vote Required for Action.</b>&#160; At all meetings of the Board of Directors a majority of the whole Board of Directors will constitute a quorum for the transaction of business.&#160; Except in cases in which the certificate of incorporation or these bylaws otherwise provide, the vote of a majority of the directors present at a meeting at which a quorum is present will be the act of the Board of Directors.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;2.7.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Organization.</b>&#160; Meetings of the Board of Directors will be presided over by the Chairman of the Board, if any, or in such person&#146;s absence by the Vice Chairman of the Board, if any, or in such person&#146;s absence by the Chief Executive Officer, or in such person&#146;s absence by the President (if not the Chief Executive Officer), or in such person&#146;s absence by a chairman chosen at the meeting.&#160; The Secretary will act as secretary of the meeting, but in such person&#146;s absence the chairman of the meeting may appoint any person to act as secretary of the meeting.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">B-</font>5<a name="16022-2-KI_PB_5_075510_8146"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=5,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=733466,FOLIO='B-5',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KI_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 08:22 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;2.8.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Informal Action by Directors.</b>&#160; Unless otherwise restricted by the certificate of incorporation or these bylaws, any action required or permitted to be taken at any meeting of the Board of Directors, or of any committee thereof, may be taken without a meeting if all members of the Board of Directors or such committee, as the case may be, consent thereto in writing, and the writing or writings are filed with the minutes of proceedings of the Board of Directors or such committee.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;III<br>  </font></u>Committees</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.1.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Committees.</b>&#160; The Board of Directors may, by resolution passed by a majority of the whole Board of Directors, designate one or more committees, each committee to consist of one or more of the directors of the corporation.&#160; The Board of Directors may designate one or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of the committee.&#160; In the absence or disqualification of a member of the committee, the member or members thereof present at any meeting and not disqualified from voting, whether or not he, she, or they constitute a quorum, may unanimously appoint another member of the Board of Directors to act at the meeting in place of any such absent or disqualified members.&#160; Any such committee, to the extent permitted by law and to the extent provided in the resolution of the Board of Directors, will have and may exercise all the powers and authority of the Board of Directors in the management of the business and affairs of the corporation.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.2.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Committee Rules.</b>&#160; Unless the Board of Directors otherwise provides, each committee designated by the Board of Directors may make, alter and repeal rules&nbsp;for the conduct of its business.&#160; In the absence of such rules&nbsp;each committee will conduct its business in the same manner as the Board of Directors conducts its business pursuant to Article&nbsp;II of these bylaws.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;IV<br>  </font></u>Officers</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;4.1.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Executive Officers; Election; Qualifications; Term of Office; Resignation; Removal; Vacancies.</b>&#160; The Board of Directors will elect a Chief Executive Officer and Secretary, and it may, if it so determines, choose a Chairman of the Board and a Vice Chairman of the Board from among its members.&#160; The Board of Directors may also choose one or more Presidents, one or more Vice Presidents, one or more Assistant Secretaries, a Treasurer and one or more Assistant Treasurers.&#160; Each such officer will hold office until his or her successor is elected and qualified or until such person&#146;s earlier resignation or removal.&#160; Any officer may resign at any time upon written notice to the corporation.&#160; The Board of Directors may remove any officer with or without cause at any time, but such removal will be without prejudice to the contractual rights of such officer, if any, with the corporation.&#160; Any number of offices may be held by the same person.&#160; Any vacancy occurring in any office of the corporation by death, resignation, removal or otherwise may be filled for the unexpired portion of the term by the Board of Directors at any regular or special meeting.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;4.2.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Powers and Duties of Executive Officers. </b>&#160;The officers of the corporation will have such powers and duties in the management of the corporation as may be prescribed in a resolution by the Board of Directors and, to the extent not so provided, as generally pertain to their respective offices, subject to the control of the Board of Directors.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;V<br>  </font></u>Stock</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;5.1.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Certificates.</b>&#160; Every holder of stock will be entitled to have a certificate signed by or in the name of the corporation by the Chairman or Vice Chairman of the Board of Directors, if any, or the Chief Executive Officer, the President or a Vice President, and by the Treasurer or an Assistant Treasurer, or the Secretary or an Assistant Secretary, of the corporation certifying the number of shares owned by such person in the corporation.&#160; Any of or all the signatures on the certificate may be a facsimile.&#160; In case any officer, transfer agent or registrar who has signed or whose facsimile signature has been placed upon a certificate has ceased to be such officer, transfer agent, or registrar before such certificate is issued, it may be issued by the corporation with the same effect as if he or she was such officer, transfer agent, or registrar at the date of issue.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;5.2.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Lost, Stolen or Destroyed Stock Certificates; Issuance of New Certificates.</b>&#160; The corporation may issue a new stock certificate in the place of any certificate theretofore issued by it, alleged to have been lost, stolen or destroyed, and the corporation may require the owner of the lost, stolen or destroyed certificate,</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">B-</font>6<a name="16022-2-KI_PB_6_075552_7091"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=6,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=299045,FOLIO='B-6',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KI_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 08:22 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">or such person&#146;s legal representative, to give the corporation a bond sufficient to indemnify it against any claim that may be made against it on account of the alleged loss, theft or destruction of any such certificate or the issuance of such new certificate.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;VI<br>  </font></u>Indemnification</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;6.1.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Right to Indemnification.</b>&#160; The corporation will indemnify and hold harmless, to the fullest extent permitted by applicable law as it presently exists or may hereafter be amended, any person who was or is made or is threatened to be made a party or is otherwise involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative (a &#147;proceeding&#148;) by reason of the fact that he or she, or a person for whom such person is the legal representative, is or was a director or officer of the corporation or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust, enterprise or nonprofit entity, including service with respect to employee benefit plans, against all liability and loss suffered and expenses (including attorneys&#146; fees) reasonably incurred by such person.&#160; Unless otherwise provided in the certificate of incorporation, the corporation will indemnify a person in connection with a proceeding (or part thereof) initiated by such person only if the proceeding (or part thereof) was authorized by the Board of Directors of the corporation.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;6.2.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Prepayment of Expenses.</b>&#160; Unless otherwise provided in the certificate of incorporation, the corporation will pay the expenses of a director or officer (including attorneys&#146; fees) incurred in defending any proceeding in advance of its final disposition, but only if the director or officer promises to repay all amounts advanced if it is determined that the director or officer is not entitled to be indemnified under this Article&nbsp;VI or otherwise.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;6.3.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Claims.</b>&#160; If a claim for indemnification or payment of expenses under this Article&nbsp;VI is not paid within 60 days after a written claim therefor has been received by the corporation, the claimant may file suit to recover the unpaid amount of such claim and, if successful in whole or in part, will be entitled to be paid the expense of prosecuting such claim.&#160; In any such action the corporation has the burden of proving that the claimant was not entitled to the requested indemnification or payment of expenses under applicable law.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;6.4.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Nonexclusivity of Rights.</b>&#160; The rights conferred on any person by this Article&nbsp;VI are not exclusive of any other rights that such person may have or hereafter acquire under any statute, provision of the certificate of incorporation, these bylaws, agreement, vote of stockholders or disinterested directors or otherwise.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;6.5.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Other Indemnification.</b>&#160; The corporation&#146;s obligation, if any, to indemnify any person who was or is serving at its request as a director, officer, employee or agent of another entity will be reduced by any amount such person may collect as indemnification from such other entity.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;6.6.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Amendment or Repeal. </b>&#160;Any repeal or modification of the foregoing provisions of this Article&nbsp;VI will not adversely affect any right or protection hereunder of any person in respect of any act or omission occurring prior to the time of such repeal or modification.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;VII<br>  </font></u>Miscellaneous</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;7.1.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Fiscal Year.</b>&#160; The fiscal year of the corporation will be determined by resolution of the Board of Directors.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;7.2.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Seal.&#160; </b>The corporation has no seal.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;7.3.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Waiver of Notice of Meetings of Stockholders, Directors and Committees.</b>&#160; Any written waiver of notice, signed by the person entitled to notice, whether before or after the time stated therein, will be deemed equivalent to notice.&#160; Attendance of a person at a meeting will constitute a waiver of notice of such meeting, except when the person attends a meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened.&#160; Except as required by law or these bylaws, neither the business to be transacted at, nor the purpose of, any regular, annual, or special meeting of the stockholders, directors, or members of a committee of directors need be specified in any written waiver of notice.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">B-</font>7<a name="16022-2-KI_PB_7_075617_455"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=7,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=693233,FOLIO='B-7',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KI_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 08:22 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;7.4.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Interested Directors; Quorum.</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>No transaction between the corporation and one or more of its directors or officers, or between the corporation and any other organization in which one or more of its directors or officers are directors or officers, or have a financial interest, will be voidable solely for this reason, or solely because the director or officer is present at or participates in the meeting of the Board of Directors or committee thereof that authorizes the transaction, or solely because any such director&#146;s or officer&#146;s votes are counted for such purpose, if:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(1)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the material facts as to the director&#146;s or officer&#146;s relationship or interest and as to the transaction are disclosed or are known to the Board of Directors or the committee, and the Board of Directors or committee in good faith authorizes the transaction by the affirmative votes of a majority of the disinterested directors, even though the disinterested directors be less than a quorum; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(2)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the material facts as to the director&#146;s or officer&#146;s relationship or interest and as to the contract or transaction are disclosed or are known to the stockholders entitled to vote thereon, and the contract or transaction is specifically approved in good faith by vote of the stockholders; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(3)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the contract or transaction is fair as to the corporation as of the time it is authorized, approved or ratified by the Board of Directors, a committee thereof, or the stockholders.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(b)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Interested directors may be counted in determining the presence of a quorum at a meeting of the Board of Directors or of a committee that authorizes the contract or transaction.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;7.5.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Form&nbsp;of Records.</b>&#160; Any records maintained by the corporation in the regular course of its business, including its stock ledger, books of account and minute books, may be kept in electronic format, provided that the records so kept can be converted into clearly legible form within a reasonable time.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;7.6.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Amendment of Bylaws.&#160; </b>These bylaws may be altered or repealed, and new bylaws made, in the manner prescribed in the certificate of incorporation.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">B-</font>8<a name="16022-2-KI_PB_8_075645_4141"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=8,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=923383,FOLIO='B-8',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KI_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 08:22 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>a2227029zex-10_1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 10.1</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2003 STOCK OPTION PLAN<br> (AS AMENDED AND RESTATED AUGUST 23, 2006)</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>PURPOSE</b>.&#160; The purpose of this 2003 Stock Option Plan (the &#147;<b>Plan</b>&#148;) is to promote the interests of Tactile Systems Technology,&nbsp;Inc., a Minnesota corporation (the &#147;<b>Company</b>&#148;), and its shareholders by providing employees of the Company and any parent or subsidiaries thereof, and any other individuals and entities who provide services to the Company or any parent or subsidiaries in the capacity of non-employee directors or advisors or consultants, with an opportunity to acquire a proprietary interest in the Company and thereby develop a stronger incentive to put forth maximum effort for the continued success and growth of the Company.&#160; In addition, the opportunity to acquire a proprietary interest in the Company will aid in attracting and retaining personnel of outstanding ability.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>ADMINISTRATION</b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>GENERAL</u><i>.&#160; </i>This Plan will be administered by a committee of two or more directors of the Company (the &#147;<b>Committee</b>&#148;) appointed by the Company&#146;s Board of Directors (the &#147;<b>Board</b>&#148;).&#160; If the Board has not appointed a committee to administer this Plan, then the Board will constitute the Committee.&#160; The Committee will have the power, subject to the limitations contained in this Plan, to fix any terms and conditions for the grant or exercise of any award under this Plan.&#160; A majority of the members of the Committee will constitute a quorum for any meeting of the Committee, and the acts of a majority of the members present at any meeting at which a quorum is present or the acts unanimously approved in writing by all members of the Committee will be the acts of the Committee.&#160; Subject to the provisions of this Plan, the Committee may from time to time adopt such rules&nbsp;for the administration of this Plan as it deems appropriate.&#160; The decision of the Committee on any matter affecting this Plan, or the rights and obligations arising under this Plan or any award granted hereunder, will be final, conclusive and binding upon all persons, including without limitation the Company, shareholders and optionees.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>INDEMNIFICATION</u><i>.</i> To the full extent permitted by law, (i)&nbsp;no member of the Committee or person to whom authority under this Plan is delegated will be liable for any action, omission or determination taken or made in good faith with respect to this Plan or any award granted hereunder (including, if an option that was intended to qualify as an incentive stock option in fact does not meet the requirements of the Code to so qualify) and (ii)&nbsp;the members of the Committee and each person to whom authority under this Plan is delegated will be entitled to defense and indemnification by the Company against and from any claim or loss incurred by such member or person by reason of any such actions and determinations.&#160; The Company will advance the costs of defense subject to any agreements the Company believes are appropriate for repayment in the event the member or other person is found not to have acted in good faith.&#160; This subparagraph (b)&nbsp;will survive any termination of this Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>DELEGATION OF AUTHORITY</u>.&#160; To the extent permitted by law, the Committee may delegate all or any part of its authority under this Plan to the Chief Executive Officer of the Company for purposes of granting and administering awards.&#160; To the extent permitted by law, the Chief Executive Officer of the Company may, in turn, delegate all or a portion of the delegated authority to such other officer or officers of the Company as the Chief Executive Officer may determine.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>COMMITTEE COMPOSITION AND DELEGATION WHEN COMPANY IS PUBLIC</u>.&#160; From and after the time, if any, that the Company has a class of securities registered under Section&nbsp;12 of the Securities Exchange Act of 1934, as amended (the &#147;<b>Exchange Act</b>&#148;), any options granted to persons subject to Section&nbsp;16 of the Exchange Act will be granted by the Board or a committee consisting of at least two or more Non-Employee Directors, in accordance with Rule&nbsp;16b-3 under the Exchange Act, and any options intended to qualify as performance-based compensation within the meaning of Section&nbsp;162(m)&nbsp;will be granted by a committee consisting of two or more Outside Directors, as defined in and in accordance with Section&nbsp;162(m)&nbsp;of the Internal Revenue Code of 1986, as amended (the &#147;<b>Code</b>&#148;).&#160; From</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">1<a name="16022-2-LA-01_PB_1_074531_4999"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=296635,FOLIO='1',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LA-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan 25 21:16 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">and after the time, if any, that the Company has a class of securities registered under Section&nbsp;12 of the Exchange Act, any authority delegated to the Chief Executive Officer or another officer of the Company pursuant to subparagraph 2(c)&nbsp;above will not extend to granting and administering awards to persons who are then subject to the reporting requirements of Section&nbsp;16 of the Exchange Act (&#147;<b>Section&nbsp;16 Individuals</b>&#148;).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>ACTION BY BOARD REQUIRED FOR NON-EMPLOYEE DIRECTOR AWARDS</u>.&#160; Notwithstanding subparagraphs&nbsp;2(a)&nbsp;and 2(c)&nbsp;above, any grant of awards hereunder to any director of the Company who is not an employee of the Company or any parent or subsidiary thereof at the time of grant (&#147;<b>Non-Employee Director Award</b>&#148;), and any action taken by the Company with respect to any Non-Employee Director Award, including any amendment thereto, and any acceleration of the vesting of any option constituting a Non-Employee Director Award, any extension of the time within which any option constituting a Non-Employee Director Award may be exercised, any determination pursuant to paragraph&nbsp;8 relating to the payment of the purchase price of Shares (as defined in paragraph&nbsp;3 below) subject to an option constituting a Non-Employee Director Award, or any action pursuant to paragraph&nbsp;9 relating to the payment of withholding taxes, if any, through the use of Shares with respect to a Non-Employee Director Award will be subject to prior approval by the Board, in which case no further action by the Committee will be required.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>SHARES</b>.&#160; The shares that may be made subject to awards granted under this Plan will be authorized and unissued shares of Common Stock of the Company (&#147;<b>Shares</b>,&#148; and each individually a &#147;<b>Share</b>&#148;), and they will not exceed 1,800,000 Shares in the aggregate, subject to adjustment as provided in paragraph&nbsp;13 below, except that, if any option lapses or terminates for any reason before such option has been completely exercised, the Shares covered by the unexercised portion of such option may again be made subject to options granted under this Plan.&#160; An option may not be exercisable for a fraction of a Share.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>ELIGIBLE PARTICIPANTS</b>.&#160; Options may be granted under this Plan to any employee of the Company, or any parent or subsidiary thereof, including any such person who is also an officer or director of the Company or any parent or subsidiary thereof.&#160; Non-statutory stock options (as defined in subparagraph&nbsp;5(a)&nbsp;below) also may be granted to (i)&nbsp;any director of the Company or any parent or subsidiary thereof, (ii)&nbsp;other individuals or entities who are not employees but who provide services to the Company or a parent or subsidiary thereof in the capacity of an advisor, consultant or vendor, and (iii)&nbsp;any individual or entity that the Company desires to induce to become an employee, advisor, consultant or vendor, but any such grant will be contingent upon such individual or entity becoming employed by the Company or a parent or subsidiary thereof.&#160; In the event that a parent or subsidiary of the Company is spun off, divested or otherwise ceases to be a parent or subsidiary of the Company, the employment of all optionees who are employees, advisors, consultants, vendors or directors of such parent or subsidiary will be deemed terminated.&#160; References herein to &#147;employment&#148; and similar terms (except &#147;employee&#148;) will include the providing of services in the capacity of an advisor, consultant, vendor or as a director.&#160; The employees and other individuals and entities to whom options may be granted pursuant to this paragraph&nbsp;4 are referred to herein as &#147;<b>Eligible Participants</b>.&#148;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>TERMS AND CONDITIONS OF OPTIONS</b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>GENERAL</u><i>.&#160; </i>Subject to the terms and conditions of this Plan, the Committee may, from time to time during the term of this Plan, grant to such Eligible Participants as the Committee may determine options to purchase such number of Shares of the Company on such terms and conditions as the Committee may determine.&#160; In determining the Eligible Participants to whom options may be granted and the number of Shares to be covered by each option, the Committee may take into account the nature of the services rendered by the respective Eligible Participants, their present and potential contributions to the success of the Company, and such other factors as the Committee in its sole discretion may deem relevant.&#160; The date and time of approval by the Committee of the granting of an option will be considered</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-LA-01_PB_2_074842_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=677810,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LA-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan 25 21:16 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">the date and the time of the grant of such option.&#160; The Committee in its sole discretion may designate whether an option granted to an employee is to be considered an &#147;incentive stock option&#148; (as that term is defined in Section&nbsp;422 of the Code) or a &#147;non-statutory stock option&#148; (an option granted under this Plan that is not intended to be an incentive stock option).&#160; The Committee may grant both incentive stock options and non-statutory stock options to the same employee.&#160; However, if an incentive stock option and a non-statutory stock option are awarded simultaneously, such options will be deemed to have been awarded in separate grants, will be clearly identified, and in no event will the exercise of one such option affect the right to exercise the other.&#160; If the aggregate Fair Market Value (as defined in paragraph&nbsp;7 below) of Shares with respect to which incentive stock options are exercisable for the first time by any employee during any calendar year (under all incentive stock option plans of the Company and its parent and subsidiary corporations) exceeds $100,000, such options to the extent of such excess will be treated as non-statutory stock options.&#160; Notwithstanding the foregoing, no options granted under this Plan may qualify as incentive stock options unless this Plan is approved by the shareholders of the Company within twelve months after the effective date of this Plan.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>PURCHASE PRICE</u><i>.&#160; </i>The purchase price of each Share subject to an option granted pursuant to this paragraph&nbsp;5 will be fixed by the Committee, subject, however, to the remainder of this subparagraph&nbsp;5(b).&#160; For non-statutory stock options, such purchase price may be set at any price the Committee may determine; provided, however, that such purchase price may be not less than 85% of the Fair Market Value of a Share on the date of grant.&#160; For incentive stock options, such purchase price may be no less than 100% of the Fair Market Value of a Share on the date of grant, provided that if such incentive stock option is granted to an employee who owns, or is deemed under Section&nbsp;424(d)&nbsp;of the Code to own, at the time such option is granted, stock of the Company (or of any parent or subsidiary of the Company) possessing more than 10% of the total combined voting power of all classes of stock therein (a &#147;<b>10% Shareholder</b>&#148;), such purchase price may be not less than 110% of the Fair Market Value of a Share on the date of grant.&#160; The Committee may, in its sole discretion, reduce the purchase price of any option, subject to the consent of the optionee if such repricing would result in an incentive stock option no longer qualifying as an incentive stock option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>VESTING</u><i>.&#160; </i>Each option agreement provided for in paragraph&nbsp;6 will specify when each option granted under this Plan may become exercisable with respect to the Shares covered by the option.&#160; Notwithstanding the provisions of any option agreement provided for in paragraph&nbsp;6, the Committee may, in its sole discretion, at any time accelerate the vesting of all or any portion of any option granted under this Plan and declare at any time that all or any portion of any option granted under this Plan will be immediately exercisable.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>TERMINATION</u>.&#160; Except as provided otherwise in the option agreement, as amended from time to time, each option granted pursuant to this paragraph&nbsp;5 will expire, and all rights to purchase Shares thereunder will terminate, on the earliest of:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>ten years after the date such option is granted (or in the case of an incentive stock option granted to a 10% Shareholder, five years after the date such option is granted) or on such date prior thereto as may be fixed by the Committee on or before the date such option is granted or thereafter agreed upon with the optionee;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the expiration of the period after the termination of the optionee&#146;s employment within which the option is exercisable as specified in paragraph&nbsp;10(b)&nbsp;or 10(c), whichever is applicable (provided that the Committee may, in any option agreement provided for in paragraph&nbsp;6 or by Committee action with respect to any outstanding option, extend the periods specified in paragraph&nbsp;10(b)&nbsp;or 10(c));</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>at the election of the Company, upon termination of an optionee&#146;s employment by the Company or a parent or subsidiary thereof for Cause (as hereinafter defined), or if it is determined by the Company within ten days after termination of the</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="16022-2-LA-01_PB_3_075014_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=3,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=266556,FOLIO='3',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LA-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan 25 21:16 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">optionee&#146;s employment by the optionee, such as the optionee&#146;s resignation, that Cause existed for termination by the Company;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the date, if any, fixed for cancellation pursuant to paragraph&nbsp;11(c)&nbsp;or 12 below.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>RESCISSION</u>.&#160; If any option is exercised, and prior to the delivery of the certificate representing the Shares so purchased, it is determined that Cause for termination by the Company existed, then the Company may rescind the option exercise by the optionee and the option will terminate at the election of the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>OPTION AGREEMENTS</b>.&#160; All options granted under this Plan will be evidenced by a written agreement in such form or forms as the Committee may from time to time determine, which agreement will, among other things, designate whether the options being granted thereunder are non-statutory stock options or incentive stock options.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>FAIR MARKET VALUE</b><i>.&#160; </i>For purposes of this Plan, the &#147;<b>Fair Market Value</b>&#148; of a Share at a specified date will, unless otherwise expressly provided in this Plan, mean the closing or last sale price of a Share on the date immediately preceding such date or, if no sale of Shares will have occurred on that date, on the next preceding day on which a sale of Shares occurred, on the Composite Tape for listed shares on the New York Stock Exchange, American Stock Exchange or other recognized national securities exchange or, if Shares are not quoted on the Composite Tape for listed shares on the New York Stock Exchange, American Stock Exchange or other recognized national securities exchange, on the Nasdaq National Market or any similar system then in use or, if Shares are not included in the Nasdaq National Market or any similar system then in use, on the Nasdaq SmallCap Market or any similar system then in use, provided that if the Shares in question are not quoted on any such system, Fair Market Value will be what the Committee determines in good faith to be 100% of the fair market value of a Share as of the date in question.&#160; Notwithstanding anything stated in this paragraph&nbsp;7, if the applicable securities exchange or system has closed for the day by the time the determination is being made, all references in this paragraph to the date immediately preceding the date in question will be deemed to be references to the date in question.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>MANNER OF EXERCISE OF OPTIONS</b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>GENERAL</u>.&#160; A person entitled to exercise an option granted under this Plan may, subject to its terms and conditions and the terms and conditions of this Plan, exercise it in whole at any time, or in part from time to time, by delivery to the Company at its principal executive office, to the attention of its Secretary, of written notice of exercise, specifying the number of Shares with respect to which the option is being exercised and payment of the purchase price of the Shares.&#160; The granting of an option to a person will give such person no rights as a shareholder except as to Shares issued to such person.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>PAYMENT</u>.&#160; The consideration to be paid for the Shares, including the method(s)&nbsp;of payment, will be determined by the Committee (and, in the case of an incentive stock option, will be determined at the time of grant) and may consist entirely of (i)&nbsp;cash (including check, bank draft or money order); (ii)&nbsp;delivery of optionee&#146;s promissory note with such recourse, interest, security and redemption provisions as the Committee determines to be appropriate and as required pursuant to the law of the Company&#146;s state of incorporation; (iii)&nbsp;cancellation of indebtedness; (iv)&nbsp;delivery to the Company of unencumbered Shares having an aggregate Fair Market Value on the date of exercise equal to the exercise price for the total number of Shares as to which the option is exercised; (v)&nbsp;authorization of the Company to retain from the total number of Shares as to which the option is exercised that number of Shares having a Fair Market Value on the date of exercise equal to the exercise price for the total number of shares as to which the option is exercised; (vi)&nbsp;such other consideration and method of payment for the issuance of Shares to the extent permitted under applicable law; or (vii)&nbsp;any combination of the methods</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">4<a name="16022-2-LA-01_PB_4_075151_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=4,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=873120,FOLIO='4',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LA-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan 25 21:16 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">of payments described above.&#160; Notwithstanding the foregoing, no person will be permitted to pay any portion of the purchase price with Shares, or by authorizing the Company to retain Shares upon exercise of the option, if the Committee, in its sole discretion, determines that payment in such manner is undesirable nor may the Company permit an optionee who is an executive officer or director of the Company to pay for the Shares by delivery of a promissory note from and after such time, if any, that the Company (i)&nbsp;has a class of securities registered under Section&nbsp;12 of the Exchange Act, (ii)&nbsp;is required to file reports under Section&nbsp;15(d)&nbsp;of the Exchange Act or (iii)&nbsp;that has filed a registration statement that has not yet become effective under the Securities Act, as defined below.&#160; Except for delivery of a promissory note by an optionee as provided above, the purchase price of the Shares with respect to which an option is being exercised will be payable in full at the time of exercise, provided that, to the extent permitted by law, the holder of an option may simultaneously exercise an option and sell all or a portion of the Shares thereby acquired pursuant to a brokerage or similar relationship and use the proceeds from such sale to pay the purchase price of such Shares.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>TAX WITHHOLDING</b>.&#160; Delivery of Shares upon exercise of any non-statutory stock option granted under this Plan will be subject to any required withholding taxes.&#160; A person exercising a non-statutory stock option may, as a condition precedent to receiving the Shares, be required to pay the Company a cash amount equal to the amount of any required withholdings.&#160; In lieu of all or any part of such a cash payment, the Committee may, but will not be required to, provide in any option agreement provided for in paragraph&nbsp;6 (or provide by Committee action with respect to any outstanding option) that a person exercising an option may cover all or any part of the required withholdings, and any additional withholdings up to the amount needed to cover the individual&#146;s full FICA and federal, state and local income tax liability with respect to income arising from the exercise of the option, through the delivery to the Company of unencumbered Shares, through a reduction in the number of Shares delivered to the person exercising the option or through a subsequent return to the Company of Shares delivered to the person exercising the option (in each case, such Shares having an aggregate Fair Market Value on the date of exercise equal to the amount of the withholding taxes being paid through such delivery, reduction or subsequent return of Shares).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>TRANSFERABILITY AND TERMINATION OF EMPLOYMENT<i>.</i></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>TRANSFERABILITY</u>.&#160; During the lifetime of an optionee, only such optionee or his or her guardian or legal representative may exercise options granted under this Plan, and no option granted under this Plan will be assignable or transferable by the optionee otherwise than by will or the laws of descent and distribution or, with respect only to non-statutory stock options, pursuant to a domestic relations order as defined by the Code or Title&nbsp;I of the Employee Retirement Income Security Act, or the rules&nbsp;thereunder; provided, however, that any optionee may transfer a non-statutory stock option granted under this Plan to a member or members of his or her immediate family (i.e., his or her children, grandchildren and spouse) or to one or more trusts for the benefit of such family members or partnerships, limited liability companies or other entities in which such family members are the only beneficial owners, if (i)&nbsp;the option agreement with respect to such options expressly so provides either at the time of initial grant or by amendment to an outstanding option agreement, (ii)&nbsp;the optionee does not receive any consideration for the transfer and (iii)&nbsp;the transfer would not have an adverse effect on the Company, such as any loss of Subchapter S tax status, if applicable.&#160; Any option held by any such transferee will continue to be subject to the same terms and conditions that were applicable to such option immediately prior to its transfer and may be exercised by such transferee as and to the extent that such option has become exercisable and has not terminated in accordance with the provisions of this Plan and the applicable option agreement.&#160; For purposes of any provision of this Plan relating to notice to an optionee or to vesting or termination of an option upon the death, disability or termination of employment of an optionee, the references to &#147;optionee&#148; will mean the original grantee of an option and not any transferee.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">5<a name="16022-2-LA-01_PB_5_075259_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=5,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=644750,FOLIO='5',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LA-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan 25 21:16 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>TERMINATION OF EMPLOYMENT DURING LIFETIME</u><i>.</i>&#160; During the lifetime of an optionee who is an employee of the Company or any parent or subsidiary thereof at the time of grant of an option, an option granted to such optionee may be exercised only while the optionee is employed by the Company or by a parent or subsidiary thereof, and only if such optionee has been continuously so employed since the date the option was granted, except that, unless terminated sooner due to another provision of the Plan or the option agreement:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>an option will continue to be exercisable for three months after termination of the optionee&#146;s employment but only to the extent that the option was exercisable immediately prior to such optionee&#146;s termination of employment; provided, however, that if termination of the optionee&#146;s employment will have been for Cause (as hereinafter defined), any option held by such optionee will expire, and all rights to purchase Shares thereunder will terminate, immediately upon such termination; for purposes of this paragraph&nbsp;10(b)(i), and paragraphs 5(d)&nbsp;and (e)&nbsp;of this Plan, &#147;<b>Cause</b>&#148; will be deemed to exist upon (A)&nbsp;a material breach by the optionee of the terms of any non-competition/non-solicitation /invention assignment or other agreement between the Company and the optionee governing the employment or other business relationship between the Company and the optionee, (B)&nbsp;gross negligence or willful misconduct by the optionee, (C)&nbsp;conviction of the optionee of, or the entry of a pleading of guilty or nolo contendere by the optionee to, any crime involving moral turpitude or any felony, (D)&nbsp;willful violation of specific and lawful instructions from the Board or the Company&#146;s Chief Executive Officer that are reasonably related to the optionee&#146;s employment by the Company, (E)&nbsp;fraud, embezzlement, theft or proven dishonesty against the Company, and (F)&nbsp;prolonged or frequent unexcused absences from work other than due to a disability;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>in the case of an optionee who is disabled (as hereinafter defined) while employed, an option will continue to be exercisable for one year after termination of such optionee&#146;s employment as a result of such disability; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>as to any optionee whose termination occurs following a declaration pursuant to paragraph&nbsp;12 below, an option may be exercised at any time permitted by such declaration.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>TERMINATION UPON DEATH</u><i>.</i>&#160; With respect to an optionee whose employment terminates by reason of death, any option granted to such optionee may be exercised within one year after the death of such optionee.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>VESTING UPON DISABILITY OR DEATH</u>.&#160; In the event of the disability (as hereinafter defined) or death of an optionee, any option granted to such optionee that was not previously exercisable will become immediately exercisable in full if (i)&nbsp;the disabled or deceased optionee will have been continuously employed by the Company or a parent or subsidiary thereof between the date such option was granted and the date of such disability or death and (ii)&nbsp;the option agreement with respect to such option expressly so provides either at the time of initial grant or by amendment to an outstanding option agreement.&#160; &#147;<b>Disability</b>&#148; of an optionee will mean any physical or mental incapacitation whereby such optionee is therefore unable for a period of twelve consecutive months or for an aggregate of twelve months in any twenty-four consecutive month period to perform his or her duties for the Company or any parent or subsidiary thereof.&#160; &#147;<b>Disabled</b>,&#148; with respect to any optionee, will mean that such optionee has incurred a Disability.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>TRANSFERS AND LEAVES OF ABSENCE</u>.&#160; Neither the transfer of employment of a person to whom an option is granted between any combination of the Company, a parent corporation or a subsidiary thereof, nor a leave of absence granted to such person and approved by the Committee, will be deemed a termination of employment for purposes of this Plan.&#160; The terms &#147;parent&#148; or &#147;parent corporation&#148; and &#147;subsidiary&#148; as used in this Plan will have the meaning ascribed to &#147;parent corporation&#148;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">6<a name="16022-2-LA-01_PB_6_075412_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=6,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=133243,FOLIO='6',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LA-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan 25 21:16 2016' -->

<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">and &#147;subsidiary corporation&#148;, respectively, in Sections&nbsp;424(e)&nbsp;and (f)&nbsp;of the Code.&#160; For purposes of this Plan, a change in status between different classes of eligible participants, such as a change in status from an employee to a consultant or from a consultant to an employee, will not be deemed a termination of employment for purposes of this Plan.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>RIGHT TO TERMINATE EMPLOYMENT</u><i>.</i>&#160; Nothing contained in this Plan, or in any option granted pursuant to this Plan, will confer upon any optionee any right to continued employment by the Company or any parent or subsidiary of the Company or limit in any way the right of the Company or any such parent or subsidiary to terminate such optionee&#146;s employment at any time.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>EXPIRATION DATE</u><i>.</i>&#160; In no event will any option be exercisable at any time after the time it will have expired in accordance with paragraph&nbsp;5(d)&nbsp;of this Plan.&#160; When an option is no longer exercisable, it will be deemed to have lapsed or terminated and will no longer be outstanding.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>CHANGE IN CONTROL</b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>DEFINITION.&#160; For purposes of this Plan, a &#147;<b>Change in Control</b>&#148; of the Company will be deemed to occur if any of the following occur:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any &#147;person&#148; (as such term is used in Sections&nbsp;13(d)&nbsp;and 14(d)&nbsp;of the Exchange Act) after the effective date of this Plan first acquires or becomes a &#147;beneficial owner&#148; (as defined in Rule&nbsp;13d-3 or any successor rule&nbsp;under the Exchange Act), directly or indirectly, of securities of the Company representing 30% or more of the combined voting power of the Company&#146;s then outstanding securities entitled to vote generally in the election of directors (&#147;<b>Voting Securities</b>&#148;), provided, however, that the following will not constitute a Change in Control pursuant to this paragraph&nbsp;(a)(1):</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(A)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any acquisition of Shares or Voting Securities of the Company directly from the Company;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(B)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any acquisition or beneficial ownership by the Company or a subsidiary;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(C)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any acquisition or beneficial ownership by any employee benefit plan (or related trust) sponsored or maintained by the Company or one or more of its subsidiaries;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(D)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any acquisition or beneficial ownership by any corporation with respect to which, immediately following such acquisition, more than 70% of both the combined voting power of the Company&#146;s then outstanding Voting Securities and the Shares of the Company is then beneficially owned by all or substantially all of the persons who beneficially owned Voting Securities and Shares of the Company immediately prior to such acquisition in substantially the same proportions as their ownership of such Voting Securities and Shares, as the case may be, immediately prior to such acquisition;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>A majority of the members of the Board of Directors of the Company will not be Continuing Directors.&#160; &#147;<b>Continuing Directors</b>&#148; will mean:&#160; (A)&nbsp;individuals who, on the date hereof, are directors of the Company, (B)&nbsp;individuals elected as directors of the Company subsequent to the date hereof for whose election proxies will have been solicited by the Board of Directors of the Company, (C)&nbsp;individuals elected as directors of the Company subsequent to the date hereof pursuant to a nomination or board representation right of preferred shareholders of the Company or (D)&nbsp;any individual elected or appointed by the Board of Directors of the Company to fill vacancies on the Board of Directors of the Company caused by death or resignation (but not by removal) or to fill newly-created directorships;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">7<a name="16022-2-LA-03_PB_7_080128_3404"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=7,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=92129,FOLIO='7',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LA-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 08:06 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Approval by the shareholders of the Company of a reorganization, merger or consolidation of the Company or a statutory exchange of outstanding Voting Securities of the Company, unless, immediately following such reorganization, merger, consolidation or exchange, all or substantially all of the persons who were the beneficial owners, respectively, of Voting Securities and Shares of the Company immediately prior to such reorganization, merger, consolidation or exchange beneficially own, directly or indirectly, more than 70% of, respectively, the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors and the then outstanding shares of common stock, as the case may be, of the corporation that is the issuer of such securities held by the shareholders of the Company after such reorganization, merger, consolidation or exchange in substantially the same proportions as their ownership, immediately prior to such reorganization, merger, consolidation or exchange, of the Voting Securities and Shares of the Company, as the case may be; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Approval by the shareholders of the Company of (x)&nbsp;a complete liquidation or dissolution of the Company or (y)&nbsp;the sale or other disposition of all or substantially all of the assets of the Company (in one or a series of transactions), other than to a corporation with respect to which, immediately following such sale or other disposition, more than 70% of, respectively, the combined voting power of the then outstanding voting securities of such corporation entitled to vote generally in the election of directors and the then outstanding shares of common stock of such corporation is then beneficially owned, directly or indirectly, by all or substantially all of the persons who were the beneficial owners, respectively, of the Voting Securities and Shares of the Company immediately prior to such sale or other disposition in substantially the same proportions as their ownership, immediately prior to such sale or other disposition, of the Voting Securities and Shares of the Company, as the case may be.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>ACCELERATION OF VESTING</u>.&#160; If and to the extent so provided in an option agreement provided for in paragraph&nbsp;6 or by Committee action with respect to any outstanding option, and notwithstanding anything in subparagraph&nbsp;5(c)&nbsp;above to the contrary, if a Change in Control of the Company may occur, then such option, if not already exercised in full or otherwise terminated, expired or cancelled, will become immediately exercisable as provided in the option agreement or Committee action and will remain exercisable during the remaining term thereof or as may be provided in the option agreement or, subject to consent of the optionee, by Committee action.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>CASH PAYMENT</u>.&#160; If a Change in Control of the Company will or is to occur, then, so long as a majority of the members of the Board are Continuing Directors, the Committee, in its sole discretion, and without the consent of the holder of any option affected thereby, may determine that some or all outstanding options will be cancelled as of the effective date of any such Change in Control.&#160; The Committee may further determine that the holder or holders of such cancelled options will receive, with respect to some or all of the Shares subject to such options, as of the date of such cancellation, cash in an amount, for each Share subject to an option, equal to the excess of the per Share Fair Market Value of such Shares immediately prior to such Change in Control of the Company over the exercise price per Share of such options.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>LIMITATION ON CHANGE IN CONTROL PAYMENTS</u><i>.</i>&#160; Notwithstanding anything in subparagraph&nbsp;11(b)&nbsp;or 11(c)&nbsp;above or paragraph&nbsp;12 below to the contrary, if, with respect to an optionee, the acceleration of the exercisability of an option or the payment of cash in exchange for all or part of an option as provided in subparagraph&nbsp;11(b)&nbsp;or 11(c)&nbsp;above or paragraph&nbsp;12 below (which acceleration or payment could be deemed a &#147;payment&#148; within the meaning of Section&nbsp;280G(b)(2)&nbsp;of the Code), together with any other payments which such optionee has the right to receive from the Company or any corporation which is a member of an &#147;affiliated group&#148; (as defined in Section&nbsp;1504(a)&nbsp;of the Code</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">8<a name="16022-2-LA-03_PB_8_080230_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=8,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=264780,FOLIO='8',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LA-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 08:06 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">without regard to Section&nbsp;1504(b)&nbsp;of the Code) of which the Company is a member, would constitute a &#147;parachute payment&#148; (as defined in Section&nbsp;280G(b)(2)&nbsp;of the Code), then, unless otherwise provided in the applicable option agreement, such acceleration of exercisability and payments pursuant to subparagraph&nbsp;11(b)&nbsp;or 11(c)&nbsp;above or paragraph&nbsp;12 below will be reduced to the largest amount as, in the sole judgment of the Committee, will result in no portion of such payments being subject to the excise tax imposed by Section&nbsp;4999 of the Code.&#160; The Committee, with the consent of the optionee, may waive the provisions of this subparagraph 11(d).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>DISSOLUTION, LIQUIDATION, MERGER</b>.&#160; In the event of (a)&nbsp;the proposed dissolution or liquidation of the Company, (b)&nbsp;a proposed sale of substantially all of the assets of the Company or (c)&nbsp;a proposed merger or consolidation of the Company with or into any other entity, regardless of whether the Company is the surviving corporation, or a proposed statutory share exchange with any other entity (the actual effective date of the dissolution, liquidation, sale, merger, consolidation or exchange being herein called an &#147;<b>Event</b>&#148;), the Committee may, but will not be obligated to, either (i)&nbsp;if the Event is a merger, consolidation or statutory share exchange, make appropriate provision for the protection of outstanding options granted under this Plan by the substitution, in lieu of such options, of options to purchase appropriate voting common stock (the &#147;<b>Survivor&#146;s Stock</b>&#148;) of the corporation surviving any such merger, consolidation or statutory share exchange or, if appropriate, the parent corporation of the Company or such surviving corporation, or, alternatively, by the delivery of a number of shares of the Survivor&#146;s Stock which has a Fair Market Value as of the effective date of such merger, consolidation or statutory share exchange equal to the product of (x)&nbsp;the excess of (A)&nbsp;the Event Proceeds per Share (as hereinafter defined) covered by the option as of such effective date over (B)&nbsp;the exercise price per Share of the Shares subject to such option, times (y)&nbsp;the number of Shares covered by such option, or (ii)&nbsp;declare, at least ten days prior to the Event, and provide written notice to each optionee of the declaration, that each outstanding option, whether or not then exercisable, will be cancelled at the time of, or immediately prior to the occurrence of, the Event (unless it will have been exercised prior to the occurrence of the Event).&#160; In connection with any declaration pursuant to clause&nbsp;(ii)&nbsp;of the preceding sentence, the Committee may, but will not be obligated to, cause payment to be made, within twenty days after the Event, for each cancelled option to each holder of an option that is cancelled, of cash equal to the amount (if any), for each Share covered by the cancelled option, by which the Event Proceeds per Share (as hereinafter defined) exceeds the exercise price per Share covered by such option.&#160; At the time of any declaration pursuant to clause&nbsp;(ii)&nbsp;of the first sentence of this paragraph&nbsp;12, each option that has not previously expired pursuant to subparagraph&nbsp;5(d)(i), 5(d)(ii)&nbsp;or 5(d)(iii)&nbsp;of this Plan or been cancelled pursuant to paragraph&nbsp;11(c)&nbsp;of this Plan will immediately become exercisable to the extent provided by the option agreement or declaration by the Committee and each holder of such an option will have the right, during the period preceding the time of cancellation of the option, to exercise his or her option as to all or any part of the Shares as to which the option is exercisable.&#160; In the event of a declaration pursuant to clause&nbsp;(ii)&nbsp;of the first sentence of this paragraph&nbsp;12, each outstanding option granted pursuant to this Plan that may not have been exercised prior to the Event will be cancelled at the time of, or immediately prior to, the Event, as provided in the declaration, subject to the payment obligations of the Company provided in this paragraph&nbsp;12.&#160; Notwithstanding the foregoing, no person holding an option will be entitled to the payment provided in this paragraph&nbsp;12 if such option will have expired pursuant to subparagraph&nbsp;5(d)(i), 5(d)(ii)&nbsp;or 5(d)(iii)&nbsp;of this Plan or been cancelled pursuant to paragraph&nbsp;11(c)&nbsp;of this Plan.&#160; In addition, in the event of the proposed dissolution or liquidation of the Company, the Committee may provide that any Company repurchase option applicable to the Shares will lapse as to all such Shares, provided that the proposed dissolution or liquidation takes place at the time and in the manner provided.&#160; For purposes of this paragraph&nbsp;12, &#147;<b>Event Proceeds per Share</b>&#148; will mean the cash plus the fair market value, as determined in good faith by the Committee, of the non-cash consideration to be received per Share by the shareholders of the Company upon the occurrence of the Event.&#160; If the Event provides for an earn-out or similar provision, the Committee may, in its sole discretion, elect to estimate the present fair market value of the earn-out or similar right and pay such amount in cash to the optionee.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">9<a name="16022-2-LA-03_PB_9_080259_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=9,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=579377,FOLIO='9',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LA-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 08:06 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>ADJUSTMENTS</b>.&#160; In the event of any reorganization, merger, consolidation, recapitalization, liquidation, reclassification, stock dividend, stock split, combination of shares, rights offering, or extraordinary dividend or divestiture (including a spin-off), or any other change in the corporate structure or Shares of the Company, the Committee (or if the Company does not survive any such transaction, a comparable committee of the Board of Directors of the surviving corporation) may, without the consent of any holder of an option, make such adjustment as it determines in its discretion to be appropriate as to the number and kind of securities subject to and reserved under this Plan and, in order to prevent dilution or enlargement of rights of participants in this Plan, the number and kind of securities issuable upon exercise of outstanding options and the exercise price thereof.&#160; In the absence of action of the Committee to the contrary, the number of Shares issuable under this Plan, and the number of Shares and the purchase price of each Share subject to an outstanding option, will be automatically adjusted to reflect any forward or reverse stock split of the Common Stock or dividend on Common Stock payable in Common Stock.&#160; The Committee can determine in its absolute discretion whether an option entitles any optionee to receive a right to purchase securities of any entity spun off from the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>SUBSTITUTE OPTIONS</b>.&#160; Options may be granted under this Plan from time to time in substitution for, or assumption of, stock options or comparable rights held by employees of other entities who are about to become employees of the Company, or any parent or subsidiary thereof, or whose employer is about to become a subsidiary of the Company, as the result of a merger or consolidation of the Company or a subsidiary of the Company with another entity, the acquisition by the Company or a subsidiary of the Company of all or substantially all the assets of another entity or the acquisition by the Company or a subsidiary of the Company of at least 50% of the issued and outstanding stock or comparable interests of another entity.&#160; The terms and conditions of the substitute options so granted may vary from the terms and conditions set forth in this Plan to such extent as the Committee at the time of the grant may deem appropriate to conform, in whole or in part, to the provisions of the stock options or comparable rights in substitution for, or assumption of, which they are granted.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>COMPLIANCE WITH LEGAL REQUIREMENTS</b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>GENERAL</u><i>.</i>&#160; No Shares distributable under this Plan may be issued and delivered unless the issuance of such Shares complies with all applicable legal requirements including, without limitation, compliance with the provisions of applicable state securities laws, the Securities Act of 1933, as amended (the &#147;<b>Securities Act</b>&#148;), and the Exchange Act.&#160; The optionee will have no right to require the Company, and the Company will have no obligation, to register the issuance or sale of any Share that may be acquired pursuant to exercise of an option granted under this Plan under the Securities Act, or under any other law or regulation.&#160; The Company may place legends on stock certificates issued under this Plan as may be necessary or appropriate in order to comply with applicable securities laws or agreements to which the Shares are subject, including, but not limited to, legends restricting the transfer of the Shares.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>RULE&nbsp;16B-3</u><i>.</i>&#160; With respect to Section&nbsp;16 Individuals, transactions under this Plan are intended to comply with all applicable conditions of Rule&nbsp;16b-3 or its successors under the Exchange Act.&#160; To the extent any provision of this Plan or action by the Committee fails to so comply, it will be deemed null and void, to the extent permitted by law and deemed advisable by the Committee.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>DELIVERY OF FINANCIAL INFORMATION</u>.&#160; The Company will, to the extent necessary to comply with applicable state securities laws, deliver financial statements of the Company to an optionee at least annually.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">16.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>RESTRICTIONS ON SHARES</b>.&#160; At the discretion of the Committee, the Company may reserve to itself and its assignees in the option agreement (a)&nbsp;a right of first refusal to purchase all Shares that an optionee (or a subsequent transferee) may propose to transfer to a third party, (b)&nbsp;a right to repurchase a portion of or all Shares held by an optionee upon the optionee&#146;s termination of employment or service with the Company or its parent, subsidiary or affiliate for any reason within a specified time (but not to exceed ninety (90) days of the later of termination or exercise of the option, if required by</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">10<a name="16022-2-LA-03_PB_10_080425_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=10,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=539396,FOLIO='10',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LA-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 08:06 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">applicable laws), (c)&nbsp;the right to require the optionee from time to time to execute and deliver shareholder, voting or similar agreements to which holders of a majority of the Common Stock are parties, (d)&nbsp;the right to require the optionee to agree not to take any action that would cause the Company not to qualify for Subchapter S tax status, if applicable, and (e)&nbsp;the right of the Company to require the optionee from time to time to execute and deliver underwriter lock up agreements.&#160; The price to be paid upon any purchase or repurchase of Shares pursuant to clause (a)&nbsp;or (b)&nbsp;above will be determined by the Committee.&#160; This paragraph 16 is not a limitation on the provisions that may be included in any option agreement. Shares may be repurchased at the optionee&#146;s original purchase price provided that, so long as required by applicable laws, such right to repurchase as to employees lapses at the rate of at least twenty percent (20%) of the Shares subject to the option per year over five years from the date that the option is granted (without respect to the date that the option was exercised or became exercisable).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>GOVERNING LAW<i>.</i></b>&#160; To the extent that federal laws do not otherwise control, this Plan and all determinations made and actions taken under this Plan will be governed by the laws of the State of Minnesota, without regard to the conflicts of law provisions thereof, and construed accordingly.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>AMENDMENT AND DISCONTINUANCE OF PLAN</b>.&#160; The Board may at any time amend, suspend or terminate this Plan; provided, however, that no amendment to this Plan will, without the consent of the holder of the option, adversely alter or impair any option previously granted under this Plan.&#160; To the extent considered necessary to comply with applicable provisions of the Code or other applicable laws, rules&nbsp;or regulations, any such amendments to this Plan may be made subject to approval by the shareholders of the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>TERM<i>.</i></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>EFFECTIVE DATE</u><i>.&#160; </i>This Plan was initially effective as of November&nbsp;18, 2003.&#160; This Plan was amended on April&nbsp;27, 2005.&#160; The amendment and restatement of the Plan&nbsp;is being submitted for approval by the shareholders of the Company on or about August&nbsp;23, 2006&nbsp;and will only be effective as of the date of such approval.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>TERMINATION</u><i>.</i>&#160; This Plan will remain in effect until all Shares subject to it are distributed or this Plan is terminated under paragraph&nbsp;18 above.&#160; No award of an incentive stock option may be made under this Plan more than ten years after the effective date of this Plan (or such other limit as may be required by the Code) if such limitation is necessary to qualify the option as an incentive stock option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">11<a name="16022-2-LA-03_PB_11_080507_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=11,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=227849,FOLIO='11',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LA-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 08:06 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>5
<FILENAME>a2227029zex-10_2.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 10.2</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Incentive Stock Option Agreement</font></u></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(Under the 2003 Stock Option Plan)</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name of Optionee:</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No.&nbsp;of Shares   Covered:</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of Grant:</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exercise Price Per   Share:</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Expiration Date:</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exercise Schedule   (Cumulative):</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This Option will vest   as to [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] of the Shares subject to   this Option on [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]. This   Option will vest for [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] of the remaining Shares   subject to this Option on the 1</font><font size="1" style="font-size:6.5pt;position:relative;top:-3.0pt;">st</font>&nbsp;day of each month, commencing on   [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] and continuing until   this Option is fully vested.</p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This is an Incentive Stock Option Agreement (the &#147;<b>Agreement</b>&#148;) between Tactile Systems Technology,&nbsp;Inc. a Delaware corporation (the &#147;<b>Company</b>&#148;), and the optionee identified above (the &#147;<b>Optionee</b>&#148;) effective as of the date of grant specified above.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BACKGROUND</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:36.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A.&#160; The Company maintains the Tactile Systems Technology,&nbsp;Inc. 2003 Stock Option Plan (the &#147;<b>Plan</b>&#148;).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:36.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">B.&#160; Under the Plan, the Board of Directors of the Company (the &#147;<b>Board</b>&#148;) or a committee of two or more directors of the Company (the &#147;<b>Committee</b>&#148;) appointed by the Board administers the Plan and has the authority to determine the awards to be granted under the Plan (if the Board has not appointed a committee to administer the Plan, then the Board shall constitute the Committee).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:36.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">C.&#160; The Committee has determined that the Optionee is eligible to receive an award under the Plan in the form of an incentive stock option (the &#147;<b>Option</b>&#148;);</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:36.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">D.&#160; The Company hereby grants the Option to the Optionee under the terms and conditions as follows.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TERMS AND CONDITIONS</font></b>*</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Grant</u></b>.&#160; The Optionee is granted the Option to purchase the number of Shares specified at the beginning of this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Exercise Price</u></b>.&#160; The price to the Optionee of each Share subject to the Option will be the exercise price specified at the beginning of this Agreement (which price shall not be less than the Fair Market Value as of the date of grant or, if the Optionee owns or is deemed to own stock possessing more than 10% of the combined voting power of all classes of stock of the Company, 110% of the Fair Market Value as of the date of grant).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade align="left" style="color:black;"></div>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Unless the context indicates otherwise, terms that are not defined in this Agreement shall have the meaning set forth in the Plan as it currently exists or as it is amended in the future.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="5",CHK=651388,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LC_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Incentive Stock Option</u></b>.&#160; The Option is intended to be an &#147;incentive stock option&#148; within the meaning of Section&nbsp;422 of the Internal Revenue Code of 1986, as amended (the &#147;<b>Code</b>&#148;), provided that if the Option or part thereof fails to qualify as an incentive stock option, it will be treated as a non-statutory stock option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Exercise Schedule</u></b>.&#160; The Option will vest and become exercisable as to the number of Shares and on the dates specified in the exercise schedule at the beginning of this Agreement; provided, that the Optionee is employed by the Company on such date.&#160; The exercise schedule will be cumulative; thus, to the extent the Option has not already been exercised and has not expired, terminated or been cancelled, the Optionee or the person otherwise entitled to exercise the Option as provided herein may at any time, and from time to time, purchase all or any portion of the Shares then purchasable under the exercise schedule.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Option may also be exercised in full (notwithstanding the exercise schedule) under the circumstances described in Section&nbsp;8 of this Agreement if it has not expired prior thereto.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Expiration</u></b>.&#160; The Option shall expire at 5:00&nbsp;p.m.&nbsp;Central Time on the earliest of:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The expiration date specified at the beginning of this Agreement (which date shall not be later than ten years after the date of grant or, if the Optionee owns or is deemed to own stock possessing more than 10% of the combined voting power of all classes of stock of the Company, five years after the date of grant) or thereafter agreed upon with the Optionee;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The expiration of the period after the termination of employment of the Optionee within which the Option can be exercised (as specified in Section&nbsp;7 of this Agreement), provided that the Committee may extend any such period following the termination of employment during which the Option can be exercised;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; At the election of the Company, upon termination of the Optionee&#146;s employment for Cause or if it is determined by the Company within ten days after termination of the Optionee&#146;s employment by the Optionee, such as Optionee&#146;s resignation, that Cause existed for termination by the Company; or</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The date (if any) fixed for cancellation pursuant to paragraph&nbsp;11(c)&nbsp;or 12 of the Plan.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In no event may anyone exercise the Option, in whole or in part, after it has expired, notwithstanding any other provision of this Agreement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In addition, if the Option is exercised, and prior to the delivery of the certificate representing the Shares so purchased, it is determined that Cause for termination existed, then the Company may rescind the Option exercise by the Optionee and the Option shall terminate at the election of the Company.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Procedure to Exercise Option</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.3pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Notice of Exercise</font></i>.&#160; The Option may be exercised by delivering written notice of exercise to the Company at the principal executive office of the Company, to the attention of the Company&#146;s Secretary, in the form attached to this Agreement.&#160; The notice shall state the number of Shares to be purchased, and shall be signed by the person exercising the Option.&#160; If the person exercising the Option is not the Optionee, he/she also must submit appropriate proof of his/her right to exercise the Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.3pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Tender of Payment</font></i>.&#160; Upon giving notice of any exercise hereunder, the Optionee shall provide for payment of the purchase price of the Shares being purchased through one or a combination of the following methods:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Cash (including check, bank draft or money order);</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-LC_PB_2_103558_9190"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="5",CHK=961271,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LC_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Cancellation of indebtedness owed to the Optionee by the Company or any parent or subsidiary thereof;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; To the extent permitted by law, through a broker-assisted cashless exercise in which the Optionee simultaneously exercises the Option and sells all or a portion of the Shares thereby acquired pursuant to a brokerage or similar relationship and uses the proceeds from such sale to pay the purchase price of such Shares;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; By delivery to the Company of unencumbered Shares having an aggregate Fair Market Value on the date of exercise equal to the purchase price of such Shares; or</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; By authorizing the Company to retain, from the total number of Shares as to which the Option is exercised, that number of Shares having a Fair Market Value on the date of exercise equal to the purchase price for the total number of Shares as to which the Option is exercised.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Notwithstanding the foregoing, the Optionee shall not be permitted to pay any portion of the purchase price with Shares, or by authorizing the Company to retain Shares upon exercise of the Option, if the Committee, in its sole discretion, determines that payment in such manner is undesirable.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.3pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Delivery of Certificates</font></i>.&#160; As soon as practicable after the Company receives the notice and purchase price provided for above, it shall deliver to the person exercising the Option, in the name of such person, a certificate or certificates representing the Shares being purchased.&#160; The Company shall pay any original issue or transfer taxes with respect to the issue or transfer of the Shares and all fees and expenses incurred by it in connection therewith.&#160; All Shares so issued shall be fully paid and nonassessable.&#160; Notwithstanding anything to the contrary in this Agreement, no certificate for Shares distributable under the Plan shall be issued and delivered unless the issuance of such certificate complies with all applicable legal requirements including, without limitation, compliance with the provisions of applicable state securities laws, the Securities Act and the Exchange Act.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Employment Requirement</u></b>.&#160; The Option may be exercised only while the Optionee remains employed with the Company or a parent or subsidiary thereof, and only if the Optionee has been continuously so employed since the date the Option was granted; <i>provided that</i>:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Option may be exercised for three months after termination of the Optionee&#146;s employment if such cessation of employment is for a reason other than death or disability, but only to the extent that it was exercisable immediately prior to termination of employment, provided that if termination of the Optionee&#146;s employment shall have been for Cause, the Option shall expire, and all rights to purchase Shares hereunder shall terminate, immediately upon such termination.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Option may be exercised for one year after termination of the Optionee&#146;s employment if such termination of employment is because of death or disability of the Optionee.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; If the Optionee&#146;s employment terminates after a declaration made pursuant to paragraph&nbsp;12 of the Plan in connection with an Event, the Option may be exercised at any time permitted by such declaration.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Notwithstanding the above, the Option may not be exercised after it has expired.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Acceleration of Vesting</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.3pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Death or Disability.</font></i>&#160; In the event of the death or disability of the Optionee, any portion of the Option that was not previously exercisable shall become immediately exercisable in full if the</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="16022-2-LC_PB_3_103738_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=3,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="5",CHK=766941,FOLIO='3',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LC_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Optionee shall have been continuously employed by the Company or a parent or subsidiary thereof between the date the Option was granted and the date of such death or disability.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.3pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Change in Control</font></i>.&#160; If a Change in Control of the Company is consummated, then, at the discretion of the Committee, the Option, if not already exercised in full or otherwise terminated, expired or cancelled, may become immediately exercisable in full and remain exercisable during the remaining term of the Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.3pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Event</font></i>.&#160; In the event of an Event, at the time of any declaration pursuant to clause&nbsp;(ii)&nbsp;of the first sentence of paragraph&nbsp;12 of the Plan, the Option, if not already exercised in full or otherwise terminated, expired or cancelled, shall become immediately exercisable in full and shall remain exercisable during the period preceding the time of cancellation of the Option pursuant to such declaration.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.3pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Discretionary Acceleration</font></i>.&#160; Notwithstanding any other provisions of this Agreement to the contrary, the Committee may, in its sole discretion, declare at any time that the Option shall be immediately exercisable.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Limitation on Transfer</u></b>.&#160; During the lifetime of the Optionee, only the Optionee or his/her guardian or legal representative may exercise the Option.&#160; The Option may not be assigned or transferred by the Optionee otherwise than by will or the laws of descent and distribution.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">No Stockholder Rights Before Exercise</u></b>.&#160; No person shall have any of the rights of a stockholder of the Company with respect to any Share subject to the Option until the Share actually is issued to him/her upon exercise of the Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Discretionary Adjustment</u></b>.&#160; In the event of any reorganization, merger, consolidation, recapitalization, liquidation, reclassification, stock dividend, stock split, combination of shares, rights offering, or extraordinary dividend or divestiture (including a spin-off), or any other change in the corporate structure or Shares of the Company, the Committee (or if the Company does not survive any such transaction, a comparable committee of the Board of Directors of the surviving corporation) may, without the consent of the Optionee, make such adjustment as it determines in its discretion to be appropriate as to the number and kind of securities subject to and reserved under the Plan and, in order to prevent dilution or enlargement of rights of the Optionee, the number and kind of securities issuable upon exercise of the Option and the exercise price hereof.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Transfer of Shares&nbsp;&#151; Tax Effects</u></b>.&#160; The Optionee hereby acknowledges that if any Shares received pursuant to the exercise of any portion of the Option are sold within two years from the date of grant or within one year from the effective date of exercise of the Option, or if certain other requirements of the Code are not satisfied, such Shares will be deemed under the Code not to have been acquired by the Optionee pursuant to an &#147;incentive stock option&#148; as defined in the Code; and that the Company shall not be liable to the Optionee in the event the Option for any reason is deemed not to be an &#147;incentive stock option&#148; within the meaning of the Code.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Interpretation of This Agreement</u></b>.&#160; All decisions and interpretations made by the Committee with regard to any question arising hereunder or under the Plan shall be binding and conclusive upon the Company and the Optionee.&#160; If there is any inconsistency between the provisions of this Agreement and the Plan, the provisions of the Plan shall govern.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Discontinuance of Employment</u></b>.&#160; This Agreement shall not give the Optionee a right to continued employment with the Company or any parent or subsidiary of the Company, and the Company or any such parent or subsidiary employing the Optionee may terminate his/her employment at any time and otherwise deal with the Optionee without regard to the effect it may have upon him/her under this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">4<a name="16022-2-LC_PB_4_103819_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=4,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="5",CHK=950911,FOLIO='4',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LC_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Option Subject to Plan, Certificate of Incorporation and By-Laws</u></b>.&#160; The Optionee acknowledges that the Option and the exercise thereof is subject to the Plan, the Certificate of Incorporation, as amended from time to time, and the By-Laws, as amended from time to time, of the Company, and any applicable federal or state laws, rules&nbsp;or regulations.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">16.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Obligation to Reserve Sufficient Shares</u></b>.&#160; The Company shall at all times during the term of the Option reserve and keep available a sufficient number of Shares to satisfy this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Binding Effect</u></b>.&#160; This Agreement shall be binding in all respects on the heirs, representatives, successors and assigns of the Optionee.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Choice of Law</u></b>.&#160; This Agreement is entered into under the laws of the State of Minnesota and shall be construed and interpreted thereunder (without regard to its conflict of law principles).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Tax Consequences</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Optionee may incur tax liability as a result of the Optionee&#146;s purchase or disposition of the Shares.&#160; <b>THE OPTIONEE SHOULD CONSULT A TAX ADVISER BEFORE EXERCISING THE OPTION OR DISPOSING OF THE SHARES.</b></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Notwithstanding the Company&#146;s good faith determination of the Fair Market Value of the Company&#146;s common stock for purposes of determining the exercise price per Share of the Option, the taxing authorities may assert that the fair market value of the Company&#146;s common stock on the date of grant was greater than the exercise price per Share. &#160;The Option may fail to qualify as an incentive stock option if the exercise price per Share of the Option is less than the fair market value of the Company&#146;s common stock on the date of grant.&nbsp; In addition, under Section&nbsp;409A of the Code, if the exercise price per Share of the Option is less than the fair market value of the Company&#146;s common stock on the date of grant, the Option may be treated as a form of deferred compensation and the Optionee may be subject to an additional 20% tax, plus interest and possible penalties.&#160; The Optionee is encouraged to consult a tax adviser regarding the potential impact of Section&nbsp;409A of the Code.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">20.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Amendment to Meet the Requirements of Section&nbsp;409A</u></b>.&#160; The Optionee acknowledges that the Company, in the exercise of its sole discretion and without the consent of the Optionee, may amend or modify this Agreement in any manner and delay the payment of any amounts payable pursuant to this Agreement to the minimum extent necessary to meet the requirements of Section&nbsp;409A of the Code as amplified by any Internal Revenue Service or U.S. Treasury Department regulations or guidance as the Company deems appropriate or advisable.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">5<a name="16022-2-LC_PB_5_103903_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=5,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="5",CHK=375109,FOLIO='5',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LC_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Optionee and the Company have executed this Agreement as of date of grant stated above.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">OPTIONEE</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS   TECHNOLOGY,&nbsp;INC.</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Gerald R. Mattys</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.84%;">
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Chief Executive Officer</font></i></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">6<a name="16022-2-LC_PB_6_104140_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=6,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="5",CHK=163543,FOLIO='6',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LC_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 20&nbsp;&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4824 Park Glen Road</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Minneapolis, Minnesota&#160; 55416</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Ladies and Gentlemen:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">I hereby exercise the following option (the &#147;<b>Option</b>&#148;) granted to me under the Tactile Systems Technology,&nbsp;Inc. 2003 Stock Option Plan (the &#147;<b>Plan</b>&#148;) with respect to the number of shares of Common Stock of Tactile Systems Technology,&nbsp;Inc. (the &#147;<b>Company</b>&#148;) indicated below:</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 82.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Name:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 82.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Date of Grant of Option:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 82.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exercise Price Per Share:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Number   of Shares With Respect to Which the Option is Hereby Exercised:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 82.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Total Exercise Price:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Enclosed with this letter is a check, bank draft or money order in the amount of the Total Exercise Price.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; I elect to pay the Total Exercise Price through cancellation of indebtedness owed to me by the Company or by a parent or subsidiary of the Company as provided in paragraph&nbsp;8 of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; I hereby agree to pay the Total Exercise Price within five business days of the date hereof and, as stated in the attached Broker&#146;s Letter,&nbsp;I have delivered irrevocable instructions to <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> to promptly deliver to the Company the amount of sale or loan proceeds from the Shares to be issued pursuant to this exercise necessary to satisfy my obligation hereunder to pay the Total Exercise Price.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Enclosed with this letter is a certificate evidencing unencumbered Shares (duly endorsed in blank) having an aggregate Fair Market Value (as defined in the Plan) equal to or in excess of the Total Exercise Price.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; I elect to pay the Total Exercise Price through a reduction in the number of Shares delivered to me upon this exercise of the Option as provided in paragraph&nbsp;8 of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If I am enclosing Shares with this letter,&nbsp;I hereby represent and warrant that I am the owner of such Shares free and clear of all liens, security interests and other restrictions or encumbrances.&#160; I agree that I will pay any required withholding taxes in connection with this exercise as provided in paragraph&nbsp;9 of the Plan.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Please issue a certificate (the &#147;<b>Certificate</b>&#148;) for the number of Shares with respect to which the Option is being exercised in the name of the person indicated below and deliver the Certificate to the address indicated below:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=7,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="5",CHK=459644,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LC_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 82.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Name in Which to Issue Certificate:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Address   to Which Certificate Should be </font></b></p>    </td>
<td width="50%" valign="bottom" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Delivered:</font></b></p>    </td>
<td width="50%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="bottom" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Principal   Mailing Address for Holder of the Certificate (if different from above):</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="53%" valign="top" style="padding:0in 0in 0in 0in;width:53.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Very truly yours,</font></p>    </td>   </tr>
<tr>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="53%" valign="top" style="padding:0in 0in 0in 0in;width:53.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="53%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:53.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="53%" valign="top" style="padding:0in 0in 0in 0in;width:53.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Signature</font></p>    </td>   </tr>
<tr>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="53%" valign="top" style="padding:0in 0in 0in 0in;width:53.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="53%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:53.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="53%" valign="top" style="padding:0in 0in 0in 0in;width:53.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name, please print</font></p>    </td>   </tr>
<tr>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="53%" valign="top" style="padding:0in 0in 0in 0in;width:53.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="53%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:53.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="53%" valign="top" style="padding:0in 0in 0in 0in;width:53.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Social Security Number</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=8,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="5",CHK=67779,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LC_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 20&nbsp;&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4824 Park Glen Road</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Minneapolis, Minnesota&#160; 55416</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Ladies and Gentlemen:</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Name of   Optionee:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Date of   Grant of Option:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exercise   Price Per Share:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Number   of Shares With Respect to Which the Option is to be Exercised:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Total   Exercise Price:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The above Optionee has requested that we finance the exercise of the above Option to purchase Shares of Common Stock of Tactile Systems Technology,&nbsp;Inc. (the &#147;<b>Company</b>&#148;) and has given us irrevocable instructions to promptly deliver to the Company the amount of sale or loan proceeds from the Shares to be issued pursuant to such exercise to satisfy the Optionee&#146;s obligation to pay the Total Exercise Price.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Very truly yours,</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Broker Name</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By</font></p>    </td>
<td width="46%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:46.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=9,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="5",CHK=974787,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LC_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:03 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>6
<FILENAME>a2227029zex-10_3.htm
<DESCRIPTION>EX-10.3
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 10.3</font></b></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2003 Stock Option Plan</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Non-Statutory Stock Option Agreement</font></u></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(Employee)</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name of Optionee:</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No.&nbsp;of Shares Covered:</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of Grant:</font></p>    </td>   </tr>
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exercise Price Per Share:</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Expiration Date:</font></p>    </td>   </tr>
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exercise Schedule (Cumulative):</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="86%" bgcolor="black" style="background:white;border-collapse:collapse;margin-left:1.0in;">
<tr>
<td width="48%" valign="bottom" style="padding:0in 0in 0in 0in;width:48.08%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Date(s)&nbsp;of</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.94%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="47%" valign="bottom" style="padding:0in 0in 0in 0in;width:47.98%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">No.&nbsp;of&nbsp;Shares&nbsp;as&nbsp;to&nbsp;Which</font></b></p>    </td>   </tr>
<tr>
<td width="48%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:48.08%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Exercisability</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.94%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="47%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:47.98%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Option&nbsp;Becomes&nbsp;Exercisable</font></b></p>    </td>   </tr>
<tr>
<td width="48%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.08%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.94%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="47%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:47.98%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="48%" valign="bottom" style="padding:0in 0in 0in 0in;width:48.08%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.94%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="47%" valign="bottom" style="padding:0in 0in 0in 0in;width:47.98%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="48%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:48.08%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.94%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="47%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:47.98%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This is a Non-Statutory Stock Option Agreement (the &#147;<b>Agreement</b>&#148;) between Tactile Systems Technology,&nbsp;Inc., a Minnesota corporation (the &#147;<b>Company</b>&#148;), and the optionee identified above (the &#147;<b>Optionee</b>&#148;) effective as of the date of grant specified above.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BACKGROUND</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A.&#160; The Company maintains the Tactile Systems Technology,&nbsp;Inc. 2003 Stock Option Plan (the &#147;<b>Plan</b>&#148;).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">B.&#160; Under the Plan, the Board of Directors of the Company (the &#147;<b>Board</b>&#148;) or a committee of two or more directors of the Company (the &#147;<b>Committee</b>&#148;) appointed by the Board administers the Plan and has the authority to determine the awards to be granted under the Plan (if the Board has not appointed a committee to administer the Plan, then the Board shall constitute the Committee).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">C.&#160; The Committee has determined that the Optionee is eligible to receive an award under the Plan in the form of a non-statutory stock option (the &#147;<b>Option</b>&#148;).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">D.&#160; The Company hereby grants the Option to the Optionee under the terms and conditions as follows.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TERMS AND CONDITIONS</font></b>*</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Grant</u></b>.&#160; The Optionee is granted the Option to purchase the number of Shares specified at the beginning of this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade align="left" style="color:black;"></div>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Unless the context indicates otherwise, terms that are not defined in this Agreement shall have the meaning set forth in the Plan as it currently exists or as it is amended in the future.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="6",CHK=884547,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LE_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 17:01 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Exercise Price</u></b>.&#160; The price to the Optionee of each Share subject to the Option will be the exercise price specified at the beginning of this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Non-Statutory Stock Option</u></b>.&#160; The Option is <u>not</u> intended to be an &#147;incentive stock option&#148; within the meaning of Section&nbsp;422 of the Internal Revenue Code of 1986, as amended (the &#147;<b>Code</b>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Exercise Schedule</u></b>.&#160; The Option will vest and become exercisable as to the number of Shares and on the dates specified in the exercise schedule at the beginning of this Agreement.&#160; The exercise schedule will be cumulative; thus, to the extent the Option has not already been exercised and has not expired, terminated or been cancelled, the Optionee or the person otherwise entitled to exercise the Option as provided herein may at any time, and from time to time, purchase all or any portion of the Shares then purchasable under the exercise schedule.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Option may also be exercised in full (notwithstanding the exercise schedule) under the circumstances described in Section&nbsp;8 of this Agreement if it has not expired prior thereto.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Expiration</u></b>.&#160; The Option will expire at 5:00&nbsp;p.m.&nbsp;Central Time on the earliest of:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The expiration date specified at the beginning of this Agreement [which date shall not be later than ten years after the date of grant];</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The expiration of the period after the termination of employment of the Optionee within which the Option can be exercised (as specified in Section&nbsp;7 of this Agreement);</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; At the election of the Company, upon termination of the Optionee&#146;s employment for Cause or if it is determined by the Company within ten days after termination of the Optionee&#146;s employment by the Optionee, such as Optionee&#146;s resignation, that Cause existed for termination by the Company; or</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The date (if any) fixed for cancellation pursuant to paragraph&nbsp;11(c)&nbsp;or 12 of the Plan.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In no event may anyone exercise the Option, in whole or in part, after it has expired, notwithstanding any other provision of this Agreement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In addition, if the Option is exercised, and prior to the delivery of the certificate representing the Shares so purchased, it is determined that Cause for termination existed, then the Company may rescind the Option exercise by the Optionee and the Option shall terminate at the election of the Company.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Procedure to Exercise Option</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Notice of Exercise</font></i>.&#160; The Option may be exercised by delivering written notice of exercise to the Company at the principal executive office of the Company, to the attention of the Company&#146;s Secretary, in the form attached to this Agreement.&#160; The notice shall state the number of Shares to be purchased, and shall be signed by the person exercising the Option.&#160; If the person exercising the Option is not the Optionee, he/she also must submit appropriate proof of his/her right to exercise the Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Tender of Payment</font></i>.&#160; Upon giving notice of any exercise hereunder, the Optionee shall provide for payment of the purchase price of the Shares being purchased through one or a combination of the following methods:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Cash (including check, bank draft or money order);</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Delivery of the Optionee&#146;s promissory note with such recourse, interest, security and redemption provisions as the Committee determines to be appropriate and as required pursuant to the law of the Company&#146;s state of incorporation;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-LE_PB_2_103656_7258"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="6",CHK=839551,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LE_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 17:01 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Cancellation of indebtedness owed to the Optionee by the Company or any parent or subsidiary thereof;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; To the extent permitted by law, through a broker-assisted cashless exercise in which the Optionee simultaneously exercises the Option and sells all or a portion of the Shares thereby acquired pursuant to a brokerage or similar relationship and uses the proceeds from such sale to pay the purchase price of such Shares;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; By delivery to the Company of unencumbered Shares having an aggregate Fair Market Value on the date of exercise equal to the purchase price of such Shares; or</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; By authorizing the Company to retain, from the total number of Shares as to which the Option is exercised, that number of Shares having a Fair Market Value on the date of exercise equal to the purchase price for the total number of Shares as to which the Option is exercised.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Notwithstanding the foregoing, the Optionee shall not be permitted to pay any portion of the purchase price with Shares, or by authorizing the Company to retain Shares upon exercise of the Option, if the Committee, in its sole discretion, determines that payment in such manner is undesirable nor may the Company permit the Optionee, if he or she is an executive officer or director of the Company, to pay for the Shares by delivery of a promissory note from an after such time, if any, that the Company (i)&nbsp;has a class of securities registered under Section&nbsp;12 of the Exchange Act, (ii)&nbsp;is required to file reports under Section&nbsp;15(d)&nbsp;of the Exchange Act or (iii)&nbsp;that has filed a registration statement that has not yet become effective under the Securities Act.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Delivery of Certificates</font></i>.&#160; As soon as practicable after the Company receives the notice and purchase price provided for above, it shall deliver to the person exercising the Option, in the name of such person, a certificate or certificates representing the Shares being purchased.&#160; The Company shall pay any original issue or transfer taxes with respect to the issue or transfer of the Shares and all fees and expenses incurred by it in connection therewith.&#160; All Shares so issued shall be fully paid and nonassessable.&#160; Notwithstanding anything to the contrary in this Agreement, no certificate for Shares distributable under the Plan shall be issued and delivered unless the issuance of such certificate complies with all applicable legal requirements including, without limitation, compliance with the provisions of applicable state securities laws, the Securities Act and the Exchange Act.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Employment Requirement</u></b>.&#160; The Option may be exercised only while the Optionee remains employed with the Company or a parent or subsidiary thereof, and only if the Optionee has been continuously so employed since the date the Option was granted; <i>provided that</i>:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Option may be exercised for three months after termination of the Optionee&#146;s employment if such cessation of employment is for a reason other than death or disability, but only to the extent that it was exercisable immediately prior to termination of employment, provided that if termination of the Optionee&#146;s employment shall have been for Cause, the Option shall expire, and all rights to purchase Shares hereunder shall terminate, immediately upon such termination.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Option may be exercised for one year after termination of the Optionee&#146;s employment if such termination of employment is because of death or disability of the Optionee.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; If the Optionee&#146;s employment terminates after a declaration made pursuant to paragraph&nbsp;12 of the Plan in connection with an Event, the Option may be exercised at any time permitted by such declaration.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Notwithstanding the above, the Option may not be exercised after it has expired.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="16022-2-LE_PB_3_103805_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=3,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="6",CHK=49795,FOLIO='3',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LE_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 17:01 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Acceleration of Vesting</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Death or Disability.</font></i>&#160; In the event of the death or disability of the Optionee, any portion of the Option that was not previously exercisable shall become immediately exercisable in full if the Optionee shall have been continuously employed by the Company or a parent or subsidiary thereof between the date the Option was granted and the date of such death or disability.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Change in Control</font></i>.&#160; If a Change in Control of the Company shall or is to occur, then, in the Committee&#146;s sole discretion, the Option, if not already exercised in full or otherwise terminated, expired or cancelled, may become immediately exercisable in full and/or remain exercisable during the remaining term of the Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Event</font></i>.&#160; In the event of an Event, at the time of any declaration pursuant to clause&nbsp;(ii)&nbsp;of the first sentence of paragraph&nbsp;12 of the Plan, the Option, if not already exercised in full or otherwise terminated, expired or cancelled, may at the Committee&#146;s sole discretion, become immediately exercisable in full and/or shall remain exercisable during the period preceding the time of cancellation of the Option pursuant to such declaration.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Discretionary Acceleration</font></i>.&#160; Notwithstanding any other provisions of this Agreement to the contrary, the Committee may, in its sole discretion, declare at any time that the Option shall be immediately exercisable.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Limitation on Transfer</u></b>.&#160; During the lifetime of the Optionee, only the Optionee or his/her guardian or legal representative may exercise the Option.&#160; The Option may not be assigned or transferred by the Optionee otherwise than by will or the laws of descent and distribution or pursuant to a qualified domestic relations order as defined by the Code or Title&nbsp;I of the Employee Retirement Income Security Act, or the rules&nbsp;thereunder; provided, however, that the Optionee may transfer the Option to a member or members of his/her immediate family (i.e., his/her children, grandchildren and spouse) or to one or more trusts for the benefit of such family members or partnerships in which such family members are the only partners, if the Optionee does not receive any consideration for the transfer.&#160; The Option held by any such transferee shall continue to be subject to the same terms and conditions that were applicable to the Option immediately prior to its transfer and may be exercised by such transferee as and to the extent that the Option has become exercisable and has not terminated in accordance with the provisions of the Plan and this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">No Stockholder Rights Before Exercise</u></b>.&#160; No person shall have any of the rights of a stockholder of the Company with respect to any Share subject to the Option until the Share actually is issued to him/her upon exercise of the Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Discretionary Adjustment</u></b>.&#160; In the event of any reorganization, merger, consolidation, recapitalization, liquidation, reclassification, stock dividend, stock split, combination of shares, rights offering, or extraordinary dividend or divestiture (including a spin-off), or any other change in the corporate structure or Shares of the Company, the Committee (or if the Company does not survive any such transaction, a comparable committee of the Board of Directors of the surviving corporation) may, without the consent of the Optionee, make such adjustment as it determines in its discretion to be appropriate as to the number and kind of securities subject to and reserved under the Plan and, in order to prevent dilution or enlargement of rights of the Optionee, the number and kind of securities issuable upon exercise of the Option and the exercise price hereof.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Tax Withholding</u></b>.&#160; Delivery of Shares upon exercise of the Option shall be subject to any required withholding taxes.&#160; As a condition precedent to receiving Shares upon exercise of the Option, the Optionee may be required to pay to the Company, in accordance with the provisions of paragraph&nbsp;9 of the Plan, an amount equal to the amount of any required withholdings.&#160; In lieu of all or any part of such a cash payment, a person exercising the Option may cover all or any part of the required withholdings, and any additional withholdings up to the amount needed to cover</p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">4<a name="16022-2-LE_PB_4_103923_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=4,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="6",CHK=392594,FOLIO='4',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LE_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 17:01 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the individual&#146;s full FICA and federal, state and local income tax liability with respect to income arising from the exercise of the Option, through the delivery to the Company of unencumbered Shares, through a reduction in the number of Shares delivered to the person exercising the Option or through a subsequent return to the Company of Shares delivered to the person exercising the Option (in each case, such Shares having an aggregate Fair Market Value on the date of exercise equal to the amount of the withholding taxes being paid through such delivery, reduction or subsequent return of Shares).&#160; Notwithstanding the foregoing, no person shall be permitted to pay any such withholdings with Shares, or through a reduction in the number of Shares to be delivered upon exercise of the Option, if the Committee, in its sole discretion, determines that payment in such manner is undesirable.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Interpretation of This Agreement</u></b>.&#160; All decisions and interpretations made by the Committee with regard to any question arising hereunder or under the Plan shall be binding and conclusive upon the Company and the Optionee.&#160; If there is any inconsistency between the provisions of this Agreement and the Plan, the provisions of the Plan shall govern.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Discontinuance of Employment</u></b>.&#160; This Agreement shall not give the Optionee a right to continued employment with the Company or any parent or subsidiary of the Company, and the Company or any such parent or subsidiary employing the Optionee may terminate his/her employment at any time and otherwise deal with the Optionee without regard to the effect it may have upon him/her under this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Option Subject to Plan, Certificate of Incorporation and By-Laws</u></b>.&#160; The Optionee acknowledges that the Option and the exercise thereof is subject to the Plan, the Certificate of Incorporation, as amended from time to time, and the By-Laws, as amended from time to time, of the Company, and any applicable federal or state laws, rules&nbsp;or regulations.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">16.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Obligation to Reserve Sufficient Shares</u></b>.&#160; The Company shall at all times during the term of the Option reserve and keep available a sufficient number of Shares to satisfy this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Binding Effect</u></b>.&#160; This Agreement shall be binding in all respects on the heirs, representatives, successors and assigns of the Optionee.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Choice of Law</u></b>.&#160; This Agreement is entered into under the laws of the State of Minnesota and shall be construed and interpreted thereunder (without regard to its conflict of law principles).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Optionee and the Company have executed this Agreement as of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 20&nbsp;&nbsp;.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">OPTIONEE</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.76%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.76%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Its:</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.76%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">5<a name="16022-2-LE_PB_5_104319_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=5,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="6",CHK=1037565,FOLIO='5',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LE_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 17:01 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 20&nbsp;&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3601 Minnesota Street, Suite&nbsp;800</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Edina, MN 55435</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Ladies and Gentlemen:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">I hereby exercise the following option (the &#147;<b>Option</b>&#148;) granted to me under the Tactile Systems Technology,&nbsp;Inc. 2003 Stock Option Plan (the &#147;<b>Plan</b>&#148;) with respect to the number of shares of Common Stock of Tactile Systems Technology,&nbsp;Inc. (the &#147;<b>Company</b>&#148;) indicated below:</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="55%" valign="bottom" style="padding:0in 0in 0in 0in;width:55.28%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Name:</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="42%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:42.22%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="55%" valign="top" style="padding:0in 0in 0in 0in;width:55.28%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="42%" valign="top" style="padding:0in 0in 0in 0in;width:42.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="55%" valign="top" style="padding:0in 0in 0in 0in;width:55.28%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Date of Grant of Option:</font></b></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="42%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:42.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="55%" valign="top" style="padding:0in 0in 0in 0in;width:55.28%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="42%" valign="top" style="padding:0in 0in 0in 0in;width:42.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="55%" valign="top" style="padding:0in 0in 0in 0in;width:55.28%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exercise Price Per Share:</font></b></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="42%" valign="top" style="padding:0in 0in 0in 0in;width:42.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="55%" valign="top" style="padding:0in 0in 0in 0in;width:55.28%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="42%" valign="top" style="padding:0in 0in 0in 0in;width:42.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="55%" valign="top" style="padding:0in 0in 0in 0in;width:55.28%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Number of Shares With Respect   to Which the Option is Hereby Exercised:</font></b></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="42%" valign="top" style="padding:0in 0in 0in 0in;width:42.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="55%" valign="top" style="padding:0in 0in 0in 0in;width:55.28%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="42%" valign="top" style="padding:0in 0in 0in 0in;width:42.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="55%" valign="top" style="padding:0in 0in 0in 0in;width:55.28%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Total Exercise Price:</font></b></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="42%" valign="top" style="padding:0in 0in 0in 0in;width:42.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Enclosed with this letter is a check, bank draft or money order in the amount of the Total Exercise Price.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Enclosed with this letter is my executed promissory note, in the form provided to me by the Company, payable to the Company in the amount of the Total Exercise Price as provided in paragraph&nbsp;8 of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; I elect to pay the Total Exercise Price through cancellation of indebtedness owed to me by the Company or by a parent or subsidiary of the Company as provided in paragraph&nbsp;8 of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; I hereby agree to pay the Total Exercise Price within five business days of the date hereof and, as stated in the attached Broker&#146;s Letter,&nbsp;I have delivered irrevocable instructions to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to promptly deliver to the Company the amount of sale or loan proceeds from the Shares to be issued pursuant to this exercise necessary to satisfy my obligation hereunder to pay the Total Exercise Price.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Enclosed with this letter is a certificate evidencing unencumbered Shares (duly endorsed in blank) having an aggregate Fair Market Value (as defined in the Plan) equal to or in excess of the Total Exercise Price.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; I elect to pay the Total Exercise Price through a reduction in the number of Shares delivered to me upon this exercise of the Option as provided in paragraph&nbsp;8 of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If I am enclosing Shares with this letter,&nbsp;I hereby represent and warrant that I am the owner of such Shares free and clear of all liens, security interests and other restrictions or encumbrances.&#160; I agree that I will pay any required withholding taxes in connection with this exercise as provided in paragraph&nbsp;9 of the Plan.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=6,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="6",CHK=928204,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LE_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 17:01 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Please issue a certificate (the &#147;<b>Certificate</b>&#148;) for the number of Shares with respect to which the Option is being exercised in the name of the person indicated below and deliver the Certificate to the address indicated below:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.8%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Name in Which to Issue   Certificate:</font></b></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.8%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.8%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Address to Which Certificate   Should be Delivered:</font></b></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.8%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.8%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.8%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.8%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Principal Mailing Address for   Holder of the Certificate (if different from above):</font></b></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Very truly yours,</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Signature</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name, please print</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Social Security Number</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-LE_PB_2_105330_273"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=7,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="6",CHK=987154,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LE_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 17:01 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 20&nbsp;&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3601 Minnesota Street, Suite&nbsp;800</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Edina, MN 55435</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Ladies and Gentlemen:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.8%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Name of Optionee:</font></b></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.8%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.8%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Date of Grant of Option:</font></b></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.8%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.8%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exercise Price Per Share:</font></b></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.8%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.8%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Number of Shares With Respect   to Which the Option is to be Exercised:</font></b></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.8%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.8%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Total Exercise Price:</font></b></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The above Optionee has requested that we finance the exercise of the above Option to purchase Shares of Common Stock of Tactile Systems Technology,&nbsp;Inc. (the &#147;<b>Company</b>&#148;) and has given us irrevocable instructions to promptly deliver to the Company the amount of sale or loan proceeds from the Shares to be issued pursuant to such exercise to satisfy the Optionee&#146;s obligation to pay the Total Exercise Price.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Very truly yours,</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Broker Name</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By</font></p>    </td>
<td width="46%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:46.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="16022-2-LE_PB_3_114259_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=8,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="6",CHK=251673,FOLIO='3',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LE_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 17:01 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>7
<FILENAME>a2227029zex-10_4.htm
<DESCRIPTION>EX-10.4
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 10.4</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Non-Statutory Stock Option Agreement</font></u></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(Under the 2003 Stock Option Plan - Director)</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name of Optionee:</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No.&nbsp;of Shares   Covered:</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of Grant:</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exercise Price Per   Share:</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Expiration Date:</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exercise Schedule   (Cumulative):</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="73%" style="border-collapse:collapse;margin-left:1.0in;">
<tr>
<td width="65%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:65.22%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Date(s)&nbsp;of<br>   Exercisability</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.4%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="30%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:30.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">No.&nbsp;of&nbsp;Shares&nbsp;as&nbsp;to&nbsp;Which<br>   Option&nbsp;Becomes&nbsp;Exercisable</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.36%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="65%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:65.22%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.4%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="30%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:30.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.36%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="65%" valign="bottom" style="padding:0in 0in 0in 0in;width:65.22%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.4%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="30%" valign="bottom" style="padding:0in 0in 0in 0in;width:30.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.36%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="65%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:65.22%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.4%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="30%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:30.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.36%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This is a Non-Statutory Stock Option Agreement (the &#147;<b>Agreement</b>&#148;) between Tactile Systems Technology,&nbsp;Inc., a Minnesota corporation (the &#147;<b>Company</b>&#148;), and the optionee identified above (the &#147;<b>Optionee</b>&#148;) effective as of the date of grant specified above.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BACKGROUND</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:36.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company maintains the Tactile Systems Technology,&nbsp;Inc. 2003 Stock Option Plan (the &#147;<b>Plan</b>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:36.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">B.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Under the Plan, the Board of Directors of the Company (the &#147;<b>Board</b>&#148;) or a committee of two or more directors of the Company (the &#147;<b>Committee</b>&#148;) appointed by the Board administers the Plan and has the authority to determine the awards to be granted under the Plan (if the Board has not appointed a committee to administer the Plan, then the Board shall constitute the Committee).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:36.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">C.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Committee has determined that the Optionee is eligible to receive an award under the Plan in the form of a non-statutory stock option (the &#147;<b>Option</b>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:36.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">D.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company hereby grants the Option to the Optionee under the terms and conditions as follows.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TERMS AND CONDITIONS</font></b>*</p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Grant</u></b>.&#160; The Optionee is granted the Option to purchase the number of Shares specified at the beginning of this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade align="left" style="color:black;"></div>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Unless the context indicates otherwise, terms that are not defined in this Agreement shall have the meaning set forth in the Plan as it currently exists or as it is amended in the future.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="7",CHK=727231,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LG_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:17 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Exercise Price</u></b>.&#160; The price to the Optionee of each Share subject to the Option will be the exercise price specified at the beginning of this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Non-Statutory Stock Option</u></b>.&#160; The Option is <u>not</u> intended to be an &#147;incentive stock option&#148; within the meaning of Section&nbsp;422 of the Internal Revenue Code of 1986, as amended (the &#147;<b>Code</b>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Exercise Schedule</u></b>.&#160; The Option will vest and become exercisable as to the number of Shares and on the dates specified in the exercise schedule at the beginning of this Agreement, in each case only if the Optionee was providing Services to the Company (as defined in Section&nbsp;7 of this Agreement) on such date.&#160; The exercise schedule will be cumulative; thus, to the extent the Option has not already been exercised and has not expired, terminated or been cancelled, the Optionee or the person otherwise entitled to exercise the Option as provided herein may at any time, and from time to time, purchase all or any portion of the Shares then purchasable under the exercise schedule.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Option may also be exercised in full (notwithstanding the exercise schedule) under the circumstances described in Section&nbsp;7 of this Agreement if it has not expired prior thereto.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Expiration</u></b>.&#160; The Option will expire at 5:00&nbsp;p.m.&nbsp;Central Time on the earliest of:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The expiration date specified at the beginning of this Agreement;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The expiration of the period after the termination of Service of the Optionee to the Company within which the Option can be exercised (as specified in Section&nbsp;7 of this Agreement);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>At the election of the Company, upon termination of the Optionee&#146;s Service to the Company for Cause or if it is determined by the Company within ten days after termination of the Optionee&#146;s Service to the Optionee, such as Optionee&#146;s resignation, that Cause existed for termination by the Company; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The date (if any) fixed for cancellation pursuant to paragraph&nbsp;11(c)&nbsp;or 12 of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In no event may anyone exercise the Option, in whole or in part, after it has expired, notwithstanding any other provision of this Agreement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Procedure to Exercise Option</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.3pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Notice of Exercise</font></i>.&#160; The Option may be exercised by delivering written notice of exercise to the Company at the principal executive office of the Company, to the attention of the Company&#146;s Secretary, in the form attached to this Agreement.&#160; The notice shall state the number of Shares to be purchased, and shall be signed by the person exercising the Option.&#160; If the person exercising the Option is not the Optionee, he/she also must submit appropriate proof of his/her right to exercise the Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.3pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Tender of Payment</font></i>.&#160; Upon giving notice of any exercise hereunder, the Optionee shall provide for payment of the purchase price of the Shares being purchased through one or a combination of the following methods:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Cash (including check, bank draft or money order);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Cancellation of indebtedness owed to the Optionee by the Company or any parent or subsidiary thereof;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>To the extent permitted by law, through a broker-assisted cashless exercise in which the Optionee simultaneously exercises the Option and sells all or a portion of the Shares thereby acquired pursuant to a brokerage or similar relationship and uses the proceeds from such sale to pay the purchase price of such Shares;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-LG_PB_2_111454_8313"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="7",CHK=453368,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LG_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:17 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>By delivery to the Company of unencumbered Shares having an aggregate Fair Market Value on the date of exercise equal to the purchase price of such Shares; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>By authorizing the Company to retain, from the total number of Shares as to which the Option is exercised, that number of Shares having a Fair Market Value on the date of exercise equal to the purchase price for the total number of Shares as to which the Option is exercised.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Notwithstanding the foregoing, the Optionee shall not be permitted to pay any portion of the purchase price with Shares, or by authorizing the Company to retain Shares upon exercise of the Option, if the Committee, in its sole discretion, determines that payment in such manner is undesirable nor may the Company permit the Optionee, if he or she is an executive officer or director of the Company, to pay for the Shares by delivery of a promissory note from an after such time, if any, that the Company (i)&nbsp;has a class of securities registered under Section&nbsp;12 of the Exchange Act, (ii)&nbsp;is required to file reports under Section&nbsp;15(d)&nbsp;of the Exchange Act or (iii)&nbsp;that has filed a registration statement that has not yet become effective under the Securities Act.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.3pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Delivery of Certificates</font></i>.&#160; As soon as practicable after the Company receives the notice and purchase price provided for above, it shall deliver to the person exercising the Option, in the name of such person, a certificate or certificates representing the Shares being purchased.&#160; The Company shall pay any original issue or transfer taxes with respect to the issue or transfer of the Shares and all fees and expenses incurred by it in connection therewith.&#160; All Shares so issued shall be fully paid and nonassessable.&#160; Notwithstanding anything to the contrary in this Agreement, no certificate for Shares distributable under the Plan shall be issued and delivered unless the issuance of such certificate complies with all applicable legal requirements including, without limitation, compliance with the provisions of applicable state securities laws, the Securities Act and the Exchange Act.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Service Requirement</u></b>.&#160; The Option may be exercised only while the Optionee provides services to the Company as a member of its Board of Directors (such director services are referred to collectively in this Agreement as &#147;<b>Service</b>&#148; or &#147;<b>Services</b>&#148;) and only if the Optionee has been continuously providing such Services since the date the Option was granted; <i>provided that</i>:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Option may be exercised for three months after termination of the Optionee&#146;s Service with the Company if such cessation of the Optionee&#146;s Service is for a reason other than death or disability, but only to the extent that it was exercisable immediately prior to termination of Service to the Company, provided that if termination of the Optionee&#146;s Service shall have been for Cause, the Option shall expire, and all rights to purchase Shares hereunder shall terminate, immediately upon such termination.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Option may be exercised for one year after termination of the Optionee&#146;s Service if such termination of Service is because of death or disability of the Optionee.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If the Optionee&#146;s Service terminates after a declaration made pursuant to paragraph&nbsp;12 of the Plan in connection with an Event, the Option may be exercised at any time permitted by such declaration.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Notwithstanding the above, the Option may not be exercised after it has expired.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Acceleration of Vesting</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.3pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Death or Disability.</font></i>&#160; In the event of the death or disability of the Optionee, any portion of the Option that was not previously exercisable shall become immediately exercisable in full if the Optionee shall have been continuously providing Services to the Company or a parent or subsidiary thereof between the date the Option was granted and the date of such death or disability.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="16022-2-LG_PB_3_111540_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=3,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="7",CHK=458930,FOLIO='3',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LG_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:17 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.3pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Change in Control</font></i>.&#160; If a Change in Control of the Company shall or is to occur, then, at the discretion of the Committee, the Option, if not already exercised in full or otherwise terminated, expired or cancelled, may become immediately exercisable in full and/or remain exercisable during the remaining term of the Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.3pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Event</font></i>.&#160; In the event of an Event, at the time of any declaration pursuant to clause&nbsp;(ii)&nbsp;of the first sentence of paragraph&nbsp;12 of the Plan, the Option, if not already exercised in full or otherwise terminated, expired or cancelled, may, at the discretion of the Committee, become immediately exercisable in full and/or remain exercisable during the period preceding the time of cancellation of the Option pursuant to such declaration.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.3pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Discretionary Acceleration</font></i>.&#160; Notwithstanding any other provisions of this Agreement to the contrary, the Committee may, in its sole discretion, declare at any time that the Option shall be immediately exercisable.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Limitation on Transfer</u></b>.&#160; During the lifetime of the Optionee, only the Optionee or his/her guardian or legal representative may exercise the Option.&#160; The Option may not be assigned or transferred by the Optionee otherwise than by will or the laws of descent and distribution or pursuant to a qualified domestic relations order as defined by the Code or Title&nbsp;I of the Employee Retirement Income Security Act, or the rules&nbsp;thereunder; provided, however, that the Optionee may transfer the Option to a member or members of his/her immediate family (i.e., his/her children, grandchildren and spouse) or to one or more trusts for the benefit of such family members or partnerships in which such family members are the only partners, if the Optionee does not receive any consideration for the transfer.&#160; The Option held by any such transferee shall continue to be subject to the same terms and conditions that were applicable to the Option immediately prior to its transfer and may be exercised by such transferee as and to the extent that the Option has become exercisable and has not terminated in accordance with the provisions of the Plan and this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">No Shareholder Rights Before Exercise</u></b>.&#160; No person shall have any of the rights of a shareholder of the Company with respect to any Share subject to the Option until the Share actually is issued to him/her upon exercise of the Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Discretionary Adjustment</u></b>.&#160; In the event of any reorganization, merger, consolidation, recapitalization, liquidation, reclassification, stock dividend, stock split, combination of shares, rights offering, or extraordinary dividend or divestiture (including a spin-off), or any other change in the corporate structure or Shares of the Company, the Committee (or if the Company does not survive any such transaction, a comparable committee of the Board of Directors of the surviving corporation) may, without the consent of the Optionee, make such adjustment as it determines in its discretion to be appropriate as to the number and kind of securities subject to and reserved under the Plan and, in order to prevent dilution or enlargement of rights of the Optionee, the number and kind of securities issuable upon exercise of the Option and the exercise price hereof.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Tax Withholding</u></b>.&#160; Delivery of Shares upon exercise of the Option shall be subject to any required withholding taxes.&#160; As a condition precedent to receiving Shares upon exercise of the Option, the Optionee may be required to pay to the Company, in accordance with the provisions of paragraph&nbsp;9 of the Plan, an amount equal to the amount of any required withholdings.&#160; In lieu of all or any part of such a cash payment, a person exercising the Option may cover all or any part of the required withholdings, and any additional withholdings up to the amount needed to cover the individual&#146;s full FICA and federal, state and local income tax liability with respect to income arising from the exercise of the Option, through the delivery to the Company of unencumbered Shares, through a reduction in the number of Shares delivered to the person exercising the Option or through a subsequent return to the Company of Shares delivered to the person exercising the Option (in each case, such Shares having an aggregate Fair Market Value on the date of exercise equal to the amount of the withholding taxes being paid through such delivery, reduction or </p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">4<a name="16022-2-LG_PB_4_111712_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=4,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="7",CHK=773247,FOLIO='4',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LG_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:17 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">subsequent return of Shares).&#160; Notwithstanding the foregoing, no person shall be permitted to pay any such withholdings with Shares, or through a reduction in the number of Shares to be delivered upon exercise of the Option, if the Committee, in its sole discretion, determines that payment in such manner is undesirable.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Interpretation of This Agreement</u></b>.&#160; All decisions and interpretations made by the Committee with regard to any question arising hereunder or under the Plan shall be binding and conclusive upon the Company and the Optionee.&#160; If there is any inconsistency between the provisions of this Agreement and the Plan, the provisions of the Plan shall govern.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Option Subject to Plan, Articles of Incorporation and By-Laws</u></b>.&#160; The Optionee acknowledges that the Option and the exercise thereof is subject to the Plan, the Articles of Incorporation, as amended from time to time, and the By-Laws, as amended from time to time, of the Company, and any applicable federal or state laws, rules&nbsp;or regulations.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Obligation to Reserve Sufficient Shares</u></b>.&#160; The Company shall at all times during the term of the Option reserve and keep available a sufficient number of Shares to satisfy this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">16.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Binding Effect</u></b>.&#160; This Agreement shall be binding in all respects on the heirs, representatives, successors and assigns of the Optionee.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Choice of Law</u></b>.&#160; This Agreement is entered into under the laws of the State of Minnesota and shall be construed and interpreted thereunder (without regard to its conflict of law principles).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Tax Consequences</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Optionee may incur tax liability as a result of the Optionee&#146;s purchase or disposition of the Shares.&#160; <b>THE OPTIONEE SHOULD CONSULT A TAX ADVISER BEFORE EXERCISING THE OPTION OR DISPOSING OF THE SHARES.</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Notwithstanding the Company&#146;s good faith determination of the Fair Market Value of the Company&#146;s common stock for purposes of determining the exercise price per Share of the Option, the taxing authorities may assert that the fair market value of the Company&#146;s common stock on the date of grant was greater than the exercise price per Share.&#160; Under Section&nbsp;409A of the Code, if the exercise price per Share of the Option is less than the fair market value of the Company&#146;s common stock on the date of grant, the Option may be treated as a form of deferred compensation and the Optionee may be subject to an additional 20% tax, plus interest and possible penalties.&#160; The Optionee is encouraged to consult a tax adviser regarding the potential impact of Section&nbsp;409A of the Code.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Amendment to Meet the Requirements of Section&nbsp;409A</u></b>.&#160; The Optionee acknowledges that the Company, in the exercise of its sole discretion and without the consent of the Optionee, may amend or modify this Agreement in any manner and delay the payment of any amounts payable pursuant to this Agreement to the minimum extent necessary to meet the requirements of Section&nbsp;409A of the Code as amplified by any Internal Revenue Service or U.S. Treasury Department regulations or guidance as the Company deems appropriate or advisable.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">5<a name="16022-2-LG_PB_5_111847_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=5,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="7",CHK=545400,FOLIO='5',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LG_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:17 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:36.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Optionee and the Company have executed this Agreement as of date of grant stated above.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">OPTIONEE</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS   TECHNOLOGY,&nbsp;INC.</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By</font></p>    </td>
<td width="44%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:44.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>
<td width="44%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:44.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Its:</font></p>    </td>
<td width="44%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:44.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">6<a name="16022-2-LG_PB_6_112200_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=6,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="7",CHK=15207,FOLIO='6',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LG_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:17 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="100%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt 10.1pt;text-align:center;text-indent:-10.1pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u>,   20<u>&nbsp;&nbsp;&nbsp;&nbsp;</u></p>    </td>   </tr>
<tr>
<td width="100%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TACTILE SYSTEMS   TECHNOLOGY,&nbsp;INC.</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4824 Park Glen Road</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Minneapolis, Minnesota   55416</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Ladies and Gentlemen:</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:36.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">I hereby exercise the following option (the &#147;<b>Option</b>&#148;) granted to me under the Tactile Systems Technology,&nbsp;Inc. 2003 Stock Option Plan (the &#147;<b>Plan</b>&#148;) with respect to the number of shares of Common Stock of Tactile Systems Technology,&nbsp;Inc. (the &#147;<b>Company</b>&#148;) indicated below:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="51%" valign="top" style="padding:0in 0in 0in 0in;width:51.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Name:</font></b></p>    </td>
<td width="49%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:49.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="51%" valign="top" style="padding:0in 0in 0in 0in;width:51.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="51%" valign="top" style="padding:0in 0in 0in 0in;width:51.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Date of Grant of Option:</font></b></p>    </td>
<td width="49%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:49.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="51%" valign="top" style="padding:0in 0in 0in 0in;width:51.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="51%" valign="top" style="padding:0in 0in 0in 0in;width:51.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exercise Price Per Share:</font></b></p>    </td>
<td width="49%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:49.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="51%" valign="top" style="padding:0in 0in 0in 0in;width:51.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="51%" valign="top" style="padding:0in 0in 0in 0in;width:51.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Number of Shares With Respect   to Which the Option is Hereby Exercised:</font></b></p>    </td>
<td width="49%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:49.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="51%" valign="top" style="padding:0in 0in 0in 0in;width:51.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="51%" valign="top" style="padding:0in 0in 0in 0in;width:51.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Total Exercise Price:</font></b></p>    </td>
<td width="49%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:49.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Enclosed with this letter is a check, bank draft or money order in the amount of the Total Exercise Price.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>I elect to pay the Total Exercise Price through cancellation of indebtedness owed to me by the Company or by a parent or subsidiary of the Company as provided in paragraph&nbsp;8 of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>I hereby agree to pay the Total Exercise Price within five business days of the date hereof and, as stated in the attached Broker&#146;s Letter,&nbsp;I have delivered irrevocable instructions to <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> to promptly deliver to the Company the amount of sale or loan proceeds from the Shares to be issued pursuant to this exercise necessary to satisfy my obligation hereunder to pay the Total Exercise Price.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Enclosed with this letter is a certificate evidencing unencumbered Shares (duly endorsed in blank) having an aggregate Fair Market Value (as defined in the Plan) equal to or in excess of the Total Exercise Price.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>I elect to pay the Total Exercise Price through a reduction in the number of Shares delivered to me upon this exercise of the Option as provided in paragraph&nbsp;8 of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:36.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If I am enclosing Shares with this letter,&nbsp;I hereby represent and warrant that I am the owner of such Shares free and clear of all liens, security interests and other restrictions or encumbrances.&#160; I agree that I will pay any required withholding taxes in connection with this exercise as provided in paragraph&nbsp;9 of the Plan.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=7,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="7",CHK=940745,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LG_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:17 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:36.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Please issue a certificate (the &#147;<b>Certificate</b>&#148;) for the number of Shares with respect to which the Option is being exercised in the name of the person indicated below and deliver the Certificate to the address indicated below:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Name in Which to Issue   Certificate:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Address to Which Certificate   Should be </font></b></p>    </td>
<td width="50%" valign="bottom" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Delivered:</font></b></p>    </td>
<td width="50%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Principal Mailing Address for   Holder of<br>   the Certificate (if different from above):</font></b></p>    </td>
<td width="50%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Very truly yours,</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Signature</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name, please print</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Social Security Number</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-LG_PB_2_113727_8832"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=8,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="7",CHK=456031,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LG_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:17 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="100%" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u>,   20<u>&nbsp;&nbsp;&nbsp;&nbsp;</u></p>    </td>   </tr>
<tr>
<td width="100%" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="100%" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TACTILE SYSTEMS   TECHNOLOGY,&nbsp;INC.</font></p>    </td>   </tr>
<tr>
<td width="100%" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4824 Park Glen Road</font></p>    </td>   </tr>
<tr>
<td width="100%" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Minneapolis, Minnesota   55416</font></p>    </td>   </tr>
<tr>
<td width="100%" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="100%" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Ladies and Gentlemen:</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="53%" valign="top" style="padding:0in 0in 0in 0in;width:53.58%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Name of Optionee:</font></b></p>    </td>
<td width="46%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:46.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="53%" valign="top" style="padding:0in 0in 0in 0in;width:53.58%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="53%" valign="top" style="padding:0in 0in 0in 0in;width:53.58%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Date of Grant of Option:</font></b></p>    </td>
<td width="46%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:46.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="53%" valign="top" style="padding:0in 0in 0in 0in;width:53.58%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="53%" valign="top" style="padding:0in 0in 0in 0in;width:53.58%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exercise Price Per Share:</font></b></p>    </td>
<td width="46%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:46.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="53%" valign="top" style="padding:0in 0in 0in 0in;width:53.58%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="46%" valign="bottom" style="padding:0in 0in 0in 0in;width:46.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="53%" valign="top" style="padding:0in 0in 0in 0in;width:53.58%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Number&nbsp;of&nbsp;Shares&nbsp;With&nbsp;Respect&nbsp;to&nbsp;Which</font></b></p>    </td>
<td width="46%" valign="bottom" style="padding:0in 0in 0in 0in;width:46.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="53%" valign="top" style="padding:0in 0in 0in 0in;width:53.58%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">the Option is to be Exercised:</font></b></p>    </td>
<td width="46%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:46.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="53%" valign="top" style="padding:0in 0in 0in 0in;width:53.58%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="53%" valign="top" style="padding:0in 0in 0in 0in;width:53.58%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Total Exercise Price:</font></b></p>    </td>
<td width="46%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:46.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:36.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The above Optionee has requested that we finance the exercise of the above Option to purchase Shares of Common Stock of Tactile Systems Technology,&nbsp;Inc. (the &#147;<b>Company</b>&#148;) and has given us irrevocable instructions to promptly deliver to the Company the amount of sale or loan proceeds from the Shares to be issued pursuant to such exercise to satisfy the Optionee&#146;s obligation to pay the Total Exercise Price.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Very truly yours,</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Broker Name</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By</font></p>    </td>
<td width="46%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:46.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=9,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="7",CHK=112413,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LG_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:17 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>8
<FILENAME>a2227029zex-10_5.htm
<DESCRIPTION>EX-10.5
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 10.5</font></b></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<table border="1" cellspacing="0" cellpadding="0" width="100%" style="border:none;border-collapse:collapse;">
<tr>
<td width="100%" valign="top" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:100.0%;">
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">December&nbsp;6, 2012</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2007 OMNIBUS STOCK PLAN</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(Amended and Restated October&nbsp;21, 2008; <br> Further Amended September&nbsp;14, 2012)</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="1" cellspacing="0" cellpadding="0" width="100%" style="border:none;border-collapse:collapse;">
<tr>
<td width="100%" valign="top" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:100.0%;">
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="8",CHK=339795,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LI-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 11:41 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">To Recipients Of Awards Under The</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Tactile Systems Technology,&nbsp;Inc.</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2007 Omnibus Stock Plan</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">You have received an award under the Tactile Systems Technology,&nbsp;Inc. 2007 Omnibus Stock Plan.&#160; Awards under the plan may be in the form of stock options, stock appreciation rights, performance units, restricted stock or other stock-based awards.&#160; A copy of the plan is attached as <i>Exhibit&nbsp;A</i>.&#160; You have also executed an agreement covering the additional terms of your award.&#160; The plan and your agreement together contain your rights and obligations as the recipient of an award under the plan.&#160; The company suggests that you read the plan and your agreement carefully, if you have not already done so.&#160; This document summarizes the material features of the plan.&#160; This summary is qualified by the text of the plan and by the specific terms of the agreement entered into between you and the company with respect to any award granted under the plan.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">General Information About The Plan</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The purpose of the plan is to motivate key personnel to produce a superior return for the company&#146;s stockholders by offering them an opportunity to realize stock appreciation, by facilitating their ownership of common stock and by rewarding them for achieving a high level of corporate performance.&#160; The plan is also intended to facilitate recruiting and retaining key personnel, including outside directors, consultants, and advisors, of outstanding ability.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">There are 6,499,865 shares of common stock available for awards under the plan.&#160; This number is subject to adjustment for future stock splits, stock dividends and similar changes in the capitalization of the company.&#160; The plan will remain in effect until all stock subject to it has been distributed or until all awards have expired or lapsed.&#160; In addition, the board of directors may terminate the plan at any time, subject to the conditions stated in the plan.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The plan is not subject to the Employee Retirement Income Security Act of 1974 and is not a &#147;qualified plan&#148; under Section&nbsp;401(a)&nbsp;of the Internal Revenue Code of 1986.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Plan Administration</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The plan is administered by a committee of two or more non-employee members of the board of directors, or by action of the board of directors as permitted in the plan.&#160; In the event of a conflict between a permitted action of the board of directors and an action of the committee, the action of the board of directors controls.&#160; The committee has the authority to interpret the plan and any award or agreement made under the plan.&#160; The committee also has the authority, subject to the terms of the plan, to establish, amend, waive and rescind any rules&nbsp;relating to the plan.&#160; The committee is also responsible for determining when and to whom awards will be granted, the form of each award, the amount of each award and any other terms of an award, consistent with the plan.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Members of the committee are designated by the board of directors and serve on the committee for an indefinite term, at the discretion of the board of directors.&#160; The committee may delegate all or any portion of its authority to persons who are not non-employee directors solely for purposes of determining and administering awards to persons who are not insiders of the company.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Eligibility</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">All of the employees and persons who provide services to the company and its affiliates, including directors, advisors and consultants, are eligible to receive awards under the plan.&#160; The selection of those to whom awards under the plan are made is within the sole discretion of the committee.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Types Of Awards Under The Plan</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The types of awards that may be granted under the plan include incentive stock options (also known as ISOs), non-statutory stock options (which are similar to stock options previously known as non-qualified stock options), stock appreciation rights, performance units, restricted stock and other stock-based awards.&#160; The following is a brief description of the material characteristics of each type of award.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Incentive and Non-Statutory Stock Options.</font></i></b>&#160; Incentive stock options are options designated by the committee as incentive stock options that comply with the requirements of Section&nbsp;422 of the Internal Revenue Code of 1986 or any successor provision.&#160; Non-statutory stock options are all options other than incentive stock options.&#160; Stock options may be granted and exercised at such times as the committee may determine.&#160; The purchase price of each share subject to an option shall be determined by the committee and set forth in the agreement, and, except where determined</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">1<a name="16022-2-LI-01_PB_1_111709_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="8",CHK=568814,FOLIO='1',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LI-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 11:41 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">otherwise by the committee, shall not be less than 100% of the fair market value of a share as of the date the option is granted.&#160; Each option shall be exercisable in whole or in part on the terms provided in the agreement.&#160; In no event shall any option be exercisable at any time after the expiration of its term.&#160; When an option is no longer exercisable, it shall be deemed to have lapsed or terminated.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The purchase price of the shares with respect to which an option is exercised shall be payable in full at the time of exercise.&#160; The purchase price may be payable in cash, by delivery or tender of shares having a fair market value as of the date the option is exercised equal to the purchase price of the shares being purchased pursuant to the option, or a combination thereof, as determined by the committee, but no fractional shares will be issued or accepted.&#160; A participant exercising a stock option shall not be permitted to pay any portion of the purchase price with shares if, in the opinion of the committee, payment in such manner could have adverse financial accounting consequences for the company.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">With respect to incentive stock options, the committee retains full authority to impose other conditions, limitations or provisions where needed to qualify the option as an incentive stock option.&#160; For example, the Internal Revenue Code currently includes the following requirements for a stock option to qualify as an incentive stock option:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the purchase price of each share subject to an incentive stock option shall not be less than 100% of the fair market value of a share as of the date the incentive stock option is granted;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the aggregate fair market value of the shares with respect to which incentive stock options held by an individual first become exercisable in any calendar year shall also not exceed $100,000 (or such other limit required by law) - any stock options exceeding this limit will be treated as non-statutory stock options;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>an incentive stock option will not be exercisable more than 10 years after the date of grant (or such other limit imposed by law); and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the recipient of an incentive stock option must be an employee of the company on the date of grant.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In addition, no participant may receive an incentive stock option under the plan if, at the time the award is granted, the participant owns shares possessing more than 10% of the total combined voting power of all classes of stock of the company or its subsidiaries, <i>unless</i> (1)&nbsp;the exercise price for that incentive stock option is at least 110% of the fair market value of the shares subject to that incentive stock option on the date of grant and (2)&nbsp;that option is not exercisable after the date five years from the date of grant.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Stock Appreciation Rights and Performance Units</font></i>.</b>&#160; The recipient of a stock appreciation right receives, upon exercise of the right and subject to the terms and conditions specified by the committee, all or a portion of the excess of the fair market value of a specified number of shares as of the date of exercise of the right over a specified price that shall not be less than 100% of the fair market value of such shares as of the date of grant of the right.&#160; Payment shall be made upon exercise of a stock appreciation right, subject to terms and conditions imposed by the committee in the agreement.&#160; No stock appreciation right shall be exercisable at any time after the expiration of its term, and when a stock appreciation right is no longer exercisable, it shall be deemed to have lapsed or terminated.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">An award of performance units under the plan entitles the recipient to future payments of cash, shares or a combination of cash and shares, as determined by the committee, based upon the achievement of pre-established performance targets.&#160; The committee shall determine the extent to which performance targets have been attained and the amount of payment due for such satisfaction.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Note that an agreement may permit an acceleration of the performance cycle, and an adjustment of performance targets and payments with respect to some or all of the performance units awarded to a participant, upon the occurrence of certain events, which may, but need not include, without limitation, a fundamental change in the company as defined in the plan, the participant&#146;s death or retirement or other events affecting the capitalization of our company.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Restricted Stock and Other Stock-Based Awards</font></i>.&#160; </b>The committee may award restricted stock under the plan, which is stock subject to specified restrictions on transfer and conditions of forfeiture.&#160; A holder of restricted stock shall have all the other rights of a stockholder, including the right to receive dividends and the right to vote.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-LI-01_PB_2_111835_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=3,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="8",CHK=656514,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LI-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 11:41 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The committee may also award stock or other awards, such as securities convertible into stock and phantom securities.&#160; The granting of such awards is within the discretion of the committee.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Acceleration of Awards, Lapse of Restrictions, Forfeiture</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The committee may provide in an award agreement for the lapse or waiver of restrictions or conditions on restricted stock or other awards, or acceleration of the vesting of stock options, stock appreciation rights and other awards, or acceleration of the term with respect to which the achievement of performance targets for performance units is determined in the event of a fundamental change in the corporate structure of the company, upon a change of control of the company or upon the participant&#146;s death, disability or retirement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If the participant&#146;s employment or other relationship with the company or its affiliates is terminated for any reason, then any unexercised portion of the award will generally be forfeited, except as provided in the award agreement or by the committee.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Adjustments, Modifications, Termination</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The board of directors may at any time terminate, suspend or modify the plan.&#160; And, except as where stated otherwise in the plan, the committee may at any time alter or amend any or all agreements under the plan to the extent permitted by law.&#160; No termination, suspension, or modification of the plan will materially and adversely affect any right acquired by a participant before the date of such termination, suspension, or modification.&#160; However, any and all adjustments made in response to changes in the capitalization of the company will be conclusively presumed to not adversely affect any rights of award recipients.&#160; If the company experiences a change in capitalization, a fundamental change, or any other relevant change as described in the plan, the committee may make appropriate adjustments to the awards in order to prevent enlargement of rights or inappropriate dilution of rights.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Federal Tax Considerations </font></b>(United States Only)</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This section summarizes the material federal income tax consequences that may result from awards made under the plan.&#160; Because this is only a summary, issues that are material to you may not be discussed.&#160; Furthermore, the tax laws are subject to legislative changes and new or revised administrative or judicial interpretations.&#160; You may also incur foreign, state or local tax consequences that are not discussed in this summary.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Therefore, you are encouraged to review with your own tax adviser the tax status of your award.&#160; You are also encouraged to consult your tax advisor before exercising any award regarding the tax consequences of the proposed exercise.</font></i></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Incentive Stock Options.</font></i></b>&#160; You will realize no taxable income, and the company will not be entitled to any related deduction, when you are granted an incentive stock option.&#160; If certain statutory employment and holding period conditions are satisfied before you dispose of the shares acquired pursuant to the exercise of such an option, then you will generally not realize any taxable income upon the exercise of such an option and the company will not be entitled to any deduction in connection with such exercise, subject to any possible applicable requirements based upon alternative minimum tax regulations discussed later in this section.&#160; Upon disposition of the shares after expiration of the statutory holding periods, any gain or loss you realize will be a capital gain or loss.&#160; The company will not be entitled to a deduction with respect to a disposition of the shares by a recipient after the expiration of the statutory holding periods.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Except in the event of death, if you dispose of the shares acquired upon exercise of an incentive stock option before the expiration of the statutory holding periods, you will be considered to have realized as compensation, taxable as ordinary income in the year of disposition in an amount, not exceeding the gain realized on such disposition, equal to the difference between the exercise price and the fair market value of the shares on the date of exercise of the option.&#160; The company will be entitled to a deduction at the same time and in the same amount as you are deemed to have realized ordinary income.&#160; Any gain realized on the disposition in excess of the amount treated as compensation or any loss realized on the disposition will constitute capital gain or loss, respectively.&#160; If you pay the exercise price with shares that were originally acquired pursuant to the exercise of an incentive stock option and the statutory holding periods for the shares have not been met, you will be treated as having made a disqualifying disposition of such shares, and the tax consequences of such disqualifying disposition will be as described above.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The foregoing discussion applies only for regular tax purposes.&#160; For alternative minimum tax purposes, an incentive stock option will be treated as if it were a non-statutory stock option, the tax consequences of which are discussed below.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="16022-2-LI-01_PB_3_111920_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=4,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="8",CHK=586574,FOLIO='3',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LI-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 11:41 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Non-Statutory Stock Options</font></i>.</b>&#160; You will realize no taxable income, and the company will not be entitled to any related deduction, when any non-statutory stock option is granted under the plan.&#160; Upon exercise of a non-statutory stock option, you will realize ordinary income, and the company will be entitled to a deduction, equal to the excess of the fair market value of the shares on the date of exercise over the exercise price.&#160; Upon disposition of the shares, any additional gain or loss realized by you will be taxed as a capital gain or loss.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Stock Appreciation Rights and Performance Units.</font></i></b>&#160; Generally, you will realize no income upon the award of a stock appreciation right or performance units.&#160; You will realize ordinary income, and the company will be entitled to a corresponding deduction, when cash or shares are delivered to you upon exercise of a stock appreciation right or in payment of the performance unit award.&#160; The amount of ordinary income and deduction will be the amount of cash, plus fair market value of the shares received on the date you receive them.&#160; Upon a subsequent disposition of shares you receive, any additional gain or loss you realize will be taxed as capital gain or loss.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Restricted Stock and Other Stock-Based Awards.</font></i></b>&#160; Unless you file an election to be taxed under Section&nbsp;83(b)&nbsp;of the Internal Revenue Code, the following federal tax consequences will generally apply to an award of restricted stock:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>you will not realize income upon the grant of the restricted stock;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>you will realize ordinary income, and the company will be entitled to a corresponding deduction, when the restrictions on your stock have been removed or have expired; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the amount of your ordinary income and the company&#146;s deduction will be the fair market value of the stock on the date the restrictions are removed or expire.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If you elect to be taxed under Section&nbsp;83(b)&nbsp;or if you were awarded unrestricted stock, then the tax consequences to you and us will be determined as of the date of the grant of the stock, rather than as of the date of the removal or expiration of the restrictions.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">With respect to awards of <i>unrestricted</i> stock, generally (a)&nbsp;you will realize ordinary income and the company will be entitled to a corresponding deduction upon the grant of the unrestricted stock and (b)&nbsp;the amount of the ordinary income and deduction will be the fair market value of such unrestricted stock on the date of the grant.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">When you dispose of restricted or unrestricted stock, the difference between the amount you receive upon the disposition and the fair market value of the shares on the date you realized ordinary income will be taxed as a capital gain or loss.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Withholding.</font></i></b>&#160; The plan permits the company to withhold from cash awards, and to require you to pay us, cash sufficient to cover any required withholding taxes.&#160; In lieu of cash, the committee may permit you to cover withholding obligations through a reduction in the number of shares delivered to you or through your surrender to the company of shares of the company&#146;s common stock that you own.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Section&nbsp;409A</font></i></b>:&#160; Under Section&nbsp;409A of the Internal Revenue Code, if the exercise price or grant price of an award is less than the fair market value of the Company&#146;s common stock on the date of grant or the terms of the award otherwise violate the safe harbors of Section&nbsp;409A of the Internal Revenue Code, the award may be treated as a form of deferred compensation and you may be subject to an additional 20% tax, plus interest and possible penalties.&#160; You are encouraged to consult a tax adviser regarding the potential impact of Section&nbsp;409A of the Internal Revenue Code.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Restrictions on Transfer of Awards</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Except as provided otherwise in the plan, the only person who may exercise an option, stock appreciation right, or receive payments pursuant to performance units or any other award, is the participant who received such award under this plan.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No award of restricted stock (before the expiration of the restrictions), options, stock appreciation rights, performance units or other award, may be sold, assigned, transferred, exchanged or otherwise encumbered except under the following limited circumstances:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>transfers or grants to a successor&#146;s in interest in the event of the participant&#146;s death;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">4<a name="16022-2-LI-01_PB_4_112008_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=5,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="8",CHK=781379,FOLIO='4',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LI-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 11:41 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>pursuant to a qualified domestic relations order as defined in the Internal Revenue Code of 1986 or Title 1 of the Employee Retirement Income Security Act of 1974; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the committee specifically authorizes a transfer of the interest in the award where no consideration accompanies the transfer.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Any attempted transfer not permitted by the plan is ineffective.&#160; And, where a transfer is authorized, the transferee continues to be subject to the terms and conditions of the award as existed immediately before the transfer.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Resale Considerations</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Shares of stock acquired under the plan are not registered under the Securities Act of 1933 or the securities laws of any state.&#160; Consequently, any person acquiring the shares must bear the economic risk of the investment for an indefinite period of time, and the shares cannot be sold unless they are subsequently registered under the Securities Act of 1933 and applicable state securities laws, or an exemption from such registration is available.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Prospective acquirers of the shares are advised to seek independent legal advice of their own choice regarding the requirements imposed by the Securities Act of 1933 and by state securities laws and other legal matters relevant to the shares.&#160; A legend will be placed on the shares stating that such securities have not been registered under the Securities Act of 1933 or under other securities laws and may not be sold or otherwise disposed of without such registration or the availability of any exemption therefrom, according to an opinion of counsel satisfactory to the company.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Where You Can Find More Information</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">You may request, in writing or orally, a copy of any additional information regarding the company, the plan or the committee, at no cost, by contacting the company at the following address:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Chief Executive Officer</font></p>
<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Tactile Systems Technology,&nbsp;Inc.</font></p>
<p style="margin:0in 0in .0001pt 2.0in;text-indent:.7pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1331 Tyler Street NE, Suite&nbsp;200</font></p>
<p style="margin:0in 0in .0001pt 2.0in;text-indent:.7pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Minneapolis, MN 55413</font></p>
<p style="margin:0in 0in .0001pt 2.0in;text-indent:.7pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Telephone:&#160; (612) 355-5201</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">5<a name="16022-2-LI-01_PB_5_112134_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=6,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="8",CHK=419433,FOLIO='5',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LI-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 11:41 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EXHIBIT&nbsp;A</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.<br> 2007 OMNIBUS STOCK PLAN</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Originally approved by the stockholders on October&nbsp;25, 2007<br> Amended and restated by stockholders on October&nbsp;21, 2008<br> Amendment No.&nbsp;1 by stockholders September&nbsp;14, 2012</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Purpose</u>.&#160; The purpose of the Tactile Systems Technology,&nbsp;Inc. 2007 Omnibus Stock Plan (the &#147;<u>Plan</u>&#148;) is to promote the interests of the Company and its stockholders by providing key personnel of the Company and its Affiliates with an opportunity to acquire a proprietary interest in the Company and reward them for achieving a high level of performance and thereby develop a stronger incentive to put forth maximum effort for the continued success and growth of the Company and its Affiliates.&#160; In addition, the opportunity to acquire a proprietary interest in the Company will aid in attracting and retaining key personnel of outstanding ability.&#160; The Plan is also intended to provide Outside Directors with an opportunity to acquire a proprietary interest in the Company, to compensate Outside Directors, consultants and advisors for their contribution to the Company and to aid in attracting and retaining Outside Directors and qualified consultants and advisors.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Definitions</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The capitalized terms used elsewhere in the Plan have the meanings set forth below.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<u>Affiliate</u>&#148; means any corporation that is a &#147;parent corporation&#148; or &#147;subsidiary corporation&#148; of the Company, as those terms are defined in Code Sections 424(e)&nbsp;and (f), or any successor provisions.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<u>Agreement</u>&#148; means a written contract (i)&nbsp;consistent with the terms of the Plan entered into between the Company or an Affiliate and a Participant and (ii)&nbsp;containing the terms and conditions of an Award in such form and not inconsistent with the Plan as the Committee shall approve from time to time, together with all amendments thereto, which amendments may be unilaterally made by the Company (with the approval of the Committee) unless such amendments are deemed by the Committee to be materially adverse to the Participant and not required as a matter of law.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<u>Award</u>&#148; or &#147;<u>Awards</u>&#148; means a grant made under the Plan in the form of Restricted Stock, Options, Stock Appreciation Rights, Performance Units,&#160; Stock or any other stock-based award.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<u>Board</u>&#148; means the Board of Directors of the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<u>Code</u>&#148; means the Internal Revenue Code of 1986, as amended and in effect from time to time or any successor statute.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<u>Committee</u>&#148; means two or more directors designated by the Board to administer the Plan under Section&nbsp;3.1 of the Plan.&#160; From and after the time, if any, that the Company has a class of securities registered under Section&nbsp;12 of the Exchange Act, Committee means two or more Non-Employee Directors designated by the Board to administer the Plan under Section&nbsp;3.1 of the Plan.&#160; If the Board has not designated a committee to administer the Plan, then the Board will constitute the Committee.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<u>Company</u>&#148; means Tactile Systems Technology,&nbsp;Inc., a Delaware corporation, or any successor to all or substantially all of its businesses by merger, consolidation, purchase of assets or otherwise.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<u>Effective Date</u>&#148; means the date specified in Section&nbsp;12.1 of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<u>Employee</u>&#148; means an employee (including an officer or director who is also an employee) of the Company or an Affiliate.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A-</font>1<a name="16022-2-LI-01_PB_1_112351_5818"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=7,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="8",CHK=248814,FOLIO='A-1',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LI-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 11:41 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(j)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<u>Exchange Act</u>&#148; means the Securities Exchange Act of 1934, as amended and in effect from time to time or any successor statute.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(k)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<u>Fair Market Value</u>&#148; as of any date means, unless otherwise expressly provided in the Plan:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the closing sale price of a Share on the date in question, or, if no sale of Shares shall have occurred on that date, on the next preceding day on which a sale of Shares occurred</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 2.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(A)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>on the composite tape for New York Stock Exchange listed shares, or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 2.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(B)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>if the Shares are not quoted on the composite tape for New York Stock Exchange listed shares, on the principal United States Securities Exchange registered under the Exchange Act on which the Shares are listed, or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 2.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(C)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>if the Shares are not listed on any such exchange, on the National Association of Securities Dealers,&nbsp;Inc. Automated Quotations National Market System or any system then in use, or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>if clause (i)&nbsp;is inapplicable, the mean between the closing &#147;bid&#148; and the closing &#147;asked&#148; quotation of a Share on the date immediately preceding that date, or, if no closing bid or asked quotation is made on that date, on the next preceding day on which a closing bid and asked quotation is made, on the National Association of Securities Dealers,&nbsp;Inc. Automated Quotations System or any system then in use, or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>if clauses (i)&nbsp;and (ii)&nbsp;are inapplicable, what the Committee determines in good faith and in a manner consistent with Code Section&nbsp;409A to be 100% of the fair market value of a Share on that date.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">However, if the applicable securities exchange or system has closed for the day at the time the event occurs that triggers a determination of Fair Market Value, whether the grant of an Award, the exercise of an Option or Stock Appreciation Right or otherwise, all references in this paragraph to the &#147;date immediately preceding that date&#148; shall be deemed to be references to &#147;that date.&#148;&#160; In the case of an Incentive Stock Option, if this determination of Fair Market Value is not consistent with the then current regulations of the Secretary of the Treasury, Fair Market Value shall be determined in accordance with those regulations.&#160; The determination of Fair Market Value shall be subject to adjustment as provided in Section&nbsp;16 of the Plan.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(l)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<u>Fundamental Change</u>&#148; means a dissolution or liquidation of the Company, a sale of substantially all of the assets of the Company, a merger or consolidation of the Company with or into any other corporation, regardless of whether the Company is the surviving corporation, or a statutory share exchange involving capital stock of the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(m)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<u>Incentive Stock Option</u>&#148; means any Option designated as such and granted in accordance with the requirements of Code Section&nbsp;422 or any successor provision.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(n)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<u>Insider</u>&#148; as of a particular date means any person who, as of that date is an officer of the Company as defined under Exchange Act Rule&nbsp;16a-1(f)&nbsp;or its successor provision.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(o)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<u>Non-Employee Director</u>&#148; means a member of the Board who is considered a non-employee director within the meaning of Exchange Act Rule&nbsp;16b-3(b)(3)&nbsp;or its successor provision and an outside director for purposes of Code Section&nbsp;162(m).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(p)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<u>Non-Statutory Stock Option</u>&#148; means an Option other than an Incentive Stock Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(q)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<u>Option</u>&#148; means a right to purchase Stock, including both Non-Statutory Stock Options and Incentive Stock Options.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(r)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<u>Outside Director</u>&#148; means a director who is not an Employee.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A-</font>2<a name="16022-2-LI-01_PB_2_112434_141"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=8,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="8",CHK=482126,FOLIO='A-2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LI-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 11:41 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(s)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<u>Participant</u>&#148; means a person or entity to whom an Award is or has been made in accordance with the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(t)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<u>Performance Cycle</u>&#148; means the period of time as specified in an Agreement over which Performance Units are to be earned.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(u)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<u>Performance Units</u>&#148; means an Award made pursuant to Section&nbsp;11 of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(v)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<u>Plan</u>&#148; means this 2007 Omnibus Stock Plan, as may be amended and in effect from time to time.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(w)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<u>Restricted Stock</u>&#148; means Stock granted under Section&nbsp;7 of the Plan so long as such Stock remains subject to one or more restrictions.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(x)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<u>Share</u>&#148; means a share of Stock.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(y)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<u>Stock</u>&#148; means the common stock of the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(z)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<u>Stock Appreciation Right</u>&#148; means a right, the value of which is determined in relation to the appreciation in value of Shares pursuant to an Award granted under Section&nbsp;10 of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(aa)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<u>Subsidiary</u>&#148; means a &#147;subsidiary corporation,&#148; as that term is defined in Code Section&nbsp;424(f)&nbsp;or any successor provision.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(bb)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<u>Successor</u>&#148; with respect to a Participant means the legal representative of an incompetent Participant, and if the Participant is deceased the estate of the Participant or the person or persons who may, by bequest or inheritance, or pursuant to the terms of an Award, acquire the right to exercise an Option or Stock Appreciation Right or to receive cash and/or Shares issuable in satisfaction of an Award in the event of the Participant&#146;s death.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(cc)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<u>Term</u>&#148; means the period during which an Option or Stock Appreciation Right may be exercised or the period during which the restrictions or terms and conditions placed on Restricted Stock or any other Award are in effect.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(dd)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#147;<u>Transferee</u>&#148; means any member of the Participant&#146;s immediate family (<i>i.e.</i>, his or her children, step-children, grandchildren and spouse) or one or more trusts for the benefit of such family members or partnerships in which such family members are the only partners.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Gender and Number</u>.&#160; Except when otherwise indicated by the context, reference to the masculine gender shall include, when used, the feminine gender and any term used in the singular shall also include the plural.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Administration and Indemnification</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><u style="font-style:italic;">Administration</u></i>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Committee shall administer the Plan.&#160; The Committee shall have exclusive power to (i)&nbsp;make Awards, (ii)&nbsp;determine when and to whom Awards will be granted, the form of each Award, the amount of each Award, and any other terms or conditions of each Award consistent with the Plan, and (iii)&nbsp;determine whether, to what extent and under what circumstances, Awards may be settled, paid or exercised in cash, Shares or other Awards, or other property or canceled, forfeited or suspended.&#160; Each Award shall be subject to an Agreement authorized by the Committee.&#160; A majority of the members of the Committee shall constitute a quorum for any meeting of the Committee, and acts of a majority of the members present at any meeting at which a quorum is present or the acts unanimously approved in writing by all members of the Committee shall be the acts of the Committee.&#160; Notwithstanding the foregoing, the Board shall have the sole and exclusive power to administer the Plan with respect to Awards granted to Outside Directors and, except to the extent that the grant or exercise of such authority would cause any Award or transaction to become subject to (or lose an exemption under) the short-swing profit recovery provisions of Section&nbsp;16 of the Exchange Act, the Board may, at any time and from time to time, without any further action of the Committee, exercise</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A-</font>3<a name="16022-2-LI-01_PB_3_112526_7608"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=9,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="8",CHK=453603,FOLIO='A-3',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LI-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 11:41 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">the powers and duties of the Committee under the Plan.&#160; To the extent that any permitted action taken by the Board conflicts with action taken by the Committee, the Board action will control.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Solely for purposes of determining and administering Awards to Participants who are not Insiders, the Committee may delegate all or any portion of its authority under the Plan to one or more persons who are not Non-Employee Directors.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>To the extent within its discretion and subject to Sections 15 and 16 of the Plan, other than price, the Committee may amend the terms and conditions of any outstanding Award.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Committee&#146;s interpretation of the Plan and of any Award or Agreement made under the Plan and all related decisions or resolutions of the Board or Committee shall be final and binding on all parties with an interest therein.&#160; Consistent with its terms, the Committee shall have the power to establish, amend or waive regulations to administer the Plan.&#160; In carrying out any of its responsibilities, the Committee shall have discretionary authority to construe the terms of the Plan and any Award or Agreement made under the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 71.25pt;text-indent:36.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>From and after the time, if any, that the Company has a class of securities registered under Section&nbsp;12 of the Exchange Act, it is the intent that the Plan and all Awards granted pursuant to it shall be administered by the Committee so as to permit the Plan and Awards to comply with Exchange Act Rule&nbsp;16b-3, except in such instances as the Committee, in its discretion, may so provide.&#160; If any provision of the Plan or of any Award would otherwise frustrate or conflict with the intent expressed in this Section&nbsp;3.1(d), that provision to the extent possible shall be interpreted and deemed amended in the manner determined by the Committee so as to avoid the conflict.&#160; To the extent of any remaining irreconcilable conflict with this intent, the provision shall be deemed void as applicable to Insiders to the extent permitted by law and in the manner deemed advisable by the Committee.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 71.25pt;text-indent:36.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>It is the intent that the Plan and all Awards granted pursuant to it will not provide for the deferral of compensation within the meaning of Code Section&nbsp;409A, and the Plan shall be administered in accordance with this intent.&#160; If the Committee determines that any Award may be subject to Code Section&nbsp;409A, the Board or the Committee may adopt such amendments to the Plan and the applicable Award agreement, or adopt other policies and procedures or take other actions that the Board or the Committee determines are necessary or appropriate to exempt the Award from Code Section&nbsp;409A.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><u style="font-style:italic;">Indemnification</u></i>.&#160; Each person who is or shall have been a member of the Committee, or of the Board, and any other person to whom the Committee delegates authority under the Plan, shall be indemnified and held harmless by the Company, to the extent permitted by law, against and from any loss, cost, liability or expense that may be imposed upon or reasonably incurred by such person in connection with or resulting from any claim, action, suit or proceeding to which such person may be a party or in which such person may be involved by reason of any action taken or failure to act, made in good faith, under the Plan and against and from any and all amounts paid by such person in settlement thereof, with the Company&#146;s approval, or paid by such person in satisfaction of any judgment in any such action, suit or proceeding against such person, provided such person shall give the Company an opportunity, at the Company&#146;s expense, to handle and defend the same before such person undertakes to handle and defend it on such person&#146;s own behalf.&#160; The foregoing right of indemnification shall not be exclusive of any other rights of indemnification to which such person or persons may be entitled under the Company&#146;s Certificate of Incorporation or Bylaws, as a matter of law, or otherwise, or any power that the Company may have to indemnify them or hold them harmless.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Shares Available Under the Plan</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The number of Shares available for distribution under the Plan shall not exceed 6,499,865 (subject to adjustment pursuant to Section&nbsp;16 of the Plan).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any Shares subject to the terms and conditions of an Award under the Plan that are not used because the terms and conditions of the Award are not met may again be used for an Award</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A-</font>4<a name="16022-2-LI-01_PB_4_112710_8146"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=10,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="8",CHK=577232,FOLIO='A-4',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LI-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 11:41 2016' -->

<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">under the Plan; provided however, that Shares with respect to which a Stock Appreciation Right has been exercised whether paid in cash and/or in Shares may not again be awarded under the Plan.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any unexercised or undistributed portion of any terminated, expired, exchanged, or forfeited Award, or any Award settled in cash in lieu of Shares (except as provided in Section&nbsp;4(b)&nbsp;of the Plan) shall be available for further Awards.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>For the purposes of computing the total number of Shares granted under the Plan, the following rules&nbsp;shall apply to Awards payable in Shares where appropriate:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>each Option shall be deemed to be the equivalent of the maximum number of Shares that may be issued upon exercise of the particular Option;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>an Award (other than an Option) payable in some other security shall be deemed to be equal to the number of Shares to which it relates;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>where the number of Shares available under the Award is variable on the date it is granted, the number of Shares shall be deemed to be the maximum number of Shares that could be received under that particular Award; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>where two or more types of Awards (all of which are payable in Shares) are granted to a Participant in tandem with each other, such that the exercise of one type of Award with respect to a number of Shares cancels at least an equal number of Shares of the other, each such joint Award shall be deemed to be the equivalent of the maximum number of Shares available under the largest single Award.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Additional rules&nbsp;for determining the number of Shares granted under the Plan may be made by the Committee as it deems necessary or desirable.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>No fractional Shares may be issued under the Plan; however, cash shall be paid in lieu of any fractional Share in settlement of an Award.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Eligibility</u>.&#160; Participation in the Plan shall be limited to Employees and to individuals or entities who are not Employees but who provide services to the Company or an Affiliate,&#160; including services provided in the capacity of a consultant, advisor or director.&#160; The granting of Awards is solely at the discretion of the Committee, except that Incentive Stock Options may only be granted to Employees.&#160; References herein to &#147;employed,&#148; &#147;employment&#148; or similar terms (except &#147;Employee&#148;) shall include the providing of services in any capacity or as a director or director emeritus. Neither the transfer of employment of a Participant between any of the Company or its Affiliates, nor a leave of absence granted to such Participant and approved by the Committee, shall be deemed a termination of employment for purposes of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>General Terms of Awards</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><u style="font-style:italic;">Amount of Award</u></i>.&#160; Each Agreement shall set forth the number of Shares of Restricted Stock, Stock or Performance Units subject to the Agreement, or the number of Shares to which the Option subject to the Agreement applies or with respect to which payment upon the exercise of the Stock Appreciation Right subject to the Agreement is to be determined, as the case may be, together with such other terms and conditions applicable to the Award as determined by the Committee acting in its sole discretion.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><u style="font-style:italic;">Term</u></i>.&#160; Each Agreement, other than those relating solely to Awards of Shares without restrictions, shall set forth the Term of the Option, Stock Appreciation Right, Restricted Stock or other Award or the Performance Cycle for the Performance Units, as the case may be.&#160; Acceleration of the expiration of the applicable Term is permitted, upon such terms and conditions as shall be set forth in the Agreement, which may, but need not, include, without limitation, acceleration in the event of the Participant&#146;s death or retirement.&#160; Acceleration of the Performance Cycle of the Performance Units will be subject to Section&nbsp;11.2 of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.3</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><u style="font-style:italic;">Transferability</u></i>.&#160; Except as provided in this Section, during the lifetime of a Participant to whom an Award is granted, only that Participant (or that Participant&#146;s legal representative) may exercise an Option or Stock Appreciation Right, or receive payment with respect to Performance Units or any other</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A-</font>5<a name="16022-2-LI-03_PB_5_111429_3510"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=11,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="8",CHK=286206,FOLIO='A-5',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LI-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 11:26 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Award.&#160; No Award of Restricted Stock (before the expiration of the restrictions), Options, Stock Appreciation Rights, Performance Units or other Award may be sold, assigned, transferred, exchanged or otherwise encumbered other than to a Successor in the event of a Participant&#146;s death or pursuant to a qualified domestic relations order as defined in the Code or Title 1 of the Employee Retirement Income Security Act of 1974, as amended (&#147;<u>ERISA</u>&#148;), or the rules&nbsp;thereunder; any attempted transfer in violation of this Section&nbsp;6.3 shall be of no effect.&#160; Notwithstanding the immediately preceding sentence, the Committee, in an Agreement or otherwise at its discretion, may provide that the Award (other than Incentive Stock Options) may be transferable to a Transferee if the Participant does not receive any consideration for the transfer.&#160; Any Award held by a Transferee shall continue to be subject to the same terms and conditions that were applicable to that Award immediately before the transfer thereof to the Transferee.&#160; For purposes of any provision of the Plan relating to notice to a Participant or to acceleration or termination of an Award upon the death, disability or termination of employment of a Participant, the references to &#147;Participant&#148; shall mean the original grantee of an Award and not any Transferee.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.4</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><u style="font-style:italic;">Termination of Employment</u></i>.&#160; Except as otherwise determined by the Committee or provided by the Committee in an Agreement, in case of a Participant&#146;s termination of employment, the following provisions shall apply:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Options and Stock Appreciation Rights</i>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If a Participant&#146;s employment or other relationship with the Company and its Affiliates terminates because of the Participant&#146;s death, then any Option or Stock Appreciation Right that has not expired or been terminated shall remain exercisable for one year after Participant&#146;s death, but, unless otherwise provided in the Agreement, only to the extent that such Option or Stock Appreciation Right was exercisable immediately prior to Participant&#146;s death.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If a Participant&#146;s employment or other relationship with the Company and its Affiliates terminates because the Participant is disabled (within the meaning of Section&nbsp;22(e)(3)&nbsp;of the Code), then any Option or Stock Appreciation Right that has not expired or been terminated shall remain exercisable for one year after Participant&#146;s termination of employment resulting from Participant&#146;s disability, but, unless otherwise provided in the Agreement, only to the extent that such Option or Stock Appreciation Right was exercisable immediately prior to such Participant&#146;s termination of employment resulting from Participant&#146;s disability.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If a Participant&#146;s employment or other relationship with the Company and its Affiliates terminates for any reason other than death or disability, then any Option or Stock Appreciation Right that has not expired or been terminated shall remain exercisable for 90 days after termination of the Participant&#146;s employment or other relationship with the Company, whichever occurs later, but, unless otherwise provided in the Agreement, only to the extent that such Option or Stock Appreciation Right was exercisable immediately prior to such Participant&#146;s termination of employment or other relationship with the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Notwithstanding Sections&nbsp;6.4(a)(i), (ii)&nbsp;and (iii)&nbsp;of the Plan, in no event shall an Option or a Stock Appreciation Right be exercisable after the expiration of the Term of such Award.&#160; Any Option or Stock Appreciation Right that is not exercised within the periods set forth in Sections&nbsp;6.4&nbsp;(i), (ii)&nbsp;and (iii)&nbsp;of the Plan, except as otherwise provided by the Committee in the Agreement, shall terminate as of the end of the periods described in such Sections.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Performance Units</i>.&#160; If a Participant&#146;s employment or other relationship with the Company and its Affiliates terminates during a Performance Cycle because of death or disability, or under other circumstances provided by the Committee in its discretion in the Agreement or otherwise, the Participant, unless the Committee shall otherwise provide in the Agreement, shall be entitled to a payment with respect to the Performance Units at the end of the Performance Cycle based upon the extent to which achievement of performance targets was satisfied at the end of such period (as determined at the end of the Performance Cycle) and prorated for the portion of the Performance</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A-</font>6<a name="16022-2-LI-03_PB_6_111611_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=12,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="8",CHK=859271,FOLIO='A-6',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LI-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 11:26 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cycle during which the Participant was employed by the Company or its Affiliates.&#160; Except as provided in this Section&nbsp;6.4(b)&nbsp;or in the Agreement, if a Participant&#146;s employment or other relationship with the Company and its Affiliates terminates during a Performance Cycle, then such Participant shall not be entitled to any payment with respect to that Performance Cycle.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Restricted Stock Awards</i>.&#160; Unless otherwise provided in the Agreement, in case of a Participant&#146;s death or disability, any Shares of Restricted Stock as to which restrictions have not lapsed as of the date of the Participant&#146;s termination of employment shall terminate at the date of the Participant&#146;s termination of employment and such Shares of Restricted Stock shall be forfeited to the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.5</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><u style="font-style:italic;">Rights as Stockholder</u></i>.&#160; Each Agreement shall provide that a Participant shall have no rights as a stockholder with respect to any securities covered by an Award unless and until the date the Participant becomes the holder of record of the Stock, if any, to which the Award relates.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Restricted Stock Awards</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>An Award of Restricted Stock under the Plan shall consist of Shares subject to restrictions on transfer and conditions of forfeiture, which restrictions and conditions shall be included in the applicable Agreement.&#160; The Committee may provide for the lapse or waiver of any such restriction or condition based on such factors or criteria as the Committee, in its sole discretion, may determine.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Except as otherwise provided in the applicable Agreement, each Stock certificate issued with respect to an Award of Restricted Stock shall either be deposited with the Company or its designee, together with an assignment separate from the certificate, in blank, signed by the Participant, or bear such legends with respect to the restricted nature of the Restricted Stock evidenced thereby as shall be provided for in the applicable Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Agreement shall describe the terms and conditions by which the restrictions and conditions of forfeiture upon awarded Restricted Stock shall lapse.&#160; Upon the lapse of the restrictions and conditions, Shares free of restrictive legends, if any, relating to such restrictions shall be issued to the Participant or a Successor or Transferee.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>A Participant or a Transferee with a Restricted Stock Award shall have all the other rights of a stockholder including, but not limited to, the right to receive dividends and the right to vote the Shares of Restricted Stock.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Other Awards</u>.&#160; The Committee may from time to time grant Stock and other Awards under the Plan including, without limitation, those Awards pursuant to which Shares are or may in the future be acquired, Awards denominated in Stock units, securities convertible into Stock and phantom securities.&#160; The Committee, in its sole discretion, shall determine the terms and conditions of such Awards provided that such Awards shall not be inconsistent with the terms and purposes of the Plan.&#160; The Committee may, at its sole discretion, direct the Company to issue Shares subject to restrictive legends and/or stop transfer instructions that are consistent with the terms and conditions of the Award to which the Shares relate.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Stock Options</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><u style="font-style:italic;">Terms of All Options</u></i>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>An Option shall be granted pursuant to an Agreement as either an Incentive Stock Option or a Non-Statutory Stock Option.&#160; The purchase price of each Share subject to an Option shall be determined by the Committee and set forth in the Agreement, but shall not be less than 100% of the Fair Market Value of a Share as of the date the Option is granted (except as provided in Sections 9.2 and 20 of the Plan or as otherwise determined by the Committee in its discretion).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The purchase price of the Shares with respect to which an Option is exercised shall be payable in full at the time of exercise, provided that to the extent permitted by law, the Agreement may permit some or all Participants to simultaneously exercise Options and sell the Shares thereby acquired pursuant to a brokerage or similar relationship and use the proceeds from the sale as</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A-</font>7<a name="16022-2-LI-03_PB_7_111834_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=13,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="8",CHK=112536,FOLIO='A-7',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LI-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 11:26 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">payment of the purchase price of the Shares.&#160; The purchase price may be payable in cash, by delivery or tender of Shares having a Fair Market Value as of the date the Option is exercised equal to the purchase price of the Shares being purchased pursuant to the Option, or a combination thereof, as determined by the Committee, but no fractional Shares will be issued or accepted.&#160; Provided, however, that a Participant exercising a stock option shall not be permitted to pay any portion of the purchase price with Shares if, in the opinion of the Committee, payment in such manner could have adverse financial accounting consequences for the Company or is otherwise not desirable.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each Option shall be exercisable in whole or in part on the terms provided in the Agreement. &#160;In no event shall any Option be exercisable at any time after the expiration of its Term.&#160; When an Option is no longer exercisable, it shall be deemed to have lapsed or terminated.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><u style="font-style:italic;">Incentive Stock Options</u></i>.&#160; In addition to the other terms and conditions applicable to all Options:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the purchase price of each Share subject to an Incentive Stock Option shall not be less than 100% of the Fair Market Value of a Share as of the date the Incentive Stock Option is granted if this limitation is necessary to qualify the Option as an Incentive Stock Option (except as provided in Section&nbsp;19 of the Plan);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the aggregate Fair Market Value (determined as of the date the Option is granted) of the Shares with respect to which Incentive Stock Options held by an individual first become exercisable in any calendar year (under the Plan and all other incentive stock option plans of the Company and its Affiliates) shall not exceed $100,000 (or such other limit as may be required by the Code) if this limitation is necessary to qualify the Option as an Incentive Stock Option and to the extent any Option granted to a Participant exceeds this limit the Option shall be treated as a Non-Statutory Stock Option;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>an Incentive Stock Option shall not be exercisable more than 10 years after the date of grant (or such other limit as may be required by the Code) if this limitation is necessary to qualify the Option as an Incentive Stock Option;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the Agreement covering an Incentive Stock Option shall contain such other terms and provisions that the Committee determines necessary to qualify this Option as an Incentive Stock Option; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the recipient of an Incentive Stock Option must be an employee of the Company on the date of grant; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>notwithstanding any other provision of the Plan to the contrary, no Participant may receive an Incentive Stock Option under the Plan if, at the time the Award is granted, the Participant owns (after application of the rules&nbsp;contained in Code Section&nbsp;424(d), or its successor provision), Shares possessing more than 10% of the total combined voting power of all classes of stock of the Company or its Subsidiaries, unless (i)&nbsp;the exercise price for that Incentive Stock Option is at least 110% of the Fair Market Value of the Shares subject to that Incentive Stock Option on the date of grant and (ii)&nbsp;that Option is not exercisable after the date five years from the date that Incentive Stock Option is granted.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Stock Appreciation Rights</u>.&#160; An Award of a Stock Appreciation Right shall entitle the Participant (or a Successor or Transferee), subject to terms and conditions determined by the Committee, to receive upon exercise of the Stock Appreciation Right all or a portion of the excess of (i)&nbsp;the Fair Market Value of a specified number of Shares as of the date of exercise of the Stock Appreciation Right over (ii)&nbsp;a specified price that shall not be less than 100% of the Fair Market Value of such Shares as of the date of grant of the Stock Appreciation Right.&#160; A Stock Appreciation Right may be granted in connection with part or all of, in addition to, or completely independent of an Option or any other Award under the Plan.&#160; If issued in connection with a previously or contemporaneously granted Option, the Committee may impose a condition that exercise of a Stock Appreciation Right cancels a pro rata portion of the Option with which it is connected and vice versa.&#160; Each Stock Appreciation Right may be exercisable in whole or in part on the terms provided in the Agreement.&#160; No Stock Appreciation Right shall be exercisable at any time after the expiration of its Term.&#160; When a Stock Appreciation Right is no longer exercisable, it shall be deemed to have lapsed or terminated.&#160; Upon exercise of a</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A-</font>8<a name="16022-2-LI-03_PB_8_111917_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=14,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="8",CHK=218202,FOLIO='A-8',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LI-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 11:26 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Stock Appreciation Right, payment to the Participant or a Successor or Transferee shall be made at such time or times as shall be provided in the Agreement in the form of cash, Shares or a combination of cash and Shares as determined by the Committee.&#160; The Agreement may provide for a limitation upon the amount or percentage of the total appreciation on which payment (whether in cash and/or Shares) may be made in the event of the exercise of a Stock Appreciation Right.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Performance Units</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><u style="font-style:italic;">Initial Award</u></i>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>An Award of Performance Units under the Plan shall entitle the Participant or a Successor or Transferee to future payments of cash, Shares or a combination of cash and Shares, as determined by the Committee, based upon the achievement of pre-established performance targets.&#160; These performance targets may, but need not, include, without limitation, targets relating to one or more of the Company&#146;s or a group&#146;s, unit&#146;s, Affiliate&#146;s or an individual&#146;s performance.&#160; The Agreement may establish that a portion of a Participant&#146;s Award will be paid for performance that exceeds the minimum target but falls below the maximum target applicable to the Award.&#160; The Agreement shall also provide for the timing of the payment.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Following the conclusion or acceleration of each Performance Cycle, the Committee shall determine the extent to which (i)&nbsp;performance targets have been attained, (ii)&nbsp;any other terms and conditions with respect to an Award relating to the Performance Cycle have been satisfied and (iii)&nbsp;payment is due with respect to an Award of Performance Units.&#160; Any payment determined to be due shall be made within such period of time after the end of the Performance Cycle so as to qualify the payment for the short-term deferral exemption from Code Section&nbsp;409A.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><u style="font-style:italic;">Acceleration and Adjustment</u></i>.&#160; The Agreement may permit an acceleration of the Performance Cycle and an adjustment of performance targets and payments with respect to some or all of the Performance Units awarded to a Participant, upon the occurrence of certain events, which may, but need not include, without limitation, a Fundamental Change, a recapitalization, a change in the accounting practices of the Company, a change in the Participant&#146;s title or employment responsibilities, the Participant&#146;s death or retirement or, with respect to payments in Shares with respect to Performance Units, a reclassification, stock dividend, stock split or stock combination as provided in Plan Section&nbsp;16.&#160; The Agreement also may provide for a limitation on the value of an Award of Performance Units that a Participant may receive.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Effective Date and Duration of the Plan</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><u style="font-style:italic;">Effective Date</u></i>.&#160; Upon its adoption by the Board, the Plan shall be submitted for approval by the stockholders of the Company and shall be effective as of the date of such approval (which date is set forth on the first page&nbsp;of the Plan).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><u style="font-style:italic;">Duration of the Plan</u></i>.&#160; The Plan shall remain in effect until all Stock subject to it shall be distributed, all Awards have expired or lapsed, the Plan is terminated pursuant to Section&nbsp;15 of the Plan or the tenth anniversary of the Effective Date (the &#147;<u>Termination Date</u>&#148;); provided, however, that Awards made before the Termination Date may be exercised, vested or otherwise effectuated beyond the Termination Date unless limited in the Agreement or otherwise.&#160; No Award of an Incentive Stock Option shall be made more than 10 years after the Effective Date (or such other limit as may be required by the Code) if this limitation is necessary to qualify the Option as an Incentive Stock Option.&#160; The date and time of approval by the Committee of the granting of an Award shall be considered the date and time at which the Award is made or granted.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Plan Does Not Affect Employment Status</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Status as an eligible Employee shall not be construed as a commitment that any Award will be made under the Plan to that eligible Employee or to eligible Employees generally.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Nothing in the Plan or in any Agreement or related documents shall confer upon any Employee or Participant any right to continue in the employment of the Company or any Affiliate or constitute any contract of employment or affect any right that the Company or any Affiliate may have to change such person&#146;s compensation, other benefits, job responsibilities, or title, or to terminate the employment of such person with or without cause.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A-</font>9<a name="16022-2-LI-03_PB_9_112011_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=15,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="8",CHK=844095,FOLIO='A-9',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LI-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 11:26 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Tax Withholding</u>.&#160; The Company shall have the right to withhold from any cash payment under the Plan to a Participant or other person (including a Successor or a Transferee) an amount sufficient to cover any required withholding taxes.&#160; The Company shall have the right to require a Participant or other person receiving Shares under the Plan to pay the Company a cash amount sufficient to cover any required withholding taxes before actual receipt of those Shares.&#160; In lieu of all or any part of a cash payment from a person receiving Shares under the Plan, the Committee may permit the individual to cover all or any part of the required withholdings through a reduction of the number of Shares delivered or delivery or tender return to the Company of Shares held by the Participant or other person, in each case valued in the same manner as used in computing the withholding taxes under the applicable laws.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Amendment, Modification and Termination of the Plan</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Board may at any time and from time to time terminate, suspend or modify the Plan.&#160; Except as limited in (b)&nbsp;below, the Committee may at any time alter or amend any or all Agreements under the Plan to the extent permitted by law.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>No termination, suspension, or modification of the Plan will materially and adversely affect any right acquired by any Participant or Successor or Transferee under an Award granted before the date of termination, suspension, or modification, unless otherwise agreed to by the Participant in the Agreement or otherwise, or required as a matter of law.&#160; It will be conclusively presumed that neither (i)&nbsp;any adjustment for changes in capitalization provided for in Section&nbsp;16 of the Plan, nor (ii)&nbsp;any amendment to the Plan or an Award Agreement contemplated by Section&nbsp;3.1(f)&nbsp;hereof, will adversely affect these rights.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">16.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Adjustment for Changes in Capitalization</u>.&#160; Subject to any required action by the Company&#146;s stockholders, appropriate adjustments, so as to prevent enlargement of rights or inappropriate dilution (i)&nbsp;in the aggregate number and type of Shares available for Awards under the Plan, (ii)&nbsp;in the number and type of Shares and amount of cash subject to Awards then outstanding, and (iii)&nbsp;in the exercise price as to any outstanding Options shall be made by the Committee in its sole discretion to give effect to adjustments made in the number or type of Shares through a Fundamental Change (subject to Section&nbsp;17 of the Plan), recapitalization, reclassification, stock dividend, stock split, stock combination or other relevant change, provided that fractional Shares shall be rounded to the nearest whole Share.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Fundamental Change</u>.&#160; In the event of a proposed Fundamental Change, the Committee may, but shall not be obligated to:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>if the Fundamental Change is a merger or consolidation or statutory share exchange, make appropriate provision for the protection of the outstanding Options and Stock Appreciation Rights by the substitution of options, stock appreciation rights and appropriate voting common stock of the corporation surviving any merger or consolidation or, if appropriate, the parent corporation of the Company or such surviving corporation, provided that such substitution will be effected in a manner that will not result in the grant of a new Option or Stock Appreciation Right under Code Section&nbsp;409A; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>at least ten days before the occurrence of the Fundamental Change, declare, and provide written notice to each holder of an Option or Stock Appreciation Right of the declaration, that each outstanding Option and Stock Appreciation Right, whether or not then exercisable, shall be canceled at the time of, or immediately before the occurrence of the Fundamental Change in exchange for payment to each holder of an Option or Stock Appreciation Right, within ten days after the Fundamental Change, of cash equal to (i)&nbsp;for each Share covered by the canceled Option, the amount, if any, by which the Fair Market Value (as defined in this Section) per Share exceeds the exercise price per Share covered by such Option or (ii)&nbsp;for each Stock Appreciation Right, the price determined pursuant to Section&nbsp;10, except that Fair Market Value of the Shares as of the date of exercise of the Stock Appreciation Right, as used in clause (i)&nbsp;of Section&nbsp;10 of the Plan, shall be deemed to mean Fair Market Value for each Share with respect to which the Stock Appreciation Right is calculated determined in the manner hereinafter referred to in this Section.&#160; At the time of the declaration provided for in the immediately preceding sentence, each Stock Appreciation Right and each Option shall immediately become exercisable in full and each person holding an Option or a Stock Appreciation Right shall have the right, during the period preceding the time of cancellation of the Option or Stock Appreciation Right, to exercise the Option as to all or any part of the Shares</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A-</font>10<a name="16022-2-LI-03_PB_10_112129_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=16,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="8",CHK=546315,FOLIO='A-10',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LI-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 11:26 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">covered thereby or the Stock Appreciation Right in whole or in part, as the case may be.&#160; In the event of a declaration pursuant to this Section&nbsp;17(b), each outstanding Option and Stock Appreciation Right granted pursuant to the Plan that shall not have been exercised before the Fundamental Change shall be canceled at the time of, or immediately before, the Fundamental Change, as provided in the declaration.&#160; Notwithstanding the foregoing, no person holding an Option or a Stock Appreciation Right shall be entitled to the payment provided for in this Section&nbsp;17(b)&nbsp;if such Option or Stock Appreciation Right shall have terminated, expired or been cancelled.&#160; For purposes of this Section&nbsp;only, &#147;Fair Market Value&#148; per Share means the cash plus the fair market value, as determined in good faith by the Committee, of the non-cash consideration to be received per Share by the stockholders of the Company upon the occurrence of the Fundamental Change.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Change in Control</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><u style="font-style:italic;">Definition</u>.&#160; </i>A &#147;<u>Change in Control</u>&#148; of the Company shall be deemed to occur if any of the following occur:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any &#147;person&#148; (as such term is used in Sections&nbsp;13(d)&nbsp;and 14(d)&nbsp;of the Exchange Act) after the effective date of this Plan first acquires or becomes a &#147;beneficial owner&#148; (as defined in Rule&nbsp;13d-3 or any successor rule&nbsp;under the Exchange Act), directly or indirectly, of securities of the Company representing 50% or more of the combined voting power of the Company&#146;s then outstanding securities entitled to vote generally in the election of directors (&#147;<i>Voting Securities</i>&#148;), provided, however, that the following shall not constitute a Change in Control pursuant to this paragraph&nbsp;(a)(1):</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 2.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(A)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any acquisition of Shares or Voting Securities of the Company directly from the Company,</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 2.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(B)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any acquisition or beneficial ownership by the Company or a Subsidiary,</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 2.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(C)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any acquisition or beneficial ownership by any employee benefit plan (or related trust) sponsored or maintained by the Company or one or more of its subsidiaries,</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 2.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(D)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any acquisition or beneficial ownership by any corporation with respect to which, immediately following such acquisition, more than 50% of both the combined voting power of the Company&#146;s then outstanding Voting Securities and the Shares are then beneficially owned by all or substantially all of the persons who beneficially owned Voting Securities and Shares immediately prior to such acquisition in substantially the same proportions as their ownership of such Voting Securities and Shares, as the case may be, immediately prior to such acquisition;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>A majority of the members of the Board of Directors of the Company shall not be Continuing Directors.&#160; &#147;<i>Continuing Directors</i>&#148; shall mean:&#160; (A)&nbsp;individuals who, on the date hereof, are directors of the Company, (B)&nbsp;individuals elected as directors of the Company subsequent to the date hereof for whose election proxies shall have been solicited by the Board, (C)&nbsp;individuals elected as directors of the Company subsequent to the date hereof pursuant to a nomination or board representation right of preferred shareholders of the Company or (D)&nbsp;any individual elected or appointed by the Board to fill vacancies on the Board caused by death or resignation (but not by removal) or to fill newly-created directorships;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Consummation of a reorganization, merger or consolidation of the Company or a statutory exchange of outstanding Voting Securities, unless, immediately following such reorganization, merger, consolidation or exchange, all or substantially all of the persons who were the beneficial owners, respectively, of Voting Securities and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A-</font>11<a name="16022-2-LI-03_PB_11_112240_7748"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=17,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="8",CHK=583592,FOLIO='A-11',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LI-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 11:26 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Shares of the Company immediately prior to such reorganization, merger, consolidation or exchange beneficially own, directly or indirectly, more than 70% of, respectively, the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors and the then outstanding shares of common stock, as the case may be, of the corporation that is the issuer of such securities held by the shareholders of the Company after such reorganization, merger, consolidation or exchange in substantially the same proportions as their ownership, immediately prior to such reorganization, merger, consolidation or exchange, of the Voting Securities and Shares, as the case may be; or</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Consummation of (x)&nbsp;a complete liquidation or dissolution of the Company or (y)&nbsp;the sale or other disposition of all or substantially all of the assets of the Company (in one or a series of transactions), other than to a corporation with respect to which, immediately following such sale or other disposition, more than 70% of, respectively, the combined voting power of the then outstanding voting securities of such corporation entitled to vote generally in the election of directors and the then outstanding shares of common stock of such corporation is then beneficially owned, directly or indirectly, by all or substantially all of the persons who were the beneficial owners, respectively, of the Voting Securities and Shares immediately prior to such sale or other disposition in substantially the same proportions as their ownership, immediately prior to such sale or other disposition, of the Voting Securities and Shares, as the case may be.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><u style="font-style:italic;">Acceleration of Vesting</u></i>.&#160; If and to the extent so provided in an Agreement or by Committee action with respect to any outstanding Option, Restricted Stock or Stock Appreciation Right, and notwithstanding anything in Section&nbsp;17 to the contrary, if a Change in Control shall occur, then such Option, Restricted Stock or Stock Appreciation Right, if not already exercised or vested in full or otherwise terminated, expired or cancelled, may become immediately exercisable and fully vested as provided in the Agreement or Committee action and may remain exercisable during the remaining term thereof or as may be provided in the Agreement or, subject to consent of the Participant, by Committee action.&#160; For the avoidance of doubt, unless otherwise provided in an Agreement or specifically by Committee action as set forth above, no Option, Restricted Stock or Stock Appreciation Right will accelerate in exercisability or vesting upon a Change in Control.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><u style="font-style:italic;">Cash Payment</u></i>.&#160; If a Change in Control shall or is to occur, then, so long as a majority of the members of the Board are Continuing Directors, the Committee, in its sole discretion, and without the consent of the Participant affected thereby, may determine that some or all outstanding Options, unvested Restricted Stock or Stock Appreciation Rights shall be cancelled as of the effective date of any such Change in Control.&#160; The Committee may further determine that the holder or holders of such cancelled Options, unvested Restricted Stock or Stock Appreciation Rights shall receive, with respect to some or all of the Shares subject to such Options, unvested Restricted Stock or Stock Appreciation Rights, as of the date of such cancellation, cash in an amount, for (i)&nbsp;each Share subject to an Option or Stock Appreciation Right, equal to the excess of the per Share Fair Market Value of such Shares immediately prior to such Change in Control over the exercise price per Share of such Options or Stock Appreciation Rights and (ii)&nbsp;for each unvested Share of Restricted Stock, equal to the per Share Fair Market Value of such Shares immediately prior to such Change in Control.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><u style="font-style:italic;">Limitation on Change in Control Payments</u>.</i>&#160; Notwithstanding anything in Sections 17, 18(b)&nbsp;or 18(c)&nbsp;to the contrary, if, with respect to an Option, unvested Restricted Stock or Stock Appreciation Right, the acceleration of the exercisability or vesting of such Award or the payment of cash in exchange for all or part of an such Award as provided in Sections&nbsp;17, 18(b)&nbsp;or 18(c)&nbsp;(which acceleration or payment could be deemed a &#147;payment&#148; within the meaning of Code Section&nbsp;280G(b)(2)), together with any other payments which such Participant has the right to receive from the Company or any corporation which is a member of an &#147;affiliated group&#148; (as defined in Code Section&nbsp;1504(a)&nbsp;without regard to Code Section&nbsp;1504(b)) of which the Company is a member, would constitute a &#147;parachute payment&#148; (as defined in Code Section&nbsp;280G(b)(2)), then, unless otherwise provided in an agreement with the Company, such acceleration of exercisability or vesting and payments pursuant to Sections 17, 18(b)&nbsp;or 18(c)&nbsp;shall be reduced to the largest amount as, in the sole judgment of the Committee, will result in no portion of such</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A-</font>12<a name="16022-2-LI-03_PB_12_112317_141"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=18,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="8",CHK=70668,FOLIO='A-12',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LI-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 11:26 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">payments being subject to the excise tax imposed by Code Section&nbsp;4999.&#160; The Committee, with the consent of the Participant, may waive the provisions of this Section&nbsp;18(d).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Forfeitures</u>.&#160; An Agreement may provide that if a Participant has received or been entitled to payment of cash, delivery of Shares, or a combination thereof pursuant to an Award within six months before the Participant&#146;s termination of employment with the Company and its Affiliates, the Committee, in its sole discretion, may require the Participant to return or forfeit the cash and/or Shares received with respect to the Award (or its economic value as of (i)&nbsp;the date of the exercise of Options or Stock Appreciation Rights, (ii)&nbsp;the date of, and immediately following, the lapse of restrictions on Restricted Stock or the receipt of Shares without restrictions or (iii)&nbsp;the date on which the right of the Participant to payment with respect to Performance Units vests, as the case may be) in the event of certain occurrences specified in the Agreement.&#160; The Committee&#146;s right to require forfeiture must be exercised within 90 days after discovery of such an occurrence but in no event later than 15 months after the Participant&#146;s termination of employment with the Company and its Affiliates.&#160; The occurrences may, but need not, include competition with the Company or any Affiliate, unauthorized disclosure of material proprietary information of the Company or any Affiliate, a violation of applicable business ethics policies of the Company or Affiliate or any other occurrence specified in the Agreement within the period or periods of time specified in the Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">20.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Corporate Mergers, Acquisitions, Etc</u>.&#160; The Committee may also grant Options, Stock Appreciation Rights, Restricted Stock or other Awards under the Plan in substitution for, or in connection with the assumption of, existing options, stock appreciation rights, restricted stock or other award granted, awarded or issued by another corporation and assumed or otherwise agreed to be provided for by the Company pursuant to or by reason of a transaction involving a corporate merger, consolidation, acquisition of property or stock, separation, reorganization or liquidation to which the Company or a Subsidiary is a party.&#160; The terms and conditions of the substitute Awards may vary from the terms and conditions set forth in the Plan to the extent that the Board at the time of the grant may deem appropriate to conform, in whole or in part, to the provisions of the awards in substitution for which they are granted, but will be effected in a manner that will not result in the grant of a new Option or Stock Appreciation Right under Code Section&nbsp;409A.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">21.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Unfunded Plan</u>.&#160; The Plan shall be unfunded and the Company shall not be required to segregate any assets that may at any time be represented by Awards under the Plan.&#160; Neither the Company, its Affiliates, the Committee, nor the Board of Directors shall be deemed to be a trustee of any amounts to be paid under the Plan nor shall anything contained in the Plan or any action taken pursuant to its provisions create or be construed to create a fiduciary relationship between the Company and/or its Affiliates, and a Participant or Successor or Transferee.&#160; To the extent any person acquires a right to receive an Award under the Plan, this right shall be no greater than the right of an unsecured general creditor of the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">22.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Limits of Liability</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any liability of the Company to any Participant with respect to an Award shall be based solely upon contractual obligations created by the Plan and the Award Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Except as may be required by law, neither the Company nor any member of the Board of Directors or of the Committee, nor any other person participating in any determination of any question under the Plan, or in the interpretation, administration or application of the Plan, shall have any liability to any party for any action taken, or not taken, in good faith under the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">23.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Compliance with Applicable Legal Requirements</u>.&#160; No certificate for Shares distributable pursuant to the Plan shall be issued and delivered unless the issuance of the certificate complies with all applicable legal requirements including, without limitation, compliance with the provisions of applicable state securities laws, the Securities Act of 1933, as amended and in effect from time to time or any successor statute, the Exchange Act and the requirements of the exchanges on which the Company&#146;s Shares may, at the time, be listed.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">24.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Deferrals and Settlements</u>.&#160; The Committee may require or permit Participants to elect to defer the issuance of Shares or the settlement of Awards in cash under such rules&nbsp;and procedures as it may establish under the Plan, consistent with the requirements of Code Section&nbsp;409A.&#160; It may also provide that deferred settlements include the payment or crediting of interest on the deferral amounts.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">25.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Other Benefit and Compensation Programs</u>.&#160; Payments and other benefits received by a Participant under an Award made pursuant to the Plan shall not be deemed a part of a Participant&#146;s regular, recurring compensation</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A-</font>13<a name="16022-2-LI-03_PB_13_112411_7608"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=19,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="8",CHK=818889,FOLIO='A-13',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LI-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 11:26 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">for purposes of the termination, indemnity or severance pay laws of any country and shall not be included in, nor have any effect on, the determination of benefits under any other employee benefit plan, contract or similar arrangement provided by the Company or an Affiliate unless expressly so provided by such other plan, contract or arrangement, or unless the Committee expressly determines that an Award or portion of an Award should be included to accurately reflect competitive compensation practices or to recognize that an Award has been made in lieu of a portion of competitive cash compensation.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">26.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Beneficiary Upon Participant&#146;s Death</u>.&#160; To the extent that the transfer of a Participant&#146;s Award at his or her death is permitted under an Agreement, a Participant&#146;s Award shall be transferable at death to the estate or to the person who acquires the right to succeed to the Award by bequest or inheritance.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">27.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Requirements of Law</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>To the extent that federal laws do not otherwise control, the Plan and all determinations made and actions taken pursuant to the Plan shall be governed by the laws of the State of Delaware without regard to its conflicts-of-law principles and shall be construed accordingly.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If any provision of the Plan shall be held illegal or invalid for any reason, the illegality or invalidity shall not effect the remaining parts of the Plan, and the Plan shall be construed and enforced as if the illegal or invalid provision had not been included.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">28.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Delivery of Financial Information</u>.&#160; The Company will, to the extent necessary to comply with applicable state securities laws, deliver financial statements of the Company to a Participant at least annually.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">29.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Restrictions on Shares</u>.&#160; Notwithstanding any other provision of the Plan, at the discretion of the Committee, the Company may reserve to itself and its assignees in the option agreement (a)&nbsp;a right of first refusal to purchase all Shares that a Participant (or a subsequent transferee) may propose to transfer to a third party, (b)&nbsp;a right to repurchase a portion of or all Shares held by a Participant upon the Participant&#146;s termination of employment or service with the Company or its parent, subsidiary or affiliate for any reason within a specified time (but not to exceed 90 days of the later of termination or exercise of the award, if required by applicable laws), (c)&nbsp;the right to require the Participant from time to time to execute and deliver stockholder, voting or similar agreements, (d)&nbsp;the right to require the Participant to agree not to take any action that would cause the Company not to qualify for Subchapter S tax status, if applicable, and (e)&nbsp;the right of the Company to require the Participant from time to time to execute and deliver underwriter lock up agreements.&#160; The price to be paid upon any purchase or repurchase of Shares pursuant to clause (a)&nbsp;or (b)&nbsp;above will be determined by the Committee, and any such purchase or repurchase will be effected on terms that are consistent with maintaining the status of Shares as &#147;service recipient stock&#148; for purposes of Code Section&nbsp;409A.&#160; This paragraph 29 is not a limitation on the provisions that may be included in any Agreement.&#160; Shares may be repurchased at the Participant&#146;s original purchase price provided that, if required by applicable laws, such right to repurchase as to employees lapses at the rate of at least 20% of the Shares subject to the Award per year over five years from the date that the Award is granted (without respect to the date that the Award was exercised or became exercisable).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A-</font>14<a name="16022-2-LI-03_PB_14_112504_8146"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=20,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="8",CHK=694487,FOLIO='A-14',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LI-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 11:26 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>9
<FILENAME>a2227029zex-10_6.htm
<DESCRIPTION>EX-10.6
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 10.6</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Incentive Stock Option Agreement</font></u></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(Under the 2007 Omnibus Stock Plan)</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name of Optionee:</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No.&nbsp;of Shares Covered:</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of Grant:</font></p>    </td>   </tr>
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exercise Price Per Share:</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Expiration Date:</font></p>    </td>   </tr>
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exercise   Schedule (Cumulative):<br><br></font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This option shall vest as to <b>[Insert   number of shares equal to 25% of the total shares] </b>shares on <b>[insert date of one year anniversary of the date of grant]</b>.   The remaining Shares shall vest as to <b>[1/48</b></font><b><font size="1" style="font-size:6.5pt;font-weight:bold;position:relative;top:-3.0pt;">th</font>&nbsp;of the total shares]</b> shares each month   commencing on <b>[insert date of 13</b><b><font size="1" style="font-size:6.5pt;font-weight:bold;position:relative;top:-3.0pt;">th</font>&nbsp;month anniversary of the date of grant]</b>   and continuing until this option is fully vested.</p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This is an Incentive Stock Option Agreement (the &#147;<u>Agreement</u>&#148;) between Tactile Systems Technology,&nbsp;Inc., a Delaware corporation (the &#147;<u>Company</u>&#148;), and the optionee identified above (the &#147;<u>Optionee</u>&#148;) effective as of the date of grant specified above.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">RECITALS</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company maintains the Tactile Systems Technology,&nbsp;Inc. 2007 Omnibus Stock Plan (the &#147;<u>Plan</u>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">B.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Pursuant to the Plan, the board of directors of the Company (the &#147;<u>Board</u>&#148;) or a committee of two or more directors of the Company (the &#147;<u>Committee</u>&#148;) appointed by the Board administers the Plan and has the authority to determine the awards to be granted under the Plan (if the Board has not appointed a committee to administer the Plan, then the Board shall constitute the Committee).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">C.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Committee has determined that the Optionee is eligible to receive an award under the Plan in the form of an incentive stock option (the &#147;<u>Option</u>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Company hereby grants this Option to the Optionee under the terms and conditions as follows.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TERMS AND CONDITIONS</font></b>*</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Grant</u></b>.&#160; The Optionee is granted this Option to purchase the number of Shares specified at the beginning of this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Exercise Price</u></b>.&#160; The price to the Optionee of each Share subject to this Option shall be the exercise price specified at the beginning of this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Incentive Stock Option</u></b>.&#160; This Option is intended to be an &#147;incentive stock option&#148; within the meaning of Section&nbsp;422 of the Internal Revenue Code of 1986, as amended (the &#147;<u>Code</u>&#148;); provided</p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade align="left" style="color:black;"></div>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Unless the context indicates otherwise, terms that are not defined in this Agreement shall have the meaning set forth in the Plan as it currently exists or as it is amended in the future.</p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="9",CHK=915308,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LK_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:11 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">that if the Option or part thereof fails to qualify as an incentive stock option, it will be treated as a non-statutory stock option.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Exercise Schedule</u></b>.&#160; This Option shall vest and become exercisable as to the number of Shares and on the dates specified in the exercise schedule at the beginning of this Agreement.&#160; The exercise schedule shall be cumulative; thus, to the extent this Option has not already been exercised and has not expired, terminated or been cancelled, the Optionee or the person otherwise entitled to exercise this Option as provided herein may at any time, and from time to time, purchase all or any portion of the Shares then purchasable under the exercise schedule.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This Option may also be exercised in full (notwithstanding the exercise schedule) under the circumstances described in Section&nbsp;8 of this Agreement if it has not expired prior thereto.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Expiration</u></b>.&#160; This Option shall expire at 5:00&nbsp;p.m.&nbsp;Central Time on the earliest of:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The expiration date specified at the beginning of this Agreement (which date shall not be later than ten years after the date of grant or, if the Optionee owns or is deemed to own stock possessing more than 10% of the combined voting power of all classes of stock of the Company, five years after the date of grant);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The expiration of the period after the termination of employment of the Optionee within which the Option can be exercised (as specified in Section&nbsp;7 of this Agreement);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Termination of the Optionee&#146;s employment for Cause.&#160; &#147;<u>Cause</u>&#148; shall be deemed to exist upon (i)&nbsp;an act or acts of dishonesty undertaken by Optionee and intended to result in substantial gain or personal enrichment of Optionee at the expense of the Company; (ii)&nbsp;unlawful conduct or gross misconduct that is willful and deliberate on Optionee&#146;s part and that, in either event, is materially injurious to the Company; (iii)&nbsp;the conviction of Optionee of a felony; or (iv)&nbsp;material breach by Optionee of any terms and conditions of any employment or non-competition/non-solicitation agreement between the Optionee and the Company not caused by the Company, which breach has not been cured by Optionee within ten days after written notice thereof to Optionee from the Company; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The date (if any) fixed for cancellation pursuant to Section&nbsp;17 of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In no event may anyone exercise this Option, in whole or in part, after it has expired, notwithstanding any other provision of this Agreement.&#160; In addition, if the Option is exercised, and prior to the delivery of the certificate representing the Shares so purchased, it is determined that Cause for termination existed, then the Company may rescind the Option exercise by the Optionee and the Option shall terminate at the election of the Company.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Procedure to Exercise Option</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Notice of Exercise</font></i>.&#160; This Option may be exercised by delivering written notice of exercise to the Company at the principal executive office of the Company, to the attention of the Company&#146;s Chief Executive Officer, in the form attached to this Agreement.&#160; The notice shall state the number of Shares to be purchased, and shall be signed by the person exercising this Option.&#160; If the person exercising this Option is not the Optionee, he/she also must submit appropriate proof of his/her right to exercise this Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Tender of Payment</font></i>.&#160; Upon giving notice of any exercise hereunder, the Optionee shall provide for payment of the purchase price of the Shares being purchased through one or a combination of the following methods:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Cash (including check, bank draft or money order);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-LK_PB_2_113519_2608"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="9",CHK=14630,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LK_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:11 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>To the extent permitted by law, through a broker-assisted cashless exercise in which the Optionee simultaneously exercises the Option and sells all or a portion of the Shares thereby acquired pursuant to a brokerage or similar relationship and uses the proceeds from such sale to pay the purchase price of such Shares;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>By delivery to the Company of unencumbered Shares having an aggregate Fair Market Value on the date of exercise equal to the purchase price of such Shares; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>By authorizing the Company to retain, from the total number of Shares as to which the Option is exercised, that number of Shares having a Fair Market Value on the date of exercise equal to the purchase price for the total number of Shares as to which the Option is exercised.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Notwithstanding the foregoing, the Optionee shall not be permitted to pay any portion of the purchase price with Shares, or by authorizing the Company to retain Shares upon exercise of the Option, if the Committee, in its sole discretion, determines that payment in such manner is undesirable.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Delivery of Certificates</font></i>.&#160; As soon as practicable after the Company receives the notice and purchase price provided for above, it shall deliver to the person exercising this Option, in the name of such person, a certificate or certificates representing the Shares being purchased.&#160; The Company shall pay any original issue or transfer taxes with respect to the issue or transfer of the Shares and all fees and expenses incurred by it in connection therewith.&#160; All Shares so issued shall be fully paid and nonassessable.&#160; Notwithstanding anything to the contrary in this Agreement, no certificate for Shares distributable under the Plan shall be issued and delivered unless the issuance of such certificate complies with all applicable legal requirements including, without limitation, compliance with the provisions of applicable state securities laws, the Securities Act of 1933, as amended (the &#147;<u>Securities Act</u>&#148;) and the Exchange Act.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Employment Requirement</u></b>.&#160; This Option may be exercised only while the Optionee remains employed with the Company or a parent or subsidiary thereof, and only if the Optionee has been continuously so employed since the date of this Agreement; <i>provided that</i>:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>This Option may be exercised for 90 days following the day the Optionee&#146;s employment by the Company ceases if such cessation of employment is for a reason other than death or disability, but only to the extent that it was exercisable immediately prior to termination of employment; provided, that if termination of the Optionee&#146;s employment shall have been for Cause, the Option shall expire, and all rights to purchase Shares hereunder shall terminate, immediately upon such termination.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>This Option may be exercised within one year after the Optionee&#146;s employment by the Company ceases if such cessation of employment is because of death or disability of the Optionee, but only to the extent it was exercisable immediately prior to cessation of employment.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If the Optionee&#146;s employment terminates after a declaration made pursuant to Section&nbsp;17 of the Plan in connection with Fundamental Change , the Option may be exercised at any time permitted by such declaration.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Notwithstanding the above, the Option may not be exercised after it has expired.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Acceleration of Vesting</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Fundamental Change</font></i>.&#160; In the event of a Fundamental Change the Committee may, but shall not be obligated to:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="16022-2-LK_PB_3_113556_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=3,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="9",CHK=178229,FOLIO='3',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LK_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:11 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>if the Fundamental Change is a merger or consolidation or statutory share exchange, make appropriate provision for the protection of this Option by the substitution for this Option of options or voting common stock of the corporation surviving any merger or consolidation or, if appropriate, the parent corporation of the Company or such surviving corporation; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>at least ten days before the occurrence of the Fundamental Change, declare, and provide written notice to the Optionee of the declaration, that this Option, whether or not then exercisable, shall be canceled at the time of, or immediately before the occurrence of, the Fundamental Change (unless it shall have been exercised prior to the occurrence of the Fundamental Change).&#160; In connection with any such declaration, the Committee may, but shall not be obligated to, cause payment to be made to the Optionee of cash equal to, for each Share covered by the canceled Option, the amount, if any, by which the Fair Market Value per Share exceeds the exercise price per Share covered by this Option.&#160; At the time of any such declaration, this Option shall immediately become exercisable in full and the Optionee shall have the right, during the period preceding the time of cancellation of this Option, to exercise this Option as to all or any part of the Shares covered by this Option.&#160; In the event of a declaration pursuant to this subsection, to the extent this Option has not been exercised prior to the Fundamental Change, the unexercised part of this Option shall be canceled at the time of, or immediately before, the Fundamental Change, as provided in the declaration.&#160; Notwithstanding the foregoing, the holder of this Option shall not be entitled to the payment provided for in this subsection if this Option shall have expired pursuant to Section&nbsp;5 above or been cancelled.&#160; For purposes of this subsection only, &#147;<u>Fair Market Value</u>&#148; per Share has the meaning set forth in Section&nbsp;17 of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Change in Control</font></i>.&#160; If a Change in Control of the Company shall occur, then, at the sole discretion of the Company, the Option, if not already exercised in full or otherwise terminated, expired or cancelled, may become immediately exercisable in full and remain exercisable during the remaining term of the Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Discretionary Acceleration</font></i>.&#160; Notwithstanding any other provisions of this Agreement to the contrary, the Committee may, in its sole discretion, declare at any time that the Option shall be immediately exercisable.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Possible Tax Effect of Acceleration</font></i>.&#160; If acceleration of this Option results in the vesting of Shares with a Fair Market Value in excess of $100,000 in any given year, then this Option shall not be deemed an &#147;incentive stock option&#148; within the meaning of Section&nbsp;422 of the Code to the extent the Fair Market Value of vested Shares exceeds $100,000 in such year.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Limitation on Transfer</u></b>.&#160; During the lifetime of the Optionee, only the Optionee or his/her guardian or legal representative may exercise the Option.&#160; The Option may not be assigned or transferred by the Optionee otherwise than by will or the laws of descent and distribution.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">No Stockholder Rights Before Exercise</u></b>.&#160; No person shall have any of the rights of a stockholder of the Company with respect to any Share subject to the Option until the Share actually is issued to him/her upon exercise of the Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Lock-Up Period</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Optionee agrees that the Optionee will not offer, pledge, sell, contract to sell, sell any option, sell any contract to purchase, purchase any option, purchase any contract to sell, grant any option, right, or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any Shares (or any other Company securities) or enter into any</p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">4<a name="16022-2-LK_PB_4_113701_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=4,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="9",CHK=445180,FOLIO='4',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LK_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:11 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">swap, hedging, or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any Shares (or any other Company securities) held by the Optionee (other than those included in the registration) for a period specified by the representative of the underwriters of the Company&#146;s capital stock (or any other Company securities, collectively, the &#147;<u>Stock</u>&#148;) not to exceed 90 days (180 days in the case of an initial public offering), plus any additional periods required by the Financial Industry Regulatory Authority, after the effective date of any Company registration statement filed under the Securities Act.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Optionee agrees to execute and deliver such other agreements as may be reasonably requested by the Company or the underwriter to the extent that such agreements are consistent with the foregoing or that are necessary to give further effect to the provisions set forth in Section&nbsp;11(a).&#160; In addition, if requested by the Company or the representative of the underwriters of Stock, the Optionee will provide, within 10 days of such request, such information as may be required by the Company or such representative in connection with the completion of any public offering of the Company&#146;s securities pursuant to a registration statement filed under the Securities Act.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The obligations described in this Section&nbsp;11 will not apply to a registration relating solely to employee benefit plans on Form&nbsp;S-8 or similar forms that may be promulgated in the future, or a registration relating solely to a Commission Rule&nbsp;145 transaction on Form&nbsp;S-4 or similar forms that may be promulgated in the future.&#160; The Company may impose stop-transfer instructions with respect to the shares of Stock subject to the foregoing restriction until the end of such period, as applicable.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Discretionary Adjustment</u></b>.&#160; In the event of any reorganization, merger, consolidation, recapitalization, liquidation, reclassification, stock dividend, stock split, combination of shares, rights offering, or extraordinary dividend or divestiture (including a spin-off), or any other change in the corporate structure or Shares of the Company, the Committee (or if the Company does not survive any such transaction, a comparable committee of the Board of Directors of the surviving corporation) shall, without the consent of the Optionee, make such adjustment as it determines in its discretion to be appropriate as to the number and kind of securities subject to and reserved under the Plan and, in order to prevent dilution or enlargement of rights of the Optionee, the number and kind of securities issuable upon exercise of the Option and the exercise price hereof.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Transfer of Shares&nbsp;&#151; Tax Effects</u></b>.&#160; The Optionee hereby acknowledges that if any Shares received pursuant to the exercise of any portion of the Option are sold within two years from the date of grant or within one year from the effective date of exercise of the Option, or if certain other requirements of the Code are not satisfied, such Shares will be deemed under the Code not to have been acquired by the Optionee pursuant to an &#147;incentive stock option&#148; as defined in the Code; and that the Company shall not be liable to the Optionee in the event the Option for any reason is deemed not to be an &#147;incentive stock option&#148; within the meaning of the Code.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Tax Consequences</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Optionee may incur tax liability as a result of the Optionee&#146;s purchase or disposition of the Shares.&#160; <b>THE OPTIONEE SHOULD CONSULT A TAX ADVISER BEFORE EXERCISING THE OPTION OR DISPOSING OF THE SHARES.</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Notwithstanding the Company&#146;s good faith determination of the Fair Market Value of the Company&#146;s common stock for purposes of determining the exercise price per Share of the Option, the taxing authorities may assert that the fair market value of the Company&#146;s common stock on the date of grant was greater than the exercise price per Share.&#160; The Option may fail to</p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">5<a name="16022-2-LK_PB_5_113756_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=5,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="9",CHK=682481,FOLIO='5',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LK_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:11 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">qualify as an incentive stock option if the exercise price per Share of the Option is less than the fair market value of the Company&#146;s common stock on the date of grant.&nbsp; In addition, under Section&nbsp;409A of the Code, if the exercise price per Share of the Option is less than the fair market value of the Company&#146;s common stock on the date of grant, the Option may be treated as a form of deferred compensation and the Optionee may be subject to an additional 20% tax, plus interest and possible penalties.&#160; The Optionee is encouraged to consult a tax adviser regarding the potential impact of Section&nbsp;409A of the Code.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Amendment to Meet the Requirements of Section&nbsp;409A</u></b>.&#160; The Optionee acknowledges that the Company, in the exercise of its sole discretion and without the consent of the Optionee, may amend or modify this Agreement in any manner and delay the payment of any amounts payable pursuant to this Agreement to the minimum extent necessary to meet the requirements of Section&nbsp;409A of the Code as amplified by any Internal Revenue Service or U.S. Treasury Department regulations or guidance as the Company deems appropriate or advisable.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">16.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Interpretation of This Agreement</u></b>.&#160; All decisions and interpretations made by the Committee with regard to any question arising hereunder or under the Plan shall be binding and conclusive upon the Company and the Optionee.&#160; If there is any inconsistency between the provisions of this Agreement and the Plan, the provisions of the Plan shall govern.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Discontinuance of Employment</u></b>.&#160; This Agreement shall not give the Optionee a right to continued employment with the Company or any parent or subsidiary of the Company, and the Company or any such parent or subsidiary employing the Optionee may terminate his/her employment at any time and otherwise deal with the Optionee without regard to the effect it may have upon him/her under this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Option Subject to Plan, Certificate of Incorporation and By-Laws</u></b>.&#160; The Optionee acknowledges that the Option and the exercise thereof is subject to the Plan, the Certificate of Incorporation, as amended from time to time, and the By-Laws, as amended from time to time, of the Company, and any applicable federal or state laws, rules&nbsp;or regulations.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Binding Effect</u></b>.&#160; This Agreement shall be binding in all respects on the heirs, representatives, successors and assigns of the Optionee.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">20.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Choice of Law</u></b>.&#160; This Agreement is entered into under the laws of the State of Delaware and shall be construed and interpreted thereunder (without regard to its conflict of law principles).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">21.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Right of First Refusal and Execution of Stockholder Agreements</u></b>.&#160; At the discretion of the Committee, the Company is hereby granted (a)&nbsp;a right of first refusal to purchase all Shares that the Optionee (or a subsequent transferee) may propose to transfer to a third party and (b)&nbsp;the right to require the Optionee from time to time to execute and deliver stockholder, voting or similar agreements.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">[<i>Remainder of page&nbsp;left blank intentionally &#151; signature page&nbsp;follows</i>]</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">6<a name="16022-2-LK_PB_6_113816_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=6,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="9",CHK=1019502,FOLIO='6',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LK_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:11 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">IN WITNESS WHEREOF, the Optionee and the Company have executed this Agreement as of the date of grant.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">OPTIONEE</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS   TECHNOLOGY,&nbsp;INC.</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Its:</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">7<a name="16022-2-LK_PB_7_113909_7748"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=7,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="9",CHK=514953,FOLIO='7',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LK_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:11 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u>, 20<u>&nbsp;&nbsp;&nbsp;&nbsp;</u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">To:&#160; Tactile Systems Technology,&nbsp;Inc.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Ladies and Gentlemen:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">I hereby exercise the following option (the &#147;<u>Option</u>&#148;) granted to me under the Tactile Systems Technology,&nbsp;Inc. 2007 Omnibus Stock Plan (the &#147;<u>Plan</u>&#148;) with respect to the number of shares of Common Stock of Tactile Systems Technology,&nbsp;Inc. (the &#147;<u>Company</u>&#148;) indicated below:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.66%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Name:</font></b></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.66%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.66%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Date of   Grant of Option:</font></b></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.66%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.66%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exercise   Price Per Share:</font></b></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.66%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.66%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Number   of Shares With Respect to Which the Option is Hereby Exercised:</font></b></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.66%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.66%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Total   Exercise Price:</font></b></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.66%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Enclosed with this letter is a check, bank draft or money order in the amount of the Total Exercise Price.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>I hereby agree to pay the Total Exercise Price within five business days of the date hereof and, as stated in the attached Broker&#146;s Letter,&nbsp;I have delivered irrevocable instructions to <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> to promptly deliver to the Company the amount of sale or loan proceeds from the Shares to be issued pursuant to this exercise necessary to satisfy my obligation hereunder to pay the Total Exercise Price.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Enclosed with this letter is a certificate evidencing unencumbered Shares (duly endorsed in blank) having an aggregate Fair Market Value (as defined in the Plan) equal to or in excess of the Total Exercise Price.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>I elect to pay the Total Exercise Price through a reduction in the number of Shares delivered to me upon this exercise of the Option as provided in Section&nbsp;14 of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If I am enclosing Shares with this letter,&nbsp;I hereby represent and warrant that I am the owner of such Shares free and clear of all liens, security interests and other restrictions or encumbrances.&#160; I agree that I will pay any required withholding taxes in connection with this exercise.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=8,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="9",CHK=1045556,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LK_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:11 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Please issue a certificate (the &#147;<u>Certificate</u>&#148;) for the number of Shares with respect to which the Option is being exercised in the name of the person indicated below and deliver the Certificate to the address indicated below:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Name in   Which to Issue Certificate:</font></b></p>    </td>
<td width="49%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Address   to Which Certificate Should be </font></b></p>    </td>
<td width="49%" valign="bottom" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Delivered:</font></b></p>    </td>
<td width="49%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Principal   Mailing Address for Holder of the Certificate (if different from above):</font></b></p>    </td>
<td width="49%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Very truly yours,</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Signature</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name, please print</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Social Security Number</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Address</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Phone Number</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-LK_PB_2_114616_7648"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=9,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="9",CHK=163836,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LK_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:11 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u>, 20<u>&nbsp;&nbsp;</u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">To:&#160; Tactile Systems Technology,&nbsp;Inc.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Ladies and Gentlemen:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="58%" valign="top" style="padding:0in 0in 0in 0in;width:58.08%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Name of   Optionee:</font></b></p>    </td>
<td width="41%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:41.92%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="58%" valign="top" style="padding:0in 0in 0in 0in;width:58.08%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.92%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="58%" valign="top" style="padding:0in 0in 0in 0in;width:58.08%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Date of   Grant of Option:</font></b></p>    </td>
<td width="41%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:41.92%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="58%" valign="top" style="padding:0in 0in 0in 0in;width:58.08%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.92%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="58%" valign="top" style="padding:0in 0in 0in 0in;width:58.08%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exercise   Price Per Share:</font></b></p>    </td>
<td width="41%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:41.92%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="58%" valign="top" style="padding:0in 0in 0in 0in;width:58.08%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.92%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="58%" valign="top" style="padding:0in 0in 0in 0in;width:58.08%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Number   of Shares With Respect to Which the Option is to be Exercised:</font></b></p>    </td>
<td width="41%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:41.92%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="58%" valign="top" style="padding:0in 0in 0in 0in;width:58.08%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.92%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="58%" valign="top" style="padding:0in 0in 0in 0in;width:58.08%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Total   Exercise Price:</font></b></p>    </td>
<td width="41%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:41.92%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="58%" valign="top" style="padding:0in 0in 0in 0in;width:58.08%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.92%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The above Optionee has requested that we finance the exercise of the above Option to purchase Shares of Common Stock of Tactile Systems Technology,&nbsp;Inc. (the &#147;<u>Company</u>&#148;) and has given us irrevocable instructions to promptly deliver to the Company the amount of sale or loan proceeds from the Shares to be issued pursuant to such exercise to satisfy the Optionee&#146;s obligation to pay the Total Exercise Price.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Very truly yours,</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Broker Name</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Its</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=10,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="9",CHK=689035,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LK_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:11 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>10
<FILENAME>a2227029zex-10_7.htm
<DESCRIPTION>EX-10.7
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt .5in;text-align:right;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 10.7</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Non-Statutory Stock Option Agreement [Employee]</font></u></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(Under the 2007 Omnibus Stock Plan)</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name of Optionee:</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No.&nbsp;of Shares Covered:</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of Grant:</font></p>    </td>   </tr>
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exercise Price Per Share:</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Expiration Date:</font></p>    </td>   </tr>
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exercise   Schedule (Cumulative):</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This option shall vest as to <b>[Insert   number of shares equal to 25% of the total shares] </b>shares on <b>[insert date of one year anniversary of the date of grant]</b>.   The remaining Shares shall vest as to <b>[1/48</b></font><b><font size="1" style="font-size:6.5pt;font-weight:bold;position:relative;top:-3.0pt;">th</font>&nbsp;of the total shares]</b> shares each month   commencing on <b>[insert date of 13</b><b><font size="1" style="font-size:6.5pt;font-weight:bold;position:relative;top:-3.0pt;">th</font>&nbsp;month anniversary of the date of grant]</b>   and continuing until this option is fully vested.</p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This is a Non-Statutory Stock Option Agreement (the &#147;<u>Agreement</u>&#148;) between Tactile Systems Technology,&nbsp;Inc., a Delaware corporation (the &#147;<u>Company</u>&#148;), and the optionee identified above (the &#147;<u>Optionee</u>&#148;) effective as of the date of grant specified above.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">RECITALS</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company maintains the Tactile Systems Technology,&nbsp;Inc. 2007 Omnibus Stock Plan (the &#147;<u>Plan</u>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">B.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Pursuant to the Plan, the Board of Directors of the Company (the &#147;<u>Board</u>&#148;) or a committee of two or more directors of the Company (the &#147;<u>Committee</u>&#148;) appointed by the Board administers the Plan and has the authority to determine the awards to be granted under the Plan (if the Board has not appointed a committee to administer the Plan, then the Board shall constitute the Committee).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">C.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Committee has determined that the Optionee is eligible to receive an award under the Plan in the form of a non-statutory stock option (the &#147;<u>Option</u>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Company hereby grants this Option to the Optionee under the terms and conditions as follows.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TERMS AND CONDITIONS</font></b>*</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Grant</u></b>.&#160; The Optionee is granted this Option to purchase the number of Shares specified at the beginning of this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Exercise Price</u></b>.&#160; The price to the Optionee of each Share subject to this Option shall be the exercise price specified at the beginning of this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Non-Statutory Stock Option</u></b>.&#160; This Option is <u>not</u> intended to be an &#147;incentive stock option&#148; within the meaning of Section&nbsp;422 of the Internal Revenue Code of 1986, as amended (the &#147;<u>Code</u>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade align="left" style="color:black;"></div>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Unless the context indicates otherwise, terms that are not defined in this Agreement shall have the meaning set forth in the Plan as it currently exists or as it is amended in the future.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="10",CHK=269586,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LM-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 13:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Exercise Schedule</u></b>.&#160; This Option shall vest and become exercisable as to the number of Shares and on the dates specified in the exercise schedule at the beginning of this Agreement.&#160; The exercise schedule shall be cumulative; thus, to the extent this Option has not already been exercised and has not expired, terminated or been cancelled, the Optionee or the person otherwise entitled to exercise this Option as provided herein may at any time, and from time to time, purchase all or any portion of the Shares then purchasable under the exercise schedule.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This Option may also be exercised in full (notwithstanding the exercise schedule) under the circumstances described in Section&nbsp;8 of this Agreement if it has not expired prior thereto.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Expiration</u></b>.&#160; This Option shall expire at 5:00&nbsp;p.m.&nbsp;Central Time on the earliest of:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The expiration date specified at the beginning of this Agreement;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The expiration of the period after the termination of employment of the Optionee within which the Option can be exercised (as specified in Section&nbsp;7 of this Agreement);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Termination of the Optionee&#146;s employment for Cause.&#160; &#147;<u>Cause</u>&#148; shall be deemed to exist upon (i)&nbsp;an act or acts of dishonesty undertaken by Optionee and intended to result in substantial gain or personal enrichment of Optionee at the expense of the Company; (ii)&nbsp;unlawful conduct or gross misconduct that is willful and deliberate on Optionee&#146;s part and that, in either event, is materially injurious to the Company; (iii)&nbsp;the conviction of Optionee of a felony; or (iv)&nbsp;material breach by Optionee of any terms and conditions of any employment or non-competition/non-solicitation agreement between the Optionee and the Company not caused by the Company, which breach has not been cured by Optionee within ten days after written notice thereof to Optionee from the Company; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The date (if any) fixed for cancellation pursuant to Section&nbsp;17 of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In no event may anyone exercise this Option, in whole or in part, after it has expired, notwithstanding any other provision of this Agreement.&#160; In addition, if the Option is exercised, and prior to the delivery of the certificate representing the Shares so purchased, it is determined that Cause for termination existed, then the Company may rescind the Option exercise by the Optionee and the Option shall terminate at the election of the Company.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Procedure to Exercise Option</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Notice of Exercise</font></i>.&#160; This Option may be exercised by delivering written notice of exercise to the Company at the principal executive office of the Company, to the attention of the Company&#146;s Chief Executive Officer, in the form attached to this Agreement.&#160; The notice shall state the number of Shares to be purchased, and shall be signed by the person exercising this Option.&#160; If the person exercising this Option is not the Optionee, he/she also must submit appropriate proof of his/her right to exercise this Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Tender of Payment</font></i>.&#160; Upon giving notice of any exercise hereunder, the Optionee shall provide for payment of the purchase price of the Shares being purchased through one or a combination of the following methods:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Cash (including check, bank draft or money order);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>To the extent permitted by law, through a broker-assisted cashless exercise in which the Optionee simultaneously exercises the Option and sells all or a portion of the Shares thereby acquired pursuant to a brokerage or similar relationship and uses the proceeds from such sale to pay the purchase price of such Shares;</p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-LM-01_PB_2_120156_4290"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="10",CHK=233022,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LM-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 13:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>By delivery to the Company of unencumbered Shares having an aggregate Fair Market Value on the date of exercise equal to the purchase price of such Shares; or</p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>By authorizing the Company to retain, from the total number of Shares as to which the Option is exercised, that number of Shares having a Fair Market Value on the date of exercise equal to the purchase price for the total number of Shares as to which the Option is exercised.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Notwithstanding the foregoing, the Optionee shall not be permitted to pay any portion of the purchase price with Shares, or by authorizing the Company to retain Shares upon exercise of the Option, if the Committee, in its sole discretion, determines that payment in such manner is undesirable.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Delivery of Certificates</font></i>.&#160; As soon as practicable after the Company receives the notice and purchase price provided for above, it shall deliver to the person exercising this Option, in the name of such person, a certificate or certificates representing the Shares being purchased.&#160; The Company shall pay any original issue or transfer taxes with respect to the issue or transfer of the Shares and all fees and expenses incurred by it in connection therewith.&#160; All Shares so issued shall be fully paid and nonassessable.&#160; Notwithstanding anything to the contrary in this Agreement, no certificate for Shares distributable under the Plan shall be issued and delivered unless the issuance of such certificate complies with all applicable legal requirements including, without limitation, compliance with the provisions of applicable state securities laws, the Securities Act of 1933, as amended (the &#147;<u>Securities Act</u>&#148;) and the Exchange Act.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Employment Requirement</u></b>.&#160; This Option may be exercised only while the Optionee remains employed with the Company or a parent or subsidiary thereof, and only if the Optionee has been continuously so employed since the date of this Agreement; <i>provided that</i>:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>This Option may be exercised for 90 days following the day the Optionee&#146;s employment by the Company ceases if such cessation of employment is for a reason other than death or disability, but only to the extent that it was exercisable immediately prior to termination of employment; provided, that if termination of the Optionee&#146;s employment shall have been for Cause, the Option shall expire, and all rights to purchase Shares hereunder shall terminate, immediately upon such termination.</p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>This Option may be exercised within one year after the Optionee&#146;s employment by the Company ceases if such cessation of employment is because of death or disability of the Optionee, but only to the extent it was exercisable immediately prior to cessation of employment.</p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If the Optionee&#146;s employment terminates after a declaration made pursuant to Section&nbsp;17 of the Plan in connection with Fundamental Change , the Option may be exercised at any time permitted by such declaration.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Notwithstanding the above, the Option may not be exercised after it has expired.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Acceleration of Vesting</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Fundamental Change</font></i>.&#160; In the event of a Fundamental Change the Committee may, but shall not be obligated to:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>if the Fundamental Change is a merger or consolidation or statutory share exchange, make appropriate provision for the protection of this Option by the substitution for this Option of options or voting common stock of the corporation surviving any merger or</p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="16022-2-LM-01_PB_3_120259_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=3,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="10",CHK=1033321,FOLIO='3',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LM-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 13:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">consolidation or, if appropriate, the parent corporation of the Company or such surviving corporation; or</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>at least ten days before the occurrence of the Fundamental Change, declare, and provide written notice to the Optionee of the declaration, that this Option, whether or not then exercisable, shall be canceled at the time of, or immediately before the occurrence of, the Fundamental Change (unless it shall have been exercised prior to the occurrence of the Fundamental Change).&#160; In connection with any such declaration, the Committee may, but shall not be obligated to, cause payment to be made to the Optionee of cash equal to, for each Share covered by the canceled Option, the amount, if any, by which the Fair Market Value per Share exceeds the exercise price per Share covered by this Option.&#160; At the time of any such declaration, this Option shall immediately become exercisable in full and the Optionee shall have the right, during the period preceding the time of cancellation of this Option, to exercise this Option as to all or any part of the Shares covered by this Option.&#160; In the event of a declaration pursuant to this subsection, to the extent this Option has not been exercised prior to the Fundamental Change, the unexercised part of this Option shall be canceled at the time of, or immediately before, the Fundamental Change, as provided in the declaration.&#160; Notwithstanding the foregoing, the holder of this Option shall not be entitled to the payment provided for in this subsection if this Option shall have expired pursuant to Section&nbsp;5 above or been cancelled.&#160; For purposes of this subsection only, &#147;<u>Fair Market Value</u>&#148; per Share has the meaning set forth in Section&nbsp;17 of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Change in Control</font></i>.&#160; If a Change in Control of the Company shall occur, then, at the sole discretion of the Company, the Option, if not already exercised in full or otherwise terminated, expired or cancelled, may become immediately exercisable in full and remain exercisable during the remaining term of the Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Discretionary Acceleration</font></i>.&#160; Notwithstanding any other provisions of this Agreement to the contrary, the Committee may, in its sole discretion, declare at any time that the Option shall be immediately exercisable.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Limitation on Transfer</u></b>.&#160; During the lifetime of the Optionee, only the Optionee or his/her guardian or legal representative may exercise the Option.&#160; The Option may not be assigned or transferred by the Optionee otherwise than by will or the laws of descent and distribution.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">No Stockholder Rights Before Exercise</u></b>.&#160; No person shall have any of the rights of a stockholder of the Company with respect to any Share subject to the Option until the Share actually is issued to him/her upon exercise of the Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Lock-Up Period</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Optionee agrees that the Optionee will not offer, pledge, sell, contract to sell, sell any option, sell any contract to purchase, purchase any option, purchase any contract to sell, grant any option, right, or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any Shares (or any other Company securities) or enter into any swap, hedging, or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any Shares (or any other Company securities) held by the Optionee (other than those included in the registration) for a period specified by the representative of the underwriters of the Company&#146;s capital stock (or any other Company securities, collectively, the &#147;<u>Stock</u>&#148;) not to exceed 90 days (180 days in the case of an initial public offering) after the effective date of any Company registration statement filed under the Securities Act.</p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">4<a name="16022-2-LM-01_PB_4_120319_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=4,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="10",CHK=693351,FOLIO='4',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LM-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 13:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Optionee agrees to execute and deliver such other agreements as may be reasonably requested by the Company or the underwriter to the extent that such agreements are consistent with the foregoing or that are necessary to give further effect to the provisions set forth in Section&nbsp;11(a).&#160; In addition, if requested by the Company or the representative of the underwriters of Stock, the Optionee will provide, within 10 days of such request, such information as may be required by the Company or such representative in connection with the completion of any public offering of the Company&#146;s securities pursuant to a registration statement filed under the Securities Act.</p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The obligations described in this Section&nbsp;11 will not apply to a registration relating solely to employee benefit plans on Form&nbsp;S-8 or similar forms that may be promulgated in the future, or a registration relating solely to a Commission Rule&nbsp;145 transaction on Form&nbsp;S-4 or similar forms that may be promulgated in the future.&#160; The Company may impose stop-transfer instructions with respect to the shares of Stock subject to the foregoing restriction until the end of such 90-day or 180-day period, as applicable.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Discretionary Adjustment</u></b>.&#160; In the event of any reorganization, merger, consolidation, recapitalization, liquidation, reclassification, stock dividend, stock split, combination of shares, rights offering, or extraordinary dividend or divestiture (including a spin-off), or any other change in the corporate structure or Shares of the Company, the Committee (or if the Company does not survive any such transaction, a comparable committee of the Board of Directors of the surviving corporation) may, without the consent of the Optionee, make such adjustment as it determines in its discretion to be appropriate as to the number and kind of securities subject to and reserved under the Plan and, in order to prevent dilution or enlargement of rights of the Optionee, the number and kind of securities issuable upon exercise of the Option and the exercise price hereof.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Tax Withholding</u></b>.&#160; Delivery of Shares upon exercise of this Option shall be subject to any required withholding taxes.&#160; As a condition precedent to receiving Shares upon exercise of this Option, the Optionee may be required to pay to the Company, in accordance with the provisions of the Plan, an amount equal to the amount of any required withholdings.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Tax Consequences</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Optionee may incur tax liability as a result of the Optionee&#146;s purchase or disposition of the Shares.&#160; <b>THE OPTIONEE SHOULD CONSULT A TAX ADVISER BEFORE EXERCISING THE OPTION OR DISPOSING OF THE SHARES.</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Notwithstanding the Company&#146;s good faith determination of the Fair Market Value of the Company&#146;s common stock for purposes of determining the exercise price per Share of the Option, the taxing authorities may assert that the fair market value of the Company&#146;s common stock on the date of grant was greater than the exercise price per Share.&#160; Under Section&nbsp;409A of the Code, if the exercise price per Share of the Option is less than the fair market value of the Company&#146;s common stock on the date of grant, the Option may be treated as a form of deferred compensation and the Optionee may be subject to an additional 20% tax, plus interest and possible penalties.&#160; The Optionee is encouraged to consult a tax adviser regarding the potential impact of Section&nbsp;409A of the Code.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Amendment to Meet the Requirements of Section&nbsp;409A</u></b>.&#160; The Optionee acknowledges that the Company, in the exercise of its sole discretion and without the consent of the Optionee, may amend or modify this Agreement in any manner and delay the payment of any amounts payable pursuant to this Agreement to the minimum extent necessary to meet the requirements of Section&nbsp;409A of the Code as amplified by any Internal Revenue Service or U.S. Treasury Department regulations or guidance as the Company deems appropriate or advisable.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">5<a name="16022-2-LM-01_PB_5_120337_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=5,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="10",CHK=885101,FOLIO='5',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LM-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 13:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">16.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Interpretation of This Agreement</u></b>.&#160; All decisions and interpretations made by the Committee with regard to any question arising hereunder or under the Plan shall be binding and conclusive upon the Company and the Optionee.&#160; If there is any inconsistency between the provisions of this Agreement and the Plan, the provisions of the Plan shall govern.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Discontinuance of Employment</u></b>.&#160; This Agreement shall not give the Optionee a right to continued employment with the Company or any parent or subsidiary of the Company, and the Company or any such parent or subsidiary employing the Optionee may terminate his/her employment at any time and otherwise deal with the Optionee without regard to the effect it may have upon him/her under this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Option Subject to Plan, Certificate of Incorporation and By-Laws</u></b>.&#160; The Optionee acknowledges that the Option and the exercise thereof is subject to the Plan, the Certificate of Incorporation, as amended from time to time, and the By-Laws, as amended from time to time, of the Company, and any applicable federal or state laws, rules&nbsp;or regulations.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Binding Effect</u></b>.&#160; This Agreement shall be binding in all respects on the heirs, representatives, successors and assigns of the Optionee.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">20.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Choice of Law</u></b>.&#160; This Agreement is entered into under the laws of the State of Delaware and shall be construed and interpreted thereunder (without regard to its conflict of law principles).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">21.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Right of First Refusal and Execution of Stockholder Agreements</u></b>.&#160; At the discretion of the Committee, the Company is hereby granted (a)&nbsp;a right of first refusal to purchase all Shares that the Optionee (or a subsequent transferee) may propose to transfer to a third party and (b)&nbsp;the right to require the Optionee from time to time to execute and deliver stockholder, voting or similar agreements.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">**FOR ALL FOREIGN EMPLOYEES:</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">22.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Arbitration</u></b>.&#160; Any dispute arising out of or relating to this Agreement or the alleged breach of it, or the making of this Agreement, including claims of fraud in the inducement, shall be discussed between the disputing parties in a good faith effort to arrive at a mutual settlement of any such controversy.&#160; If, notwithstanding, such dispute cannot be resolved, such dispute shall be settled by binding arbitration.&#160; Judgment upon the award rendered by the arbitrator may be entered in any court having jurisdiction thereof.&#160; Arbitration will be conducted pursuant to the provisions of this Agreement, and the commercial arbitration rules&nbsp;of the American Arbitration Association, unless such rules&nbsp;are inconsistent with the provisions of this Agreement.&#160; Limited civil discovery shall be permitted for the production of documents and taking of depositions.&#160; Unresolved discovery disputes may be brought to the attention of the arbitrator who may dispose of such dispute.&#160; The arbitrator shall have the authority to award any remedy or relief that a court of the state of Delaware could order or grant; provided, however, that punitive or exemplary damages shall not be awarded.&#160; Unless otherwise agreed by the parties, the place of any arbitration proceedings shall be Hennepin or Ramsey County, Minnesota, United States of America.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">**FOR UK EMPLOYEES:</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">23.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Securities Law Compliance</u></b>.&#160; The exercise of all or a portion of this Option shall only be effective at such time as counsel to the Company shall have determined that the issuance and delivery of common stock pursuant to such exercise will not violate any United States&#146; federal or state securities or other laws, or the applicable securities or other laws of England or the United Kingdom.&#160; The Optionee may be required by the Company, as a condition of the effectiveness of any exercise of this Option, to agree in writing that (i)&nbsp;all common stock to be acquired pursuant to such exercise shall be held for the Optionee&#146;s own account without a view to any further </p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">6<a name="16022-2-LM-01_PB_6_120505_7748"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=6,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="10",CHK=234741,FOLIO='6',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LM-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 13:03 2016' -->

<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">distribution thereof, until such time that such common stock is registered and freely tradable under applicable United States&#146; federal and state securities laws, or the applicable securities laws of England or the United Kingdom, or proposed to be sold in a transaction exempt from the registration requirements of such laws, which exempt status shall be confirmed by an opinion of counsel to the Optionee (such opinion and counsel shall be satisfactory in all respects to counsel for the Company), (ii)&nbsp;the certificates for all shares of common stock issued upon exercise of this Option shall bear an appropriate legend respecting the noted restrictions on transferability, and (iii)&nbsp;such shares of common stock will not in any event be actually transferred or disposed of except in compliance with applicable United States&#146; federal and state securities laws, or the applicable securities laws of England or the United Kingdom.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">24.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">United Kingdom Tax Matters</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>This Option is a nonqualified option under the United States&#146; Internal Revenue Code of 1986, as amended.&#160; The Company does not make any representation regarding whether the Option is tax-qualified under the tax laws of England or the United Kingdom and provides no assurances as to the tax consequences of this Option under the tax laws of England or the United Kingdom.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Optionee represents that the Optionee has had an opportunity to consult with his or her advisors respecting the tax treatment of this Option under the tax laws of England or the United Kingdom, and is not relying on the Company for advice in this regard.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>In order to permit the Company to comply with all applicable United States&#146; federal or state income tax laws or regulations, or the applicable tax laws and regulations of England or the United Kingdom, the Company may take such action as it deems appropriate to insure that, if necessary, all applicable payroll, income or other taxes are withheld from any amounts payable by the Company to the Optionee.&#160; If the Company is unable to withhold such taxes, for whatever reason, the Optionee hereby agrees to pay to the Company an amount equal to the amount the Company would otherwise be required to withhold under applicable tax laws and regulations.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Optionee agrees to indemnify the Company against any liability it may incur for secondary Class&nbsp;I National Insurance Contributions and agrees that the Company may recover from the Optionee (in such manner as the Company may determine and notify to the Optionee at any time before this Option is first exercised) the whole or any part of any such contributions payable as a result of the Option being exercised.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">25.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Blue Sky Limitation</u></b>.&#160; Notwithstanding anything in this Agreement to the contrary, in the event the Company makes any public offering of its securities and determines in its sole discretion that it is necessary to reduce the number of issued but unexercised stock purchase rights so as to comply with any securities law limitations within the United States, Canada, England or the United Kingdom with respect thereto, the Board shall have the right (i)&nbsp;to accelerate the exercisability of this Option and the date on which this Option must be exercised, provided that the Company gives the Optionee 15 days&#146; prior written notice of such acceleration, and (ii)&nbsp;to cancel any portion of this Option or any other option granted to Optionee pursuant to the Plan that is not exercised prior to or contemporaneously with such public offering.&#160; Notice shall be deemed given when delivered personally or when deposited in the United States mail, first class postage prepaid and addressed to the Optionee at the address of the Optionee on file with the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">**FOR CANADIAN EMPLOYEES:</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">23.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Securities Law Compliance</u></b>.&#160; The exercise of all or a portion of this Option shall only be effective at such time as counsel to the Company shall have determined that the issuance and delivery of</p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">7<a name="16022-2-LM-03_PB_7_120700_5798"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=7,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="10",CHK=689238,FOLIO='7',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LM-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:05 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">common stock pursuant to such exercise will not violate any United States&#146; federal or state securities or other laws, or the applicable securities or other laws of Canada (federal or provincial).&#160; The Optionee may be required by the Company, as a condition of the effectiveness of any exercise of this Option, to agree in writing that (i)&nbsp;all common stock to be acquired pursuant to such exercise shall be held for the Optionee&#146;s own account without a view to any further distribution thereof, until such time that such common stock is registered and freely tradable under applicable United States&#146; federal and state securities laws, or the applicable securities laws of Canada (federal or provincial) or proposed to be sold in a transaction exempt from the registration requirements of such laws, which exempt status shall be confirmed by an opinion of counsel to the Optionee (such opinion and counsel shall be satisfactory in all respects to counsel for the Company), (ii)&nbsp;the certificates for all shares of common stock issued upon exercise of this Option shall bear an appropriate legend respecting the noted restrictions on transferability, and (iii)&nbsp;such shares of common stock will not in any event be actually transferred or disposed of except in compliance with applicable United States&#146; federal and state securities laws or the applicable securities laws of Canada (federal or provincial).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">24.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Canadian Tax Matters</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>This Option is a nonqualified option under the United States&#146; Internal Revenue Code of 1986, as amended.&#160; The Company does not make any representation regarding whether the Option is tax-qualified under the tax laws of Canada (federal or provincial) and provides no assurances as to the tax consequences of this Option under the tax laws of Canada (federal or provincial).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Optionee represents that the Optionee has had an opportunity to consult with his or her advisors respecting the tax treatment of this Option under the tax laws of Canada (federal or provincial), and is not relying on the Company for advice in this regard.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>In order to permit the Company to comply with all applicable United States&#146; federal or state income tax laws or regulations, or the applicable tax laws and regulations of Canada (federal or provincial), the Company may take such action as it deems appropriate to insure that, if necessary, all applicable payroll, income or other taxes are withheld from any amounts payable by the Company to the Optionee.&#160; If the Company is unable to withhold such taxes, for whatever reason, the Optionee hereby agrees to pay to the Company an amount equal to the amount the Company would otherwise be required to withhold under applicable tax laws and regulations.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">25.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Blue Sky Limitation</u></b>.&#160; Notwithstanding anything in this Agreement to the contrary, in the event the Company makes any public offering of its securities and determines in its sole discretion that it is necessary to reduce the number of issued but unexercised stock purchase rights so as to comply with any securities law limitations within the United States, Canada, England or the United Kingdom with respect thereto, the Board shall have the right (i)&nbsp;to accelerate the exercisability of this Option and the date on which this Option must be exercised, provided that the Company gives the Optionee 15 days&#146; prior written notice of such acceleration, and (ii)&nbsp;to cancel any portion of this Option or any other option granted to Optionee pursuant to the Plan that is not exercised prior to or contemporaneously with such public offering.&#160; Notice shall be deemed given when delivered personally or when deposited in the United States mail, first class postage prepaid and addressed to the Optionee at the address of the Optionee on file with the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">26.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Governing Language</u></b>.&#160; The parties hereto confirm their express wish that this Agreement and all documents and agreements directly or indirectly relating hereto be drawn up in the English language.&#160; <i>Les parties reconnaissent leur volont&#233; expresse que la pr&#233;sente ainsi que tous les documents et contrats s&#146;y rattachant directement ou indirectement soient r&#233;dig&#233;s en anglais</i>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">8<a name="16022-2-LM-03_PB_8_121118_7608"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=8,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="10",CHK=944671,FOLIO='8',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LM-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:05 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">[<i>Remainder of page&nbsp;left blank intentionally &#151; signature page&nbsp;follows</i>]</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">9<a name="16022-2-LM-03_PB_9_121124_8146"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=9,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="10",CHK=975042,FOLIO='9',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LM-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:05 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">IN WITNESS WHEREOF, the Optionee and the Company have executed this Agreement as of the date of grant.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">OPTIONEE</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS   TECHNOLOGY,&nbsp;INC.</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Its:</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">10<a name="16022-2-LM-03_PB_10_121222_7091"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=10,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="10",CHK=813355,FOLIO='10',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LM-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:05 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u>, 20<u>&nbsp;&nbsp;</u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">To:&#160; Tactile Systems Technology,&nbsp;Inc.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Ladies and Gentlemen:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">I hereby exercise the following option (the &#147;<u>Option</u>&#148;) granted to me under the Tactile Systems Technology,&nbsp;Inc. 2007 Omnibus Stock Plan (the &#147;<u>Plan</u>&#148;) with respect to the number of shares of Common Stock of Tactile Systems Technology,&nbsp;Inc. (the &#147;<u>Company</u>&#148;) indicated below:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.8%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Name:</font></b></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.8%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.2%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.8%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Date of   Grant of Option:</font></b></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.2%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.8%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.2%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.8%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exercise   Price Per Share:</font></b></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.2%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.8%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.2%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.8%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Number   of Shares With Respect to Which the Option is Hereby Exercised:</font></b></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.2%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.8%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.8%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Total   Exercise Price:</font></b></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.8%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Enclosed with this letter is a check, bank draft or money order in the amount of the Total Exercise Price.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>I hereby agree to pay the Total Exercise Price within five business days of the date hereof and, as stated in the attached Broker&#146;s Letter,&nbsp;I have delivered irrevocable instructions to <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> to promptly deliver to the Company the amount of sale or loan proceeds from the Shares to be issued pursuant to this exercise necessary to satisfy my obligation hereunder to pay the Total Exercise Price.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Enclosed with this letter is a certificate evidencing unencumbered Shares (duly endorsed in blank) having an aggregate Fair Market Value (as defined in the Plan) equal to or in excess of the Total Exercise Price.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>I elect to pay the Total Exercise Price through a reduction in the number of Shares delivered to me upon this exercise of the Option as provided in Section&nbsp;14 of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If I am enclosing Shares with this letter,&nbsp;I hereby represent and warrant that I am the owner of such Shares free and clear of all liens, security interests and other restrictions or encumbrances.&#160; I agree that I will pay any required withholding taxes in connection with this exercise.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=11,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="10",CHK=173581,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LM-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:05 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Please issue a certificate (the &#147;<u>Certificate</u>&#148;) for the number of Shares with respect to which the Option is being exercised in the name of the person indicated below and deliver the Certificate to the address indicated below:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.66%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Name in   Which to Issue Certificate:</font></b></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.66%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.66%;">
<p style="margin:0in .5in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Address   to Which Certificate Should be </font></b></p>    </td>
<td width="43%" valign="bottom" style="padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.66%;">
<p style="margin:0in .5in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Delivered:</font></b></p>    </td>
<td width="43%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.66%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.66%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.66%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.66%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.66%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Principal   Mailing Address for Holder of the Certificate (if different from above):</font></b></p>    </td>
<td width="43%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.66%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="43%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.66%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="43%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.66%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="43%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Very truly yours,</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Signature</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name, please print</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Social Security Number</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Address</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Phone Number</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-LM-03_PB_2_121521_8991"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=12,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="10",CHK=560701,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LM-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:05 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u>, 20<u>&nbsp;&nbsp;</u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">To:&#160; Tactile Systems Technology,&nbsp;Inc.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Ladies and Gentlemen:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="86%" style="border-collapse:collapse;margin-left:1.0in;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Name of Optionee:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Date of Grant of Option:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exercise Price Per Share:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Number of Shares With Respect   to Which the Option is to be Exercised:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Total Exercise Price:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The above Optionee has requested that we finance the exercise of the above Option to purchase Shares of Common Stock of Tactile Systems Technology,&nbsp;Inc. (the &#147;<u>Company</u>&#148;) and has given us irrevocable instructions to promptly deliver to the Company the amount of sale or loan proceeds from the Shares to be issued pursuant to such exercise to satisfy the Optionee&#146;s obligation to pay the Total Exercise Price.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Very truly yours,</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Broker Name</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Its</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=13,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="10",CHK=878751,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LM-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:05 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.8
<SEQUENCE>11
<FILENAME>a2227029zex-10_8.htm
<DESCRIPTION>EX-10.8
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 10.8</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Non-Statutory Stock Option Agreement [Directors]</font></u></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(Under the 2007 Omnibus Stock Plan)</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="100%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name of   Optionee:</font></p>    </td>   </tr>
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No.&nbsp;of Shares Covered:</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of Grant:</font></p>    </td>   </tr>
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exercise Price Per Share:</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Expiration Date:</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exercise Schedule (Cumulative): </font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This option shall vest as to <b>[Insert number of shares equal to 25% of the total shares] </b>shares on <b>[insert date of one year anniversary of the date of grant]</b>. The remaining Shares shall vest as to <b>[1/48</b></font><b><font size="1" style="font-size:6.5pt;font-weight:bold;position:relative;top:-3.0pt;">th</font>&#160;of the total shares]</b> shares each month commencing on <b>[insert date of 13</b><b><font size="1" style="font-size:6.5pt;font-weight:bold;position:relative;top:-3.0pt;">th</font>&#160;month anniversary of the date of grant]</b> and continuing until this option is fully vested.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This is a Non-Statutory Stock Option Agreement (the &#147;<u>Agreement</u>&#148;) between Tactile Systems Technology,&nbsp;Inc., a Delaware corporation (the &#147;<u>Company</u>&#148;), and the optionee identified above (the &#147;<u>Optionee</u>&#148;) effective as of the date of grant specified above.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">RECITALS</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company maintains the Tactile Systems Technology,&nbsp;Inc. 2007 Omnibus Stock Plan (the &#147;<u>Plan</u>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">B.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Pursuant to the Plan, the Board of Directors of the Company (the &#147;<u>Board</u>&#148;) or a committee of two or more directors of the Company (the &#147;<u>Committee</u>&#148;) appointed by the Board administers the Plan and has the authority to determine the awards to be granted under the Plan (if the Board has not appointed a committee to administer the Plan, then the Board shall constitute the Committee).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">C.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Committee has determined that the Optionee is eligible to receive an award under the Plan in the form of a non-statutory stock option (the &#147;<u>Option</u>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Company hereby grants this Option to the Optionee under the terms and conditions as follows.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TERMS AND CONDITIONS</font></b>*</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Grant</u></b>.&#160; The Optionee is granted this Option to purchase the number of Shares specified at the beginning of this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Exercise Price</u></b>.&#160; The price to the Optionee of each Share subject to this Option shall be the exercise price specified at the beginning of this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Non-Statutory Stock Option</u></b>.&#160; This Option is <u>not</u> intended to be an &#147;incentive stock option&#148; within the meaning of Section&nbsp;422 of the Internal Revenue Code of 1986, as amended (the &#147;<u>Code</u>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade align="left" style="color:black;"></div>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Unless the context indicates otherwise, terms that are not defined in this Agreement shall have the meaning set forth in the Plan as it currently exists or as it is amended in the future.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="11",CHK=632941,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LO-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 13:26 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Exercise Schedule</u></b>.&#160; This Option shall vest and become exercisable as to the number of Shares and on the dates specified in the exercise schedule at the beginning of this Agreement.&#160; The exercise schedule shall be cumulative; thus, to the extent this Option has not already been exercised and has not expired, terminated or been cancelled, the Optionee or the person otherwise entitled to exercise this Option as provided herein may at any time, and from time to time, purchase all or any portion of the Shares then purchasable under the exercise schedule.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This Option may also be exercised in full (notwithstanding the exercise schedule) under the circumstances described in Section&nbsp;8 of this Agreement if it has not expired prior thereto.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Expiration</u></b>.&#160; This Option shall expire at 5:00&nbsp;p.m.&nbsp;Central Time on the earliest of:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The expiration date specified at the beginning of this Agreement;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The expiration of the period after the termination of Service of the Optionee within which the Option can be exercised (as specified in Section&nbsp;7 of this Agreement);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Termination of the Optionee&#146;s Service for Cause.&#160; &#147;<u>Cause</u>&#148; shall be deemed to exist upon (i)&nbsp;an act or acts of dishonesty undertaken by Optionee and intended to result in substantial gain or personal enrichment of Optionee at the expense of the Company; (ii)&nbsp;unlawful conduct or gross misconduct that is willful and deliberate on Optionee&#146;s part and that, in either event, is materially injurious to the Company; (iii)&nbsp;the conviction of Optionee of a felony; or (iv)&nbsp;material breach by Optionee of any terms and conditions of any consulting, services, advisory board, confidentiality, employment or non-competition/non-solicitation agreement between the Optionee and the Company not caused by the Company, which breach has not been cured by Optionee within ten days after written notice thereof to Optionee from the Company; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The date (if any) fixed for cancellation pursuant to Section&nbsp;17 of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In no event may anyone exercise this Option, in whole or in part, after it has expired, notwithstanding any other provision of this Agreement.&#160; In addition, if the Option is exercised, and prior to the delivery of the certificate representing the Shares so purchased, it is determined that Cause for termination existed, then the Company may rescind the Option exercise by the Optionee and the Option shall terminate at the election of the Company.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Procedure to Exercise Option</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Notice of Exercise</font></i>.&#160; This Option may be exercised by delivering written notice of exercise to the Company at the principal executive office of the Company, to the attention of the Company&#146;s Chief Executive Officer, in the form attached to this Agreement.&#160; The notice shall state the number of Shares to be purchased, and shall be signed by the person exercising this Option.&#160; If the person exercising this Option is not the Optionee, he/she also must submit appropriate proof of his/her right to exercise this Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Tender of Payment</font></i>.&#160; Upon giving notice of any exercise hereunder, the Optionee shall provide for payment of the purchase price of the Shares being purchased through one or a combination of the following methods:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Cash (including check, bank draft or money order);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>To the extent permitted by law, through a broker-assisted cashless exercise in which the Optionee simultaneously exercises the Option and sells all or a portion of the Shares thereby acquired pursuant to a brokerage or similar relationship and uses the proceeds from such sale to pay the purchase price of such Shares;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-LO-01_PB_2_115833_5807"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="11",CHK=521187,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LO-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 13:26 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>By delivery to the Company of unencumbered Shares having an aggregate Fair Market Value on the date of exercise equal to the purchase price of such Shares; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>By authorizing the Company to retain, from the total number of Shares as to which the Option is exercised, that number of Shares having a Fair Market Value on the date of exercise equal to the purchase price for the total number of Shares as to which the Option is exercised.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Notwithstanding the foregoing, the Optionee shall not be permitted to pay any portion of the purchase price with Shares, or by authorizing the Company to retain Shares upon exercise of the Option, if the Committee, in its sole discretion, determines that payment in such manner is undesirable.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Delivery of Certificates</font></i>.&#160; As soon as practicable after the Company receives the notice and purchase price provided for above, it shall deliver to the person exercising this Option, in the name of such person, a certificate or certificates representing the Shares being purchased.&#160; The Company shall pay any original issue or transfer taxes with respect to the issue or transfer of the Shares and all fees and expenses incurred by it in connection therewith.&#160; All Shares so issued shall be fully paid and nonassessable.&#160; Notwithstanding anything to the contrary in this Agreement, no certificate for Shares distributable under the Plan shall be issued and delivered unless the issuance of such certificate complies with all applicable legal requirements including, without limitation, compliance with the provisions of applicable state securities laws, the Securities Act of 1933, as amended (the &#147;<u>Securities Act</u>&#148;) and the Exchange Act.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Service Requirement</u></b> &#147;<u>Service</u>&#148; or &#147;<u>Services</u>&#148; means providing services to the Company as a member of its board of directors.&#160; If the Optionee&#146;s Service terminates after a declaration made pursuant to Section&nbsp;17 of the Plan in connection with Fundamental Change, the Option may be exercised at any time permitted by such declaration.&#160; Notwithstanding the above, the Option may not be exercised after it has expired.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Acceleration of Vesting</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Fundamental Change</font></i>.&#160; In the event of a Fundamental Change the Committee may, but shall not be obligated to:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>if the Fundamental Change is a merger or consolidation or statutory share exchange, make appropriate provision for the protection of this Option by the substitution for this Option of options or voting common stock of the corporation surviving any merger or consolidation or, if appropriate, the parent corporation of the Company or such surviving corporation; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>at least ten days before the occurrence of the Fundamental Change, declare, and provide written notice to the Optionee of the declaration, that this Option, whether or not then exercisable, shall be canceled at the time of, or immediately before the occurrence of, the Fundamental Change (unless it shall have been exercised prior to the occurrence of the Fundamental Change).&#160; In connection with any such declaration, the Committee may, but shall not be obligated to, cause payment to be made to the Optionee of cash equal to, for each Share covered by the canceled Option, the amount, if any, by which the Fair Market Value per Share exceeds the exercise price per Share covered by this Option.&#160; At the time of any such declaration, this Option shall immediately become exercisable in full and the Optionee shall have the right, during the period preceding the time of cancellation of this Option, to exercise this Option as to all or any part of the Shares covered by this Option.&#160; In the event of a declaration pursuant to this subsection, to the extent this Option has not been exercised prior to the Fundamental Change, the </p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="16022-2-LO-01_PB_3_120333_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=3,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="11",CHK=62718,FOLIO='3',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LO-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 13:26 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>unexercised part of this Option shall be canceled at the time of, or immediately before, the Fundamental Change, as provided in the declaration.&#160; Notwithstanding the foregoing, the holder of this Option shall not be entitled to the payment provided for in this subsection if this Option shall have expired pursuant to Section&nbsp;5 above or been cancelled.&#160; For purposes of this subsection only, &#147;<u>Fair Market Value</u>&#148; per Share has the meaning set forth in Section&nbsp;17 of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Change in Control</font></i>.&#160; If a Change in Control of the Company shall occur, then the Option, if not already exercised in full or otherwise terminated, expired or cancelled, will become immediately exercisable in full and remain exercisable during the remaining term of the Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Discretionary Acceleration</font></i>.&#160; Notwithstanding any other provisions of this Agreement to the contrary, the Committee may, in its sole discretion, declare at any time that the Option shall be immediately exercisable.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Limitation on Transfer</u></b>.&#160; During the lifetime of the Optionee, only the Optionee or his/her guardian or legal representative may exercise the Option.&#160; The Option may not be assigned or transferred by the Optionee otherwise than by will or the laws of descent and distribution.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">No Stockholder Rights Before Exercise</u></b>.&#160; No person shall have any of the rights of a stockholder of the Company with respect to any Share subject to the Option until the Share actually is issued to him/her upon exercise of the Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Lock-Up Period</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Optionee agrees that the Optionee will not offer, pledge, sell, contract to sell, sell any option, sell any contract to purchase, purchase any option, purchase any contract to sell, grant any option, right, or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any Shares (or any other Company securities) or enter into any swap, hedging, or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any Shares (or any other Company securities) held by the Optionee (other than those included in the registration) for a period specified by the representative of the underwriters of the Company&#146;s capital stock (or any other Company securities, collectively, the &#147;<u>Stock</u>&#148;) not to exceed 90 days (180 days in the case of an initial public offering) after the effective date of any Company registration statement filed under the Securities Act.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Optionee agrees to execute and deliver such other agreements as may be reasonably requested by the Company or the underwriter to the extent that such agreements are consistent with the foregoing or that are necessary to give further effect to the provisions set forth in Section&nbsp;11(a).&#160; In addition, if requested by the Company or the representative of the underwriters of Stock, the Optionee will provide, within 10 days of such request, such information as may be required by the Company or such representative in connection with the completion of any public offering of the Company&#146;s securities pursuant to a registration statement filed under the Securities Act.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The obligations described in this Section&nbsp;11 will not apply to a registration relating solely to employee benefit plans on Form&nbsp;S-8 or similar forms that may be promulgated in the future, or a registration relating solely to a Commission Rule&nbsp;145 transaction on Form&nbsp;S-4 or similar forms that may be promulgated in the future.&#160; The Company may impose stop-transfer instructions with respect to the shares of Stock subject to the foregoing restriction until the end of such 90-day or 180-day period, as applicable.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">4<a name="16022-2-LO-01_PB_4_120613_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=4,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="11",CHK=746955,FOLIO='4',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LO-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 13:26 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Discretionary Adjustment</u></b>.&#160; In the event of any reorganization, merger, consolidation, recapitalization, liquidation, reclassification, stock dividend, stock split, combination of shares, rights offering, or extraordinary dividend or divestiture (including a spin-off), or any other change in the corporate structure or Shares of the Company, the Committee (or if the Company does not survive any such transaction, a comparable committee of the Board of Directors of the surviving corporation) may, without the consent of the Optionee, make such adjustment as it determines in its discretion to be appropriate as to the number and kind of securities subject to and reserved under the Plan and, in order to prevent dilution or enlargement of rights of the Optionee, the number and kind of securities issuable upon exercise of the Option and the exercise price hereof.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Tax Withholding</u></b>.&#160; Delivery of Shares upon exercise of this Option shall be subject to any required withholding taxes.&#160; As a condition precedent to receiving Shares upon exercise of this Option, the Optionee may be required to pay to the Company, in accordance with the provisions of the Plan, an amount equal to the amount of any required withholdings.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Tax Consequences</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Optionee may incur tax liability as a result of the Optionee&#146;s purchase or disposition of the Shares.&#160; <b>THE OPTIONEE SHOULD CONSULT A TAX ADVISER BEFORE EXERCISING THE OPTION OR DISPOSING OF THE SHARES.</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Notwithstanding the Company&#146;s good faith determination of the Fair Market Value of the Company&#146;s common stock for purposes of determining the exercise price per Share of the Option, the taxing authorities may assert that the fair market value of the Company&#146;s common stock on the date of grant was greater than the exercise price per Share.&#160; Under Section&nbsp;409A of the Code, if the exercise price per Share of the Option is less than the fair market value of the Company&#146;s common stock on the date of grant, the Option may be treated as a form of deferred compensation and the Optionee may be subject to an additional 20% tax, plus interest and possible penalties.&#160; The Optionee is encouraged to consult a tax adviser regarding the potential impact of Section&nbsp;409A of the Code.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Amendment to Meet the Requirements of Section&nbsp;409A</u></b>.&#160; The Optionee acknowledges that the Company, in the exercise of its sole discretion and without the consent of the Optionee, may amend or modify this Agreement in any manner and delay the payment of any amounts payable pursuant to this Agreement to the minimum extent necessary to meet the requirements of Section&nbsp;409A of the Code as amplified by any Internal Revenue Service or U.S. Treasury Department regulations or guidance as the Company deems appropriate or advisable.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">16.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Interpretation of This Agreement</u></b>.&#160; All decisions and interpretations made by the Committee with regard to any question arising hereunder or under the Plan shall be binding and conclusive upon the Company and the Optionee.&#160; If there is any inconsistency between the provisions of this Agreement and the Plan, the provisions of the Plan shall govern.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Discontinuance of Service</u></b>.&#160; This Agreement shall not give the Optionee a right to employment or to continued Service with the Company or any parent or subsidiary of the Company, and the Company or any such parent or subsidiary engaging or employing the Optionee may terminate his/her Service at any time and otherwise deal with the Optionee without regard to the effect it may have upon him/her under this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Option Subject to Plan, Certificate of Incorporation and By-Laws</u></b>.&#160; The Optionee acknowledges that the Option and the exercise thereof is subject to the Plan, the Certificate of Incorporation, as amended from time to time, and the By-Laws, as amended from time to time, of the Company, and any applicable federal or state laws, rules&nbsp;or regulations.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">5<a name="16022-2-LO-01_PB_5_120654_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=5,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="11",CHK=265527,FOLIO='5',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LO-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 13:26 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Binding Effect</u></b>.&#160; This Agreement shall be binding in all respects on the heirs, representatives, successors and assigns of the Optionee.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">20.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Choice of Law</u></b>.&#160; This Agreement is entered into under the laws of the State of Delaware and shall be construed and interpreted thereunder (without regard to its conflict of law principles).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">21.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Right of First Refusal and Execution of Stockholder Agreements</u></b>.&#160; At the discretion of the Committee, the Company is hereby granted (a)&nbsp;a right of first refusal to purchase all Shares that the Optionee (or a subsequent transferee) may propose to transfer to a third party and (b)&nbsp;the right to require the Optionee from time to time to execute and deliver stockholder, voting or similar agreements, including as a condition to exercising this Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">**FOR ALL FOREIGN CONSULTANTS:</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">22.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Arbitration</u></b>.&#160; Any dispute arising out of or relating to this Agreement or the alleged breach of it, or the making of this Agreement, including claims of fraud in the inducement, shall be discussed between the disputing parties in a good faith effort to arrive at a mutual settlement of any such controversy.&#160; If, notwithstanding, such dispute cannot be resolved, such dispute shall be settled by binding arbitration.&#160; Judgment upon the award rendered by the arbitrator may be entered in any court having jurisdiction thereof.&#160; Arbitration will be conducted pursuant to the provisions of this Agreement, and the commercial arbitration rules&nbsp;of the American Arbitration Association, unless such rules&nbsp;are inconsistent with the provisions of this Agreement.&#160; Limited civil discovery shall be permitted for the production of documents and taking of depositions.&#160; Unresolved discovery disputes may be brought to the attention of the arbitrator who may dispose of such dispute.&#160; The arbitrator shall have the authority to award any remedy or relief that a court of the state of Delaware could order or grant; provided, however, that punitive or exemplary damages shall not be awarded.&#160; Unless otherwise agreed by the parties, the place of any arbitration proceedings shall be Hennepin or Ramsey County, Minnesota, United States of America.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">**FOR UK CONSULTANTS:</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">23.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Securities Law Compliance</u></b>.&#160; The exercise of all or a portion of this Option shall only be effective at such time as counsel to the Company shall have determined that the issuance and delivery of common stock pursuant to such exercise will not violate any United States&#146; federal or state securities or other laws, or the applicable securities or other laws of England or the United Kingdom.&#160; The Optionee may be required by the Company, as a condition of the effectiveness of any exercise of this Option, to agree in writing that (i)&nbsp;all common stock to be acquired pursuant to such exercise shall be held for the Optionee&#146;s own account without a view to any further distribution thereof, until such time that such common stock is registered and freely tradable under applicable United States&#146; federal and state securities laws, or the applicable securities laws of England or the United Kingdom, or proposed to be sold in a transaction exempt from the registration requirements of such laws, which exempt status shall be confirmed by an opinion of counsel to the Optionee (such opinion and counsel shall be satisfactory in all respects to counsel for the Company), (ii)&nbsp;the certificates for all shares of common stock issued upon exercise of this Option shall bear an appropriate legend respecting the noted restrictions on transferability, and (iii)&nbsp;such shares of common stock will not in any event be actually transferred or disposed of except in compliance with applicable United States&#146; federal and state securities laws, or the applicable securities laws of England or the United Kingdom.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">24.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">United Kingdom Tax Matters</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>This Option is a nonqualified option under the United States&#146; Internal Revenue Code of 1986, as amended.&#160; The Company does not make any representation regarding whether the Option is tax-qualified under the tax laws of England or the United Kingdom and provides </p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">6<a name="16022-2-LO-01_PB_6_120918_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=6,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="11",CHK=1014976,FOLIO='6',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LO-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 13:26 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>no assurances as to the tax consequences of this Option under the tax laws of England or the United Kingdom.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Optionee represents that the Optionee has had an opportunity to consult with his or her advisors respecting the tax treatment of this Option under the tax laws of England or the United Kingdom, and is not relying on the Company for advice in this regard.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>In order to permit the Company to comply with all applicable United States&#146; federal or state income tax laws or regulations, or the applicable tax laws and regulations of England or the United Kingdom, the Company may take such action as it deems appropriate to insure that, if necessary, all applicable payroll, income or other taxes are withheld from any amounts payable by the Company to the Optionee.&#160; If the Company is unable to withhold such taxes, for whatever reason, the Optionee hereby agrees to pay to the Company an amount equal to the amount the Company would otherwise be required to withhold under applicable tax laws and regulations.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Optionee agrees to indemnify the Company against any liability it may incur for secondary Class&nbsp;I National Insurance Contributions and agrees that the Company may recover from the Optionee (in such manner as the Company may determine and notify to the Optionee at any time before this Option is first exercised) the whole or any part of any such contributions payable as a result of the Option being exercised.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">25.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Blue Sky Limitation</u></b>.&#160; Notwithstanding anything in this Agreement to the contrary, in the event the Company makes any public offering of its securities and determines in its sole discretion that it is necessary to reduce the number of issued but unexercised stock purchase rights so as to comply with any securities law limitations within the United States, Canada, England or the United Kingdom with respect thereto, the Board shall have the right (i)&nbsp;to accelerate the exercisability of this Option and the date on which this Option must be exercised, provided that the Company gives the Optionee 15 days&#146; prior written notice of such acceleration, and (ii)&nbsp;to cancel any portion of this Option or any other option granted to Optionee pursuant to the Plan that is not exercised prior to or contemporaneously with such public offering.&#160; Notice shall be deemed given when delivered personally or when deposited in the United States mail, first class postage prepaid and addressed to the Optionee at the address of the Optionee on file with the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">**FOR CANADIAN CONSULTANTS:</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">23.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Securities Law Compliance</u></b>.&#160; The exercise of all or a portion of this Option shall only be effective at such time as counsel to the Company shall have determined that the issuance and delivery of common stock pursuant to such exercise will not violate any United States&#146; federal or state securities or other laws, or the applicable securities or other laws of Canada (federal or provincial).&#160; The Optionee may be required by the Company, as a condition of the effectiveness of any exercise of this Option, to agree in writing that (i)&nbsp;all common stock to be acquired pursuant to such exercise shall be held for the Optionee&#146;s own account without a view to any further distribution thereof, until such time that such common stock is registered and freely tradable under applicable United States&#146; federal and state securities laws, or the applicable securities laws of Canada (federal or provincial) or proposed to be sold in a transaction exempt from the registration requirements of such laws, which exempt status shall be confirmed by an opinion of counsel to the Optionee (such opinion and counsel shall be satisfactory in all respects to counsel for the Company), (ii)&nbsp;the certificates for all shares of common stock issued upon exercise of this Option shall bear an appropriate legend respecting the noted restrictions on transferability, and (iii)&nbsp;such shares of common stock will not in any event be actually transferred or disposed of except in compliance with applicable United States&#146; federal and state securities laws or the applicable securities laws of Canada (federal or provincial).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">7<a name="16022-2-LO-01_PB_7_121040_7748"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=7,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="11",CHK=365971,FOLIO='7',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LO-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 13:26 2016' -->

<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">24.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Canadian Tax Matters</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>This Option is a nonqualified option under the United States&#146; Internal Revenue Code of 1986, as amended.&#160; The Company does not make any representation regarding whether the Option is tax-qualified under the tax laws of Canada (federal or provincial) and provides no assurances as to the tax consequences of this Option under the tax laws of Canada (federal or provincial).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Optionee represents that the Optionee has had an opportunity to consult with his or her advisors respecting the tax treatment of this Option under the tax laws of Canada (federal or provincial), and is not relying on the Company for advice in this regard.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>In order to permit the Company to comply with all applicable United States&#146; federal or state income tax laws or regulations, or the applicable tax laws and regulations of Canada (federal or provincial), the Company may take such action as it deems appropriate to insure that, if necessary, all applicable payroll, income or other taxes are withheld from any amounts payable by the Company to the Optionee.&#160; If the Company is unable to withhold such taxes, for whatever reason, the Optionee hereby agrees to pay to the Company an amount equal to the amount the Company would otherwise be required to withhold under applicable tax laws and regulations.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">25.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Blue Sky Limitation</u></b>.&#160; Notwithstanding anything in this Agreement to the contrary, in the event the Company makes any public offering of its securities and determines in its sole discretion that it is necessary to reduce the number of issued but unexercised stock purchase rights so as to comply with any securities law limitations within the United States, Canada, England or the United Kingdom with respect thereto, the Board shall have the right (i)&nbsp;to accelerate the exercisability of this Option and the date on which this Option must be exercised, provided that the Company gives the Optionee 15 days&#146; prior written notice of such acceleration, and (ii)&nbsp;to cancel any portion of this Option or any other option granted to Optionee pursuant to the Plan that is not exercised prior to or contemporaneously with such public offering.&#160; Notice shall be deemed given when delivered personally or when deposited in the United States mail, first class postage prepaid and addressed to the Optionee at the address of the Optionee on file with the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">26.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Governing Language</u></b>.&#160; The parties hereto confirm their express wish that this Agreement and all documents and agreements directly or indirectly relating hereto be drawn up in the English language.&#160; <i>Les parties reconnaissent leur volont&#233; expresse que la pr&#233;sente ainsi que tous les documents et contrats s&#146;y rattachant directement ou indirectement soient r&#233;dig&#233;s en anglais</i>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">[<i>Remainder of page&nbsp;left blank intentionally &#151; signature page&nbsp;follows</i>]</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">8<a name="16022-2-LO-03_PB_8_121323_3925"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=8,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="11",CHK=1040886,FOLIO='8',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LO-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:08 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">IN WITNESS WHEREOF, the Optionee and the Company have executed this Agreement as of the date of grant.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.76%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">OPTIONEE</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.76%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:49.76%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.76%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.76%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.76%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS   TECHNOLOGY,&nbsp;INC.</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.76%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Its:</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">9<a name="16022-2-LO-03_PB_9_121828_141"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=9,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="11",CHK=442091,FOLIO='9',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LO-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:08 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u>, 20<u>&nbsp;&nbsp;&nbsp;&nbsp;</u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">To:&#160; Tactile Systems Technology,&nbsp;Inc.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Ladies and Gentlemen:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">I hereby exercise the following option (the &#147;<u>Option</u>&#148;) granted to me under the Tactile Systems Technology,&nbsp;Inc. 2007 Omnibus Stock Plan (the &#147;<u>Plan</u>&#148;) with respect to the number of shares of Common Stock of Tactile Systems Technology,&nbsp;Inc. (the &#147;<u>Company</u>&#148;) indicated below:</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="86%" style="border-collapse:collapse;margin-left:1.0in;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Name:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Date of Grant of Option:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exercise Price Per Share:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Number of Shares With Respect   to Which the Option is Hereby Exercised:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Total Exercise Price:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Enclosed with this letter is a check, bank draft or money order in the amount of the Total Exercise Price.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>I hereby agree to pay the Total Exercise Price within five business days of the date hereof and, as stated in the attached Broker&#146;s Letter,&nbsp;I have delivered irrevocable instructions to <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> to promptly deliver to the Company the amount of sale or loan proceeds from the Shares to be issued pursuant to this exercise necessary to satisfy my obligation hereunder to pay the Total Exercise Price.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Enclosed with this letter is a certificate evidencing unencumbered Shares (duly endorsed in blank) having an aggregate Fair Market Value (as defined in the Plan) equal to or in excess of the Total Exercise Price.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>I elect to pay the Total Exercise Price through a reduction in the number of Shares delivered to me upon this exercise of the Option as provided in Section&nbsp;14 of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If I am enclosing Shares with this letter,&nbsp;I hereby represent and warrant that I am the owner of such Shares free and clear of all liens, security interests and other restrictions or encumbrances.&#160; I agree that I will pay any required withholding taxes in connection with this exercise.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=10,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="11",CHK=867941,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LO-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:08 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Please issue a certificate (the &#147;<u>Certificate</u>&#148;) for the number of Shares with respect to which the Option is being exercised in the name of the person indicated below and deliver the Certificate to the address indicated below:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="78%" style="border-collapse:collapse;margin-left:1.0in;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Name in Which to Issue   Certificate:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Address to Which Certificate   Should be Delivered:</font></b></p>    </td>
<td width="50%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Principal Mailing Address for   Holder of the Certificate (if different from above):</font></b></p>    </td>
<td width="50%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt 5.4pt;text-indent:174.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Very truly yours,</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Signature</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name, please print</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Social Security Number</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Address</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Phone Number</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-LO-03_PB_2_123346_9053"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=11,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="11",CHK=617942,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LO-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:08 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u>, 20<u>&nbsp;&nbsp;&nbsp;&nbsp;</u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">To:&#160; Tactile Systems Technology,&nbsp;Inc.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Ladies and Gentlemen:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="90%" style="border-collapse:collapse;margin-left:.75in;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Name of Optionee:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Date of Grant of Option:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exercise Price Per Share:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Number of Shares With Respect   to Which the Option is to be Exercised:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Total Exercise Price:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The above Optionee has requested that we finance the exercise of the above Option to purchase Shares of Common Stock of Tactile Systems Technology,&nbsp;Inc. (the &#147;<u>Company</u>&#148;) and has given us irrevocable instructions to promptly deliver to the Company the amount of sale or loan proceeds from the Shares to be issued pursuant to such exercise to satisfy the Optionee&#146;s obligation to pay the Total Exercise Price.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Very truly yours,</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Broker Name</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By</font></p>    </td>
<td width="44%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:44.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name</font></p>    </td>
<td width="44%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:44.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Its</font></p>    </td>
<td width="44%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:44.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=12,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="11",CHK=806977,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LO-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:08 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.9
<SEQUENCE>12
<FILENAME>a2227029zex-10_9.htm
<DESCRIPTION>EX-10.9
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 10.9</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Non-Statutory Stock Option Agreement [Consultants]</font></u></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(Under the 2007 Omnibus Stock Plan)</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name of Optionee:</font></p>    </td>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No.&nbsp;of Shares   Covered:</font></p>    </td>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of Grant:</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exercise Price Per   Share:</font></p>    </td>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Expiration Date:</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exercise Schedule   (Cumulative):</font></p>    </td>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This option shall vest   as to <b>[Insert number of shares equal to 25% of the   total shares] </b>shares on <b>[insert date of one year   anniversary of the date of grant]</b>. The remaining Shares shall vest   as to <b>[1/48</b></font><b><font size="1" style="font-size:6.5pt;font-weight:bold;position:relative;top:-3.0pt;">th</font>&nbsp;of the total shares]</b> shares each month   commencing on <b>[insert date of 13</b><b><font size="1" style="font-size:6.5pt;font-weight:bold;position:relative;top:-3.0pt;">th</font>&nbsp;month anniversary of the date of grant]</b>   and continuing until this option is fully vested.</p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This is a Non-Statutory Stock Option Agreement (the &#147;<u>Agreement</u>&#148;) between Tactile Systems Technology,&nbsp;Inc., a Delaware corporation (the &#147;<u>Company</u>&#148;), and the optionee identified above (the &#147;<u>Optionee</u>&#148;) effective as of the date of grant specified above.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">RECITALS</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company maintains the Tactile Systems Technology,&nbsp;Inc. 2007 Omnibus Stock Plan (the &#147;<u>Plan</u>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">B.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Pursuant to the Plan, the Board of Directors of the Company (the &#147;<u>Board</u>&#148;) or a committee of two or more directors of the Company (the &#147;<u>Committee</u>&#148;) appointed by the Board administers the Plan and has the authority to determine the awards to be granted under the Plan (if the Board has not appointed a committee to administer the Plan, then the Board shall constitute the Committee).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">C.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Committee has determined that the Optionee is eligible to receive an award under the Plan in the form of a non-statutory stock option (the &#147;<u>Option</u>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Company hereby grants this Option to the Optionee under the terms and conditions as follows.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TERMS AND CONDITIONS</font></b>*</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Grant</u></b>.&#160; The Optionee is granted this Option to purchase the number of Shares specified at the beginning of this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Exercise Price</u></b>.&#160; The price to the Optionee of each Share subject to this Option shall be the exercise price specified at the beginning of this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Non-Statutory Stock Option</u></b>.&#160; This Option is <u>not</u> intended to be an &#147;incentive stock option&#148; within the meaning of Section&nbsp;422 of the Internal Revenue Code of 1986, as amended (the &#147;<u>Code</u>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade align="left" style="color:black;"></div>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Unless the context indicates otherwise, terms that are not defined in this Agreement shall have the meaning set forth in the Plan as it currently exists or as it is amended in the future.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="12",CHK=263562,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LQ-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 12:09 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Exercise Schedule</u></b>.&#160; This Option shall vest and become exercisable as to the number of Shares and on the dates specified in the exercise schedule at the beginning of this Agreement.&#160; The exercise schedule shall be cumulative; thus, to the extent this Option has not already been exercised and has not expired, terminated or been cancelled, the Optionee or the person otherwise entitled to exercise this Option as provided herein may at any time, and from time to time, purchase all or any portion of the Shares then purchasable under the exercise schedule.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This Option may also be exercised in full (notwithstanding the exercise schedule) under the circumstances described in Section&nbsp;8 of this Agreement if it has not expired prior thereto.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Expiration</u></b>.&#160; This Option shall expire at 5:00&nbsp;p.m.&nbsp;Central Time on the earliest of:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The expiration date specified at the beginning of this Agreement;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The expiration of the period after the termination of Service (as defined below) of the Optionee within which the Option can be exercised (as specified in Section&nbsp;7 of this Agreement);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Termination of the Optionee&#146;s Service to the Company for Cause.&#160; &#147;<u>Cause</u>&#148; shall be deemed to exist upon (i)&nbsp;an act or acts of dishonesty undertaken by Optionee and intended to result in substantial gain or personal enrichment of Optionee at the expense of the Company; (ii)&nbsp;unlawful conduct or gross misconduct that is willful and deliberate on Optionee&#146;s part and that, in either event, is materially injurious to the Company; (iii)&nbsp;the conviction of Optionee of a felony; or (iv)&nbsp;material breach by Optionee of any terms and conditions of any consulting, independent contractor, employment, confidentiality or non-competition/non-solicitation agreement between the Optionee and the Company not caused by the Company, which breach has not been cured by Optionee within ten days after written notice thereof to Optionee from the Company; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The date (if any) fixed for cancellation pursuant to Section&nbsp;17 of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In no event may anyone exercise this Option, in whole or in part, after it has expired, notwithstanding any other provision of this Agreement.&#160; In addition, if the Option is exercised, and prior to the delivery of the certificate representing the Shares so purchased, it is determined that Cause for termination existed, then the Company may rescind the Option exercise by the Optionee and the Option shall terminate at the election of the Company.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Procedure to Exercise Option</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Notice of Exercise</font></i>.&#160; This Option may be exercised by delivering written notice of exercise to the Company at the principal executive office of the Company, to the attention of the Company&#146;s Chief Executive Officer, in the form attached to this Agreement.&#160; The notice shall state the number of Shares to be purchased, and shall be signed by the person exercising this Option.&#160; If the person exercising this Option is not the Optionee, he/she also must submit appropriate proof of his/her right to exercise this Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Tender of Payment</font></i>.&#160; Upon giving notice of any exercise hereunder, the Optionee shall provide for payment of the purchase price of the Shares being purchased through one or a combination of the following methods:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Cash (including check, bank draft or money order);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>To the extent permitted by law, through a broker-assisted cashless exercise in which the Optionee simultaneously exercises the Option and sells all or a portion of the Shares thereby acquired pursuant to a brokerage or similar relationship and uses the proceeds from such sale to pay the purchase price of such Shares;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-LQ-01_PB_2_120125_1081"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="12",CHK=817506,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LQ-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 12:09 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>By delivery to the Company of unencumbered Shares having an aggregate Fair Market Value on the date of exercise equal to the purchase price of such Shares; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>By authorizing the Company to retain, from the total number of Shares as to which the Option is exercised, that number of Shares having a Fair Market Value on the date of exercise equal to the purchase price for the total number of Shares as to which the Option is exercised.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Notwithstanding the foregoing, the Optionee shall not be permitted to pay any portion of the purchase price with Shares, or by authorizing the Company to retain Shares upon exercise of the Option, if the Committee, in its sole discretion, determines that payment in such manner is undesirable.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Delivery of Certificates</font></i>.&#160; As soon as practicable after the Company receives the notice and purchase price provided for above, it shall deliver to the person exercising this Option, in the name of such person, a certificate or certificates representing the Shares being purchased.&#160; The Company shall pay any original issue or transfer taxes with respect to the issue or transfer of the Shares and all fees and expenses incurred by it in connection therewith.&#160; All Shares so issued shall be fully paid and nonassessable.&#160; Notwithstanding anything to the contrary in this Agreement, no certificate for Shares distributable under the Plan shall be issued and delivered unless the issuance of such certificate complies with all applicable legal requirements including, without limitation, compliance with the provisions of applicable state securities laws, the Securities Act of 1933, as amended (the &#147;<u>Securities Act</u>&#148;) and the Exchange Act.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Service Requirement</u></b>.&#160; The Option may be exercised only while the Optionee provides services to the Company as a consultant, employee, independent contractor or member of its board of directors (such services are referred to collectively in this Agreement as &#147;<u>Service</u>&#148; or &#147;<u>Services</u>&#148;) and only if the Optionee has been continuously providing such Services since the date the Option was granted; <i>provided that</i>:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>This Option may be exercised for 90 days following the day the Optionee&#146;s Service to the Company ceases if such cessation of Service is for a reason other than death or disability, but only to the extent that it was exercisable immediately prior to cessation of Service.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>This Option may be exercised within one year after the Optionee&#146;s Service to the Company ceases if such cessation of Service is because of death or disability of the Optionee, but only to the extent it was exercisable immediately prior to cessation of Service.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If the Optionee&#146;s Service terminates after a declaration made pursuant to Section&nbsp;17 of the Plan in connection with Fundamental Change, the Option may be exercised at any time permitted by such declaration.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Notwithstanding the above, the Option may not be exercised after it has expired.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Acceleration of Vesting</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Fundamental Change</font></i>.&#160; In the event of a Fundamental Change the Committee may, but shall not be obligated to:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>if the Fundamental Change is a merger or consolidation or statutory share exchange, make appropriate provision for the protection of this Option by the substitution for this Option of options or voting common stock of the corporation surviving any merger or consolidation or, if appropriate, the parent corporation of the Company or such surviving corporation; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="16022-2-LQ-01_PB_3_120317_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=3,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="12",CHK=181801,FOLIO='3',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LQ-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 12:09 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>at least ten days before the occurrence of the Fundamental Change, declare, and provide written notice to the Optionee of the declaration, that this Option, whether or not then exercisable, shall be canceled at the time of, or immediately before the occurrence of, the Fundamental Change (unless it shall have been exercised prior to the occurrence of the Fundamental Change).&#160; In connection with any such declaration, the Committee may, but shall not be obligated to, cause payment to be made to the Optionee of cash equal to, for each Share covered by the canceled Option, the amount, if any, by which the Fair Market Value per Share exceeds the exercise price per Share covered by this Option.&#160; At the time of any such declaration, this Option shall immediately become exercisable in full and the Optionee shall have the right, during the period preceding the time of cancellation of this Option, to exercise this Option as to all or any part of the Shares covered by this Option.&#160; In the event of a declaration pursuant to this subsection, to the extent this Option has not been exercised prior to the Fundamental Change, the unexercised part of this Option shall be canceled at the time of, or immediately before, the Fundamental Change, as provided in the declaration.&#160; Notwithstanding the foregoing, the holder of this Option shall not be entitled to the payment provided for in this subsection if this Option shall have expired pursuant to Section&nbsp;5 above or been cancelled.&#160; For purposes of this subsection only, &#147;<u>Fair Market Value</u>&#148; per Share has the meaning set forth in Section&nbsp;17 of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Change in Control</font></i>.&#160; If a Change in Control of the Company shall occur, then, at the sole discretion of the Company, the Option, if not already exercised in full or otherwise terminated, expired or cancelled, may become immediately exercisable in full and remain exercisable during the remaining term of the Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Discretionary Acceleration</font></i>.&#160; Notwithstanding any other provisions of this Agreement to the contrary, the Committee may, in its sole discretion, declare at any time that the Option shall be immediately exercisable.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Limitation on Transfer</u></b>.&#160; During the lifetime of the Optionee, only the Optionee or his/her guardian or legal representative may exercise the Option.&#160; The Option may not be assigned or transferred by the Optionee otherwise than by will or the laws of descent and distribution.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">No Stockholder Rights Before Exercise</u></b>.&#160; No person shall have any of the rights of a stockholder of the Company with respect to any Share subject to the Option until the Share actually is issued to him/her upon exercise of the Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Lock-Up Period</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Optionee agrees that the Optionee will not offer, pledge, sell, contract to sell, sell any option, sell any contract to purchase, purchase any option, purchase any contract to sell, grant any option, right, or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any Shares (or any other Company securities) or enter into any swap, hedging, or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any Shares (or any other Company securities) held by the Optionee (other than those included in the registration) for a period specified by the representative of the underwriters of the Company&#146;s capital stock (or any other Company securities, collectively, the &#147;<u>Stock</u>&#148;) not to exceed 90 days (180 days in the case of an initial public offering) after the effective date of any Company registration statement filed under the Securities Act.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Optionee agrees to execute and deliver such other agreements as may be reasonably requested by the Company or the underwriter to the extent that such agreements are</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">4<a name="16022-2-LQ-01_PB_4_120452_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=4,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="12",CHK=46281,FOLIO='4',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LQ-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 12:09 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">consistent with the foregoing or that are necessary to give further effect to the provisions set forth in Section&nbsp;11(a).&#160; In addition, if requested by the Company or the representative of the underwriters of Stock, the Optionee will provide, within 10 days of such request, such information as may be required by the Company or such representative in connection with the completion of any public offering of the Company&#146;s securities pursuant to a registration statement filed under the Securities Act.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The obligations described in this Section&nbsp;11 will not apply to a registration relating solely to employee benefit plans on Form&nbsp;S-8 or similar forms that may be promulgated in the future, or a registration relating solely to a Commission Rule&nbsp;145 transaction on Form&nbsp;S-4 or similar forms that may be promulgated in the future.&#160; The Company may impose stop-transfer instructions with respect to the shares of Stock subject to the foregoing restriction until the end of such 90-day or 180-day period, as applicable.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Discretionary Adjustment</u></b>.&#160; In the event of any reorganization, merger, consolidation, recapitalization, liquidation, reclassification, stock dividend, stock split, combination of shares, rights offering, or extraordinary dividend or divestiture (including a spin-off), or any other change in the corporate structure or Shares of the Company, the Committee (or if the Company does not survive any such transaction, a comparable committee of the Board of Directors of the surviving corporation) may, without the consent of the Optionee, make such adjustment as it determines in its discretion to be appropriate as to the number and kind of securities subject to and reserved under the Plan and, in order to prevent dilution or enlargement of rights of the Optionee, the number and kind of securities issuable upon exercise of the Option and the exercise price hereof.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Tax Withholding</u></b>.&#160; Delivery of Shares upon exercise of this Option shall be subject to any required withholding taxes.&#160; As a condition precedent to receiving Shares upon exercise of this Option, the Optionee may be required to pay to the Company, in accordance with the provisions of the Plan, an amount equal to the amount of any required withholdings.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Tax Consequences</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Optionee may incur tax liability as a result of the Optionee&#146;s purchase or disposition of the Shares.&#160; <b>THE OPTIONEE SHOULD CONSULT A TAX ADVISER BEFORE EXERCISING THE OPTION OR DISPOSING OF THE SHARES.</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Notwithstanding the Company&#146;s good faith determination of the Fair Market Value of the Company&#146;s common stock for purposes of determining the exercise price per Share of the Option, the taxing authorities may assert that the fair market value of the Company&#146;s common stock on the date of grant was greater than the exercise price per Share.&#160; Under Section&nbsp;409A of the Code, if the exercise price per Share of the Option is less than the fair market value of the Company&#146;s common stock on the date of grant, the Option may be treated as a form of deferred compensation and the Optionee may be subject to an additional 20% tax, plus interest and possible penalties.&#160; The Optionee is encouraged to consult a tax adviser regarding the potential impact of Section&nbsp;409A of the Code.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Amendment to Meet the Requirements of Section&nbsp;409A</u></b>.&#160; The Optionee acknowledges that the Company, in the exercise of its sole discretion and without the consent of the Optionee, may amend or modify this Agreement in any manner and delay the payment of any amounts payable pursuant to this Agreement to the minimum extent necessary to meet the requirements of Section&nbsp;409A of the Code as amplified by any Internal Revenue Service or U.S. Treasury Department regulations or guidance as the Company deems appropriate or advisable.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">16.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Interpretation of This Agreement</u></b>.&#160; All decisions and interpretations made by the Committee with regard to any question arising hereunder or under the Plan shall be binding and conclusive upon the</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">5<a name="16022-2-LQ-01_PB_5_120607_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=5,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="12",CHK=636329,FOLIO='5',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LQ-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 12:09 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company and the Optionee.&#160; If there is any inconsistency between the provisions of this Agreement and the Plan, the provisions of the Plan shall govern.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Discontinuance of Service</u></b>.&#160; This Agreement shall not give the Optionee a right to employment or continued Service with the Company or any parent or subsidiary of the Company, and the Company or any such parent or subsidiary engaging the Optionee may terminate his/her Service at any time and otherwise deal with the Optionee without regard to the effect it may have upon him/her under this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Option Subject to Plan, Certificate of Incorporation and By-Laws</u></b>.&#160; The Optionee acknowledges that the Option and the exercise thereof is subject to the Plan, the Certificate of Incorporation, as amended from time to time, and the By-Laws, as amended from time to time, of the Company, and any applicable federal or state laws, rules&nbsp;or regulations.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Binding Effect</u></b>.&#160; This Agreement shall be binding in all respects on the heirs, representatives, successors and assigns of the Optionee.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">20.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Choice of Law</u></b>.&#160; This Agreement is entered into under the laws of the State of Delaware and shall be construed and interpreted thereunder (without regard to its conflict of law principles).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">21.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Right of First Refusal and Execution of Stockholder Agreements</u></b>.&#160; At the discretion of the Committee, the Company is hereby granted (a)&nbsp;a right of first refusal to purchase all Shares that the Optionee (or a subsequent transferee) may propose to transfer to a third party and (b)&nbsp;the right to require the Optionee from time to time to execute and deliver stockholder, voting or similar agreements.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">**FOR ALL FOREIGN CONSULTANTS:</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">22.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Arbitration</u></b>.&#160; Any dispute arising out of or relating to this Agreement or the alleged breach of it, or the making of this Agreement, including claims of fraud in the inducement, shall be discussed between the disputing parties in a good faith effort to arrive at a mutual settlement of any such controversy.&#160; If, notwithstanding, such dispute cannot be resolved, such dispute shall be settled by binding arbitration.&#160; Judgment upon the award rendered by the arbitrator may be entered in any court having jurisdiction thereof.&#160; Arbitration will be conducted pursuant to the provisions of this Agreement, and the commercial arbitration rules&nbsp;of the American Arbitration Association, unless such rules&nbsp;are inconsistent with the provisions of this Agreement.&#160; Limited civil discovery shall be permitted for the production of documents and taking of depositions.&#160; Unresolved discovery disputes may be brought to the attention of the arbitrator who may dispose of such dispute.&#160; The arbitrator shall have the authority to award any remedy or relief that a court of the state of Delaware could order or grant; provided, however, that punitive or exemplary damages shall not be awarded.&#160; Unless otherwise agreed by the parties, the place of any arbitration proceedings shall be Hennepin or Ramsey County, Minnesota, United States of America.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">**FOR UK CONSULTANTS:</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">23.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Securities Law Compliance</u></b>.&#160; The exercise of all or a portion of this Option shall only be effective at such time as counsel to the Company shall have determined that the issuance and delivery of common stock pursuant to such exercise will not violate any United States&#146; federal or state securities or other laws, or the applicable securities or other laws of England or the United Kingdom.&#160; The Optionee may be required by the Company, as a condition of the effectiveness of any exercise of this Option, to agree in writing that (i)&nbsp;all common stock to be acquired pursuant to such exercise shall be held for the Optionee&#146;s own account without a view to any further distribution thereof, until such time that such common stock is registered and freely tradable under applicable United States&#146; federal and state securities laws, or the applicable securities laws of</p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">6<a name="16022-2-LQ-01_PB_6_120743_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=6,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="12",CHK=101862,FOLIO='6',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LQ-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 12:09 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">England or the United Kingdom, or proposed to be sold in a transaction exempt from the registration requirements of such laws, which exempt status shall be confirmed by an opinion of counsel to the Optionee (such opinion and counsel shall be satisfactory in all respects to counsel for the Company), (ii)&nbsp;the certificates for all shares of common stock issued upon exercise of this Option shall bear an appropriate legend respecting the noted restrictions on transferability, and (iii)&nbsp;such shares of common stock will not in any event be actually transferred or disposed of except in compliance with applicable United States&#146; federal and state securities laws, or the applicable securities laws of England or the United Kingdom.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">24.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">United Kingdom Tax Matters</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>This Option is a nonqualified option under the United States&#146; Internal Revenue Code of 1986, as amended.&#160; The Company does not make any representation regarding whether the Option is tax-qualified under the tax laws of England or the United Kingdom and provides no assurances as to the tax consequences of this Option under the tax laws of England or the United Kingdom.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Optionee represents that the Optionee has had an opportunity to consult with his or her advisors respecting the tax treatment of this Option under the tax laws of England or the United Kingdom, and is not relying on the Company for advice in this regard.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>In order to permit the Company to comply with all applicable United States&#146; federal or state income tax laws or regulations, or the applicable tax laws and regulations of England or the United Kingdom, the Company may take such action as it deems appropriate to insure that, if necessary, all applicable payroll, income or other taxes are withheld from any amounts payable by the Company to the Optionee.&#160; If the Company is unable to withhold such taxes, for whatever reason, the Optionee hereby agrees to pay to the Company an amount equal to the amount the Company would otherwise be required to withhold under applicable tax laws and regulations.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Optionee agrees to indemnify the Company against any liability it may incur for secondary Class&nbsp;I National Insurance Contributions and agrees that the Company may recover from the Optionee (in such manner as the Company may determine and notify to the Optionee at any time before this Option is first exercised) the whole or any part of any such contributions payable as a result of the Option being exercised.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">25.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Blue Sky Limitation</u></b>.&#160; Notwithstanding anything in this Agreement to the contrary, in the event the Company makes any public offering of its securities and determines in its sole discretion that it is necessary to reduce the number of issued but unexercised stock purchase rights so as to comply with any securities law limitations within the United States, Canada, England or the United Kingdom with respect thereto, the Board shall have the right (i)&nbsp;to accelerate the exercisability of this Option and the date on which this Option must be exercised, provided that the Company gives the Optionee 15 days&#146; prior written notice of such acceleration, and (ii)&nbsp;to cancel any portion of this Option or any other option granted to Optionee pursuant to the Plan that is not exercised prior to or contemporaneously with such public offering.&#160; Notice shall be deemed given when delivered personally or when deposited in the United States mail, first class postage prepaid and addressed to the Optionee at the address of the Optionee on file with the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">**FOR CANADIAN CONSULTANTS:</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">23.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Securities Law Compliance</u></b>.&#160; The exercise of all or a portion of this Option shall only be effective at such time as counsel to the Company shall have determined that the issuance and delivery of common stock pursuant to such exercise will not violate any United States&#146; federal or state securities or other laws, or the applicable securities or other laws of Canada (federal or provincial).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">7<a name="16022-2-LQ-01_PB_7_120830_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=7,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="12",CHK=826459,FOLIO='7',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LQ-01_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 12:09 2016' -->

<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Optionee may be required by the Company, as a condition of the effectiveness of any exercise of this Option, to agree in writing that (i)&nbsp;all common stock to be acquired pursuant to such exercise shall be held for the Optionee&#146;s own account without a view to any further distribution thereof, until such time that such common stock is registered and freely tradable under applicable United States&#146; federal and state securities laws, or the applicable securities laws of Canada (federal or provincial) or proposed to be sold in a transaction exempt from the registration requirements of such laws, which exempt status shall be confirmed by an opinion of counsel to the Optionee (such opinion and counsel shall be satisfactory in all respects to counsel for the Company), (ii)&nbsp;the certificates for all shares of common stock issued upon exercise of this Option shall bear an appropriate legend respecting the noted restrictions on transferability, and (iii)&nbsp;such shares of common stock will not in any event be actually transferred or disposed of except in compliance with applicable United States&#146; federal and state securities laws or the applicable securities laws of Canada (federal or provincial).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">24.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Canadian Tax Matters</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>This Option is a nonqualified option under the United States&#146; Internal Revenue Code of 1986, as amended.&#160; The Company does not make any representation regarding whether the Option is tax-qualified under the tax laws of Canada (federal or provincial) and provides no assurances as to the tax consequences of this Option under the tax laws of Canada (federal or provincial).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Optionee represents that the Optionee has had an opportunity to consult with his or her advisors respecting the tax treatment of this Option under the tax laws of Canada (federal or provincial), and is not relying on the Company for advice in this regard.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>In order to permit the Company to comply with all applicable United States&#146; federal or state income tax laws or regulations, or the applicable tax laws and regulations of Canada (federal or provincial), the Company may take such action as it deems appropriate to insure that, if necessary, all applicable payroll, income or other taxes are withheld from any amounts payable by the Company to the Optionee.&#160; If the Company is unable to withhold such taxes, for whatever reason, the Optionee hereby agrees to pay to the Company an amount equal to the amount the Company would otherwise be required to withhold under applicable tax laws and regulations.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">25.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Blue Sky Limitation</u></b>.&#160; Notwithstanding anything in this Agreement to the contrary, in the event the Company makes any public offering of its securities and determines in its sole discretion that it is necessary to reduce the number of issued but unexercised stock purchase rights so as to comply with any securities law limitations within the United States, Canada, England or the United Kingdom with respect thereto, the Board shall have the right (i)&nbsp;to accelerate the exercisability of this Option and the date on which this Option must be exercised, provided that the Company gives the Optionee 15 days&#146; prior written notice of such acceleration, and (ii)&nbsp;to cancel any portion of this Option or any other option granted to Optionee pursuant to the Plan that is not exercised prior to or contemporaneously with such public offering.&#160; Notice shall be deemed given when delivered personally or when deposited in the United States mail, first class postage prepaid and addressed to the Optionee at the address of the Optionee on file with the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">26.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Governing Language</u></b>.&#160; The parties hereto confirm their express wish that this Agreement and all documents and agreements directly or indirectly relating hereto be drawn up in the English language.&#160; <i>Les parties reconnaissent leur volont&#233; expresse que la pr&#233;sente ainsi que tous les documents et contrats s&#146;y rattachant directement ou indirectement soient r&#233;dig&#233;s en anglais</i>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">[<i>Remainder of page&nbsp;left blank intentionally &#151; signature page&nbsp;follows</i>]</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">8<a name="16022-2-LQ-03_PB_8_121457_413"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=8,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="12",CHK=983564,FOLIO='8',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LQ-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:15 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">IN WITNESS WHEREOF, the Optionee and the Company have executed this Agreement as of the date of grant.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">OPTIONEE</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS   TECHNOLOGY,&nbsp;INC.</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.76%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.76%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Its:</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.76%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">9<a name="16022-2-LQ-03_PB_9_121914_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=9,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="12",CHK=247959,FOLIO='9',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LQ-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:15 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u>, 20<u>&nbsp;&nbsp;&nbsp;&nbsp;</u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">To:&#160; Tactile Systems Technology,&nbsp;Inc.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Ladies and Gentlemen:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">I hereby exercise the following option (the &#147;<u>Option</u>&#148;) granted to me under the Tactile Systems Technology,&nbsp;Inc. 2007 Omnibus Stock Plan (the &#147;<u>Plan</u>&#148;) with respect to the number of shares of Common Stock of Tactile Systems Technology,&nbsp;Inc. (the &#147;<u>Company</u>&#148;) indicated below:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Name:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Date of Grant of Option:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exercise Price Per Share:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Number of Shares With Respect   to Which the Option is Hereby Exercised:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Total Exercise Price:</font></b></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Enclosed with this letter is a check, bank draft or money order in the amount of the Total Exercise Price.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>I hereby agree to pay the Total Exercise Price within five business days of the date hereof and, as stated in the attached Broker&#146;s Letter,&nbsp;I have delivered irrevocable instructions to <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> to promptly deliver to the Company the amount of sale or loan proceeds from the Shares to be issued pursuant to this exercise necessary to satisfy my obligation hereunder to pay the Total Exercise Price.</p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Enclosed with this letter is a certificate evidencing unencumbered Shares (duly endorsed in blank) having an aggregate Fair Market Value (as defined in the Plan) equal to or in excess of the Total Exercise Price.</p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>I elect to pay the Total Exercise Price through a reduction in the number of Shares delivered to me upon this exercise of the Option as provided in Section&nbsp;14 of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If I am enclosing Shares with this letter,&nbsp;I hereby represent and warrant that I am the owner of such Shares free and clear of all liens, security interests and other restrictions or encumbrances.&#160; I agree that I will pay any required withholding taxes in connection with this exercise.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=10,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="12",CHK=806302,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LQ-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:15 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Please issue a certificate (the &#147;<u>Certificate</u>&#148;) for the number of Shares with respect to which the Option is being exercised in the name of the person indicated below and deliver the Certificate to the address indicated below:</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.36%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Name in   Which to Issue Certificate:</font></b></p>    </td>
<td width="29%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:29.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.36%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="29%" valign="top" style="padding:0in 0in 0in 0in;width:29.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.36%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Address   to Which Certificate Should be Delivered:</font></b></p>    </td>
<td width="29%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:29.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.36%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="29%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:29.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.36%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="29%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:29.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.36%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="29%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:29.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.36%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="29%" valign="top" style="padding:0in 0in 0in 0in;width:29.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.36%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Principal   Mailing Address for Holder of the Certificate </font></b></p>    </td>
<td width="29%" valign="bottom" style="padding:0in 0in 0in 0in;width:29.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.36%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(if   different from above):</font></b></p>    </td>
<td width="29%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:29.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.36%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="29%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:29.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.36%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="29%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:29.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.36%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="29%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:29.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Very truly yours,</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Signature</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name, please print</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Social Security Number</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Address</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Phone Number</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-LQ-03_PB_2_122810_5278"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=11,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="12",CHK=504726,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LQ-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:15 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u>, 20<u>&nbsp;&nbsp;&nbsp;&nbsp;</u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">To:&#160; Tactile Systems Technology,&nbsp;Inc.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Ladies and Gentlemen:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.26%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Name of   Optionee:</font></b></p>    </td>
<td width="35%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:35.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.26%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="35%" valign="bottom" style="padding:0in 0in 0in 0in;width:35.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.26%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Date of   Grant of Option:</font></b></p>    </td>
<td width="35%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:35.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.26%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="35%" valign="bottom" style="padding:0in 0in 0in 0in;width:35.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.26%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exercise   Price Per Share:</font></b></p>    </td>
<td width="35%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:35.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.26%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="35%" valign="bottom" style="padding:0in 0in 0in 0in;width:35.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.26%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Number   of Shares With Respect to Which the Option is to </font></b></p>    </td>
<td width="35%" valign="bottom" style="padding:0in 0in 0in 0in;width:35.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.26%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">be Exercised:</font></b></p>    </td>
<td width="35%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:35.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.26%;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="35%" valign="bottom" style="padding:0in 0in 0in 0in;width:35.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.26%;">
<p style="margin:0in 0in .0001pt 1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Total   Exercise Price:</font></b></p>    </td>
<td width="35%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:35.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The above Optionee has requested that we finance the exercise of the above Option to purchase Shares of Common Stock of Tactile Systems Technology,&nbsp;Inc. (the &#147;<u>Company</u>&#148;) and has given us irrevocable instructions to promptly deliver to the Company the amount of sale or loan proceeds from the Shares to be issued pursuant to such exercise to satisfy the Optionee&#146;s obligation to pay the Total Exercise Price.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Very truly yours,</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Broker Name</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By</font></p>    </td>
<td width="44%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:44.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name</font></p>    </td>
<td width="44%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:44.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Its</font></p>    </td>
<td width="44%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:44.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=12,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="12",CHK=19939,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LQ-03_ZBY12202.CHC",USER="CPELLEY",CD='Jan 23 05:15 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.10
<SEQUENCE>13
<FILENAME>a2227029zex-10_10.htm
<DESCRIPTION>EX-10.10
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 10.10</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Restricted Stock Agreement</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="100%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Full   Name of Employee: <b>[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</b></font></p>    </td>   </tr>
<tr>
<td width="72%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:72.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No.&nbsp;of Shares of   Series&nbsp;A Preferred Stock Covered: <b>[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</b></font></p>    </td>
<td width="27%" valign="top" style="padding:0in 0in 0in 0in;width:27.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of Issuance: <b>March&nbsp;3, 2009</b></font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vesting   Schedule:</font></p>    </td>   </tr>
<tr>
<td width="1%" valign="top" style="padding:0in 0in 0in 0in;width:1.66%;">
<p style="margin:0in 0in .0001pt 20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="98%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:98.34%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="1%" valign="top" style="padding:0in 0in 0in 0in;width:1.66%;">
<p style="margin:0in 0in .0001pt 20.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="98%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:98.34%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">All   Shares subject to this Agreement will vest immediately in full upon the terms   described in Section&nbsp;2 of this Agreement.</font></p>    </td>   </tr>
<tr height="0">
<td width="12" style="border:none;"></td>
<td width="499" style="border:none;"></td>
<td width="197" style="border:none;"></td>   </tr> </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This Restricted Stock Agreement is made as of the date of issuance set forth above (the &#147;<i>Effective Date</i>&#148;), between Tactile Systems Technology,&nbsp;Inc., a Delaware corporation (the &#147;<i>Company</i>&#148;), and the employee set forth above (the &#147;<i>Employee</i>&#148;).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company desires to give the Employee an inducement to acquire a proprietary interest in the Company and an added incentive to advance the interests of the Company by granting the Employee restricted shares of Series&nbsp;A Preferred Stock of the Company (including the shares of the Company&#146;s common stock issuable upon conversion of the shares of Series&nbsp;A Preferred Stock, the &#147;<i>Shares</i>&#148;), on the terms and conditions and subject to the restrictions set forth herein; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">B.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company and the Employee desire to enter into this Agreement to set forth the terms and conditions of such grant.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Now, therefore, the Company and the Employee mutually agree as follows:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>GRANT OF RESTRICTED STOCK</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Subject to the terms and conditions of this Agreement, the Company has granted to the Employee the number of Shares specified at the beginning of this Agreement.&#160; Such Shares are subject to the restrictions provided for in this Agreement and are referred to collectively as the &#147;<i>Restricted Shares</i>&#148; and each as a &#147;<i>Restricted Share.</i>&#148;&#160; The term &#147;Restricted Shares&#148; also refers to all securities received by the Employee in replacement of or in connection with the Restricted Shares acquired hereby pursuant to a recapitalization, reclassification, stock dividend, stock split, stock combination or other relevant event.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each Restricted Share will be evidenced by a duly issued stock certificate (which may represent more than one Restricted Share) registered in the name of the Employee.&#160; The Employee will have all rights of a stockholder of the Company with respect to each Restricted Share (including the right to receive dividends and other distributions, if any).&#160; However, all restrictions provided for in this Agreement will apply to each Restricted Share and to any other securities distributed with respect to such Restricted Share.&#160; No Restricted Share may be sold, transferred, pledged, hypothecated or otherwise encumbered or disposed of until such Restricted Share has vested in the Employee in accordance with all terms and conditions of this Agreement.&#160; Each Restricted Share will remain restricted and subject to forfeiture to the Company unless and until such Restricted Share has vested in the Employee in accordance with all of the terms and conditions of this Agreement.&#160; Each stock certificate evidencing any Restricted Share may contain such legends and stock transfer instructions or limitations as may be determined or authorized by the Company in its sole discretion.&#160; The Company may, in its sole discretion, retain custody of any such certificate throughout the period during which any restrictions are in effect and require, as a condition to issuing any such certificate, that the Employee tender to the Company a stock power duly executed in blank relating to such custody.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">1<a name="16022-2-LS_PB_1_115755_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="13",CHK=348223,FOLIO='1',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LS_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 17:00 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>VESTING</u>.&#160; If the Employee remains continuously employed by the Company or a parent or subsidiary thereof until a Change in Control, then the Restricted Shares will vest upon a Change in Control.&#160; A &#147;<i>Change in Control</i>&#148; of the Company shall be deemed to occur if any of the following occur:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any &#147;person&#148; (as such term is used in Sections&nbsp;13(d)&nbsp;and 14(d)&nbsp;of the Securities Exchange Act of 1934) after the Effective Date first acquires or becomes a &#147;beneficial owner&#148; (as defined in Rule&nbsp;13d-3 or any successor rule&nbsp;under the Securities Exchange Act of 1934), directly or indirectly, of securities of the Company representing 50% or more of the combined voting power of the Company&#146;s then outstanding securities entitled to vote generally in the election of directors (&#147;<i>Voting Securities</i>&#148;), provided, however, that the following shall not constitute a Change in Control pursuant to this Section&nbsp;2(a):</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 2.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(A)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any acquisition of shares of the Company&#146;s capital stock or Voting Securities of the Company directly from the Company,</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 2.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(B)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any acquisition or beneficial ownership by the Company or a subsidiary of the Company,</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 2.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(C)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any acquisition or beneficial ownership by any employee benefit plan (or related trust) sponsored or maintained by the Company or one or more of its subsidiaries,</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 2.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(D)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any acquisition or beneficial ownership by any corporation with respect to which, immediately following such acquisition, more than 50% of both the combined voting power of the Company&#146;s then outstanding Voting Securities and the shares of the Company&#146;s capital stock are then beneficially owned by all or substantially all of the persons who beneficially owned Voting Securities and shares of the Company&#146;s capital stock immediately prior to such acquisition in substantially the same proportions as their ownership of such Voting Securities and shares of the Company&#146;s capital stock, as the case may be, immediately prior to such acquisition;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>A majority of the members of the board of directors of the Company shall not be Continuing Directors.&#160; &#147;<i>Continuing Directors</i>&#148; shall mean:&#160; (A)&nbsp;individuals who, on the Effective Date, are directors of the Company, (B)&nbsp;individuals elected as directors of the Company subsequent to the date hereof for whose election proxies shall have been solicited by the board of directors, (C)&nbsp;individuals elected as directors of the Company subsequent to the date hereof pursuant to a nomination or board representation right of preferred stockholders of the Company or (D)&nbsp;any individual elected or appointed by the board of directors to fill vacancies on the board of directors caused by death or resignation (but not by removal) or to fill newly-created directorships;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Consummation of a reorganization, merger or consolidation of the Company or a statutory exchange of outstanding Voting Securities, unless, immediately following such reorganization, merger, consolidation or exchange, all or substantially all of the persons who were the beneficial owners, respectively, of Voting Securities and shares of the Company&#146;s capital stock immediately prior to such reorganization, merger, consolidation or exchange beneficially own, directly or indirectly, more than 70% of, respectively, the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors and the then outstanding shares of common stock, as the case may be, of the corporation that is the issuer of such securities held by the stockholders of the Company after such reorganization, merger, consolidation or exchange in substantially the same proportions as their ownership, immediately</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-LS_PB_2_115856_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="13",CHK=235155,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LS_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 17:00 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">prior to such reorganization, merger, consolidation or exchange, of the Voting Securities and shares of the Company&#146;s capital stock, as the case may be; or</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Consummation of (x)&nbsp;a complete liquidation or dissolution of the Company or (y)&nbsp;the sale or other disposition of all or substantially all of the assets of the Company (in one or a series of transactions), other than to a corporation with respect to which, immediately following such sale or other disposition, more than 70% of, respectively, the combined voting power of the then outstanding voting securities of such corporation entitled to vote generally in the election of directors and the then outstanding shares of common stock of such corporation is then beneficially owned, directly or indirectly, by all or substantially all of the persons who were the beneficial owners, respectively, of the Voting Securities and shares of the Company&#146;s capital stock immediately prior to such sale or other disposition in substantially the same proportions as their ownership, immediately prior to such sale or other disposition, of the Voting Securities and shares of the Company&#146;s capital stock, as the case may be.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>ISSUANCE OF UNRESTRICTED SHARES</u><i>.</i>&#160; Upon the vesting of any Restricted Shares, such vested Restricted Shares will no longer be subject to forfeiture as provided in Section&nbsp;4, but will continue to be subject to the provisions of Section&nbsp;6.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>FORFEITURE</u>.&#160; If (a)&nbsp;the Employee&#146;s employment with the Company, or a parent or subsidiary thereof, is terminated for any reason, whether by the Company with or without cause, voluntarily or involuntarily by the Employee or otherwise, or (b)&nbsp;the Employee attempts to transfer or otherwise dispose of any of the Restricted Shares or the Restricted Shares become subject to attachment or any similar involuntary process, in violation of this Agreement, then any Restricted Shares that have not previously vested will be forfeited by the Employee to the Company, the Employee will thereafter have no right, title or interest whatever in such Restricted Shares, and, if the Company does not have custody of any and all certificates representing Restricted Shares so forfeited, the Employee must immediately return to the Company any and all certificates representing Restricted Shares so forfeited.&#160; Additionally, the Employee must deliver to Company a stock power duly executed in blank relating to any and all certificates representing Restricted Shares forfeited to the Company in accordance with the previous sentence or, if such stock power has previously been tendered to the Company, the Company will be authorized to deem such previously tendered stock power delivered, and the Company will be authorized to cancel any and all certificates representing Restricted Shares so forfeited and issue and deliver to the Employee a new certificate for any Shares which vested prior to forfeiture.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>LOCK-UP</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Employee agrees that the Employee will not offer, pledge, sell, contract to sell, sell any option, sell any contract to purchase, purchase any option, purchase any contract to sell, grant any option, right, or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any Shares (or any other Company securities) or enter into any swap, hedging, or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any Shares (or any other Company securities) held by the Employee (other than those included in the registration) for a period specified by the representative of the underwriters of the Company&#146;s capital stock (or any other Company securities, collectively, the &#147;<u>Stock</u>&#148;) not to exceed 90 days (180 days in the case of an initial public offering), plus any additional periods required by the Financial Industry Regulatory Authority, after the effective date of any Company registration statement filed under the Securities Act of 1933 (the &#147;<i>Securities Act</i>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Employee agrees to execute and deliver such other agreements as may be reasonably requested by the Company or the underwriter to the extent that such agreements are consistent with the foregoing or that are necessary to give further effect to the provisions set forth in Section&nbsp;5(a).&#160; In addition, if requested by the Company or the </p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="16022-2-LS_PB_3_120007_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=3,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="13",CHK=392773,FOLIO='3',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LS_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 17:00 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">representative of the underwriters of shares of the Company&#146;s capital stock, the Employee will provide, within 10 days of such request, such information as may be required by the Company or such representative in connection with the completion of any public offering of the Company&#146;s securities pursuant to a registration statement filed under the Securities Act.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The obligations described in this Section&nbsp;5 will not apply to a registration relating solely to employee benefit plans on Form&nbsp;S-8 or similar forms that may be promulgated in the future, or a registration relating solely to a Commission Rule&nbsp;145 transaction on Form&nbsp;S-4 or similar forms that may be promulgated in the future.&#160; The Company may impose stop-transfer instructions with respect to the Shares subject to the foregoing restriction until the end of such period, as applicable.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>TRANSFER RESTRICTIONS</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Employee understands that, notwithstanding the vesting of the Restricted Shares under Section&nbsp;2 of this Agreement, none of the Shares issued to the Employee pursuant to this Agreement have been (nor are anticipated to be) registered under the Securities Act, or any state securities laws, in reliance upon exemptions from registration.&#160; The Shares, therefore, cannot be sold unless they are subsequently registered under the Securities Act or the Employee obtains an opinion of counsel satisfactory to the Company that such sale may be effected without violation of applicable federal or state securities laws.&#160; A legend to this effect will be placed on the certificates evidencing the Shares.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company is not required (1)&nbsp;to transfer on its books any Shares that have been sold or otherwise transferred in violation of any of the provisions of this Agreement or (2)&nbsp;to treat as owner of such Shares or to accord the right to vote or pay dividends to any transferee to whom such Shares have been so transferred.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>LIMITATION ON CHANGE IN CONTROL PAYMENTS</u>.&#160; Notwithstanding anything in this Agreement to the contrary, if, with respect to the Employee, the vesting of Restricted Shares as provided in Section&nbsp;2 (which acceleration could be deemed a &#147;payment&#148; within the meaning of Section&nbsp;280G(b)(2)&nbsp;of the Internal Revenue Code of 1986, as amended (the &#147;<i>Code</i>&#148;)), together with any other payments which the Employee has the right to receive from the Company or any corporation which is a member of an &#147;affiliated group&#148; (as defined in Section&nbsp;1504(a)&nbsp;of the Code without regard to Section&nbsp;1504(b)&nbsp;of the Code) of which the Company is a member, would constitute a &#147;parachute payment&#148; (as defined in Section&nbsp;280G(b)(2)&nbsp;of the Code), then the &#147;payments&#148; to the Employee will be reduced to the largest amount as will result in no portion of such &#147;payments&#148; being subject to the excise tax imposed by Section&nbsp;4999 of the Code.&#160; Without limiting the prior sentence, the Employee will have the discretion to determine which &#147;payments&#148; will be reduced so that no portion of such &#147;payments&#148; are subject to the excise tax imposed by Section&nbsp;4999 of the Code.&#160; Notwithstanding anything to the contrary in this Section&nbsp;7, if the Employee is subject to a separate agreement with the Company that expressly addresses the potential application of Section&nbsp;280G or 4999 of the Code (including, without limitation, that &#147;payments&#148; under such agreement or otherwise will be reduced, that such &#147;payments&#148; will not be reduced or that such &#147;payments&#148; will be &#147;grossed up&#148; for tax purposes), then this Section&nbsp;7 will not apply, and any &#147;payments&#148; to the Employee pursuant to this Agreement will be treated as &#147;payments&#148; arising under such separate agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>EMPLOYMENT</u>.&#160; This Agreement does not give the Employee any right to continued employment with the Company or any parent or subsidiary thereof, and the Company or any parent or subsidiary thereof employing the Employee may terminate such employment or otherwise treat the Employee without regard to the effect it may have upon the Employee or any Restricted Shares under this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>TAX WITHHOLDING</u>.&#160; The parties to this Agreement recognize that the Company or a parent or subsidiary of the Company may be obligated to withhold federal and state income taxes or other taxes upon the vesting of the Restricted Shares, or, in the event that the Employee elects under Section&nbsp;83(b)&nbsp;of the</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">4<a name="16022-2-LS_PB_4_120101_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=4,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="13",CHK=838801,FOLIO='4',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LS_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 17:00 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Code to report the receipt of the Restricted Shares as income in the year of receipt, upon the Employee&#146;s receipt of the Restricted Shares.&#160; The Employee agrees that, at such time, if the Company or a parent or subsidiary is required to withhold such taxes, the Employee will promptly pay in cash upon demand to the Company, or the parent or subsidiary having such obligation, such amounts as shall be necessary to satisfy such obligation.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>AMENDMENT TO MEET THE REQUIREMENTS OF SECTION&nbsp;409A</u>.&#160; The Employee acknowledges that the Company, in the exercise of its sole discretion and without the consent of the Employee, may amend or modify this Agreement in any manner and delay the payment of any amounts payable pursuant to this Agreement to the minimum extent necessary to meet the requirements of Section&nbsp;409A of the Code as amplified by any Internal Revenue Service or U.S. Treasury Department regulations or guidance as the Company deems appropriate or advisable.&#160; <b>The Employee further acknowledges that the Company has directed the Employee to seek independent advice regarding the applicable provisions of the Code and the income and other tax laws of any municipality, state or foreign country in which the Employee may reside.</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>DISCRETIONARY ADJUSTMENT</u>.&#160; In the event of any reorganization, merger, consolidation, recapitalization, liquidation, reclassification, stock dividend, stock split, combination of Shares, rights offering, or extraordinary dividend or divestiture (including a spin-off), or any other change in the corporate structure or Shares of the Company, the Company&#146;s board of directors or a committee thereof (or if the Company does not survive any such transaction, the board of directors or a comparable committee of the board of directors of the surviving corporation) may, without the consent of the Employee, make such adjustment as it determines in its discretion to be appropriate as to the number and kind of securities subject to and reserved under this Agreement and, in order to prevent dilution or enlargement of rights of the Employee, the number and kind of securities issuable upon lapse of the forfeiture restrictions of the Restricted Shares.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>MISCELLANEOUS</u>.&#160; This Agreement is binding in all respects on the Employee&#146;s heirs, representatives, successors and assigns.&#160; This Agreement will be governed by and construed in accordance with the laws of the State of Delaware.&#160; This Agreement contains all terms and conditions with respect to the subject matter hereof and no amendment, modification or other change hereto will be of any force or effect unless and until set forth in a writing executed by the Employee and the Company.&#160; The provisions of Sections 5 through 14 will survive vesting of the Restricted Shares.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>SHARES SUBJECT TO CERTIFICATE OF INCORPORATION AND BY-LAWS</u>.&#160; The Employee acknowledges that the Shares granted under this Agreement are subject to the Company&#146;s certificate of incorporation, as amended from time to time, and by-laws, as amended from time to time and any applicable federal or state laws, rules&nbsp;or regulations.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>EXECUTION OF STOCKHOLDER AGREEMENTS</u>.&#160; At the discretion of the Company&#146;s board of directors or a committee thereof, the Company is hereby granted (a)&nbsp;a right of first refusal to purchase all Shares that the Employee (or a subsequent transferee) may propose to transfer to a third party and (b)&nbsp;the right to require the Employee from time to time (including as a condition to receipt of the Shares) to execute and deliver stockholder, voting, right of first-refusal and co-sale or similar agreements (including in the forms in effect as of the Effective Date.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">5<a name="16022-2-LS_PB_5_120150_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=5,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="13",CHK=648814,FOLIO='5',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LS_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 17:00 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Employee and the Company have executed this Agreement as of the Effective Date.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS   TECHNOLOGY,&nbsp;INC.</font></b></p>    </td>   </tr>
<tr>
<td width="50%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="48%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:48.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Gerald Mattys</font></p>    </td>   </tr>
<tr>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.66%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">NAME:</font></b></p>    </td>
<td width="41%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:41.66%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Chief Executive Officer</font></i></p>    </td>   </tr>
<tr height="0">
<td width="47" style="border:none;"></td>
<td width="295" style="border:none;"></td>
<td width="18" style="border:none;"></td>
<td width="348" style="border:none;"></td>   </tr> </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">6<a name="16022-2-LS_PB_6_120442_7748"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=6,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="13",CHK=191181,FOLIO='6',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LS_ZBY12202.CHC",USER="CPELLEY",CD='Jan  7 17:00 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>14
<FILENAME>a2227029zex-21_1.htm
<DESCRIPTION>EX-21.1
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EXHIBIT&nbsp;21.1</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">List of Subsidiaries</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="80%" style="border-collapse:collapse;margin-left:.75in;">
<tr>
<td width="36%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:36.28%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Name&nbsp;of&nbsp;Company</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="61%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:61.22%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">State&nbsp;or&nbsp;Other&nbsp;Jurisdiction&nbsp;of<br>   Incorporation/Organization</font></b></p>    </td>   </tr>
<tr>
<td width="36%" valign="top" style="padding:0in 0in 0in 0in;width:36.28%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="61%" valign="top" style="padding:0in 0in 0in 0in;width:61.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="36%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:36.28%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Swelling Solutions,&nbsp;Inc.</font></p>    </td>
<td width="2%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="61%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:61.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Delaware</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="14",CHK=539279,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-LY_ZBY12202.CHC",USER="CPELLEY",CD='Jan 21 08:16 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>15
<FILENAME>a2227029zex-23_1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;23.1</font></b></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We have issued our report dated September&nbsp;25, 2015, with respect to the consolidated financial statements of Tactile Systems Technology,&nbsp;Inc. contained in the Registration Statement and Prospectus. We consent to the use of the aforementioned report in the Registration Statement and Prospectus, and to the use of our name as it appears under the caption &#147;Experts.&#148;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ GRANT THORNTON LLP</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Minneapolis, Minnesota</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">January&nbsp;25, 2016</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2227029",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="15",CHK=770804,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-ME_ZBY12202.CHC",USER="CPELLEY",CD='Jan 25 23:12 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g202980.jpg
<DESCRIPTION>G202980.JPG
<TEXT>
begin 644 g202980.jpg
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M)ODONCE];=4:_LY$EF@-"DV;O*A"&/ $&U+65*L=)JM5J23!2  Y(T]R;FG
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M>N=]C6?V4\N/V*:5_A/977!4W']4AS6?_<:X?R6W?B]?;[_JZ-K./'B:F:\
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M<7X0)W_79_\ []SKA-*?;CU1Z^WOD4KOG&/_ %%'_+\7RX^/I+K]]=ME7?\
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M62A:S8ZL4B=K6;2R4#8I. DW'QVV++ >UR178%E+>75D-N)=7A2,8[]Q)^"
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M=<+:\A"R<F.;;-6/0L),VR<IP5AC(HPN:K*Y&6BX;$LF,K5]>K^92"FA86:
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CZD/*@A,1[MN;E>F[>:M1K7$X\4(]C!L>]'/8(37(-O\ _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g981962.jpg
<DESCRIPTION>G981962.JPG
<TEXT>
begin 644 g981962.jpg
M_]C_X  02D9)1@ ! 0$!L &P  #__@ Z1$E32S$S,3I;,35:0EDQ+C$U6D)9
M,3(R,#$N3U544%5473$V,#(R7S%?249#7S1#7U-!1RY%4%/_VP!#  $! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" -[
M JP# 2(  A$! Q$!_\0 'P !  $$ P$! 0            <&" D* 00%"P,"
M_\0 =1    8" 0(" P4.#PL) P(7 0(#! 4&  <1"!(3(0D4,146(D%1%QDC
M-E1A<7:!D9>QMM(8,C=55E=8=Y.4EK71T]0*)"524Y6AI,/5\!HS.4)RDJ+!
MUC1U>#A#8G-TL[2W\28U.D2"F"=(8V2R9J.EX?+_Q  = 0$  @(# 0$
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MZ)WK!W#JS2T^XG/&3<&=M5FQGX*)K&63 Q3B%J6UO1P=,%T])S6^IZ?ZIX>
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MVK9=S4F,9L&H/7U\C5)FF,&\]''?V:*1.1-:0AF0./67S1%50B*RZ"1DTEC
MB<Q5/@Y[-4OE+O:4JO3+3!6E"$E7,'++04FUDT8^6:< YCW*K155--RCSP=/
MN$0$!#VE, <+NC#:5*<T18FTIP5J7YZTI3E:FAN*M1@)RXVML9QEQ"T_1)4
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M/?U^/0K:J]<NG_Q=Q_5J>CIT1ZS=4?C[7^L>S^PY_0]QGSPOG@_7)^ZUW_\
MA*GOZ_'SP?KD_=:[_P#PE3W]?CT*VJO7+I_\7<?U:GHZ=$>LW5'X^U_K'L_L
M.?T/<9\\+YX/UR?NM=__ (2I[^OQ\\'ZY/W6N_\ \)4]_7X]"MJKURZ?_%W'
M]6IZ.G1'K-U1^/M?ZQ[/[#G]#W&?/"^>#]<G[K7?_P"$J>_K\?/!^N3]UKO_
M /"5/?U^/0K:J]<NG_Q=Q_5J>CIT1ZS=4?C[7^L>S^PY_0]QFI%Z&/J[ZD=P
M]:*- VSOK:VQH%WJ>]3J-:M]TDIR'(M"/*^D,HI'/%%" Y05E&[=FYX+VB=X
MF43&(8"[;N>#:UTJ]HK44W3<BX1+E)MZ8_A$B"'0PEU]AN1P1QD(65M(=0'/
M%PE9*>M)KZJZ-M<L])&C[9K&+:9]FAW94HPXMQ4RJ2N/&DN11)/ 4I :?<9<
M4SS)4V$KYI6DEC&,JE7NF,8Q2N#>P?L#^+-"/TPW_22]2O\ V]8?_:TKV;[A
MO8/V!_%FA=Z8MDLEZ1WJ*<BHB*;SYFITRAXG>7P=<P*)P4^#VA\(H"7M,8!
M>1[1  &Q:8TS?M57!VWZ>MKUTFLQ'9;D=AR.VM$9MZ.TMTJDO,H*4N/-(("B
MK*P0D@$BLZJUQI30-O:O.L+U'L5K>EMP&IDEJ6\VN8\T\\TQMAQY+H4MJ.\L
M*4V&QL(*PI20K&3C/Z\,_P#C)_\ C_-QX9_\9/\ \?YN7S^PSTH>LZX?E-K_
M %^O/_1-=!'^4>T?D-]_[3W_ !^0U_.,_KPS_P",G_X_S<>&?_&3_P#'^;C^
MPSTH>LZX?E-K_7Z>B:Z"/\H]H_(;[_VGO^/R&OYQG]>&?_&3_P#'^;CPS_XR
M?_C_ #<?V&>E#UG7#\IM?Z_3T3701_E'M'Y#??\ M/?\?D-?SC/Z\,_^,G_X
M_P W'AG_ ,9/_P ?YN/[#/2AZSKA^4VO]?IZ)KH(_P H]H_(;[_VGO\ C\AK
M^<9_7AG_ ,9/_P ?YN/#/_C)_P#C_-Q_89Z4/6=</RFU_K]/1-=!'^4>T?D-
M]_[3W_'Y#7\XS^O#/_C)_P#C_-QX9_\ &3_\?YN/[#/2AZSKA^4VO]?IZ)KH
M(_RCVC\AOO\ VGO^/R&OYQG]>&?_ !D__'^;CPS_ .,G_P"/\W']AGI0]9UP
M_*;7^OT]$UT$?Y1[1^0WW_M/?\?D-?SC/Z\,_P#C)_\ C_-QX9_\9/\ \?YN
M/[#/2AZSKA^4VO\ 7Z>B:Z"/\H]H_(;[_P!I[_C\AK^<9_7AG_QD_P#Q_FX\
M,_\ C)_^/\W']AGI0]9UP_*;7^OT]$UT$?Y1[1^0WW_M/?\ 'Y#7\XS^O#/_
M (R?_C_-QX9_\9/_ ,?YN/[#/2AZSKA^4VO]?IZ)KH(_RCVC\AOO_:>_X_(:
M_G&?UX9_\9/_ ,?YN/#/_C)_^/\ -Q_89Z4/6=</RFU_K]/1-=!'^4>T?D-]
M_P"T]_Q^0U_.,_L$C_XZ?V/A_P"@0*/XLY*D;_YPQ"__ $HPG^_W)D^M]\?;
MQF9GH3Z47E;1I*4WU>,]/L[2>9QS*[B/@R>ZL$CYJ+H&CHWGI"@O<B0B-:=1
M/K..S#=G(!.>0417YX !$> \Q$!'CZP (\_8X*/WAS]2I@ !W&$P\" @4 *4
M>1\O:)C )0^,! >>?/CCC^@ H<]I2EY$1'@/,1$>1$P^T1$?/S'CGS  STK2
M_P S-J"6^V]JRYQ+1!!2IR+;5B?<G4Y\9L.J0F#%)'(/;IV,\V#V>(Z\^;DT
M?;HCT?H^L=QU%=%(4EF?>V56FR1UD#:\8Z7572>$D^-'*+7NP<2@,9_E,IBE
M'N'X9AY$ \RD*'L( \ )A'VG-YAS\$OP0Y-_>,9]BV2R6O3EJAV6S1&X5N@M
M!J.PWDX&2I;CBU$K=?><4IU]YPJ<==6MQ:BI1-?FSJC5%]UG?KEJ;4MP>N=Y
MNKYD3);V!DX"&V66D!+4>+':2AB+&90AB.PVVRTA*$) 8QC)6H"F,8Q2F,8Q
M2F,8Q2F,8Q2F,8Q2F,8Q2F,8Q2F,8Q2F,8Q2F,8Q2F,8Q2F,8Q2F,8Q2F,8Q
M2F,8Q2F,8Q2F,8Q2F,8Q2F,8Q2F,8Q2F,8Q2F,8Q2F,8Q2F<@ F$ * F$1
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M+999*T[_ )^SQ$]6'Z$42O02,$6P"BK#*MD"21U5AAD?&]=76*;QE1*5,2D
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M#!9](_,N_5 NGWJ3_P!*6:OCKYMSZDMJ^_6U?HN]UB^QC&?>]?E)3'M 0'S
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M\EL2&"Y:5>-H[(V8: /L2^6Z\GJL*A7*R:V3\E/#7Z^U!,&T)#C(N''N=%(
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MM8F=OU[;[/1K5' L5A9*C.25>FVA'*8I.4T)*+<-G1$W"0BFNF"G8J0>TY1
M RD\9RW;X#3#L5J##:C/@AZ.W&90P\"VEDAUE* VX"TA#1"TD%M"4?0I !V[
M75^4S-?N4]Z9&(,>6[,D.26"'%O LOJ<+K1#SBW04*3\\6M?T2B3-$WU'=0%
ME:F96/=FU;"U-;65^%&>OECF"EN\<LBXC[:E[HOW HV%BLW;J-)1(2.FYD$O
M"4+V%XZ;3?N\6&QI';[+;VR&FU9=HLPE-CM[C.(W:19.&3>-7:/;*1X$JY;+
M1[1JR415<F3.U;H(&**:1"A$>,Q)M-J0A3:+9;T-K;<96VF%&2A;+W#XK2T!
MH)4T[PFN(VH%"^$WN!V)QE7?KVZXV\Y>+HXZT\U(;=7/E*<;?8XO >0M3I4E
MUGCO<)P$+;XSNTCB+S)U W7N'5#F;=ZQVGL/7CJR(G0L"]*N$]65)M)0RICE
ME!B'K7UT1,NN(*+@=0HK*]IP[S<]"[;6V;LIM76FP]A76]-JC'J1-71MUFE[
M$2OQBIR**L(@)5TY%@U5.F0ZJ2 D*H<A3' PE 0H#&91;X D^&B##$PX_ML1
M6!*\5LLI_MC9Q>31+0\?DVI2!XI(.)5VNJH7F<JY3U6_G_:*ID@P^;H?/]K%
MPL\WDI>/B<W0'/H@#3&,9MU'TQC&*4QCZWR^SY1'Y #VB/\ ]T?+D<A.][$
MY7$!5713'$10E;$W,11)L!#G3<QD$L4W:K( 8HIO9<H*-60#X,<9P[!1PA2=
M=Z^L/1_9UW6]/[G7-Z+=;65),ZYR$@'A1VU'Q6T;DF1)6 S'0I)62XMIISTW
MHLZ*-5=+6H$633D;9&8+;EXO4E*Q;;-$6H@/2G4@E;[H2L1(;>9$I:%[$AII
M]YK^MA7T0![5J\X43="*K2?FFJH$/'$X#Q(>,5+R8))R4>V1?HB48QL8S1 _
MKBZHH0P4I2%*0A2D(0H%(0A0*4A2AP4I2@    'D  &?RFFFD0J:1"IID#@A
M"\\%#D1'VB(B(F$3&,81,<PF.<QC&$1_O/S;UMK2\Z[OLB^7ET;UY:APVRKP
M6W0TJ):B1DJ.0E&2IQQ7SQ]U2W7#E6!^RG1KT<:=Z+M+0M+Z=8(:9 >N$]U*
M/#;O<5H2F1<)BT@ N.%(2TTGYW&82VPT-J,EC&,J-7^L^O\ <W/_ $B4S_\
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MTM ="B!DFZI]*47IMZ>-7ZM<=4Y=O;D?VV4G++J75.P4;GH+7D D1UZI+I>
MV023MLJ==N8BA"-SK&7DC^J@FW]9<TEZ,_<T1I7J_P!<25JD6T91=@(S>H+Z
MZD%T6\4WK&QV/N(J_E5'*J+5./B)$S"4<*N#^"D1J)C@8O(#8,!2E "E*4A0
M]A2%*0H?8*4  /O9SY#Y" " ^T! ! 0^00'D! ?C ?(?CRV^=<R=-7;3]UN3
MUR7>F[FF=<#&C1%!RY%PE<:+'2&V41=Z/!DK6\Z"TE;LAQPE=>>JUYX+K:Q:
MOL-G9LS6G';*;9:O#9<_<Q9@R B;.EE3LER=PW/"U(:88P^MMB*RT$MC+IZ4
MN]ZPK6QM ]-.E+&RN6H^E*AM&$>^BI9A-14M9+=.I7&<%"2C7"\6\41CPCHI
M?P3"#=P1PW54[@,4F7*][]I%ZVQ2^LO3%T]''"5.$U1#"KL?<KNWJ]1-$F(N
M"DVLQKY.F0-M@'3Y)1-\>,BXUL@T-V/'29C.E%6IU=1@"E* %*4I"A["D*4I
M0^P4H  ?+Y![?/':43 82$$X!P!Q(03@ >P .(=P 'Q  ^65*=T40IMIT_;C
M>)0D66)=X<F:]&;D>:Z-0O-2KV]+C*=0V)$R8T9*5*6\PA3KK;S$II02+_;.
MGVXVZ_ZNNXT]#,/4DZP3X%LBS7X1L#FDX[T'34:'-;9<>5#M]N=3#<0A$>0X
MEEEV+*A/("ZS2]1&TZM>/115%NC:ZDYM]IZS-K7^4ID+(MF;UJRL<Y;IM%XG
M2U9!U-0\(!I%)2,;R9%SL$%D4#NU5RBH:^RQ=5&C]5]=71[:;5?J\I2I_H9B
M].6"]P,Y&3#76M@M3& *WFY=\P<.0B%8QU%F:OU53)N8])X=PY(F@FN8NK=V
ME[A-V$[Q#@3]A>\0#V )^.[@/DYX^M@H%+SV%*3D1$>PI2<B/M$>T Y$?C$>
M1'XQSM)Z)[7+87$>N4H15R-9/*;:9:;<"=7-1FE(0YN4E)MHBMJ94II:9!\5
MUM*,I5VA_- WFWNMRXMCA>&M0NCR*AU^6^\RIS04F5)#KK10EQ2;N9;B'T)?
M0Y&2 II];F%#8)T]KW77H[:!UB;)V-U/Z,VZ;<^I+3JW5-"U/>$KI/;$=6L\
MBFPM%IA4O#-'IM DDW,@1RJ[%@D1ZLI(B)D"KU\\@]1=2-%]%CNV.ZE]&4&N
M=+%4UE2MP5J^W%M#7YC.T:<I!SL("JE!P\DG,M(UQ9JR!V>.:A'.VDN+OU4R
M@$UN *0O/:0A!'],)"$()O\ M"4H";[O..THCW"0@FXX[A(03<?&7N$HF[1^
M,O/ AR AP.=7^C"1*DKNS^JI9U ])4N1=$6J VRN$JQ/Z?,-NV@EEI?@<AQT
M2RXXL23NX992AE/2/TX0HD5NQ,:%A>=*- 0S$LCM]NCTI%Q;U-$U6)[]X4!(
M?:-QAM,*A)9:280X8>3(4Y)7LV$VV9+KPZ^W^H^I/IMBGUX>4Q*.U/O]C'S6
MA^H&!;U2%(]3/L9I8&["$G8!<Z\>DT0;20/$W+HK@/5T'(HV?^E!/T\%U#H!
MM66VFZEU'$F[$ILC6/39LAY>]*U&KBV> S7:LD%O>Q 34D\/&+))0S-!PL)Y
M=%=R^;H)+9A3[2@7M A.SCCL["=G'_8[>WZ_L]OG[< !2AP4I2%#V%(4I"A]
M@I0  Y^/R\\R6GHO9M-ZLEW:O<D^8T.VQ5,L0V83EP\S;&BQMHG/Q74(EQ%M
MH3*X4R-+F,O!+3-P1%0E@8=0].3^H-,ZGT\]IF(E6HKG>9R),JY2;DS:1>=2
MKU*\NV19K3BX$]#CBH)>MTN#;Y$=2WY%J<FN+DG,7I>Z4]CZ&CJ_I;VUUMI<
M9G>E8>Q%3<S<:A991D">O2B\CH-5R63>M2F:N0,X;-5$2"W6[CAX9N+B^I38
M] D^JOT0<K'7RH2,32M:Z>3M,@RL\.[CZD[;VUFH]+/ND'JB%?<)((E.Z!^=
MHN1)$IE@ B91#7I[2]P'[""< X XD*)R@/M IQ#N !^, $ \Q^4<X A Y $T
MP PB)@!,@ <1\A$X 4 .(A[1, B.;3W1M%>N<VYFZ/A<RYZFN1:\&;*6U:ET
M[#T^ZT%<7*DQ6X@DH40"ZMPMJ"$IW'6B=-DR+8;98Q88ZD6ZT:,M*9'AKJ5N
MITAJR?JEMY2 R0DSG)HAK0%$,(:XJ5.*7M3L\1.XG#CJ7](36]<;TZ3)^.N>
MZHVPH]/G4RTBG>G-R0QH&N,5[56-J$GTXQE9F0LCQRL/ZA*,R&81T@X42#PS
MI4]:]L]'&B^N3H$O,+8-?TN7K;.XLNH>MZ?O\C?- ZGD[15W-9@&]6<++^X-
M?:-9>4=JSPP#.-8HPJ)'SYLH=N1536H["=O9X:?8 < 3PR"0 ^0"=O: ?8#/
MZ  *  4 * >PI0 I0^P4H  ?< ,B&^A^"'E%=\FIBNV)VR2F(<6/!7,0_IQ.
MG%NS'&%\"6EME)FQO"HCTQJ6&TJN#L9I+%3;OS0]Q,1"&M+VYR='U1'U)!EW
M*=+NC5N5$U>K5[+%N9DH\)MZG)!%OF> 3HMND02ZI-K9F/+DULHUW4^N.GUI
MZ4FQ2W5%T]726WWI/:DQKBI4>^Q\M,N:].SLY8V3F75.H@R:3SAW,H1+&M1Z
M\D_>>&=^02)&*D%K>S+G27GH]_175UM;:FXGZGO6:>VF#3G8A27K3)2[J+E>
MST85R9[#LA1,587;]!N@*8@IWB7X684.Q,   22  -W@ ))@ ''_ *X !0X/
MYC\,.#?7SGM)R)@(0#&  ,8"% Q@#V 8P!R8 ^0PB&2$/HU6S)C3)VHI%PEL
M76%<U.FW18J7#!TQ,TNS'#3#NU"/!I0D%9*UEULI.4N91%S^FF.Y$DV^U:/C
MVF ]99EG;8\V9DY;7AVN+;K=Z4I^2QO<7X5;U0TM^(@,O!?T39#FTRAM35Y/
M3VRU_'8U#)15-.I,BW4;= %J9WGS+(ML#4+)Z_[CF< Y*9 4O7!4!8ADNWQ"
MB4+28*$H76=T$5#IFJ6\=,ZKVSH7J4V?;YR!VW<&E,K][JEKL-S=-;1$R:@.
M$IL\>VLB -E4VS@O>Q4:G6:"LT64P-^&GV]GA)=G^3\)/P_;SSV=O9SSY\\<
M\^?MSD2D,'!B$. >8 <A#@ A[! #%$ X^+@ S58Z*6XB+0Y#U!)8GV*VZ3A6
MV88$=YM#^E6+W%;E/Q7'2A]$Z-?93;L<.-EA2&W6GRH<MZ5T]JN#M[:N.DHT
MJU:CN^O)]W@IN\N.\Y#UQ+TO/<AQ9K$=*XSUMFZ5@NLR^&ZF0VX\P[&"%$G9
M+Z;IW0^I^H?J>HM=ZJ)7<L-7.@6UT-?9.SKU%JUI]L!1^V7=TS4TC(N$4GU;
M8I"C[G,V;E\=1X9XW1%86IU#>IJ_8^O^H#I(Z+XC7J_0B_NG3I5D:9L*O]8,
MW-UJPZ_E(8\&H6_:^0BK%#$>LWAHL)5RY(DH\?KHM2,W2:B+M(FM )2FX[B$
M, " E Q"F HAY )0, @40#R 0X$/BP)2FX[B$/VCR7O(0_:/RE[BCQ]SC,4O
MHC8E.F8=0S3<0Y:WT3'8<<I4]!M,^TRE/QXCD)M:)S5P=>X;!C",XA"$EUHN
M(7E@?-!2(3(@#24!-H6W?&'8$>Y2T.(CW.^6F^P40YDQJ>ZTNVOVB.PIV4F:
MN6TXZL\![AN-[)CSJ1KVRZCZ8F>L6V-+S5HL^F-/4ZN6'7)G])KNRGE3KMRB
M'JM*A[=8Y>Q6!5MXZ,:Y>,WSQ.2Y26;HIM7"11@'3F\]<:HZ'.@&PV2;K\F?
M5O7]*W2V4].1CWUCBJ@W&6,M.FK)%CR1&C)%P#YBL+1-!5R1 C=3Q%"<X,1*
M4P@)B$,8OZ4QB%,8@^SD@F 1*/L\RB ^0?(&.TO<)@*0#"' G I>\0#V )^.
MX2A\@CQ];-UKHJMC49R$+@^(;ESM,]32(S+*@U:](C27@B%-*0AH/Q]TOB-M
M(2PXKA-,\, U&N]/%Y<F,W+S)CBX,V74%K2\Y-D26U2+YKU6N_#G4R4NNOF+
M)4F"6WWG')3:?"'I'%6H'82W%H#3$;OOJ2ZT;!U\U&#U'L1K:+KK]/I_V<DI
MOVX2UN3;KQ] >0::2CAO%-54TV;UNIZPFNW\ 5DXM-DY.66_1>7?6&UNE& '
M:<[ZB]]''MZP]1$,#T6JB[NC/ZQ;I!NS 5!.HDR:34BN=18@)]\DT9ID!00+
MQK) ! -W@1/N'],8"$ Y@^,#' H&'GX^1'GX\O1KO6=-TCI7M?3%0-4ZZIJF
MR$48W:FXHPDJMLC8-?:RR\JU@)55TN>,9,TO$08'.P23,>/:@B4B9G3LZL-J
M#HUNTK3<>R,W>7=YGFAI^)$N!8M=J38K+;H[]LE/%#:0Y,>=L\RX1GRE3SS\
MB4T6(\5EM93:-)]-E@B:REZE?L,#3MO1:-5SYUI\)O=]<U1J2\RX5XAQTK>4
M6+>Q'U!;K5-BI4F,S'BPGQ)E39#C25VX[:V--[>VAL+:=D5,M.[#N-AN$F8Q
MC&[',[)+OO ()O,$6R2B3= @ !4T4B)D*4A2@$>X$>1Y_P"/N?6^3&>T1V&8
MK#,:.VEIB.RVPRTD82VRRA+;;:1V)0A*4@=@ KYFF2Y$^7)G2W5/2IDAZ5)>
M6<K=??<4Z\ZL]JG'%J6H]I)IC&,RUKTQC&*4QC&*4QC&*4QC&*4QC&*4QC&*
M4QC&*4QC&*4QC&*4QC&*4QC&*4QC&*4QC&*4QC&*4QC.0 1$  !$1'@  !$3
M#\A0#D3#_P#0E 1'X@QU==<@$D  DGD !DD^0 ==<9UWCMI'M5WT@[;,638@
M'<.W:Q$&Z)1Y[?$54$ [CB'":1>Y94?)),_ \47:-A0E<%RR1,$S/H=A1@V:
MY4S-C* !B'EY 4UF\4@8@B8H"1U(*\E,WCU4@472@&=GYBSN4'<VZ!8&BBBL
M?&MP,G%19E1Y$6B!Q.HNY+R)?=%\HX>F#D2*) 829X%TD=/FF]'H?MMB6QJ+
M42=S?"8<WVNWN=1,^8TK:\X@YS#B+6[N2IN0[$.TJ^K^AOYE/6'2"N)>M5-R
MM(Z064NAV2UP[Y=F>1";9 >3OC,NIYIN,]M#)2I+D5B<G<$U=;MBO; 56-@C
MKQU=5*)'#E5N=G-3)1']('<8'$-%GX$#MNTDE()F#UP[1 PLACDA")$(DF0B
M::9"IIIIE*1--,@ 4A"$* %(0A0 I2E "E*     9_6,^$]2ZGOFKKJ_>;_/
M=GS7S@%9VLQV@241XC"<-1H[>3L::2E.2I:MSBEK5^HVCM%::T#8XNG=*VMB
MUVR* 2AL;GY3Q #DN=)5EZ7+=(RX^\I2L80C8TA"$L8QD!5JIC&,4K/K_<W/
M_2)3/_P]7C\H:UF^WFA)_<W/_2)3/_P]7C\H:UF^WBE,8QBE,8QBE<&]@_8'
M\6:(/IDO^D0WS_V-??D#!9O?&]@_8'\6:(/IDO\ I$-\_P#8U]^0,%GTC\R[
M]4"Z?>I/_2EFKXZ^;<^I+:OOUM7Z+O=8OL8QGWO7Y24QC&*4QC&*4QC&*4QC
M&*4QC&*4QC&*4QC&*4QC&*4QC&*4QC&*4QC&*4QC&*4QC&*4QC&*4QC&*4QC
M&*4QC&*4QC&*4QC&*4QC&*4QC&*4QC&*4QC&*4QC&*4QC&*4QC&*4QC&*4QC
M&*4QC&*4QC&*4QC&*4QG(%,/L 1\N?(!'\7.>5,3D+7^2SLO'Q*WAE5*T>N"
MED5$3B)071BDP5E7*'<42F5;,ER%-P4P@(AD;<[Q:;+',N\7.!:XPSE^X2V(
MC1QC(2M]QM*E<P E)*B2  20*FK)IO4.I98@Z>L=VODQ1&(UJM\J>\-V<%3<
M5IU2$^*HE2@$@)420$DCU,Y*4QA[2@)C<<]H (CP "(CP'(]H  B)N.  !$1
M  YR(9#<,202!!0LC,<AR=U*@,!'E,  8!21'UJ7>HJ"(D$YD(E5,2@8R*A#
M!D92]TMLXHIZY-+,F1B&2)$P0'B&()&Y#AVN@I[HR2X (D,X7<HD63,9-9J<
MH\!X;JGYI#0MD#C-D\*U1-3N2D0D*B6Y*QD#B3Y;:2M!/4N)&E(4.:58P3]/
MZ%^8WZ3]2J9DZF,'1-M7L6H7!Q%PNZFE%)):M<%U2&W-I.6Y\V$XE7)2,@I$
M]V"]UFM^,B[>B^DT^0"&ARIR$B)R\<IN1(LFQBC"!BG*$N\8J*HF,NT1=%(8
MN0M8MBV6P)*LFYPK42J<WB-(IR925>-3!QZI*38II',D;VK(Q+:.3,(%$BA3
M 8QJ"101;)@BW1202*)C DBF1),#&$3&-V$ I>XYA$QS<=QC")C")A$1_7/E
MG6_39K?6H>BN319;.[E)M-H4XPAUH\MDR65>%3-P'CH6M$91YB,CJK[FZ,_F
M:NC/HT,>?'MIU%J)C:L7Z_I:E/,O#GQ+=!"1!MQ222TXVTY,0,!4QS&:_DA"
M)E B9"D( B(%*' <CYF,/QF,8?,YS")SFY,8PF$1S^L8SR&OH&F,8Q2F,8Q2
MF,8Q2L^O]S<_](E,_P#P]7C\H:UF^WFA)_<W/_2)3/\ \/5X_*&M9OMXI3&,
M8I3&,8I7 ^8"'R@.:M_I$O1-=7?4MU>;4W)K*.UVO2;82HA#K3EV&(DSC$52
M+B'OK# (=WX %>-%BI_1S^(GVG\NX2AM(XRXZ(US>] 79^\V$0E3)$%VW."=
M'5(9\'>?C2%[4(=9(<XD5K"BH@)*@4DD$>>])71GIOI5L+&G-4FXBW1[DQ=6
M_,R4B&^94=B3';W.KCR 6N'+=*D! )4$'< "#I*_.(NO?]:=2_A('_T]CYQ%
MU[_K3J7\) _^GLW:L9ZIZ)GI(]3T[[UO=WV]W?#[.?"?06=#GU^KNS_'D?NS
M_BOV?;]K25^<1=>_ZTZE_"0/_I['SB+KW_6G4OX2!_\ 3V;M6,>B9Z2/4].^
M];W=]O=WP^SEZ"SH<^OU=V?X\C]V?\5^S[?M:2OSB+KW_6G4OX2!_P#3V/G$
M77O^M.I?PD#_ .GLW:L8]$STD>IZ=]ZWN[[>[OA]G+T%G0Y]?J[L_P >1^[/
M^*_9]OVM)0WH(^O@ $0B-3&$ $> V0/(\?$'-> .1^N.?A\XIZ^OUAU7^$<O
M^X<W<L8'S3/20/\ !Z</5_BM_N^W^[_SSR]!9T.>J:N[/\>1N[/^*O9^"M(W
MYQ3U]?K#JO\ ".7_ '#CYQ3U]?K#JO\ ".7_ '#F[EC.?1-=(_J6G/>M_N^W
M^[X?9R]!9T.>J:N]_(W=_%7L_!WUI&_.*>OK]8=5_A'+_N''SBGKZ_6'5?X1
MR_[AS=RQCT372/ZEISWK?[OM_N^'V<O06=#GJFKO?R-W?Q5[/P=]:1OSBGKZ
M_6'5?X1R_P"X<?.*>OK]8=5_A'+_ +AS=RQCT372/ZEISWK?[OM_N^'V<O06
M=#GJFKO?R-W?Q5[/P=]:1OSBGKZ_6'5?X1R_[AQ\XIZ^OUAU7^$<O^X<W<L8
M]$UTC^I:<]ZW^[[?[OA]G+T%G0YZIJ[W\C=W\5>S\'?6D;\XIZ^OUAU7^$<O
M^X<?.*>OK]8=5_A'+_N'-W+&/1-=(_J6G/>M_N^W^[X?9R]!9T.>J:N]_(W=
M_%7L_!WUI&_.*>OK]8=5_A'+_N''SBGKZ_6'5?X1R_[AS=RQCT372/ZEISWK
M?[OM_N^'V<O06=#GJFKO?R-W?Q5[/P=]:1OSBGKZ_6'5?X1R_P"X<?.*>OK]
M8=5_A'+_ +AS=RQCT372/ZEISWK?[OM_N^'V<O06=#GJFKO?R-W?Q5[/P=]:
M1OSBGKZ_6'5?X1R_[AQ\XIZ^OUAU7^$<O^X<W<L8]$UTC^I:<]ZW^[[?[OA]
MG+T%G0YZIJ[W\C=W\5>S\'?6D;\XIZ^OUAU7^$<O^X<?.*>OK]8=5_A'+_N'
M-W+&/1-=(_J6G/>M_N^W^[X?9R]!9T.>J:N]_(W=_%7L_!WUI&_.*>OK]8=5
M_A'+_N''SBGKZ_6'5?X1R_[AS=RQCT372/ZEISWK?[OM_N^'V<O06=#GJFKO
M?R-W?Q5[/P=]:1OSBGKZ_6'5?X1R_P"X<?.*>OK]8=5_A'+_ +AS=RQCT372
M/ZEISWK?[OM_N^'V<O06=#GJFKO?R-W?Q5[/P=]:1OSBGKZ_6'5?X1R_[AQ\
MXIZ^OUAU7^$<O^X<W<L8]$UTC^I:<]ZW^[[?[OA]G+T%G0YZIJ[W\C=W\5>S
M\'?6D;\XIZ^OUAU7^$<O^X<?.*>OK]8=5_A'+_N'-W+&/1-=(_J6G/>M_N^W
M^[X?9R]!9T.>J:N]_(W=_%7L_!WUI&_.*>OK]8=5_A'+_N''SBGKZ_6'5?X1
MR_[AS=RQCT372/ZEISWK?[OM_N^'V<O06=#GJFKO?R-W?Q5[/P=]:1OSBGKZ
M_6'5?X1R_P"X<?.*>OK]8=5_A'+_ +AS=RQCT372/ZEISWK?[OM_N^'V<O06
M=#GJFKO?R-W?Q5[/P=]:1OSBGKZ_6'5?X1R_[AQ\XIZ^OUAU7^$<O^X<W<L8
M]$UTC^I:<]ZW^[[?[OA]G+T%G0YZIJ[W\C=W\5>S\'?6D;\XIZ^OUAU7^$<O
M^X<?.*>OK]8=5_A'+_N'-W+&/1-=(_J6G/>M_N^W^[X?9R]!9T.>J:N]_(W=
M_%7L_!WUI&_.*>OK]8=5_A'+_N''SBGKZ_6'5?X1R_[AS=RQCT372/ZEISWK
M?[OM_N^'V<O06=#GJFKO?R-W?Q5[/P=]:1OSBGKZ_6'5?X1R_P"X<?.*>OK]
M8=5_A'+_ +AS=RQCT372/ZEISWK?[OM_N^'V<O06=#GJFKO?R-W?Q5[/P=]:
M1OSBGKZ_6'5?X1R_[AQ\XIZ^OUAU7^$<O^X<W<L8]$UTC^I:<]ZW^[[?[OA]
MG+T%G0YZIJ[W\C=W\5>S\'?6D;\XIZ^OUAU7^$<O^X<?.*>OK]8=5_A'+_N'
M-W+&/1-=(_J6G/>M_N^W^[X?9R]!9T.>J:N]_(W=_%7L_!WUI&_.*>OK]8=5
M_A'+_N''SBGKZ_6'5?X1R_[AS=RQCT372/ZEISWK?[OM_N^'V<O06=#GJFKO
M?R-W?Q5[/P=]:1OSBGKZ_6'5?X1R_P"X<?.*>OK]8=5_A'+_ +AS=RQCT372
M/ZEISWK?[OM_N^'V<O06=#GJFKO?R-W?Q5[/P=]:1OSBGKZ_6'5?X1R_[ASJ
M.O09=?[8""G5-:O.\3 8&VR&P"GP " G\>&2 0-[ [>1Y#SXS=]P( /M !^S
MCT372/ZEIS\%K?[OM_N^'V<\CYBSH<!!*]7'N-\CX/5Y+6#Y>WR=]:.OSCWT
M@?[!=?\ X2H[_=>/G'OI _V"Z_\ PE1W^Z\WB> ^0/O!C@/D#[P9QZ)GI(]3
MT[[UO_KWL_L.?;T%W0UY=6>_C/=_%W<?;[JT=OG'OI _V"Z__"5'?[KQ\X]]
M('^P77_X2H[_ '7F\3P'R!]X,<!\@?>#'HF>DCU/3OO6_P#KWL_L.;T%W0UY
M=6>_C/=_%W<?;[JT=P]!WZ0,WE[Q]>E^03;)8"'_ (8OR_\ /ZV?M\X[Z^@Y
M(-/H8J 4!^#>V?@B80Y$OCF:@/D/D)@1 !'V<!F\%P'R!]X,<!\@?>#-=_YI
M/I-=3AN19(I^N8M#:U9__M/24>7EL/7W"MN)\QMT*1U%3T+4<X$ <.5?WD-C
M'61X$Q$=R>WY[CR 'G6C.Z]"#Z1TC?AAJ[5[EV"@\'>[LBFC,R?</ F*A5U7
M9!$O'< =PE'GM$>,HR0]!UZ6=ZL(L*'TVU]$J@]GA;5?6)PHW$/,BQI2N,T$
M%S>SQ6Y5"D  [2";D<WR^ ^0/O!C@/D#[P93KITQ])EWW"3J^Z,(5GYW;5,V
ME.%8R,VUJ*XH# P%K5C'+!)SZ%8_F>.AC3X0871_8Y#B CY[=VW[ZLE P%$7
ME^<VE1&=Q0A.[^^S@8T#)3T!/I79I(K>2;:N5;E3\+P6FZ B"&3 >X$U30M6
MC5ER /L*X66\O(PGY,(TZC_<['I+&X""%+T@EW&$YA)MD@&.<WF910WO:[E%
M#B(B=0XF.<PB8QA$1'/H*\!\@?>#' ?('W@SSR7-F3WE2)TN3-D+)*WY;[LA
MY9/,E3KRUK42>9)42:];@6ZWVN.W#MD"';HC20EJ+!BL1([:0  E#,=#;:
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M1X]O_'V?DS^>\GE\(OG[/A!Y_8\\T";3Z=/J7ZR.N_5FM*]-2&J>G.Q[ !G
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M3(VYL&=,W%?;D]K^R-A0].JE6H4F+=:6B;"288R<BC/\=D:26!1RZ5-RQ;)
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M_D5T2_IED@\^/-0@>?R>8^W/F]!MW;:5655^:AL RR4"!A5]]TV93Q 8$Y5
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M\N1']F;4/K/LOX=73P>S/_LWN/M]U0PZ/-.G'_J>]X(Z_.K [O\ 6[/E[/\
M_=@[UAO_ )='^%)^=CUAO_ET?X4GYV:^@0$. ?\ L <@'U2\\_O.ASD("'\A
M]1 !X^J7W/V.1="/_'L#V9P>FC4"<9T?9>S_ -WSNKES])OL^WW4_L>:>]<U
M[_\ BUO[O];3W\_D-;!7K#?_ "Z/\*3\['K#?_+H_P *3\[-?;W AOJ OV?6
M7O/_ -E<9R$!#!Y>H$\^/,7+WY?+_P#*O+CZV=1TU:@Y?^CK-U@>F^=W9_\
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M]G  (?&(B(>>1QIQZ*FI=9+*%.!E-=TGO34 WC%.6M1A!*H!R@8%"B42J=P
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MVX-S$9^YR3X[EJ+6/.9<ITP(4OAHD4$P$!,R(F/Y&&T6,)<@S&R2#Q%$'&0
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M:3-R[Y746.B*5Z^SM@MZIT;=-:D0E)M8NZT7<M;<U5C)+%8OH.4LC8QVC\J
MHEDB1S@J2K!9R42(*@"JZ)@,<HVO6353&#(R6<-"/Z><B*JS9%8R*DHP*0QG
M96\@B85BE$Q#*(+() 80 JA4^#&$+D]E1L(]Z6.CGP1+'MB0.[0AE7+I)-*/
M1-/BHD#@ZPB190 130+W )O'X 0$PB(RZ+HW<FV7H[I $YI!&.$IOYPZE25
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M$?;\0>>6\;7*!4G8B(CVPZ8  AW<=RJGL\O(>?9Y"(?%\N;,4^.V/\[//_\
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M]7R^3@1]F4=7($]N![..6/CY?_56@=?;D$X&>SD>7+EV8\GQ56P3'M+Y"(@
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MEDTF3AZJ07J:2IA0( EYPJOS*3UM%Q)3->CW3SU1LA$(>[(LFD6R%)!"$;J
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M'G@?+FH9,#&V)2S%Y Q81SW"(B8P*^Z;, +SV@)1$O %'DH@(@(AR(YXU/\
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M,>&S/#M\0<\CQE(B^+_>XZB2">><>05FI9)@'8 <<B;CVCP';Y@;@1YX$"@
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M&5>RK//O)[.KXZY[0,GKQY/)S/<.T]F2!SKJ6,.5D ^,$Q /_HAY^(.?:'D
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M&.6?VY=_5FL@R",#.X  <OHN6.1Y<SCKS_\ 5)JRJE 4R&$ \P #"(>0C[!
M1#GXQ ?/D/+S\PSIT!XHXV+15%#"<0N$$8.>>T1!X ^?F/'Q  ?'Q];G+('=
MRV5.S5G/1I5X\JD?,3+6(DG=M9&]9:QDHXCR^LE5KL@BS=.#("NDT,J'8U5:
MB/)E!$*DIFTK50-[=-L%L&R,V@7R\K#)Q"S:+DU&K&->1C&",UEH]@P<%7F)
MF1(F8ZK<J*2*!R$%0_=V:%W=91"N$5*TK?5;IJL(.[;B$ZZ0HG!&$ $X!2"0
M"03BMAZ%(;@O25IPUPE84K*<Y 0-N0,^,0.9!QS [:^F+4OI5K/VOPW\W-LC
M+J0_4+VC]J$G^)+)-J7TJUG[7X;^;6V1EU(?J%[1^U"3_$EG?5?U,]1_>-=O
MT#(J'T5Z;])??)8?TI$J2*9]*%6^UR"_FIIE2Y35,^E"K?:Y!?S4TRI<MMK^
MEMN_D,3^CMU#W']_S?Y4_P#SJJ8QC-ZM.F,8Q2L;O7LWBEI'5II'S430MGJY
M10*L ]PQ'B#\(0 A@X*)3<?$(^7LS'@^=((CX;<XF2* <!WE 3>P0*7M[0*7
MV]WP1#RX]H<Y?3Z15PHC+:D*0QB@9K<S#VCP ]IH7R$?;SY^7^CXP''"9514
M0$PB8>T/(! .WX^1,'D40]G "'LX\N<\KU$<7B;U?1,YY<_W!H?A&,9Z^LYY
M9Q=+2C,*,2>6'.7,8^?*'7V#EUCM/E&:]I>2.*9RE/P)C<B)1'D $>."_)[
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M(&,(\!Y\\\%\N2AVA\O(#QR$%OMDV.5*5G D9L5Q\,OC./HJ?!CB42E[2'
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M+J;F@AU7_27=&.IVZ=7K)! T3+SCJ.6?.&!G @^465665,Y56*5LFF(  %*
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M@N1\R$5A,";A-(S1R8 $2)K'$2B&5K>=\T:OSE,]<C*[:72<@S1H#.;;+M+
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MLRQMY*8+JSM4%,/%P)-4G8X]%@\CYI ?';D?-#JG(@<3M7Q0/X0NP(($*FH
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MQ0*JF =Q0.(B%7B!NSPRJ"J4"J]B9!."XCQX92B4>4C=W @(\#R/)B\>0X(
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M\M"<9PG(!(*B<+UQ]$%//%W<A [G SQQPFBPM-0N$3&E( >9S*5J6F&[9,A
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MJ")9IVL5A-@BR>2$<FK67K>"D[ D@5NJ@W$?4HTC5%!4%S+F/F2L;<?!<,)
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MTH5;[7(+^:FF5+E-4SZ4*M]KD%_-33*ERV6OZ6V[^0Q/Z.W4/<?W_-_E3_\
M.JIC&,WJTZ8QC%*URO3X1F^IDF@(G2L$VE6TI&[(97!T653CIAK%G<U,1:Q'
MCIBB*LBV%VBNL95(Z:9.U,P&/W!B:K&Q]GU B$7-ZAN[1-!!K&LW\;'(RT.T
M;D(BD94WJ+A19 B94PX]81*8>#'$Q^[N'89]*)()LIS2)#BEWN6=\(D54P%
MQP-7P I1$0 #")@ #"(<?*'/.8M!GT&RADG+8A%TU"B<ABF-W$X'@QE$^2
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M554TG!1.4I1*=+M%LL@ ]B:A1 QB&X,)B@4 D'7H*W"E$,MMA6T/-O+2X0"
M%E#G%0<XR DI(^N4K"JHJXTQI2E,SO"D@Y;;DL- E(YX*F$LG<<=:D\\@$
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M**9%RE1'U@WPDBB)^?$(7R 4Q  .;O$X<E\_Q5>H+K=JAP+W&#M.9,J?:8.
M2$WEP!SB4P!VFX#@!   !#/)<>&*I^3&3X,)SKD$BI40[C'[P!0 **G883E-
MW&$H\=I3"(@'?:2>>X@\L@X(&$G&#CJR<YY#R;<8XP,$#D>L>0\]HY\SDGD.
M9)QDDDY5^KN36*7PQ40,Z5,DV73!43 GZPKV&%(INTG )D-YI@ $$2]G #W9
M1LY)3$L;W-B'<+$)(F,DN[G$"KMV)D3G$RK9%!0AG+I0"$45$.U,$R%(8P"8
MW/>D"MER*I@JHNJ84@ RIRF(<"\'\99(O</<0%"E)VC^F./(%  SSD&1#N7Y
M4W"Z8E>B(&09H@F=$"$$ISG, E*)EB@'83R<"4J8" G$0=14D 8.T8Y\SY,C
MM.!SYY!P,XQ78#Q0<G( 5S(R#XIR<G& ">6!@^R:QY=04/(QG4WT]/7]N=6=
MDZK&UPCRK)LD"#9X^&B#KE;(( 0$TUXMZH<[4/%6Y2(=8QQ+W%R5P3IVO$,D
MRJI%*J@BW2'W).F@<@=X<>LG]J2/D1/D_D)A(41^*PKJ]A0C+WTT3AC2,\W2
MLMXAW79%-VKAI)3E6*K'/42MS@N@858TQ%UBG[P3[DC@8G(9>!59.6=1-1C(
M=-_[L7,T9$UU&8;K'C966?F*B=1FY:<^&@R$5W!R.BI*)@@'>"@"(9Q(5XT5
M.<J5&*$HR-RCX7((QXW(DK2,>-_>@Y!YY D%DK.  Z2H@;4)2EID<_% (PE2
MNH# )R,$5='5G3:NPLQ=7!4G1HMZE6JLR$IDCS%T>%(51-,AQ%11K"IKIN%D
M@ QE'0E0,)>P<JQJS]5>-8Z:6 [6AL7-WNLDNIVG=VJ72*[48*&$W8F>.(1O
M'D3%0PIJG5*F4!$2Y%UF>&I\X"J16TK0]#12T#%&?"=1Q>=W/P%9\Z! GP7R
M4*H^2>2+XH^)ZV5O') (D-VTO833477H/7KV<DVUML$D78.QY1R0L@LB5^H#
MR+JRZC@"D% RJI^]NJ;O)PH4QS%(7-W' !"R=K*0IP<B''"L'! !'SZ0A+:>
MK^UHCBQD/9,,D&0I)2 "\HI;//<TWL S@^*.!'65KR"1)EM))RU@58K*N5E'
M#]V!TUI1RL^=& HJB!W0E.FF0""8P%0;@1'M(0H%[0[1[N1#RU9=,  "F,/B
M 0J9E/$;D5$GPQ*@(*'!<4@ 5#D3."( /M,;N#(BEU7\>F9Q)22SQ$IE2 >&
M/R<3B<QO%4;J"!B%2  2."9@2[1\@, !S3,C<HI)"1.H_%NFV!1=5=U_>S2-
M\,I3'(@<Q^QNAVG-W'$2 <QN!*'<&1A7E145%9*MQ)\51*ADX)!YDYQ@=?81
MFIMMD8"0E*< )"0,C;E"4@C(Y#ERR?("#C$T.K&5,'8<IE,V,7QB"(&\=+N.
MJFLFJ42K)$-P'8 "($,(I\B'EGF*U:!W-KK8S5]75=AU_M=TRV:[9R@1Z,FI
M*M4%EXF1E?'079.3-%4')VB1TW()J%.*I"F+S;"6Y!>:=/V:NV8&<3]%:QLI
M'^"KZZ:+[D'"R*RR:J1D2JD.1 J91!PJ0XB<"  #1<7M2BT&K2-+&?D%V]K(
MO8P>C? J;B8LWBD+(.I62$@-_=EX<$V;=PGRFB@FDV$H%(3MQ,RE//+8:0ZE
M;:5!"TI!*5)5@%.X'!0D<\IVE7/ '7:;?84LKC3)9CJ1O;<2PHJYG"%I+VU;
M>T*5] .*%@XP.H"W;?NG?236_7%]T7TU>CEZ8-*:0M\,XHQIA_\ ,K<W![#&
M3!FG.H+K$2=1$DL@4/4)%5=W(-W92O06!P4#9JY[UZ?MN],&Q9'3V[JHI3;Y
M"1\;(KQ0RS"<0<Q$FD8\9*LY6-66;/&STB2G!S"FX!1,X+)$-P([1/4AU']/
M^A]72]SMNO-/6.3(?UFLT&\=8FU+Q9+!/(@FX281M"H4JLDV,L(B=9U,/6,4
MG\(W<50@)YK%=2O4&XZFMJN]KJZUH^IW,W%0->9TZDN9QQ#",806;!]*2]D?
M2$H_EW?CII2$DX732\%),Q4@*0QS>\:#>N*VU?VHAJWEHJ?E*+ZWGI:4HP2_
M)E.+>&TK+A0REM"AA.T>*GR#I8B6AE+8;N4EZ^)?#<"W1_ VHT>TN%UQQ"HM
MNA)0QM7L+0DRUONMA3B^)M+BH+Y_X^QGOP$6XL#X(A(Z:7:QE9113M B@-H=
MD>1=BF8A>XSCPD.&X!RIX@AX8E,!1#8$HWH7-,*M-9R&QM\[)CJ]N6J-:)%V
MN.@*ZFWU'U5O$&\O'5&]LT >MY'7%EB/6"U&5,[9/)5RF9N=PFZ.U26P_P"V
MNFG<?2WU.FZ>=D-4ZK?FUHC*Q%V!-=3WKV.O7*01@(VZ0,LHB0LC3YAL^$SA
MTFGXK8I'K%=--XAV#<+7J.TW!\IB2@M;"4R2%MK0E32%'>MO(!<2@H*70GQD
M'&1@I)\YO.A]46!,1V[PG AV28J4,O-2ELOE(4RVXE+A2RJ07"6>(4H7X^"3
MO37BUO<FX:V"*E4OEYC?5FQ$4W(3DBF5%J0 !),BBRZZZA2D$/#.<R0$'V"'
M/&>)9[=<KQ*M5[O;;%;Y@J9U$W-FEGDJ:.1-XAS&9MGBRB35103B4IBE!02<
MB)Q3 H9<QU2],FW>BW:C[5MO>,5TY&(0EZK<Z[W'JNQ:<X< 4DA#B_0*Y122
M=$%I*1+U CN->$(1504U$E%+4BCXYUU5@,5P5V?N6$  52JB"J/<H4O_ ,WV
M@4HE^"'F0  O #?[;&L<M+%UMD>WK\+:#C,^-&CH<<:= )VNMM(< .2E25**
MP<H<PH*2FJ721J.W..6.\3;NAR&ZJ._:9DJ06&GV"D'+3KZV\!2 $**=JN2V
M_%+:W/Z;0K%T5QP0%!<LD/%'D2E\)%3O)Y%#DP=YA Q@$![3''X0"(9DRZ'O
M2*[6Z3U8S5\H+J[]/$O.IOK%1_H2DY!%7<LS/Y:D/UTUEFI2)) H]KYA]S9@
M"BF4S1R8%AQN-5"1_B'4[@]6;$4<F^,"GY,84^1  $ZA@2 .. .(<% 0\OZA
M'YG /'X" %*5-H8_PR%(1)0RKD$0Y*8WACVHF,/Z<R2I@$ [1,U!IJR:GMDF
MS7F&U-@S6UMO,+)2K:X@MEQMP*#C+J4+(2ZVI+@W*'T!(5J6>[7*SR&;E;9'
M@\J/LP\C:M1"%)5PEMEH)=:!2-R%-XY-C)\;'TVND??.KNHO2,=LK25PA[16
MUSBPF98[<K:2K\\R%8ZM;GH%T<'%:EV+4Z+DS!PJ @@<JR*JK=8HY@Z]-QTS
M;UVKJB7O.N]?S^PX2O.6958ZCP[N8E8UL"ACR\H$0S!1TY9)%!-5YZBBH9LD
M)ENU4.1"QCT!?4C(:XZG7>B)J1<FU]U!PCYJI"JG.9FGL*!BUY*!G$F_B 5*
M1<0S20BG#D.XRS4R!5"*'23XW(H"QQB;%!@W5!= #J'56$P"!P<"<3&$Y0*
M]J?:!B]O:'(@)0+Y#\G7'2!T)KA,..!+A08;=QM+LA6]P,25.1T)6EMMIL/(
MX<IEV2T0X\M+JU@(<X8]^MM_3J"P&8\ W(D/>#3D-#8GBM)0XO:5%2BA04TM
M+2]R6P4H3N*2NOFD="U7@9GJFJL18XUM),8BI7V8&/?IG%-K/P2L4=BY.BKV
MJH/HIV8ZB9%P*NW6[P.!#B8,]Y9F,YU3WP01$Y)=K8"K*M"*F!JW=;";-SJ*
M%+W))%[0,43B)$3FX'DIC" [V.Z/11](FY]D,MZ5>OJ:<W!ZO--I6Z:W91,>
MA;F-D!J,PG:JVHB$-+.G M4U$I@B3253545.=TX PIYA^G?[GXZC:'L>^[#U
M9N[6>PHVTP+J,BX>U,GM'GHYRZL99TI7RH-)6#?I)B HD6!=NF<"D%1L!C";
M+K+O[4FR7YA*W&ID^WPHS;"PM?$<8E%Y80XA"T 84%>.&U+ /(D8K);7O ]7
MV.]H:2&HUU<DK<6M+:F&G+>F&%NKZUEM2G"@IWX!"O%W* P:]3K9"+V'J>+0
M7,Z(?7;)P144O ."II9ZW /!^$;@#(EY. AW<B \EX#(,J-6*IU3=/TVAR8@
M;SU$T5.!1*551C8X]1U]@2&$AC"'(A[1  ,4<F;J^B++KWJ*::XO#=JTN>J8
M9*CVILDNFX;-)B,?KK./"<M_H"R0@N#A [;A!0ATQ(4#"(!3VFT3/]T]//Z9
M0%MZ5=\502B(G*6RQC=)4GD(\J>& \&^#Y"7@/8%"A>$6^PV\NY2KSN/LO;T
MX)6N-(?7E)2DH4DM#( 24\R<%-76ZM1+M:=2-LKXS0N$R5&*TE2BA)0E"U%2
M4Y*R\258!W8!QU5]?VI^=7KG_N&&_FUKD9=2'ZA>T?M0D_Q)9)E1Y]ZM:Y^.
MOPO\V-?_ #R,^I#]0O:/VH2?XDL]'U9]334GWCW?]!2*\"T3SU=I(_ZQV'])
MQ*DBF?2A5OM<@OYJ:94N4U3/I0JWVN07\U-,J7+9:_I;;OY#$_H[=1%Q_?\
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M.#+"N8"$(V*!2G 3%%0H<\_0YZ5:$%:U)1X]=(/7$8!JHZ,KPB(NUC&6<G4
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M=C-MDTE%XN3 WP'"2I$RD5(H!1*3S'5?L)$WL*Y;D3,LLH4A&[=)(ZJHNN\
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M?C$ Z?O\A.\HI L AZNZ]J8@("'/'GQ\']-\64WI )&DKH02"'+9S!((_NO
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MJ"1@+4VI"5CF5$I""L@9Y%*<GQ2!S!U(&NZ8IR\49'\1J8I4E11<I+MEB^(
M]B8IN2$.4X"!@X, #W ("'(".6,=3^RX^Z7QA&L9=$C*D1QXE-1*022$\Q)+
M)OY9=-,QBD<"D84F0* 8/^94(!C  !F^D>OH/5_%>ZRU:X2.0OPWA(Q=\ D
M#<.#.*ZJ4WA]W9VD.'8;R*4H% <IF4TW3Y587C_1_3VY%0AT3K/*["KR8MU
M$3BBJG60;JB(\=JBO<)N3%,8!#G)NR:HA6:X)G^8KCBT,*;;1X<E.Q3B0E3@
MW103E'$;!\4I2M9/,"J;JIZZ:FM!M!N+,9IR4R\^Z&"OC-,+"TL;4R$E">+P
MW5$+)):;QMYFOGF>ZYTRF%86JX% H"X1=( 4PB/ &6*4P@D CP'/ %$W/F(^
M>?RI-LP P+&;D73*84P\=%1,YNWM$$U"' >3=W;P4#CP(F$!X$,W]I7H[T?)
MHM2S/3ATW24>V,Y7;-C5PB#ALH^(5NY5*X+&)QYE%"E3*=-4B[=("]Z)$U/A
M#5%8Z8-95HA%ZYJG1%6.F@")&Z>K*]-J@BV**2)@>NV(G R/D0H-TP3-^G*<
M0#RNRNEJ)A.RR2BXH$D*F-\/"2"$E:6E*'BD<P,9*AE6.?EHZ-'2O+ETC) Q
MXZ6']RLX&PI\)4G: %) R<A65Y)Y:$6O-;;CVG86-;UKKJWW"4,4JJ$/!UY\
MZ271*=--51U(F13:H(%!1(#F<+IHIF,4W)3  #DMUMZ'KK=NAFCJ0J5;U6P=
MF%87MSMT:C*^K&*!12=P$ :0D%E2F,8@.R 0JX@7Q@3[3'#;]0ITJT0.1G;H
MFMM4@$? IM(KT?XRI0#O2%%ZEZJ4I1X.#A-,JHG("1Q, \YZ 5QZ<Q/=.]R\
MRT*B*I$CQ\-"2KU,I0,X0"3B$"D]3 G>N1(B9' K\@"GACY1,CI:ONTHM\"#
M$0I0PJ479KK9YA2VU!49I/82E33@R =I\8&4B]&]J0I"YLZ1+=2 GYTA$=LH
M\4!LI<1)6 3D)4EU"D;U;5 C<</_ $6>B3==-]XC]G7&]UC8EXC#,5JVV=4=
M-Y7ZNY;+"LZ>M$)IT\)(2SOA)%*44;H'8I$,HU*"J@G#+?>ZR2_1CQAM-*G2
M<&J"2"XS-?ATFQ!(8Y4RDDES)*LCG-WB4R#@JH@?M(<"@'/HJ5VIB15N8)QR
M"(]B[56U3RR9&ZI!,W^A"[2!)-9+DO>8_/BIG A@#@N>4G&4IJ](B:#9G=&2
M4/&N7ZSF3;&0'CM;%2DW#IJ"HCVF $TA,/AB(G#D>:3<]4WZ[O>$3[F\MW;M
M2&0B.E" !M2A$=* D#)P>LG).5DYM5OT]9;8T&H<%M"4DD<0%U>XGFI2WEN*
M4>0P<D@  >* !"#GH[Z.&Z)75GU%I(Z0I>O)/92 A';Q< $"E<LWZRJL@J0I
M/,BS9?OY#M PAR.>QKW7/3MJUP^#552F"MY)8Z8IU-.6EHH@J$ YRHEEED&<
M:F(=A_#0<JB0#<D(!!R1V<Q689^:+EV5?8+.%A=1$TW9,TW:G> ][98AD0!$
MZ)^00,V%(@$X+VCP(%XEKHG'+>YLHLK(1+_O*@]$ X;.%#%,F8%"@4R0D,!1
M(83@0Y0$H )0$,@GGGY*2W(D/R$;LE+S[CB=WBG.U:R$G/4<<QGF1@5/QEF$
MHN0]T9Q0VE<;$<J2-O(EI*2M.4CD5$ ]0!%=%.L0\@[0DEZ,UDE6,BA*,$KC
M9XHK1FY2[_5UB1L8TD%@=I"<XMB+E$R!CF, ]P .5PY6F'ZXJ/I]E!L%"]@Q
ME427,[.J/!>Q:>?B#I)L*0 D*+)F@90X<@<G;SD(STFU("CIA*@(F[Q\0#D(
M4%"\^8@0!!4"]OEP!1*;GR[1$!H0VV73,#,79G*[Q+X*<@!4A%0"]@]AA.;O
M$0*/()B4. $P$$!X#-9"&V!M;;;1S. V#Y02<G<022>7(\L#L S2)$N:OBRG
MW7UA*4A3JBH[4XPGQB1XIY\@#E1(&3DW+"XCH;Q#,42(KJ@!%G"?<9Z](!A$
M </AY<N3D$0*)5U1)X@^8!P(Y2KJTI]QA.X[QX,FHH<3=A#B/'AG+P)1$/(A
MRD,(@(EX+P&6^GO3QWXB+=1X\<N#%44*BEWF3[U0\DTR\JD2*(!XI.T@#Y"!
M0 ,A/974AK#4S1RXONQ*O NQ4,E[W4WQ)2T/.PHJD*WA&"BJZ0B;R44=*LS$
M$0**8B(#FRTEUY89::6\XH\FVD*<6<D?0H2%$'ES40 ,9SG K47M;3O=4EI&
M.:G"$('(<RH\L<P,9/L#)Q>TE84CNVZ:BWP0*FL0ZO(%*D"@AWIB(C[ (/:(
M\=_F3@/CUSH+W-B/2ART;#J&,Q8=5E109H%5,HB1 LT9V5)(G/8W\-1951=(
M [15$! 1  XEW;_I/7]2B"V>C=/VP[1345TF3O8E\16KM/8R;P3DB4D6$;RX
M7$ZPD7:IRBZ";TPE2Y,)B\X\^E#=DUNGT@>J[K8W2;F9OFY("PRRY4&K$JSY
M!P0PD29M (W1 H"($32+W%(4HJ*&/R.7VQVFZ1++J*5);#49VT2VPV'T*<4X
MW'?5AU#2W @MIW$(>6AT%23P\ J%&U3<;<]%?C-E#DI+.UMU2-@1QWXV[@+=
M"%.EYMM8RRE;:TH4-Y(VU]BJJCS6*X/RP,./_P#CV^1AU(?J%[1^U"3_ !)9
M)M2^E6M#\M?AA^S_ (-;9&74A^H7M'[4)/\ $EEWU9]334GWCW?] R*\[T5Z
M;M)<L?\ J2P\O)_=.)R_!4D4SZ4*M]KD%_-33*ERFJ9]*%6^UR"_FIIE2Y;+
M7]+;=_(8G]';J'N/[_F_RI_^=53&,9O5ITQC&*5JV_W168H6SI, 1X$87<0!
MY /F*]( ?+@?/CS /+GV<YK6.U>P3>&4?,Q1 >2B(EY$Q \OA@4WQ>0CR!OB
M+FQ?_=)MIAZS9^DA>7?H,4E87<QBG7522[@17I &*4RQBI_"[P >X0\@'@0'
MSS4@O/6%H^CI*-WEUBW\CV]H1T>X(^=E.!C H;L9"KQP'  @)RCR81$H^0YY
M;>V7W[],0RR\\K>QA+3:G",QV0"0@$XSS_!CM->F65Q#5FA+=<:90$N^.ZXA
MM)'A#A)RM21D'(]@'!R*N%F5&RJ"S=0WBG<!W"4P%'Q%0 !!,.0  (4W!S"(
MB("4! !Y ,QZ;@AVT=(.'!C)D#O,)E#\@<2F5.8 *4WP@$W'/(@4/9P' ^5%
MV7KT>695RUUMKVS6%\HH1!!PJU3:->TJ8%24$$A763(/':43@D83#]$#S#+<
MK:ZZK]G+K]FOI9J+@X_WC"1#B8?B)N0+RJ!77 $ 0  #M[1.'<4I@S=AV^3'
M6#,<BP$GK5-DM,JV\CD-J)<R,<B4@$D<^>1RY*CO()CMR)A&-IB1GGDY.,;7
M0E+/:"?')P?+4C0$7"7V^T77CIXX:IW2SH097J!2G>-$U&SMR9TB4XAYD% 3
M<<@50OT,1^&!L\BT14YK"SR%"NR/:+,OCM7[4ZBR#YDX\4L?+,%A$QSM%Q()
M%"E,91LJ"J"O' F'G4'1]UJQ][K&R&-(<U&7J<JTGHF1V0LFWCD%44CHBHK#
MD!VZ61%!<2JH)(>+PH53M*)3 $W]5'S2FT&U9;1U7,OI6)(9W'[(U[#KO:@W
M<J$,#J)<%=J^ZJD,N0!,H<Z"8HN!3<(%\0##EHL.KHEIO,6VQ;Q;;A%E(VOM
M1IC+CC$G?R>1A10M!3PTNMI675#"VT9;VK@+MIR9<;5+N#MIG07XIRPJ1&<;
M$AC8DJ2H;%+;/BJX:L%I*N3CB0L*3 YW+N.9>.F=.0BGA"G4,"15!23$.# 4
MI04X*4#?1#\%.4  0, <92TA3Z[-%1>H>&U=B0HJ=H=B:H)CW&/XY1+X@^12
M^$  <H_12^8<#'\!>5(,I7;991:.7.4JJ!3"JW'N-W^&/> \>8B!> *( !RJ
M!SP4) @IFJ6=T)HJ2+%20_!+%N')5VBBPGX,1L<X=Y3"?DPD4*!B (IE ?@B
M/N#<F-) 0LH*BD$-K(YGD?G9/)0.<XR""1W$^5%#J5+"0=@*D$@N A"2@+65
M[CM2"D#:0E94DK.,''7=1"[5NP;QR1(N8.8Z9"F_OUI)$#O4*DJ02E3.=% A
M@154*F?PA%!$#&*4<VL?[GFU/(0FB-[;NE1AVY]A["@ZW MVQRJ*'A]4HOBS
M;ET81\4B3R6GD6Y2  H =J#DWZ< #6"7+(Q)CNSQRSKPQ.B#AJH9R >L (F
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M>*NY)<Z8G0*"29&JO<8%4P(;M"!G>V%$4RD1<ID*"H%()$>52@*0G[A66 0
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M\,I  Q )P?N[A*/!A ;Z!8KG(HF9NFY3$Q3+G5 H^0=R94^TO:'GR E3*/
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M*1L04A17E S6ZZMD;>M=0%TC5T7"$]"M)(3H]JAO'7:I+.T?A<&^ N<P% 1
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M/<8H^)\$2@8 -P(%[S&$H&X*42E ,ZCJ_))@)U'JZ !P(I@NF0J9Q,!2>)W
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M-(%"";N X*&Y-W@/(B<##\$!*(&]OYK;A8(&,LK*$4#PRJD#Q"@=/LY(4QE
M$/H@G >$RAVJ 8W)1]N8=G'4+ 2RKA" L3"97[O"*%2K]ZM*Q.!,4@)*L*Z9
MBN"@B)#&.N F*0I@4+P A5,= =2%P(W<52F;+?L3E1$'1*S#4\B:0\"5516U
MS":RB1P.4_9ZB@8 $!$ $#!F;SOO-^-)<3$!(.Z6X&$D\N8+@2.7/GG.0!CG
M@=!<HJ^3!,C!Y^#(+P&"/4RKKY9P2>X=F4%WN)3M^ABLLH;Z&0&Z8@0H&'Q/
MH:IQ+V"?D14X 2^&/'//D'A?-D3."QE70M12,H4R:ZXBF3@@^)W=J@F3,8_
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MT]63N/M@5B<@^J#J&LAVC>H:HE7S1R)RH2$94['+F*<G)A%=1XDR #F ?A>
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MM,.0M-]6&I*ZJ9(\\F_%,YR"<@$9H>.GVD2 SQ\JV:H%X#L447,0#& GPO\
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M&2XL8\@'7R.2<#.T0Y$S^,X/WBH01*L(?!4.43<%.4OP@X[^SE/CN$ Y$0
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M=P]OF7BVNQ>F&TM'<MJ_4[+/J$6.=)V5N'J10#X94BKG.F8"]P%^ =$@% 1
MQC"/.:WQ 1*!2I@F7M#X(%* "4/;P \<AQ\?G];/TY$?:/.6>-T9Z=2 IQZ9
M+QVF0VE.>2O\"VGRCD5'LZLU7972)?0LI1$B1!R(0MEU2\#EG+JP""0K&U
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M:-(D4#(+E)W]X]IB&3*50I!,"B2;D0(ER<02;*B<IO$4X5,KW% .W$/(YSC
M)/(]G5GEW'OQDX)SSMYD8QU'D.Y/62<^7&<>V*PF>DUMENK]LHL1:*<L]T9[
MF^Z3"426E4XZ7NRQB YB;2Y24!JP7:(D($&5TD8IDS.SI%.KW &+6R7^CL3^
MZ$' O7+LZ IM&+R2CG,8Q.* D*(.6(-Q<-TQX\,HMTC@' B7O( CMRR,<V?-
M%F4PS*_CUDDVKIJ^*Q>,WZ0F$@D7:R .$/",<Q@X.'>@"G8H)3G#C'OU%TSH
MKU5"#+3W39IZR7Z8,=]#P9H,\61J4QEFY;7;TXQ=,\93VC@$R**)-#O9(RB2
M31!81572]2TEJFW)9A6AZQ39,I(+:%6R6E(E;U%17(8D*2AE6,%YY+P0I(*R
ME"008>3YO1RXN!/MR65\T)G04J<C]1(;D,*2MU(45J0AUM:D;@A*U)"<:],
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M0\PF3NY*H>-?I&5,82%,"ZG@K&3 QN!(*8?1!'S'M+\'^5DI(J*:)HR83$@
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M1V5FH^('K!$#H)")R$22.@81 @?#46 H  H?!,/PS&,!Q'MX#@.?Q&23["(
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M1:LTTW!!;)MK(T77<>"F0PD200;*KG$W*8I%4.82%#G*08Z!N]PD64;7=<[
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M@2-@5PVF&@SAMEKB+V@Y4H**E*^A2F)(6AQ$,S;H1C)LU%H0K,JHE,LY%LH
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M>>SM 3@8,[ 1<H85%/<YXGP<XK"#3@1(82J&."(E$%14+\),P&\3@"%[2^9
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MZCIA<MWM)M[QHJ1=JZV_M9=NNF8#)JI'N,CVG(8/(2FXY <N/RR[H%,8_3C
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MK487ODK#*L(./('M,\E'*;1'CS ?@&5%0PA^E(0QOBS*'U 4C75DU-?]>4"
MA&ERZ9O>(ZFI*.81B$G/,U:^4)T%EFB*;QT*8K',^]855Y?(]YP[@ 0]&T=T
M<S]86+5%\CSX\,:?CDPH;S+CCVH+@U;KG>I-K@*0H)1(CV:SW">M2PI)#3+(
M <D-UYQK'I(@Z.OVEK')@R)AU#)2F=-9>0VSIZW.W*UV6-=;@E2%E<:3>;O
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MP.#<\CVA;YOFVP=]W+L6YUIRJ[@+'85I&*<K-U6BJS4Z*)"G.W6 JJ0B8A@
MJA2F$  1*'/&13X+GZE>?Q-U_58\%S]2O/XFZ_JLK^H-=W_4EM7:Y\:(B.Y+
MLDQ2H\9]#G%L.G8^F80"EO. (7 CMK?&W*Y)4XDH00W6NY)==;+:@@)*V5G
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M,Z$ZMAQ+B6I<.2AR/*CN$;'F'D*;<;*D*&":OETB1;O;YUMD27V69\5Z*Z]
MFNP9K*'VRV78DR,XA^+(;W!;#[2PMMP)4#RP;\]?;9T#HA2TS]!O>X;ZZFX"
M6A86@SD8G'5V-4D2<(+SBSB140=@R,4J95D$3+>"93@ASG\Z[Z2K6:KZ-V!:
M]@5V0-5=7S8[&UK/.VRC6&7L\FUE(MY$P;I;M1>J>ZCE%(6J(F2;&=I ?M4
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M9O\ P*?YN=C&."UZFCW([N[N%,#R#]O_  /:KK^J-/J9O_ I_FX]4:?4S?\
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M7]4:?4S?^!3_ #<>J-/J9O\ P*?YN=C'_'W_ &8X+7J:/<CN[NX4P/(/V_\
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MJ8DXAKNU+<"\G,/SK3@PTSM]M(HRKM@P?.13".CU7P*M8<BR33A-0A/!*N8
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M'4,:UOM9ZY[I66RNID7JM)8]'U_G8>NPXKC:T4[(-ZCF:$;=9)\DD:"*@+R
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M@]5?4TU%]X]V_0+]6?1/INTC]\=@_2<2I(IWTI5?[78/^:VF5)E-T[Z4JO\
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M?G^"1VH9/M!2L=/SP[9+JKV6:D'E&H=F>[KZ(ZI4Z#8FZ19R.KG4- 4&<ND
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M0U(@&=>C)6QV*VR#1D*YDW5CMLJXF['*JBX67/ZS*RKIP]< 4Q4@44$$DTR
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M(&.ED'[IB@R4!Q*P,JU%D5P,@AZKXSAJD@L@HHI4MXSCG_C@?^.?K>W'(?\
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MY1](TRVS4O I*[4V2U=R+>0VLK0JX Q=<E:WK]Q[PDI9=O%O7A9>90CH]**
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M"!MG5I%UJ]6WH(G%[5XVW!M 2DSNTL?U,IQ5QNE;9/X15&LF0C=HQL"PBZ5
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MUE]](/\ U^\>W3B(^O1[H?+WCVZD%-N@DD5%-%)-$@@)4B))D3*(&[P[4RE
MA?A<F^"4/A")OTP\YR=!%11-8Z1#*H]_A*&(45$N\  _AG$!.GW@  ?L$O>
M !N0\LCWYL&J_P!L2G?R@C?[1CYL&J_VQ*=_*"-_M&//'I[^'K+[Z0?^OWCV
MZ<1'UZ/=#Y>\>W4A@BD40$$TP$IC'*($( E,<! YBB!0$#& 1[C!P8WQB.?P
M#5N"9T@02!)0#E.F"9 3.503"H4Q +VF*H)C"H!@$#B(B8!$1YC_ .;!JO\
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MUO\ L&'^3,_U.[X_*:;$?6I]R/DKP$*I6&JR;AM7(%NND8#IK(0\:BJF8!Y
MQ%$VI3D, ^8"4P" ^P<]_&,SLQV(X4&&6F0H@J#3:&PH@8!(0!D@=IKD #J
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K,8I3&,8I3&,8I3&,8I3&,8I3&,8I3&,8I3&,8I3&,8I3&,8I3&,8I7__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>g865608.jpg
<DESCRIPTION>G865608.JPG
<TEXT>
begin 644 g865608.jpg
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M,146(D%181<C,G&!D4+P"A@D)3.AL<$94H+1X2<T8I)#4W+_Q  5 0$!
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MPC]XU@&+]!,A"](B0"\@(@'3]P']>!Y$ '@! ?[[RW,\Y#S43EX 1,("/ B
M?KP'(_S#[:#*.44NCJ$.!+W#OW_H(C]_;V'6A7$G^YW9BB40\I01Y#@> #W
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M0 (% 2 7@Q>L!.8P!SWX ./;1,8S+U"^PZ4<Z51!H[:*//+4,!%2+/$&0M5
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M\UD  /(D   1  ]@XY^GCV 0$.W'MVYT$WPR9'P 58"F31*)Q*8HF$1XXX(
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MB0DXF77A))V=L$^S;*/8^*44.0&Q)@B(&>-&ZZBAVQGY4E&C4R9/5>0DMYI
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M;GGE0WTCT]^.H.>3!S*B47$T>K,8N'9H1T5$1C6,BF+< (BR8LT2-F;)/@
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MC(Z%F5R+,(R28'C9-<RLXV6.S;[%.-J5A6WXYKL!!4*@!C6S5IVA%LD&+=C
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ME42*PV.:'9"#&BZ6*I,7:P6!Q8["NH=XU;L;Q(>22F(^/E&YBG1?,FKI,2"
MATN42JB'//?H-R00XY 2F >>^JTLE+-9.D2TC%J=3"9K+.R0+DOT\@LV9V&"
M>AR/2!@ S%R!!,*?T]Q[%TZ6!)SXM1T6JIQ.M#2K^*Y-WX01Z7#4"CP  4J:
M_E@7@1'H_&@G'1HT: T:-&@-&C1H#1HT: T:-&@-?DJ8"%ZS=R% QCASWX .
M>>/N <<C^ [^W.OUUI60+.UJ-8D9=T8H=*"C=NF8P$\YRN02D(!Q$.CH("BQ
MU!^A-)(YSB4H"8 J_P!P+ES85&U817%%?*&5JC02"0ICG.WM=H(M*+I)AU'.
M#*&:.G"Y"\F(V255Z?+3/I@,-0T?>]S.2+M\/\V$V_U^/PE47PK%5:+7B[L(
MO(.7G;0I%!2!Q%1CG'=265!,JQ1:O6JH%\D2F4S ,98\Y;N,?Y"F'!BXXHU#
MN61:) M')1;/&5ME6^/*A?K&V'@RDM<B-KN]J[41 L54HF'ET0!S.KGTX.P6
M$4B]L5?N<B<5)_,5OR=G>?7$>0</\N9 GK8V3(!A$P-X^$>Q$1'D^GH81K4O
M)A((F"?<ERX(QZQ.HI2B >X@ " CQP?GL7@?<>!$/8.0 0"GO<^>(R5AO+E?
M<)*//,J%N1+&).3-'*DO%M7*T00APY5346>-D5&9@ Y1/T]9>.P68Y6F0*1R
M(F$0*(F$1$. $H@8?Y@7C[\@/ "'?CBN%]$!(L+,H1!)=PL,BDD54@J =TJ5
MR!.HO28YP 3D.)2B!AXX 0Y#0,#@6\65/%]'LR% D$QF:A!DN-4<O$XVWPUB
MK%>8Q\DY23<MC,YH)*/9-GA&RBS5ZNH"JS9<Q%R$39BF6O%N>*?'6MDRKUVK
MBWK 31G8".DCQ+MJ<4GS!PPE6KU2/DT%""D\;IE!1,R(%ZU3=/.AU,Z!FKOT
M_EN3*TZMW2*=-P,45RLN(J543 Y@."AV3I(HHGZO*32$@=TC#KW/@@HMU,M9
MV!]5CV\(QB;]U$L'!8R+L@$39+IV-K!@@]9L)0K6-5"81 &Q7:2GQ19!-P98
MP37&91Q6E4C6AG?*0VIL2Q4%>10GXA*,C6L<?TBK19L1<JC55BL7T7PPC4KE
M%PF5F5J5T!4-1BGN):K6H]+QK@S*MLG9IJXMBT@:LQ6.JN[:*O4HH]CE9FUN
M8^52*^=$(FF]=5M1])%04.@#DK!R5ODWN#<;V>T8]L2]<JK1+'<^K:V;!A6(
M5D$A946(M("6D'[9NW74"NKK.)%FBH"Z3J2,BN[,)VY"#.S.JQQ;6\O1 D1E
MWU98U)Z4S@3Q[B*B9B3GHY91 2F*#UD]F9;R7(J!U(2"Z:H&Y(<@)YGO'F]7
M,T/7JG0[G@K!--F)H6N622L)8LQW6;QVZ9.FTG!5QZLA6:U!32YE4CMY1-%5
M9NLFDJV>,54RJ'P1\$9QS2_R#3LA;D['#8FJ4G#5&OP..Z/2:M+6><K+"+E9
M9]<GLNPM[UY1E#O(V,+2OC#@MK1;/U;"Y1;.$8\TN9YWN;9MM<K4JUE;)<?'
MVR^39:W5*=7V3VV6Z8G%D%%FL>C#5U%ZX:.7Y40;,4WYFWKGRB#5D#E4Q_+C
M*$W1*X]QY<<C3^"=P<HI(6J5N<RV;XX+5H^)3L4I&Q$)$)N\A3=57=K,8]O"
M-I=9!DN4TLL^59E.R(BH(0WM:S'D="_;G*W+XWDLH;BVVX3Y5R8WJ$JE XZH
M-/JN.ZM&8NDG=FMB#<D="VV-4E[1%UZOL+ _C',T^8J-T&S--9SSMKF;K'^)
MGNXK.3(6,JDWD+"^+,@UZ B)52<B'E8K"S6GIRS"9.U8?$G"JY%&\F*D:Q.P
M<H@T3!PB0BY\7@]A5]F6;;FUR,PD9#,^[BHU7)<S#TUA+WJUV[+3*\Y&+=:Y
M7F;0PH.H2J5Z9A5EI 1BX*#B80%UWJ3==FBOCT\H2SSQ<,1?'\57S&25PVJ9
M,H%9DKTV@V_SLM$3S*^N31A(":FDDC1*<:X369OET7Z9%#J':@F8BF@M*M-K
M@J/6[-<K NHUKM*AI:V3SEN@J[70A*VR<3,J=)HW*HNZ5*P8N/+;)%%1P<"I
M$ 1.4-51;'=L&&-R6U*LY7MTU9KV7+!+0\Q)8?C;^O6/;]C@;79V=&I6,7T"
MZ9+U&8KC5VK)69Z7JEY.R/'\?-*.(^/CVC=LMZV;:K@';OEFQ6*[0E.L=MKU
MCQQBL\N83FGLJ76"D8>FP$<W%)0KF0?2*Y3H%7*FS2(B8[Q=% JAAU3&..<N
M;6[/$X4Q#^RZVXMML2_O-2:7F6M%7F:Q.5>!I</<JS!.*["6*)EHJ>D!6R$R
M=/DHY1J]L$NQ7\]LBU<&"+L+;/H[+U;V^[@VV>MRU RA26=DC3R$!EB4L\19
MXZ-L<_6C1-AKV16ELBW< NZBBSX0A4",&SYX[211*@H3AO+FIN*Q14Y2T-[E
MCS+$;6VAI.496^D.J)9%8=LJ0\D[).4V8>03ETPC_4R'IRU*.3=BT%J@D59=
M,2P%#9:W%;?+Y X[?;-\A7'$-WM<],L[OB&TU.\-<2)RI%)B<BIN!4>P4RM
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MR2(5D&E.BB/G=B,V=E9QCW#U#99)(9JR7EC-&Y?+^X&MWXD.,)@F\GB(O"U
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M0135@(&-CWT3,0JY&,O7)1%1J1X+=RUC9)J)T7A"E(N513RU#:71<10%8J^
MKID7"E:I4.TA(*IUNS*V2CE8-"^4@1]3;FG.,'!C%Y.==HX8*F$3B4I.L1T!
MFS M74H%B<XRJKRKW])%@XK#G&\[)T%TG)$FXWJ,HG!RD5#F9%:'=J29'#-4
M_P .([%LF+H$ UKCA>Z8;7M,E;\BO+SB"&J4G/)25L.#[)U3E(KS'4C'A+1T
M6R;7.MO(T#*12\J1K9HY^V19*N)Y*1;_  _:+//;AZ<@FD1'%.6B= KJH-WT
MOB"V^B*/2=1L#[YVJ<DYZ>CD5EZLU!0Q2E,0B@=*?O\ =M1KN\L=#F8"RTNZ
MQDFG!2%+R-&$10D7R[=)\BE%2Z"K^ L35XU53<,E6[PIWP%Y;-5 3,8@8&;K
MTKFS).,;=DES)0,=5+(VMM*QHQ6:)(Q!%8=XU++WYX@"Q)RR.6;XRJ,"@NG!
MUU4Q44UI"40<N#LW1(BM03)->NQQHT+%,6:6LY!<N7:CBXR<PI*3#Y59XLNJ
M8'2;QLB@F3H2;M6B#5!$C9!#IA:AG<.;NR?/B@D=0RZIBEY.DF5%LL8J11X#
ML0P?2/L  '2'VU+U$3<3+"RQ341,]C"HV9HD!#&.?X<L9K()@(#U=:S5PDH/
M #]29.>>=!N+-3X5.J-1'H1<#YA1Y[#U"8>W/?W,'(_?GV[]H\WL"X>;)=R
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MWF.0F'*DW%1T&3)=JL$,M&NT6K<]DDU8^-J[\DB=JX,$3'3"**153F>.1$A
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MM"R3]L1U90:GAT)5W&QCQXSCG3SUKU% RI>ZA>I]-LAE7>0GBX ;R"UR175
MP<D 73IBFD'W*(")1#I'[E']=5>Y>QY$XTSMMDSC;X:J6/(%:R39\%NLFN(*
M*2N;_'F8Z1:J[14;%,HLFPDDHNWI0R;I1H=.-(=R_78HH&F'2)+G-KE+6B*J
MZM<@F";^S*)^CY 1Z(1J)A;"4H_P X=&76]P$Y")F'W#0SXVC[5JV1*S\DV+
MEN0_P&<457:B8@""#I4QO5-!Z>P=)C@H@ \@*:H=1N0Z1PU3DPB90K<1,"1%
MR/$.>.L4B#U$Z0#@@G(H "4>>  # (!R/+=7:J,;; NXET4 643,=BX'@#-G
MQ ZFZY3@ B7E0"@J ?Q)]7(#TZ1UP1[&N'#-V7RI:$<*MUR#_%THG%-0 ]NI
M,W(*)B <B!BF'L/8-KV9R:,-2KUBSREVRV&\QY'I()+ !B%KTO-#D&E>E5*(
M@=,]+N,"H;L04%#F0Z?HZAF;<=BU]F'$D]6JZ[2BKU%K15WQ=8#] GKN4*1(
M(66CR1C*E$$F:DXQ2B9D.H =0,G+,5P%!VH05/QO-IT_<Y.,2+*(Q6=\9Q]T
M9(F*;R#9 Q$];5FT&+W\LCJ7HMBJJZ_<3*DK8 7I!(2C8:Q= NW ##UE$@@8
M!#CMV'N =^>>!Y]Q'V[CSH*LZ+=5;]/OY]W7W]5=YPIR.096J+B@JC0\ZXJ4
M3QCGG'@O@ H!),)"-@91HGR(RS"+EK0)B^NX-9/BRV$M-38+*J=<HQ3382Q
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MBG*H41 !$2CP/80Y*)>#?;O[CV_ ??G0>YT_%-Z*91,(\@<1,' ^_;N4>1,
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MK@4@D:9=Q=FO \LN;A--:;KGRYFNA$,;IZ3JIQM;RF1N@?H4*+I8[<.DRY#
M[6C7 #S]N.P#_?[?S ./[ZYT$$YNIWQR#^.-4@"2@BK*B)0* N(X>#NDS_XC
M&2$@+)#R EZC@4?<-5<V& <P^6WMW@2KGM4-"5O*-=:-N@R\ZPB'"=#S!4C)
M%* ./F>C*UV0:-C#U%G*U&/"*)&4<'-=HX;).D5T%RE427241.0Q>2BFJ42'
M*("/ @8##S[<AP'V#2 Q6+IV<RW2I*)!HBC0I^R-[$LOUID-6I^)<Q+UJ@H4
MAA&4%9I'.6;53]V &7<>80R1>H&^IT.@9!)X41.W,4#$ZA,4IS  !R!0XY
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M-1"GIHGX*)DI1F(&'W*(BJ00'\ )3<&[\"'8> [:",(1X,A%I>9P*B9"@81
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M ."HW<2@DVBHUL3I!-!@T;E#MQP1NF0"_P!0#V[\_KK(&  #G@.PE$?MP!1
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MSP/8.0'MSTCP# 8]LI+758N4* E6*EZ-XEU%$$GC+I06 !#CCK,!52=@'H.
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MP+B0Q',U0@)8Q=YQB9,EE2NKNHD-AD,-*1A*1$3:SFT+N&;8&]@/]&0(%#V
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MRD*)M*ZZPNKD!BI<LWQSJS7ER#^7KU+0M]ECZ7C\I&BJD'4V+*%DXME)21%
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MV&8ZW:8HD>JZI\_7\;LK8E)?$TD7L>Y:**L$E%O(.$)9SH=9Q'XQNTW-^/\
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M'3NZ0FOO"1>9*R^$Y015=JME#B(&$4GZ2K8..!^YA(("/;CGCOI]!,  (B'
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MQDS \ RCE\35IY:HBEX_RI)S%A1BX*ZNIJ$DIA.6=1\U,1KA^V\H%0 UDW4
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M@7,-;'+E9&(DR*P[*/E:Y&R30+]$GR3MPV*W7*J@J4JY5B& Z:J9R@)%2&
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MD)+'3Q0BE4KMW<IQ1Y*QIBR>1#!V*C)N%PW67\_?@!X$0'MR/ \<" ![B'(
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MQ-5A(IDR=M'*Z(#)NEY!TJZ;IM6YT!HT:- :-&C0&C1HT!HT:- :-&C0=#\
M4>1 /;N/L \AQ_STL>5'19*YQD6F(F)$,P*M^CAZ<' _^LJ14>P=@ >!_1GC
M!R''ZA_8! 1_Z:@YYC6P/[3*3R[R*!!\Y.JDD55T*I$B\)H$.!FG2 E2(4#
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1' ?@-&C0&C1HT!HT:-!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>g71132.jpg
<DESCRIPTION>G71132.JPG
<TEXT>
begin 644 g71132.jpg
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MB[_EZEI!>-V:G5VGV32RY;S;KFI$:%>M,CS&IJ&+:2[$FH9K;K26%.AO*?\
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M2&]1E$K0XE04G&0,$ @YZHZ&E5$29;?R;C&V774ALJ0[NS(*4D@+5PZ05(
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M'$O%UE2@E#;B/&02L*RD(Z>__28 ']%M0N>1_K=;_(__ )C_ +_?I!^_X_\
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M"1US^UELMJ\P ;2H*&TE6X %1!.-V%A1"B=VP\X)QT'\@$R6D,RRTA925(.
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M1(F27'6*:X%.%YN5'?SN.U*=M>&IVVPILNQ5EM;C\-I.U("PM];J7"V1MQM
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MO^;B#':<R_3)<],V*I:=S;,J6MZ.^VGA9:3O4T]])2E>P[OJ( .(4LK4"?\
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M/5-U#F+VMN>5QER ZO"$[T24I#K"0E()2^UM!3DJ)W*,6M-J:8LA+:$N-I*
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M$A$10:(4IM#]/>"%O%K*BMR(_(!;:+A2 DX!3X=9^8C,X44%8VO<*4,A0"E
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MRMRMU2=!.-F"D!).<8!!.0>F_P!>B_(2GH*'G$1Y[+K++R6E)2RI2@8H4C*
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M!M>]/A81Y%AK/D0AUM0;A D=W\N0L/MPF)3[@"5%MN_Z@E:\*0S^J<D1$)#
M*0C8ELO%.]PJ6I21C1NZBZX4'Y6GT5L*E2A,EOO6/=4V6F4PG=&>>DRIJB^
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M,\D(4H+"=P+2TK.])"$[-@00L %M)Z#BY6G6B$QL(D:<T6K);#7UM:>2YK:
M0G#GS;E(;=RK=M(0M:=N%E>WTT$_0OMRJ[ C3-*Z9,9+GD=BLV!<#:Q(0@I9
M+:&X<<(=0E92GQD?1DA9<4DE=&:^\H!Q2E)=)6E:%*2I?(*T$9(R=[>4E?"@
M&ANVD@Y:JTI3@#C[CC824JR4J1C#Z D)RA3:RV@ % (40.0O:>@9_+[1NV5]
ME<4:/5&$IQW>TX:1>T%U:PH'QL/LREK ((!84I Q@*XXZT,GLD[<W\29^F5X
M42*W&=90\U/N./37W%;'$2%&)5JC4&I:4J*$NR&6F%M8#@"\9?.W52E2E%UU
M* "5O*>;;5@)4@[6]RU*"4H]RC<HH&24D'T_%&,K6Q)CMO*)4RI*#E#R"5J(
M4A&[8%*_6%.$KR<?LI !F5$[*^WYGPR8^C2ZRR@)0ERL7#*98>4C!*TP:U6&
MW'5K!*5.NL,^8?2A R1TLU%T1L"@AMFW=$[+H_@*$H<DTZTG@E+:\<O,-5&8
MM/EV'=@@H0%G&4$K Q<,=]+JTD(6U(^ME2RHK<?2AQPI4D@A*7TNM(#BO(H*
M"B4GKS<K* X'"4A:P3N7DH;&"=V4J3E*D-I;6."0"G.1NZ#'BT^M0T[4TZTE
M-(7XS"9JE3:4E*R 663^"I;:\K>/"LI0TD ':D8Z\FJ/70^I;U3A4-A+*GF8
MD2GBLR@D.%"U.S9[T>(H-#84(9BN!Q)5LD(6I>/ARYVHKK+BU;FUA3"B"UE*
MD(4XUGRA1&4EY 42<X00?J /BFZ8K)6S+>*R'$NQE HV*CNI2TMM]6Q"P&\I
M*,;2K<0"GU(;55*EK3A^[IRE!L("Z?3:514*2HH4TH>.)*?V+#A&\N[]PVC(
M^HZZ71Z=4@J-.K-P35!7C>AS*NIN+*::4L-J**<Q3GW]P& 7WG&\J  &%9T+
MESLL.2(3KZ!X7%",\'#O,59"VV]QRD):)*$E*<;-B2"K*NN5EW>E9,A"RN1!
M6D +04(= ( 4V75I!;*4X2@$$X"1]:>@[*-2[5C2/PVHP9#;#Z1\@6JE6!2F
MI"#^L$NF?B:HKCBQ^TZEOA1 &3UN9+3-#;2N)2Z.6&]CN]BGP1@$90M"PRE8
M*1MRH++A*N%9"B4@JMVQ:BPIIR0M*E);DQUM;$+WC>V0,J3E2593@$*P.,D)
M(Y>GZF!KR4VI+<<\02&W5E+:2V4GZ\@J.X* "L ^I (X(!<YK\:I(5+AN(2A
MU"0ZPEPI2VM"@I:@5*4MM:U?TE<8!VC '7&R:K/I[GE25NA)4I"4@J6GDIS]
M2@EP**4E0VXR2=PSPD#E^,4V8^&9#;4=X%U+;?(WH4K=E:U@Y*7"=F"/?]KD
MZ9W4I$QY2$*+W 28\5!E27&U')RTREQ6,G)^D).-@ROU!=T7M$=27%N)$L!2
M7(P<2E(*2.$)2"@$$9.5'/MD^NF=NXO//O.K#;>Y*6FT$I\FU(PL):(4>2D9
M64@G.23D%!Y]>A0O+,JTF!;T3"U&37YT*@LM@I WE=4>C+>2CT"&X[CBB/H&
M5)REU1[CM.*5),2F/5V]IS:E(;8LRDNJ@N+X2&5UBKB*%I4LD%4:#+;2, *Q
MZ@ZYRO>1:G"XX5>B5E02E6\$I20>1ZH21X\$X4"3C.BK%UPJ"V9U:GTR@LM(
M6M4BO5%BFM-MH&U3R(\AP3GFR,_4S%4E:L;-V2KIJK%T=PFHJE,6?0Z/IG1Y
M:E;9\]1E5M#)5C=\X^ ^T[@@*5%^6!4?U9V*(&VIG:?#JTY53U,ONL77/D++
MKR?FG6V/*4*"@ -^_*L[5.[L!(3NST'Q=7=]I91V:]'I52D7=48D&>F$Q#B"
M);K\A4)]M2I$N>I4AZ*VHJ\WAIQ6\E0;:+9/G1^AYV<.>7M%[67 E*0OMRT.
M6$HX2-^F%K*PD9.$C=A(R> .3Z]?F =Z^E=E::2K-?LV&BEBNVW<T>HQT2%*
M3,?H9BIBU$LJ.&9+K-04S)+)VR"RAU8#H45?IZ=E)SV<=IQ/!/;1H,?_ /%5
MI= YOHZ.CH*[GQOK(CZA/4FW%T=%:J'\T<^I4", 1-:KL"Z:B_ D4MY*D.,5
M%*D*1'4TM'E4OP.;D.;%4H)R*[<#,BEW%3YC?X+,E,S@]',>IQBU(,9;+L:4
MTVX9;:L>1A]L+RG&0H@F]I\4UT-ZO:<9XSIK)P?S_2NI#U]OW_V=0G:FZ(Z8
M:CE^?<=MQ_QAQHM+KM,<52ZNL$@@OR8P\<Q2"E)2N:P^M.,!:1QT$75K=LE$
M;TXFW+;E]/23\DF4_3G:56:14XLA.#,CN3:1+4V['7AK<R^EME+K25EO<$JZ
M1#MSUU5VSZS5&;<\55Q:5WZQ)LO6BT7A+J,:[K+J7GB2I;D6<"AVJT9$I=0@
M/;DO.MIDP=^R60))G=*V;+HLVA42OSGJ7)^;26J@TT9*&)!VJ95(C%M+J4I'
MTK6R%DDG(P,,+U/[>9DY^=6($RCD18TR6['6U+;??$='E0TP0A:$K+3)0@+5
MA2B,J]^@<'\0/1.VM(.VCM1LRR:[&N2T6M7]0J[8%8CH5(2_9=^J;N>TVPH;
MTR)$:'5&:>Y(;.UYR+N4 ZI:$[ONDT[&I'Q5]!+":;<#E*T[T8J]S2&L%#$*
MT6+@NB27@,J!3'BP61O 0HOMH*DA2<N[[<.WJA]RO8_VNT6OU,*JVF&KZ;]M
MMRH.NOA-I6UJ6Y!N*VFVU9<73GJ8OPL,J"H\)XQ^$,_3UJY%F&E]T_>UW75>
MLN+-J6I4]([/8;AMI>HLU4.GT>EJCRW'G6G9+2*8TEE#2$(V5-7*@%(4$-7<
M1K!5+T[I]<:_:$VGM6_+ONHTFFSW&G:B[*A6TABVV9T<2%!E'S?X2M]DJ04H
M0ZE(3]('4E789I'->=J6HM9I\A\R*,[3Z=6*JQY9$B8_);,E5(;<;2EB*B*V
MN.[*B(0EPO>!#B\K"8]:)I7:-I51A4>(]5JA*DH*IM9?,QQV9(?2%OAD):C)
M6M]PK_R*LJ)/)QU8XTHI#=.MNEP4);3^'0H\0!)3L_Q5(CJ*0V@)2G+:B$<I
M!((/K@,:\-,:/7- >X"FMP8L:>O274&?$E-Q6V7&IK=JU-\OKSXDJ/ZH!:E;
MN$DG.[/5,JK*P7N-GDV*V?\  6LI4M(],H4#N01Z)5C''5QCO)J5X6SV>Z_U
MRR;NI5FU-BU&(U1J]52Y_C-MU.HL4JO4"DK3#FAJO7+'FIH-*<D,ICE<]X*>
MCJ*'VZ;];DG]874HW>JMA^G" !A/O@\!/L!P,GH.+G.*"U%'*T E&T94%C=L
MQCG)(&T>Y/YYZ5NZX,VE3WJ;4T+1/A-LL36WFRTZB2B.T74.LJ^I#B%+(6DC
M<A8(/(P$UL]NN5J^;4I-M4YJK7#4+HH42B4V0"IB=5G*M$$"(^D CY5^0&VY
M1.4IC%U2L(2>G,=RXF)UIU(54&(D6HOU]^94&(+A>@1ZA+CQGYS4%U:$+>@M
MRUO)AO*;;6[&2VXI""K: ;W'<"'0?1(RD^N<'.."#D#/(]?O]NI$OAG7E#L7
MN9I-?G2'8T&72JU2WR@%3+RWX\9:$2@ 26_(PE8< (;=0ATE'*A'$I6WD_?D
MY]/S]R?RQ[].R[-+E@VYK;8-0J1;--7=E,I\LND>)#-7_P 2WNA7!:#BD[P<
MC[\=!^B/HA>U+N>S82Z5*:DM28S$Q #J%<O(#;VQ:5@K0B0AP'(X6O)*@>E?
M7*F0T;PE!:00%Y21E (*2>$YR#M0OE()4 2K)$3VC#=XZ?RTO6A(,VW']DQB
MD/*+C#!>2GYIF,YP$1GED+;C\^-S:I)&0#(Y8NI='NMAVERU&FU5L#STR:&V
MEX!(6@*)05MA7*MHY&-H2D%/0=A<U3B,4AYYQ*7),AO9$83MVI?6DI65E6U9
MV92M* %!3BD-I.%J)9]=>B4K5:[+2M"GQ8S%L)5,KNHE1+*74IA^-26*>0X@
MM&55)*PVDK_6B.RM:,I)/2J7==$<U.H/I<2:7;L9U2% C8]*7N\"4G ^A;I4
MYR 0RVD@)]>OCM7U BW?:=TUI)<5(GWQ7($KS$!IV/2%1HM/+"2%)#:66RHI
MQD*=6 .2>@72C6+1K4IL&ET2&U%BPV6(J&([2&"&X[266D;5(0IYS8E 2XXI
M1.W:@DYP^2P4%JS+;;((**3%20K@Y"?<')'[L^G3,W9P<DO8S]3ZDIPZ4K27
M!^K6T I(*0H)2-A' !"2H_4\RPE(79EM*0I2T&D1"%+.Y:OH]5')R2>2<GH*
M9MYL*%V72T")!%QUK@(.%J,Y\I'UIW*R"K<HA( 0#GZTD)'<UKR:T&/#(:CB
M$2A27&R&Y#V!Y!](7^K9*@GA004^Q*N++]6^$7H35ZE.J3VH^LC+L^=)J#C+
M%3LSP(?E/+>< 2[9SJUH2I:@@.N+(3C*CUJ'O@[:&.9V:JZULCG;LG6$HHSG
M)2I=D*.2>23G'&,8& J ZP=GKFI508K,*])5O5Q#*4SS38C:H<QE!*FDK:E(
M4EB6@JP9D9O<M(0EQ2R@'K@J3V 6LXV';@J50JCA "Y$VL5-3[K@V!2U,LO,
M--;\G"2E(4DXW$8'5RU7P:M#MJ@WJ_KBV5'.X3[!4>2<CZK'/!!Q@8Q[8  '
M/S?@J:22E'P=PNO]/:RC#45G2%>U* $I0E<O3*2K   W'+A Y63G(51:#V&Z
M'P4MN3[;C5)U(4HI=1(D)5]:2EQ:WWEDX&X*(&<9W+(QTI</M-T%IRFPG3FV
MW%[DC$F$RZCE'TI2A16M9Y2H%)^PP3QU9=5\$/21?#G<KW)E&,80YHVVZ!]D
MOC2DN#']'.<>P]^OD_ TT)<"_/W&]V#I<.5[+QTVCI)XY"6-+D!!&/I*-I3Z
MCH*Y,;MZT5IZ4(;T\M$%.0K;2(F]."3N)7N44':1A."G:KD$8&\8T@TIBI#K
M%D6LVO)(0*/$;!((V$(0T2"A:E!)*AY0E& LJYL.?X"[MU*2'M>N[&0?IP7=
M2K804E'H1\K8L<?; ]!CCU/7R[\"'M1E;?G]1.X.J%((W5._*;+6K.=VY7X
MV"% X*0D)_+''05_FK*T]IZ-Z:);D3"U/)\D2&PI(3A0*5D,MI&W*T*0I2B0
M$G!ZQ'ZSI32%E#T^T((0I*E(>J5*:6E )\A;RZE2BI*B5.;E#<%8QMP+ @^
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M*L *+2JE.=#:0<CZ"00%*'/5E$?!A[> M*QJ5K6"E(3Q5;''IQZ_H3D93].
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MI53/PB@Z@7A06_(DNQV*C6(T7?G:4H81)6PTV3M#:&4):;4%!QO=M+BPQO\
MWK_XT_\ *$]?R=^VS_\ QO\ BV^@TU5U9ORM,&'5]4*Y6&B\A28\NKUJ0TM
M;0XHJ82ZIM*TJPEX+(0ZC<64 [T%#[ZH[EV0FG&ZFP[,C/2GVV##DPVGFG $
MK;*PP\X/J2DH6Z'7,A86H9^E7(?^U4_^(:_XU'77(_VF?_K+7]C/0,AHVEU?
M<J;"*NTXQ :>CN2G(:%O+?87L*6V"['CJ;#R?U9E.8;;4%!: 2DET_=TY$K]
MB=L=?IJW3<[%M7-19<=P[JA"3:=9B4EEV4UP\RRJ5#:>CN/-H2^IQQ3:EH4%
M'L)'[:/_ !C7_*&^DIU"_P"N(_\ JK?_ !CG02U_#WTEIUZP+)U=>:84Z[#=
M+<4D.N,W%$D/TNJ)D ']3\I*9=+#!2%^-YATIPI)+\/B4:ZT+2C1VV=#J)46
MC<VH3WS%8B-.H#ZZ+3 Q+DN2FN5*CH?=BK*5#Q_,R*>DA2R VV#X37^Y/5?_
M "H7!_R&B=,T^)Q_V\,#_P GRO\ TFG]!-E\/.F+D:?TJH/ A+D5*FPX,[LJ
M4 4D\%("B3Z>_OSU*/';1#DM-LE.YUA2C]05E0<"C].XJ!PO*<9SZ>Y C^["
M/]QNTO\ [&C_ /G*Z?\ ?_"$/_P'/_/3T&JK:VR5(+A6X2<C.<#.2 $))V@C
M'.Y1'H3Z=2Q:#Y_F:TUR,']$Z9QSQ^K./4 YQZY .?8>G43E8_VR[_X#?_G'
2J6C0W_<?TX_^ZE+_ .*/0?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>g804100.jpg
<DESCRIPTION>G804100.JPG
<TEXT>
begin 644 g804100.jpg
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M,14B05%A%B,R)#-"<:$70U*!D;$*&#1BP271\"9%4W*2_\0 %0$! 0
M              '_Q  9$0$  P$!                 1'P,4'_V@ , P$
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M'Q5J7F6724^Q)?8\.05 )()YYLX[I]J;0LW&]G[)B056+I2<8E9538-3P&G
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M]7L*-.U=57MK$0EV\UG39>U1-+9#GB]+Q?(J>]I78S07\K<6$JK8<;"DJ6/
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M*0VX&CJ>V"7&S"@@O9?#PG#;NYAU\RUS-RQO*+%:R3(#-G9HMZ1N5<V=15L
MJ;HRPW;M@(;<DH9#CO08VN'-E;IRK&]*8%A5IL_(LPLC!QO#:E[SGS+AALRW
MIE3*E.LQ,=74QFU3+S*3*K8%=6LR'[6:J.E+;G55VN_12P.FQ:EL^X_-IV8Y
M@&H\BTQ;!'5TN-UKJ_%W]+DY38MS<KR0L(/VTFPC.4$*6M#AA,!GQ<5+7Z=O
M9=VJ=N^$0,LT1)KMHW&6T@:M-_OJA6=SE4#Y27*FBDPT?9XCB\&:R QC-/\
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M=RN@>Z?%-6;0V9H+?<S7,7/M*4&4ZOP[)<3G:JU3LBEE.X;E>5;%LZRYB/;
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M:S:L*Z7">2GQ1-0B0?630UEY/4F7!JV3)E%96Q5Q2Z7'"I:9#DMZ*_XO ^2
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MIZ#L^PGXO76<:ED80FXCXBG-Z2\H_P#%ES&KZ2)$9J;JVL(5/D-#8V:_UO\
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MNN[?^ZFGOLAT!L6!LK'L<ET\.PR"GILHA4+[E]5HN*IZDN;ZBJ*W)X,F$O\
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M40UJ02Z[-F+5+="4A ;6/>(Y>)4^'D^)\?\ ( 4L?* GGEP_&7%*\?+@-'A
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M^)/^H'^@   '_/K>1I/S+XC+;3\BU)"5)6@)6H_(0DJX;6XI(*' DCC\*/\
M'2BQZL-O8(:+*0RREZQGNE(2(T"N*5OK45'Q"5+4E*>?]:E<))X) 0D^I)EL
M_">WK7^MZYB5(F9UFL2TLXB4%_Y*7 :Z7;.*60H*#;UYD->TE*/%)7&!62I"
M1UVO_2!P;+]=?38[/L6SJ*] R9G3&/7,^OD)6E^OCY3(L,GI:^0A826Y<.@N
M*MF6UX)#;R2@ ^)4J-/:Q]-+26;XUK/>.]\%3G&Q'80LL:QS*UN.XIC%!*LA
M<TH5C"0Q'E7A989GS)EBIR(XLU[3U<\N.0;J*JM36LAI"&6T!IE"6V $-I*
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M<GA&Z8^,]G>2&#NKN@TEW,8;JC5V]-\M:&S_ 'OISNK702IN-&5"<MY+T'N
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MH3^K-(CH3&CZXV-:N3)#4A]EJNQW*E/5LLQXUM3K9[5,O4M<=WR\BD @?G@
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MM(/DE_S#C:PH $<.!()_"0>#^SD=!+/%,C,93YD/%16M/ 4I0\2E:TJ;XX_
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M=;6II"2M2>"A0'#@4H E'F@<%(2I/B1PH>^ U@I=L/!MMVEQ:O+:4,E-AGD
M!E"5J5\?Q5\*2D-H3^5L,MD^@L@>^LQO#\[<\#+R' X#'"DA4:5?WTDN?P U
M%KXK9X)\4EUQ(('\ ]?MW(DI'@I*D(YX4A+A:4#X'TD<) 4$@$ _\/)(XX/6
M$[DCC12I!\@MMLMN>7@7%#\(6 #XA/()_ 4HD@$$=!LU8/7-E*\@RBSME*4C
MF-41:W'8ZU-%SS9=E/.6MJI"BCE!:;C+))_<A7'&9#G5N/-(1C53!JG'0_\
M-.2')ES*;5RE:IEW/5(L21Y (0PY&;\00$ #CI)&\6I)X2!X+*EH1XJ_825-
M@E?)Y0I2O%(*0KGC@^N,<6Z>"X%!*5,H^12E>''*^"M20" #P 0"">1QR>@V
M<ZR?*PXK]C?R)45%;A2X5*#9+BN4D\\^1 X!)YXY))U7ZU%;(3X)+OQEOD A
M!2!Y)(//OQ(]<J)/KDD_G\3):'V6UK(^/@?O#H+:DA7*5>/B5 )5P3_0CWUH
MT0OU24*ZO9=L[!;2GD0ZQ#K\A(2#X//J:_RX<=( 6ZZ^4A202. 3T"OJKTV,
MQN"Q\ZI3KK"&8J"I2I<J4/)N/';!/R.O']Q'*0A8(\O$<BW7L"[2[+=.3JFY
M7&FLZNQ5]M_-+%YMQ,;,K>+Q+1K^FF!*P8\-I#$C)9*%*9C0%/1@'94U2&HQ
M]D'87M#N6R6):1Q+Q+ Z^?';RW9/V/E!C0V^'9./:V4\%,Y)EDAE#C%E<)4F
MEHE/N!3KDB.AM77GJ_66&:NP.AP##:"+18UCT8PX%:P'3PD.N.N29+[Q^XF3
M9CSBY4R;)4J1+?=4X\02&T O(<)N*VVEL!*4H;"&PTAM#*4-_&EMEM "66T-
M!#*&D?M0A 2.L[KX    .   !_0#T!U]Z Z.CHZ Z.F\VWM+#='ZMV+N38EA
M)JL"U7A&4;#S.SAUEA=2Z_%\/IIE]>3(U34QY=G92(]=!D.,P8$9^7*<2EIA
MI2U =-WVG]T.IN]'MXU=W/Z,LKBVU3MZBDW^(SL@H+#&+I4>!<V>/64:RI+-
M*94*7 NJ>R@.E*Y$*48WWE;,G5TB+,?!X%85ARLQ:V(O%<<.>Q\9DX8QFRJ:
MN.5L8A,MHM]+Q=K(3'_56\>E7<&%;R*=,H5[UG$C3G&%26&W$ZFRU;K*[FYK
M9V^OL(MY^R<9J<+V%-LL6HK&3G>'T7ZZ*7%,P>EP7U9+CE2,HR05U)<_>UL-
M.0708C(%I-#T ^Y+96\]O]W.']C6@]Q/=NK-3HL]S._-RX[BF)9GL]O![S/Y
MFL-:ZUU7!SZJR#!L9N<PR*AS*ZRG.<CQ?*G*7'L98J:&D;MKY%U58G;3L#*-
M9[2W/BF2]]NN>\+0F+ZVF9_ M,BR?55UW3:ARO#+:="V)B>2X]H3$Z*ISC6J
M:-J)<5EY,Q>NS[&\K8LL4FQ\CCVM6NJ":^ONVGMVU-BN4X-J[0^F]<87G*'V
M\UQ+!M985BN-9@W)A.ULAO*:.DI(=9D+3M:^]6K:MXTQHUSBX(0(JE,G$P/M
M:[9]6XSF&%ZT[>M(:^P_8<=<3/L5PO56"XSCF;PUQI$)4/+J6GHHE=DD/[*9
M+A)B7,>;&1"DR(B&DQWG&U1!QGZHFMK+(L=Q[.NW_NETG_VCZ;VGO/2MKMW
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M/'X\2>:0I2.5R?E80CD#@J\U*5Z!\?9Y)/'/\@:]75BP[[]-H3XF9W#R3P4
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M*(*TI"/1'O@<) ]<<\\?^6"#PE:@"?%*N D$\D@?M42"E"??!6X4H2"5%7H
MQ:<VWF$II25V]=5LJ2I/A A-2G2M0(\$"2\I'D22$CE+?( _ Z15MD-Y>H$:
M9:W5FRXKA:[&6@Q D E*#6Q%TM:I"%D+2W*<D-@I27"\D>"@6FZ\YQA$*?5U
MLEBXNEE,10A.K,"KD%7DIBSLXP47I0]*BU]6W)L)2N4):;:!>#*X+KV0_9.9
M9D[+"WUIBNQS8D-*2VT%-Q%/L(>XC*B,*<_3JTAU7FZM]Y:IJ0\%;6PZ&O?:
MG2WEVMPDDL?&RF:XTL@ )::C1F:B$X GQ*H+#8 ">5K(\CLK:/<9- 7"7,?Q
MNK<7\ <A):=M'F7"0ZVF0\E$:%SRI?FRA;K;GH$G]W0,7M#,['+I<G7>&RC
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M]P((/) ' (_J?0')X_@GCK9(45(2H_DCW_'_ $_C_E_'1X(_'BGC\\>(_/\
M7\=?H  <  #^@]#H#HZ.CH#HZ.CH#HZ.CH#HZ.CH#HZ.CH#HZ.CH#HZ.CH#H
MZ.CH#HZ.CH#HZ.CH#HZ.CH#HZ.CH#HZ.CH#HZ.CH#HZ.CH#HZ.CH#HZ.CH#K
M%<CLI2I81XJ'L*1_J!Y'L>_R?_R?Z]977Q20H$'\'_\ !YZ!'W5:W.94HMH#
MG"DJ#8_RR G@<#CD*YY\N?1XY!X)X9JYQV3#<+\9'I1],+2"AX\?NX!')/\
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1 ='1T= ='1T= ='1T=!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>g556508.jpg
<DESCRIPTION>G556508.JPG
<TEXT>
begin 644 g556508.jpg
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M$#(0C9J\4=;!T43A6DU$\[BX;)1VI"-*GO\ 8T9\BR^'/"2(*0,3$8/./#-
M7#*R>$J&2-KXR(IHW.CFCF8J2,EC<YDC7(]KE:J*O9XXXXXXXXXXXXXXXXXX
MXXY%00L[=+V8##&,VP./S-]&&LC6/MZ.;,5]$K9Y'*]8&DF45Q6PSM8U!Y1H
M9E_Q*KK[SJHZE <CD<JQ.5Z(KE6*599%E'?[VL?\HTBO'E1T<;DDB>BQQJGL
M;6N6):6+*G3%&FSM8%#G6%R2DN>T.LJ )K O0'R/1?BA_$57$KI/1TRNC]?[
MD9[D[F AD@Q66CFC?#)^B5\BPR-:R2%LP[)XXI&,1&QR1QR,8^-O[8W-5B?X
M>7?QQQQQQQQQQQQQQQQQQQQR..P\^P@+^KJSYA-7DPR#*JQ$*(%FFKXB!+"X
MHBXXI6"6==;BU[H%!MH# H#%'L(8H#1HB8[CI2(9CK9PCVO!)6MLAU:GHCG6
M(*2R2M3T16I.V*&96JB>LCY)%3W2.5;DY#YM&#K=E+564Y95;7 3W&AI_NYX
M!;(@F^^RQD-@T98%,JJ^'-Z$AM1---7%$F2360<[_BY,''''''''''''''''
M''''''*/?7%-1U1=C?%C"5D3/C(>4K59,LZ_#&''$J.<649(]HHH,+)23)Y8
MQH(999&L=;G6XA8>3JXCX2!S6!UXY YLT9)PT@-6" X8PB)/CE(AD%>V3V*K
M6.56?AS7(E]\BS(6(";#8CDQN!N;><(X6$I_M<=5U@K09XZ_W^U)&U%C(3^J
MC0JY1"[..PFCC@N0YR93XXXXXXXXXXXXXXXXXXX543_[^?\ ;EBF]@4D9)5?
M30V6LM0IV#%5V8#6Q^T(>KV)$?9OD&HZU[)&*R9AUI!+!^5EB:C7^V@7EKV6
M95F?IR8KKXN<25M:9J2"=>5"6^-5C:524Y5 "KQU]JR1BZ*S8Y?56+,Q/22S
M\3H,U,8!<[Q]S4:L\\:NH(NSHQ:RZ83;6M_6TXU-7#2/S%=/=)0F35@],Y;P
ML21KS/9 6&V>?0C #1X2:XH0H0AC2()PIX9QYXYG/5LT4L#GQ2LE<V14D8YS
M9'->J.54=SZ$E#!PO)*FC@@C5B/FD<C8V?(]L;5>Y?PUJO<U%<OHUOKZN5&H
MJI&.UM<4;&&+8ETMHCYZF2$2N/\ ;IQ3-#8SU6>MZ$RJD<< 1865:?6AG?-7
MC%SAECI9L^S*@?8V5[ V@,DTMN+)=T!?V9M%26P4N7[=IJ.8$=)G::LMFUN>
MT-D):_<CR!4A(EK#6_IY$GZU9ERP-FRDUV=T,I8U3:0$' /]A]9*DH=L [U1
M$0ZI-C'LA$<J^C'SBLCD5')&]ZM=Z7'QQQQQQQQQQQQQQQQ_'(.T9ECJ[XZO
M]Y@^>I;&.CKZZ F<*'7Z!1X)K@FUFA?$\O.4'WH-2/5K/&%:7[[1EU"8#7Q#
MKV <PTK],JJ_X@PAXG3#R0H0,,#713.A=-55U<\,>+]3F;\(A$TS/01LY(=:
M"D<2+>).?#%1DL][^DHR2&:4@6"GJY)VCR)*L1)CQG%O%>YC/E:PF-[FM]KI
MU:YZ+\9+.F0EQS9Y+\MK/41Y#XF5PJ.<B^T)$B^)))5:WY)PQCCWHUK/<K$;
M'SJ@X_)!J):'T>;"G2*A_3@0J 2OC";G9B2<]' .T9IQ!5'+8&K6+(QGZ2IQ
MJ !@_=EI-1<5F<.94.1V?IS" ;BRC$%,ILZ.4,-F]A>V.;A'"KB#!(F4I1<T
M]21-)%9PRS.*M8J^YE/&AKM)54N4'B!R=2/G*L<?X!\VE!)45 4,,LQ*AU$U
M>"D%>,D\Y,[ AD,KDG)ED#&C?/*Z2N$E55L"D%W2EH-(U)EA/JYB8(U17-9,
MDL,4S!Y&JJK$]RCDL1R2(V/U]4CJQQ](7$'-:"#70-9ZLI+F.68:>O#1SVMA
MBO 72F54HD:J/,\EC1Y6-]CK 9DLX[:9$5I.NFI8 VE]L\;$?$/;U6A*6SU&
M<&G_ +Z4ZKME;,?>CAC/88P$F>R;8@-?^F6(Y,4(QD^#SPE00DC2QSCD11SP
M3PO;)%-#*QLD4L4C%5LD<D;FOC>U5:YCD<B^BISZ\<<<<<<<<<<<<<Z%K815
M-78VI#7O@K #+"9L?I[W1!#R$R-:KE1ON<R)4;[E1ON5/543UY!V>K"J[/PL
M-L)9+6:F&,.="J^BVL[)-;I%A;(C71RWJ::^2./VJZ$:OA;#ZM"]O)%E+8AA
MD(1D-:)\0L$QOK$C!:6HB19IA'/]T39IBK'].ADD1S84AFF;&^2%K7=D8&-[
M7NK*$6&)?56V-_\ /*42CU>V5ZP$)/9.1['.19#IQI'HY5=$YBHKOPUL,4JP
MKIQ!"9&HGV](!4Q32HK%:CEAGBMB95C3T6)8_C1C6)[VO;Z^M$BRH\UBXB)^
MDN"5D;(3:W1[ Q7HC7>P:&+]/1711)^UK *V&")SW.0CYD<C;7RV*'92-2SS
MQZ/BTNNF^6J4+/&0))JK66&>&NIR(6/#(8YA,9GW\UK<Q*VVNQFVYA(S)*AC
M!%_;'-KE^-'P^^?^H#/5/<BK)ZDQD)*OJ[T;*J/=[45&+[6KZ?J<I(7M0;2H
M+*]/[H2Z@A4:9?X]&NEBKS_<YRM:JQEO;$JK_<JY43G7&,^UN6-? T-]FY(S
M(8I$G"/D<Q?M;<"7VQH_T>S[&Q8L;"$6<-Q#',;#.^BQCR1F7#8$?)%ERJ])
MF*BO0F&*6:V%$A3T]Z/ HK>0=?7U25SQ(U58X/1*CU^]HE?:YKT5J9*]L*45
MCY&.>E-(L=MGT9$WT=$-!2V08 OJGMDC!5[%5BHC;]XX]?3G2BLJ^>=XL!P<
MQ+/=[QX2H)9V>W_%[H8Y'2M]O^?JQ/3_ #].=WCCCCCCCCCEG;]STR5Q Q(E
M<?&+5^LSD9&U+>P$JW2.551%^-ICI$9_[CFI&B*KO1?CI*^4EZ&BQBU9%9**
M6R[.L'AA.417O^(D89SE-#;!(2,2PQP:-A(F0>9$]7<PPZO[+[)I.TB.G.U1
M,W8V)8"['";W.,@%P5]GWLM+HJ6,9QLQRQT!!$P5>47 T%#'AL).+/C&D*S1
M'J"37.=8VH1<KVJY8?>^QCC]WX1S(99!J_V>W\M]*ABHOHCG2(CE?6HJ(>+T
M:A1Z1HOY@@G8 .OY]5]8*V$*/U7_ /)_M][T1&N<K41$^1><%(D9/"9:AS,1
MR(L%F<Z!Z.5%7YA9IY1Y51$]&/6-)(O_ &WL_/K9>!PU;54Y$1$)KG.O]3,@
MLL+*,!K2--:DI/#GZBT+IF*6DB%36/M8;=22NMK,<4\TD6&_WU-/'&Y7AB11
MHGM<YS6QHU%5?3]_JWV_ER^BHJ*BKZHOKZ<H!!6>DBE:++9&,C1Z2R5D]B0/
M&QC?=*DA+YEKDB8GHV5DDRM9ZHCVM1%],/\ MOM.[&VF&ZXZ<KB2-[<6<>B+
M?JU"=AJ/*5P-A;+?7Y$-D!*&+;K3E#!_;'MM#*^ PVOK+&.&)B915)PUA"7/
M[K"2CLC2#C+(:J,<V_E]8X/N/N(VS.&I/MA1@1&0,DF*"'9),5#"]S)JW2)7
MLUVHD"GBD2WJ\O=N^.9LC9W+';4WW,*-]42!1JH*']BJSY(W+Z(Y[O6]^.:1
M?.KRTV%IN;WISKZ\.SF3R<ZU.JL*8J<&UTV@9&Q]C7OL1UA+%HZATB5[PQ)8
MOU(^,N4N:86(:!NJZJWM0%NC<M1ZZ +L?.4=/LSZBHMIQ-524%]86-90Z IP
M,D9M>+<6%59C5D\D\,QJ@DS01R#-2=V^_P "O*6^[@K[CK;L0]UIN<I7Q6U7
M?S)!$3I,PV: ";]1;&V)LUU2ERBL+,8Q'60AXQ,S4*A+DFV)F&"5XA1YY(X0
M(0\Q9AA<\0PHHP\;I9R"29WQPP00Q,=)+--(R*-C7/>]K454M>H[#P>@.@K*
M/:9*YL2892!P*K34=D;/! U7S30B!6$Y$L4+6N=+)'&YD;457N:B*O+P]S?R
MON3T3T]5]4_'K_'K_P _\N?E\L<;7ODD8QD;'/>Y[VM:QC$57O>YRHC6L1%5
MSG*C6HBJJHB<_ Y(Y<$!(L\)(Q,,1(\X\L<T,X\[$DAGAEB<^.6&6-S7Q2QN
M='(QR.8YS515^W'''+'WDJ_IE2'[O:RSUF3KY7-<YDB0R7P9$B1N:J*CGH,C
M%_G]CG^J*GXY9U_04_8L!=+? -MJW2!E 3A'I\XGZ/;B%12M09S6MA'BI'-(
M5$:R0FVN _NE5H<#&:3KW<5N3[2JZ#+=BZO*9[J_;FY#''9#.::QMC^M+_6G
M6+Q["LK["&:XIC](RHS1M@5BX\M.#/"''84M)01W=AO1S;\WL<O0ZS$$5-GF
MKZN&NJ:&<6 FG)"/B;/ @Z?&\BJ<Q'K$^*!%C&E8^&0%71K&E5BBK19&13_J
M.:)DD:V-$L)?T^=_KZ,8--))/5RM54](A9(AR%8J(HC%5&I]9G:@8AL4\T1%
M8BL<AU77QNM&I&C?DC,%(*DA5)554;-6B3N3_,>!$]RVED(+F"F>+41V8,LF
MCV1+W6^1K,N%&TS46Y<94M7"YI)?W39_NVV KON=&LWZN?\ I9)TT<-T.C %
MF<A#I--?0QH^19?C^$-48B_(L;U6MH8%3W.3U]I4L:.5JF/3T7I04Q>ID^\O
MYUDIF.]]?5#K*.&6J(J-,F:BLGE$]JK]HA"ME)1RENC&B?",FF3R'[@MH>W/
M(F:K[(R&G _H5.I:K)9P4XLS.XO4QV$"B'A9FI=$9:":"CL75WZO;&71Q=B^
MMJ\Y99X.X%DVI=5TH?7N)Q]#BS))<@VFI3,T-.R&(2>KM1H#FS0H@0K 1#S[
M&2.: 4<-E,65731@QU1#@A)!J8XW;R<T6)8PS<<.3[99E;/"5/H39"8'!^]6
MQ)\BNDE?[7)]RZ=K)5:JIR2><+_'_5%_V5%7GE9[JJ+//]Q=IU5Q&YED#V)K
MW$I)Z2)(I-Z;8#S>JJJ2Q%"%#$,=^YCXIF_E454YK)ZJZZQ?77G/WU%CJ2&H
MDU_C5U)M]6:I1]E:Z367G>?=+K"[N[:V+.LCB?AB'KZ^*8G[*FIP@:6F% J@
MAA(][GTXJBUL/(X>Q!25 *'$:DNYD:CDB^VL$!K H)E3U;[I[*>&6%CU3W_9
M2/8BK$[TWV7M-4:*EMZ"_JZZ\H[JL.J;FFN 1;.IMJNP&D%/K;.N.BG#/ -%
MEE'+#+AF&)@D?#/$^-[FKYOJ[+YGH3JGZS7;G0.6ZTZ@[CZW\[8<=U7V=F>L
M.O'WG65?J>D_"NI+ H(RJ!PX](]-7<DFYE%'K+)UI8?/$R:PE)67O(;RSWOB
M[!YP].7GE1?3=CX*J\+'^.)/9<O6T':.K'[6U,%!N;[-4U1B\Y7;$:PO4MZ.
M]/J\N75Y8>M>X[]':+.?)W)NV._2"Y]OH_(#7Z+,[[ZB7FUX?$]4V%'U]%U[
M5=(9C%^3Y&8#&_3LJ+LBMQDKSJBCL*G5S:Q)'TDAF8MJBR%<\YU\?1M[=[*V
M?66=P?>UL_$]A8WQA\3K/JKH6LM::PQ4/B]==/9L;KGNW/W,-16W.WU>\U%9
ML:'M$^:5E5U_H,Y6]?U=-" ,#L-WNTXXXY8>TD1Q69&;'[Y66-O9-5WI\<3:
M[*WC6SN]5]ZOA+-#=#\37R-E]LK43XU<GU$^.L-8](XWI*5(&U$]L?P>L]+2
M^K%5J^J+]DQ_L:B*[Y$8BM1OYA2RSN>S,EL#29/'TU"8VIM>Q9GYNL(ET#.P
M=@)E[5MB^5(D6"3.U5B><0U[T0@*M>3$0/&\,B9J'VYZ%HKF##5D$C:PN 0>
M 8.IL!V11#DQ0#,BA#K+<51B71MB9$&7.UZI'$3*L-\R11S,6.6-DL;O\3)&
MM>QW_!S7(K53_@J+RVB\R$]S%BL;2M$156>O%/5E:2GJCO9(.0R9(&(J>YS
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M(DCW^V1Y+"XI$C^)B-OBMO*\YU!;M14K]U2B2PLDC:L3BU!:>-$0GN?&R4D
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M:NGC,KC/B56K+%&3$UA0[9(_NPI"@W2-C(>O.I@Z:USV4J:6YE$E,KHYQF-
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MRJ_X_2;57T15_P!$]>:NNR_*[LJU[YV'4^&T-?U^%C$M:^OEERM1KK'::"F
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M?X(QA*311"/EF=Z),[0T90T XLCD:BQP2:B**56O7Y2F#0?&[UC6.=D_A/\
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M,7\/BFAD?%(Q?PYCE1?YYAS2>!O05%IAK^"OTAE<%:1W8>-LK^8S(PVD*(V
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#<__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>g801727.jpg
<DESCRIPTION>G801727.JPG
<TEXT>
begin 644 g801727.jpg
M_]C_X  02D9)1@ ! 0$!L &P  #__@!!1$E32S$S,3I;,35:0EDQ+C$U6D)9
M,3(R,#$N3U544%5473$V,#(R7S%?3$5'7T%235]&4$]?2U]02%0N15!3_]L
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M%KUC36;$?4U\.7(@VY[-]](KOJ,:;57<2M/02XL.*&M3.JM1THD43*..>KF
M;7(:;&FV<'93GJ( *F#)V";+*MQ=V :V,. ^=L;[*5*C(\9SR&%>KX;.U"71
MWZRZVSLJR;)4DP,ZD;'@AO%1"+)B7M(P1J>XLA(HS1I0*4EJ1GDHT> )@KDQ
M-MWS6W$-LL2HV[6D[JM[JR2(FP5?K&\Q0W6LRV-'*+ZVN];:HL6<9[&1X]1*
MER&"2W:FVK;VMA6]1-CV%98QQRH4V*1" D *G=A&.3_S:YKD:\;VN&1K",>Q
MNPSI&_7:ZZMZZ,.D^JJN([,^N\M\_P"TS>-]:V^*UBSM*UJ#1GNMZVFD(]RI
M'V058L*CUZ:H2K56%ZVY%X2JV,N? 7Q_H6X\N[I$U#5&UT[9;]UO;2;#:=JI
M=6I(L:OA2KO9-JW#=-MLH-345-77QIMQL.PW=BI&1PGD.6;,>*/(FO41PY9]
M-O._(?"\K;:O;[7BS8JRL;NFJI.@TUO-+KM!L\:\UDIB)9 AM^M!6GL_9&FF
M""/:#' +(;&C?==^@OUU[IUC=*=SJW+5U)V;E[IVV&MT/8=LL#>^XW33KFK?
M::!M-](<_P!DS8%B1+;6;JQ<)I+:7KC;>4\T^PF%?VQ<^<]:%TX<>DY*Y&79
M242[1I&E0(&G:E?[SM%UMG(VVU&C:904>KZS#GW-I8WFT7M75QA18SFC)*:4
M[A@8\C<?AKG6GYI!?&K= YHT!:&7 AO!S-Q#NO$<FW)81I4II-<C[K75Q=@C
MQ&1'LL3UC3C@%( 4E6.,SO'^7.J_A/@_98&I<A['8UEW9:S7[=$! UN^NPDI
M+/F'C/@F)(=+J8,J,,SN2.7-'IR1'D;)#$L9=P4;:NJL9,>9<\<Y\<]-O$6\
M\X<L6TVEX_X\J4MM@FUE);[+;O::?$J:ZMI-;H(D^]V*^NKB? IZ*AI8,RUN
M;6;$KZ^*>5(&-T\UG;->W#6=;W#7+6)9ZWMU%4;)KML B)%M:2^@Q+*IL(KB
M>*O!-A3HAPN[=U0XVJB/<C5VRV$%J/<Z7&1HG!:1RR HT;I'CZ&D<K^S''\V
M^E'JU3>3?7Y=T[YG_P#O[?\ WQE*W0K"WW6VEM*0,"MCUFE1G.>Y QWVXVW=
M].8C>Z/67-D:54R6O9V%"C3$$7_6S#;OJTD8-=63I\=8+9,E2RXLERN?55^N
MADN8 Z-<]"D;:#8:05'.::QG(1/80@N\@+-GN: ]C8!H1RG^,>O$ 4NS(UR_
M@UQ"(5OS%144@(T*0,"JHU(54\TU#ZSY1"':#;+=[#*4*VAJV)$85.RL: 4X
M4<T82(B]Y,6"I48]R>;U7Q3TRTVJ$TKX\:BH:OV><N;*O3S;2:]6(,?^LS(+
M(D)JKV:CGNF$:QK1QA#\OP@(DO1;S<G#:K5L9IFJ.;:S_IY*LQB7NVN<!9*B
M?L4KP16O*ZS1FM-&<'\/O2V+LJLLF)5WLH;)=B/4["8YH4;:5K+2O)(%^:%>
MA@OD%8KV*U!^N01G^TCE5JM1,\]89/:X^OUUI[7M>]RV!GRT]2*T2#)9@_=K
M7O0(VR@"$YSD1S/-S\PCR88F.51ROB#&\EMKMR)YRN@M*P9;&$DHAT>V!_OC
M?$/)AFCH1&M9(]#U\)HAUUK"'&5I63A#!"0SU.-\.4YT27!,]?,DB $IJ^PA
ML(\K@]I80N%&=Z\T&AHRBOYM!&1HJ;8*<.W5$96,$:'<1Y ZG>(9!M<YK5=:
M%JK8JL08UL+6S08_%KGNM[/FL_TF;@+=>2.E;B3F;5*V3<5/3[R1=6&_1H03
M'/4Z9R%K\?7R[6<8QO1M51[!5T4>WDN<QD"';+..B1(\DHOABG@<>%-CJ-A7
M%B2A-$]&JBD<%[6(]'IX=_9X^/EV1CNSU5%1%SE5UI\B:ARYU4<R\C\?6WU_
M3MMO-7ET%O\ "L*Y; %?QOH^OS")!M8L*P HK:GL(GA)B@>3X_N&CP$$4GUN
M?Z,GT[;=QWTW\S<_[/ E5=;U"[KK,/002V/$MMI/%D&^KDVN*-XT1]?<[3LV
MQ5]=*:1XYL6B^6%OI*(A>W#]1_A[<^=.G_5>/-&A[J:SG=3O2'<VMEQY9MI-
MRU74-7ZD^-=BW3=Z&[4C'TLW2M7KK39FVT=IY5<E8LN+%E'$,!*$YMZ;N0."
M-AZ,N3M%E]3'55KW _5=NO)W)-?M.^CY;YFB:AR1TP\L\%P2::'9IFK!M-9U
M[;]OUJVN-;BSEF5\2PN]DC F,B2VAX$OZ6>J.VT+B0EAP+O]5>CT[E$^PZ])
M+KUE8:O9;7^LWT_]0U?K]I.K;^952; '#M%L&[D-4S["K)14%B>%.D.;$!([
M6.L_C3G7GCE'I?XFXN>+2='U'>;;J6Y(Y<V+3A[OI\"_X6)6-X4XU-K+]DU8
MEY<[+R-M4?D0; 6\%*F%Q0LTTA22(D<_ [I_Z+^4X7.73/P/U'\4%Y=X9Z(]
MKZMX?%_*NQ:M6CXSVW3N0JWIYY)Z>+H.KRMCV  +7B^QL>1.*:"IL8LQNKS^
M*Z>YK"MDBJ+;(1T\_IQPA4W @^3NE6"Z2W]-KGC7^40;/KU1-'9]26S<E:)8
MZX/>HY+&5'V7DT5-:\@&T^^N&6DW5J^=>@UVYI1R5 3NVZ1J7<];Z4>F+7>1
MXES7\A4'3UPM2[Y V,[I6PPMSJ^-]:@[1$OI3I$QTFYC7@)P;0[I<IQIS#D6
M0=7>UW(1?V7_ #^W_7[94-.)LG6["X9/! /<;-M\H?S1/.AOD6TVMBQ7(-R2
M7R(Z5L D5\5A"#2*$# E"BHM+V'4)JM1RG&XQVZ!9:O>V,"JL*:?M0(U'J=K
M=3(-EL%I5TD^?/#:VK$=11)Q7I5!%YH6E8XMGVB)R"K[-Y'>VIA29T@_?Y=Q
M-AR#RC]U\O!C$=&AQ8['+V% ^I!^*U4:^(QS2*[;NAWTI5]I)2-54[,)9 K!
M=T3[N\:B*>8B=U7Q3ZFJ/7_>-:U.R^)ZJ[$,1H(J \T/=PEM'6\A!.<]$=X2
MR'DF]CAI^4E ,>KNR*/P3[Q6*/;3<AVY6Q*>&(NGZB&3+F5E(9SV#O-T<6+&
MF5UP[:IBB:9I$C708>N1FR&GI'%M)NQ@CS%-<\E<XSJARJYSF-%01!C&CW-<
M].Q#'([R<WNY?:U57L[[*G?/U]'+0*,%*CC<Q&^*QDM8"N[)V5OG&MG>H:_=
M?!@GL;V:B,7Q14C=J"\\!QFR:BSE>3B5T4]G'%8,.P?W^#*+$"1[_6CD.*0*
M0*5%<<$EW@57)DCCR8,[773QOD3*FGE08\2$Q%6?83EB(KHZD5J"AU4.,YDB
M3(>.*)TT;4(\S&M7T644];=Z-8R'#$25LE] GH%7%CA!L-+9R@QO,C$(KGVM
M74!;(:P+7F5S48QAO'+*S6W%/5;#4VE#>UL"YI+NOFU-Q46L./85EK5V,8L.
MPK;&!+&:+-@3HAC19<22(H),<I F&\;W-7YI^I[_ $9SIWY*VBTVWIOY9V3I
MU':E=*)QW.UP')''-;)*;R*/6!R;F@VS7*SP5R@IG7MS7P7*@*YD"O8&$#U=
M,G^C,]/?'&TU.V]1_+VS=0@JDXY@^.ZO6X_&W'=G( ='C#M"!N-AVS8:I[$1
M9-.&\HX<Q4],Y9D%YHA_I8H*"CU6CJ-9UFGK-?UW7ZV%34=%2P(M73T]36QQ
MQ*^LJZV"($.!7P8HA1HD.*$4>. ;!"&UC41-LJ(O[HB_=%^Z=_NB]T7_ )HO
MW1?Z+A41R=G(BI_9414^W[?9?[8\6_\ RM_Z)_?R_P#R1%_Y_?\ ?'9._?LG
M?MV[]OOV_?MW_?MW1%[8\6]_+LG?^_9._P#3^O[_ -$_Z)CQ:G;LB)V3LGV3
M[)_9/\O\OVS]1$1.R)V1/LB)^R)_;"_Y_P"2_P#3[Y4-'/DUVH:]$KR@9/E5
M;;8TV3%"YH9%\:98N00AK'CB9['6$R;+>UP8==!*8D<Y3!&[KEZI)_(K"7^J
M;Q&F\EMLC!Y0X3EOU>H ZCIJ>-;0]\UMQ:F=H-E M++3"6$&(!E]=VKXUB2V
M?)C2@1:L_/\ XAV3=]XXYUO<[J'*U^RO()94_46R!RI>O%%+D1Q1(DFYHZJ7
M,BRX0XUA'C;%75EY&#*$*<9TCS1+.A3+$[B"C6T.7("C'GK[2N)!LP,(GV60
ML8S$:WOW]9&5K@E[*C#/1/9GOF;"M6X;+2MFA4ST&.1$:R77N<O?LA)KG1QP
MU<J=FI.;&:YRHP9".5$R+BF6(-YO;4U0@:]VFZL)992:H!J("[W$A/.U89+X
MRB8<920+$C=?@C*R32G-9S[\091'LK&Z$KZZ,^KB*OC]0L@->8Z=D525\)I4
M0@7)]AS)9!B<O8HHTH/97QRUD".\<* DW9;&1YB$LB:0-*UX$\#E*&$Z)$.V
M*YS4D^@3FA>1H"R!F<(+J@YJV>3POQQ>[-7VNOQ=[L([:_7)=G60FU;+>8CH
MU=1U<#SKQFDRB/--BPC3JZ-9%K3/M)U?7CE3(VL-R'9:P/BUW(=-K=QL&]TD
MN+=626CX,?\ B&NI*[9(<*F^.MQ5R*XE<2VM9PH1B@J8U?+MF2Y=?'E366@:
M=%MZS7+>B'8L@"W?7XUO23&G?/H;0-N&%+$<)3%^&R.Z7[)J,.6O-&6-9USC
MQY33R+I1.R(G]D[8QC&,8QC&,CVVSPU>K;'92"N""!16TLI6(Y7C8"!((KF(
MQ%>KT[=VHW\O+MV^^0F'&;$KH%<4;!%;&@UKV*]KF"^$W7-9D1PJK51GFPED
M-CQM3N([FJ[^;^/'KG'IRT?EK>/X[W"YVFQ@QZK6==IM1H_II5LB6$PI@1ZX
M]ZV55UU7=DD.798SH F2Q5L2RD6<-M<O>7=.'&.G\':N>KT2SOY&@7TR!:UE
M9?%AJ+5:R161:ZE% '"B1?$0D@OK-EGV9+"ULKD3;FQLY"ED2'<H9E=#GM:D
MD*.>Q'((['/#*!Y=O)8\H+F2 .7LG=1$8KNR([NGVS4R(]]#CJR"^%>#:UZ?
M$N2OA2"L5O;U+918LH)/LGBGR*Q[B*[N:0GW>M:PJNZ9N5M.9I=/'DKI^L!%
M)=34+*]9$;8-J."M%L8)SKJ8.M9+))?7'@A@5#I8[.H"2;?6L<$]DM.@HR;+
M,&4QE5HZ*D;(0$TO=4]3E([YU@-B.8A5*L.O1%1TP*#S8UL-M7'DV-DZ,&2\
M7G(<-&LBUL".CG1ZZ*J-:C8D)GDYSD:WWR'F.K6^;!LJ[D*7HX]8OKGELVNU
M^@-K_KFW'W-\4=-3Z[$<^%2Q3+-<@X<ZQE33%<\?^N/DE/6Q/.06,)>D/]83
MJBVOCWAOA:UX?U*\U:OUCF_C;D#6-JOJF+1!<75:J^D4<&@U\4P=[&U*SURJ
MET]NL^MK06&O6,NM*/TSFN?;'#761O\ R1T[%Y<K2Z9QYL6P.U%E#Q.:HF7-
MU'L:+DW7*NEUPI[7;*JUNTF4FPQ(,"76TP9$K5ZB&D<?G#20_NKTC8DVW3]8
MV;L%K[VBJ[0S([7M .3+B"+*$%I"&>@A25*-B/*5R-8B.(]?R64XQC&,8QC&
M0'D]5?H]W"[L:RX^F:^5Y$[H,&QW-=02"HWR9Y$$"R(03?)/(K&-[_?LN')7
MP.I3_GW%!GC JN:Y'SMP1XY".:BL:C1)&1XO+\E8QJHJM5Z:@DPDRXXVK0C5
MH62(LNP"U?)RQ:O2;6<&1W>GL9'B6UK2@(Y'J]YY,=A$\"+W\=&;$AZ_$AD5
MIG:K?[%H-PPS7*I*]ES(!6DF,+W:Y9,,U':*Y5()D:Q,K'(PKD29 GRZ2Z;2
MRF//22(T=]58*I'F@&>9\9U=8/>JJ:,I/CL@S45Q!N..-.5RO!)))9@9A6L2
M),;$<GGYJZ*R3Y]V]F=D>0:,\'?E]E7R_P!E>R?=*U=!VF+OMU,@#KYWR-.U
M>,2?,UVNKGN<"\V\JQ@[+$FOM+-L)LCWCU^? %7U#YQ+"-92SW<V+#G5-6S(
MJR)EK,;/M):M80S C"&-$$KUCP8K&-1WJ&I'D*1ZJ0\@A".\6((8]/(.^[OX
MD)'M?305G'*!J*K;&?7K%&U\ER]D=!B2I2,")O<9Y\0ZF5R11L7C]U%:FG(F
MI[CJYHP9XI6G\B[2&ODHUP9LK2*&/4ZQ$(-_V.(>T7)K!PW^L+D<XBE]X(CF
M=4DSCN+U#<(;7HFYOO;BQ=#V#C_7J'8=E2[;JVMAU/:K3CMD$%6D. .U% MM
M2%$G'%+F-C+* DLC)YE-5'Z<0=DY#Z2>/N0['9@TT[5K^YT-&TFD:F[:!V''
M\&JM0M)N5S%N)Y(T:36M R.&L ^.;R,*2IW%>O?ITZL6!QA"U@LF7+DZ+LF[
MZ&>1/(TL^0S4]QNZNOES",&)KY$ZI%7SWD00D,V4PJ#&CT8V\\8QC&,8QC*X
MY+GL#5TU4BF63?[/2P8K8Y6B+[()W; Y5?W\AB<E.V.\C6N1'R1#>HVE4K/&
M^:D*2P+5&\@ZJ@AB8YKOYIAV<V8)S4:Y%7N2L1']W*K4(B]GN5$75:,CKG:M
MDME8]U?J?_L)42WH-4L)\8-:;;;$2]D>@VSXE?2L<[NY[ZB3^2HOK%LWUD5+
MGD&F,4+Q[)7U=R* TK E><M7)IY;QA:[S4CUHXIB2F#5SG/:CE<H.Z933NG5
MB+(>21*HQB;9!D(\;[.BLHHR.,5$5%0I(:,D(\:KXVM:82*U4<K9"SZ] %Z!
MACW+!JK02#3709:A3NHVR_*-*$8K&]F.DC<U9"M]I C>YR+746TV$?(%Y))I
M8P3#ZAJL()65JJZQ2/?;<1X6;\%'PIL6N9-66[79E? )1+-=8#E3S[)\*%9)
MTN"!-\F175<=!/<:2 ACG")/N]S"R&Q0 <P2._U@C2M&OY^OLW(]7V=3!KK/
M81#,.OC(RIJV+',CSQH"^ F1(SFLD/+/LCG_ .!KY'@(C^Z,]F8U97QC;#)@
MRXR'+&TBLASWF&3\6W]G;%FQ6F[*)WRG05?)8(SW_P F.XJ=E$Y>I_@C6K;6
MN7>6(FSBKP+70>'-FUNIB22R)-I21.0+[C#=[>8,\8!QRXECI=)&EI&:6'31
MR $&<X<E.W!C]-;CV_'QKUK<4#V[;*FKX9ZI-KKH$779U7"JK(ER"?1V)'7(
M:J;>*HJ]@9!04UC!&<)&HYAGG7MWL=*X(-*'D76ZMLY*UUSJN[1%M+"PM+%#
M[QI-,2];+GVLJ9/DF;M%%>>UYY!$;(<<8/&.P;&<M<8QC&,8QC*KMAK:\I:Z
M)"A>#6J*=,(#Q:][)U\?P"5[NR^IZ0*.0,8GJY3"F$(U!H'S<L90Y5XDEP7%
MBU;K+8Y+D=^7IHXI(%:(*(O\Q#RQ3I#FN1S4:]G=&O(-R9/#L!T#C#25*XI)
MEI00]BLR'&\1RV^SM78K8AF%_G-(ZQLY*.0ZJ=$1J&52(Y<AX[BYGV._;!7:
M])V.D'.L:VODU%K ;?1;C0W5M.")55L_XL0XI=U-VB0>4:VA+#^D2([HMB*V
MC*NR/R)K;(U?<7\AU"I$GZ[L)[&NLH=8T/U>+KXY@[,\=(20)FPV%9_#[Y!A
MELZVZ;-CL^.V206YT_:(K4BTB6E191(I'U,:3%M!RYX)-=()3RZ^P8A3J255
MW<*;0V"^U),.Q#'C3@L.?R7+DVD*KWR\,6&1YUTG6B/DAUZ4)SHD:\V[R&?;
M#3DJY08KS.*.B^)%F5CI+YRR;%EY'C0O,U_4%1DW;+.MU^,+YLF-K]G:0 24
M95P%MYDJX#\C^:>%5-^KDKQ*4-; 5LZ=['M1\:OR;W3VEA4TM<&TOR#AW6US
MXM/5RY33-6,S9@#C2I 8]7XVD"8.NJ9IK($"5)MD@LFLFL(T&YT&UO;KD+D>
MRL]=D:]6GHN-W:XDZ?&D6%G6D@;+,-83ZV,KTHI(K&9)K"5I2R"K]/24XZMD
ML 'I^ZM^,>8=CY&E/U?<M0BU[.3>5-#I=5BZ(&QY"^G[+31>6MDM$V&YFNUT
MM%05 7W38DQM2D1CC"$V?)G=B\7OT^]0F4O5KU>]-G(FP;V&/R+6Z?R96#U[
M9V:K"O[NSUJ='NF6;-/F/))4M:V7+KP1; -<@*24*3!1R,&/M^Z4Y.NZ=RQL
MW&.O!I*^'9\8T>[@@UTD1YJDA;).KK1E@XLR;;'-76UU9QA2;,SBK#)$A!1D
M> %N;'D']4+H4XNY/G<0[MU!:Q4[G46B45^,5=L=I0ZW>*]!+4;#M553S==J
M9XBN]<T,FQ1*U[2MLGQ%"9!\\X4V'90XMA7RHTZ!.C F0IL,XI429$E"8>-*
MBR0/(&1&D!(PP#A>\1A/80;W,<URY.,8QC&,93L0I ;QR#9M5[I$8L*LBB_E
M.89(>KZP:J$Q43N([[/:[%CO=W4C"B5&^MC5=[9*QZV'8R#%8&,"O:";-?XH
M-E<ZV#!*4Z.[JQC8=+8R3%3[(XY'JUKD1<S8M_+UKB&GO)$<TBTA:11.9"4*
M#/*O)%5!C0H*@:BM$63;2(\91-:[UJ16M:[Q1J^[5H M7@5<  $ALIXT.AOH
MK5]@RF\6.A; ,ZHUY629!"J8Y6L<H93T,UCJ]&YB;!4.K9=@ 97AH]B'&E!0
M8T5E/L5-+#/&4?\ 1H)\8+BC'XN0<FO4:?RS!&' D\=:KN\8S-FU&AES(=C=
MTEG\ZJCBE2*6SN*_9;")%LXX1V#(EA=P*/9QN!)$V585M?(F*^5']K-%*XFT
M^XY-V!;'5!RJJ9J0)ME,E!VQPKRQV2WWN+9T]A:R+TNO754"+9398M495#)K
M9[$5BTC8UK5!@V=+I-;UBOL[.JUVFBSE3Y:$AU<(,R=:"I8VO02FDC"R1)F)
M40H%,V48I)#:F("#[/B1QB9&X48KIT"-8#!"F6>OPEL!KXM?&H*8XU/%<9A'
M#:*45[D,-'-8)MI)5CU>)SUVM;/4^]/*L5(\>YT]IJUZL5LB3&H;P@CGEHYK
M/4-Z;#"+6@_F/2.4Y".&\GH9POY/I9D/J(/<6=Z?Z%)W+5 CHC1*=:^,SE#A
MO9^,R723UB-NV'2TU*)#?&=8)6+&/(<P'RCN(SIEVN+6T_ZF5+)V"J;)H.4^
MGGAOD*$.5)E5E>5*CZG'LG)*ASXA?A@CVEO"F#%)\43U"*T[Y/V[6M -QQ2=
M2O'FK\76VHU,NY@=0VHNBZ8RM>:#7V%/K/)-7>V8*L9XYY$.4:/7P?JTIDM&
M5KF"<81BM;\G>]=.?5!Q4O4-TP;EQ-S9?\B;SROQS<ZI U_1-DV35=[EZ]LV
MZR+?=H&P5T0]3+?=UEY6NK[ 9B#(*PL8UF:N?",Q?MNZ(.,-[X7Z1^GOBODV
M0DC?-'XOUJBV9J2TG) L8\9Q%I4F-<]DE*&.8%(A@O(!Z0.X"/#X/=RHQC&,
M8QC*DK_ISMSW?U(J%9LU2RS<]CD8^:[6^/Y@6M(Y>RJRMKXQ7C&G@Y@G*[NK
M")FIWA.^C;!'&A'R;X&HZH ;5\2'D[5;Q@E:C>R/5S7[#(D2&B:I1PAN>QGD
M/NLHW21'BGTZE;$<>,EH:[D!81R)'KM)JY%U&._R55<-ET#7XR$>1?"1)CO<
MTO96YM9#Q+:4T*2I9#KBDE0;,:>3A*%@6&CR9#T7Q$1YUF1@*J->9T@JM<GH
M5%U,I;&556=#9'%*5KG50+)C'QI,&T\6EI#V#4/(\H\[V07CG!5BM.]P9(40
MCB,E-#[9( VI504B=!B"M(?9KO1:PFJ"4GFU41'A(A8A6(WQ<@!.;X]G(Z.K
M%L"<BW)H(HT03].U:-+MB45K\I_Q[O;CB@QKD\SZ!9L8R44JU\:$RPHGG=+L
M#3P7E9'KUH(\,%C<VLJ8T 6/AU<*9+$9'R[![8+9I(T00P#.[W_'@Q1*91!>
M4I7-,96 ]:01W&WVS6/4T.)74]58D8[\6L@FF6#ZQWDQ45;$\R,Z:@W(OQ:]
MP#*C9(\_+>6H>2=,='1KVFJMOH9RN\E];RQJ+8 -&J?@A&I5L4B.5%04@?C^
MZ]N%_7!KMBDG^*H-K?5PX?&MAL!@5<MHJZSE\3;SK&V.C7,)\8K+!D?2=AY"
MFQ!OD15$:-YM4Z>3&=4G6Y'H]?ZI>@#;I42))U>ZXDY0XKD,E!$Z-,JM(V>N
MLX,.4$BO"Z--C>+BB(US?BNDJK6^MS6=CV@;EHEOU!=/]+HMG3S'1;J]FS/X
M:@.6G6$3@6?76BLLX%>R@136T6L0\:'8%,0@0&*-GXJ[M4[)_G]_[*J?M_;L
MOV_S[=N_]?WS]QC&,8QC&4<Z:^)N6^!0G\QMK'L_017"&L8W'U/#@E9X!&A_
M9)AV[$0CSN[Q2]B,:%@F;B4$-ILVGT[C"(*';7NWDCO1/*1&U>&'6:LR(U6J
MUH;6UA3&N5R^1XB=QN8_NST[C0U^U;;#@6M>V;'HZJDGUQ2HCDK[FTVV.2'8
MPF-5'-L8(=8++'(=W:!H6HO=A2M=ZY(=PIVN/620;7'J[S7:GX]U(; V(M?4
MTYV2"BMHP6UUM?;!>3H0T99 HJJ%'DSS$D]VA9D4Y(Y^U/1-=V(VV4MY5V59
MK=O93J6;&'7R9\BMUNNNU@:_=SEC:Q=+[[/Z:VZ'=AHHTZKN5+8L952E9D:;
MR7K^V)J\W6MKH*^]Y"UNMV8.JV%U3SY"V7TF'.M(CJBNLB'4[894=,G41R1P
MR8I9,@<IDH!7RR-!VP6Y;%8GL:D#/X<UKW_3]2V63,EMCS=F(V$"UFV(M>F(
M)3*H8E9%)<PGG<2[>Z-.IO56'+/-FK\9:5<[W?V\/;INN7$&"'2ZJ^TP-I!M
M&3HK)$&<6;;5E5 LE4\4=B2TF,%3Q)*A$\AI7>5M*'EF! K*^KT[6=IY%V*U
M9.N+J950AUE%&V!UG6#O:FXV.V?&K85Y";9E+&HH[9ME(KZ:6P(B2AL8:0/K
M=D[:GM-]?T3XU?MD:02NHH9$K"R[BZOM?%:ONK @K(1GTM_60IU6420PV->1
M@'/0PV"KWK!U*)M&A:V^6V:K(VV?1RK"M;2G\6[UK.PZ-"=*D5,N$>1#!?WM
M',/7R3.@6'Q6Q)L>2$J@?T!=>$]6<:=#FUF4[3Z#U$P=</92&IV?K?+>H1 1
M)XG(QO<(B0YSU>]K&GDQRO0;U57+VC<+[[7;)RIT>UU=7;&5X]#M)ME:DUZ9
M!U\$HFH;E7L"MM,CP8\^69]3* ,E.R;&=\9XRG\1M<WMNQC&,8QC&,H/:(WP
M.1W2G^11W</5FE];6HX(*QVTB.,KE:YY!G:]48(:M\U>J$5/%J.E^G0_D;)L
MER0;?]0@T6K1'N<CWHX<8FSW+T14<HGR+'8Q!D.$YC#MK8C"#]D-KU\:X_U3
MDS91M,!6T%=K() 1J3VHXD*YFP_E->BB<UZWDHH'"7NU8S?+LYOY3&Z8&)7F
M*-4C^VRKI)BHKD_F?.A->553NJ.]0FM^W9/Q1%[(JKE$;N#;+BFW\FI1QMVZ
MWU:1&UF58CK95=$NK5KJRM!(#< FTTIT1LU\.+%M*FQK6RED2K&&:$<S']46
MG<;4&O\ 4=I]?"T4OU$%L_C]=TXNF#U^^UWDVN=4[UMUK$'=0#4%S75&P7]C
ML#]7@ZS"T&U92R)]-,GU];:4#.WF37;9)V3<C,W65 @SM3KV13U&HV5?L<8-
ML6YC:\V#<[$6UT9EM1S6S)!WQ=6D6)W6 6;)5QXD>A0O3KHO'L.9RMO@=+X[
MC:CO-PX4#B^NW<S-RN'W/&$TD/:03[G9:C8]7N+\=)=;''@+R!3QP53P0*>@
MLK[8&3"UW<['@2++7J\\YL2MM&11G,VF5&08E]&B1KT5OKCBHY8L><(15DP'
MH^/)>B"D(1\8QS^6W!+.U3:HX&K]1+3S;H !.8P#MGTZ5&L O8QR-9Z[0X*N
M28355IX["N<Y'$>1WAS35TN]\'[P(\=MM4S]-D;%&BN IAV/TF,+:ZP3XQ6*
MI1RI%;$:\#V>3V/<-4:Y?M\N/ZE?)&A0.,XG%%)LFK[8W3-]X>WJJEZG>3''
MU_5QW#I5?5W,(-,6#4V]-K-I!K)<FON9X0]V%BQ0D,:"WMWZ2K,4[>^GRHA5
M&S+$UG0+2-%VJV'"JZZV@-C\M'>RMKGSIUO.BS)5_&."<44*.-M9V>B$*$9>
MW[&,8QC&,8RA=[")_+W'SWB)V;J>U/0["HP0C/VG0:ICSC5'>UXX5Y:-AJ]/
M6(L@JIV(]BI*]%E_ M]GU>6B,EML#['!(JHB3X%F=T2P>)?%OL?6WD.5&D,:
MKG1HTNJ]BJV2$A<75ALB\I\GM>X'MM(VD3 (PA7&]$&D/"(R0-S4$/Q*Y7@4
M;GO*QY%(C4$WO,ME&.<.'6$(]@7R&6D_P1J^5;3&#-,%SG*WUMER$BQ'.:YC
MU$4RM<B,?VC)'E#!F3G^*F!_#!)!?6UC6S"3B7$EK1JG9OK6PC%5J)V151J)
M^*-RC =.^GP^6-*Y0H[$^O2=9V[:G[/651; D7:-EV2I@QX4\YWV+ P20>TF
MJFQ6094.7!LCPPBKW*>0>]@K#G<D;#7#M(C94+6]%L9U:"5=ELUBI:[>ZN=+
MB3"/UN'!DRXY%'(I@,NYSHAX]V;X0*9$K#C3IUU;0]\V+:Y\Z=N%^;9MKW'6
MK:[)-^3J8-^ED?;4T1'6DH%@XQXL@YK"1'"@T.)E=!KE^4Z599@.@VTA[&*R
M*^U4WBJ^0P@CR8(Y16-3OX#6+L=HY&,[.&037(U1C8QGNBQ.YX8SM1XG2!U\
MX7Y*)2-KK/7YZ.=W1R)(#7U7K\7-[=_-&M0R^6ST-CETNEA2V,<L"$6DD#>O
MO&]*:3)IB-\GHKC"<R$K6N*BD()44O=[G9\[O7?HT/>.G;GSC2S*9UWP'IA*
M'4Z8$6570)476C;S.6U\@AC!V'8"5NJ:9Z)QY%BE/5L+&"V))M917SG]+C=%
M;R]H>O7<\TJ)NW$5OMVG3SV:.!)N0Z[H1Y53$K8[6 #/G4$^XV:R&T,:*.2&
M<8$9LDTE[OH>QC&,8QC&,I3<JSZGOH4/\EP$T616QVQU\U]EGLT*SE.:)RH-
M2M36(+V&1?8%C"/:BHBHN9;S"5NSZC?#8%03;B%2V16(QT@,?<J<PD@HU%1X
MFIL5-K,\WO<QJBDO40RF<WML[ PX&[V$WT(ST:_KEHKQ@1KI,<%EL=3=$*4;
M%(=\"#85YF"(O9K6#]:]O+PW<LK9C[60-J(TIH.LQSM5>Q/?*8R>]$=V:]HC
M2WA<YB.7RBE\7(Y'>.HNSD:V[4;%5L>=-M#!(J>)1TNOP&Q!(WQ\G#DV1(2M
M3\E5S'-3V-56IX/<L?6+CU,<2<8]=(A#&YK7FN3UM381W>3T<WLLU4*9R^2J
M)A%1%54:L5B28C=UA[='&R.VUWJYTN=-(,*%D02ZC7,A1R'$0IGL9L^MQXT
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MLG:A?":KA!MGZU<(QKE>M'M"QQN>C1^1#.CWE=1E&'UO9W<XI%&,3WYHP'4
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MB1IVP1YLM:/9H(Z2=*E61:+9=?+L (-G,F2)L@]1,@WNNS(\0YY1C$K; EH
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6^/5U1I<*, Q)LR8>S,8QC&,8QC/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>g654163.jpg
<DESCRIPTION>G654163.JPG
<TEXT>
begin 644 g654163.jpg
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MUT]?$4R.UFBFAMARZPV>O=MS_3Q](I/2KFNXK='LQ>@]2Z_T"RZ=T_3U5/\
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MGT_UA;NQR7II)ES]=7/MM]J,SDJ++Y0=,]E00SF%CCJ'6Q2V%H:*J3NFBL;
MQT:2@,_I@43FO9Y;+KJ'F7KY;<&.IZJYTI-AAW&Z*II]E3ZFX3+UE4-GK:DS
M^B"=-9UH]15LS>.I1(<_)01P"C,IKV"WFNIY4U%KC^W^LM9<L_H$.MY\!F=?
MJ*"2O1#@2ZR%V0S.$SU:6R8@84W,CV][+^V&,='8H2*6L9D%A'!1"*/ T/4+
M,O2[:JAP/:..Z785ATTY-A_3X]$"=#79BQ/L)K*V-+C%&O*;[_F_+;RR. (A
M<-),*N%GZ>KM%5\Z[;Q2I4_;18GN%+FEKJ.O-?;$4.(GNO\ 1%H5=&+79BJ#
MT]-<)32NO;8*886K@6",AT,0B^K/%6$=KC\I:0O22&SS5%80R-5522(RJ$(9
M(BJB+\.;(BHKD1?Y_E$5?+G\>1%T;@G'>M3CE]#Y]GM,<*S\4%F2-*);,A1/
MJT=;>LG"LGC,156,>4I\$2N<Z.-JJJK].<\*Y#R1Y,W.L!GLN68Q8BK$,:0B
MVG@56JHTEO83&6:BN<QCW#(6T=SVM>Z)7-14EGQX\>/'CQY8?2_L_&V8B)(Z
M*T(I*0M(D195 O;^JIK%8_F.5&O0 \E6O5BI&[X>JM1OV;^X!6JB3$.<LKI*
MLYKF+\_*EZ,\F)KD7^W^6S0ME<W^42/X:Y6M3YM8@F)+[& N26:.L9/;+#$U
M72SBY['2Q2S22(J-*E'.TU6R*![FN6:=LG\MB54QRP_2.H7N/S9>,RN'S.<%
MGM,\FBWEV9H+DJBFM)XJR4O(9<80$8ML#ZLXJ$G8J(O[N:/[CM63RY:O,60.
MNK[;H&H/W9]:)&W+'G#C4=%D9[!TX)3*/(U[I*\:6;\C:X?26AEYI@ R8:F2
MZ:(8OWE>:&61T21E3"-1_P RK%"--]VN^$^/^\0R?56)\JB,1/E5^KOE/X\T
MR7[3:7H?>(.L7&6AN#G:=E)1;6HFG/VQ]I 97YLFCO(\]:S@4F?KYQ[@.&K+
M#:7<BU@$3(F2$%#X;=:U!.WM/0KGNIO:P?,E>V&29=CW]\YMG/6X!Q5W5V]W
M73I^$;)"##SYC+H9.L"SNT]C&&Q+8(Y=D/N%I2=]T'DD6:MLZ-&=<W(60OG$
M!2&61JVH=8/;AW<<JM6OBO'3$T"?NX01H:8W3N)CFBAB7Y=FY9E^C[.KTV/L
M:VST86<ZSU7>6U%;@JNOH<!)A>;QTA\3&VM36$:LBQT-H5>%U;CF@RV#V?N'
M_BD9C1J,'G8.:.T-]5ER;0'H-SC]4V&W@L(PJFI*O*JAC@"!J:2L=:SPV=$?
M_47TX4Q)C2T(=,LR_EQW].FSU7N!T:C$MK[*9+L'),7TJBILV8)0E2Z/FW1,
MEC;\$^<88DH,NL$L3UEFJWB6*.8),\B/YF:NR+L&VVL GKGRA\>@ML)19NWI
M+[/5Y-L.=IC^=[+18*S8416V]!9V]G4Y_.!60==+="NF-/C*,^7%?9<G/2G1
M:6+I7=><PFE6?-LN;6V&6;-;65Z/EYK*>=8<V/8V19Q"$)7*BVX;BR&CV]>8
MZ*5\<GY)-CGCQX\>/'CQX\>1ITTL=0*"BDB85/H=/500BJ_ZJY*B5=!^=Z,5
M)D'B*JPHI)HOA()2AG3.2%SD7OW9CZV3]D&QTQ+1L^,.QK&O=.])[=S(T9\?
M7Y:X:*65J*URPJOXU1RM\MOGT+K2_P!5>-9(VKI3GXC.RR?PTR.F_9QZBRA^
M6?'X2;T1*EGXG_C>RA5RL:]SFIA/R[;X7(4>]YYL-AFZ<VF.(K?V=[>5X3Y2
MZVTT^-F ##F)_/.4D^&B/E''@6>::R9(R%['M59:'Z93W@,;Z7.;[;/JXU85
M-48/0I7&T1T4;G.)M="-G:S\L@J-(:YI,L+CZZ9T+W+\2)6+L;V1DS]Y)BL%
MCZ\ZM!GFI?\ M$U3K"[N9(&.DB";48]L].TTB%BP#%6FJ"A4QX_[Z-87D3QX
M$]'O3;6DMJNK 'Z+UGL+<KFLM87T=_'LZ!1+HQIQE5<A@U^7YY'A-!]1ILG0
M5 -IF-+/^34&W"JIR87>\7(K7">Q'H93'Z.ETA\=3V6]NXKM'#9:6KYKS^&9
MP\(RQ!. '<"5<4]#"/-$:R<D)P=F-<D(0Z=>1[G@=+OIMH%20A4MISS24]3S
MNPI;K<-K]@RW;GZ;/5]-8TLYTT)+QB;AG[V)\@E.<K2RHIX?VS<^^%Y[G^CZ
MST#+9;,S4%72^M61Y_>ROQ,F+6P*U^@U9!A<(\]752G?N!!(7.,F&:Z98HU^
MSV(WZ8;XK*2647L%2;>QHH;W25_&-]G@A)I VR4=[4:#-7F@CAMB'%R2U/3J
MPMUX=^1X]=."R.)( Y!VKKHGSA55U?U,WUJ;9_T_6=2Z7ZQVD]39DU0E6WH_
M*:&[R@W[N@EK[-#77(@UKH()CE4F98H7L2%LGY?0[Q?FG&>DXK:X6SRN9T^,
MHNC2:7.53W*9!11[O*9G:2CAE1$N- (@LKJU&)8TMDSWQO\ W#51S?G*G"<X
MPO,:9<_@<O4Y6G<0\J0.J'_$DY+VM8X@J:1TA!<_T8V-)B9I7MC:V-JHQ$;Y
M>WG'RB?_ '\K_P!$\?*+_P#?PO\ T7SGQX\>/'CQY%5A%/:=7J?G[?L,UG'R
M1.^OVC=:WQ)$A*?*HBQ$BU]&"UCV*K9!K<F.1S%:QDG!IC2+B2Q2/\D%1';Z
M*14^Z-F2M'6LJAT^4^S)7R03DK_:Q5B(8Q/R),GQU^=G5&-XEE[ZRG>-65^"
M$UUV5.U[9&N,JETUZ6^*9L4K7REEFS_AD8R1KWMA<U'I\>8;UG>C*F'1;T_A
ME8()TNYM"Z5<QL,W9=!L]EFAJBJK*BKS3**LMK8A(*VSO[BR>5_[*-<]K6'U
M1R6J7!0^]?,+J>,?7XCMN#U(%>P#69VYY/H[66&NNK:OS]1;/3*II(F5MI?6
MM2M(LKFFOKKQ"9Q8 VF3CR-B?:_D#WU]"_3GK$D1@L#2\=LA2Z]].<^@L1"W
MOJ9VRCU.F%+R<A#DB_';1" M>5).CVX[=]M>/6.EVNZQ^NM\9T2&EQMG+<TV
M(W\%>6?1D6Q6>/V9I><@KZ^VC(D6NS)^=,2^M1BSZ;05.FJ9!:UFH;V,W6XZ
MA[E^H:=;K[*[J<3@>OZ"U"Y9D2+[9TE*+#3$Z(FQI?VE,ZSUM&QX$QHT5-0A
MT4\M;<QU$R#LB-S%P1U8G::?9Y7AW7 ,_E<4-<ZBHTM)GN># 35@:G5]U%8;
M/2UX!6:NQ_Z8T<Z,@@NS.%LHX1Y"X)9H\]_5+;WO0>]^Q>AT.3J<G.F*X5#2
MB@Z>JU]F1FY7=)GKY=1:T<\]6#I6D(7%8YZ"29U/'&&CBRG$.<S _P!C^)=*
MUFZ8VAZH9$TC7=XQ-)SFDQV2 LZS!YO1&;J]N)]S>LMHS(*V*^S$Z#%5/]2=
M^^>!3?AC=*]->GM&$W+\6$37.+GL.<>PO&=9322Z(PBI*E"T4-+T@(FCAC&J
M7%V-)JJXUEXR*0PZM@M(&K!",C9?0!ZAZ?&Q]%ZAAL5-GDH%RF#W-/7YQ:]0
M:V&]*T2GUJLJUD$AGJ2#1Z^6.2=QGXV#I+%!"P=GFP'RS]_N*'FV+TV\TQ#A
MJ++5!5O8/C:CIY6#L_X(@K'.:V4T\ET((,+GL28LB&-7-1WRGG:[?[K=AZ(?
M;7]CO3>98FO68L:DH=$[)TM'5Q.5&D:#1Q$UD]A.R-R*;96EA#7,G5?VHH<7
MXF>=_A_NMV/F%M66;MG9]*Q1BCD&Y[27<VD$L:LG\<BF9R_(*+*!,>.JS5I0
MI\]04]T?[H4B"5TK/0_B]A1;_)Y[:9DO]]0Z:J#N*LE6_CD<*9$DC8YXOLY8
M"AW_ ''+'<JO'*BFA?\ W,7RY5<B+\+]O_-&N5/_ )JB*B?_ #7SGY^?_I_R
M7X_G_9?\+_\ +Y^/^?G/CQX\>0\(9(W8]!(;+^4L Z*MKV?=$2)TV4P;@1'M
M5GRC5L;N<C\GRK6J6OY'HU/AG;GF!#KK<@]T;*T8%)397HK7,K1; R"17K$C
MG2(P#.O<V)BOF=-,YL;E=(B)!/<KPVKX;SC!,25;[?18[,S"R3RO,D&K:@2U
MN(9)T<DLSC2@P*,AS96SSNN?B)[R'L8^T\&'*+T71D,''&I>7T>:XZ.H[D6(
MBV/%$TVHU</PUKHUD<3DZ8V5D<;I&,MH)U5E:Q%B/DX?^KNI]UZ\T=/Z%;:0
M7G>0-AED:E2'@"0"3BQ_EZ?$=Q/%'8$I CHX+*J;##]6O7[9%:4G'5.=;9]#
M'J1APKMU.\,RL_K95S//;CW-72TM> ,7:WED3<PU][1UM8,29^_%'*49LH\L
ML4)08"ZW72+F8?F>0Y[E:FM6UBEWP-OKM'>W>UCO1#[:7'C6K<."CPHRY2JL
MN]+LUE.#ET];"2)4@"X)^SV?DQ?Z@'J_+HMC<Z(VR]7?:(J F>>IYK7LM_W=
M ")$&F(ASLHM4V%K3[:(^YMB3QJQD+S_ ,,4 [)6#HN(Y[MF7GVMESN6@@YD
M%::Z8HH;?1,MZ V!M/F([85VEF*,9& ,6?'"2]Q'WL((F*I34=F5Z[WV=NO8
M?6VN=HGY<'3\0SK0*9<'<8W\H6-Z1K/_ &@9.?455?;VTT6Y$G,BK'$LIABP
M 2I7%K.C:5O*:LSW;=3I+"UMG?DU]]3 TTTXG^GZX;I? D-)LA 8J^$Z,ZSM
M^>DL.*?9DLG465L<4+W.7S2U^I?2A6F(ZB+/6#!PA<ASW5*:5'1QJ=MCA)M1
M7V!BR3*V$Z&BLO\ 3+D<R)YC1@!6,D?%'*_;+ZD] Q>EZSRDC#G"E@V_!=Y5
M&15=;(%4"OKM1@=B$O[J.O$JSK<ANK)'(@!FG(K@JD52&10F0_.UCS!G]1*.
MV?ZRZ%:U"/VT>HQ<EY^%51G]'2\B:_\ <_"HBCI8OK5>COEOW_$OQ\HGQY>^
MY9GE>TBYSD>DQ92XN+/<S6?)<5NS;-N*W/4LSD]#;4U1I,^$R</: U8"6&B9
MF;4&R:I-9%<TU:3?5-<L45^CD4M9RG<9(L.CK;C!^PG<<G?5.(E;)RBENX]1
M!H"J3B[5CAG"Y=41:$4.GICXH[2COX]156D4!@TL$7KH_3[CMV>K^*6T63]O
M):["2D21?GXIG::P0=(T_P#RQ*6A[F(OQ\HOV1/JJ>:DO=>C[AM_9/\ 4=DY
MMC-7M3.5^KOKW=X/: ^XW2_7=_KUI;3$=VMRM[B\?GRA,=L;<6>B!V!P6BN\
MG5WYN5K,WH;B"GLRCPIEP7MWU+4].IL/RC99A"O8BX],\GEN[=6S&G>5!2;7
MT8Z7['V^QL^4MWP>29TG9LP,55F,%GEQU/!9WEL;?D:6;-CCG_KIOOQ[9U6@
MT_/^<"\EZ'J.#>NY7:>A;OF^138<=ZIJ(>F=UY\-DWZ;5=EYU_V)8^F3AYU=
MU?5-*Z.1S?HMQ<9J>>:JP4QVMN7!>\WLS>76RZ/>V?#A^;YK]0OF?II#Q""E
M/?T]^;Z]'Q02*Y?T.KW%M1VG1>?V74C-##45&4ES&SYSFK:^8>-^]KSZ^7O2
M#VV[MV'K1V#[]/BLO>:?F>HZCF.>4_.=&$#_ $G,;O-YB:_XQ[!4.PZ!QCV0
MY(E1KLU+9Z:MN,KT"FO+VBFML/55U_)5Y[:SX\BX28>77:QGY(7(%=T\9#&/
M1TC)YJ/,VB(1"UKE;]!*M"(Y)%1?JK$;_EB^477A_O\ (6M1$2M<3HGX[*#S
MK]D<YUT>'-8Q(C4<Z1SA[6RG)^/ARPNF9^2-K?LR"NPVH-CW[$YZ-(2EPF%M
M=,'6,>T=)BY%(LI:^.69JB_E:[/XMWU_B<)IP=A$[ZPR?7'-W=<G@.,"PC72
MZ+K6QI=7!9YL4,^?1MZ;L+(XQE985*#OE"EK[HXNN!:5(UKQ*V".N>6V8"*:
M3,A60\,]?Z#*:(8LP\:,2H4"N&9/I;7I6L)4^JKQ!XWMALC+NV,C#E,5T$5?
M&,<58R_TP0@J&YJP</',BZ_U@E;WIEW&VGJ,YG@9KA<]92Q21+S_ )/1*C3[
M*ZECCE@O]$YD-C?,'FM;0NFS(D< E,7-]FZ'K[MEKK">,YY]'F23J'GA,UUN
MBV2/OU&KC=K?UQ>1SI<(K'2V\_.JR<N.66(<ZYF<-7GIJD[C4\VRGZA/K:*6
M5%LX+;AO=:6TJI-!HN^:N'06.BRU4+_6IWSZ@HC53UA5E:05M)6 "5@\#I((
MYGOD*7-BMVM=J?; TC+8/;&9ZAP24X.4K<W78F2U(H; <XDVS O3*-D=*)<3
MCR3#D,A)<;7@_O 9(7*QL]T?1-K8^VW'4M,,;D\Z=E>T<T),L]'07Q-GJ756
M'Z1&/!_03"8QV5-?F2AR?SO?]K$LT5%60/[+:_O%E5$T1^XAGNQY1N?Y3510
M 75H'5$LY7U&K&V$EC3#2I5V!#^;]/T(<=A8"$F #R+&%+"DCE36![_9B8&$
MTX\UEL'T'C]K(#%^Q_$M<R@S5EFJBH8R5Y:E0HM''9E3O?&](VR.8B)$BKEI
M^G-U /:4?I6@H=W.4'P335=K=V-':"4D(=;SSE]:;%67EE$* 805=94><G^E
MN.C5C)99IV(]WQL((]X>%#Z$NG0_2D4U?=CYZPWXF;-(P -L4LB0#DZ*-RL9
M'*L,ZQD_M_PS103E0+*)$^=,DMAE<YTK%WN2O8HK3-:^D)K3/P2QO;.#8C_\
M(L(A$EC;/$KH3:\MB/\ PD1#DQ*JL:J^=/V9_3=W*?U#&Z3DXOL#R\FS'.J2
M(<V/J&235\CB:H^TS<:36V?T-8Y5?':5K%BAG5TE9;1_G=!'5O6O].KH-BS/
M8X+FL?!>29[_ +NL4E +EHZZM<1(64#E,@QHY4UB=,021^_*%'!0P@BQ/,,+
M5\)/HDRF7I,3FJ+(YL*.NH<Y5AT]4%'_ "D 0,+8(6N>J(Z65R-_)/,_YDGG
M?)-(JOD<JX]=1])/4CMNW*Z/USUWY-T;:V-734=KH-?CZZ[-NJ7/*8M)3WC3
M&O%O*NK_ *B>T.OMQC1(8S2XFP_C(E:Z[]CZQ>O70 -;6;/C/-](%NIL85K(
M;3)U4ZW1G.@75N!.)E2!DT5ABP'N#RQX<@IE$.YT-;./&YS5M;6>E7J3N:/
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M-I0PK/O),V3JZG$8N[V5X1H,C0W4A&?R]@1+94PAQ$X@1V@J+)(S)H7%P3"
MEA20-AFC1',:]JM<KW>6 9ZX8-U@R\R]KM\>0*<1G<XF?V5J;5U@ELZ$'42U
MV>U*Z3/"?O\ \14),8M;"QPX#/QOB1\J/LG5\ MY<[T;+UG7=A!!L+;97U]*
M=F\18GS3W]:!4,@#-@I*V8)Y9D\,($K56,2 >5@D$"0K*ERG<$M705=U8=7V
M1-]E!;.JI4IL_@*$2.6]@HC;"9!US%K(A3H*H6!L[B'.;]"&LC12I4DP'[#R
M'&X'HQ'5SK+3Z#.U^SBZ;H:35'F:(+:1?]K>:Y#T,VY"^$K2:^GSA_\ 7?\
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MVK^K!+><2HFG$(L6>0CL?5WK1?L3T2*3UO(U'3=S[Q<=]A^;>]3+KGTXG*N
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MF8B95:[Y2<P&CK%E8V.7\QD3'N:B*_R</_/SHVE<+;UMA5',_(%9A%5YD?\
M8OY!38)!B&*CVO8OVBE>GP]CFK_^9KD^46P>?V$Q -5 ;,DME7U9F7MW.F2>
M5+?'V']-)66;Y^9)BVSJ<][D3\C)&2M1J.<U%T^="ZUE?' \J.[M7R12I*C'
MHVUJBY!W?1[?J\M)(/QRN^8VSRP/>GXU>U?CS(N.>3?01RMF;!O;0AKFNE7Z
M0W%;3W XTD<WPX<@6$UD$P[$_%&YJ*Q?[G(DI>/'D.]]Y2-VKDNRYW--$(7=
MUJ24I\S?M'7Z&MGBL:,R54CD>T9EB-#$<L3%F<!,4R/X>]//*)["<.Z0)=56
M8)U^PX?TGG&L_P!0"/%"#N:&]5:NQIB:/;9(\D*IZ-SNZ"LG&10"VM=-%8#5
M-]0WM=9@LD7\>LOK;I8+2ZQV-GN^I]/ZKO[CI&^T\]96T[KK5WPM14%6I%73
M,2GQN-SE#1T=)4A.((CJJ2IB0NTM[<DDHWUE\2Y@%QKEF-YP$0AO^FJI(3K!
M&?3^HVYA$UC<GM:J(]L15F65(/')]GPB_@A<Y5C^?+:ROK_G,GVONW;P[R^*
MON]YGDF7T504M<E-2B<@J]Q54I-'^W"BL/W-I#N["6V_J1AL*2A@J#&*U)VR
MZY=E^C!QC8\NBY(1USIH^;(]6^:^J=I:%YGCFHUX^+Y7675727.&TVOYY?'<
MKNM'%>$2= 'Y_P#T:IU10XEF@=7>,FMI\QK;TIP=T/LQS]5K)8MS[?\ ./<6
MXC=%G7P_ZRYR+RH,7'102U$D3\3>0\HK([F EL]RZ.YN(A;0=BA(+9G#O0:H
MXCO>*Z</N?7=AC_6_E_0N+\,Y;J(.>,RF(YSO9<,C*TJSH<94:W4V^3JN?9[
M+9B^O[TDF#+BH%80'V<QUR=L!\>/'CQY%_1B7M+QPT3'2K#;V]_-#\I]"8,_
ME+V:,;ZJOV?,^R-K91D:U?I/ V7_ #&WY^\,WTN:,)/R, GK@["65Z?*.F)J
MW4H,:O8Y&L*^T;OLC4<U45BM1JM^R6F.24%L<>0Y[_Q2&'4=A(OT^B-LJVUG
M<UL2,1S$ET-<!^W<U$_"R:9DC?J]SF3K_GQY$%G^>AVQ@X"(V32K5Z:MC>J-
M@EMJV0?.:<5%=]8XWV=,10+$QCF_<J,HZ1/F![WUP<@4ZR?)$]/DJ:&T&5S4
M2?\ "0E$PB)6.;\M_#. H\_RJN9*CHGHV2)42TZ2,G.=@T(\?Y'TVY _>N;\
M*D8.CH&MF<Y&HYK?M<55E,LDJL=(_P#HP\;WMCBA22;_ !X\>6EJ,%A]M%%#
ML<?F-7$.U[1F:.AJ[I!DD5%?^V6Q%(</]E1%=^%T?RJ(O^41?/WF,-B\5#*/
MCLEF<K 0C$(BSE%5TK"%B^WXU(2N%'6=S/L[ZK,KU:JJJ*BJJK=7CQX\>/'C
MQX\>1UKX_MI,?)^(1R1,U"NFF<G[N!'50Z?]S8O\/23X5A?RJ?2#Y=_E$\XE
M5L<%C]%7[U D1$2*C?NJ4%]8S.9&K6_;[?M5CA1Z_+%_<(JL5?R)Y9FZ=(/7
MVUY#&CY\G?4VEBB;$^3\D==I;/\ J35<Q5EA_/6(3'*0SY:/$LDKHUC:]JSM
M&]DK&21O9)&]K7QOC<U['L<B.8]CFJK7->U4<US55%:J*BJB^?OR-=R.Z>XQ
MGX#'#&):%M%:U[&+)(L(TG]RJUTGXVNAC;.L2*OX)96N1R.1%ZL2*80)>B#R
M*R*V2F*$B^&2BPVEE3V,A#T1?HJ5=JIL,Z(C4E'GFD8JOC8C[7ZD2M7<5%K&
MGUFI+:IU;96HOYI PR!:JX!:OU<QS"ZF0P*-9/AL!)[9U1',9(R>T_Q_M\?Q
M_P!/X\Y\>/'CQX\>/'CQX\>/'D8]%'6,O&VS6?*#WIM*5*]$=% 'J:"UJ6.=
M_'W:^6X2E%BD:JHUY/Q*GX7/<RKAL0DIR(J/;8@:66)')]46,PNJDCB<BN^C
MG-9(GW^6.7X551Z-5WVM^!1]#F[QIK',K+D >&:5KW1/4&S,/@.C?.C4^CHA
MW2*]4548DGY%D<BH];\S3OOG*!_Y%E^]+5/_ "N8L;I/L .OW6-418U>G]RL
M5$5JK\+_ (\K?D7]&G95'8;0RRMA&K=5"";)(Q%B:/>"3@0-EF7^T1DMHRMB
M_<O3Z-<](WN8R57)46O:(1HT2-/HPP0[Z)]6M5X9\4Y#(D3Y1%06<*55<C5_
M,0Y/\)\I0^F?A>+;1O:P=[\9?L@LW.^[1SDF&,KH'CO18I&S25Y,K?E/LY\*
M0?RDJ?%_YFR=<YR@MW,9&ZTI*FQ<R-RNC8IU>.4K&.=_<YC5E5K7+_*M1%7^
M5\KGCQY\IIX1V.DGECBC8GR^25[8XV)_N^1ZM8Q/Y3_WG)\_\O.8IHIF-DBD
M9)&]J.9(QR/C>U?\.8]JJQZ?^+'*G^_GT\>/'CQX\>/'CRT-Z#(?D;QD"-4H
M4-;0+Y;]E_?4\D=J']516N8YTX;&)(QS9(_O]V.1R)Y0\Q:C606=MA_Y%E;>
MO&>BHJR MAB? [^YGW8V6"&"1(GK'*SZL29OY&N:VQ+<U]1R?8(YTDQ4%")1
MK$QOU8PBPC=3QK$J.<BM8AC)B'Q_'_PY7,7^$<D]5PO[$ ()%:[]H(,+\M;]
M6K^VAC@^6M^5^K5_'\M;_P D5$_Y>=SRW]7GQM5F[O.E)$D5O6E!-DFA2=@\
M\L:_M#$B5S/N\(ML!<2(YJI+ QS7-<B.2)\?:'WE"#86<?[2V8 ZBTHI/PLH
MUR#*3EKI)%5L2?C::-16;26PL0F!KIH?QQ2-8SO:&4?0L-JRH'JVQ"!B69Z/
M_"Z-HT +IA)V?W*6"9>62R_^Y-"\2*5(OI_QO+PYHA#<'E8BH7P3#TPHGX99
MU)DCB$^XH['SN55E>@\,2.>J_+E3_E_A+Z\>8[>V7LAC?4;UUZQ[%;N*8R@Y
M?E2;M*@65L!NCO")H*K+Y8&9T<S8#=/I;"JHQRGPRPAN.4TABCCRJG\XSV-]
MS/<[]1/K7SM=/T'>6FEMIX\+PGF<>EGQU!%\3$CT6/YUG5F6XFK@(7N-T%N)
M:Z$V(8FUM;..+\C8+E]6_>KW2_3=Z\P.DNNA9\?.6]>/TCURZF[2#YB\KU>-
M8%TEGB].K9L5>6%80DU-JJ$6JM0OWPUBDME53R"&?T</7;NN(]F>(<P[WS@F
M4G&=3R-7K*5"6HPT!#6.BL*6SC:JLBM\_;0'T=O"QSF165<5&QSF-1?(9V7N
M;69_LO1.'8[@7L-V78<JS?/--N2^7T',I<_3B=0%U!N0#2PWO6,$2=8&C9"Z
M>3&#7D"@+$.PDQCR8FKD;7]2P1H;R)]7FZHH324&'NJBSTN:9:YOH.F"I#JC
MG=_")<&# ;HR+1T;1LQ^ZELCG6M;)6Q&CV($Y4)<$]Q>3>QEGFZKGXVQ@*U/
M!L'[%UJZ.A'J8FX#HFOVV)H("GQ6IZPZ-EQ@;QUC4M;+$($^O(:?.XIT,-1F
M]M^/#^TPOJ%*=>)U8OGZ[Z$MM.K\4CU0P^+#2Z9A3FP]%(RU;9;L?+2@MDEQ
M(!5ZTOZ,9 ^]+3V0]>J.SNJ6Z[OQJHN<W,2/H:FSZCA:^SH2 OZW^\@N0"[Z
M$NKF$_TUHOW,1T(\D'] NORM;_2C_P!O<>;Z_P GV-]'E<CT[GFIT\N6K=S%
MG<YMLS>7LF*N4@6GU\=/5VA5B_+VJ$C+6Z!HRU)R$0**9*DL:ND7QX\><.1'
M(J*GRBI\*B_"HJ?\T5%_A45/X5%_A47X7R$\##&"'?Y=T:Q$Y+:Z&IC:]_Y%
M;66-%+<TLWPWXC:R>G/!5(?L^1B,^9%1[U7S[7U8ZU%GJ%3Z!$Z^A:;$Y_XX
MIP*Z>F0R.)L7Q(B$$F1_9CD5KWL>LGVC<YKIG_\ O_KX\?Y\@.<.6AZ#I!I4
MF6IOV!W44K?LZ(=E[ ZCN(6HYOU^PUK5!VOPQ$_&18"K^5SC)$9=(PT7_LWZ
M.8GY"K%SE1BLCC).=9'S?VN^7J])R'#K^)%560HC6?#?CRO<Z,988K.F11RQ
M1SU[7-CG:C)6HD\[/A[45415^OS\?*_PJ>7KX\T4?^D6YO2WWZ:>O.H!R9Z_
M)];XYI]BX=?[!\J/I9JB4HI/E/L*->W5#)+_  J,7\<BI\,^S?(3^G]%229O
MWC@GRNOWFND]34?E\%SJ[GSF\VU$)VOF1G5,U1W-967&H!IBL+#*5T9V(KB=
ME+S8+4P5C8Q9K(@>,_=NA6DW7''K'T'/+?>L?&[X;DW4] ;JMSP>O*=J@ZKD
M1^AN*7/Z:PHJX *'989NOK(=;6XC;T%5</(0(,J?W _H$Y[5T'Z7_!GZA\[8
M+ZWZGILH*0Z3[B8^ZZ3HYJ5L<4B-="*8^,VU#:U/QS"V,142N80URR[+Z+5?
M2O=7V?[=V"BUC<7L,+ZO4?*K3&]RZASQUC8\YK>JIN(KW.<JW^/<6E;8:+.M
M!(UP=@TH<HR"K<@G]0B? 6M]7/9P/NG6<]G>24^DYIUG]3?U8]WE[ O0<945
MF>YSS3+>O-%N,N;C#BUVQ_1*>WXJ4370B54F<N,Y;CG#:8>[!3-DRAZ >JO;
M>#Z3FMCTW-UE,)G?0/@7![>0#3TMV\?IF&[%W#6Z>GBCK9YGD! T.USI8]W$
MUU:=,7,(-*Z<,AK8@O/1?V@L<WI/9\38WT?M1_ZXO_KH9S@I-ER#_1[I<F<S
MD&5XL3UQF1EU4(EWZ= R\O/GCW(^2$U6EL;!T,=6A4<_?7T"VY.PXGI#^1<^
M+)H_U>O8/VZZ1:D$8TBP-XSJ<[[+"<SU9Q$K'%WUN-:;/E[ALRKR+JBEB@*<
M/"M#))!\><>I._\ 63"^JG0ZGA^9BN/6WKGZBO8^FT>#.QM?H+;%]7IO96\Y
M[0U!H20QW9.U)M^1 /I(7S#TI8E$ZU&ABR4*!;%__6)V'_[NO6__ .51_P#^
M9YE/X\>/(%U,S\SU,&=R?2KZ#1#C/E1R(D&CQ,Y3XF*U?E5DN,[H"8?EK6JJ
M4;&?:21T$?G;LRFBUQUBYQ*L"V+)Y) _B:5T MMDS)88_AS8G0R@!S?G?(]O
MUA;,Y?E?LGDWI_/_ -?_ *+\>/'D3=*1 +'%7LCY%#6Z?E+.&-KG_8/6(/$$
M0C&JGS,+?5E0D<KE5!QR37M8KG?9MK3E2BUP\/YGO(0XZKB^L?VE8V$9D\$L
MOT170I_Q)IYB&M1S8V/5B*W^&RASR-L>%Q_U+E.23-4L_P"]G8L<Q?[JO@*_
M<2L<Y[DEF697R?9RN5ZJKOY5?+R\>6+T[FV,[%SO;\JZ)2#:3"]#R]UCM91E
M_9L-E0WX$U=8C)-&K9A9U@G<\4T9\90);(#!98R((I&^&KVB_P#1[O>+A?3B
MKGU/BF[KSF.QFL,5I,_NJ'GW7\E JJ@@.F#N;K)137(;)'"MTV*N9H+6"-QA
M-912D/!\N'U$_P#1YO<+MG3Q--[GI-Q;F*6,%OL7V.YI>@]DZ*B3,<735TM)
M=Z0>CDM8H7!6>NU%]+:5HLC9:BGLBT@F#]Q>/R.:P&4S>&QE*!G,CCZ*IS.8
MS]7%^"NI*"C!@K:BJ!A^7+&*  - -"U7.=](T5[G/5SEPJW_ 'WV1V_<.H<5
M]4<)QFQ3@M)BY>J;KNNLW='2F]#Z%02[+,\GR%/@,S=632@\/)G]3LMW;E/K
M<^+M<P#3Y;5FI=LJHWL?U(ZSEG0KW*>SG+M?Q2NR_K%Z^]ZWD];0Z7K,/(['
MJ._[)@=X!T_8\VJ;_$4V)Q5ASJB)J=DEA#)=T]S<7Y=77U^>NHZ?(NY]VN!4
M73C^7V%UKD)INB9WC^AW8W-=^;Q_-=;U@-989WFNAZZ+GI<!4ZVQAO*$5X1-
MV@M9=:"@S=P=7:*\JZHK'_HWZG7)@?7'M7=.09GH._(YQQ6'N>(K='S7H_/\
MUUG 6UNRBS^RPVPT&8%J='DS#GL+,*IR)[D&DF!NB*:&LMZ@LW92"7^^ $._
M;%!_NQ8"OVAT/X#1?SQ,E_;&#HYZPEP??\1,".>L4[)(T<]6_*ZO/6WW^VO?
M?=COOK-#S_)Q9GA]MU3/;*:AN[ZUW'+#,/ILC3<ON.H'*"G/) O9:DN=5L.:
MY_)W16HS-5B;8'6"R6HE_!G=IWPG_C_U7_\ OYSX\>/(3[TQT>)'M8WMBGH]
M)16 \Z+$TF"64B2L;*&LGQ_WAKK!KT:U?NK&/<Q%<U$\I&S#2MR>I$:YKW2P
MS%B#*W\ZE3!@.:1!&UL<KGNEK7"3K,YCVM>V1\RHUB,6> "XSPA#H?\ X1@T
M!<7\H[_ADQ,G9\.;_#O[9$_N3^%_RG\>=OQY&O7',;A3G/214_K6-:U8Y/Q/
M;(_:9]D;TD^C_JC'N:YZHW[+&CVM<Q7?9+5LEA$F)F1S6?#IFL6&-&1R0$B6
M@+AFHY'?A_.PF/ZRJGVC_:R?+5^6N21>?-1F#Q34BD@1N2S34AE=]Y84;2@H
MD4CU8S[/C^/H]WT9]G-5?JW_  EW^/'G"HB_PJ(J?[*GSX1$3^$1$3_9$^/.
M?,'=QZT=AJNV]*[9ZV]WQ_)[+M>3Q]'U7)](XX9U_,'Z_ UY^?R'5\K'4=6Y
M594&U%R!8.3OPK,W0YC44^9R*3U=<533$V,,;W]-RQWO'O8WE]S[$[#1W'L-
MZ5\W]2[CI>]H(];L67&(O^\Z2WZU?RLOZD70&::R[B2V#' QY^HS%=G0::G.
M2J<&)6VP=^E5D_\ M_U?6JF]Y0VAW'LC4^SETFIX&)N.P4VO@FR]SH<WC.FZ
M#H$N1J<U=;+*AZJD/M^27VLP,IMI7YF[:KZ2QS]M4OZ4MV'AO8[$$=YS^?$[
MWP*[X\;6\MX_8<\Y\7M;2_\ ]00]_P!KQ^+K-SS8CI;)F+6GC<GH..YVRKK/
M1P*)!$;1#Y?9_P Y9U]3-Z-U4C%EU\-]GQ\"?C*NVH);"B3G.+76G6X!^DTL
MP4Q'47[Q^=A9:?N@,FE $>XVP$GN;34[B_TA]#B]?ZD7]9[ 8P03TRTI!F",
MJO7M:7;=@QY^O-T4V4]FM/6=?&K.HEU$-O;W&;TE;F,N6)U\I.QV8EG:$WF?
MNMV?X6?^/_7SZ^/'CR&>E*NCOLG@Q8))7R2%[*Y+C1TC:RLS\$\59&^!&*PD
MBZNR8H Q99&MG@KK.7Z3,%E8G4+G2L#FD/<R-U13F7KI9!Y)I !HT)K#9(YV
M*_\ <SQI5 S.:GWFF&G-9(WX>R7R5,LUT>9SL;F+&^.BJ&.C5?LL;FUXZ*Q7
M?+OLK%_M5WV7Y5/GY7_*UWQY%74)5-3(91KFM33:D7]U]E>U%!ST$VB5J/8S
MY3\EE7U4,C6R,D6"656-D8V5$Z!+E2SJQ+$5$:18S#$%2_*"/C L11YW&,1$
MC@;/!!(T=BQ_BF9>"JYS$>]WGXXN?.'3V>"LH2!;3"6,U>*PQSW$G9,^<@W)
MVCG2-1TBK7N?4ER*KG+8U);GN^9&?,S^/'CQX\U*>WF#[%+[;^K>>QGN5[1<
MJQGLGN.IYC6XGGQW#H\]EZ_FWK=KMY42X-^OX=K[RK-L]1D0[*]EN[K0Q%_O
M[0<.&N'E%C$J%5[Y]$H.B]"YM)QB#1<VXE[;>OOHU8]BTO8X$Z'N^A=9K>%E
MKNI<!3<G$H8J^HH^P06NAE32T[[+1U\E;34HU78/L*BN7?OQU&W[S8>NW'O7
MC.[3<1=4]A^<!VNR[1-@,G$'P#E'KKTTC379M?S';7(<>L)[^'CJZHJ*.\(K
MK:K!LCB?Z+9V9F?Q3QWZHVIUOM[Q/)T=#<SA^X?IEZ@=#XQQ#4W5)09#G^]W
M?4_9A>XZ3:]7%SQT4)M!@.? U^>H15LK3JU[F:6BY_F!9[/2W-)OJ1?E$7_?
M^4_\O^7_ -/_ /J_Y\Y\>/'CQY#%:2XB_L-5]5%&76GAO)E_NC)JZ49^4%'A
ME<L:*(A8VAN6,B^[8R9OLY)4E:_SXW8;;/&7 YD9$%M<U6C$,%0AJI6L04T(
MIDA3($^S_P 984(K6,<LMF\)K%_ DRI)V4FF(R^<((C2(B>AIYIXD5JI'-+6
MBOE8BL56*C'N<U%8JM7X_M54^%\K_CRU];DZ[7U?]/-E+#('E<74W%;-^UMJ
M2R0><6*RK"?JYL1,<!,\+XY8Y12QIYPS()Q9YHGQ01_JVG-$R^I02^@M%O)Z
M^[KQ)(A] (M67)>TVA"-E(:!<Q"HRSJ6@E/ L8!2(X8165CAI>O<?O*<D+9T
MW_>KC/#L%+KYI/V8US0F0C,?6)9D*Y"@#I4'*H+6:9S:6[&JJZW<T.>RFCG*
MCNZW1U(%Y3E1F5MD.T@4B/Y3Y:JJR2*6-WP^ D>5L@Y8LS63BE13#3L9-$]B
M57QX\>/(IVW&L5O^@<>Z7H8;.33\.O=AHL)(':$! 0V6YP-[S>^=; 1(L-O
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%>/'G_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>g618561.jpg
<DESCRIPTION>G618561.JPG
<TEXT>
begin 644 g618561.jpg
M_]C_X  02D9)1@ ! 0$!KP&O  #__@!!1$E32S$S,3I;,35:0EDQ+C$U6D)9
M,3(R,#$N3U544%5473$V,#(R7S%?04-4251/54-(7TM?4$A/5$\N15!3_]L
M0P ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M_\  $0@!+@)] P$B  (1 0,1 ?_$ !\  0  !@,! 0             "!08'
M" D! P0*"__$ $<0  $# P0! @0$! 0% @4!"0$" P0%!A$ !Q(A,0@3%")!
M40D5,F$6(W&!%T)2D20SH;'P0V(*&#13P='A)7*2&F-S@O'_Q  4 0$
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M&"/JD<L_*3WD_7K(QT=![]-2L*/N*"7>\*Y9P?&#D93@]G/USG.==F,(1AS
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M=K!K\/RU7J9Z=[:NR;[GYEN+,F7>\2L_+3EN&FT-@C&2E,"%\3C/$KF+5V%
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MG-A;!;@;@4AQUKWDMBI4:N0^FVVW4)+B6):$J7E1 Y8^19"B =4K5?3A?Y:
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M5])7X,WXC]\>J"W:ALCOK.A57=FRZ9'JEOWLI*(L[<FUF1\//?J[#/",J[*
M!'74),9IM-8ISR:@XPU)CRUK#?;J!SI!/76#V<#H@^<'_MJ($* *2"#X(((/
M]".M0N$!"B2 !CL^!V//C_\ ;XT'@RD<2",E7C*<^!X^4G!^O6/Z9T!00C]
M&%8 "?V'G&?/9'],><Z@''+>"G/S9/RYQUQQ\Q)\]@).,ZC/M_RP2DGBH>$$
MY'$XZ4"?F[R>\YR.M!R@I'+M !6L#]./^8GQT,X(S_M^^NMSCU@I&.0\IS^M
M78'' _\ U[SG7(*/G_0!R..D8S[B3X*L=8^GU/GOJ%_C\H!2<\R.D#(]PD@#
MF>NCGSD^<=X#LRD!(^4_RQ]AD<U?^W( ) [\GH?74 X\D9+?DGOB".B%?L1Y
M!^F2<YZ&HTE&$_I[;..D^ M7@\_OG&21]CKH''D">!!! SP)\*QY7UDG)'[]
M_;0=HQ[9^9!^= &.( _5C.1GK[?7KP#J)K]9['D@8XY\#!&!]?L?ZX[U GC[
M:L%(PI!_2@=]_P#NP!]AX.,9U$T1[BO!SD Y&3\N1WGK([R/ P<8[T#D,) X
M_,01@I^Q^Z.\?0_0Y ^FN>2,X^0'F,]IR2/OE.1^P(']3UCCDGB@Y2/F2?\
M*/HHYP%$9\#)^^, :%2,=E) <'D(.>E$#/,$D8&,\>L@^1H("4@J!"<8R0"
M?TI^R2,GL?8GHXSJUEU/A*7<92M:3TC'$%7+'' 4,  =9&"#T .[G.XX.=C
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M+SZD)]QRD2'?EFLD]N,I69$97)IQ!P%JR'44E"1\@["ACB 4_*<#KL'SU_7
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M4=0XG)ZQDD=6MEPHKJ_G91R(Z6D<5 $84!@ 'EX4>^NOJ=!ZV#_+?0",*8?
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M!/>O7MP^9FWK/+YU-K<'9!S@DDY&1DD]DGQT1C5,5,+8FI<"N(&",Y!.%DD
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M--- TTTT#3330---- TTTT#3330---- TTTT#3330---- TTTT#3330----
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M!IIIH&FFF@:'P?Z?;/\ T^O]--0.!90H-GBLC"5===]GL$9QG'7G0?.?^,]
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M2XI;SZR25.K40>]3U*B'#@+/0).0,)Y# P6\?U(\^,]:["4^<J& ._E'U_\
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MM".S-C.!493A/(M*!PXT]G_TW "D_P#4/3>EK(N*8W5J=),"<6VO?"NVW%H
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MB(!40%+&.L5[HVYO3;>4Y3JQ DL.]B.Y,;$!YY*0>VG@I5(G(<3A:7(DE/+
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M6A1!RPX1DI[*0?&%*^0 Y([.1X)!UH)O]#E1KE90WD_%5>-&) R?;8Y.K.?
MP7$CZ_T!SH+IT_A,886M7RN-A15D']2 ?&!CSWCQD_3SWJMJ'(&4/)"G,X)
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MSU\I\> ,$$XSH+R@@@$=@C(/W!U"L921X_\ /WZ_WZ^^B$);0E"?TH2$CZG
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MNDL*L^KI9&5HA22<$?-AH]@'_*/H/)!([\ZW+[62&Y>VVW[S?:'+,M=P**<
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MF  &   / '0']M-!1%'V[M.A--LTZDQF$-@<$MMI0E/R@'"0,$=9&<D'ZD8
MJ]J+'8XAIEM'$83Q0D$=Y/>.1)(&22?VQKT::!IIIH&FFF@::::!J%?:3_;_
M +C[8_[ZBU"O])_\^O[]:"7!)' @)(23WA7?0[(YG./(Z/[G47$X0H)3TA1
M/(%0..Q\XP1]>N_.@R D^VH')'+I( P/J4CL@#Z@=^,#.@/2,M$D(/$\DXP
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M/WDQRPAZ;$D^V#@<U4-@9P<DG+8)Z/@Y\:^M3?% 7;+WR*2#$?(! R,A0.<
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MEK;+1;J-G0E)Q@I4Q29;P3Q)P$E,@*3WV%9 \$[PHR2(D; 4"&FAY  )0CR
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MLTT'D]A?)2@484",'D.L$ = ?<YUX9M'C5!'MRV6GFPE20VLJX@*QWTD'(
M'V&<:G.F@I^GV]!I>/@H[+/S*40G(3WTGY>.,H'@GO.3G.IJ&'.?++>, #SR
M'S G_+CQD#.<]9SKUZ:#REETI*<H[SY)R1RR,D)!\9S]\XZ\Z!EP #*/ !\_
MZU*Z^7/A76>\Y/[Z]6F@::::!IIIH&FFGC0--8(;B_B,^FS;2X;^IE6D;H5Z
MU=GJS*MW>W=VQ-F=R[ZV5V6KE-8C2Z[2]R]T;9MV?:]#EVE#F1I=^)ARJJWM
M[&=4]?+EO"/*$?.&GU.G5:!!JM*G1*G2ZG#BU"G5*G2&IU/GP)S#<F'-A38B
MWHTJ)+C.M2(TEAUQA]AQMYIQ;:TJ(>[34)6D><X'UXJQC[YQC'[YQJAK)W-L
M3<9^]H]D7+3[C>VYOJK[:7LBG"2K^'KZH,"D5.L6W-4]'92JH4Z%7J2]*^&+
M\=LS$->^7D/-MA7>FH>0SCO[?I5CO]\8_KWT?.K8[:[PV)NU1KLKUD5*54:;
M9.XFY6UEP/2:54:6N+>6TMV56R;WI[+%0CL.S(U.N&C3XL6I14N0*HRTB93W
MWXKS3B@NAIK&!/K!V*7Z8K<]7R;DJIV+NNV[)NNBW)_"EQBJ2*+N%7J);=KR
M';5_+_XBC.3*M<-+8?C2*>W(@MO.2)B&F&'EHR<"TGQR_44_I5C*5%)[QC (
M/><?7.-!'IJS-&W\VVJ]T4&R'JC6+=O&[+@W9M^T[7O"U;FM*MW2O92IQJ9?
MU:M^#7:5#75+4@JG4R?2;KCJ-!N:CU:E5>WIM2@5",\N\V@::::!IIIH&FFF
M@::::!IIIH&FFF@::::!IIIH&FFF@::::!IIIH&FFF@::::!IIIH&FFF@:::
M:!IIIH&FFF@::::!IIIH&K*?G^Y?_P P_P##'Y0]_A%_@U^??GOY*KV/\1OX
M]_+ORG^(?<X>]_"O_&_DWM<^'_'^YCY=7KU8[_$.[/\ YC?\*_R>+_!'^"O\
M?_G_ .75/XS^*?\ $#^&?RC\V]_\G^&_)O\ COR_X?\ ,O>_XKWOA/Y>@OCI
MIIH&FFF@::::!IIIH&FFF@::::"T>\=A7O?U HD3;W<Z;M5<U O"W[KBUUFA
MKN:EU2/1ERQ,MFY;<17K956;>K<>6IN;#%:AE+\>'*"EJCI0KT;@6UNQ6Z%0
MX6W>YUNV)7H3S:J[6ZYMH+[B5IA,!3+C,6C&]+6%'6NH%,X/"I5'@RDPO:5R
M^)3=3306LN*V]V)]@4BB6YN;;M W"BHI K%]3MM$UZBU5<5HIK"XUC&]*4*4
MFK/8=BH%SS_RI(]H*G9]P$6WNP-L%6ZK<VW5;IF.XVG<D;:!-OIDJJYE(D';
MC^-"%-HHY%*5'_C$<Y(_-/=3GX$73TT%KK2MS=6F616Z/=^Y=O75?4O\Y_([
MSINVPM:D482X*&:+\79HO.N"L?E$\.396;BIWYLTL0_^ "/B5=6V-M;M6]&K
M+>Z6Z%N;D29;L-5$D6_MD-N6Z.TTP^B:W+CB]KP_-U3'UL/M.>]3_A$,K9X2
M/>]QJZVF@LYMI:F]%OU&K/[G;N6ON+39,5END0*!M,G;Q^ERD25N/R9,\7]=
MQJC;T93<=$;X6"&7$&1[SG/V4PVC:F]5+O6JU>\-W;6NJQY*:N*19U,VD3:M
M6I:I4UIZCF3> O\ KIJ8I,%+L*4/X>@_FKKJ9F8/M?#KO+IH+,M6GO6G<M5P
M.[O6JYM@9SSR=ND[1I;KP@*IBX[,([B?X@+47FJH4U%4W^$1[L=)IWPS?+XL
M0W':6]L^_P"GUNV]X+5M_;UB11%U&Q9VT*:_6I\>&\E5=88OD[@THP5UED*:
MB/\ \,2OR91#H:J/'@;T::"S6XUJ;U5ZM4F7MKN[:VWU$BQ U5J/7=I$W_+J
MDP32\9<:KF_[3-+;,'$/X7\OG8='QGOG/PX]^Y]M;MW$S1D;5[H6YMJ]$7.-
M:=N';$;D(JZ'FXZ8"8K)O:S?RDP7427'E!RH?&ID(;XQO8YNW6TT%KKSMS=:
MK6A0Z796Y=O6A>4-=,-=NRJ[;"[J96D1X#C%41$M4WG;XHRJC4%-SHZQ7:C^
M7,H5!XS.?Q2>JH6UNT_MK"M^G[GVY W.98IR)NXK^V29U!F/L34NU)YK;S^-
M8J8:*A!"X;#/\72/R]U0F>Y+X_#FZVF@M52K:W:C;<5*@5;<^W*GN5(9JJ*;
MN%&VR33*%3WY+RETEY_;\7K.%012V"EF2R;LB?F:TE[W(7+VQ7M#B5B'0Z/#
MK]5C5NNQ*=3F*S68=+_)(E6J<=AE-0J,6C"=4_RJ/.DH=D,TT5&>(3;J8_QD
MD-^ZN<::#1+Z</4':OH9]-]]^D[?3;?=J^/498VYOJB?MK:^@[.;BWE.]7L'
M=;>G<K=&PKFVMN*!:E?LV[J9N91+\I-)O&H5RX6V=O*XS<<+<X4&!1GGW;!>
MJ&FT]ZJ>MM&\NUV^%L^K&I[4[7(_#4M7;AK=2Y$;?U]CTRV4FBVAZ5KLVRC1
MK(HMU65ZK/XRB[NUFF_PTFIVE&HE5O\ CC:ERG1F/I1"V%!;@<24M*6ETI=^
M1"F\^XES"^"5(Q\X7@I_S8U&.#@2M)"DJ 4E2590M*@"#\IXK!3C![!&,=:#
MYG*]L'N#4K0_$'W]OBU=QIWJJVW];'I7J&T=ZT.1N&F7:LFG[0>A6/NC.V-I
MT)]$"+8ER7/4MTH-ZIM2G.6U=U+15J3=3=0@4ER)"D-3V!M2Y=V=RMD'MN+Y
MHDR]?QO8MW[ZT>V*#N+9J+Q],^X/IRW0KUIS:_=5OQZ7"K>T%X7$*]!JIIU<
M=H0FSI] K7P,F>F&[]0#BVVD*6XM+: 05+6L(2"2$CYE* 2"2 !D DXP2>X^
M(R3WDX_S*QUD=#.!Y[P._)R0-!\Q>YUCKMG_ !LL^T[1WFA?B643UBVS"]($
MVCTS<YU=$],U$W9L"G[/M[=77%;=VOIGI0H?IHBU2E[Z4>LU5JT'[EC;@Q]Q
MX,W<.?2WI>WOT&6]6Z7MQZBH%:I%4H;]5]<7KMJE.;J],FTU<NB7!ZE-PIM#
MK,1J8Q'7*I%5ILJ/4*748X7#J%/=:EPWWF'$.*SXXC.>\_;DKB?ZISQ)_<C.
MH@,??R3V2?/]?I]AX'TT'S,4:_!6/PS]G_PSHMD;JH]:5O-[%;#7#L_)VEW+
MAJM^1M?OI93UT[J5B])EIQMOXFRJ+)M.=N)2MR_XJ<MNMV_+IE/I4V9<DUNC
MZK#>/8JX6;?]6OJ-H]L[K.>H:S/Q:-A3LW>,*;N1)N"U=HJGNOZ/[1ON!MS1
MV9;E/A;5W19%?W'3N/#HM)7:%TPWZ]4+N3/%%;D4OZ->(SGO/VY*X_\ \N>/
M].NOIJ%*VUJ<0AQ*E-+"74I<!4VLI2L)6$J*D$H4E02KCE*@<%*LD/G9V]LB
M)!]7GI;W'WEL.Z)35.]=/XN%CV;>=SV;>59:H-:O3?EBL[ 4\5=5,FHM^@5N
M%1:_,VVJ=3<A6A\-'<_))S3<B*E[Z*AC QXQU_37'$=?JZ/+]2AW^^#V/_:<
MI_;7.@::::!IIIH&FFF@::::!IIIH&FFF@::::!IIIH&FFF@::::!IIIH&FF
MF@::::!IIIH&FFF@::::!IIIH&FFF@::::!IIIH&K)UW<R\:%O=:.W)VINZK
MV%=UH5&HC=>A1TU*W[:N^G5;VS;5W,I=:<H<.=0@:C3JTM,AF5.__=8;;=*5
M+O9K@@$@D D>"0,C^A^F@L?=.]JK8W!IM@C:3>ZX4U%Z@L_QI:^WYJ]@0?SV
M0(Y=J-R_G$816:/GWZZY\"Y^71_YO%[''46Z&]2MLJM2J2G:;>O<'\T@KG?F
M6V-@&[J33N$SX3X.JS16*=\'.7_]2B/[3O*)_/YC].KVE*2>12DJZ[(&>O'>
M,]?30I2K]24J_J ?^XT%I-U=VE;71*)*3MINUN)^=.3FS&VMLHWA*I/P3##_
M #K3(JE-^ ;E^_[,%?)[XA]E]O"/;Y*]%[;I*LNR*+>HV[W2NLUERD(-IV79
MYKUZTK\W@N3N=9H J4,P$4PM_"5=7QCWP4Y;<?#O/F+J%*5?J2%8\9 ./]]"
ME) !2"!X! ('TZ!Z\:"TLO=A43:V-N?_ (:[L2528T.3_A[$LLO;GQ_C*BFG
M^Q)M'\S26I,4*^-F-?F2O8IX5*Y+Q[9XHF[*JUMI5=R#MKNS2E4MFLO?P'6K
M+,#<BH_D[BF_:I=J_FCQF/53CSH[?Y@W\<V4JRUG&KM\4XX\1Q_TX&/OX\>>
M].*0.(2 G[8&/]O&@M+MYNNK<&W:_<"MMMV+)-"D/QQ1-P;,-LW#6?8IS=1]
M^@TPU.?^8QWN?P+#OOL>Y44.1>(X^X?%M3O(K=-^L,*VKWEVZ_*(].D![=.Q
M#9S%3_,')+?L4APU:I?'2(/PW.HM<6OA6Y$97)SW<)O.$I2"$I !\@  '^N-
M<!*4_I2E.?. !G_8:"RFW^]*K]NRLVJ=I]ZK,%'8J+PN._K!-MVK5/R^I-T[
MVJ/635YWQST[G\?3V_AFOB::A<KDWQ]L\T;>A58W-G;:G:?>FEIA2ZQ$_CZL
M6$8.VDO\HCJD?$PKL_-W1(B5/C[%(>_+D?&R%):XM9Y"]02E)R$I!/D@ '_<
M#3BD'D$I"OO@9_WQG061J6]:J=N@QMG_ (2[V3DOU"F4_P#Q IU@&5MDS^90
M&9YFOW;^<-ANGP/=^#J4G\N5\)/;=C>VYPYEN#O8JP;LI-JC:3>V]!58U-DF
MX[!V_-RVK3?S*I/4[V*K616(/P4F![/QU2:^&=^%ISK,KDY[GMIO=Q3GEQ3R
M_P!6!GKQWC.A2E1R4I)'@D G_<C06;W6WB5M:]16D[6[Q;B_G+-1=+FUEBF\
M&J5^7KBH]JLK%6IOP#LWXKE3T8>^)1'E*RW[.%>O<;=A6WE H->3MKNQ?)KK
M[;!HVW=F&Z*]1_<IZI_O5VFBJ0#3F$<?@G'/?>XSU)C8.>>KLE*5?J2E6/&0
M#C_<:Y*4J&%)! \ @$#_ 'T%IKEW75;FW=&W!&VV[%>56&Z*LV1;=F&J[A4O
M\Y9+W"LVS^:1S!<I6/:K*?CW?@'B$9=SG1O=93FU2MTO\-]UT*3%=E?X=.68
M4[IJ]JKJI/PZ;/\ S,DRG /S-IG\R'.DD3>0S[6KLE*2.)2DI'@$# _MXTXI
MQQXCC_IP,??QX\]Z"U%G;JJN^Q*]?)VXW6M@T(UD"S[PLTT.^:S^3TYJH T&
MWC4Y7YB*K[OP-&/QK/QU0;=C?R>'N'JVKW95NC%KDI6VF[6W?Y([!:$?=&RS
M9\JK?&L/O^Y1&35*E^8-1/8]F:ODS\.^\PWA?N<DW<"4@8"0!]@ !WYZ'6@2
ME/Z4A.?. !G_ &T%E-KMZ%;G5*L4U6U&]&WOY1$8E"?N?81M&FU/WY3D;X:D
M2C5ZE\;*:X?$/L^VU[<9:'>2N7$==G[V*NZ^ZI8QVEWMMD4PUH?QA=U@&B6+
M4/R:6B(#3+A-8E?%BJ\_B:,1";^/B)6]_)QQ-[@E*?TI2G/G  S_ +#0)2#D
M)2#]P #WY[ SH+)M;U*=W15MC_A-O6VE,]Z!_B"[8)1MB?9I:ZG\:F[OS@@P
M'>'Y>S)_+OGJ:D1. S[@AN;>Q5M[B4[;X;2;VUY-1D4&/_&]M;?FJ[>P?SUY
M+)?J-S?G$<18]'S[M==^ <_+F05\7L8-[N*<\N*>7^K S_OC.A2DGD4I*NNR
M!GKQWC/7TT%D]S-ZE;;5RD41.TV]5_"K0A,-7VUL$W71*9F<8/PM7J J]/\
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2YH&FFF@::::!IIIH&FFF@__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>g122410.jpg
<DESCRIPTION>G122410.JPG
<TEXT>
begin 644 g122410.jpg
M_]C_X  02D9)1@ ! 0$!A0&%  #__@!#1$E32S$S,3I;,35:0EDQ+C$U6D)9
M,3(R,#$N3U544%5473$V,#(R7S%?24U004-47TA%3%1(7TM?1DQ/5RY%4%/_
MVP!#  $! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  +" !I FL! 1$ _\0 '@   04
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M?EY9\_+_ "YVX<.'#SQY^7GCS\O/R_Q\O\_+_+ASCSQZO7CU_1Z_I]7GZO\
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MRMIR)G/Z3'7W]HN_XW_-6-?HQ^K'[N40[C=U\]394"C/DWR=_'>.(G_N^"K
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MV$=&Q[-)%FP8,6B*+5DR:(HMFK9))NW2323TTU]VO]K3_7I_'CF7I9^51/\
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MI@1##@2#HA!?):,Q3Y1]%HR"3]/$?,2+%75-#9PEGW7??7577;.4O3SKG7E
M#GH[VAK81(#LTK32&%1:.4EIR3^-X2^RS8(J))*+:LH\A=/G6==UD\>XM&ZR
MV<9SMA/.NNV<6#\/?IEO>!,E:EC1F<U$(26=6,8[3VPG891'JXS\&XTSY86%
MH)QIC<@5SG*4H^T2']-5T,3.$/T@IIIHIZ))::IIIZ:Z)IZ:ZZ::::8QKIII
MIKC&NFFNN,:ZZZXQKKKC&NN,8QC&*/\ ?K\T0S_R/#?@9)Q T_NT_P#;3_@U
MYVY6CM[24QV%H0EK$=P&;$3@MIPW@4K";NE@]Y)5'=E=6WB'G%F$,12,:S)&
M00]%E9>/@Y=S&ISBCC:-?M<.F:]7>M_3.RZIN.O"0J;4M'B]',^V[:#L@!7F
M'%T=E'/:NSD3OW]?*,@"#S8?UK]HAH[DF:)I9&#.QFL.3Q#H5A(K,4YC.[/#
MG.)YN-%=8.:ZV-XGLQW2NPO&7$ZG6L):4=VN<$<8-S!6?.*4NI=8ZJ43D(\=
M][3%:D;"5#I@[#A8@%E'T5,K1YMX7=L-JXLKKS%2/6_ -98FBHT[,3\4>$?9
M6HIQATY@NK,+7571SB)9;:!< [AWSD=/)FU-GL739<;5XXK)X83FA<W<X)X8
MQ*2095&7;N#P$=92-BCQV-AIU)6,JV@YSJ:_ZZ!9,/$.:7HZ 1*QTB>,2N&;
M-@"'5'1<3"(Z3*#$HAMGJ'VD_#1M([! %*X#FH+"M0C*VEF]K"!U D.P=;%B
MO^XW4J_"32#@I6&D7"P<WJ3K&QJP<B"9-'&KA >1>M&\,M*.6=;NU73P^K6=
M[*, NIPRZ=^VL9V-@ZF#U*.LPR$Z71M.^!>S81*O)D'KF?":YMF9?.Y"9-V9
MQ*5'7>J(B+6:WMB75$)T77TM[Q]/R+M"0C<L,NJU3294+W1H2?V.FTEN[S&=
MH08('X:<@WT2.3BKUM!RH0JSGX9VK$)NQXNEG\8\6?-U8>6J9V&\,JR2NZ3V
MV:<D*K8"! 2D>@]0NTQBHP9E V!U5I?KX2E#]S&49;PZR)(N3J15.0@H>OUE
MSJKRZ;AVQR%E*:6[W7.J ?2L*KK*M$WNTDG7-= P"G(;*O5LODPP6B1I-UJK
M)+.9)1)72,QLWVDG+J1RW]R^$'3EY[NNH_\ G.O]K3_7I_'CF7I9^51/]8YW
M\5=\MCUG_),A^LV/PAERR&<XQC.<YQC&NNV^V<YQC&NFFN=]]]LY\L:Z:::[
M;[[[9QKIIKMOOG&NN<X@:]Z-9WM&5;NA8AC69'5ELCMT5J:@2(9*O$SB$#SL
M6AT7D.;CY0,%XS(0AT0*28VHQQF>;(::H2#1!-=QBHD1X5M!0UF!]EQ$\1+$
M\8_!R.U%YP"H<U(+M,Q2Q2BV(LYGBTJJN8+JGGC,S*R;)QM1[T CCD3V8"C9
MI%(#L?*H_25\+7KR2AL ,/3.V73 :IOL'28;/QQ"'M9:!%[VLJ6LQF0QLG%A
MZ3-Z?4043I<E2)H[0<OQQ(J)LDNA/)O-W::]GPTNO"%VP=RQ65(MFR0JW8BK
M[<#IJ?C"Z5IBNHFJ0AYM8Q/7DQ<(-$+A(Z+,#D0KDX&(,U?BT),+_ [U0A^,
M3:ISPONOU#2 $]A3 CV:5C8]+%=6,=Q*A -6%9TO,$3\"!R4F!*O%2RX7<JN
M1HPY :6).3=A$\4-BS!&0;2C:9EB"P&.L<*/50\JNL;PLVH9J#O$Q[+15D"T
MH"2)@)&MAVL>W%+-YL>)1U^%D=9O)8S*H;(B;#KB*EAEFVV<R2\S!:SB%7W?
MA/4HN[J*2'+>L^%S4,%1>1&15'J&.YW)+0UR2E^B!W#F1I5D]-!29B?D,O+6
MH)UFY$PJRVRT,@_9M(V#;,GDBDWAM4Y-@%4@\?8%KBSNC@DW$:L,HQ\$OR$9
MEB_L=6/::+.7+*<#WPY/D05:=2".1^,E8G86DA?,Q!$D+*;R"<BTBFS_  BJ
M?M@<<CY?>-S23N<^7UZ9$\N-=?24AG"7L/9FMQ&)H-:D=0/H"HRYB>ZX^#9Z
MK8(=DW +A&O'[W>*:,I)M)W8#IBE;5<5W0\)*:3HXOVU>]@;NL2<-X\=/AN'
M+B@NL.VQX8%Q0.583V+XB; -J<D1-TN%PT)6=@2\NX?S2+-DP<Z,Y4TSG??&
M$4L9WVS[FCC71%+TLYSA)+3'EJFDEC_X))XQC":>NNFN,:ZXQSGD-''YX.NO
M_(<;^/C?-9>'#/KQG'^?(5JVB0JJB*T#&'0R]+K:-Y@R*2%XBCA]LF^=;K18
MZTVTQGW"$@T=\ZMF^NV/?3Y9Y)N<9<NO12FKB7-_]'E?V:__ )-?F2_6[\W&
MWUBE/Y6,Y/VFV=-]-\>6<Z;Z[XQGZ,YTVQMCS\O+/EYX]?EG&?+_ !QRB3WP
M^J:?0UX0:Y'8WO._!L3%S'.),=RI'L [LU;':N.6'_2&\IMW;FP+C*(1_O(:
M2":H8SAH]!)O+(O9E[%2?A<@38U*[0CKVMV(M>2,04]";-B!*C(XM#R^N;3D
M;5%BTX5;5KI&=ESEHYE'@,H?=@8XM*E:X7=P.K].8E)DED7NS\.6IF%)GM)-
M+'ME9E8%<QM>39?,.@.9(U4HSL=:?:+,[)1.P6R#"!6<LFWBN,,!:7'-@DKK
M[=,(?P*#%Y*.7B75'AJ5%56AEAI8UBSS<U$NU0:K'YA*>!QX>8=R(NIFER;B
M0S6E;B0_"Z)2U0PDZ Q"+!2&#=Y25AM64M&I,<I)ZWA@5<Y C"E7ET]@E.NQ
MA!265*#0FP-B$L[$FV0C[]MMQ*)@>Y,7RK8J"8>S1D -I$@J49LMU.D;0.>,
MI)K"14DB_1BEF'6^ZNK)1+Y-1>\\3+FUGT,(4Y3SWW4C81+"'<#0)2P*(@((
MV'<"L3(B2>1:4P[F8Q[)33HC3=OV>&A ^'#4,/7TL'31P2/G$RYME_/E(P"4
M+2C=76UZ<S2LKJR"*AK 0KR ;CH;[O+Q+A.%<O')>^EB(@?R+%]K"LHC@^BE
MA$]MSL88$*HSU:C&G:E6NQ83M@7,6F^G:"R@JSOA$''<4:,% =EM)PQ!,$&]
MDV7;,?$JD.XI5?N@B[^'(^:HGP\*\0PBPG[9MPV$QPALLKJP3G]*T0:5*0W+
M?,=V L^0&YV" XLB(=9\@B6@;#-C60G=0RNG4[!0BF\E.KS;5U-.BU:0D\$&
M(^56*S**ULNM;;$W&)$1405)JK+>S1?%0\DE)!TBTW@2GYUMGBI'OAK\(LH7
M Q)P+R,GH->0DO=T8ZTO>LE/3<"0LHN+-;%M _M4G'8(I>' Y7C FFUD:[I@
M0,9$?%7Q$$TK6[$9 1F06'(1%75A)KQ\:UCW+?7:YO(F<_I,=??VB[_C?\U8
MU^C'ZL?NYSQ&(XC:?'YR#U>*Q^TS#RD5J_0UQNLRVD6+AEAVEIG=/&ZK;*^%
MT],[Z8VW3UQG?7&?2PQ:7I\-HFN!JLP5CAI"#S+1-5RKC7:1FY5333:4()EQ
MC&-G<M+NM=G3M7/DFGC*;1HF@Q:M6Z4I\K+W$_1UL'_2-_\ MD%RMP'^0X=]
M6(/\.;\\=G&&]>5G95@IL-)52OZXL ]3BE'&S1.4W" V<*](Q1UIHINU3D=H
M?#'=UHFINVT<97U34V3QIME7.>)!?E5HR);>'7:HH^MA2=HZ$,'547$<F)TJ
MX[!];"7L:*-@Z%)*W&HB1<AD>.8%S!S,O6#4E=2[>5$T8S6.<QCM<U[Y=F&1
M?55,RM']>WEV7D0]57@)L-W#9+VI1BNNUXCV$)(1>P9]U7VA.N>UTK0$MLZC
MQJ/T'[<'9=O/!2XHF@YU:P6)]\>X=Q'C+ E!4\,,7,[T1&V-?ZDI-K%8L \[
MD=L.M5\LYD_7 7,^[JPIQU_E)>-T0B-C!L,Q8BSB&$85$)>[9RX-^)79\H85
MQ%3].5R+!2)XM4]YV)N26X4!T!9.G::S>KJ<(,E8971"PJ="6D*]CSBNGW:>
M)KV!N3!<C7@B5Q)&-3<QR>>P?<FRJ:MZX!*"JT *:WZ[TI0-\6S+3)Z4P=F3
M ]=5MV55;L>JT1C!*8'I L'DJ]WEHG)9,QD>42\HR"$]F#Z0;2K>&97OE=$8
MH$D$A504UE+>DK(KFB QM:Y#\2I"71[ITYU%!SB^'RU=;20SLZGR>;,UVX*Z
MFEA\*WP&>XSAL4(OQF8J2[;W9:=YIT)*U54T5,UI(7M$=BC>%L W>BS5_2YQ
M7X0S^0N(D1!.7)%#-U9X\XE(T]D(;>L)0=.Q">DB&=C(S9[%+/MQVL7[,=@.
MN8N-T"3DWSCST8I"0L,C.PL#"Z=ISJ5UVO,[;GLF)B+XC(#&?F;K@M!_WAER
MW@/A(_()Q^X"0" B)I?L_M];)757AYW#2[0?!A3M>[+YBQ(4QU=3!1"BVW2N
M^;RBHT5D&D#O'NGT&35ZC,QA)[G"-R7X(%ML:I")//Z(PS$>(_?(*)5-75F4
M\%D%^V8!=%Y((D@B4N2TAE_CM/5UV%<M.V; U_5.]CRIB+J]=#20=BU/"DC'
MFLF5PD<./H)I'RKU+3OK3;LW>U'@EIDP.YK<D)$2!J0!;A:6<:0TT*EQ '2.
MT<O/PHW/JPDLX']YR"Q/CT(0-8B39L""*83C.1:I3GM]&?U9_=Q!ZP_I.7-]
M4F'\\/<T?X<C:WJTB[BK<MK*;?/HV',XOX&E'D9E+602CU7399WJS46UW30<
MK((;H).<Z*9;;JX<:)J;I:Z;.L7%Q\*'843%8EG!#@]'-8F&B(]+"+1A'LDL
M)-VZ6GGG;/HZX])153;=9=791==11953?9>Y1SOU^:(9_P"1X;\#).(&G]VG
M_MI_P:\[<.?9NE[NY;-_2]'WPY;M\[>6,^CA=;1+.V,9]6<Z^GZ6,9]6?+RS
MGF*I5XG]U!]9#UHO.O%4S<;;1E>0#1T#!W":H3"Q)0_;(2ZTS*EQOW]<+0X@
M/E3 K1*(R6$MB=<4(DX\.(8Z2W(&#UO[#[Q+KN!B KIO3KV&E78"LR[M0P/6
MP>KV"-*GD1;K)!T<2ZN ]X!U066)"S5@L+_$8MW-6!"1]?U0]AIV?+9F9@7\
M BY?4SXETFP"%S%M3+1)?-G=U0)J,SAFX832#/JATYD>UL0YE_>\2NFUF3)P
MV9@A$V;)+QHVB[R11;B5UV:-''O9=Y[\$K%0'[NIBAA8%:74+480EH/=1[,O
MF9&>=0YWM["D3= OK(;B&0<'#D+@)L"3FG*+M[).'!@+,48..VB'=?1/Q'NS
M%IF=0B,< 5A7FTAV.ZRPI^OF/O"+1+:.[(]=.T%P1,*,L;?J\7*M9J%=47E9
MK:+&(BA@\]" F!2/A1M]/M-[,=6^XML7BZKQRQ$JK:4^VE:EI0U(+&N9TQ[$
MSEO&'5(%['2)")CV1." 3F(9MS6'@_BM'[,;&/6^A=:@]#P0B,KPBVG.,^>,
M9_SQY_Y__P"_X\.'.=?[6G^O3^/',O2S\JB?ZQSOXJ[Y;'K/^29#]9L?A#+C
M8[T*CB?6"PDBNKCV[(-Y)URR=5+7NQ$F_/UE;+$56(^8*B@J<3B=/J/6Z#Z[
M]68>49=U.Q+H[8>F\OM(E[BV3TO&Q0X>XFZ\.+596M0E_..GXS4?6SL'7]<=
M>^\YW=N261!^O(4;"<<7=>THB*:U&35I<)M' <7(QHU<Q# SH5"O9T):*AK6
M5HO!FVH8;IFW2#N2U&/$[8=P#T0#S\57M@2MQZ_C>N:<+9:L7M!W-#R,2^KD
MUZ_U\#S9=(P8E6AH"0<*&R4C)>C<#J,T+*EZW]^R.K1V5(HM(C++!H*5I;K+
M.=9(2P)AGUB"HMTQH3J59S"44#GPW8HKO%N57[<@';9L9:5E-F<@JVE8M>M?
M7HR[MW194/3LO=O;X7JG8ULTC=V[!0!GI/35<R'388)P1I%WO?/4VIY1:*5[
M/-S=G$K?)I"RK*:AGP,.Z8 9&"2<?!(L[:7.IU+2[!;=FXJT&G8/PK+%;TV/
MTO(LJ6FZXB8&JS3L)=MIR#*KW+84-Q"\7EBQYTVD[#$G5;+#86/,PEH-3[I6
M6E+M_4%ZQE_]^^S5/@UB%TK%=*Z6J)U7D#'R[AEV+J4RJKM'"VJ%U^PV04BB
MBY:;,)*O+1!6<5HI-.7J$U6CA9#6SV6NK9KYWW'E'8!28W:79>J[LWV":<A0
M76M5F?6BL.G[#I:/,A_L:X))^JG(HI;<!=NL:^5DGMEN3W>R6SZDI<#8A[:2
M39->P[Z\1N? J_MLI87?U_"K/FK,@2 0&1PVBCVI32GJAK4!KMAEE7'6_LP?
M:#5_]@F?8>T!YN] -!>T(B+I@*FB\9'21G'E%IX\9[NV$? &32^NR-7-9FZN
MNM;6)"5<+ @J#1U=RO0UE8UW%\%\9*I(9H7?RG9UIO ;FJ\VX1K.97D*]@VC
M)\]=I;4FZ_$O=UL0$!YLMV4BNWULE?2(AQ4Y=4<D(=<;SAAKK)6X5V$GKF(G
M%4?%P7D!N,A)+6>E&Y]7\J&G+0:CA:'RL3R48^E#K49=_;<C!4=+[=[$C*1,
M?]4X"[R-,))69Y51M+,;@D>S(N'S=J]3*E$P$<PE#A\#.CH6PN4#IR2V%)D-
MLQ\N6(*/=_4_/">F,YVSG&FF,YVSG.V<XUQC.=LY]>=L^7GMG/KSMG.<^O/(
M=./SP==?^0XW\?&^:R\.'#AQ+F_^CRO[-?\ \FOS)?K=^;C;ZQ2G\K&<GSAS
MNGC&RB>N?7C91/7./\\;;ZXSC_SC.>?GJ9]B.Z1%!7)-4+8?8*UK4A+!\1P:
M- <@J=I+575M951=)X$=>B2C%U:KB1\RMR(T'VT*$BC4Y/']G/(HLA3(9<KC
MS5-NAW+=7:@?@2!Y2]T=SC#KU"6(;.*/L$Y K+%;SOAW"TD 2KFO7%CQ/4P_
M+&R<5=3PI94H-W5UPBZROU]\?JW*+#@QRMPY0@LG5"?>VN*Z[L/J<!,%AK)]
MC>VEI-(#M%/'$99+.3+:H!"VE&%$P(U6_P D=BQTT0*.8R78.#V/"D"B)V%F
MDNEA)ZVQ461*>R8G8=P694AOVZ*Z@/IGH@+7)V,MT"L:L;9C@L1I?M:H9Q(E
M+!O4HN/8@=@+TEZ_$K")PGKP82M9.R1R):OHD0<YGX2S 84^(M(J597QH^LX
M@B;=I"$[ E5H+UBW@D AI2M=V^/6%UV*(68 QER/G':$G<=7R9,0(0N$(9+4
MEOS2+'QQK'*0</&;VT^\40(6(W#9+M@AVP%ZL?(T]UZA*&CUNJ>]+PW52O7(
ME8<L\?5PS"V%J+VB\,'D2RB#*=LA:Z1UAU]Q33:MM7;9MH7X?)=<!F"VI)V2
M8&IX(HV<T:TX36*PL?!>Y%L PXJ7,G!-:O7WK(:&\(Q/5)?$-.2=3QR<,Z6G
M AC,ST>+,W:=_N'#D3.?TF.OO[1=_P ;_FK&OT8_5C]W.>'#ARLO<3]'6P?]
M(W_[9!<K<!_D.'?5B#_#F_%Z3C8Z9C9*&EV#.5B)F.?P\O%R+9)Y'RD3*LUX
M^3C)!FOKN@\82+!RX9/FB^FZ#IHNLW6TW24WURT7%75HZ517=5Z$NEFTV'$K
M=1R+PSC9$AKN!W%0"=3RJSWQK+A PHH."C_R]\0,$HI$QV[=CONALR*ZZQ]<
MJB:M&-6434U>M&!Q'69'H"0-!Q&L=84-!R(Q"&4;LBURK&ST ,R\L-CCI@HV
M3&AV4D8(>0BXI\Z9JI#,'ZQ#!(\E]JYJ$#( &5AH5B3SHF%@NZ3Q^3H7%$Y$
M"*5UC,2K5&RK$<%"+N,7VU8VN13FS?W,ID7N[Q@V!672,/MJDY$TJ*EDKG)K
M49B-0NFH- O#9M8QE(6-<K.5<Q\5IJ]9MGY5"6&<M#$GC'49'6$]D9>)?,BV
M>4=.%5SUQZQV3?RG9Z;CP"U+$V':^ !1Y+/ <TB N3Z_D]B&;22"<MM7;MH;
M0TU8\@_+T'$C)Z03D>$9K:&@9J";2V9%+:PZZ2P(M&G '3,A6L@-30KLU(XD
M-V#7XJ=$K$[F1QDN_P IQ#F/,C2)BC#WA'.<[SQ?&Q1"Q]WG63!ZDRZ$E>IS
M*MZ>)J.8U. !Q=2NYI4D2T9#@ 4;TF2N4++F)!D*2KAF9)#KF9<IF!LX>-G6
M-2?=69*WN\WA9UE"7KOHUVM%ALSD@/KO<D!V)CQFVAJ3G( 5<3-N,QX16@1T
MV:,Y%.,,2-R/ LN[%GKO9IN_B!1^^#R=)"&5=P_+$$-:5R71@S"E0"%D<,%R
M<7-!T3-#$+(1@E+PD4\@H:2%V"[+9J/O(J#D7\)'+1"3/+2%?.XA'&L:Y6:[
MM,MZ\T*>P,J+FE,UD3CTV- H;*Q,N'0Z[9X*5<\?2-9#_NJ;=%XUC:YD9.2?
M@23!TT5#GL@^=#BT:N[7W4D 1$!, %X (!!@?"PP5BVL&,"8I#QX^-CT,RTS
MHTBX6%BF[6/C6+?7.V=&[5NGIE3=1;?TUE55-W#M]&?U9_=Q!ZP_I.7-]4F'
M\\/<T?X<.'#E'._7YHAG_D>&_ R3B!I_=I_[:?\ !KQ*E2$?@EH=O.D _!."
M*53@AU"<G8B%7(9U5'=PE!#Z$J]9K3TXJW3472AHC1[)J()[K:--D]-ML?%N
M4"[MY/QS0G&74B)N6;,LCFI)!.9 3>2*.KB.9E;%"04=C#N0;[Z+Q[6?1CG#
MY'?55HDMIMC;)'F@BNJDYCR\.D/>K5I/YRS+1M\GK$YD,-&LPMEI*JXTA',D
MEF.1EMMM(YP_UWCT'>SW&4<5)IGJ!T\J0:<(#0;4Q>XL(E)7\E8)2WKHD([%
ME"6]Y2ZF\.I/M&Z,:1[#UL2L5N/,X=NI*?"XJ$8E]Y<H'8IZD];-J'II: W/
M3=O@G6DX$(ZS9,R+)\Z2K61&65O2#"'#)^7+B.0>IQ+<WF8J.@ \ICR.2U>D
M,8QA1@FC)-FV81^OP**8Z>Q=@6!9<U3-$RMTRE;S4X;NF ."SUU%-:H!CT%E
M=\#:":A?.0,T$Y6KQ59G':1Y/#[,@MZ^?LT8Y@VDMX.47,S,BPE(.HY FBG@
M]:$[#2Z 2Y)85_L&*UL+GY)!/E%)6'7R!.7%?0Q/-,FR"PNLX%&3Y6,549;Q
M?7?4?I5 MTI"JNO/7!NV;RD$DE*@X6$2VB<[6Q#)20RGB:B]9/?,[7I'(RNL
M%KN^VEPUPY=0C#X,8:XBDF\,Q?1G2[RDO' [K_$W%UXKFK("6ME$?!H5.OZ[
ML2,*16MAJ%M+91 ;:(XA@*?"TX]A*)2XS$LVP0HLSBY!O"JVMF":$@XJ8F'C
MY!5M!HNMGK>/7:OY+=VUC-I?2$91R#CWP]))%EA/,*.I8Q+3"KIBFP;+>_FV
MZGS8%HS(O](=O/PNI#D:C3!P*N)B);E\:+RR>BC&=F!/=]\/Q$2IOMLUVE'[
M!&-T>I+L_?FRZ.^N%"'FH4BC&<V.S,,0PDBGNK'38]+QL]"R*2:NZ"BL?,0[
MI[&/TTUTE4%%&;M?1-=)5'?;55/?353U_M:?Z]/X\<R]+/RJ)_K'._BKOEL>
ML_Y)D/UFQ^$,N61QMMIGTM-MM=L8SY9TVSKM^K&<9QGU_KY0*Z>[Y#U_LU5A
M9]1:0=*O"4Q$(@R^4G12YS.)KJB9V];"N<3HGXKZHD'7 +3&Y #(CS-AH2D2
M4I:R\F.L(39KAVR"/Q [!KRE[XL.T.KL^W+Z7ZXU_P!L(NMJXM<7.F\U3EJ0
MIY(1KN?*"F-K5H*DE>35=S,%=+& B3-K'^[QDQ72]B:O-8U*6[L[7V!4=C![
M"1I9O*U<3&G7ZM4#:5LW6&LBQCV^9C6)6BNNU6J"4IM<;6D(]S%$MR>_"\1E
MHL<WG'D%&.FXH_=NGW<795.NK!=U^V:14@[@:Q'[5-R$ADR#X''XZP+V#Z"K
M*,3;#L3-S$K)G92^-UTW2;71I$- MLXDE<-);==A%41XE?5N<:R3N/E+B0C5
M(N=F0A:6HRS8O2[%QFY8SKQ.0-%-5HK9S;YG%7"0#8$Y'Q=JLZ</26(DXEQ(
MBZ[R;9, 4\46CUV-D/+$@;-!UJ^MV]Q22A&=66).DX/4%%DHB&SMZWD-ZPR$
MM40R@5$^\+-)/&\HNV6BG\C MI^"C)B7CK3@W;&E[(N JZ]B!$12EM ;DQW/
M =01)6;@&:B3L;8MB0M7=-=8R'';)T+85[29+NX597+"*2<L"*RD</D*L7 9
M=XB]8#-RAE?0P[94V'23;M=L86PPK*SUA91;JP),7YG#TO)0PW(,[UETS)=W
M7D_$!RCEPUF6#I.%TG46<@NS3DO$THM0V$!MP-VN+##L9[6S=L&U@ <R'L>O
M[[J.)UJ;GX[9D=JC-HX>.1JS8.61<CTU+,4$7PZ@SWFY0G;QT>Y7OB1]=&+!
MJW68W[L:R)7D5;TIK0QYB\'"R%>8M[!$E5RN$Y*2%ODN4W.64C$NY27D(]-]
M"0\"^-V4@*-['5E<C>R"ZW@M2/<QLM4\V!Z-MU=I3")#7-KU[%615I:W;3#&
M-DH=U)QCJ?@B$7>M$G(V3B<NU4Q[DNVUTF3D-''YX.NO_(<;^/C?-9>'#APX
MES?_ $>5_9K_ /DU^9+];OS<;?6*4_E8SD^<.&,YQG&<9\LXSC.,X^G&<9\\
M9QG_  SC/KQG_#/$4?&QX3C5886@X@;B%YHB)%HJ"CVL5&JD1=-O24KGE&+)
M-%MM,DQ%)2,]/R64_?DO,/G<B_67=.%5=G!APYPINMARYPLIIE-5;WPM[LJG
MG&-<IJJ^G[HHGG7&NN=-]MM,ZZZZYQY:XQCXY]>N-<^O7&,XQKGUZXQGUYQC
M&?5C&<YSG.,8\LYSG.?7G//K[NOA35;"Z^%M,XSHMA97"VF==?0USHKC?W33
M.NF,)Z^CMCRTQC3'EKC&,?+_ ,Y^GS^G/KSZ_7G_ #SZ\^O/K]>?7Z\\[9VW
MSI[EG??*7IY4]RSOME+W3.OHY5]SSGT/=,Z^6N5/1]/.N,:YVSC'EPW445WR
MHJHHJIMY>DHJINJIMZ.,:Z^DHIMMOMZ.N,:Z^>V?+7&-<>6,8QSKPX<B9S^D
MQU]_:+O^-_S5C7Z,?JQ^[G/#APY67N)^CK8/^D;_ /;(+E;@/\AP[ZL0?X<W
MXZ^'#F25Y>'/(7CV-N^V#*%IDS#3FC.SX+7\,=L%")\-6)<O7?JA3X84N8B3
M%Y*'C\0TQ1YNM(S;%P\F8>&F(1U"(.'[Z0;1T FOAD]A35I""RSJCXLPULY2
MT)+NKDBF)#L)!1D[T2G^JZE60$9\G291)QM<'<FC.CLF[LZ,&YNN&[)=C!C]
MBZ/$D69OX4-\EU,3U=*)4Y29*2D]5R.2V'.6I9(!C2BJ./*_;J K>A:$ZIQ<
M:V['.3#6C;:5<8<F:G5%P2LSF;-;$7%8@9T5O[K>>67$]5Y5C3'74S:4X'V"
M,F'5TTGMF=#Q,Q9=2#E>PI+7LO(UD2L7[>@W45-0(4VE*^AIF3K Q)DAY<>+
M-FT=(9\"OAE=GADDZD8D87KN5PW7R&Z*1)++HE([#ID8[U^IA2G;<#7#2<ZV
MDUJECAP\GBDD!'3VV!.M)8 V;!<Y7Z1C(RLJY^M.^%;?%>%G71,@6K&0'Z\$
MND<-*3XH<"4-O4;[INBLPF=:]C9GJ[+V:0,[D?-5;'9M 6TZ4C4BFRK('KB0
M,(])&?*OT&;9]+;;;T<:^EMMMZ.O]G7SSG/HZ_\ ]=?/RU_[8QSCASC;Z,_J
MS^[B#UA_2<N;ZI,/YX>YH_PX<.'*.=^OS1#/_(\-^!DG$#3^[3_VT_X->9R=
MJ.KE@6I?(U9D%4_6Z^A:0IJ(I-V.=DI<ACHZC'[6ZDK1G+G HT>%YR7*)0H@
M4XX=F((2):M.-IT#KIPU/6PVE,XCJDQ7AH6O*B\A7Y0(=>X-I!5(?U&465%3
MCB<*^\*UF=K:BO&4/^QL?I6\1(0JD2)5R1/'<"33EER\E;-C3[>%G6-?IKNI
ME@]W?#4DHBH[H+J)J.IMG\Y:'<8NF@D$$WK4@L*N^R)Q1K.I:Z<Q D'KNY*!
M$,"3F4.A1GHK BT2R=D XTG9%%?.;0LO#S(BJT;"LDD&*:H]N2;]L'E6 %8.
M61M"=7[ MVE^O=)@UO54HP J_%U;!<R%3FMK%4\-P@NYAY<D@D(!^[(W1&0:
MU,'/"VOB%K5DRD *L7)% 2M#QF@F.W;5$6C/:4G4UP5XA:L'LYZ21?7]9^_>
MV=F,P$=C*2O F)JQ6EDBT[CK''P61:.!#PTNT&9M?*\;UJ82L_1\F!FI]"/(
M#<(DGSOHZ_ZS,(0 K2:HY[;]($4>5J1$2Y(ZHN<;H*7I^)5>+T W-I5W"\]]
MT>&#=]JCEM5TT'NOD*[(IKN 78[-+$TEM;=\1W9T;F!D:HRU8IC6^"$: *[C
M2!C'D#]T:FT,^B:9J'2OA^%>*R6!F_+7IW*CPSXBH#5TB%4B)]L$V^E(ZUI#
MX'65423SJD*T=/$S\6&HN!CH:6>FX_\ &%^L+K.Y*;BDT)9W(:D._N2>=I3X
M9E\SAZ[MH:J#K/4<(SENOZ^O5:I3H!; YSM5=!7C2$R53A)9/4T\IYB0P\E9
MD.2 K8@I KW?!24M&RLN,V0SBY'27(#PO[%'<#(NR,P;:JFW6/54H"W<J22[
ME[WG"^MMC=4ZCL%E,.!:(0D:M&JHLEOA_,/H*&*=B&J*UE&8@CE!5-BTCKPU
M+T+@^[:N:B_6%E*'>UE&$)V]D9TI7OR4R="]>P4?US?PS( WV@JW:08=(TP5
ME1'/V2&.J/6']12G4BU.2;QNA'1SK^74"!V:@;0T.*3=I7#,V?N$CY:$F,2*
MHNQ,/$M$_A&LJ1Z\UHVF9WXJ9FR!B!5=##^'CE%VL^FB%W/2CFZ^O]K3_7I_
M'CF7I9^51/\ 6.=_%7?+8]9_R3(?K-C\(9\L?G'GC.//.//&<>>/IQY_XX_[
MX_PY3+YEHRM<%X6M)V<=3S#L8UE!ZVJ\GA.EY6)GJVDP'6O,4[&6$[K56Z!6
MJ(Z+PO,10<,V+%Q[8KD9@E5U<2LQ(KKHD-T/$-:GO6K3ZX+CMA>^Z(@.L<]8
M1>N!1QH,T8&#1@+@P>,)B@9#"ZDQ -#PGF)<X((&9(C@JDMIPDVW10:Q3=YO
M>IS97LDIV:BKCL*&*UA4" _BXH)4F5P<8!A+=1)^&!T^;5D0V#74'8[EP[E;
M.P %HX^+I==!Z\=X^"85*/\ M:G6O2RKA7-5Y95H('%/"E6V7'M)%5I.(NZ9
MON#[%4J0BZ;EA)P[G&Q,H;B)PU?),WFXY-Q+V*?*.F*Z&L53/AQT[)C5)PC$
MVM2!ENNT <1U0&$?("#F=&"0P[! ?95D=NFDH)/(&=G!"Q*[A&4-$249D6E
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>g700946.jpg
<DESCRIPTION>G700946.JPG
<TEXT>
begin 644 g700946.jpg
M_]C_X  02D9)1@ ! 0$!L &P  #__@!!1$E32S$S,3I;,35:0EDQ+C$U6D)9
M,3(R,#$N3U544%5473$V,#(R7S%?2$5!3%1(7T-/4U\T0U]/4D<N15!3_]L
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M8^C&:>V)\Y?A1;4_.:Q]&<LR-ZQ^,?TYIE:_E;=OMIN7\OM_UVO:[_!YX?\
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MG%=FM[A/C%\ET5_GTED@^'=Z[:W2ZEFY;LHM LJ6+,TRJWI$ YE65V ;!(R
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MY#?;$-T#O%$#=THCT!B'+O%R8OSLA#QRQ%2K, D\/0D 9G:090D@ESRL<CL
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M8:-,8QAHTQC&&C5GO:!^XDY4?(7L7]0.<@9&]8_&/Z<GF]H'[B3E1\A>Q?U
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MS6V^:W,EJ99Y#<DAD8.L8C 0PUZX"X'<,K'/?(\M=E:K'55EC9V#,&/.0<$
M#MA1YXSKE-GCUH#A-F\>M"OFXLWA&;QTT*]:'.!Q9O2MED@>-#* !Q:.05;B
M< .*0F#KETS7B1OQ;0"V\&Z<*6B/H-?9!Z4%_BTKU*:ZAG$@P=[?/K4TB1Z^
MJ,6_BW+9&:5;+RXM6[N79M/,\>Z=DM0 >@@(CT /2(A]X ](C_@#TY("H>FK
M)<^ <=!V#6NZ=QLU-0I(ZHH$UQUFG6RJ-M:;BK/+5.QZ<W36(V%C%-!F>S:$
M^"=JGK H2">RE848 K.LV">'$V[2;/'MLL35T%G<Z\-@S0M,S0=R_2 DA1'4
MA"99I8HHT#$R!^17+,IA$9!4<TBALC)*^W R!D=NY( 'M!QG$M9>*G)R"+I:
M+GM:7E6>W)&VD^I: ))&0NSF$JKIDG+'0IZ@BZK,.Y3?(RS!(X-&SV'*M,N4
M&K-,%3T_O6J-FZZVA/<>9QHX7O,/=HVI/J= 3*LQ%2%WD"QC6+:L$T5&\7*2
MBZDLPCVL@+8JA5510(Y*B3OY?OLWC+RJLW'7B/KV(XT<AE[?J-7D :\-SZRM
M#4D>78&SX:S5GR6373(WDP>PK-PLN6/<+^0F*#1V"2QRIC4_??#S;6]>3?)?
M>;C3_)N)IKS:FOK74(:#TO.L;CL*E3D[6:S?W=9?3PM4:O;*1!(K6:'8344\
M--'14+X35!FJX%.K\3Q(Z>FW]IZ/+O"Y@ R+5??(*6UR!!<F(BNU)Q853R^I
M'+:-D5^9HL%LJ".:2+EQ*/5Q\Y9E2(XYSV=&#?P%^;E[BSJ;X3<FXBY5BFN'
MM.E',PC>V:MGAMUP4U1*&IH<I)39<%?[DC)C'T1YJ#Q47TW%O2"G"N%T5H '
MKPX]./$<-.2TGL6WP@2=2AY:KQFNI.0VA/;JB(:D6!CNP$F6HPJ^UEI(R5K5
MVP4?(:>T:KBI+%;+LY$D>1H=,F3V]<3++-TG1FC'E8WY+,=>SV[9NI[AI/%K
M856JU?A[5'U8-90W(37\I7R/MI62?F:XHKNNRUFO2<C+Q:Z,<XF)=F+LKGTL
MUH#8-UY+Q.U0H^VJ;<=8U#C=',+?/<2]@V?C#LN9UO#/(#::D%I1.#D[;1R1
ML6>'5TFV-%P$/"3$=)239O7I!PPDTT$<93F(YM;9DT[AY_D^R 7CW*.&K(4]
M),O)<J?/K]-K%5@MEJ\U8'6CTPX^?%\U^_(WLD"H<<V0'3L5^<A 8AEU'OL,
M/:Z)-VB@V)M+UN9KU@D*_;:NL[7:@RL58D'$8]92C%HY\A<O8A^V<-TEC@X!
M$Q!.S6\(Y#F\UEP'*U-0O)C?3@]4N='3EMK7.Q,ZIL1%\A>(>-M$NO8XQ.SH
MR;R1D4Y1Y'RK:3.F]?O72:#YNFLY6.03C;_DFTI38J5;)55>S7@L.$QR\\L*
M.<$,X(&< AW& ,.P[E10\R*QQEE5CCRR0#[S^4_=UG([%WE!HSCQ*;YB=PWI
M"G2&PS:R+36Z\-893SVI6R7@TNBBK"Q4BBW7;!+L/"0>J-U7HKB5D5P=)0I<
M_/M@_$?WU@_F;?/HQD$ ASD,4Y#&(<ABG(<AC$.0Y# 8AR'((&(<A@ Q#E$#
M$, &*(& !"\S4&YPGS-JM;%R)S@E(A%RZI@(G-F*'=*U>B/0B4P)0 $E0Z)2
M8@/H(]'NN(VXL\/*.[;A9WMI[YEL"'TB&&6NJQB""*NCQJU9V*F.%3("[,K%
MG'J'$</>*MSCCA^FW$/"E+:MVH5HB^[TK=6[+?JI&%_3U<UK]=;%18UQ9B$/
M7K!38YIJ[2^BR\_;!^(_OK!_,V^?1C'M@_$?WU@_F;?/HQD9[&,K] &S?YSN
M?\=5_L?]\GX8K,/H@>,?M;PV?+_LFY_#_O?VX/X?PR8?;!^(_OK!][_Y-OGT
M9_V_ /JR/1N:P1-LW!M2U0#OR^"LFQ+C.PS[P7#;RR+E9]\]8.O)W22+I#QV
MRR:G@N$4ET^]W%4R' 2A37&+.S<.4=CEGEJ2VI&L1K$XL/"X"JP<%>G!$0<C
MODD8]GEAF\9^).^<<5:53=JNUUXZ-A[$34(;<3L\D0B82&Q=M K@9 54/,>Y
M([:WDW#E%-=%%RY02=%3*Z20<+HI.B)'\1(CI))0B;DB2G]<2*N50J2GV:8%
M./>P+AP+;R(7+D60KBZ%D+E<60NA)X8NA9BIY,+H4_ZV+D4O'$GV'B=ST9LX
MQ?P/</,'^$>1^Z,#!^&H_P"9L8YFP 5 R<!2<E<9\B>Y'D3W/?5:XO1VT;1K
M\NR6Q(]U!IP]ED8:+D[:S3N,W4Z*J1&W3-2JCUR,G+5BJ*JB65/'@5%L*3DS
M9HN5!0<] ?C'NU2)K1&\=%2@6%[41)4(ZZ1#Z>JZVQ&RKBGRMTJ?EI3U%M9&
M":SA*8?) FDU(<LHX9F$J)[GM.:@ES<?TK#2V=]5V;?*K;X@+)*:BV?=H.LT
M&PI/F:U4U4O"MSUF-D;LB"I+'=%SN :)R*J$:V;J [=A5JP1>[H754R_J>LK
MU)[ANM<TO"IV: TI=*=LV 5U<^BY11WL"POY![2I16&2A6-;K*5&0!O/MS!+
M6,A 0*W*SYM]G6P\$$M'"W7K()XI(>0==(^>1C+TQ!'&97:<.'DDC[0HDBYE
MZCP+0EV^&[=J;X#+L<.XRFA;K7.LS5)+ AKHM1IS?M6%J0I0:%H:]>SZ]R6>
M"3EQKV_6>PZ8>6?S4HR=1\1'4N;9VN$NA9Z LC"TF?-Z6\I=A8N5$[""J#"=
M68^2&15B(^&GE#@R3:G(M2XKY^5=PZ(_D".W9%DW;LC]X1V[3<  .$W;HJP+
MNDW %*#A-PHJ1<"E!8I^@=,MU=UO:[V9Y'\B=1[9N*\5 5V3+8'VO+RDUF)I
M\P>)W:,IT;2$8!M V6M105.EZN<R\8VI#(L7;YA\AWK(HJXQ&N&SADY<LG:"
MS5VR<.&;ILY*!'+9TT6.W<-G) ]!'+=9-1%P0.@%6(<H    8K;3N NB>*00
MF>N(>=X IKR)*F5,3<[.XS&S.'CB:,NL31AD8Z:7%G#[;(:%J VXZ>XM<Z,%
MXRIN%>6K,!(MR+I)#"W)/''"8+%M+"PR64G:*5 !7#@C<6A'+E-H94JYF:;A
M8C,ZY4_"*N=H50&QERI"*15C)"J5+^M <$_L<V#!U 0#IU$! .H] ZCZ/2(^
M@ _"(^@ ](^C-<8L^6>7 /F#C(S["1D9]F>XSY9&F;DG&22!V SY#W#.<?@Q
M\-2,-*<PN.U3T[JNKSVP2,IRNZ[IL),,PKMK= UDXNOQ[)\W!RTA%VK@$7*"
MA 7;++-U0 #HJJ$,!AJ=]?%Q@]\LO\UKG]'LC304\>/,5LZ,<[$P_8B'4QVI
MA'TF(7TB9(1])TP])1^S)Z>\4]22'(H0JB9BG(<H&(<@@8IBB'4#%,'H$!#[
M^>;GC'Q]XQ>$W$LU+>-GX5N[1N,T\^Q\0U]JWF.CND'.':,J=^E%3<:P8+<V
M^25WA)66*2Q4EALS7OX!XWVSBC9*WR>5AL[?6KU;NW3N'M56BC6)'9E$8G@E
M"9BLI&B2=U9(I5DA20A]?%Q@]\LO\UKG]'L?7Q<8/?++_-:Y_1[(^.,A_P#_
M "<X\^U7"GL_[#NWP_[\^!_N3I\^E2?K4_ W_P"VKTN<.VM?[@V)4)[7<^%@
MBHNE'B'SD(^5C? D#3\@]!N*,LR8KJ=6JR2OBI)G1Z' GB>(4Q"V8I++-U4U
MVZRS==$W?1<-U5&[A$_00[Z*Z)B*I'Z"(=],Y3  B #T$<V\9"'$G$-WBC?M
MQXBOQUX+VY3I8G2DLL=>.2.&*%>BLTT\JCEA5O7FD/,20P& -#N78N< G'ED
M#L .W<GV>_6^FZ=)&6.D[=I'<)*(.3HNG"1W*"H]54')TU"&<(*F^R506%1)
M4WV2A##Z<]_K_75NV,6;9U]W$QT-7F["6GY*SV9M5ZE%GD'Z,-#&?OI!4L>6
M4DY%9*.B2>$=VLH!BD.FBB<Y:<Y=EQ=UQ'W!Q;IR<A;58X^!1C4X:OQM6NEE
MILS:^^J]CSWYO34E'CN'@DR)R",&91JI*N')"^5HM$W15>CA+:FW[?Z&U,DD
MZ6?2N>,7!24(E6>9G>RU>WR1*T:O,BUY)9T#00\LTL;K]C!9U7OCO[<#&,]R
M01C/F,=_+S(U2<VF]L1D7L>=<UR8A(G6P.HR\RCERJP9).DI-A&/(%)XW4,W
MFW8K2+1TJP067;*1QROU%!1.W\;G+:5V@RC*HY,5B#2Q.6C=!@VMC11>IJV*
MNN+.Q4N<6@Y$U,2G::V>V0KA^D0KRN-7B[L0!,S4UR#C6V[%'_)EQ.TK9%PE
M-H5%NQAK&SUK9(1C8YY:YU:>=^'"/$/'K[-M'Q[MJ@E(E12*DP21(JH95$%>
M[U_6-[.(FMUG;]"W#9*@:51JZT$:I3'AUNAM(8R+AZ_=0[9C,3(3+LT+5#)D
MDI&;C-?L+9&11V0S35)60X. Z36H*C;7QA +,-E8K$J1O7J6(>(+U:,;E/6I
M21UXK6W0;?,)*8W)(VGDN*TU-DL0;A&,@8<=O,GL/7[9(& " #D9QG/<8(QZ
M*NW2WD_BO73@K,I4V)E';I8K5),Q3I P\903,T@,1-1(B!4 ()4S 0AR%[NO
MEK[RA5X#Y\#Q<%"KO0>N@>KE6*!%BKO/&\I7*L0I2+%55.54A2D4 Q"@ 5@Y
M U*/I>SI2'B:U(52.-%P#Q*->1<]#,UGJT4@C.R5<C;2JM8VE4>V!M*&KR,V
MH:239)^&X O<(4M%LBK=:=K:-SO[99E#V-ON2UI)(FEZ3R57:%98C(L;M&P7
MFA=D5C&RD  ZYV!4D$]P?9\/+\&@C^$1'^4?0'J#_ 'H /O!Z R_KB5SMXN<
M;Z%8Z!N;9*U,M;B[/K VC%Z5>Y8KF%?P< V:R+9_!5N3CEVZKEB[0 R3LQR*
MH'(J0A@Z98+G@=B:YKVR808B<2.DN@)UHJ7:E3\XQ#LQ>@K-CG#HJW5Z 5XP
M5'R=VF'I\-<J2Z3I\..,1P/Q17WTP+.HKV*;\X=UB2UR*TYC1HWEZ87/361"
M0206(",[>!VX-'$5*/CT;\G#=@]"Y;X<L4X=RV\R,@2\(KNW[C%=KP -Z14C
MCAL/&QD@F:2(5K&=SVV[@%[^W_=QM/Z&8]MNX!>_M_W<;3^AF0Z+Y0;)KJ</
M"6% "F.4Z\;(-Q.:/EV15!(#QBJ;T^@0 '+100=,53 DX('4BBGB>H_A'^4<
MN16\4MUMP16:T6S3UYD$D4L45IDD0X[JPO? @CS4Y4@%<:]&=I^@_P#!K?=M
MI;QLW%O&>Y[7N-=+5&_3WCAV:M9@D&5DCD3AG![@JZ'#QR!XY%21&59IOMMW
M +W]O^[C:?T,RW3EWVE_"O:7&#?6NZ/N0)FX7/5EOKE:B!HFQX\9.9E(Q1LQ
M9 ]DJFTCFHKK' /'>NVS9, ,958@=.L3WJ/X1_E''4?PC_*.?9_$3>K$,T#U
M=K"3120N5AM!@LB%&*DW2 P!)&00#C((&"O[7]!SX9[3N>W;K7WSCA[&V7JF
MX0)-N6Q-"\U*Q'9B654X<C=HF>)1($D1BI8*ZG# /I$?C'.01Z]2:JLDGCQ)
MDNLDY79).W*3)=RB42(.5V::I6R[E @B1!PLD=9$@B1-0I1$,XV,88)'D2/9
MV..Q\Q_#JV+*K !E5@"& 8 @,I#*P!SW4@$'S! ([C7(6>.W#9JR<.W:[)@"
MP,&2[IPNR8 Y-WW(,&2RIVK$')^AW(-$40<' #K <P=<J]K/4&QMZN;D]@).
MN%0HU>BK!=+7LW9$%1Z]"PCV;8U:$-*7&^2K.,(9S-/F45$L%Y %%%52I,TO
ML>Z%&<R8]G=6=KV)#=+35=@MU.?OT=9-9"RLN.:7(6A.6<+9WEC=UJWL&U9M
M\[6YARQ37E*DO'PBL=,O&:[&8>1O<9/D%'::RWMP@JRK/)'()>9*[1B9NE6E
M:,(9GCB&&55/.Z#IEE5@2-,KQ WR;A;A/<]]HR;75MTI-O$5C=8;DE")+V\4
M*]UYH]LK6[[%H)II$%:M,QLK%))&\:/JV<_&7=2M M-Z0=567J^LWMV!DRAM
MI5^?D)R.UX[@R;*N.GH"-E'8W6F4E[8J^>VVVF +%NO(-UT32!T')VU(;C%W
M77USEJ]8)F0;6^O2!AF5(^SOWSR+L+Z.9FEVB\PU=@J6Q,"J$@[,9%P=PWDH
M]W"NG;GS<(%R_N:QS)K^Q.0ZVIN/7(RD\=I6TW"_:JT074JS2*G+1/2D&WK[
M)1NA$NU:A423#!#:-RJ#&>B:].I5>%J4DPE/*3MT[<NT(TI1=9(ZJGZ+I[8N
MMBV96W^?YBYU'9M9&;!<D'*5B/M[K9;YZ:P[O;?VX2>S9VE"E19,CR)6ABG4
M1<&*L7]D$%&>W7%R)JCQK,+8DC$P6=ZXFI@0CJ1,W(ZF9H)888PS1,)48QSP
MEXFS;IQ/M>P;Q)P[?CXB@MR[6W#[5;+[:S;55W>3;N)&?<7%.]#&;%:==OBW
M.EN&Y6I(8;T;;?:KIC=3?OT2OB(OWR))1,490B+UVD241,J9<R,H1-8I9-$R
MYCKF2?@X3,N<ZQBBJ<QQ_)GKT[1)@9X\,Q056708F=N3,4%W/3RE=!D*HM$5
MW(% '*Z2)%7  'C'/T#IQL8UN9O+)QC'F?(G)'W">^/?W\]3STX\YZ:9#!P>
M1<AU3IJV<9YEC]0-YA/5!Y>VOT0>Z<HCZ@,41_P" _> 1_D ?BS*C7^WRE^"
M.EM'Z8)Q4B]P5ZNZ\B(Q#8$)N^4K $F2.9%5_6;-7I73#DL#9HX!!06\;.V:
M$E(\Z$C%3[DYGL?&8K,Z>P0$/:89_7[ P1DXB31%!XS7 0*<H#WDU4E"]%&[
MINH!5FKI$Q%VRY2JI& P#U6=BWNSL=I[%?'TZ,0S>JK/TNHDAZ?/E V4!]8$
M$ KE<\PC3Q4\,-F\4]AK[1O!D!VVXVY[<!-+#7:\*T]5%N&N4L- T<\B_2I%
M:-RLI681])\L']5HG^ B;_*/)_J9Q_5:)_@(F_RCR?ZF<BE;GTQ,ZHF $!6D
MZG)K*!!3HD#O"( *@Q4J"8 FWEFZ8"/H J$B@47;0 Z.&[:BF2?!Q'?L1)-#
M<#QN 580P?#(8=+(8$893@@Y! .J-[EX-\)[/>L;=N/#DE:W6?DEB?<=U^!5
MT87BLD4BX>.5"4D1@Z,5(.ID']5HG^ B;_*/)_J9S'1VG_;J^V0<;6''TW&,
MVH#,=I4S9);8.WB7DJ@5)C9&9H880-=U8Q1D!GRJ _"4$&H-#$%FX%P!T(^V
M,^R[ON,T;Q26.:.12CKTH1E2 ",B,$>7F"",D@ZUT?#K@_;;E:_2VDPVZDR3
MUY?3]RDZ<L9#(_))<>-L$9Y71E/M!&G_ &@/H$!](" ^@0$!] @(>@0'UYL%
M:M"%,4C1H0IP IRD:MRE.4H@)"G*5, .4A@ Q"F 0(8 ,4 $.N;^,3=/;7HZ
M50;#LJUUZ@4FO(6&UVB2")KD#Y57HDLC*.DUEO)BR5ED(:O1OCIHK'7>R\M&
ML"E*<[MXF7TC?/)]FEN&L\@=U\?=C7[0VLS\==25#>&^=M7:XRP:<UU3;I T
M&7@UI&<K]3L-@LTRK+;$J]11;U.KSJ+V?\I=1C]U7FB$TO:%J+0^TN2UU0TW
MIFGA>]@VB$LSB)K!IBK0)'S2%A'<G++*2=SF8"O(IL6"*CLZ;R3257*GX;-%
MRY$B)I;-4T=RM#ESRSV_!Z8V9H<=\\0>.^A-3;^5A^*F[9C4%KU90=(5S9(S
MNBIK?*T/:JUL(NMI>N,'W>E%HI D)-A&-_*%C,U*C46PO,T,SXF1>9 >0ITI
MF9/)5!ZBQ L95 $B@F,$OIE<4<0R[/.L4.X;; S[;8FZ%EXEL)8^4-K@AF]:
M225XS4EW&2.**C/(SU972*XR+5. "T]DYR8ID#OA_:C:CCIO0\MM>.0H!;.]
ME;7N",T?1Z=M;<%HTPC&55W 3%=IVMK_ $V\JC;9FE2UG9S1(VL1$Q8V+R+1
ML7VIJV3TY?YK75E6KKJV50L.ULZ5?5*_;URSN(2/DIJFNY'R5NBO9*,]D%JG
M; CCNHZ.M$7-1#&0?),3N%).VUM,=I=-\J.6FX-3:;W92=*[-7-LJL:+=[RT
M8PI>\^14)3:=2ZQLW=%$A-\N*O"1,E=XEQOVX5$'+V*>A78'5CDDM'NS(-;+
M.V X^576.M..-VJO%5YHA[+3=EA[I:GC+6D7+OWLI1:;)Q^O=B3%*WAMF2WO
MM5G=(#;6R+'R*>1528V6-ND96Q: \CRM6^ZUMZ)#-+%'/&(7(^G+)],3J% R
M'D .<@]^0A0"4(/4*=L7%L]G<-MI7;NV7&W.NC!=NFJYJ6C2AL25[">DO(#&
MZR1*(O24DGED'I"M&*D6!@&[<H'*5LV*54O<5*5NB!52=X3]Q0H$ %""<QCB
M0X&*)S&-T[QC".J:2*(""***(&'O&!%)-(#&_P"48$RE QNGH[QNH].@=>@
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MY*UFNXDAFB8JZ./:"/,$95E.5=258%206NCM&P=&*LIR&!P0?[]B/(CL>VH
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M&C ]P_O_ /0_!KOO95:?[JK5_.BP?M/'LJM/]U-J_G18/VGG0XPZ$'^1C_\
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M4@B B14A%""(#U 1(<#%$0'T@(AU ?2&;/D3'_F++\S;?^5G)QAHUQO(F/\
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ML,Y D[!'/82?!O<_N]C?!L X3L8_ /H$! ! 0$! 0$.H" AZ! 0$! 0Z@("
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M&ZQ#)JIE, AG!R>00P#*05(!!!!!!&001V(([@CL1I=\_+3&  1'H =1'T
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M(+%.DN@ND<Z2R*I#I*IG,FH0Q#"48N?:3=E4[U26?WWQJA%WVKD4W4S?-9,
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MN'HM^X<L^N@CBW7:IV0;CLUUU+&K=B4GU7Y7-6T@->Y&C/$W,DL<3&,T$0*
MF,8I2E 3&,80*4I0]9C&$0  #\(CB1J0M:_A$1   !$1$0    ZB)A'H %
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MRLS&,NUX5\*]X\\=XP6C-&P174FZ*E*W&XRJ3HM,UC3"NB-I"ZW5^V*)T(]
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MDBF4"D* !G8(ID23*FF0B:9.I"$(4"$(0GV!"%*4 *4I"%*0I0  *4H%
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M.NZ=+G4<NW*BKERJJNJ=0WH,8RW<,,5>**""*."""-(H88D6.***-0D<<<:
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M!F&KL]+U94%'!FZMFM2[84U%UW"B:K2M5=FNG-6R53,RCQ:LVTK+Q7TG^!/
MG1W9[Z.C-.:<C#NGSHS:8V1LB8;-2W/:5S*U!NYLMF<MP$B#= @J,ZU6F:@P
MU3ANY&1A#JGD'\ACP^IR:G5H'LY("9@ZU7X:8M&W]S+V65B8:.CI*Q+P=T=P
M4*M.OF;9%U+*P\(V;0\6H_5<'CXINA'M!1:))HESV9Q;'0AAK1V\<\\Z<W.P
M^IH?\1!DXSCUF\V\NP[:<?BAQ=N>Z[Q;V+/HVU[99,0K1.3Z7/& ?2;+87G(
@)^DPXZ</GZ\F9-,8QB]J*M,8QAHTQC&&C3&,8:-?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>g953521.jpg
<DESCRIPTION>G953521.JPG
<TEXT>
begin 644 g953521.jpg
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M>Q<1F^N-&\>HJ5>1D-OS=U>E+59=IFB'CAG*S^M]?M7#.,84=)1%1-K8+2Z
M\J9/NK0&PI/&J/QFMP<Y>(T6.Q]^FUERKX^(+$<W*\:5JCVB[6UQ73]R UU<
MTPSQ]6;G4X]-07,P2$>)R;-H55_W<C1 _;U:VI7N-;[B=H2A7RPM*[IZS.M'
MU?7D,TFI*O4?84S["(26M]=W*4@8N3+[G]N>Q[8D\F[*UC9!)%-%V\,98K5W
M2SL:2<:SU)RAUK9XJ(A6=%Y-[DKUBJ5<DU[#IRFQ4K#P4DYINJYYZF@X?4>+
MC7:ZKQH]813F.F9"617AX]-1-$<RY=HC<E45-F@&V-NJ:,9R.GVQ6TE6P5KN
M@'+43% ;9*'$QD/$I3%XCX UR\@+* PWQ05L[)2.-*0<B2[\<+.6>8(2%;@G
M9][4G-7L]?NM<@K=5)=E/5FS1,?.P$U'+ NPE8B4:I/8]^T6#IVZ#ILLFJF(
M@4P ;M3E*<IBASN0)=CU[(AQ$TKQ8I.KMG;Q9P$U3;#LF*A(>1KUVE7C&ACL
M.R/* FH\BJ[(,3IFJCJ-.W22=G,U0,FV420,GW(+V/"Q=C]^L3#>9NQ_5')I
M^%+Y%G3(T>SW>2Q'E/LLR$VV64OM-NJ0VZ"AE2"'$;*P4J*??;B1OJ+D*0EQ
M:4,/+2E:DI4&ED* 5D"#LY;P0=V[?4BN,CJ\+%V/WZQ,-YF[']4<>%B['[]8
MF&\S=C^J.6G4WB+O#>?1DW3^PU%2<DE=S/\ DEZ?-U%2*XR.KPL78_?K$PWF
M;L?U1QX6+L?OUB8;S-V/ZHXZF\1=X;SZ,FZ?V&HIR25W,_Y)>GS=14BN,CJ\
M+%V/WZQ,-YF[']4<>%B['[]8F&\S=C^J..IO$7>&\^C)NG]AJ*<DE=S/^27I
M\W45(KC(ZO"Q=C]^L3#>9NQ_5''A8NQ^_6)AO,W8_JCCJ;Q%WAO/HR;I_8:B
MG))7<S_DEZ?-U%2*XR.KPL78_?K$PWF;L?U1QX6+L?OUB8;S-V/ZHXZF\1=X
M;SZ,FZ?V&HIR25W,_P"27I\W45(KC(ZO"Q=C]^L3#>9NQ_5''A8NQ^_6)AO,
MW8_JCCJ;Q%WAO/HR;I_8:BG))7<S_DEZ?-U%2*XR.KPL78_?K$PWF;L?U1P/
M98^Q^@ C[XF&Z  B/^9NQ_('C'_X0^+'4WB+O#>?1DW3^PU%.22NYG_)+T^;
MJ*D5QG7*?;*_?:G6;Q4Y$DQ5KA Q-GKDJFBY;)R4'.L$).*?D;O$6[M CMBY
M07*BZ01<)@<"+))J 8H,PZDJ0I2%I4A:5%*DJ!2I*DG)25).1"@0000"",CO
MJW(()!&1&X@]D'M&NQY0CD!R4T]Q?JD/=MU6=>J5N=LK6I1T@A S]@%6<>1\
ME*(ME&M>CI-VW1[PB7[E5XN@1HB1N8%5B&,0#5WR,OLF>K);<=:XO41A!3,S
M&SG*ZE15H7B8E]+)P%9GJ+L2N2-AEP9(K%81$::81.ZD'ID&2)S)$673%0G6
M6E7;27)[2D5O2G<;G5Q*;;][JZ]QK=8:P\T\1=UY!E,R0OG,ZU8*P4:99C 2
MKIJUD)!LZ=(M>V01."J/;U\[8!Z>7X_((?\ D'E\H /E#Q@ AF-OH^B\A[CM
MGCEN*4UW=:OM4K#?FFFTI8:[+M5H131_#EGJZDV6QR<JQ(TC(V^[:>6>R03F
M1,E'O5I !;*NC"<<IUH?6O)4U7O9=2OMFUK=K3B!N6N;<@&>F]Y4J3G-R2$0
M0T"GL/:&U-B2E5M>[D+6+V0HEEUC7RM'L.Z=E1&%BE&;=HI61'?.0FK=<6Q>
MC6>7EB6U'5%YW46!AZO9K%(.]?ZY7CVEJD8Y""BGYY"3:.91BW9UUB"U@EUE
MRIQ<<[,4P!5.!FH^R0<-8HP'@1T]$QLS'@^8/HM\#*59(/F@.XR00;2$:[[W
M73[Y8/6[=XS5[=!T@BLFH0N-?$5"NR$E:)7C?J'D54X9GV+OE#4)MW;ZEMJ+
M6=;U>LJF#^*KR]K!615V&ZE6CA.?=5PZ25DFF[->(5E';!TX1[QL*M@%S=(\
MCM8<M+Y)R_&#BK$<0R:;]OS><A[Q'U5F7:K*M6.-.:M:^VFA<N\Y6<G=B%:
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M'DRE2WG"\A+#2 B$X%+D*(8"5HN$,MJXPI<+VR@J6VZE$ ^T20'$^]WDY^]
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M4_00 1Z#TLCVUV0/1.HKU=: ^C-N7B2U>QCI/;<OJS5%MV'5]3LI5F63:J[
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M'DX<8+N0EC. JD(M6JQ7JZXEY&P+0,)%PRD[,* M+S!HQB@R]DY58O[%>3?
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MNN:K^DJ@>>E9]*8]US5?TE4#STK/I3/.J[S9_B;/]$;_ *O'>;/\39_HC?\
M5X]S-#\,)/-\B-Z9_*OCZ>A[JN;X%1O3SNGU3H>G2O15]US5?TE4#STK/I3'
MNN:K^DJ@>>E9]*9YU7>;/\39_HC?]7CO-G^)L_T1O^KQ[F:'X82>;Y$;TS^5
M?'T]#W5<WP*C>GG=/JG0].E>BK[KFJ_I*H'GI6?2F/=<U7])5 \7C'_/2L^0
M/*/^E/@SSJN\V?XFS_1&_P"KSY+M&8(+]&;/\ M_[JW_ /E'_P#IX'L989('
M5A)WD#^A&_FY_*OCZ1_D]U7-\"HWIYW3ZIT/3I7I+-739ZV;O&;A!VT=H).6
MKILLFX;.6ZY"JHKH+HF.DLBJF8JB2J1SIJ$,4Y#&*("/WR@/%( +Q>XY 4 *
M4-%ZG "E "E* 42!  *4     \0    !X@#IE?LY2FQQ$F2XH67!&DOQPLIV
M2L,NK;"RG-6R5;.>SM'+/+,]FNP(,DS(4.64!LRHL>24 [007VD.E 5D-H)V
MLL\AGEGD.Q3&,9;5=4QC&*4QC&*4QC&*4QC&*4QC-#>3QAU\9?ZP>/\ B#RC
M^0,4JUZ/YH<893?[[C QW'3'&ZX],Z:]-)*)=U/-($=+OJBUDNOL6[O$8P:*
M2DI3&SM2Q1\6)7SE@1$JW<MVN^9_&#;&W;5HK7NYZ/:-HT]1\C)U>-ET%'#Q
MQ#F73L;6NN1$K*T.:FNW.UMR-?<2)ZT[$K>7!LKVY20!4BV,:?V02!H&E:_;
M;DRL7*:8G-B<.^0VFR25XTU/2.TME6:Y\B]/;8C&G>-8I\,NZ/MJGV.Q3TPC
M+0.P"U5K)I.U$6++]/!NW1T/S6TQJ?3,'9=H:PC9_9#R9T_R'TFC$<@. *R$
M%L!Q*R++;T:Q0B&L(M9)5:@H1S]Y,2%X@K7'@VFY9PS%VC=F. %$;6YL+&>[
M?[[:VO>;AN&SF=DDY!PG(&.0U[ /-V3_ /&1\=92F,T+Y ZAT'H'4 \@>+R?
MS9KEI4*8QC%*8QC%*8QC%*8QC%*8QE.)+;5 A]G5S3TK8F<=L&WUB:MU6@'H
MF;JV&'KKUJQG1AUU *@^?11GK9R[C$5#/RQYSR":"C1LZ50D6XAL)+BTH"EI
M;25*"0I:U!*$ DC-2U$)2D;U*( !)JO'BR9:G$18[TE;3#\IU+#2W5-QHS:G
MI$A:6TJ*68[*%NO.D!#325.+4E"214?++N?FX+MIOC5:976+A-CLZ[6&BZCU
MY*K?@H.V[7ML92HV?$.T4 RL$G)N95L42&#OMHW,8I@*)#7HY9]SJTE;]\\<
M;;5-<+M&^SJ[+T[9NLA?G(DR<WS6-HC;G7HQTJK^U))3+B+/$ LL8J""KU-5
M<P(E4$,K9C&%VMAF<5R43HID<=_(AKCD;9>[.;(&]T9;V]JI6"@/M%S+8#B"
MK:^+EM#/:^;V],ZHS$Z<G^&E/U7J_B?I*M7N_P"Q):8':^]]F2,BQB&#J&@E
M)VQ["W!<H>-E+E+R-NF!4C:U%-0*R3<.%4Q.R:->U6H==(%CS3XD1G,[7U3C
M],\LM3DV!9Z)>:D^175=V?4%BL$)9:L:V-V4<M>]5[#3K,DWCR3C;N8LY1JZ
M,D44WB3OC-@;9D.R5:AH50T7N?66JY&*F78\H=![9?VF!L\ZZBD6S1SK273I
MLM"6M;7YITDM[//ZW.-F=G9IQ\6M((%3DHX>M<L.:L#Q0XA2/'US9=%2W(Z;
MJ=@US7J3QNCW\?KG6E4D0=0K"7>1,I,3;VJC7ZHX[1G$R3XS^8L7<56+(L5W
MTZ;YJW1<2.XF:9XJ:N[KEI3*#Z7%;32E@/\ *\P4+@J9*@[M9QEQB0-IM0!K
MM(E&4D;*R\5C:V\\BG,;6WS%LCL_U2GL;LJD\TER@UAMK3^L-GKW&F5]S?Z'
M5[:[@GUJ@F3J&>SD2V>OHM5L]E"NDA8/5'#4I5R@MW-(@J@503%"J'NNZL^D
MB@^>E8]+9YV8,V8  =Z-1 I2E 3MD#&$I"@4O;&,F)C"!0 !$1$1Z>,1QWFS
M_$V?Z(W_ %>>G.\#L-;KBVKX^TVIQ:FVC;T+XM"E9I;VS,25["3L[1 *L@H@
M9D#)FSMDDA]0!)('%@Y GL9[>_+UY#M[O1,]UW5GTD4'STK'I;'NNZL^DB@^
M>E8]+9YV?>;/\39_HC?]7CO-G^)L_P!$;_J\I]9N/X0/>C4:?3?'ZM:>TR.Z
M%^3'W_'^3N]$SW7=6?210?/2L>EL>Z[JSZ2*#YZ5CTMGG9]YL_Q-G^B-_P!7
MCO-G^)L_T1O^KQUFX_A ]Z-1I]-\?JUI[3([H7Y,??\ '^3N]$SW7=6?210?
M/2L>EL>Z[JSZ2*#YZ5CTMGG9]YL_Q-G^B-_U>.\V?XFS_1&_ZO'6;C^$#WHU
M&GTWQ^K6GM,CNA?DQ]_Q_D[O1,]UW5GTD4'STK'I;'NNZL^DB@^>E8]+9YV?
M>;/\39_HC?\ 5X[S9_B;/]$;_J\=9N/X0/>C4:?3?'ZM:>TR.Z%^3'W_ !_D
M[O1,]UW5GTD4'STK'I;'NNZL^DB@^>E8]+9YV?>;/\39_HC?]7CO-G^)L_T1
MO^KQUFX_A ]Z-1I]-\?JUI[3([H7Y,??\?Y.[T3/==U9])%!\]*QZ6Q[KNK/
MI(H/GI6/2V>=GWFS_$V?Z(W_ %>.\V?XFS_1&_ZO'6;C^$#WHU&GTWQ^K6GM
M,CNA?DQ]_P ?Y.[T3/==U9])%!\]*QZ6Q[KNJ_I(H/GI6/2V>=GWFS_$V?Z(
MW_5YM.S9]S4_R-G^#4_]T;_]@W_T\#@:CD@=4#V_+Y-1I]-\?JUH+,@D#E"M
M_P#9C3Y_C_)W>D2S>-)!HV?L'+=ZR>H).FCMHNDY:NFRZ954'#=P@=1%=!9,
MQ5$EDCG34(8IR&,40$66Z\-2E+Q'XPE*4I2AH#4(%*4 *4H!0H$  I0  * !
MX@    #Q &,\0E,B/)D1PK;##[K(61LE0:<4C:*<SL[6SGEF<L\LSV:P2QLJ
M4D'/941GV\B1G5<;?_T4LW^S\U_9CK,6A$1[FCXQ_!I?"/\ V"YE+V__ **6
M;_9^:_LQUF+.C^#1_DTOZA<H5+4V/9-O_9O\LO\ N_6C^S6F><V;H*PG$"B<
M#F #B4!.4!,/4"G$!,4!^(!#/1D[)M_[-_EE_P!WZT?V:TSSFS?A#?ZX_P!.
M=W>Q0 ZD\3'+>,1(R/:SMD3.OGI[,8GJPPF!GD<.O9Y=@_\ U-\9'3>=U>DE
MV-K^ )PZ_P"[EJ?^Z<?E#]D\4MOV;LL?'GEU%,*^IIG7/'6WZWLTBO84$+$C
M:)CW208HLJV9L9P]9&&SQ7='Q'1$TP.X$Q/\G$%*W]C;'IP$X==0'J'''4_B
MZ#\TH_X@SD[XVWJZL=T=U0)Q*O2TJA*QK8[?JO%>XZC'21(E@CVY57#'=C\B
ML6FNB*?>K5B94"+>R!@'D2XWF99<58Q<AADJN+^*+-(XY"E@0[H_*BR2V$K1
MLO!I1XI9*DI5D5(4-U=HVNQPK[A#!#4TOA-LC81OD;B%I;)FVF/$EQ0Z5(7M
M,%U XU V5+3F M)WU9!SJXE\M'O-G0/.KB?6-4[:LFK]=26L9C5.V9X]=9HI
MNG=M<MK3 RJQD&R"Y6]N>$%5L_92D7)L&3QLA*-7SU!MU+C-PGY>N.>6\>4?
M+J(T^,!R)XO/-:VJ(U+8Y)2/JLK)JT>%3HC=C.(*3,J6/J535+)6X')F3Z7>
MJ=XHBV(D.2W;H2EY?7J00J$V15S/TMR\181-BDI%"'&P1KB6*ZA*S)0UB?((
M,.[%DHZ-DV+LZ)5DA6( ' 4FSE0T9)L(E.86E_:'((,DF,798.;5=BP6*FFS
MBIJ4D[1'R!S")6[9Y+.Y5-42?Y4942&"Z:X1;VS9D6=$6T9HL+F&4W3DCHNP
MLJIXN;<-,A,I+" Q-"7FGFXR'E%*4ON/) %6KW!E8'[TN\KE7G)>(6L4FTB:
MV;/[>(MXM;DQ49493SG*(8+3K+DE;"2I2V&V5*),)6B>.'96.QW1MLX_<7ZK
MQWY(\?'-LF;3K&T[4N$E2K72$+ J47,78(EI)Q0NP(HW3?R+2++),G4BJ[D8
MQ\Q)(KQ#.NO9 N)?,7D-KCA#M2EL]06#D_Q9V+7=GW*D(SLI ZTMUE*E6WTP
M2K34\DT?)1#:Q5AD<C*8<Q;E>#>ORMY )!JT(YDZU,U?-Y"Y*,(VXPU"5/!D
MJD7=E)D9<)1%L_\ ;._8MK&Y=V*.@W@JPJ3-G)JH@:09RKIDR;M7 *NNPZX0
MGFXW[V<3E2 OLJTN(?V2,X/V\$H$=['J1_=SJ=K&&[5?O0B':(!T5[D0H]ME
M5SA(N[E[AXD-KP\B^1WI#\VXMV]YMZ]N3(3MOF&[-HF".OE<=]_E!@LP%+>=
M6_F'LEBFWP865NPSL,"[8D789+$>/"MKES:<9L;<.<S<80M#BX9D(,.1'8$;
MEST\-L-(CY%G-!AXY;<;N?G-3B]HN)VAKS2%0W52^7M5VG-U2D["?*U>*U+7
M8V<:M%5IV;;/4WUP2<2IDGD=&.7;%X@5N];.6JJCB-:\]S'XH<Q$>R':,YS\
M5*SJO8QJGJ]UJVUT[9-L7JB<:U=N[.QDI1%5$6JCU)Y7K@Z/&+,GB[F.G(T@
MO8E_'+@DK(_JA@W:6$#6VO7X-L :PIV6SOVMM5JD@D+Y4Z*\9+ X]I)H-VS[
MR"NP[,@.XTB9D5&#1^D]5-^K;#[;![;7WE!@Y)W Z^3;VRP))O@C@NBK]9:.
M=56-:K1KH)U5E5B3[PC5-RP(G9G]6-WT)VJJ.4XG"'=H7)FH]NL:($9C$D--
MK,22J N%BE#"+G#<29ID\2D1VN2J1)0\T4G;==!4#5F<&UFG<I=DW*_.3Y,K
M#$Y5UY;&3<&YV$EO+M4QM:8(CA\F0Z)07&6T\%#9:;*4D1?;0X@<TN,G,';O
M*_@;#:AVI5^2[9@\W/HK;DVM5@C[M'B9P:TUF?349MED';Y1_*&.K(MW3>0G
M9EHYBY2/4C'$5)!Q*D.7$O3+'+<OJ3I+7]QD+**]4JVEIF<G6L14R1K- K.U
MR,J59H\G@EDG[M-W#R+MDJQ>HHG29K-C)J5@V>ZE$*O&242TL#HS&X:_DWS2
M!8R3N94A&EOA7<V0L9'D&0=)A$D==_L4D5#JM@70504*)TQJ(S=$>M&KPB3E
M$CMNBY(B\:KLW:15DRJ%3=-')$W#5P0# 59NN0BR*@&34(4Y1 ,9=L73+W;X
M\.XVZSO3(T6#!3?1$>1>G8=M;0Q"8??1*$1WB8S3,7E"H7*W([+:'9"R"HY.
MSX+@V&YR9ULN=Z8AR9D^X*L!F,N6-J;<W%OSGX\=<54ID/RG7I?)T31$;DON
M.-1V]K(?ISCI111)FJ9,YB&[4W[(HB!@\7P"'C ?R@(#G(YQ<Q_S%7_5-_1F
MIGL'Q&MO/_R/M%15<GSG.J\.<QCG,)^V.<PF.;]B;]T<PB8WY.HCT^#.U]C9
M_P!$[F_VFJ/]E26=2Y._NW7\9_ZIL[;V-G_1.YO]IJC_ &5)9C8N^2/'_P#J
MJKU7\W7_ /;_ *ZP]-J.W26UMJ%36. !L_9)2@8"*=J7V\SX]J7NI3B4OC']
MB40#QCXO&.4\4555$!5.8_:]>U 1_8E 1$1 A Z$( B(B($*4!'X,[WMG]]?
M:OYT=D_WXG\Z!GU=M[;:8<-:6T!:HD;:6$)"C\"CLJ S/^9KY#7.5*7*EL+D
MR%L(E/[#*WG%-)^%5\5M2BA/;W)&_?3&,9?5C*8QC%*JWIW0^X.0,_*5;2]
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MU[>;2I1-2=^PH)(! W%1!3&()]]D,N/((WYA.XY[CCA 4P^0!'X/$ ^7XO\
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MI_P:G\FI_4-F[-I_P:G\FI_4-D4]D>,?;44]D>,?;6?QPV_@D<8OS ZB_N%
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MF[1VU3E&#A@=RU/U#M'"!7 JH&ZAVJI"#\&6R1_$^'B+%3IR/OMP<$J;]>1
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M%Y57;#!0ZI#6$;2\VE#1#NW$;"UJ+ =2E*HVWLMI6\I*U!/&<24[*"XBN/\
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MT[/E4?>IR63W.]Y->FFHKA,9S?M8M'S6M/FS/>CL>UBT?-:T^;,]Z.QRB/\
MIV?*H^]3DLGN=[R:]--17"8SF_:Q:/FM:?-F>]'8]K%H^:UI\V9[T=CE$?\
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-8QBE,8QBE,8QBE?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>g341538.jpg
<DESCRIPTION>G341538.JPG
<TEXT>
begin 644 g341538.jpg
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M?_TSQ\WZ]_XR1_\ VT/_ .F>/F_7O_&2/_[:'_\ 3/'S?KW_ (R1_P#VT/\
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M/;^W_'\_./;&?;WQC/MK\&/?[_;3[_\ 1Q[_ (:_?G_1Q[8^_/W??X^'7_\
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M765VU32123UV4554VU33TUVWWVUUUSG&K6ZKJ(.B"!S5]7N56%:L%=<DY/\
M"JGH1:)J_<JK_P#!3Y!])IGY5%>^C@A<::O'FJ4>DFGIEHJ*PX=#MX6$;_1-
MDO\ 6+KJ?#L[?N]M<85?/E<8Q]*X5]O;&,>R:">-4$-=$M,8\R/QX\>/'CQX
M\>/'CQX\>/'CQX\>?!RY;LVZ[MVNBU:M45'#ERX4U20;H):YW5665WSC5--/
M7&<[;9S_ ,L>^V<8S D1$%_4A?N(B.[F$K*$<H*DQ,JAMC1;3&WQI;[I;_#J
MY?N===MH*"VV^%/7_>\O\"6FFFNS:(B*\HBO,MFV60L&BS)1V^?.U/=17?/P
M_69&1<_#]/)2\DO\.-ML:*.GKK=%HT1]OJS;36H<G)9U<6?1Z?7QJFAJ0SED
MRSGZ-U*NDO?7#QWC'Q).)]RCOGZ)+W69"[)7.NN5I%911S,\7%Q\+'M(J*:(
ML8]BCJ@U:H:_"FDGK]^?OS[[;J;[9RHLLIG95=7;=57?;?;.?/0\>/'CQX\>
M/'CQX\>/'CQX\>/(FLVS4 M!&)B4<2QE+831B8E)+=ULALZWPBV=NVR.-E5M
MEE=L)QT<GC+B3<9UUUUPWQOOM8#FGFE<17UM&T=<RUERV=GK-F]VT=:BFKK3
M.-E%-L9V16)%D=OHG#A+_9X=OGY;&^WLX<+3)>U[#-(#.9"0RG)$LDFLF,C*
M:V$W$DX3Q[;NG6^/BV90S+;;39^_VTS^.K5KJL\622\U["(B2GQ*M;=MK*2<
M_)J).H>'=)93;1[9/.5(]12/4SNFS9,T]_\ <T-]^$,9S(2&5GJV<[3]_P#>
M<_?G.?OSG.?OSG.<_?G.<_?G.?QSX\>/'CQX\>//WE13;31/9579)/.V4DME
M-]DDL[YQE3*2>VV=$\J9QC*F=-=<[YQC._OG&,^-E%-\::J*JJ:I:?1I:J*;
M[ZI)^^=OHTM=]LX23^+.=O@TQKI\6<[>WOG.<_CQX\>/'CQX\?C^'E?28F*+
M3*$ZBJ)/9\^?;*H$! @ILFR9LD]L)2'^\$L;8:1+3&WT<I*)_$HZ4VUBHK5=
MPO\ Z[8S2-(B])B^D-#::OII]JBL1D:R.J3V9>I:YQKKKKC._P!3BV?Q[IQD
M8GOLDU3VV44V7>+N7*TT^//BY<MV;==V[71;-6J*KARY<*Z(H-T$=-E5EUUE
M=M4TD4D]=E%55-M4T]-=M]]M==<YQJUNJZB#H@@<U?5[E5A6K!77).3_  JI
MZ$6B:OW*J_\ P4^0?2:9^517OHX(7&FKQYJE'I)IZ9:*BL.'0[>%A&_T39+_
M %BZZGP[.W[O;7&%7SY7&,?2N%?;VQC'LF@GC5!#71+3&/,C\>/'CQX\>/'C
MQX\>/'CQX\>/'GP<N6[-NN[=KHM6K5%1PY<N%-4D&Z"6N=U5EE=\XU333UQG
M.VV<_P#+'OMG&,P)$1!?U(7[B(CNYA*RA'*"I,3*H;8T6TQM\:6^Z6_PZN7[
MG77;:"@MMOA3U_WO+_ EIIIKLVB(BO*(KS+9MED+!HLR4=OGSM3W45WS\/UF
M1D7/P_3R4O)+_#C;;&BCIZZW1:-$?;ZLVTUJ')R6=7%GT>GU\:IH:D,Y9,LY
M^C=2KI+WUP\=XQ\23B?<H[Y^B2]UF0NR5SKKE:1644<S/%Q<?"Q[2*BFB+&/
M8HZH-6J&OPII)Z_?G[\^^VZF^V<J++*9V575VW55WVWVSGST/'CQX\>/'CQX
M\>/'CQX\>/'CR)K-LU +01B8E'$L92V$T8F)22W=;(;.M\(MG;MLCC95;997
M;"<=')XRXDW&====<-\;[[6 YIYI7$5];1M'7,M9<MG9ZS9O=M'6HIJZTSC9
M13;&=D5B19';Z)PX2_V>';Y^6QOM[.'"TR7M>PS2 SF0D,IR1+))K)C(RFMA
M-Q).$\>V[IUOCXMF4,RVVTV?O]M,_CJU:ZK/%DDO->PB(DI\2K6W;:RDG/R:
MB3J'AW264VT>V3SE2/44CU,[ILV3-/?_ '-#??A#&<R$AE9ZMG.T_?\ WG/W
MYSG[\YSG[\YSG/WYSG/WYSG\<^/'CQX\>/'CQX\>/'CQX\>/'C\?P\KZ3$Q1
M:90G451)[/GS[95 @($%-DV3-DGMA*0_W@EC;#2):8V^CE)1/XE'2FVL5%:K
MN%_]=L9I&D1>DQ?2&AM-7TT^U16(R-9'5)[,O4M<XUUUUQG?ZG%L_CW3C(Q/
M?9)JGMLHILN\7<N5II\>/-:O491>UF+N@0"K&Q6M>MU,:24GJ-R+5T:+IYUW
MQC=%;1%RU'&ZF,918.$TEY1=/#E^EJVT;M<PX*L[T#H9O"PO.1$BW2_UBZZD
M?.[NW[O;7&%GSY;&F/I7"OM[8]L8302QH@AIHEIC'F1_/NC/[O1%_+Y__+X^
M?=&?W>B+^7S_ /E\?/NC/[O1%_+Y_P#R^/GW1G]WHB_E\_\ Y?'S[HS^[T1?
MR^?_ ,OCY]T9_=Z(OY?/_P"7Q\^Z,_N]$7\OG_\ +X^?=&?W>B+^7S_^7Q\^
MZ,_N]$7\OG_\OCY]T9_=Z(OY?/\ ^7Q\^Z,_N]$7\OG_ /+X^?=&?W>B+^7S
M_P#E\?/NC/[O1%_+Y_\ R^/GW1G]WHB_E\__ )?'S[HS^[T1?R^?_P OCY]T
M9_=Z(OY?/_Y?'S[HS^[T1?R^?_R^/GW1G]WHB_E\_P#Y?'S[HS^[T1?R^?\
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M9_=Z(OY?/_Y?'S[HS^[T1?R^?_R^/GW1G]WHB_E\_P#Y?'S[HS^[T1?R^?\
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M;\Y_^7,__*>/WDJV_.?_ )<S_P#*>/WDJV_.?_ES/_RGC]Y*MOSG_P"7,_\
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M*7SU:23>R@:0GI_:)##BM8TPKXO-%1T3V,H5N2H$#.4 _P!0'CX^OC?F<0O
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MLJK<R<J$24H-D$2RF4XQ\.+0&_\ 2PZ=CQ=<T&@ZHVMU&5K7><SCN#]0[U#
MZY*W9F]:TW65=O(?O"58619]RJ(P]-Q:EU5Q8-(0E16(EFO4(D6AWM.1LJ8V
M.KKC7O.L2R<&EB+DFWPR^+"XJN'H:\K)@YM&PXHXYUJ*AJRN!B#<^Q]8.ZQ*
MOVC.^?8(HITK>V+7N:+(#&5G4!(@D0X;P_@;I;T^K/J3TX84?;2XG/RO+?I3
M^I/09'#A\822SPW/.A:F#$H"2#(CY0Q=3;9.6!IA:;;R>L;-S#J6:8:-W3IV
M\40S@GX2[=N>PM>G;'8\Q#-N"#;TZP^OJJ [/M%:NC$&X_ZE==+V$6FIY.4H
MQG LK/',_*0M= \6!&T37K%FI'3AJ5JD:\Q"]5KZ;O8-)HRTQ0\IRY8Y3:E"
M]0\RV.TNJ2L$9@085N/K:^.CJ[LP->CE<F\D>JPD3>LO 6E2TTT!8HUD8 :5
MA[,BFL8JN\E*"]+(Q"J1OVEQFPQ&40L(S]-EV$%$\REF,KL(<+!_* E-X-4(
MZ->Z-YXLTY_)9& 90[B5BFC@ECTWCQGC:141L]VQQ-,]=%=7;:&<<'B _5/9
M-5F;O#9X]*$V?45$+T]'3(JQU1Q$O'@PX=KS#MM,2$<DNDDBDW544WWQI1QG
MZ<?6UP2-?D/0ZG*H5)4A6_&%$ T!3DD>E S88/SSVCSYU'9I^79**T#7 ,Y)
MH;GV$&:JI2+9FT&$2<Z0.)NSI5H];JM-@W=?.]JWA"<Z&E'NP%:U^5^H0?I<
M/#;4E9\=KFRLP879-8$X,3%8R/&4T%KOPNUR.5%#%F$F.!XUAQYV\')*-V>Z
M::D-?2G[1C3Z;Z5VE*?GKB.;S[.L$EIZO.Q>S.2PB!%.J6_-<T+8B^B.?!.&
MM$HGJR*>=6$4:#9#7Z(1;0^1*D4<C7Q/ P;1"PP?Z1!.''/"&T18@3$4Y2U6
M42+]:5E!-;#^7V^8<>EI9<W);JNE3$F."!B)@=[66;D4XRL<Q))M\+0H%":2
M#M6-<90QP?\ 3V[=HK)_K23GD"R'%^T=8U!V(^O=P?J0M8LYSL;K7H81/8L*
M:UD6Q]_0K@'ZTGX&P:1+9*K88@*@R&2U.W(S-2N[?K5UZ4URAW38[)3;\(+:
M&$^V3;M*(/I?J'LK4@2=E$H4V%#UY"\-PI% \CB9<+V:7OH]M=36=EH][6K'
M5J^J-T5S<E()?T :X^'777[O]'&,?=CVQ]V/;[L>^?;'Y8]\^WYY\Y\>//SM
M\7MCX?Q^+3W_  _^/QZ_'^/_ /;[_P#/\OO]O-'?I3POK11=Z]BK^IX20TW2
MCR=CMN2FT8MSXHO'PN#ZQE)'5UK3D5'D.GQ!*H"DG]N57+KX$=<:YQ+XF=][
M1^L#LTT],7N+>0V:ZQVG.E@;R6S[*.&.D;HR1VD-WV7/^S:L=6>%]GFSG.&^
M&V%<KYPEC?S5?TE<U#U;>QGT)Z3K2B#>PJ5].SN(^Z34Y<:@1+6,HS'X8'D.
M4!ZY4ZL9NQF?/6ELLRTHK""<R"1UI7D'<2+;ZN+S3Q;>#*ZZ0O"XGL$$'=W,
M+YKL4[!](&Q1\BD^@.9.AS<>-K-[!=-Y/58KY2JRO:WAZ_L</'X4R" >;6D#
M,0=14TNSTR#$HTHUD*K.S^OX2I^-*8%"UF/E7J,<P\N0/*9 *U!6,4/4W<H;
M:TK']ME$&'C 3$!",*+\MS4-?,"*SL8Z'FQ&%S<7#1:$5*N&:&"M_49[->]!
MV1+(VZT&GNET]^59(<_$EU\P/VP97/.E>]*2X&L)<VQ-2/>F!BT@V.K:K;BF
MK&M$U6K^P($FE]'[9@)G-6,(_:PM8G1-(^C'<72T]T,6VATICAT^ZC0M4N$:
MX08"%FON=TK!8L JO14,@Q9K70:2-M70T(SC GE'+;+EM/D,^L\RIKK:DNJN
MCM[?C.<.;_4C*.@JYM^<].N0ENHVT#S18)53!1TW85[#%PU2,.!*L&E?1C@W
MK$$@+1K(6-!N:)JG>(ZRJN9\2F&L/O)L/UK>HIT,S;?OED!S=(UZC:?#[3T]
MR!*H4'!CS) C6(II<1#!-*VC[I_:P5!C+3KJ6OI@5Q%0ZPTFL+-!1@(:)QFF
MN,G[,N"0&..NJ6/<ZET=(SOI]^I#UC8-8+P=&*,N-KK@:AJ=&5#AL)&PEH7
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M9K^H-!AM]J'#%H\#SIB3#MJXDG^C,4T%9::0=R4-NP=NH'D/5ZA[, >RI4,
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MQ.;%#QL/"P_!HR!4JGIHY*7Z,3&LT79(\RGA1W.K)[2:ZF<YW<YQ[8QWOV>
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M.VUNUO!-ZB71N*5YB$00  YA_9<Q5[ZX*R6*@:LP0+M=G3!R"19V+CJ3!)K
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MUKQ Y,@%%6383N)0CA"V)I(Q$HE^//6RK$2+B@> S69'#:;C!]SDO3W>5/\
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ME9<4WD2WXS@MALGML\G5CBX3DS)7A24*DJL$'Q^1^%&!9TA$RKTCN16O+B0
MRZ^8+FF\NCU;=!U;:NR<#JP4"$C:FZSJ10?3^.6?:$&\?K7FT[K*;:Q.KG:7
MQ';1R.&.7CNDH-Z79BUYHMRDS^\1IZ56[Z:%,>G2^*@^LY:,@(%G2$5T4+CU
MKLQ^</I62D'4T-W9#*S @O.-$VTZ*23AB0_4)]JS@XV;>C1%Q_9KN_FDIS=(
M5U+=3Z=@23\KYD1+NIV9VH\8E;^LQR[)X_>@D16FUGQK4U'R'6H5+5"X95V%
MCA6W<?+S&/WJ_P#QQCWSC[L??G/MCWS_ &Y_+'OGSGQX\>/'E4NXNCB'D7DR
M]^DQ2JI6[R*G@)^91%40DD^AY4Y>,WC!JG!,Y2-'"Y\Q56U>;+Y<-1N9533;
M[YPQ4QG.=(O],SM O[]Y$!>FCF@B'F<C,""PX5W413,RD],P2 2;3 FR?N9*
M8#0-^KJ0-(Q*9125&VFC=-WJ@BN^2TU>*Q+ZPO3"W/G*4>*P%IR]+6!U#;U:
M\QAUKC*<D[*ZIB[#F-Y&WKA'&$"V?$"DS4=&#EDG4,ZBV:F[(CBX'==9HDI]
M8TUH5OZO&0OC7E^]K#T/;FL.D GO"MK?Q V41 S2S;2X\%8T3A)8W%Y8;41(
M'M^(NZ^L*&DR]G$YK;6QU3#$6_4258[[!N3[A[%(/4,N^F^L$JV&90)XBYEL
M1B&T98!T8T\XE;)O3I>,D"6/9'PN+3,47LFP6B#3K]1N^2)XH8@2!KO"H2&!
MB$A[3N_IY3;]F/,-2U\5E"[3U-[H("KIN]K$DXN"@.0.Z9VBMQ**4&P:0)'R
M-B[RFNH%#I+,8&EQUHS@/B*X@>C6DS;VVNX3F*XLYGZ9IVJ1P@.^JIOC<;!:
M\L$Y?C@V-2?7Y !0,:Y*C ?&)M^XCZ_U.M925^4CNSH@0A7#..19.7[?9&J8
MIZC_ & 1WO"\:;T3S\AT<)75<%<WR=9LVP]*3&Z_JJJN7NA&%K ,-J%N3TE?
M'M3])1L!'UK*2$<\&[+BU-)8O=B.BDHM@:OK%W35U.P_4-_\Z@+.B^A.7+LZ
MAY-':SLN<EK:^HU:Q$2(+K:^\3XPV"X*<MX*/QDA1+ %]-P=<2S<@%IZ,G46
M4<2RGU'.U.SJH[Y6JKJ86J_$L25]Z?E?MPFD[3L">IV)==0WUU_$S%G1C,Y"
M(2:2-AAI5" ++(+(;-C2,@X,A3DQQLXU%8NP,OW[TC9EG2'/?,M*U"ZN#2[N
MQ@YN07/9!?#5DPJ[CAQ1L.0$LGJ%B$N7N32PB_H$"&8(>BVFT..1V2(MDI:7
MQ!M!F=R;A3I#KZ[.H^OQCH,. ZZ 0@%Y ) "KX(\C#\JJTEMJGW)>=B<X6#0
M5&"AHCF72=K+$T&9$D/ERQ9IC>RD2_65;5EE/6*L&L;+ZP:WK4]:@8KS[6O4
M5C1-*RD_<03U/+07.KYUH*$T0RL&IH:G[N";R@&S4K;DO/)><1E0Q)(-9*'Q
M5HK.NH.-8/U)NB;O-J5KDA']Z[E(WL7C%64/ZD$^JZ^K0Y +<GKD'3RB)I7I
M>DJ:G9PG")$)B79 M"H2(U8(M/P9(TBA1W'S XP\RNO7I+R <G[8E.<71%51
MC1]B6Y2\>&#'2<#/C$Q +#B50@5[6G:-%"E";[7NB4QN[<XJ<Q)Q^OI]N]&$
M&ME,MV!<ZL\6=)>IX+]"<6U/9%;<P L0<=AM:[LXKKJVB0K&+<J:<Y:O2VG<
M0)#Q+7"]BA<_7,M6)%N^>%2 >W/B<=K387EM HRLMB!P"!^J+T$SYU3MJH:2
M&C&E>3^0:)Z8ZM>7A?1L37J3CMLQ1D<2(E3Y-@.WCB\VKZI@UV:RQ;:>\'''
M!',0@!&,X?5*6+X^SC?U#^DU.@$F3FD*=9<PL_4&E?3T>SW[3#!Y>$R6N1SY
MN/6]$#>@:W!8H/8SBK86G0^3GGI%(8Q)$49+1[5E'QLUU>L[S[8!^]=A;E>+
MK$Y'X'T_R>ZS$#O*SSH$KS1Z(WNBUT4&V(,'&3MY91K"8>"D:1R3:/@Q**9+
MR$MB>U4:#[V!-/6V)RJU>:WU=UG5TQ1=V3G"T%.#F2JSRN_@Z)[CBJK>1%A'
M#^N:W):'I)A6,E;X_&N*WND\'#ZS64++$(M\G83X$W)^]CUG;$KZ9ZVD;ZIV
MMP=K0=77;84!SVO/W0&]3)N:NL6'K\'1F(:PZ?B@.V@&W42&")W-N<W2MB"=
M6,Y>)8/$3W29BY9UT SU=.FCDD@^;1VB*WENFK9M@+KNF+&E1WKBGN7EXV;K
MBZ[5L]Z4*WO1-<VI(E%&C5$D;)\+AS![I9+HQKJ5CY0&;2)5&B=YO2YN"X[F
M!.JYB\GF,G =WOU95:D"Q+I0X& ^-K(JA1-J,@I#-0HW)N09!PQ?2HRW>CT(
MZ8L9?#1W'I.TG&ZFSOQX\>/*N]F='N^3>=3:](ZNW]L2PU,5J.0==QA''"+T
MJ(+0M4(J> CDB268R4;$:ZS)PQ=KNWK-5#5!LKIOE+X_IDZ!%GJGG]:1%Y!-
MN4A1U6=#T-<U,UH9-#KL" $.5V09?E>$=DUM<+GH<RJH:.5H239AA8"*UZ.<
M^D]K.+/81T/#"<F'RJAS&54)/5TN^U0$-MD-J;0%Y^+/3X]3J[+-F@>YQ5W:
MXI:'$]FCM2R,K2D^4TQ-CL[%,9OZ!W6I(6"3>/-(:T8XN*Z]B-ZW7$RVRF?6
M9KQ/KI'FYF.U[+#;7J*&XXDG2%W8<=*:VI(9C!]U8*'-S6L=F*]"1%C2C8$F
M3QU;,46(Y3D#M&NOL$TTE7$0%/J]=+3?-Q';8WR,+UIO;G#'6/4_)TX0W_'F
M,JY?\P1HLL5I6\&LJG:10JS=PQLQL*M$H(G.=C2.A_LJ>MJLF)C;:,V%6+V#
M9M4<O\Q';ZF&!WTITS/4=5 74$/8&L2"8N&U15X5S&Q1;&0MZO 5P$C V:&)
M(51=<3DMO%0&T:/B4I+/V#52ND=ZG%Z&!( T17G'L++=8S=A]4U38X"5]#:B
M5,UF6\K1-0%4O-:W$C3L\5&M=62&7;7\T ST)3K4G3?DD5$%(;")H$LH.SC/
M>H:BT].,'[^&:6(B5V?AE%SD'1JQA 0D_L4W?8@'6# .5-]V4D.Z9A2DW32W
MG\L?J$BRC\N\(,<._A;5_7]3^_F-L9Y-=\>B#SLG6^X&FU >%Z75<48F,&O.
M9OTH&W3M<\I1L27?8?(K6IX.%\#M36IW!E8YLU@( O8S$([>=H>]5PQ?9A;(
M(>6G,)S%;KOK* YNM-K;24I8!T3<G UL6+(?M0J=2NHYC4@E< E1-M354$$=
M8EC2F68Y#IFXT+2)2P8-H\D_6=(JD ES+J+EZ.J%<\Y/ .N.>8T:O^&/(XT%
M+ M*J*93 ;<*)JNJ]BJ:.A ZO>H%S228)637S .)Y<BB2R8<B4I#+_6N_6-*
MK?>C=7TY0E3W1?9/T#FB8W-7]0/)?F5TU<\\%?1C6SX^_IRAA\AD1*#'P8O$
M+ @$:?U.Q8W@\1L:/$K.:@'LCM0+N@&@CT56//C@9</'UD49?-UI$Z4JDBTB
M4*,*:,&'H]O%J,=UWJY"I=C9ZVDM'C9.-3'G"*S)UM))*,]8P_ZQ3HPLWE$(
MA*1KT::=*5'R-;,>PN/IP=IRQ31CU8BBX>0W*H^9UTSK[IF9H5NX1VMB TMB
MM35X_P [0 &'$D^K&,)7O\_^L]6U]]3"%%08]7"H9:=GW/4E<30M=>Y?=\20
M4UD]_P#YIN^A4:SB6]35S96:U*$P"=1LXPG6CEX$,3T9$7YFW:1DK]0>I ;4
M98M^1H%S>K:]/\:5E6EN]@64XL[0*)A /LG>=FE&-'5S]@2A*Z3(#K 9FK4-
M(2>,ZIB?DOR8='"&;*9?=@P^W!5V7V>F/J/GW1DBHT!ZN[!L^KJIC6IC#$XT
M*U?2D(U;*:P(S#5<&S<"N]CW+0H(7I"3GTR3SDTY0:ZC3. ;LI*$F'J]6! U
M;O=%O\AKU^!V7Q]8O;?+Z<7=K$M*;"JNM9&NE9<0N6*UK2%C:/MI\#6_65B1
MH_#35MC&\1-3T&L7)D@H[8OYTZ;]1XGI:Z9KG>L><WES6LH?\P5B$LG-I15=
MCLX3=/!?3AA$21%-/1$D6%Q(";\UR2YE)M(XEF5X2>6D!T?E9>%;CL_L]AE9
M5>)BUYQHP832T<Q5EV,4_<2L8SDU&J6\@UCI-Y&P[J18MGFRR+-\YB8QP\;:
M).5X]DJKNU1]+QX\>/'CQX\U==T7UU#5/2_"0%S*(PEFRER372D.45B7V$RJ
M8#G6H?3S$H@2,UL76O;/)8&%#93"CM)N'AL[.3$I),&&T:K'[.WC"DYSZ_ +
M "87(1=5@$ >)4_85K7!6UV]&Q-62\1,U7<MJ4"64G1$I$5K83*^;;DK-HVU
M6(7AZA6%?S$/%"DA,F8Z\.8N,9V8V]44YFK&=N0/F#6=YC&>B..>>3.[2"XV
MPD=9ENW0CG@JK$C"J16KN2<R[$%?]*U]$V_$&!X"2T*W7<O0M,W?,9:&BZM)
M>NJPM1I9<+28;5,G,DM/]?$_-^T+>F#"S8TNYN #PT@G'4%1IU,WBJ*';-A
M2>) 1XQ/+3RBLRB VP6 F1DK9DUB^G^]^QQ0-Y>%FF9>TK9+[K],RN.@'%T7
M #2\ V&>KZ:,++G9JO'X3S2#N&TM-Z-VRY8F]CW"<#(MHZ-"6RD2W=+.MD'#
M'J42G9-O6+73FKJXKYF&P!7.+CR'14 0]*5D\%K$P")!G4G+,^#U]8M)%Y.S
MWP4C[T7<6Y6^J#24'Y6PF,WI Z$GYE_4>.&EW$D9%<V[2?*P-V!7/"9G?REH
MZ,K";WS9;L*%HV<'*,^P#EI-4C 6K90#512=O;7@REK.RTT01%?3 L-+R+["
M^%NL[BAO3\Z1[4[03GG2P197:=HOX0>+!JPU(BJ:%.S\:0!:YC82O*L;1+,>
M;5E)BP]!3C@GF2.6:J&LP;IX,/D SZ(YZF%L"QC 5?TSR@PIRT3:5X[E@X?#
M;QUM6!<UMUU=B%"XDR I<50!:1%F4H<N&K.RJ]9Q<Q!22,E#/ BPYU@[>NXS
MW#7U)SC-W-.=J8YJ2L>RY;JFWN9X]T47$SKT*C&U+T14%_%MI%4RA7Y?,1PY
M]FK34@V<#!CY*0.".)C6Z*:K(@7=P,M]0=<7K6-WAO/7.?-HO?5B$E"6YT1(
M*G%ZXI$9BQ.HBROA!V,-9)"K+1>R9J:R]B1+ .04C8T=2>H.=RJ=@(A/>4TI
M>V]:&6-1F4LVF^3"(\J>/I3CNQ8R;F+7A!,T,++[ZCAJ,YGHX;"TQ @9)3^U
MBE<7 W$8SQ5%"-=AZ;PS@W!Y):MPUQ(KSU-;K8E[3F!QRL'_ +]TGT4THJ-J
M='H61QSVZ&7-!ONF5KUUZ)=4:U*LU['57%2K-Y!(T.O8.;(8["#4;<Q2NA5Y
MX?"WJ%V+8B!\,W0(2^YSK,>IO;'U-<F'7R5=C'(783.AF-&H/X$?9L2?2(T(
M-&,*>)8TP]BH!%X_8O7DKMLSR^MO4IO2^%((FH/BM[857147RBTM^;=7A%CY
MX(GO5E.UC=S"( @7-<R<98P-3 3<U9S-TGDH9@+YA"3,_(@@8:O@V4AW-.03
MUFK_  OF[EHMO2E:'8VG=XS>I@](;,ZAB^<:2*/V6W6^K@?I^K+>*Z==UA+=
M)&D7C>7@*W/IZK0S,#$-9R4L]!6=>,Q_;OV=U>\Y6IT8LMH/5FH[+CD8"$W]
M\WT&<[U(#;$,3,S2D[8]FR+$Y?ZM$$H12!B1VKP>T38J+Y:"BX,<4A%I@GA-
M;HYZS5H6M58V=T7QW!F\UKS-T7T]8S(EZ4:!P4."_+E_'] 6 /!9DWILDESV
M5.I^O)6<I24=A(?"DD$Z:.;!7K+[_I,4Z[]5*]9ZD^A37E>GEA^J*8GN0J[,
M^B)ZSQR(L<5M+IC?G.Q4H8.I!P!ET*8BP/7%^U_$642RUBC<@E-&,@V 1LOT
M%W\AG^AE/.<ZYSG/OGXU,?X:J;ZXQ_AC&,>?OQX\>/.,X]\9QGW^_P#+.<9_
MPSC.,X_PSXQC&N/;'O[?\]MML_KMG.?_ +\B8NHVKSJTZFNDK&=9>QJ,:6*T
MJR=7E)A%$3S:T-$CAR^;0S:00A'LQ+#T.A!MIJ3CGLK"Q+R;CX-W'-B&<3?P
M(9>GAQY8)+:149TW'S\A=3ZPY*S6+PF-=!LKD;9I 8YSLI^Z%&Q(@-M'QM3P
M6*"I"[BXQBYD%H&.)%%<%+?6:\[O-O"E!\LEQ=8M>ZVJ1V4>B ;7I98UQWG<
M%XFDN"UT_GY$ $E)JTS$HW:0P@L3SFD1HP19N%-9%SO)NI%TLHXWR<,Y-YM@
M)-4O#@MMH^D1KH(1WE&9:3R;=P/=.W(M>MYL$\*$#MEG[96UA8DW<I:X=CJF
MN\(-KPT+IF,Q#/4_"(M=_,5'<H@NR(55516QR3,(16I8=PLLPJ;FJP@LB3'1
M4X'7^QW%F;8;#V;01*$YYG+M"!JPE'9 U<:*/\9_1W!O-_/\T-%X4.%DM8PY
M+6N1JVA8=GV-95CE91=[&NHFS"<]+C4FF)(XG)V%J6MAYB](\OM149#((;$4
M8*#:88;1B)>E5Q*(;V$UTK*?*!(^K6SZ91K4^M.TCZK*SJ.ZWZ4I;E;4=7!2
M728I20C8$BV8+3T;6<:.[)M8F$AXEQ%0,'$13/%H?TH>-,0YVST7O(G-296H
M8V:N DZNZ ,[P&'W/1!+&=):BUISMCRA4!2]7OB^9W@5X!S%2#F)))1B1[3;
M&<?:O/5<>DYQYH%#(@/QMU@\D*G=NV0PM$$Z;Z"$[O?%W06D9B^G\[<T78B5
MA3S6XW,+$2I[$2LXYB9*?B8@A9LHZ;AXE^RL%2'&_/W-IB_+*4%I.O=)6I:@
MI#<-BS J5KQ(+H>(?058:QH+*2SV 9D8Z+N]QU0J9MM9^7@VS=K-/7^S?*^8
M>;>E_P @_;0N*IH1.#*#*VEW,TZB.[CM8TH4-QTFUG&-\+US29"6OJ\K]S9S
M(I+&,]N,0K#5E'EQ7'CJ<(Q(I5NY[%?>G+RC4.^"=ZE:9S.PYE4I^S/[YZ-N
MRX"H?7H+[5[4Y"LB^S[ G)"/!:\7.S*0BQ#9U@>?S!/-3Q(UFYM\K(YQ$8]*
MOAEFG844D&EIB#DP):5+-JJ++UM\WJ.G@:W'S"2M0)HVMI<\?BM#)$3Z.A]U
M/V<,!N8%VL9$Q DZ&X1BTC=,C!O3?Y8#)6(D8Q[;Q':0E>M;=)/;7-NC+>L&
M[Y4\KX&+*N FQM8I693!>05RWK$K.@!.LYMUN RHV3%Z3F$=2$Y-R+KR2/TG
M>(R30#CU:],H86"0 #JB1 AFZKD'*^M>L*M()$KK2O[["XDX;0-ZBH.03$R\
M@(RSVA'A-E,S(\]4?#$O(PCFPR'*'.3E1VBV"VZZS#IO7K!\DB6$ZRC/HO=N
M@\U-76B<]MNV7V:NFSG446PF+Y;N$%M8'Z%5+?; ^D_3^YTZI+F)]9;:U8<U
M:UO,TP^):EOFYJ5E"*FBB;0(2VJBK>K3861(@DKE6K1S-QTFBL[6RT;89OV7
MT6,^1H5>E+Q^3D+Z;;0EK@\6Y(ZC/&%>5?T!=%95"/6A1+>O8^JK8':C"S6'
MKR+L@/B*IKV'8$NH\KNJQ%(O+QJX?);/MN]&^EAQJTF3=[,!9N;#!H*W&$-:
MLL&Y;8-Z<KP6Z$?YDKFAZ>JXA+W@A4R!VZSG5RJ"Q\.[@6.VT0'N!R(VRQSX
M;+TL>0Y<)DX]R_O8V(B UKFS(F_";JN_#;H,;**CBB6!JR3 +^F;$D[!%& 5
M FIS#1D2/SS>#DF!V>:$;&=5-"9:3M?S;R]37)@'*UU2(_,P0\0'1C:!*L1F
MQK81$3V+8DEK-GAH0EA_/DA++SQ;.85FIIT[E-]%Y-RZ<I(H?6-]/+!>/'CQ
MY2;U$.;27KGDL_Y^%'R49*')91SEQ([DLL'.F(\$W[5U@E[N&*()!Q,P1*W$
MA2<5%9*-U2=MB72*W2=LMO\ ;$(14]**G54-R52\.H]^@M[J8WGGK1:Q@UST
M)]IXFJ"2B8B"3D7=8N*Q:@L73Q>4 T8(-*M1CXU(@FBECL@>2;TK7^*'I'\[
MHB+8#6L7HZ4$M!WM0(DXR>M9L1OR6O>]GD.0W\"E);.B4@:S\4]L*#8V>,ST
M@1J'D,;?3J.R^7&UMAS$EL_3LJ&+OUQ=,/9_0\'"R5NI]$S7.L';SN'YYG[X
M1BTXQ>V)8(CHAL4.)&0?Z-"B=#D#AO4Y =-T3:>K^1)E7,@Y]-?TYN:W%6UA
M3RT67[A51\ZWGRX(-OM>]^OIU1T..#(M9#*2D/J_TTC-NHD3B-(F<4U3<1*^
MCA=)-39QMC&56%Q57MH\ZUAST8'=O/%J95K.<K.\8XLB!Z^!*P:E;)LPVTHT
MM@!:.%_MNBT^NLIO1<(6$2>)F)V!(1.1@)J0C%_&HS@&BZ$(*]-QYY8I99(+
M(7V0R-F6&:K$QK9)ITL\KYY;1Q93U./C(V<(IC6KPF-A4HF)'QX0@(-B-BT#
M%0+-E'-8KZ<X%C3#T[=.#Z,7>P8S%J\_#8\YFC::A9V+!JVORL; )7#,[AVN
M\['EK41&)Y48FF"*#U$ETB=TG+';'UQ#-J?].FF*GL.(N:0,+CMZ\(^U9:W)
M*YK>-8R?.RD@=TN1<_043/Y'!82&-0X(JPIFX0-$8$;@XB)DI.3)W*4B2S$U
M*R4+%'I1U-#,[/G:T++9D7_V.ZD7YVI$]LYR^YQH"U>H @T';",*W#6\ G*P
MVY0X."MC]7)ITV@0&!.CF,K4>%(X@>L%,8I7T>*7AJ1BPN]SJ]+=.U^9JDYZ
MC2$GN:6?ON>ARN9$&L-I"<U$X_"B,X(X@KH  NPH0Z(E"FPWTK7=>ZS1&^A1
M>-@D;25/P-6M:%(;89#9]_WC:09:A-;[2S;OLM(I)9 H):9F*#RR<1< ."0-
M"BL+6LY(1D**A@@*P^DPNN5R:$J3/I&4>9-T[QB%=/$-?&4C9UXTZ;5X/60#
M,3&ASQB#$$[6=OIBF++K8@<R@T4ME!TJ<@H=)XEX9I"'8Q+CL?*!1B-/<NEG
M,"2?I14&\A:Q XZR>CQZEJ[ >;JXEJ"B[81>5):([R@\@WE+;V!%DHL0$K6:
MA<C(XW(I^M2JN94^:P46F<.)[=IHIY(]3>GG55-W,VM83LWH947@#*U[%KOG
M:5MATOSE5I[=J\LZL<E#*^80T;*+XE'9*8/($6-"LP!:^=F)"YKD5$UEV.\?
MYO17IKT1TK9!#81>4W2)LK,% H!Z%K6L[)6#:QZ= ZZFG\T&"%X#R4._D96,
MB,3$Y NWP5.@I"3!4W) 9=-3X<JC"(6CK"AZ\J5O:;06CWBS2Y+4.KA.6DZ]
MS-MGY=8J<<B4:H(.TOHF\*Z1BVR*,/G15L@CE9+&=]%<ZXHN*^D-R_ #!P"S
MI5T%9(#/\_G7*];!5C7)+3L)S?SW8LC$R9/65 JL8V'FAABNN+@S1B3EDN<G
ML9 U\#BC$K1%1]"%4S.L?3*I6O[ UMTEL?H&[K?5M&I[=D[/N>RF) 22Y72=
M=VU5E<HKQHP)AH;%C\(&72:L51X:%X*-E))PV(Y--T1[2<I*;&<8QKC&N/PQ
MC&,?],8]O.?'CQX\>/'CRI/3?'P;TY,5.7R%CW-3]CT?+&$U5UF4>9QHB6C#
M\\&M0\IPH@0#)B)D<?*CGTT<K#%@Q.0VNRV)'1AB59QCYC6%]Z1_-J0P$"]7
M67TS1>HW5,Q29Y/TM>LH.%U]5J2'A/99-$W83RT432LZ13UE&]FFB]G"BP3:
ML40V582@T;P;<A=,T;1+<6T>I'G,6G'$;9E8%]\^]'SB2)*^VV2LCF1G0S"J
M%8]=SHY70A8UISA624O%+JN\SV64NK(.MUIIVIB!0OTM:'!Y2?;L[&Z1EJM<
MC5V"E?<^3-R2*U&TI&]!LY..LK]F(E&PT9+8^GCIN=C0UG81+8$/5T9-R,96
M<:)L%4FZ.027IH<]+I1RD#*6@%SL,:\EGL(4C1<P4FHF>XQ'4P^H\()$HT1P
M#F/>".S\;-V$I"/TB:/EY%;3,;)Y9OV?LTEZ?-7TE<,3<C>S;]LV2!PZQJ[I
M<5N*QF9T+T2 VL4CI6:B-=.U!>-.Y*-D%Q 2AV+NTC>R9N"&AN,@H258-,O/
MK?ES7ILT3-] KWLN572SB)*YP[I0DY[C+(68\Y%G2%?QL3'AUY3X E$?.532
M%6'!,@VBHXPC:^FC01&3HC")@PBDYK>?1;EBEQ;G\LYBV&ER*F#IO<\>8BA-
M)OI3[11%_%IP8V;#R$@CNS?YCIN3L,G;I)MUD%X^.=(-6KC3=JDOBG<5Z3-%
MI"!G#3UT=4V =D"%%10E>QW<S0DNFFH3F(ZULFC!VJR/</;CT9' 9_A<J?*E
MHD8S-C3+E5Q;DH>Y3:Z-I5HSTYJ)H@I&3Z)G[<.[%'[3NBZGE@6A82I63%=E
MW\!!]<V81DVZ$3$1*J<H.@\"E$0$+%0@T*;(9:C,/%0Z;**9QWU'PB7],=<U
MI;J-S6Q1P*&\LW?34B64%8R #:SV;M.SZ=GUQU7$J'%D*\"I@2"9W+Z4W00)
MA@E9C<V%/X*?;H3K+/-/3*Y,:5-9U)08B2"]>V: \^5[M&C)N10TD!QO*T#%
M0O/\W69"U<XGA OK-U 0!/!$R,B\D5"V%8SLEL^6^M).L%V]*RE\CJ;I6X^F
ME+\;WFVZ+2[#6LT>4Z81LME6KJED%=9]0!S6.H3K3#U[5JE7?LI_9HN+.W+A
MP*JDRZI#MC6_I \[HA(H(AUM=35]M$,>CH4H,PJ[/HCVV@[K<^CK5O\ $[),
M9L5GY&186!8<:V+_ +2"^14_&911SL'&<"U=KMU,HBO2DYZ'3 *FQ4[Z$%04
M87YGEB6BX*U]VU-6T7<AC 6(4*:VE!KC[DHF)T3@JTK)G,LQXQ%12P$ZZ#T[
M"&BA",W1<^-+^DS4+VMFE3P5_P#6P,%8@KQ )R(#[4$VC,PIJ_3B7/BZEBR.
MEZQFH:4$(66(2&/!RQ*+9W.*CT[*P;6U%V;KX=+&7GQ55UQAU'#<:5691TES
M/.LR&C3^EB>)@C2N,M:WGZB>QL8[-QL^'9")EZR)IL1DDB,<F72;)YB2C'L;
M/-&<NA&52>F?SO3,4>Q,7/W 5M[$KN\:CDGED6<],9MF"]&6@0W'9,&R)9&.
M2(95]*688EI2R)2R4)BU%Z2R#1:;>QZ48S81R;>D!S0:O9=I]N>B1:NC%&@7
M5H4L(VW\JJNVC#F2$!1JG+$/(ER,R1"J8CT!6%<14QN,DXP.'+8%%MCH<(G,
M.U7TVKZZXUQ[8_#WVV_QVVSMG_[SGSGQY^-%-%/B^#?7?X-]D]_AVUV^'?7V
M^+3;X<Y^';7WQ[ZY]ML>_P!^,><Z[Z;9WUUVUVRGMC13&NV,YTVSKKOC7?&,
MYSKMG3?3;&NWMGX=M=O;VVQG/Z\>/-7??5QV2.W3QMSZ+=&H<@@W0,S?#P^Z
M#:0]:2!>W>5!7$44!M2 DA=@H<U)"$%@NIJ:+91X2"4W+NPJJRJ,&$6+UXZF
M8W4ZV[<[VN7G.X;Y'.IX^M]>7?30$>N(_2O:8JN8%NEK,@;S[C"&1N0N;!&2
M&2BJ%ORL.7A(Q4$*_7%IMO\ ;UG-@5DPD1':-)_:/ZB^YZZ//2TF!:YB>IXF
M0]0RKHDSAA]H(*QA]&SE+77,HC4ZZ)X>1=:M'RD Z%F;&/<H8=*F&TCJV=$\
M*)/XG3O372/4_$?%U)VJ$6LZM ;.>9_5.L ?YZ)*] $@($G.;GM@VO4CX3F!
MZ'B;8EYENYQ)LK/5+[&(H(RA=U5(0?KURQ;NDMF?I@=-=&VG<MTU;;1W*6J%
MC],47;(^5G5B\3FEE0I'94R?L'R.C;AV0?U^TIVPAX?AS"I4R_7!S%YCBQBY
MGS& =0$PC5H4[TO8?M&O[1FNR(FS8PL]2ONGCNS.0VU?5"XCZEH&@5NH)2&M
M-BQ Q9IT(X/*8%*8"S^QI:3+9<9-  NTBM!6 FI*!*7.N^X>W>OK@IN\ZZ?]
M7V@P'COA*G>PX<R)([AR%/1J:SU;0$ \E:Z!>>)>Q9:GN>CP M9%U#A71A@8
M7-&Y&6.7AU\:)Y'REX[C[(Z$ +],: K:5E0F,.>TNKHTIL>D67$-0W&79H+E
M;A\B@(U\:=4Q\-0$V:&:EK%QZ:S<T-D-FS@'6*(R&MH4)')"5%?/==G^H#:?
M.EG7RPZ7'ZFD.:O2HIWME<>JL"HRR@F^+@=6'V,P<NR$REHDU:?L/M:O^=1M
MW-"U53D)+QLL5;O@&UXR.A/A(K5T0*%VN_JG6@:7VT.#OE_N>\KAH-[<K(?C
MZ^HDH;<("[2 D2/4 '4C)&L6HY;TC&D$<T46>/!T04EF+=[.S1:J12;Z5/2E
MOVE/6Q6E]V_:%B6/"U?SY;[>#L.(Y$)H>*@[11/89\9U->O%<UO7)U3A^0AC
MQZ !UF H'=(,RB73V=5+1PHA74+K$[#ZBM*T^1^GC$X[0#4W%OR?J,47OP*_
M! -94'&^;2.Q!D2^Q\\+##:YH.U12*J^)L:W2FZ2AY6)+!6-F!@!81?KUXXD
M;8"=J])VOU0ZYGJ:ZHWEP7/NN/5 Q8)O3U)4:XL26CJ!:<M_8%['NC<$*A+<
MY=3EG/E3(\+P\SF"R 3<1,FE\U^0$0[7RNN\NABR!JZ2E+%K&FC_ *B!/2"
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M%@1LUM*\>>S\J@!,CBRX1BB$L]-CA>:F$A FA):>AYP2=OW:\H,2<;-2S5W
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M88@8V!4#Y^@9HW.RD+$D060>:-3QI;CU?N8%K/NG2P!BE[-L&PB_TK/5$Y\
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M#_8I 1^J.=B;GU:JE90FS!Q171;V\\7R,<W:<R"L=2Y];*MFG]*F-_5O]"0
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MV3QSN.3@\C]8&J"6J#LR&16\*5'9R@[=OWF>_+,I\/+Z^Z#K>FIN&AS8]J@
MB+L@#:90BVA!!&,0%VMFDR8UKR;9'(RFZ@$)%RSG9MZG=4.;US3>M/\ 0J0P
MUZ;E>.9GH)T'!S:DX7HMF-.RR* UG6UA;6/*QY!%M,-FAX/5S+@4).O6 Z9$
M0S,KJ-&_UYQ]3FI>F+/KFOA.HNAA0?O2O[+MSG.XCX)%(:J;^J>K)D5@YX_
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M:$44LVE!FQ9A#!3#,7P\;HR[YO%("3%9RWS>ZX.]+C:7>=<NT94]=S%Q;=0
M_.-;$5FFQ)$5VBPDN,F_9=@V2?-1@;D"39$3%T9(2'0L74W?&!$Z@]W4^-1B
MDN^C<>Y<Z5[HL;NXEJOH"OZDJNN(7BP&L"7K4/LU.RY2'N'/15X51(E\ 4Q@
M P;3 F?L:V6DHV'ER=C."@CJ%I$0K"V.[/1^%C(H]4FY@OJZ\*<,:GJ0$&:\
MA^C' &"6,170 7O:<-1]0$EIC%MUG,D-2MZ&N<%L_86>LW /4!Z26%60PZ^V
M)3N[=CAP)C.4WQZII[5X8-RX91 T9EAAQKS-TL.C\S9,B+Q2YAT=TC5'/L<
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MB)V0%\R0$*CY&3(IU>0F0TX1YD-:[NNL%0)V+"]^.*L?GNE?EQ:!R+>5H^
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M[<E\'!(=CW04'58HVONP.5[#G7!094K'VW'U?6U_\L.8>I^AL+C\(9V+%L-
MP-N$+'/FD*<"68B AIU[N5QG&<>^,^^,_?C./PSC\_'CQX\>/'CQX\>/'CQX
M\>/'CQX\>/'CQX\>/'CQX\>/'CQX\>/'CQX\>/'CQX\>/'CQX\>1 96W68?:
ME/5@4.\HV';?[1,UDVQ!/'_UK]GPRT)#;_?*+19K!?5X%TV4_P!K<M/FOO\
M4V_UA73*>)#^1#K9#">(B(0;-HIQ$ZZ:QS%)%"%<9T5=QVN-4-4THM;**:CE
MGCX6:F4]-EDMOAUSC H^FJ0: <C4L75M7-JSE]%G4K6S $$$ 623D7.CQ=Q(
M!C:(T''J<@\;Z.E5G46MJ\<H:+[;JK(Z;Z8U81E1='#8IH41@_ C9D>@'/L
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M\>/'CQX\>/'CQX\>/'CQX\>/'CQX\>/'CQX\>/'CRK'6]Z<OTY6;B!ZIFX;
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%'CQY_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>g1002989.jpg
<DESCRIPTION>G1002989.JPG
<TEXT>
begin 644 g1002989.jpg
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M04MI2VXJZ^Y'<#778:=NC9';]4-:7[L[+5_8.]%CB3"5N+HQ3;W7;^40;*M
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MDW\EZ_@[?L5_19[5_A+6 ^[';O\ ./3Z+/:O\):P'W8[=_G'K\=3N4/K=O\
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M#!OYG;_4F_[G1_J1_P# U^JYV)Z::79>;1B))II$"AI\0(D0J9 S7M5F'!"
M4H9,(B. #(B(CS'7R_RJ>1^F\G.49=F<.>SYJU?F/F)AEH8Z58U%-/4&0.E3
M,6-X@NG2!9B=6P!]MP3QZ_%]76TS98M#YI3I/K6J-1KUR"/38P0Z;;F]ST&V
M^TJ&FFFOAF/HV&FFFF&&FFFF&&FFFF&&FFFF&&FFFF&/%)\UV?SQLO\ ["Z_
M_NYKQ9:]IOS79_/&R_\ L+K_ /NYKQ9:_HCY"/\ U8</?IYI_P":UF/RAY4/
M^^68_P#]#+__  4&&FFFOK^/GV&FFFF&&FFFF&&FFFF&&FFFF&&FFFF&&FFF
MF&&FFFF&&FF!'H&=:X'T#\FF&-----,,----,,----,,----,,----,,----
M,,--,#Z--,,----,,----,,----,,----,,----,,----,,----,,--,#Z--
M,,----,,----,,----,,----,,----,,----,,----,,----,,----,,----
M,,----,,/ W]B;_%'7ZK?8I?\%_M'_M&GOW>55K\J3P-_8F_Q1U^JWV*7_!?
M[1_[1I[]WE5:_,_^4]_W5X=_^8&_\NJ\?:/(O_VKG7_P^#_Q(Q*;IIIK\3X_
M1&&FFFF&&FFFF&&FFFF&&FFFF&&FFFF&/%)\UV?SQLO_ +"Z_P#[N:\66O:;
M\UV?SQLO_L+K_P#NYKQ9:_HCY"/_ %8</?IYI_YK68_*'E0_[Y9C_P#T,O\
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MBR;]I*/=D_8GR=&5/(QRX*QDA7MRW]4595#Y$A *1-=06#8' ]V5006+Q&,
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M>W>U="VYJ";JME"5/<9G!R=0T>C4-0 \JDS,JCX&^5'JS./(_4BF@&.Y(@B
M"$3UB=L>X?<]-RE.;=[*W)O3-P;)&1FV%NJ7?5">&8N3JIM74NX0*1E&).U$
M%TVGESI [HZ"Q&Q%3)* 7W8O-P-[7'S2[35B#W.K'WEFNV S,;5DF7A:!=^Z
M-MF%3.W[^EP4]R'TN>9,#@LR[:*R:2*:;--T1HF"(17[1[,W7@MCV_:Y-)5Y
MN7=VGJ7>Q5E$%VY[!(6@*<W!SU0Q-4M6D;,5'=J7C'=3T-0L>JZCD4H*G$E&
M_N8#YRJ@9"05(/$X?\IN?T'#E#39I]2ZC,'R'@RKRW,:R?,9C5GB"HJZ.3ZI
MFVN>N H9*E2)J.F8R<N>KC6,SOTLXX$RJMSB2IHUJX:4YAG,-;14D=+&L?U/
M@@G0T8)5(8':H2)AIF<'TDB](JGFMD]J&YB$O=#;;)NQ-T(2_E1.632 M%-4
ML[B*YFEY(BYX[W,B9(S4CU!\1JY,T>H.3L7 -U@2=&,D<I:IJW8SO)H*W-07
M?K7:]?&F+6TG*OX6IJ_F;?33.EH.0BY#W)D4I.4,D9-LW9R8"P7DQ*:)([^D
M^7B;7L/W6QC]EVK'S/NXG82I(6JE;4QC&I4*XG&U75^@_CFL84\57%:MT4@J
MNI8IPX=DEI0/I2TJM(.$$D07.4:?VWWON[=S?1V^EIKFW#JBN;64W9JYJ--6
MVJ626E:$II*G2!"1*=.TJ[%2%@R)1SA9)R6-9M@D553.WX.78%7+MCRO9]+0
M4>9093DYITR&FSO,XWGJS(X/%DO#%1#021N\:\P(M9 \W-6+>-S4!@ZT_8UR
MA*FHHY*^O$KYG-E]'(%@T1WR6/-HGJ5*ZG,9+PORV3F"S 1],>6"NK,VOBNS
MTL5>>(L;?^'O#6=[JGI&H[Z39^]V^UI3C)C-GC*,H1LF\5.-;LW31HH[*$<W
M.*,?)D!P\,H":-"U=V?6^6@;9FO+6NT?<'2UK$XM*<<5U-6RJ!G L89=$KA.
M6DCF;F>Q4:*!@6.^E&3-L@CE5RHB0#&":N'F)>G^Q,[)"?@(^CY:?ANTY9R\
M)%W#?$C*"E)E@\JMU&1];2:J2Z<=2SY\DBVG9!1%8C)@HNZ.DJ"7 ,\R-%7#
MW$[JKC4U6MN^T-V*[@;BVRFV-P+N47<6C]PO9]RD 2G4G+Y1"/N,$G2+N%D&
MJ9HV-*G0](NO+'#@@%CCNW+@<5WE.S3A_P XM3T4]*.(.+35SYC7S5$\=+E6
M<1TR14],*GSZ*G$,CGG4=)F4=(1% E 4<'$8^!LOS5E4O4QSKD^2+3I14L<,
M3SU-&[O--*(?-GG+JIY51/2&<:F:I! MX5[?[&]XMV*6MW6]L=LUYK@TA=J3
MFH>V]24=1;V?B*PD:<,Y).H1;I@=7NDXD[-T1\\DR1[%(Z"A"NCF  'O(?L\
MM]M0R5Q(>#V?[BY65M,Z(QN1'LK65(JYH]\HS+(I,I8@MB@+Q:/43?H-6!GS
MA=DH1TBFHB<IQGEW&W2NWMA[!#8M'V*O755'OF.\R]%&N:]M74,E2:M8PE)W
M$O$,>[;R,0NU>FIV:=Q#*<)%]]Y"[2,T(Z06313(62_<IN-OU$]NYV4]N(B[
ME=Q%O:\L/;^7KFA8J=>Q])UG+UA!W+3J.4JJGV:B,74$B_)$QA2/I5J[=,"L
M4"L%6Q4\:V:CRG\4ZZIZ/+N'VI0_'7FC5#9HDQAX*=)G>H12!KKZ21841='(
MJ+U#L4'FN*DX!R%5A%159HLNCAOGB-J5DYG$(,"+&QCOIIZE'E9K'7&1&H&\
MF/!2LBLW66;.$56[ANLHW<-UTE$5T%T3F260715*15%9%4IDU4E"%434*8AR
ME,40#*2U6QO>3?.B'-RK.;6[[W-M^U\HXZRHRV]0S-.K"T.9)T6/D46Q4Y@S
M95-1)<L,$@*2R:B)P!8ATPN/VI<;&Q':,;XXR+8-8V,:[DKLD;,(YLDS:MTC
M5"\44(V:MB))(@8QU#\"1" *AA''$81UZE-[5&]HC<:Y_95U5V6TC<P-H;.P
MMF$J;5LC5"D);.GJB;S[=>LE+P1T5(M895/YR08,GA9AE(  MI^..B24,Y35
M];Q#QW5Y=0\*U%''E%"W$N7U68M6Y_530Y90K299#F/F3RP\MGJJOG<JG.M
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M _(.F!] _(.K^>_? ?!UV]?:Y6OY\Z>_? ?!UV]?:Y6OY\Z>=U_Y)F_6Z/\
MM?7\'9YCEGY;A_4:W^S\?I[CBP>!] _(.F!] _(.K^>_? ?!UV]?:Y6OY\Z>
M_? ?!UV]?:Y6OY\Z>=U_Y)F_6Z/^U]?P=GF.6?EN']1K?[/Q^GN.+!X'T#\@
MZ8'T#\@ZOY[]\!\'7;U]KE:_GSI[]\!\'7;U]KE:_GSIYW7_ ))F_6Z/^U]?
MP=GF.6?EN']1K?[/Q^GN.*2HJ]5X+;TM7=#T!<RNJ+HVZ$>E$W'I:F:CD8B
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M5M/5/'0Q03%(/<YG*.UV[<Y4Q$A5"IBH4IC 4X<1L\&J[Z7IKNK:.KVM;J7
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M=,B28 0N-575VX>_=?!0 5O>2YU6#:E%%M;(\_64Y)*V_;MBMRMT:.76="O
M)H%:-BI%CU$@(5NB4/-( :[CW[X#X.NWK[7*U_/G3W[X#X.NWK[7*U_/G5>A
MM-.AX=BTTB-'2KKRW331O&(72G&JT*-%>)EC"JT8"$:382'(#3L.)G#53K)4
ML(,Q!GD602J\QTWD=9+2!GN0_I @@G%/W3OY?*^)XA2\MWKEW4/ (&;08W K
M&;JDL0W.F1(R4:G*.ETFA3))D2,9(@'%,H$$W#R&I&VZW<XS@K=4PVW 7C1I
MRT-11U76L@BU_4(Q5NZHB$W"454-&LE'9T8&8C4G;E)@^9%36:)+JI("0AQ+
MK;]^^ ^#KMZ^URM?SYT]^^ ^#KMZ^URM?SYU6::,PPTYX8IC! S-! ?J6886
MD5ED:&*^B-G5W5BBJ65F#$AB,6"51+)..*9N?,JK++RLRYDBH59%D>VIU1E4
MJ&)"E1:UMJ+?7@NQ)W+?WF?W(KEU=R4EUZ@DKFGJ66+7;Z<=)$0<RSJIDG"<
MHL_<H)D1<+G7$5DB%34 Q  -=A=&^U[;W2D=-WCNU<BZ<Q#D D5)5_5\W5+N
M,*!4BX8'E'2Y6@B5! HG0(10Q44@$X@0 U4GOWP'P==O7VN5K^?.GOWP'P==
MO7VN5K^?.K!&1)#,.'(A+31<BGE#9:)((-.GDPN&U11:;KRT*IIVM8[0)A,<
ML1XFD,4\O.GC,&8Z)IB;F61;:7D)-R[ M?<G;'259N"OM7=P:<NQ6MW[D59<
MZCT85M2EP*@JN5E*OIM"G%%%8!&$G7*QWL<G"J+*J1A&ZA2M#JJ&2 !..J,K
MVO:XNE6-0W#N15=15W7=6R!I:J*PJN3=351U#)G220-(3$J\,=R_>&0011%=
M8YCBFDF3."@&KG>_? ?!UV]?:Y6OY\Z>_? ?!UV]?:Y6OY\ZS"KT[1M!P]'"
MT,)IHFADRZ-HJ<N)#!&4=2D)<!S$I"%U#%;[B,JT\ZNDW$C2K+*)Y%DI\P=9
M)PN@3.&4AI ATZS=@MQ>P.+!X'T#\@Z8'T#\@ZOY[]\!\'7;U]KE:_GSI[]\
M!\'7;U]KE:_GSK:\[K_R3-^MT?\ :^OX.VMYCEGY;A_4:W^S\?I[CBP>!] _
M(.F!] _(.K^>_? ?!UV]?:Y6OY\Z>_? ?!UV]?:Y6OY\Z>=U_P"29OUNC_M?
M7\'9YCEGY;A_4:W^S\?I[CBP>!] _(.F!] _(.K^>_? ?!UV]?:Y6OY\Z>_?
M ?!UV]?:Y6OY\Z>=U_Y)F_6Z/^U]?P=GF.6?EN']1K?[/Q^GN.+!X'T#\@Z8
M'T#\@ZOY[]\!\'7;U]KE:_GSI[]\!\'7;U]KE:_GSIYW7_DF;];H_P"U]?P=
MGF.6?EN']1K?[/Q^GN.+!X'T#\@Z8'T#\@ZOY[]\!\'7;U]KE:_GSI[]\!\'
M7;U]KE:_GSIYW7_DF;];H_[7U_!V>8Y9^6X?U&M_L_'Z>XXL'@?0/R#I@?0/
MR#J_GOWP'P==O7VN5K^?.GOWP'P==O7VN5K^?.GG=?\ DF;];H_[7U_!V>8Y
M9^6X?U&M_L_'Z>XXL'@?0/R#I@?0/R#J_GOWP'P==O7VN5K^?.GOWP'P==O7
MVN5K^?.GG=?^29OUNC_M?7\'9YCEGY;A_4:W^S\?I[CBP>!] _(.F!] _(.K
M^>_? ?!UV]?:Y6OY\Z>_? ?!UV]?:Y6OY\Z>=U_Y)F_6Z/\ M?7\'9YCEGY;
MA_4:W^S\?I[CBP>!P;D/U)O ?ZD=?JM=BF AV8&T@! 0$M#SX" A@0$*]JKD
M(:_,@&]\!PF#Z'3;T.2'#_>[6H?K1_\ +D/PZ_3S[&R03E>S5VKR",1$02;N
MCZA5)$P2+EO$L0&O*I#N6*+QT]<II9#B$%G2QA.8P\0 (%#\W_Y2TU3+POD
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M+!Z]IV7>0C]>+=+H( _8B]8K @Z1+PG)P"<J9S"0-=:VD:J:A6HB:K2".J:
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MN!,""@N3H%0!-<2'!!05 (N)# B902B .8E[:TOJ"VU"^HVLO7Y1N+#KN._
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M7]<<-;VM+%M2Z0;$ZA8&]K$WL#<@6/;C4Y4NI5Y<FI@"JZ&U,#N"HM<@C<$
M@XXVFN:A&2+I,%6L?(.4A,J4%6S!XY1$R"7?K@"K=!5,3((@*RQ>/B11 5E
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M(;T:PU(9KE9HH]-AOC2R?BRKR=:=8((V-/3U-.KF21'*U-7253-=2+%32B,
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M<IR)>3<[,R+@1!!E%Q,:@X?/WJP@()H-D%5CX'!>0B'./DHRV*0U4F<2Z8X
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M9HV^JA6E*#FV[@&CB(JZH$XLT53DD@Y,#=9E*.FKA-8P)J$*<<:[@FV+<@I
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MS#;G;Z-A'E.Q5167K1HM*3THQ-) XC2Q*Y3QZ;S]U4?N;V!5B-RKD6TK>\5
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M:J:7FI!&"KC=E2#6<:50TK"Z#B(IME-7>-&GEHPE25#"4Q-5BI*-W*440)%
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MLA%E6FJ1.O3KV2IYDS>.WK!<=>5;B-UXASC&<CT]'L]733B-D!XAR 8 <CD
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MO5=V-WU+Q>]>I]T$%O"=6H<[:MG4Y0-=P;#9J2EZK95"Z7E%:BBVU"4<^M[
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M3^(A_#K[#YDOVBB&?HE=P?7ZVH3^(!_EZ-/MA/)I^4,R'_\ R:SP_H>OW>.
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M&>[N'C\QQX(=->^4/F2G:,( /T2NX3G_ .+T'_$'RZU_2E&T;X2NX3['H/\
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M?"3W"?8E!_Q+I^E.=HWPD]PGV)0?\2ZQ]L/Y,ORCF7[(K?[/U_!VS]B;B_\
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MNC\R9[/@#/T36X+E_P"+4)^;^OG]*;;//A-;@_L:A/S?T^V%\FG7ZHYC;O\
MJ36>']#U_-W[/L3<7_ZBBWM_^MB[;?Q]7=?'@DTU[V3_ #)QL\(&?HF-P8A_
MS>A/X@UM?I3W9W\)C<)]CT'_ !!I]L+Y-/RCF/[)K/#^AX_1W[/L3<7_ .IH
M>S_];%VV_C\Q\+^"O37O5#YD\V>#TW+[A/L>@_X@UJ/S)WL] !'Z)?<)R_\
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MG#3333##3333##336TJLFD41,8 P _R'X_C] 9TPQNB(!S$<!Z1UUCUX"9!
MAP*.<"/+T#Z\\_#ESY^C7 =2@* 8B88P Y$.?0>H#GID _EG'39%0XF.(X$<
MCS'T_'X?)X:@S@;#?Q[OXX 7Z=OL^G&JAC+&$XCQ''KS#H CC\6M2@( &?\
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MR]FG$4!\XY1'PR( /CTY^/J]&J45DG*O3D'C@.HXQX=.0\L8Q[<#K9XW*P@
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MR@)E%%#%(0H"8Q@* CKA-9>$?*@WCYZ!D' @(E;1\U&/7)B@&1,5NV=*K&
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M376=)IUT(Q3'_5<AZ5)*"5L D_U*XGAA7S']WYOTK]3\W6-$"F0+>VR "$
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MJLN\_J(,_P#*?5K)-#RQ+*]'DO$O#66PRSW<T],*>,)%1").NW; !MOM?@8
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MR4BPQ1T-!/,\="\$<SUR9A61.HIYL_S[E#,'TTTTU]!Q\LPU7UL! *WBA'D
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MD UT=9V0IRKZI^?AC4E:V_K%6/)%2%14#+)1CV7C2%X"M)--PBNBX^EX1[\
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MZ2D9"4F'=:5W7$U+-T&BTG6DND\%LS;B D;,(]B@UCFH"8I15<%0%PMP^><
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M<2554W)&EB2#W@ =>T$$V/[K''?[>(9V@P>2RQ1!-P8Y"F,',V39#F(Y$0#
M8 !  Z=,ZR2 .?(.8ZZN A&=-Q+>*9$(4B)<&,   B?F!C<@\<=?2/J#7;@
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MMRU](&PW^3?\.VYSJ>^G6;^S<FUK V/[_P"CC 3]"]MCC'T0&[?']VY]X_\
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MEG@5BZDA79".HYVDJ4R?$)3-5C!])7$1P%?C?.**<0\G.).8"/"8!QGG^M]
M:Q-WA;1)6 EG.Z_:G"L86^-+ $E7%!,4/):5OO2J&1F(2H(9H5-HO4Y&9E74
M5+ B+IPX1(D?B<%;*DO[M[J:T6XRT=,74H]F9!G.(*LYJ&=  2=)U7&\"%24
MC,(G*"B,A!2(G:J$6 BBJ'<+X %0U2>?JTAAWB_4C:Y'J[K@VOB6E NH E;V
M(W]$V&QM8$=;6]6YQ<9&]-.+B0IA,F;(9SZ_: =/'XM5C'UU3,B4HIOTP,/+
MA-CD(^ <A_EC5+N[-4HZYHIBD(9'), .1Z9QX\NO+&/;JC9*QK@AQ4AI Z0!
MD0#O!+S ,AX@/4?C'[^+S@W(#=.FYV-MK&U^E]SZ]\0] ]MOF]Y(MX==_$XR
M%15:O2?S,N14,9R4P8 .F1#&<!G6.5U]SMK+4RSZBBNI*XMWD617D99.VS)2
MIKE2HK-Q<-Q4BVQ1:0,>HCPJJ3%0/(^.0*=,#K=\L@DICCN'N_6>U^B4Y9)0
MTS5]5RK2AK9TT0QU']15M.&!A%E1:I\;E=C$K+I2,NJ@BL9!N0B12"JX2 <F
M-J^U6D-N=,KO5%%*QO#690EKJW<GP\OK&LI]\<KQ\@K,.BFD$*=8.A!O#0I5
MBMFS5L@91(RX"8)HYDV":2/E$BX'3L)!N;>Z]^NTM(4:B203Z*@VO8 DDV(L
M/ 7-Q8[$C%)"+[2+<H8THWEJ5V.6W>&(,?"&CF=P[U/8TQA.1S+.R+!"PCU5
M,03,T3%DNV, &X5,"4W?H=FF,W_-5S=W^Z^NY<QN-5^A<%O2Z1A$1R";.,C5
M4TR!G!2B8XE .9C#SU)]_+Y>NFK>4AZW;MW)M?P /NQCFL/DA5'< .FPW)N3
MT[3B,S]"ZM?^S]NU^[8]_B?7&-V8UI2'%,VX;=<50.0IFOFN!P$,9 2C% 8,
M9#P\0](:D#GWCN0E24\W<.8]@FR!],R+54$72A5SG29Q3-? G:JN 36<.W2?
MT]!NFF1( ,X Y.8WI&GO(13&!BQ.X[M98JR'>"HH7A$AEEE!.NJH4I2\2ISB
M=0Y0.?GTJ*1ZB%0$J+F[..FGY(%[[@#UCH1OC.IP 2[;]+6/ON1V ^K:_7$?
M(=EW:X0S[_V[7G_^NQ[_ !/_ */1I^A=6O\ V?MVOW;'O\3ZSG$'%*R+9=JN
MZ]R73U!C*PBIUGB#('RH(,Y>)55,=5JBW<F*23: <[8Z"PN"E0.C@]S-(UAD
M!(0BQL02U]K#M(/5;;@';ION9I%M=CN+C<>OLN.WL)&(S/T+JU_[/V[7[MCW
M^)]/T+JU_P"S]NU^[8]_B?4F>FK.3%^+_P S>'CX#$>8_P",<1F?H75K_P!G
M[=K]VQ[_ !/I^A=6O_9^W:_=L>_Q/J3/33DQ?B_\S>'CX##F/^,<1F?H7=K_
M -G[=K]VU[_$^OH.R]MB'2_^[8.O_P"6U[XX_P#T/Z@U)CIIR8OQ>[\)NRUN
MWP&',?\ &.(Q#=E?:0ZHKFOINN,N/5<;T.N^''3*GN-Q#CUCKE?H7ML<8^B
MW;8P 8]^U[CETY>X^I,=-.3'^+\[>'CX##FR?C'N^/=B,W]"[M?G/O\ V[;/
MI]^U[G_V/I^A=VO_ &?MVWW;7O\ $^I,M-.3%^+_ ,S>'CX##F/^,<1D*]E[
M;\@%4C-QN[6/=IB)DG0WD<N^[-CD8$58DI#8' X$<#C&NE=;5=]%H/\ 56Q6
M\V3N@RCRBHE;?<13C&:82B*7GEC$JLB@1?,15QW22_=->[XN-9R)2B RHZ:<
ME!T!7U$_OOC/-?8$A@.QE!Z^L7[!V[6%L1J6TWT"QKF(LENVMP_VT7EEU2LJ
M<5DWR4S:NXSDIC) O15:M 48M1=*IG(UC9AT583 5('!U3@34A D HB4PB4P
M#@0$0 0'T"'\@$.8<AU05[;$6OW"T-)V^NG2[&H8.02'R9PHDFG,0+\ABJ-9
MFG)8$S.X688KD37;/69TS<9 36*JB8Z9H_MO=VZYVOW2=;,]S53/*H9^0'F=
MM%ZYOOS.;C4>B947=$U)(NC&[^L:53,U;(@*JJKA$W<]ZHEY&H;!NA&JQ7L8
M]G@1[/'M)-B;-(<$H+,-RM[W'>O;[/=XR>\!!ZCGXP_>UWK; (I@'0 ''LXA
MU:#WUJ'QRDD1](<1 ''7/,WW@Y_CNG#2#25C&D@Q."C5R0QT3AS Q04.4<#Z
MC%$/BU)&4W *GM]$GPW-_9Z\5V/:"/HO]/S#'9Z:::LPPTTTTPPTTTTPPTTT
MTPPTTTTPPTTTTPQU4D #W&1P ''/LP/[WH'4<MP/<>_>^RU-EGI6[^F=L5%N
M=PU7QBOG)R5?5:9:DK>LWB*A1351I]J=S/D3#B SIP@=0H=PF.I')$,B@'I/
MCY0$/QZC,V:LRSF]+M%JY> 920:W&H&@&2B@9%O$T_3BQO)DC"(B5)99-!<R
M8"!0.''PY-RJ< E1VL=^FX%C8@[6V'M [\3CN!(?Q1<>MM*W'3I<[^KN%I1@
M#'+^7K'VCU'UZ:::MQ#'050]48P4@LBBFNLHFFR236,)415D%DV)#K"!3F%)
M(S@%5"%+Q*%(*91*)@$.%3C)>.09Q:K@SL(MDDU.[*B" NW*)"H+K+)%P1(H
MB43-T4P%,$A 0$1#7>RD<WEXY[&.A5*W?-E6RAVZ@HN$@5*)06;K%\Y)=$V%
M45  1(J0IL#C&J3IA]*%=.X67,=P\AG@QPR)B=W[K,/)"NHJ26\XW$_41!1.
M1%,J: NN(R1 (8"EI<6DC;>U[ CQ-B#Z[@CP4^HS4^BPL#MO?KV6(-NS?:XZ
M[7/2NC%*8! P ("&! ?$/1JWC14Z%7QBJ2I#M):(E60)"X,0Z:D:_%V5UY+W
M8E.=<B@HKG,<#% J8@)P-JOUE!2155 HG%-,YP* "(FX2B;  ',1''0.8ZH6
MF&HR[Q2I7 %!NW5DHZ 2*0"B#,7(D>22QQ$3&7?KI'233P4B#1%(@<1S"?6)
M%O+&0!<!B3VV#1WN>ZUQZS@/DM?O&WL/3VV]8OUMM7^FFFK\0PTTTTPPTTTT
MPPTTTTPPTTTTPPTTTTPPTTTTPQCCNQL5![B[#5];270*,@]AG<M1\D!0\I@:
MWAFRSZEYEFI]4DLUE$T2*B3FHU5<(& 2JB&K9[$[S2U[=L5N*EJA01KRFF+B
MW5QDE! %T:XH94L#-G<E "B19V=L1V<! 1$RBF3&-Q"&;0AGY0'Y!SJ*G8.8
M(.\/:$4 D8$XBF-T;N7BD0, )-R5;'.)-ZF4N0*4QWG&J;A(4,FP(F$,ZJ;T
M9$(&[!@>F]K6W]=M^[%B^E&X-_1*LOM8*1;QN/=W[XDW'F.<@.0 >7AZM8S;
MQKT.K!;;+HW+BR@I4<?")0-'-^?$O6%6O$*;I[NP !$QVKZ1(^ O"8#"U !*
M(<0#DH51$<B1=,X%R& .41Y8 >0<\A_V:C8[1PQYIKM,MVMQ&B*_W;6W:RZ0
M#@J[>G5/GC0(H C@Y>_9?4B AD1 0YB.LNQ"DVWMU![RHN-Q^-<;@[8Q$H9T
M! M>]CML-R.G:!TMX8R:V3V 2VX;=J$H)V=5W5[UJI6-Q99SS>3%?U6"<I4C
MIV<%%2G.W=*ECDA(8$Q09)G A3'/G+'6@?C'\(ZUU-0%  [ !Z[=N(L2Q)/4
MF_QZL-4;5HJN58"(1,HD+Z72=JKE(H<H-8<AI%RWRFHGPJNR) @B*@F2R8>,
MA^0:K+5/5+$+RS%(6+DS.4C'2<I%.0#C3*_:IJE21=)<A69.B*J-GB13IG,@
MJ<4U"* 0P1<$H0!>]MN\7%Q[1? =1O;?K:]O''+B"F,W!53'>")D0 IC"F"2
M)S%)P%-TR',XCD1/GGC :WY," S6.8IA,4N4Q+]4"AA*0@AS#D)A*!L\A+D!
MSTUU-+R2DG').5")I&4005512!0"(NC@H5XF0%!$Q4BN4E!2*81.4@AQ"(B
MCS9]Z6/B'SLW" (MU3^>."F,!#=VEG^K74X$$@#SA54(!0$V &E1_FQ7Y5D9
M=][D7&_7M\!;L MB9/W0';Y0-ATZBV.CI5!5C(U2Q.+11):6+-HJML%. 3"!
M5%4'9"Y)WZ"J!@(J0<+HF(<2D$.'5::IJFH8\8V6=/# I,2ZJ;^65*3NTBN!
M0(F1FU3$QS),F*?TALD910P8.<3B)Q *EU=&+(NUNIMW DD ^-COB!-S[!]
MPTTTU/&,----,,----,,----,,----,,----,,!#/\O$.8?(.HEK;-3[9.T-
MN#9",1\@M/NJHZ4OC1\;Q%(PB;KP2QR5RVC4\\#<9M#+M1L02=X(M"I)F!$3
M&EIU&1OY3+3]Y]@5QF^"24/N9C:* Q?-.K&5_'^02"*A@X3&1X&!?,,;@*)S
M#PB)M52[*&_%8=][$@$"Q'6XOX8LBW)0]'4CU$ LI]XMX7OX&0DIBEZC]4(
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M '6Y^CX \<5O+3\/!D(:4D&[0RV0;MSG SMT8! O T:$XG+H_$8I>%!)0<F
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MG!2CR$,C@1P/AG'/'*9[4$5F)5U';INT$(V,<H+W^BN\ H /$4D*L'/(#D0
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M.M!)4#27GR+$615)*/W239RW5'NE3C',5&#1/O$P^EI'(H IX$#<1A'5;5"
MV4,YL3903< @;  D]=MK'L)OC(B8@%CI!]1/N) ^>_?CFSLJVJ9TV@*>4+(.
MFCUK)/95J<31\.1DXX3I&D4N)+W67R=%&/24\I!$ZRRW=HE'BN*4 *4  ,
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MIB-2MF2:I_J@4!9T*JQ^,O(0XC"(Y'A\!YB)$B<E(U8RJ0G^EBNDL<0(0WG
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M*4<#YRAA' 9,81R([8ITYEVDC)_&YKL2UQ<6+>NRZC;8#IC5+,5MI:X[D [
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M@ V TAI&1"U[)J);T5-LRGS4D?4-/U,*A6SE<6\!*'.L5,CR,DR+*1J+HO$
M*.6,F0/(U. #?S2HF 8,(ZN=JWM2J<-,KKJ.VY.Y>Q#D7Y4>$4>[E60BH9-7
MO#$.H43))JEP)!4'AX0 1"X6NO3VTD7#'9B1TNUQ86V-M.Y&U[[DWQI/O8VM
M8LO;T%B-B =@;;@;6V&.*]?,HUJN^D7;5@R;)F5</'KA%JU02*&3*+.%SIHI
M$*',3J'*4/$0U1M,W2MK6;U:-I&OJ/J60;\7?,8.HXB3>$ F>,_DS1VJL9,N
M!RJ0AD@P/G\AU"?VKUYJF?5_3MCV#YTUH^'IUE5D_&MS=T6?J"1</$XXKT2"
M473&-CT@,W:*B9N+YR9PH3O$4C%C[JRB9"Q@V6N%0MQ64C-UK2IK@P514DS<
MQ9*9?L)QY"*1B+Q8Q'$F9!PS7;R9E$4&ZQ@=,P26:F*J?\X\7_Y0$O#_ !1G
M&49;PVF:93PQ-!#G^829@E-4AY9XJ604-,4.L05$RPZF$@ED!N(8RLC>6K>(
M#354\,=+SHJ4H*B0RA&N[(AY:$>D%>14O<@N;-RULY]>&FK*;<KDO;O6.MC<
M:33(E+51244^ER)%*1(98J -Y)5$A<%(BN\16633*&$RJ 0.10U'UVKMP]Y]
M@K7-+_;:=Q%M[;TU!U19.VTY;6N=NC:ZRM035XKZ49:L]7MZT/<ZCG4(G3L;
M6R+]"G20;]"3=Q(%7E&:;TPH_HG+JZGS2@H<RI&+4N84E/6TS,-+&"JA2:(L
M+G2Q1UU"^QN+[8]%'(LL<<J&Z2(DB$BUU=0RFWB"#B7#34(Z?:"7"VE[FJWV
MY[O:HJ6]E-4#9#;G64[?:TNVM_3%+4W.WCN?<.AI"KKG-82M*M8T%1B"L32\
M:@V(]F'++$A.+'59'7!G=64[4"T5H%JR@:SDKQW^K1I>W<?3Z=(6*VRU5+5=
M;NW=BJGCX.L)ZK*9@I^H73VWMO'<BUAE;N+*QA+@OE53T[2P.&;QFCN8GB6/
M34']K^V"HF5O)>L:RIZY\AMU(_VC2MKKG4O9.HU:9MA0NY:U,+4$7.;@*N*_
M5;TVG(5O*MHX@>0J/Z?0D6!9)AY$*T@E-^ @8 $! 0$ $!#F @(9 ?C <Z88
MUTTTTPPU&3VCO^[6R'^_,M7_ /C#4FVHR>T=_P!VMD/]^9:O_P#&&JIC:,GN
M9#[G7%D7WQ?;_5.)$EOU9;_TRO\ UAM<5Q_.[G_FKO\ R5;78*@'>J\@_55?
M /\ E#:XKH \F=<@_G1WX!]:K::#WCX^#\':L;D#OQ'?V37]+!/?W>+U_NS=
MZD4JY=RC3TF#,PD>.42L&QR$,HHFM(+),RJ)D()3'.D"YEBE*.<IY$!*!@U'
M9V3G]+#/_P!WF]?[LW>I"JL %#4R@=(JR:U51AE0,(@)"M47CU-8HE$H@*+A
MLB<1YEX0,4P8,(@7[T-P+K:Y-K7V&_MQ:^TI/<5[+]@[,<-HBE'M"LDC839-
MDF38Z0%[PWDPE;#GA#@$Q&X 4I.$I"X,8H#S'7?&,HJ7B$QNI ,F*X-VJ0?U
M'&7SEC@7DIP'X>+(%$,8UAINKK.H:>^=HE-25842H"DC4J%RV"+!S;Q*<@TC
M*1UO:^@E%T'LTE73=%W&0Z2#A$J,DZ0>F,HJD5(+[6EN%#W5H"E[AQ97#UE.
MQB:O&5NO&H)234XH2+!JQ?)INB),WZ:[9)94W=N$TP4(HJ4X&'B0YC"U=/EM
MP9HPK[L%#K==7HG[HVGFPAV"&(<Y$$C,;'<DI'%-#5[B-R5N%)TN NE2VR M
MI?2H</9&9E46O<<R:*0"9)RW1,/51)JJZ4XQ.)DS)G5,*8& I1(&0$ , "!L
M!PZIY^S<#4,$X!\\*(,)@#K>7L$ECCP- (/='P7)3" "0A3D#EW@DP&:P(6.
M*)BK-5$0$HB)W9#F2$"CD1[TYCD# G' B)<E 1#S<ZZ"0:P0S\!QH-#)E93:
MJ9 2XVQRB5D)U.$H"@<"8 2F$IN V!()3<QW9:<.!?E@:EZ2R1F^I-_D$:AM
MT"GMN.@UU<@6LQ-B+\M3<6Z @W(ZC<D#NVMCF)'024%%1P]6<8*D9VHS;J"
M&YB519$H$4X>8'$2C@W,0R( /+3\F. F15;G.4@F(HB06[@HB %$3)CA(X\
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MY%ZHRF*O=*4K'I'8?/1(PE0NV9:D 0D&Q6\<9$Y?(B ?AS^]>O=H=5[D=O\
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M'$!0 3 <> 2X'AP3A.'MVYG'Q06>/F3^9DE.,@G=R$@=8I$@6*8P& .-!DV
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MYDX[PC=P47#)H=0IT!X%$5!!$1PDH1(4LG$0*FF;!1#&HWE$R("&1B;7 L5
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M:;:=X8R@=TF#!^N5!NFD'_' F\.=R<.0""90P !GI4072J.JD1(<4@>-Y'(
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M8;D8F:H;<;8JY<N: H2ZU$5+-E,8I(J.GF1Y!QP<S'9M%%$UGJ8  B)VI%0
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M^_EL1[^F+HNC_P"YZ_OB=/'$A]0%3<Q*D>@("6=>,(,N3G./D\J]2*[.44C
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M6(ACJ&D8E>6O)$TAD422%3$NH2!B&5E(,:D$8O<ZKBCJ8=L4YV=9H3<T0S6
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MXHJT[MPWB85(CL2\(KMW:CYT*0@(>:*"Q1#A' X, X#(:ZZK&8M:HIZ>35=
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M$AT'#"1DTF:AA*<IUYU5NNV6.H(8$R;^2,L %P9 B1$SF*8Y3!I2L$2$GIJ
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MS2!60,#*F\=E/0I(JR*QLP==2M< C*%M@K,-6E&*DJ0C@!EVM<%6TD#8J2"
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MG),],4A0\<Y3D9*EI2YJ3V3D&1?(HZ$@JMDX(DFHV:$0;*APB9)@T:N ,(X
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M@P&13<(&;'XC" ]\@MG F*&N;7"1O<5)\ %,E#RL=,.2BGWAO(V+KB=F3 !
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M6!N D3*:2FJE1CZ>,LN5$B2:Z0B5UD[8X*R[0ATS%(4ZAE%6ZAP)@IBY'!P
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MH^]D U&AVA/.O=A(A\+>FL_:])\OE^7KJ3+A$"B X]/R8'\0ZC,[0<,5YL*
M>H;MZ:_<_)CK,OWMO9_6&$7WQ?;_ %3B3X.GQF_".M=:!T^,WX1UKJS%>*2K
MAJJYIM\=OR78':RJ7U&#&BW2+TQ#<93 !3I(J%,82^: B(8$,AP8QZ#@59 H
M\W#9!R8_(Q0;R#0BZ8<0#D") HT$A@$4^$3<S#GAK-VD5=JY1,!3%5;K)&*<
M ,0042.00.4<@8H@80,40$! 1 0U;^F2%5A.$#*+&)3K1N90V4U.3<J)0( @
M!, 5MQ (#]+ "%$ S@-*I4\V)@>NH:/QV56(]=@6/J%^@QL1,!'(I%]U.KM
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MR<I^(Q#8$ R.!,(8QU$0]'/MS6BE14PNSF%.ZG8]JZ0<(*& #F$C14HB >.
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MK4[41Z?G'S1TD8S5EY'3LIQ/%%$!,X;@"9E"ID-J3TARJ$(<HY*<I3E'TE,
M" _(.L%M^L!$OK5A+RQP;-VK:I8,'?=2SH".ZD@7#6*04CX@JCB1(O*HH$*V
M.DHGWA@/W8F* AI\4P&?)JAD*AX"DT;%M 4@Z->L!B!&KF2UK.4"/="RMT^&
MI$3.:-9%#QS2<F2,B_,5K-R]F0CF,BI<,"NJXW Q#AVD4G:Z0W'[>]T=/7 3
M?4K:6^=GG%PG5.U&#.(94E?5,;22DZ,@Q4*\2G:?A';*5EDFR@ RC(X_EQ"$
M<\>I&[?6"VN;R[#51MNO!1T)=&@J9JJ&JI"*<R51MWT-4I6RR05-3M4(O&-0
MM91&21>/T)F+DB@FA-@R*8&O=HC@)>JPU-5#L.E(VU](EB7E;6:K>V=64U&F
M;KJ2-45!;YW7%#U VD7R2HL:@@[ATJN[9*)&*]30DS1(%\I H)YY=GG<^K[F
MPEE[CST3"Q;"Z>WZF)=,\?(+OG[J12A(!225>)F02:-"&FHZ;$Y45%%R+&1:
MG#"2AQU\JJZAZ/(LW810YC19G4TQDH$J&6.DSI8,SH?-ZQR)$C6NKJ^:0MN)
MXRJ#2B7Z^?T%*L^?Y2 T]'+E>4UA2N\V^ZU.5O5Y)6J],HD661Z&BR8L$D95
MAD#N+NRKG+MIVLV(VA6T:6CV]V^B[>4.UD'DPM'LG$A)R,M-R*G>2$Y4%03+
MM_.U!,O#<(+2,L_=..Z(D@0Q$4B$#(/337K7D>9WEE=Y9)&+O)(S/)(S;EW=
MB69B=RS$DGJ<>'BBB@C2*&-(HHU"QQQHJ1HHZ*B* JJ.P  ##3334,68::::
M88::::88::::88::::88:BSV+?TTG:5?WPE/?N><:E,U%IL5#.Z3M*@#X0E/
M?N=<:J?Y<7K;]V+$^1+^BO\ ]1<2A\\EP&<& <>P!_!J,SM# _V0-AGKW<4T
M(Y\!&GI+4FX%$! ?'/Q8P/W]1D=H:.;@;#?5NYIL/_J]):S+][;V?UAA%]\7
MV_U3B3H.GQF_".M=:!T^,WX1UKJS%>-I<_=H+'P(\"2A\!U'A(8<!ZQQ@/7J
MV]+H&;0,*0G>%!VS20RKDJH<*AUN 4LX3,8A\*<0B "&.8:KF;*4T-+E,1=0
MIHQ^4R;81*X.46BP"1 0Y@L<,E2'P4$HZI2",F6%BR%!4"EC&"[<ZR@"<AV[
M)(W"LIDYSN&Z:1$7*A?-%4QP*(@.=:M0NLKT]$,W;?<J#8BQ'HZAW;]-@1;&
M; [7OMM>^UB.T;7M?;WC'50 F]\%V+E(Q3?.4Q1CE>\ &YDFTT^]TB)(& #@
MY[U9DHZ6* $,DHS3R;NR\-TCE Q#%-S*8HE,'I*(" A\8".K5*B9K4],RI#"
M9-S)R4 L0$S\1D)!EY8W,4>,$TT4W;8O><8G,8#D I.(!Q=<>@^S^732DN(=
M)L=)M?K<%01W7 !T^-O:4ORR>E['U$"QW[3<7/K[,0N7(;FM]>=6%KF3B8:V
MU>0]XK NJE,S71:THQK!!*;IB5J%X\=>2G3;/W7?)I"#1$Z2BYVZN"&(,8U+
M4C;BVN]F1D)ZN%:CI7<-MG\AA7RLU*0[:;G]I]QX2"*R;1L.JW779510\M)3
MU-QK@RBAQB.-!59-TJJ:4?M&:8ILU11P3\($ZK54O;>8:H."S1X7W I:36B*
MT:31VH#',4WS)Y&@,DY%([9N@)?*$Q.&8M;F%J:S ;>:S9';U.EMYWNT@]1,
MH9&';4]0%W JBRM2T\]54:JOE::GG\[2=1('<*F3C2-2 <![Y NOE662"C\H
M,F1-ET<M-GF49_EDE:SR5313JD5=E%%/2@QHL-3-E"U*66659&=5>.G)MZ_-
M66/+^',Y6)^>)J:HJ*E)4IU$>55U.DJZB[DO+E^?YY"\A104I5] G63]=JQ=
MV\,E<#:PPJ*XU_+:=GP-AJO-*5YM]AJS10J;<U#&J:!H6G[BU#1#=.X5*0S%
M5C3,[$L4VHMIDRI63AL)7CE=";?LC*GW15?V?>WF=WBL*@97S<4W((S*U7M0
MCZQF*99SDBVH6?JV/ J8LZ@FZ33BW[XBJ:;I;O4W3XA'JS@A;V;3'50%IVM:
M:JUG%M)> JXG&TBWCM^T(B]AXU4 (I(H(.U@;+)%;*.#I"FHN@*B2AL".LN0
M  # ??YB/,1YC[1$?CU]FHLZ%;PWEE U#!#-3%!)4!.7*33&IA8"+2'C>=I2
MU099IM:P4H01"-A)\^JLADR_BC-J\U\LB3F1%H[AXDYI@D!,P;3*L(CM3".&
M!4$\]]8=0GY['S4W:NLJ7[02V=V*H:R\G:^YEF:5C:;?H&.DV;.*&J"4;5G1
M<>_435;LYD6KU"=(GPG$B<ZF]*FJ"#@$XU.T?W5;=]SU ;(FEB8:MJ8>68LW
M6EMZDMY4:46NRMW#FN=-2=O:%AY"'@XAM4S]M!N4U33C'RDLBR>Q+:0#YY$I
M917],;='M-L#O,M:_LYN+MW#W$H=X[2DVS20!1O(P<VV261:3].S#4R<A"33
M1-PN1!^R6(84U5$5B+(G,F,;.V3YGZ[.#:S=:&O)2- 5M7M8TP^"3I,MWZU4
MKN!I>33 X-I2*@%8N/CU9)GQB9F\DTWZC54J:Z)"+IE4#Z7DW&V54F6Y4M=3
M5K9AD23QT2TSH*6J6:*2$<\.WW-@C@,P1F!0,C$,T>/F6>\!YQ6YEG/U/K,O
M3*^))*63,FJHY#74C4TT4Q\U9!9U=HSI1SH 8AE# 28R;[)&UE<V7[-_9];J
MY"+QE64)9:EG$O$R &*]@1FVXS;. =)F\Y%Q$,9!LR7;FP9NJD=$W,@ZQUWJ
MV'W$79[2_97/V.NM<#;VQIG:UO$B*FO;1]KZ&N;&QKNH:OV[KPM$S32Y4%/4
MC&K5&$0^EHU91J26<&IU=)BJ5$'8A-"  4   P !@ #ER#V:UU\TJ9VJJFHJ
MG 5ZB>6=E7Y(:61I& O?8%B!?LZX^ITT"TM-3TJ$LE/!% K-\HK%&L:DVMN0
MH)MV],><K>G6.[&R-8;A+=HJ[L+T5/<G:ML_IBR5?VMME,.H:K;KTQ?6I&5[
MZG5/;>+)05J*A9TE*P=0UJC(FIF.=4@B080)(Z!VA:TVAVDNE3G:!/JMG;<U
MK"TFI=#M:WJ512=/2#.#%A7NXBP<O0;PL@JD5N#6L8B)E)*EU1,!)AA'/7#(
M5$VZHAZ <?RZ?@TQ_+(ZHQ?B"^REZX7;1VA':4QEUZ)O;&)WXOQMPEK35!3]
MAKP5W1541:6W2B*(?2A*RHBC:@IF+CXFJFJL5,JR\G'F8'(HY73!HFLY3CTI
MB0[4V(J.Z]0-:MN8RW!1=KMV[B_,,ZMW<6!MNYJ1X_DF&WI&D[BW3JL-OJDW
M#0ZL=)61&Q5/IL)MZ1E%W*%JW6DE=>MK'CS^4?P9QJE:ZH:D;F4;5%O:^IZ,
MJNBJU@I.FJIIN9;@[BYJ#F&JK*1CWK<PEXD7+=8Y!,0R:J1^%9%1-9--0K#X
M^/C]]X1>RN>KP^\'>I;.F*IW:S%HJ3L9LKJ>DX+=\]NBI7T%6=P&=ZWUQG3&
M,NTU955%,YJ1B(T\DDHW3BCS[*63IP I]!@ 3RZQKVT;1K";1J<GJ9L71:E,
M-JIDF4K4\K+5'4M9U343J*8$B80LU5E82LU4$@S@(A-.*@F"[\S.)8E.DS13
M,NY.MDIIAAJ,SM&?]W=C_P#?FVK^^$CJ3/49':/+)H3.R)94Q2));R;6J*',
M( 4A"A(9,81Y !<Y$?  SJJ;[VWK3^NN+(OEC_>\/P3V]F)+1'A,/!SXS& P
MA^L$##GH'MZ^/B'76,UXQ&#K:E)EC@'+Y46KI,,?3D>!0! X!D<#DP9QXCZ-
M7L&NZ<3<*MP>H"!%%0.H!R\.2',!AR(@ Y$!$,B'+U:QZ>/5+D7+%VU*9:&I
MQ ZQ% #*7&@18P^<&0'H&1 0'T\N>H3,K*JJ06++IMN1N#?PM_=WX(#<WVV/
M7MZ=/?\ 3Z\6$[)L1-MAGC#R$U][U&$/0)JR="(<O6.I-]1D=DY_2Q5  = O
MU>P SZJT>!^+4F^K8_D+ZL)OOC>SKUZ#KAJ@*J$AZCH] 7"B1U GP!(O%P+)
MG9-T3\8 42G[L5""!#&)R,8P#YH@-?ZHR<*(S\68P-S 2.D.Y3-Q"Z67,LTX
MB-BCA,H 0I3*JF')"X 0X!'5=0+PN.H]&X[UU+J'K*W (W!W&^,)LZG?KL1U
M![#[#[.^PQQ'C]0[)1P0JA?(D'S!(J:9N,KA)@<@+(@8O&J7RCS$S&\P1(!N
M?")B][28(EIF!*W$@I!$L>$4U 5*(B@3C$%"F,4^3\0B8#& 1R("(<]=8Y*D
M!"\"?)=8%!1 1.)U$GATES 4  3^:N)L";'/! $"B([E#B9&%/&*<0JPDG)Q
M)SB4"D4*W=J*-SH@ _J(M5D )DJ?0>$@% N=>EN)7!(-T4[=+@ >XJ!:PM93
M[;) -"D=;D >';T &S=3XCM!Q:[<M R4W;-RM#HQRLK"2\7)M?=8SLL:"*BI
MXN1"0!@8CQ5@9A(K^5-T1^G$ "G 0#E"G4%"TQ>FRB%%5-5+:%K!:$F]I3VE
MB%\FFIJ7=3=2Q<9/Q2[L5.XB"4)54G%J(/&QEC1Z)%O+ [OR@GH KV.5EZ)J
MV,04,DX>TY,MVRI!,!TG)X]<6ZI!*!C =)8"'()2F,!@ 0*(\M>9ZM*!;2UR
M;F71ME4C1K*TE<>W"[2IZ@-)2;P6DI -HQX>6:N6R;61)"UN@Z]VG9P!%6+D
M",T%%%&ZA"_,/*7/+E$M'G=-0"OGI>74"):AH9H4I)!45>84P5D#3T-%3R2W
MD=(@@TR/I8HWILH>(Y)FDLU.]4N524N8<J.-27@DJ(LMK8Y79T40'+<QS"1U
M).K0;C8%;X]FI?IM(63LG5+6K"S=QT+0/K)*PDS4ZKY%W<2TYJIMX2G&<><P
M@@P7JBEJ34C5TDP<&93ZB*BIT$DA&+K8#ONWZ7+WA[8XRI;V7+J>[=P+UU_1
MNZG:_5TK3DW24/;^-2FEZGJVF:+@(5N^L="V:6:HQL>A5#IO,5-(*,P9N))D
MLZSG;M3FW]N+N[P+44G;0S*+C[U4EN@IE8DK3D C3E$7XI& E7R48AW+U9\P
M=7 I:IUH=JV4;D!J"2)E$G)5 #TE0M/TOY4>KXVGH1A,U$S;.7\PTBHM"7?H
MN$4UR$?RK9JF\?%*!BA]/<+%$2@(9# Z^Q9-FM)15?$<,>705%-FXI<WRV1X
M6C\VI\XH9)HT4SQRB5!%54\K"$PNDL,11XW'H^&SW)Z_,J?A2K?,9Z.3*H9,
MKKXT92:RJR*K3+YYG6EFA6&9JB@J%TRBHC>&=Q)$Z-I>J2_4ACIX9SG'@//G
MS#7G][5>V%00MXJ:N\I%NW]#U#34) R$B'>!'L9V#D7IQA7SI,148%F8YR06
MBY@*03BL5 PK@!->@3753<%"U+%O(2H(J/FH>01,W?1DHT0?,72)@$!(NV<$
M424 !\XHB7B(8 ,02F !#Y]Y2>!H?*#PM4Y!)5^8U'/@KJ&L,0FC@K:4MRS-
M"2.;!(CR12J&#!9-:ZBH5H9E0C,*5Z?7RV+*Z/;4%=#<:E[5(NI%P;&X-QCR
MNWJO/%[@*?LG1]&6]D8.LJ:>5K#MZ5BY=S4,>JG5$K$_.K3M(BLFB[6;D18)
M]X1PT;EC51\G*JZ146=AZ4]O5!/[861MA04J<32U-4=#,94!$# E*&;%<R#8
MA@$2F3:O%UFR9BB("1(! 1 =:T+M\LG;.45FZ"MC1U+RZQ> \G%PZ";TI1$1
M$J+E7O56Q1R("5N9(! 1 >0XU>/7E_)GY,LQX1S3-^).(<THLSS[-:*@RH?4
MRE-)04V7Y?#3PQA5*0F2>9:2F,A$$*Q\HA0^LL-7+,LEHY9JFIG6>HFCBB)C
MC$<:I$JJ#I4*"[Z%+65%!'HJ 3B++=+L5'=)O@LI<:NF=;-;,4#MBO31#^H[
M>W<J>UE0-[AUG<&U\E"1+E6AZ@@JHDXQU3L#/N_JUXEL\:H*..[> SX\%-R7
M9PWGE[_U_$6\VV6ZNW!7:>;1TK4[T[B7>.%V-F=+;="P+*2@VC&?:2E>3[^-
M5AI6N:-D:-DSK7!JJMIJ/NN[&-9MUE?1QIK[+CLX\Y<GV=]]Z@W1R47);9;/
M'C5=VER=RDQVAC^NX)[<>N[6US0]10Z-AI>W7N":K%WBZ,TQM--TS).U;0L[
M>1(51!($J8C&.0E;[.>UU962V4;>+0W!MA%V@K.VMOV%%5#0\)(4U*P[.0I]
M=RP/*QC^DU%(=PSJ--).=2$H)/2 ^[J22(^(N&LV<!UQS].FF&&FFFF&&M!Z
M?&7\(:UUH/3XR_A#3#$$>P&KJJHFR]S7L:T6<PTON(OBV,J4!$C9VA5C@J@A
M@!#B,&.H?'J:6V\BM+43 2+@3&6=-53G$_U0B5TN0!'UB! '[^HX.RPB&$WM
MLN4QD4"+HJ;G;^8*< '!@J]< $!P(EP F#XO9J4>*CF\3'MHYJ4"(-2"1,H=
M  3F...0<LF'PUK0(P.O42I4V'<=0_@;>OUXNF8%B+6((W[QI'S]^.PTTTUL
MXIPTTTTPPTTTTPPTTTTPPTTTTPPTTTTPQC-NFJ92#M\$>V,)7<XZ%HD!1$#"
M0J1Q4QCT (9]'H'IK"+LPV7N;<3>]'B&!:7DII(P>'%\ZQSCCXS<]97[MD@6
M);A,<87J-9L8!''F*H% 1'GC'( R/IUCYV?K0K&^W:!,RXX6M^8!$!+]2($I
M0 Y>KG\8:TKDU1OT&E5]U_7V$]V-@6\W>W;8GUZU'T=WCTQ*5IIIK=QKXMPS
M [*<JEFX ARJ/VD\W @&*!D'#=-(045$ZAA4(LW$H%X$TBE#"8#DQM*M1;_.
M_5BJQ0(88Z32*8" <#"(&*AQI%'SR]X(<0" B( 8IO#7*J$?<ZI(F1Y<,Q'/
MZ=P( ('?D(I*10& QN PF%%ZDD4"@8RBH<9A*!>'IJ@*HJR%!RZ50&7E*<;
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MMN'GG2T]5]IB041=]!DLN]/52989VT>,TDQ(+1:7>(+*,TY95%!1=1@DV.Z
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M/[X6 _<XOJM_EI[?I3%B?(E_17_ZBXE)$< (^@,ZC%[0T<W V&#Z=W%-#_\
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MWV%@;@GH0#B>6324^99?/$+RPUM++&-]WCGC90;;V+  CM!QY7J_FJ<G[A[
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M2Z$;=*6(I2547#G%K;VMJVX3:B[;T49D2K*^K)[ LSLH2G80\@T*N0SEQ./
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M%MM/1,E\_5"4R99CY4ZEHBO$E'TJ^LM4"R;SOQJ6#X9.3JVQ\_&.I.G*@HZ
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MBK+.8:F0/(7?O*Z4M59^ :&S(/*MJA T:$PDF7)BM:;;O!E%UQ#NBK$:HJ&
M%LA66U^@Z1VU6#MG9P)5FO)T=3+%K4KUODX2=6N$P=U/)G4 Z@*J/)E9T852
MF$B@ 4Q"E*/"%3,.8H) "@DWMU:P !/0]OCBP;1MMNY '3HINQ/;UMV6QE9J
M,OM.FBD%0%B;R !3M;*;E+559*D-Q 4D1+SC>F9!V<P%$"I,T9 55!$Q>I0
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M*=M1NBA(ZW%W06(9-E2UV8'"=#5.^,<O"5I4!'*\>NX+PE0[PZBYQ(APA-6
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MN;_A/A_$8:#^,G_&O\<2D:^#ID4*8IR@8I@$IBCS*)1 0$!*/(0$!$! 0$!
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M]"EMJ<<(X[Y*]4PF0^.7$":B(G)GKPB(XR 9SK=#]A5P?5MUML>WJ/?C7*;
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MD$J#9))!--,M2ZA%D-]?:"QDD:(>;9]OQ'Y3"0R:=U9Y5,# ;AQWI2 7.?\
M1TUR3;X>T*)(LHE3;3MX2?R!RD:I*W;G"$,)^9>\5%/@3 0SYQL!G >G72CD
MIXHTBCTI'&JQHB@!450%50!L    .ZV*7261VD=@SR,SN[,+LS'4S$GJ23<D
M]2<38Z:BS1O#VKRZ2:R6TW;8HDJ0JB9RWOE3 <AR@8I@$$.$0$!SR''/KRY[
MOON=K!\$O;=]VV6_S.KM8[F]WJ_B,5Z#^,G_ !CX_AVXE'TU%O[[G:P^&TO;
M=\=[9;\2 \_O:T]]SM8_@E[;/NVR_P#F--8[F]WJ_B,.6?QD_P"-?X_'L.)2
M=-1;>^YVL?P2]MGW;9?_ #&M??<[6'X)>VW/]VV7QCV]QUTU@]C?\)\/XC&>
M6?QH_P#C7^/C]/<<2D:Z2H:DIZDXA[/U1.1-.P<:D=>0F)N1:148R1(43&4=
M/GJJ#9 H  CYZ@"/ZT!'44<5>+M0KEU1(4%'T#M@L[+1R93R$R\J>H*Z*U24
MX@[QNU1(JFX73 !,5(S<2<0%*H'#G5=H=GG.7;E(Z>WI;@*UW&%8*$>MK91[
M5"W-I8]^!P5*92#II9L^GTD#<1$O=-P1(Y!^F-0$1U$2:KZ%)MM<[#L[>VU[
MVV.,\L+8NZ@&QLMV8@]VUNG:3;NOBV=P+FUSVD51K60L$>HZ1VEL9$&][]P)
MFKR$/<N/:+=XI0MH7:J9#OV+UTV*VF9U$X)*-3JE-P-2@F]E8H*AZ7ME1M-4
M!1<.U@:4I*&804%%LTR$1:1\>@1N@4PD*7O5U )WKIR<.]<N#J+K"910PZY]
M.4S TC Q=-4M#QM/4_"-$V41"Q#1%C'1[1(1X&[1H@0B*28"8QA H<1SF$YQ
M,<QC#WH&,8! 2B \PR',,_B#T^/JU)5MN3=CU/8/ #L'\,1=[^BHTH#<#M)L
M!J8]K&WJ'0>.A@$QPP<0*  (@'CUZ]?2 Y'IR'J :^%BIK9261(JB(<^\*!B
MY$!# E, @/(?D'6Z "4!'J/@ ?R]>M1 #@(" AU#GR'IU^_J>(8Q]O/MGM-?
M>B:BH.MH!-:'J-KW#I9@8C5^Q=IF[UA+Q;HJ9C,Y6+=<+MBZ3P9-0HD'S%#@
M.%EH-RMP-J=3PVVG>JX5+&J.TX2RNYP4'0T-7L+WHHPL%<&;6(#2E:W9-"I,
MUUY1=-"1.W.JHJ)C$<KRI@0"E*0N<>(^SKZ<"/AJC;@6\HBZ-*RE"W"I>'K&
MDYUN=K*P<ZT*]8NDC (9$IQ!1)8N1%-RW.DX1-YR2I!ZUE+'4EE/:+6#=-C[
M.T"^)JVVEA=3[UZ;K?:]A8@['IMBJ8Z2CI=BUDXI^RDXY\D5=D_CW2#UD\0.
M&2+-7;915NX1,',JB*AR&#.##@=<W47Q-A=T['JO7>S#<W5=IJ?.N+IK9JXD
M<WN5:M!0PCQMHQ::%U4-/,A*()D2;*O2HX$42D,.=?"M;=K-2@#'*V6VMW2%
M'.*AC;@5)2 .L!U"+>(%[L3".0 03Q@<XTUD&S(P/>!<>_Q_QQDH#NKJ1W,=
M+>X[>T'OQ*)IJ(*7W/=IQ K WEMJNW=FJ.<$/>.7,)A 1#S1*00$,AU ?BTB
M=T/:7S:HH,-LNV85NG=N+VRS8XB/0H%41 1-Z@Z:QS4O:YOW=O6W?WX<IN]/
M^(>'OZ[6\<2^ZZV6AHF>8K1DY&1\Q&N  '$=*,FT@Q<  Y %VCQ)9NJ!1#)>
M-,V!YAC48X7>[6$P 8NTS;68I@ 0$+W2X@("&0$!!# @/4-:^^YVL?P2]MGW
M;9?_ #&L/RY4:.2/F1N"KHZ!D=38%65KJRD&Q4@@@D$6OC'+)_"CW[W7M]OC
M]/<<2=QT9&Q#)O&Q,>RC(YHF"32/CVJ#)BU2#.$F[1LFDW13#(X(FF4O/IG6
M.M_]JEI]PT'(1U60R$;/+MSC'5C$-&:<['R)$^"/DEA50.A+*QBH%49$D2*J
M-OII&BS?OU##B=[[G:Q_!+VV?=ME_P#,:>^YVL?P2]MGW;9?_,:U:JAH*ZDD
MH:JDBGI)8^4]/)$#$8R@0)IVT@*0%T%2OX)!%\7TTM122I-33B"5+:7215(%
MP=)%]+*=@R.&1A<,I%[=?M![-Y';Y>2LKYU14-/NZ[J5&)CG3FW["5IMA4K:
M$ Z;68JB+</G,;[KNTA(F\49M@?+MBDCG$HO'-T6X2L_>U%M[[G:Q_!+VV?=
MME_\QI[[G:Q_!+VV?=ME_P#,:JRK+:/)Z..AHEG$$2QQQ\Z6:H=8XHHX((A)
M,[N(J>!(H*>($)#!''#&JI&H"9C,1ICHJ:-=?+IZ.&GI*:+F2-+)RH(%2-.9
M-(\KV4:I'=CN3B4G346WON=K%X[2]MOCC_9ME_O_ $CEX^W6OON]K#X[2]MO
MJQ>V7'Y?YGY>W^0]+6/Q6W_HGP_B/B^*.6?QD_XU_CX_%CB4C346WON=K%\$
MO;9]VV7_ ,QK7WW.UA\-I>VWX[VRX>W_ +G]N!TUCN;L_!/;:WTC#EG\9/\
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M&-E3ZM+ED1,//H(8#^7+77IB8ICG#]8<?D$<8^/(_P"G78J  F3Z (&SZ\
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M0.0P8-PIB<A '(YS@ 'QYCGU4[0]4&K*.=N5$Q2*W="D0PA]4 &'&<@&0\W
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M3")V@F#(" " B/AGD'Q#JT4?/FIN;+(4NHY;QIE.-:.> 0!$N.92&2$Q.>1
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MZP>:HBH',HE.', R "( (B&!''77?%$"B CC "'7IUUR.'  L3 "&0P <O\
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M$@@;&!SK"2\$<[E-TL8V8VNA;P./>C(I\YT\^91K R23E3CF3.WYTVX+Q7$
M(I\8**>4'%,!P.*R1EJDHBI]OU.1=!P]DT;@5U4[:N*!II6,DV$JC&QZ(1CA
MW(-@<E4672$JH"U6252 P(G$>' ?(X?*+F"9UG\-;EL2Y)DO$B\."6ER_/GK
M)YJG-,HR>BG&934L7#=Q69Q3RU=&N9&O2DCGEBII&55;[U4^2+*WX;X7JLMS
MB5^(N(N$I.+6IZW->&(Z*EIZ+)<]S_,:<Y-3YA/QEH^I^0545%F3Y(,IEKIJ
M>GFKH@SNF6TA(Q\0Q=2DL^:1<8R2%9[(OUTVK)FB @457+E4Q4D4P,( )SF
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M2T$DR-S6RRDI.-AF#J4F)!E%1C%+OGLC(N4F;)HCQ%)WKARN8B21.,Y2\1S
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M8@7&QPTTTU=C7PTTTTPPUF':\X_./#*'/YJ)'X#D1'! >KF .HX I0Y!TQC
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MTQLMW#>02*Y9+$<HB(AWA#E$ X>? /"(@(EZY'F/CX:WS&((Y(<>(, (B
M!UYACU^WP'6>O3&>WW[>[Z/WX=V41* 9 W& &#Q* AG/I ,\LX#U:HFX=<,J
M$@U79Q*=\L04F:/$'&HJ?S2X#F8V!'(  >&JYXBA].$<$3*8RJIA$H"!0SS
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MZEJHUJ-1ENYMQ-VKIB?C+=13Y:7(UM?+04S30MWB2:RKNGFS=JP++',W.#M
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MHL)" *AP(4#&$1 H!RUVFJ^IBW<Q5D4E+QSR-2;K% P).E5BK$ 0SA0$T3E
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M(DZYBQE8ETP01*J9$R+PZI'!3% !$PE234+PCG #Q#S =5<-E*JP(E>PQA\
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M+6GHT:UAZ\8,U(&:AH26I\K>GTV,5$R4=,D53=EE6+=F4KE<I%C%17*9,Q
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M$^8U,P[)<P:"$5YCT"L6&%*D2I%&JV=U\G 1*8 ZB40#VB ZO)[R=4_7T/\
MMKG^#ZW4K+3:9%EWDE'@BBBHH4C,5UEU5"D$2$+QI$(0./ &$1,..@:[PAE/
MX#>T8\SS4_&'S_'\.W%YHJ(I^IJ>B'2[!JL52/;%,;NR\8*)HD2/DP  B/$0
M>8@(^D1'.MYK;^E6:I5DHM(3@.0$Y0.'%D>8ACED.7HS@>NK<V0G5EV#VGG:
MG$XBEERE*(AQ%(5<Q>8#YV,"'LST#GJ_&38-Q!C&1 <]<=!^]G\(:WH]#JKZ
M1>UB2.T;'L\.S&H;J;7(MXD>(]_7%(3=#TU.(^3N&:*)P*)2*-RD35)GQ#
M;(8#',.8:M))6BG(<!>4E.+$71,*J23@QSB(!D>#)CB&!P'3GUY"/3('@*J8
M#Y$#9QZN(!\>7I]'WNNMSB,0P H/%GD !CGZ_ !\>0^&LO"C[D6/XR['^_V@
MXP&(]5[V[#_"_0V]^+&4'<R8>2:M*U/&+)2S7"9G@%$J*P@..(H<(!R# Y 1
MY^H,ZO@H;A# \\E$>OAC_3KKEH2+,["0(U1(\ 0,*I2@4Y@Y?5"'/..H^//Q
M'7/4#*@"8/,,0,<_2 <O ?7[-9C5U!#MJW]$GK:W;X_OP)!Z"W2_K[>WIV_
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M$XB80P&>G@'J#^7HSJ20HC,Z]6^8=P\,1:1F4+OMV;V!(!))Z&VW\,;9AQS
M.?0/C_ &/7\>NJFY1"#@Y28=' I6+59< $P (G(0YB]1Y!D \/CQT[7SL@)1
MS@>8>SK][J B&K(;A9<&5%A'-S]VM,G,T P"(" #PE$>N0 !-R'F'MZZE(VA
M&;N&WK.P^<X1K<JI(.XO;U@^'9OWGOQ:6SC!&J:HFKKUNJD;A<.&<$@Z ! J
M13\1#)B; #D"Y#S?0'ASS78.T'S1!TVQW"Q1,GC !P@82] Y!S =1Q+S:S)I
M!T\T5,W;,VZ:S@2")>\5 ,'$V!P.1-G(AD>8B(@&-9Z6[4!6C()0#"<#-E!
MPCD1PY7#KXXQCXN?/6M3-N4%MAJ)_"+'3U]73W8MD Z^( %MM(!M;W=N*TTT
MTUN8JPTTTTPPTTTTPPTTTTPPTTTTPPTTTTPQ96\$U6]/D@)*CVWE:9'3E.50
M\W)D3(@*(X-R'!RB \N6=4O3-^6SM1*/J:-68NC"!%%,>8!P'.<%*(8#P'(
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M/JV6!%B4Y5FS#' )""8!P8@X'(E'K@,XY@/+-:/K.TH\[LH$51X"<)BHJ=V
MCRZ@3'7'0>N!ZZ@@E&\:VC.X5SO8@=.VP-^W<=^!TFUS<]I7YK]FW@+]_9BW
MEQKTLT8.090B:OT](6Z+P0X0$QAP/!D"\/CG/HQGGSK.R%+%IRBTGK@0,ZGC
M^ZCE3A'O!\HP)0.("/J' =/'P#5KKPTY#-%*1H^)1(#IR_2.J %**QT@ >:A
M@P80'J'(0#("/CK**&CP80L9& '"#5D@D(>@2$#ER\>(>?L'D/@C#M,QD()1
M=(MT!;23:W9ZQMW]V20$ 7:Y)-QW6 _P'S8[%$1 . ?J1SP#XXQXX#KC&?1U
M].K$P*"$!=N70.;NR2C)1<AA''&<3EQTSU] >GE@!U?3(G$IB<113$"CUZ!U
M ?#G\?+KJBYVC$I>I(J>*<4E&( 4YB#@5"@8!P80YB "',/1UQXW2*3H(%RC
MJ1ZKV._J_OQ $"]^A%O;M;N[<5R8"\Q+U,.1Y8SX9Z>K\.M! 0Z^W7V( )N,
MV,% ,"(ACGCG\OX?'7R F4'(#@H#R$0ZX'T=/'[WAJS&,   $.+ERR'XO3K[
MP43 /+.,AR]?7IUUJ8!$ #BQZ1QU^^&,ZTY%P(]"E')Q$  "AS'/CCEGU8YC
MIABREXC#))0-.I'P,A*) L7Q%,IB9Y=1+C/M\!U>&/:$8,&;(G(C5NDB'AR3
M(!?PA\>L#K^[F;461JI.L;DS+U=)/,31= TPQ-4%P:ZG!.5,$:6I1JIY;())
M*"4',@)4F+;C("C@#& -6D9..T@W2G))LW=*[)[12P HQ0=1H5I?EU%'-A%P
MZ0<BWB::?KI@#@J!_)5FQ3E1.1R&51UT<%Y& +$D* !>RJ+7)Z6+7[^TVL<6
MZ+JMR%&Y+-L"38V'4M86Z#PQ*QD.G/\ P3?AQC5MJVNI2M")F-,N#@J!!,5%
M,AA,8? H"!3<QSCIUU@VW[->+ER"ZN1NQW@UU-N!%1\\2O$\IB,66,/$<[:%
MBF!T61#'R;NDW)R%R!2@ !D>(Z[*:PSX>)]=3= ],'B\O?,.A^5>/4'4V,I'
MHH >\L#;V;?O]6 6+;5(;=MD/AN+G?MZVQ?N4W2L#H$7A(ITY!17NTR=T83G
M$PB!1 !( B&<#C >OERUV%JJ$FJCJUW=.M6RJ;AV0AH9JX)DZ*?$( ;A+]2!
M2@  (E+GIZ=8W)]D[M^2P*5S-S*0E')13O3*$$H^DHEC P(>&.FN]3[,:TR)
M 31OCNY23*&"D2W!5(F0H>@I"- * >H  -4B.8L#*-84W5;A0#WG<W]7KZW.
M)_<@I"N03L24)-C:XV-O7MWXD?R7BXO/SC&.$^/DX>NL6K_MEF<[1=0-T53"
M@^[DRA$S>D/-$W(0P @/3QU8C]#*M5^SKN]_Z0M3?P77#=]ES9F0 @/[S;L'
MP)CQ)@\OW4#D$S?U1 69' H^LN!U9())$*\NUR"#K!M8@WMMW;8BH13<2=A'
MR#O?UXD<8+'58,EC@8IU&R*AP,0V0XDP,("(AR'TYYZLQ6][8.GW1HB/,=S)
M@8Q#@4AA!,P#@0P)1 1Z\\\A#6*9>S&M*5/N0OCNY!'AX 2#<%4H)@3^IX :
M@7A_\'&/5KI3=E#8(ZHKGNAN=.N(B(K'O;+G5$1ZB*AHX3B(^(B.1].L-SR
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M( \.KM-^S.HE9,JE1;F-Y-221P SE\YOW,,BJK"'TPZ31C'))H)F'(D2XE.
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M>;'" @8<\\$$,!R\ 'GU ?5S\-"#PYSS 1\/#F(_'U]6/7K0Y#F. @.2!@0
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MMV[&XE:W.M#)732L_="D+I2GSTUK:NJGLO\ .:G*4[6,BH[E6S>F*F6;?/!
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M['T#3E;OJKD/(T:-J]>1:Q#ZK*6I)V8Y%Y&H+<LJHH]Q63=(%0C"U,P!<$1
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M!*?O .3.0'F.,>( (]0P'+4C&X+^@5=X,\_>SK3&>HX@'N?7[?;JFF4-'*6
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MJ(&>KIH$4(MPF4.!2B9,"FQS\1 >7KZ:^V[A"1;E=-E"*)*!YIB" @(9QGD
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MZ1R(ZRG@X"+IUFFQC&J3=(H 4133*0QQ .IA#'HZ9^_KN"@ !P@ % /J2A@
M OAR#I][0>+/(,A_VZNCB6/?JW:QW/J\!B!8GU=@'3'UIIIJW&,:#T^,OX0U
M&)V7/]#S<3_?;7F_RN,U)V/3XR_A#48G9<_T/-Q/]]M>;_*XS5;??8_T9/\
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MNT4?W]5O]\B_W[W[M.+$ORY;&VR>OY0M;Z<=D_BFE.;DFL1' #=H=,RHMT0
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M65UJ*=4JH8Q;_5EHB>4$9P--I8D"BH0R+&KKC$#<[N;VX[1;4DO-?RZA+?4
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M-]AL?4/$VZ#8XH:Q$8N=)>44(8$CD$J0F 0\W@#AP(ASY> <N>LBQ,!C" =
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MTC"I'.4CT)!)1)+("H! X\FQRP \L9Z#@<:VX&?]V]G=S2G5 ZS"VE:-U R
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MIIAAIIIIAC95,(<!"AS4'A$1Q@ \>O7V<_E$-=!,Q#>>BGD.\*!TED<)&/U
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MGBZ@?J8AW8B&.G00]8X 3<AZXY>%P1 !*8H@ @8,#GT?@^]K8CF#9FJNL0
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M]F)@Z!>]F(]P\=^MO=VC%E:-V[TG2TB215;-7:J+E-P@0R9CD*8A@$.1^0@
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M7UZS(4. >/(,_&(9\0SK#+L[N$VR+;F '#B+1+D1* @(\JCFQ$!#F(<N0YP
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M,X$ @& 0$"*IF5,!. 2YY"/35$KDQ ,!=B8UN=_1)  V(OJ5=@/PKWVOBV,
M2;,3I&LCO(TE@3UZ:MQ>Y ["<4S7'N@\I\D-%/5&<G/DAV17"*ZC==L8Z@**
M*-5B*%%-R=%N8Y4R^<HD54H%'B 0J^&DPEVU//A*9(SN-4<'15*"2A%#$3(<
MIT@,<I%"J$5 R?$84\&*(Y*.:;FT5QD*.*B0RY"3T*N*C84N,B",?(H*.')5
M29%J(J%*!BCWH'.04Q+YV?JG4U44G,:B82J4Y,/XQ$Q^Z*!DU'0/6ISI\!"!
MWK)^0HE3*'FB42G$1$=25PJEK#3K4%>\ZD<@#?<ZF).USUMV187T[[%203?M
M&D7L#M?2.\#;;%2*IX65(1+@XP7 #%   QE?*PXA#J!$S$3,82B F,J'$(9#
M-.I'[FH:47,4 %PA-PWTHRQBD%=JUE3%6(7*8*'4C5#@NY-QEXNZ3R9<1UW(
M@(G9N514.+E%<1X!-PE3!4JRZ)B";/U?F 8!X03 .HXUU$DF!#0)T4SJB-6P
M[D>$%"@B59-TR4$2D, F321\3AW8B('.!A#4$+&16 "BVJQM<:C$PN+'KT&^
MWA;;)^00;_@B_JU*0;G;Q!]0[<0]]IQ;J(J6AMX5*M9(0J*N=N4_7,33SEX[
M<DE*@M P95Y"K0\<L'D)'948>7,[:,!!^^*B5PN4Z*8'+4/947225-4-( B4
M(6ZU,4E?*G7S-1%6(<U=4=+0LK<9J@5(A3L7[L9>'F5XQ43E;CW_ ),HHB4W
M!=[M"[05]<IQ3,!1U0TQ2C"M&;N/G9Z8IX)N9:LX:+F6<U'TVX%\P)#R4]!U
M"5L#\QW >1-'Y'"!V1%RC&+V.:KZC7%E;15J^?A5E@JVW!6(?F-("!9"JZ!F
M9&WYX6423:H(2 ,Z5C&4U!NG*JSL(\2=UP-3)$+YR4RT\J/RFC7*N+DM*VDQ
MM3<4TLD,JZ%=G4"3+J<AW"(\]1$B*"EV]-$T4T<L3RK+]5.$I7Y8N)(J[A>O
MI#3.68(I)ILSK%,:"0B".1W?< >H?3337ML>1PTTTTPPTTTTPPTTTTPPTTTT
MPQH;H/L'\&HPNS" !H[<X AG_;;WH_\ ;1=2>FZ#[!_!J,3LP _UH;FQR//=
MO><,> 8FR]/;D,^S5;??(_\ ?_JC%B'[G*+=0GL](8S9O56PT-1RKU(1*NY4
M!LF8HX$.)-01'(@/40  \?5J*"K9,*DM+=J1FWOE+X]*U.HU(H83&)F-<\(%
MR;.  .H9$>NI)]SK%)W1Z1G)Q(@FL/,.G%P*#S#(!GU>CF(\AU$!52ICT5<(
MJ2ADTTJ2J3!2&'@.7W,<@ B 9+C \_Q:T*ICS@#\D 6%^^USW=2"/I!VQ? /
M1N#8E@0?41M].]NW<8D;V6)@?L_-ORPG53!A:^EY0_<I$65.2,<$>G2(4_FE
M,J5$2=X(&[H#"H ")0UD7550.@=-W:#5%1C U% .$'2;A4SOW2DFQ70MGA10
M.@C&.V$HX9IN"&.9)4J9OJW"7!:'L]4DU]D&W!!8A5$5K5PB2J9PR51-1)4A
MR&#Q*8IA*(>(".K_ %&L7<!4,Y3#IJ^<L/(V,C&2R[5,6BS9N/DB;95T4"@=
M\@0R*7=G(*@$:BIQ 3@S<8M1A874M$J%UN2+ ,H/38GM%K$#??$'<7D!%SJ)
M [+'2#V;]!UVWQV4<F9O.U+&$*</*I=M)*',4YT3-Y1@EQ"4%@$JBQ%6)TCD
M3 "()K9SD1#743-M[<S'>JR=#4F^<+OI!1VX4I^-,Y,)B +[B<)MDEU%72*9
M$UA.<QEPX4E3'*  %2.DRMZZCEQ XEDH1RD'"0!*#B-< 8#'4XL^<@_, %X0
M*'=Y 1,8>'FR(*(!(B!C"7C3<)$ I3=YWZ*B2J(B<0 .(P<0!YN/2(ZKGAA=
M9#)''((V8A)$5["RR#0&! )([!<G>^XQF.22,H8G9"54ZD8J=0.G<J0;+U[+
M#:_7%L4K86\AX<Z\;;^C&:C1HH:/;#3<67A%NW5=),OI[<X-TEG/TW@P!0XB
M8 ! #!A,W4^<:]U14]$UO3MJHJKZ.^>6;!.,@T%Y!TQ?,9J%>LE)-XW8(H+(
M+/88)86T@F9!J9!J +(F+J1V6(DA&NU#B57NB@4Y% $4D3!&*%/QE$1 B8X
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MN<?@UR")F.7) SCJ&,"'LSC/R:OQ D].EM]MNMNO>>GO]VT4HESG'/'X]?8
M(] \<:W"ICU$.F<@/7QZ@/R^.MP,!X!\G+VZ=U]O'&0M]_'IV]1^Z_=V8TP(
M  "'+&/4/+6T8N.8=/#Y-;XG$0P(!C\'L]FO@W0?8/X-9-NPWQ.UQN+'LN;^
MV^-C6\@0#J% 0SYQ?3TSSULZY+?)52"7!@$P9\.@@(!U\1#\>@ZCUC%0!ZCL
MWZVQW;L.%H&?3]X/Y9UV+#^<T/[#_P"\.NO?B -2E']<'X@_?USX\,,VX?\
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MB1(PG(8QBJ.DFQ@(42@*B:9C&P3 VE0\$UO1],Z=KE?06.]K]003;;?;KOB
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M%G+I*0RYDRE, '.8[Q(F!(H!0,*@E+P"<O-< 5=9%00(N=XX4623.8Y?YG2
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M;IMW=.AZ^-[XXVM#=!]@_@UN&*(!Q>!A''RCSUM&$,#SYXZ>//5>+0P(O[_
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M8)B.0\?#ITY<_P"0ZWBIX# \A#V?+\OKUJF XR.<XQ^#^7HUN:8R !TQH'
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MH&]M-KG&9B=0%[@"X/9Z0!)'Z1]*^U[W(OBWM-MBHM7D< HM^XFJBBR))E4
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MXO#&H*@06&Z]?5>U[VZ=?'Z#B18L;G:UK6'=8=_A?U_-Q1*8I0 1$2AD"Y\
MS_+Y.>N.?ZH?B_ &N6H42\L\@Q@/B]H_>Z^/37$/]4/Q?@#0]?=]'QW>H=,2
M_ /3:W3V=?'OQ\Z[)L.5T\>'  _X9==;KLV?ZH/J ,>KS@T4V8>NWOVQ$=&/
MJ^<_W8Y<L8N$^?@(?>-KM8[^<F_]@/\ C&UT,F.3$]6?P@'XM=]'?SDW_L!_
MQC:L'RV]7\,1^/CNQS=---3PPTTTTPPTTTTPPTTTTPPTTTTPPTTTTPQP76.^
M;@8< 83 /R<M=:=(H%<,Q4_52' AL<P 2\L<^> #(9QGF <P#7;.0#*8X 1
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MD9)BBY379,5.(0,)39*(@;'+(<Q ,@'+//6+/9;$!.W.X9,H8*GNSO(0H!T
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M.F"U9(MP&3F42F0%4HB=- Q2&XB\6<"; !D/7C5[-P1P&QMXBX$!"V=:#S]
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M-Z0QCX\ZPO4>O$>PD==[B_9M;WD_%L?+]3*HE'G@OLP(\_P\^6JCCOYR;_V
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MT0'D #C/+F//P]&!^4=:KN&C),57;E)(I2\0\1BEY /4,F#/LQ\NK,5%>1!
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M.@*TV9;?I8%56<HZHM9=1=,Q2\:I9^93+^MR( 4A<ATY>CF%YY"WMW* 7[^
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M+GS#'3&.>JY) @':2;*!U)_@.W&42]CV=23T%[>^W[\534EW6C(QF<*@>1=
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MIM*%K+>=:!XF+68IO</,5ZW:F$.(U.W CF2T>X H\Q*=W'/,B43 7B*4W";
M#6Q DC'>'_\ MQ:OWN7;?T#Z@#O?M[1O:WCB5_3335F*L-6SK-%5M4%,R"*!
MEDY('U-OA OF)$>%3=,7*R@@)4R(.6YR<0CQ&[[@(!N(0U<S5N:K46DIV(B6
MJGF0R:E2R9.\*4AA0,",0U6((>?W[CREP0>(O=^2\8Y ,#K5BZJ>11?4P 4+
M\HM<$6V.]QW6 O?%T!TRH3:US>^PL00?IV\;8^XUPJ2KH]L)$4DC4L[3P41
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M[!',8HI'CG)4D7K-#&# ,=(IJ]XF<!4*1R14QA*;(7!UM4[ZX8VVOI -A87
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MR<)B&:*R!VO?D/P]Z5,2$'ZK$93:*3:_HD6[[BW9OV]F^,)NZ]@U"Y\ ;G%
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M+/AU#5SK77!:U[ )BK])E([#>01/]6!T@*4QC!@!YCD! !$1SCTZRC,&T/\
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MHF)G3L0XE%%,#G)Q#BP CT\==?;NF&U.0B+A5/BEY$G?N7"@94,98 $Q>+P
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MD/'WR1%B?JJ21RUO3TZE-M#B8@M)1D<&TS&*&RO'/P >\2, X,HV4,4RC)T
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MB]1(HFTE*JDQ.)(U;Z8JD1!51/@04#5?;HM]K6D95S8S;)&-[V;EI1)1J,#
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MAE3 /"*B9#<0%' 9$<@(<^7/Q#5?$P"9$3AYP$X14$ $1$  ,CXX'',,AG.
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MW#$X\_R#2->=Y2NE]6^948-K#H#,+[_/[1CT@[<HY6-M73Z2Q1*HJB5<0$!
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M:E<K\S=/K&XR_-?BGL_T)FGA_LOC\_@</KBR'\J9-V?Z0IO#_:/'Y_ XN/\
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M=F]0-$ZK,[4JLJK$ZN]T'D^9*IZ',<RAAJ8Z^AHY6IP\T<)K:"OK45M42EY
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M.0# Y'H&!R/L#57T);VO;HU7%T+;2BZJN!6TV#P8:D:,@9*I:EE@CF+F3?\
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M7BRU[3?FNS^>-E_]A=?_ -W->++7]$?(1_ZL.'OT\T_\UK,?E#RH?]\LQ_\
MZ&7_ /@H,----?7\?/L=W3,^^I2I:;JJ,*W-)TM4,'4T:5VF99J:1IZ5:3#
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M>[FS.WZK:\@K>4O753(-ZAFIBH4*;D7T.WPH]IVB'KJ)FVCJX4RF8$J5BWC
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M[BW<B]OUF(*U2]WJRB)-J\1JBYTC&.GKVHWB#A%*250*9JT</&C1PL@LHU0
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M]M%O:@W(1,;![B;NVCL13] WAO7$QSI%[Y%7-9,'[@JR<BZ;IK2QXJ-C5I
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M:B]T7N%N2E9RVE8[?+D1]RZ.>W4,<A5Z#G)=JT9C3\ZR2%5XY!\B+8K!J[=
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MEAZGOC:ZC)E!NX;SE8T&@Q0,T2:D<H!*-FS]PX8'. "58#)F/$[R$ $! 0$
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M:!2D*4I"$"X\   4A  I2E+T*4   # <M2N_I:?M8 SBU%L>?7_9SM_S]O\
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M7-*(M71%P*SF*IJY\TD7C2(C9>AJZB(]VNUBVCV153<2$Q'-\-VBRA!<@<Y
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M3/)[^>?#?[6I/[7Q^GN.'UF<6?F]FWZE-_TX@,TU/G^EI>U?_8GMA]W.W_\
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$#'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>g820079.jpg
<DESCRIPTION>G820079.JPG
<TEXT>
begin 644 g820079.jpg
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M01 LI7Y(4Y6'71<D5(XE)S-Y$X#5."K+I>G3P>=PE-:V+[%!#4O58 2F.R!
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MV!,HT7/M4CZE9;-F)S;H=E'6BOVM)S J4BHPQ':CVNOGS5NH,C%/D?!5U".
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M@W7(SFXF(5>HJ1_A8DJBJ<%[B0FFU( VW)103%.B:4#(^+!@3H+!T%#%EC7
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M@ Q0,4P 8I@ 0 Q3  @/,![0'2+R:V<O<<7]FS;KNW;JDVMLU:MDCKN7+A>
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M7@VS3LK*R%[N>:<0TXLX-RG<+.,K493<,2FU:TS-QIK,)FCLLR8\9PEGF9&
MBU ;M[(NO'Q?@JR+0'ZY8P;A3*>4*5+9.P]BW(TK&PJ[".D[YCZI6^08,"2"
MS\C)D]L$1(N6K0CXQGA6R"J:)79C. ("PB?2VS71*1>L9251N]-JMQJBR\.9
M:L6JO1%AKRIHV0;+QQE(679O(U0S!=%%9D)FPBU52240ZLZ9# _:K1QQ: 1X
MDG.0R.)DA[7\FBF/EFIV88>@)+T9.6U%;M%)H2)*D(&\GX]>9W5DEFYG,DSP
M#%XO,PV#$3UY)\I#5OU)Y^T,D(?$04YJ-,/!/O'>GZB(?]69MK[%>67&SZ>K
M&/2>+S,]<=R5ZQPVAL\Y S@P5NM1M);?6H*6R;=V==LD_7+JI&A6+/7IAB,3
M'P\\^B$DW#9LBL&,V@Y8L6ZN\7K<^@:TUS#Z=9JV'\3T28/)QR9[%$=38\[V
M^8A5Q39.9B/R$]0PZPD?!S*-28NL)XYP#.<7ZYTV":13,?8YC*S0JC6*16VK
M^9<M:]4("*K4&V</I)=V]70B89HR8(K/'2BCETJFW*=PX.=98QU#&,*VI43%
M0M?3CX:,CXE@66LKP&48R;,&@.Y*S2\G(N@;-4TD0</Y)X[D'JX$ZUT^=.':
MYE'"ZJAFUE;BT5U+C9*T-BU'FI:T&0)D[2""U*SWU5;#VK$C6#B:B02379'K
M0RY%"9WO/+&[L)0;(MH_+1VYZM.33U>W9Q8$/969Z4,:8QG:M'3JQ)5&:NR3
MQUZ$26K$.*D45X\;'#)%*SS!E"M\,JRY%C;]8HNTAF'*%8GLK/ 7ML_C?'4E
MO1M5!MU_;I21)$R_BQQFYD9**5<IKQU990;60<(#$PJB /AP?@/"6)9AM9<9
M6N[3DK;JCR<O;+GC(N4FUYB1D8U^-V5C+C=+)$/I4[E1 PVV"8,@!O+JL"+%
M8/D6P;DHU4J\)2@K4-6X"(KCB0M9UX",AXYA"+'L%FF9&>.K%-6R3%0TW(2,
M@^ES'0,,D\?/'+P5EW2YSL[VAX8P]CG*F>Y+'N)\:4.10G KJ#^F42KU=ZC7
MS2CMZ:"2=0D4Q73AC/&C1V,610&0N6K=<4.M02.7=3Q')XG6\]61\7'BLYD+
M]JO6 ,>4KY2U#!5H62@@(AQ;U)9J_4)HM[<O95ZTG7-*W:\ZXC,\NJ]R"/,R
M9G3V+QE.S;W$N&M8BI+/=R=3M#8!GS$=R&"UV9KS@4XNVM6HNB&+3.P"'OT[
M/RN2K/&#+M9.Z[DXQ&^RN[#+-OL+]",SI=8*(CW&W:8A1QY5VL='1"$.Q>1E
M@<KQ,=&,UVB!#RCENAB:@Z0QAO-+=KY>9C+L#G#<5DC&.*LJ8_SW:GT90+02
MG2KC]2]F7;TE+EIC>*H@5>P!6K76F,P^C[ U825^85R3=^F;UW.)\(86IN99
MVZU#$.+ZI<I$;<:0MM;H%4@[,^--RA'LR9Y/1<2UE70R[W]ER@KNSB_=?LAW
MUJOK]8VO8@Q,PWP6[(+'%^.V5^5Q)'S"EX:4FM-[>I+RTLK"2LH>RHQA)H\C
M)PR:<1(/C/1<O(PA&#E51J4J0;V_6'QQJMF($$VB[&3:"%K*%8'9S#3CGDM3
M2Q"&62%B(BF.ECA:%\4$=.P;F,L[8'0Z("UB+7M/%+8G6I*&M+' )[\M>.G!
L#.9HHIT4SB3*PRSK83,F2.3VA[(#S !#N$ 'X=<Z-&N)<2)X-&C1HX./_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
